Zurueck zur Suche

Reporte zur Charge EN6202n

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

500Reporte angezeigt
169Todesfaelle
281Hospitalisiert
56Lebensbedrohlich
30Bleibende Schaeden
TX 85 MI 63 NY 37 WI 35 AZ 32 KY 28 PA 25 OH 19 MN 18 IL 14 OK 14 GA 8

VAERS 2723133

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
80,0
Geschlecht
F
Eingang
12.12.2023
Impfdatum
05.03.2021
Beginn
01.01.2022
Tage bis Beginn
302,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Ageusia Anosmia COVID-19 pneumonia Cough Diarrhoea Dyspnoea Fatigue Lethargy

Symptomtext

Patient presented to the ER with c/o cough and SOB. She first developed symptons on 12.23.21. Since then, she has had worsening cough, SOB, intermittent diarrhea, loss of taste and smell, fatigue and lethargy. Patient admitted to the hospital with acute hypoxemic respiratory failure secondary to Covid-19 pneumonia. Patient was treated with Decadron IV, vitamin supplements. Patient was not a candidate for Remdesivir as she was outside of the window. Patient was discharged home on home o2.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2718363

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
62,0
Geschlecht
F
Eingang
28.11.2023
Impfdatum
01.03.2021
Beginn
22.12.2021
Tage bis Beginn
296,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute kidney injury Acute respiratory distress syndrome Acute respiratory failure Brain injury COVID-19 Cardiomyopathy Cough Cytokine storm Dyspnoea Endotracheal intubation Haemofiltration Hypoxia Imaging procedure abnormal Ischaemic hepatitis Liver injury Myocarditis Renal tubular necrosis SARS-CoV-2 sepsis

Symptomtext

Patient is a 63 y.o. female who presented with cough, shortness of breath as well as fevers and triggered severe sepsis with a severe cytokine release storm. Patient had a positive Covid 19 test prior to admission. She was hypoxic on presentation and placed on a non-rebreather. She was started empirically on Rocephin and azithromycin along with Decadron, Singulair and Lovenox. Unfortunately, patient continued to worsen and was subsequently intubated for acute hypoxic respiratory failure. She was treated with Veletri and is immunocompromised given a history of rheumatoid arthritis involving multiple sites. Patient developed acute liver injury and had to come off of the remdesevir. The acute liver injury was felt secondary to shock liver. She also developed acute kidney injury with acute tubular necrosis from the Covid sepsis. She was seen by Nephrology and initiated on CRRT. She was on dobutamine which was weaned. Patient had cardiomyopathy, felt secondary to Covid 19 myocarditis. Patient was not responding to stimulation and cutting back on her sedation. Brain imaging was done which showed anoxic type injury. Patient underwent a tracheostomy 01/07/2022 for her ongoing ARDS. Patient will be transferred to LTAC.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
28,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2716092

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
90,0
Geschlecht
M
Eingang
21.11.2023
Impfdatum
26.02.2021
Beginn
17.01.2022
Tage bis Beginn
325,0
Dosis
2
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure COVID-19 Dyspnoea Pneumonia Positive airway pressure therapy Procalcitonin increased

Symptomtext

Patient presented to hospital with a chief complaint of Shortness Of Breath (EMS patient on NRB 15LPM with shortness of breath from home, recently hospitalized for pnumonia) and was admitted for COVID-19. Patient was diagnosed with acute hypoxic respiratory failure secondary to Covid. Procalcitonin elevated- started on cefepime and vancomycin - as well as Zithromax for atypical coverage. Was initially on high-flow nasal cannula and bilevel positive airway pressure p.r.n. - now on nasal cannula. She is out of the window for remdesivir. Patient returned to home with resumption of home health services.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
7,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2672977

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
66,0
Geschlecht
M
Eingang
17.08.2023
Impfdatum
03.03.2021
Beginn
05.01.2022
Tage bis Beginn
308,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure COVID-19 COVID-19 pneumonia Dyspnoea SARS-CoV-2 test positive

Symptomtext

Admitted with shortness of breath for 7 days and identified to have covid 19 . Testing for COVID19 is POSITIVE. Acute hypoxic respiratory failure due to COVID-19 pneumonia POA. remdesivir ordered , dexamethasone.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
13,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2672370

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
87,0
Geschlecht
M
Eingang
16.08.2023
Impfdatum
25.02.2021
Beginn
19.12.2021
Tage bis Beginn
297,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Breakthrough COVID-19 Death SARS-CoV-2 test

Symptomtext

Breakthrough case admission/ patient expired after 2 vaccines Pfizer 1/28/21 lot# EL9265; Pfizer 2/25/21 lot# EN6202

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2671145

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
79,0
Geschlecht
M
Eingang
15.08.2023
Impfdatum
02.03.2021
Beginn
12.01.2022
Tage bis Beginn
316,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 pneumonia Death Dyspnoea Immunoglobulin therapy Mental status changes SARS-CoV-2 test positive

Symptomtext

Presented to the hospital with complaints of altered mental status and shortness of breath. COVID-19+ w/pna; tx w/remdesivir, abx, Vit C, steroids, O2, IGG, zinc, O2; did not improve w/ tx; DNR status confirmed w/comfort care & pt expired.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2670369

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AZ
Alter
67,0
Geschlecht
F
Eingang
12.08.2023
Impfdatum
08.02.2021
Beginn
02.01.2023
Tage bis Beginn
693,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Angiogram cerebral Carotid artery thrombosis Cerebral infarction Cerebrovascular accident Computerised tomogram head abnormal Echocardiogram Facial paralysis Headache Hemiparesis Laboratory test Magnetic resonance imaging head Migraine Subarachnoid haemorrhage Swallow study

Symptomtext

12-24-22 was having migraine that got worse of the past 2 days with headache in right occipital region. Had a stroke early morning 1-2-23. In ED at 0817 with left-sided weakness, left face droop. Noncontrast CT of head - SAH blood on CT. Primary diagnosis of stroke. Facial palsy, subacute right MCA infart secondary to right carotid thrombus with extension to R M1. Hospitalized from 1-2-23 to 1-18-23. Discharged to acute rehab, then skilled nursing, then assisted living. No evidence of atrial arrhythmia during hospitalization. Hospitalized at a local Clinic Hospital.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
4 CT scans, MRI Brain, IR cerebral artery angiogram, echo transthoracic, swallow function. Standard hospital lab tests done. Summary - R MCA infarct involving opercular cortex and i
Aktuelle Erkrankungen
n/a
Vorgeschichte
hypothyroidism
Andere Medikamente
D3, CoQ10, fish oil, B complex, spirulina, WPThyroid
Allergien
shellfish
Vorherige Impfungen
-

VAERS 2657982

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
SC
Alter
74,0
Geschlecht
F
Eingang
19.07.2023
Impfdatum
27.02.2021
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fear of death

Symptomtext

fear of death; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 75-year-old female patient received BNT162b2 (BNT162B2), on 27Feb2021 as dose 2, single (Lot number: EN6202) at the age of 74 years for covid-19 immunisation. The patient's relevant medical history included: "I have had a serious accident" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot number: EN9581), administration date: 05Feb2021, when the patient was 74-year-old, for Covid-19 immunization, reaction(s): "Fear of death". The following information was reported: FEAR OF DEATH (non-serious) with onset 2021, outcome "unknown". Additional Information: It was reported that the patient was vegan and practiced yoga for 50 plus year doing fine even though she had a serious accident. She overcame all of that and reported that 3 shots took all of that away. She reported that it was never listed that the underline diseases or effects of covid shots caused her fear of death and job loss and reported that she accepted the poison.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300146105 Same patient, different dose/event;US-PFIZER INC-PV202300123302 same reporter/patient/product, different dose/event;

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fear of death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Accident
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2653120

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
79,0
Geschlecht
F
Eingang
06.07.2023
Impfdatum
02.03.2021
Beginn
17.01.2022
Tage bis Beginn
321,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Atrial fibrillation COVID-19 COVID-19 pneumonia Cough Death Dyspnoea Hypoxia Renal impairment SARS-CoV-2 test positive Vomiting

Symptomtext

Presented to ED w/chief c/o vomiting; tested COVID positive 4 days prior to arrival w/ symptoms of cough, hypoxia, SOB; admitted for PNA d/t COVID-19; tx w/abx, remdesivir, ascorbic acid, steroids, zinc; pt remained in afib despite being on IV cardizem t/o stay w/worsening kidney function; pt made DNR d/t poor prognosis and expired 1/19.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2626575

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
70,0
Geschlecht
M
Eingang
04.05.2023
Impfdatum
07.03.2021
Beginn
21.08.2021
Tage bis Beginn
167,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Chronic kidney disease Glomerular filtration rate decreased Pulmonary embolism

Symptomtext

ACUTE PULMONARY EMBOLISM 9/29/2021 CKD STAGE 3A (GFR 45-59)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2621578

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
74,0
Geschlecht
M
Eingang
26.04.2023
Impfdatum
24.02.2021
Beginn
27.07.2021
Tage bis Beginn
153,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Arthritis Pulmonary embolism

Symptomtext

I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 7/30/2021 ARTHRITIS OF RIGHT KNEE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2616034

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
71,0
Geschlecht
M
Eingang
17.04.2023
Impfdatum
17.11.2022
Beginn
11.04.2023
Tage bis Beginn
145,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute myocardial infarction Brain natriuretic peptide increased COVID-19 Catheterisation cardiac abnormal Chest pain Coronary angioplasty Coronary arterial stent insertion Coronary artery disease Coronary artery occlusion Cough Echocardiogram abnormal Ejection fraction decreased Electrocardiogram abnormal Hyperhidrosis Left ventricular dysfunction Left ventricular end-diastolic pressure increased Malaise Pain in extremity

Symptomtext

Heart Cath 4/11/2023, Dr 1. Coronary artery disease as follows: 100% distal right coronary artery culprit lesion, 70% mid LAD, 70-80% distal LAD, 50% mid circumflex artery, 50-60% mid 1st obtuse marginal branch. 2. Successful PTCA stent mid right coronary artery with a 3.55 x 18 mm drug-eluting stent, successful PTCA stent distal right coronary artery/PDA with a 3 mm x 38 mm drug-eluting stent. 3. Mild LV dysfunction with ejection fraction of 45-50% with severe inferior apical hypokinesis. 4. No significant mitral regurgitation. 5. No aortic stenosis. 6. Mildly elevated left ventricular end-diastolic pressure of 20 mmHg. Echo 4/11/2023 1. Left Ventricle: Left ventricle cavity appears normal. Wall thickness is normal. Systolic function is mildly decreased with an ejection fraction of 50 - 55%. Regional wall motion abnormalities present. Inferior wall hypokinesia There is no diastolic dysfunction. Hospital Course: Patient is a 71 year-old Male who presented via EMS due to complaints of crushing chest pain, Left arm pain, and diaphoresis that started at 4/11 at 800 when he was raking the leaves. EKG in field significant for STEMI in inferior posterior aspect. In the ED, Vitals : 97.2F, 56 HR, 18 RR, 121/76, 97% RA, Labs significant for Trope 2120-- >2823, BNP 389 and positive Covid-19 test. Patient admitted to cardiology team with emergent heart-cath. Heart cath performed by Dr showed complete RCA occlusion requiring 2x DES, notable 70% occlusion of mid LAD and 70-80% distal LAD, 50% mid circumflex and 0-60% obtuse marginal artery. Echocardiogram obtained showed EF of 50-55% with regional wall motion abnormalities, inferior wall hypokinesis with history of diastolic dysfunction. Patient was initiated on DAPT: ASA and Prasugrel, Lisinopril, and Metoprolol. Patients COVID symptoms remained stable with no significant symptomatology besides occasional cough. Pts hospital course not complicated and patient was discharged with instructions to follow-up with pcp, Cardiology while obtaining stress test and referral for cardiac rehab.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
3,0
Labordaten
Positive COVID PCR 4/11/23
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2610753

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
75,0
Geschlecht
F
Eingang
06.04.2023
Impfdatum
27.02.2021
Beginn
20.08.2021
Tage bis Beginn
174,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Cardiac failure acute Chronic kidney disease Glomerular filtration rate Left ventricular failure Respiratory failure

Symptomtext

ACUTE RESPIRATORY FAILURE 9/10/2021 DIASTOLIC HEART FAILURE, ACUTE ON CHRONIC ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 9/10/2021 DIASTOLIC HEART FAILURE, ACUTE ON CHRONIC ACUTE RESPIRATORY FAILURE 9/10/2021 CKD STAGE 3 (GFR 30-59), UNSPECIFIED. ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 9/10/2021 CKD STAGE 3 (GFR 30-59), UNSPECIFIED.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2609979

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
76,0
Geschlecht
M
Eingang
05.04.2023
Impfdatum
25.02.2021
Beginn
06.05.2021
Tage bis Beginn
70,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Cardiac assistance device user Cardiac failure congestive Cardiogenic shock Obstructive sleep apnoea syndrome

Symptomtext

G47.33 OBSTRUCTIVE SLEEP APNEA 11/11/2021 PRESENCE OF CARDIAC DEFIBRILLATOR J96.00 ACUTE RESPIRATORY FAILURE 5/6/2021 PRESENCE OF CARDIAC DEFIBRILLATOR R57.0 CARDIOGENIC SHOCK 11/6/2021 PRESENCE OF CARDIAC DEFIBRILLATOR G47.33 OBSTRUCTIVE SLEEP APNEA 11/11/2021 ACUTE RESPIRATORY FAILURE J96.00 ACUTE RESPIRATORY FAILURE 5/6/2021 ACUTE RESPIRATORY FAILURE R57.0 CARDIOGENIC SHOCK 11/6/2021 ACUTE RESPIRATORY FAILURE G47.33 OBSTRUCTIVE SLEEP APNEA 11/11/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED CHF, STAGE D J96.00 ACUTE RESPIRATORY FAILURE 5/6/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED CHF, STAGE D R57.0 CARDIOGENIC SHOCK 11/6/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED CHF, STAGE D G47.33 OBSTRUCTIVE SLEEP APNEA 11/11/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 5/6/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED R57.0 CARDIOGENIC SHOCK 11/6/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED G47.33 OBSTRUCTIVE SLEEP APNEA 11/11/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 5/6/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED R57.0 CARDIOGENIC SHOCK 11/6/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED G47.33 OBSTRUCTIVE SLEEP APNEA 11/11/2021 CARDIOGENIC SHOCK J96.00 ACUTE RESPIRATORY FAILURE 5/6/2021 CARDIOGENIC SHOCK R57.0 CARDIOGENIC SHOCK 11/6/2021 CARDIOGENIC SHOCK G47.33 OBSTRUCTIVE SLEEP APNEA 11/11/2021 PALLIATIVE CARE J96.00 ACUTE RESPIRATORY FAILURE 5/6/2021 PALLIATIVE CARE R57.0 CARDIOGENIC SHOCK 11/6/2021 PALLIATIVE CARE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2603729

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
73,0
Geschlecht
M
Eingang
25.03.2023
Impfdatum
26.03.2021
Beginn
20.03.2023
Tage bis Beginn
724,0
Dosis
1
Route/Site
SC / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Death

Symptomtext

Death.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Successfully treated for lymphoma
Vorgeschichte
unknown
Andere Medikamente
None
Allergien
Penicillins
Vorherige Impfungen
-

VAERS 2599573

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
78,0
Geschlecht
F
Eingang
20.03.2023
Impfdatum
18.10.2022
Beginn
20.01.2023
Tage bis Beginn
94,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute kidney injury Acute respiratory failure Asthenia Blood creatinine increased Blood urea increased COVID-19 Chest X-ray normal Cough Glomerular filtration rate decreased Headache Lethargy Renal impairment SARS-CoV-2 test positive

Symptomtext

1/20/2023-Presents to ED, was seen at PCP (1/18- started on PO doxy and Paxlovid), Covid + test. C/O weakness, lethargy, cough and headache. Afebrile, HR-40. Spo2 100% RA. CXR- no evidence of acute cardiopulmonary disease. Admit acute hypoxic resp failure s/t Covid. AKI eGFR 27-hold remdesivir. Start Decadron, IV doxy and ceftriaxone. Start Combivent . Will consider remdesivir if renal function improves BUN/ Creatnine 44/1.9. On 3L Spo2 now 94%. 1/23/2023-Cont. V decadron, doxy and ceftriaxone. Start remdesivir, eGFR >60. Spo2 93% in RA. 1/30/2023-Covid downgrade awaiting d/c to snf. 2/1/2023-Finished IV antibiotics, continue decadron taper. D/c to sub acute rehab.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
12,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, Parkinsons, Fibromyalgia
Andere Medikamente
-
Allergien
Cephalosporins, PCN, Pipercillin-tazobactam and tazobactam
Vorherige Impfungen
-

VAERS 2591909

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
90,0
Geschlecht
M
Eingang
06.03.2023
Impfdatum
01.03.2023
Beginn
03.03.2023
Tage bis Beginn
2,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Asymptomatic COVID-19 Cerebral ischaemia Cerebrovascular accident Hypoperfusion Ischaemic cerebral infarction SARS-CoV-2 test positive

Symptomtext

Pt admitted on 3/2 due to ischemic CVA due to global hypoperfusion and watershed infarction. He was tested for COVID on 3/3 due to nursing home placement and was found to be COVID positive. Pt is asymptomatic.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2575939

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
66,0
Geschlecht
F
Eingang
04.02.2023
Impfdatum
08.03.2021
Beginn
13.03.2022
Tage bis Beginn
370,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 pneumonia Death Pneumonia bacterial SARS-CoV-2 test Septic shock

Symptomtext

CAUSE OF DEATH ON DEATH CERTIFICATE LISTED AS: ACUTE HYPOXIC RESPIRATORY FAILURE, SEPTIC SHOCK, BACTERIAL PNEUMONIA, COVID-19 PNEUMONIA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
COVID-19 PCR TEST COLLECTED ON 1/13/2022
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
DIABETES; KIDNEY TRANSPLANT; END STAGE RENAL DISEASE;
Andere Medikamente
UNKNOWN
Allergien
UNKNOWN
Vorherige Impfungen
-

VAERS 2574357

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
88,0
Geschlecht
F
Eingang
02.02.2023
Impfdatum
02.03.2021
Beginn
18.12.2022
Tage bis Beginn
656,0
Dosis
UNK
Route/Site
SYR / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Computerised tomogram neck Death Ischaemic stroke SARS-CoV-2 test positive Vascular occlusion

Symptomtext

TESTED + FOR COVID ON 12-14-2022 AND WAS ADMITTED ON 12-7-22 FOR ACUTE ISCHEMIC STROKE AND DECEASED 12-18-22. PRESENTED TO ER OUTSIDE WINDOW FOR TPA. HAD LARGE VESSEL OCCLUSION PER CT OF NECK.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CVA ,HTN ,HYPERLIPIDEMIA, PHYSICAL DEBILITY , DEMENTIA AFIB
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2568641

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
90,0
Geschlecht
F
Eingang
26.01.2023
Impfdatum
30.11.2021
Beginn
19.11.2022
Tage bis Beginn
354,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure COVID-19 COVID-19 pneumonia Cough Hypoxia SARS-CoV-2 test positive

Symptomtext

Patient with history of CKD, diabetes, and lung adenocarcinoma with metastasis to bone. She was seen in the ED on 11/19/22 for evaluation of a cough for the past several months, however the day prior, her cough began to worsen. COVID-19 PCR test was done that day which was positive. To note, the patient also recently had COVID-19 in September 2022. Ultimately, patient was admitted 11/19/22 - 11/25/22. Discharge diagnosis included acute hypoxic respiratory failure secondary to COVID-19 pneumonia and COVID-19 pneumonia with superimposed pneumonia. During admission, she developed hypoxia and required supplemental oxygen, however her respiratory status improved. At discharge, she was on room air.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2561493

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6202

kritisch
Staat
WI
Alter
80,0
Geschlecht
M
Eingang
17.01.2023
Impfdatum
03.01.2022
Beginn
01.03.2022
Tage bis Beginn
57,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cerebrovascular accident

Symptomtext

After receiving 2 (two) of the Pfizer shots in early 2022 I had a slight stroke (vision was and still is affected) in March. Do you want this recorded? And what if anything should I now do?

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
Too many to list.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2543545

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
80,0
Geschlecht
M
Eingang
27.12.2022
Impfdatum
18.07.2022
Beginn
25.12.2022
Tage bis Beginn
160,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute myocardial infarction Asthenia Atrial fibrillation COVID-19 Confusional state Cough Fatigue Gait disturbance SARS-CoV-2 test positive

Symptomtext

Pt has a history of hypertension and hemorrhagic stroke with mild residual expressive aphasia. He presents with generalized weakness, gait unsteadiness, and confusion for one week. He has increased fatigue and a nonproductive cough. Pt is admitted with new onset Afib, NSTEMI, and is found to be COVID positive.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2528880

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
83,0
Geschlecht
M
Eingang
12.12.2022
Impfdatum
18.03.2021
Beginn
27.05.2022
Tage bis Beginn
435,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Acute respiratory failure COVID-19 Cardiac failure congestive Chronic obstructive pulmonary disease Death Pulmonary hypertension SARS-CoV-2 test positive

Symptomtext

PFIZER COVID VACCINE #3 GIVEN 9/7/2021, LOT #FF2589; requested medical records from Clinic Hospital, was only send records of death; pt admitted to hospital on 7/1/22 and dc'd due to death on 7/1/22; pt had a positive COVID test 5/27/22 at Clinic; COD on death records show CHF, COPD, ARF with hypoxia, pulmonary HTN; no other information

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2517408

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6202

kritisch
Staat
TX
Alter
54,0
Geschlecht
F
Eingang
26.11.2022
Impfdatum
04.03.2021
Beginn
01.04.2021
Tage bis Beginn
28,0
Dosis
2
Route/Site
SYR / RA
Tod: ja Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death Myocardial infarction

Symptomtext

Heart attack/death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Diabetes
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2500470

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
95,0
Geschlecht
F
Eingang
07.11.2022
Impfdatum
23.10.2022
Beginn
29.10.2022
Tage bis Beginn
6,0
Dosis
2
Route/Site
IM / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Blood gases abnormal COVID-19 Cardiac arrest Death Dyspnoea Hypoxia Inappropriate schedule of product administration Metabolic acidosis Oxygen saturation decreased Sinus bradycardia

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization/Death. Patient received Pfizer-BioNTech on 2/02/21, 3/02/2021 and 10/05/21. Pt received Pfizer- BioNTech Bivalent on 10/23/22. Pt presented to ED on 10/29/22 with SOB and hypoxia. Pt had been diagnosed with COVID-19 4 days prior to admission and was taking paxlovid. Pt was chronically on 2L of home O2. In ED pt had shorter O2 saturation and was placed on non-rebreather at 15L then deescalated to 6L. ABG showed severe metabolic acidosis. Pt had an event with sinus bradycardia and evetually systole. Pt expired on 10/29/22. Pt treated with remdesivir and decadron.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
paroxysmal afib, HTN, cancer, CHF
Andere Medikamente
amiodarone, apixaban, calcium carbonate, dorzolamide, furosemide, metoprolol succinate, omeprazole, potassium chloride, timolol,
Allergien
aspirin, codeine, neomycin
Vorherige Impfungen
-

VAERS 2470738

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
71,0
Geschlecht
F
Eingang
06.10.2022
Impfdatum
10.03.2021
Beginn
24.02.2022
Tage bis Beginn
351,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient had a positive COVID test on 1/6/2022 and expired on 2/24/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2469974

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
94,0
Geschlecht
F
Eingang
05.10.2022
Impfdatum
29.09.2021
Beginn
13.02.2022
Tage bis Beginn
137,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient had a positive COVID test on 1/31/2022 and passed away on 2/13/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2465588

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
71,0
Geschlecht
F
Eingang
30.09.2022
Impfdatum
22.03.2021
Beginn
19.09.2022
Tage bis Beginn
546,0
Dosis
1
Route/Site
IM / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram thorax abnormal Death Effusion Haemochromatosis Inappropriate schedule of product administration Lung opacity Malaise Pneumonia Pulmonary necrosis Radiotherapy SARS-CoV-2 test positive Superinfection

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization/Death. Rec'd Pfizer BioNTech vaccine on 2/24/21 and 3/22/21. Presented to ED after being discharged 48 hrs prior for COVID PNA. Admitted for c/o worsening malaise and weakness with acute hypoxemic respiratory failure 2/2 superimposed PNA. Developed a completely opacified L hemithorax on CXR and on CT noticed to have a large effusion and/or necrotic lung post radiation, possibly a developing abscess. Transitioned to comfort care; expired 9/19/22. Tx'd w/zosyn, methylprednisolone, doxycycline, and ceftriaxone.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
4,0
Labordaten
covid + 9/3/22, 9/13/22/ and 9/15/22. This sample was analyzed using the LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
Aktuelle Erkrankungen
COVID PNA
Vorgeschichte
Lung cancer
Andere Medikamente
lidocaine, tylenol, apixaban, vitamin D2, famotidine, HC/APAP; methylprednisolone
Allergien
Meperidine, amoxicillin, ibuprofen, nsaid
Vorherige Impfungen
-

VAERS 2465585

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
65,0
Geschlecht
F
Eingang
30.09.2022
Impfdatum
27.10.2021
Beginn
22.09.2022
Tage bis Beginn
330,0
Dosis
2
Route/Site
IM / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Atrial fibrillation Blood lactic acid COVID-19 Computerised tomogram head normal Death Hypophagia Hypoxia Mental status changes SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization/Death. Rec'd Pfizer BioNTech vaccine on 2/9/2021, 3/2/21 and 10/27/21. Presented to ED from rehab yesterday w/AMS and decreased PO intake. Prior admission to rehab after being hospitalized and tx'd for COVID, discharged 9/8/22. COVID + this admission as well. She was hypoxic on arrival to ED and placed on supplemental O2. Head CT negative for acute process. Lactate was 4.0. Admitted to the medical floor and started on decadron and Zosyn. That evening she went into Afib RVR. Transitioned to comfort care and expired on 9/22/22. Tx'd with cefepime, decadron, vancomycin, metronidazole, and zosyn.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
10,0
Labordaten
covid + 9/3/22, 9/13/22/ and 9/15/22. This sample was analyzed using the Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
Aktuelle Erkrankungen
-
Vorgeschichte
Dementia, Parkinson's, DM, HTN, and HLD
Andere Medikamente
tylenol, carbidopa/levodopa, vitamin d3, cranberry/vit C, dexamethasone, divalproex, donepezil, memantine, metoprolol succinate, multivitamin, omega 3, pantoprazole, pioglitazone, psyllium husk, rosuvastatin, venlafaxine
Allergien
codeine, iodine
Vorherige Impfungen
-

VAERS 2449985

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
78,0
Geschlecht
F
Eingang
17.09.2022
Impfdatum
23.02.2021
Beginn
01.03.2022
Tage bis Beginn
371,0
Dosis
1
Route/Site
SYR / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cerebrovascular accident Death Dementia Gait disturbance Laboratory test abnormal Magnetic resonance imaging Thrombosis Wheelchair user

Symptomtext

I am writing this report for my mother who is now dead due to these shots. Prior to these shots she was in good health. Right after her first shot she started showing signs of dementia. Not long after she had some tests done which showed she had multiple small strokes. She was having trouble walking and needed a wheelchair. She had more tests done and it was found she was full of blood clots. We had a procedure done to stop one of the big clots in her leg but she died two days later. I looked up her batch numbers on a website and found that all of her lot numbers were a part of bad batches with multiple deaths and injuries. I believe Pfizer murdered my mother.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
I cannot remember what all tests she had, but I know she had at least one MRI. One of the hospitals is refusing to give me her records even of though I had MPOA prior to her death.
Aktuelle Erkrankungen
none
Vorgeschichte
She was dealing with some depression from the loss of her husband, but other than that, none that we know of.
Andere Medikamente
Aspirin, Bupropion HCL
Allergien
none
Vorherige Impfungen
-

VAERS 2442760

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
80,0
Geschlecht
F
Eingang
13.09.2022
Impfdatum
08.10.2021
Beginn
07.09.2022
Tage bis Beginn
334,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute myocardial infarction Asthenia COVID-19 Cachexia Death General physical health deterioration Pallor Pneumonia Respiratory failure SARS-CoV-2 test positive

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization/Death. Patient received Pfizer-BioNTech on 3/1/21, 3/22/21 and 10/8/21. Presented to ED c/o generalized weakness progressing over the past 6 days. Pale, ill appearing, and cachectic, admitted for respiratory failure related to PNA, nstemi, and covid 19. Cont'd to worsen, transiitioned to comfort care. Expired 09/07/22. Pt treated with cefepime, and decadron.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
7,0
Labordaten
COVID+ 8/31/22 - This sample was analyzed using the Biofire Torch system using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
Aktuelle Erkrankungen
-
Vorgeschichte
GERD
Andere Medikamente
vitamin d3, clobetasol, estradiol
Allergien
Penicillins
Vorherige Impfungen
-

VAERS 2427515

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
88,0
Geschlecht
F
Eingang
02.09.2022
Impfdatum
03.10.2021
Beginn
29.07.2022
Tage bis Beginn
299,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure Asthenia COVID-19 Cough Dyspnoea SARS-CoV-2 test positive

Symptomtext

Patient with 3 COVID vaccinations who admitted with complications from COVID. Provider d/c note: "89 YO female with a PMHx of ITP, HLD, ILD, essential tremor, CAD, osteopenia, colon cancer s/p colectomy who presented with dry cough, SOB, and generalized weakness. Pt was suspected to have acute hypoxic respiratory failure 2/2 ILD and was started on prednisone 40 mg daily. Pt's oxygenation and dyspnea improved with prednisone and we were able to get her off of oxygen briefly on 8/2. However, she started requiring it again on 8/3 up to 5L NC, which we were able to wean to 2L NC before discharge. Plan to taper her off of prednisone after discharge. Of note, Pt tested positive for COVID-19 in June 2022. She was treated with steroid and paxlovid at that time. Pt given COVID-19 2nd booster on the day of discharge. Pt discharged in stable condition. Recommend weaning off oxygen as tolerated. "

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
7,0
Labordaten
COVID detected PCR on 07/29/22.
Aktuelle Erkrankungen
-
Vorgeschichte
CAD (coronary artery disease) Hyperlipidemia Osteopenia Anxiety Pulmonary fibrosis (HCC) Personal history of colon cancer Chronic interstitial lung disease (*) Primary hypertension
Andere Medikamente
-
Allergien
Heparin
Vorherige Impfungen
-

VAERS 2422892

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
37,0
Geschlecht
F
Eingang
29.08.2022
Impfdatum
28.03.2021
Beginn
26.08.2022
Tage bis Beginn
516,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute kidney injury Acute respiratory distress syndrome Acute respiratory failure Aspartate aminotransferase increased Biopsy liver Blood alkaline phosphatase increased Blood bilirubin increased COVID-19 pneumonia Caesarean section Cardiac arrest Chest X-ray abnormal Condition aggravated Death Disseminated intravascular coagulation Endotracheal intubation Foetal death General physical health deterioration Haematocrit decreased

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA Rec'd Pfizer-BioNTech COVID Vaccine on 3/3/21 and 3/28/21. Admitted 8/12/22 @ 37wk gestation for tx of sickle cell pain crisis w/IVF and pain relief. ED labs - Tbili 3.2, Alk phos 172, AST 80, Hgb 11.2, Hematocrit 31.1, SARS-CoV-2 detected, CXR revealing Increased interstitial markings bilaterally. 8/13/22 clinical course c/b nonreassuring FHR strip, acute mental status changese and hypoxia. Underwent Cesarean 2/2 IUFD, DIC/abruption noted. Rec'd 4u pRBC, u1 FFP, 1u Plts. Transferred to ICU intubated. POD #1 c/b resp failure & liver shock. Postop course c/b worsening resp status w/sickle cell crisis, acute hypox resp fail. severe Covid PNA, asp PNA, AKI, leukocytosis, transaminitis, reactive hyperglycemia and thrombocytopenia. Pulmonary status cont to decline; VV ecmo started w/improvement in sats. Severe ARDS w/refractory hypoxia present; trach place 8/23/22. 8/25/22 PEA arrest c/b multiorgan failure. On 8/25/22 overall condition determined to be terminal and irreversible. Status changed to DNAR and transitioned to comfort care. Tx'd w/decadron, , zosyn,cefepime, clindamycin, azithroycin, flagyl and remdesivir. Expired 8/26/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
14,0
Labordaten
covid + 8/13/22 ;This sample was analyzed using the Cepheid GeneXpert platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
Aktuelle Erkrankungen
-
Vorgeschichte
Sickle cells anemia, protein s deficiency, 37 weeks gestation, heart murmur
Andere Medikamente
enoxaparin, folic acid, hydrocodone-acetaminophen, ibuprofen, Vitamin D3
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2420071

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
90,0
Geschlecht
M
Eingang
25.08.2022
Impfdatum
05.03.2021
Beginn
01.11.2021
Tage bis Beginn
241,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Atrial fibrillation COVID-19 Confusional state Death Dyspnoea Hypophagia Malaise Multiple organ dysfunction syndrome Myalgia SARS-CoV-2 test positive

Symptomtext

pt to hospital with SOB, malaise, poor oral intake, myalgias x 3 days; positive test for COVID in hospital; Decadron; worsening confusion; AF with RVR, treated with medication; multiorgan failure; DNR; pt passed away in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
8,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CKD, prostate CA
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2413416

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
74,0
Geschlecht
F
Eingang
17.08.2022
Impfdatum
04.03.2021
Beginn
01.01.2022
Tage bis Beginn
303,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Blood gases COVID-19 Chest X-ray abnormal Death Dyspnoea Fatigue PO2 decreased Positive airway pressure therapy

Symptomtext

PFIZER COVID VACCINE #3 GIVEN 10/14/21, LOT #FH8020; 1/29 - 2/7/22 pt hospitalized with COVID; was on supplemental O2; dc'd to home on RA with 10 day supply of Omnicef and Dexamethasone; 2/9/22 back to hospital with increasing SOB and fatigue; home health nurse encouraged pt to come to ED if SOB worsened; O2 supplementation; PO2 45 on RA, ABG; CXR worse when compared to the ones done on 2/1 and 2/5/22; givO2 needs continued to increase requiring Vapotherm and eventually BiPAP; family chose comfort care for pt since she was not improving; pt expired in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
16,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Mantle Cell Lymphoma
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2407104

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
75,0
Geschlecht
M
Eingang
10.08.2022
Impfdatum
25.02.2021
Beginn
04.08.2022
Tage bis Beginn
525,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Atrial fibrillation Death Endotracheal intubation Gastrointestinal tube insertion Hypercalcaemia Hypotension Mechanical ventilation Positive airway pressure therapy Pyrexia SARS-CoV-2 test

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA Rec'd Pfizer-BioNTech COVID-19 Vaccine on 2/4/2021 and 2/25/2021. Transferred arrived with worsening hypercalcemia and acute hypoxic resp fail requiring BiPAP. Intubated and NG tube placed. Failed weaning trials. Had an A-fib with RVR event and hypotension. Transitioned to DNR/COT on 7/28. Continued on full vent support and became febrile. Pt expired 8/4/2022. Tx'd w/cefepime, vancomycin, meropenem, metronidazole, and dexamethasone.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
20,0
Labordaten
7/21/22 - This sample was analyzed using the assay platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology. 8/3/22 - This sample was analyzed using the assay platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
Aktuelle Erkrankungen
-
Vorgeschichte
Atrial fibrillation, Cellulitis, DIabetes mellitus, Hypertension, urinary frequency
Andere Medikamente
Vitamin D3, Coenzyme Q10, Vitamin B12, Diltiazem, Esomeprazole, Folic acid, garlic cap, glimepiride, luetin, multivitamin (Theragran), Trulicity, warfarin.
Allergien
Penicillin, Hydrocodone/Acetaminophen
Vorherige Impfungen
-

VAERS 2374933

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
72,0
Geschlecht
M
Eingang
20.07.2022
Impfdatum
26.10.2021
Beginn
06.01.2022
Tage bis Beginn
72,0
Dosis
1
Route/Site
UN / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 pneumonia Death

Symptomtext

Patient admitted to Medical Center 1/6/2022. Per Death abstracted submitted by the state Patient Died 1/16/2022 at 14:04 of Covid pneumonia acute hypoxic respiratory failure. public health has no further information.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
10,0
Labordaten
unknown.
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2364283

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
70,0
Geschlecht
M
Eingang
11.07.2022
Impfdatum
26.04.2021
Beginn
26.11.2021
Tage bis Beginn
214,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Agitation Alanine aminotransferase increased Ammonia increased Angiogram cerebral normal Anticoagulant therapy Aspartate aminotransferase increased Blood alkaline phosphatase increased Blood bilirubin increased Blood creatinine increased Brain hypoxia COVID-19 Constipation Cough Death Dehydration Dyspnoea Electroencephalogram abnormal Endotracheal intubation

Symptomtext

Patient was admitted because of cough congestion and sore throat for 5 days. He went to urgent care on November 26. After discharge he had a COVID-19 test resulted positive. In emergency department he was having a generalized body ache and very mild symptoms of a cough and shortness of breath. Emergency room physician expressed that he could of possibly go home but his creatinine is slightly elevated he is dehydrated need some IV hydration so patient is admitted for close monitoring. He required high levels of oxygen but did not require mechanical ventilation and was progressing well on medical floor. 12/28 rapid response called for sudden mental status change. Code stroke activated, CT/CTA head negative for intracranial pathology. Pt was intubated for airway protection and transferred to the ICU. 12/29/2021. Remains intubated VC/AC 14/450/8/60%. EEG performed, results pending. SAT performed and patient following commands. Ammonia check 107. 12/30/2021. EEG yesterday read severe diffuse nonspecific slowing of the background rhythm, indicative generalized subcortical and cortical neuronal dysfunction likely seen in significant encephalopathic state including cerebral hypoxia. Agitation off sedation, Precedex added. Trial lasix. Creat 1.2. Ammonia 82. Trail SAT/SBT today 12/31/2021. Remains intubated VC/AC 14/450/8/45%, breathing above vent. Trial on CPAP. Fluctuating mentation, reported response early this morning but unresponsive even to noxious stimuli during rounds. Oliguric renal failure. Creat 1.6. Nephrology consulted. Ammonia 101, lactulose increased. 1/1/2022. Pt successfully extubated. Requiring HFNC 60L/60%. Ammonia 110. Small bowel movement overnight, rifaximin added. AST/ALT 518/370, total bili 6.0 and Alk Phos 369. U/S Abdomen ordered. Creat 2.0. U/O remains inadequate 1/2/2022. Remains extubated but more encephalopathic. No bowel movements with soap sud enemas. Pt was started on heparin infusion for portal vein thrombosis and GI consulted. This morning INR 5.8 and heparin infusion discontinued. Ammonia 146. Hepatic panel worsening. Creat 2.6. Pt removed NG overnight. Pt was made a DNR and they would like to proceed with CMO-AND tomorrow when all significant family members can be present. 1/3/2022: Family arrived at bedside and again expressed wishes to transition to comfort care measures in the setting of his critical illness with multi-organ failure. Comfort care measures initiated and he passed @1450.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
35,0
Labordaten
Positive COVID 19 test on 11/26/2021
Aktuelle Erkrankungen
-
Vorgeschichte
2/8/17 Pacemaker at end of battery life 2001 Colon cancer Date Unknown A-fib Date Unknown Cancer Date Unknown Cardiac dysrhythmias Date Unknown Hepatitis C Date Unknown History of mechanical aortic valve replacement Date Unknown HTN (hypertension) Date Unknown Hypocholesteremia
Andere Medikamente
aspirin (HALFPRIN) 81 MG tablet atorvastatin (LIPITOR) 40 MG tablet diltiazem (DILACOR-XR) 240 MG XR capsule metoprolol tartrate (LOPRESSOR) 50 MG tablet warfarin (COUMADIN) 2.5 MG tablet
Allergien
Ribavirin
Vorherige Impfungen
-

VAERS 2327303

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
71,0
Geschlecht
M
Eingang
22.06.2022
Impfdatum
04.03.2021
Beginn
01.12.2021
Tage bis Beginn
272,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death Dyspnoea Fatigue Hypoxia Mechanical ventilation Pneumocystis jirovecii pneumonia Pyrexia SARS-CoV-2 test positive

Symptomtext

Pt had a positive COVID test on 12/27/21 from; 1/11/22 positive COVID test from Hospital 2/2/22 and 2/22/22 had positive COVID tests from Medical Center; 4/8/22 admitted to Hospital with fever, fatigue, SOB; dx with pneumonia secondary to pneumocystis; given ABX; hypoxic; noninvasive ventilation; DNR; inpatient hospice where pt passed away..

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
45,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
anemia, diffuse large B cell lymphoma, emphysema, HTN
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2324219

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
80,0
Geschlecht
M
Eingang
20.06.2022
Impfdatum
11.10.2021
Beginn
15.06.2022
Tage bis Beginn
247,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure COVID-19 COVID-19 pneumonia Chest X-ray abnormal Dyspnoea Malaise Pneumonia Renal impairment

Symptomtext

Presented to ED on 6/5/22 with COVID pneumonia and symptoms for 5 days. At that time, he was saturating well on room air with normal effort. Chest for-ray showed right middle lobe pneumonia and he was treated with doxycycline for CAP. Paxlovid was intended but unable to be used due to renal function. Presented to ED on 6/15/22 81y.o. M with PMH of Chronic mesenteric ischemia, hypertension, CAD status post CABG, PAD with SMA stenosis, chronic mesenteric ischemia status post iliac artery stent bilaterally, type 2 diabetes, CKD 3 and secondary hyperparathyroidism, normocytic anemia, and HLD who presents to the ED with complaint of shortness of breath. Admitted with acute respiratory failure 2/2 Covid

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2316748

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
61,0
Geschlecht
M
Eingang
12.06.2022
Impfdatum
05.04.2021
Beginn
12.12.2021
Tage bis Beginn
251,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute kidney injury Acute respiratory failure Areflexia Blood creatinine increased Blood lactic acid Blood potassium decreased Bradycardia Brain injury Breath sounds absent COVID-19 Computerised tomogram head normal Corneal reflex decreased Cough Death Electroencephalogram abnormal COVID-19 pneumonia Cardiac arrest Cerebral ischaemia

Symptomtext

Pt was admitted on 12/12 after presenting to the ECC after a witnessed cardiac arrest. The patient lived in an group home and was noted to stand up from the dinner table and suddenly collapsed. CPR was started by staff. Arrival of EMS noted a PEA arrest. Two rounds of CPR and 2 mg of epi were administered prior to ROSC. Upon arrival to the ECC, he was noted to have minimal neurologic response with no gag reflex, no corneal reflex, and pupils fixed and dilated. He also had a witnessed seizure of 15-30 seconds in the ECC and received Ativan with termination of the seizure activity. CT of the head was performed which resulted as negative. Lab work showed no leukocytosis, hemoglobin 12.5, platelets normal, potassium 3.3, creatinine 1.4, troponin negative, lactic acid 6.3, negative procalcitonin, UA negative, urine tox screen negative, COVID-19 positive. Cardiology was consulted. Patient was admitted to the ICU. 12/13-12/14 patient remained intubated and sedated on propofol. Receiving Jevity 30. Noted to have myoclonic jerks and intermittent episodes of severe hacking and coughing. Neurology consulted. EEG reported to be severely abnormal consistent with post-anoxic mild clonus status epilepticus after cardiac arrest/severe diffuse anoxic ischemic brain injury and with an extremely poor prognosis for survival. 12/16: Remained intubated, off infusions, unresponsive, myoclonic jerks and seizure-like activity was noted. Episodes of emesis. 12/17: Patient was extubated to BiPAP. Remained unresponsive. GCS 3. Continued myoclonic jerks. Neurology resumed home medications of Klonopin. Depakote added. 12/18: Early a.m., patient was noted to have episodes of desaturation of 83-87% on 6 L O2. He was transitioned back to BiPAP. Patient remained in significant distress in spite of multiple doses of morphine. Patient was continued on BiPAP/Ativan/morphine for comfort. The evening of 12/18, patient was found to have marginal blood pressures. He continued on BiPAP with high settings. Guardian was contacted again-requested no escalation of care. 12/19: Patient remained on supportive care . He developed significant bradycardia with decreasing SpO2. Clergy was called in for bedside prayer. The patient developed asystole with no breath sounds or respirations noted at 0220 hr with a five-minute confirmation. Discharge Diagnoses: PEA cardiac arrest, acute hypoxic respiratory failure, anoxic brain injury, COVID-19 pneumonia, AKI, death.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
7,0
Labordaten
Positive COVID 19 test 12/12/2021. CRx: showing bilateral patchy opacities.
Aktuelle Erkrankungen
-
Vorgeschichte
7/25/2018 Incarcerated incisional hernia Date Unknown Cancer Date Unknown HTN (hypertension) Date Unknown Mental disorder Date Unknown Mental retardation Date Unknown Sleep apnea
Andere Medikamente
Acetaminophen (TYLENOL) 325 MG CAPS amLODIPine (NORVASC) 10 MG tablet aspirin 81 MG chew tablet cholecalciferol (VITAMIN D-3) 50000 UNIT capsule clonazePAM (KLONOPIN) 0.5 MG tablet famotidine (PEPCID) 20 MG tablet fluvoxamine (LUVOX)
Allergien
Abilify
Vorherige Impfungen
-

VAERS 2313178

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TN
Alter
74,0
Geschlecht
F
Eingang
08.06.2022
Impfdatum
04.03.2021
Beginn
10.01.2022
Tage bis Beginn
312,0
Dosis
2
Route/Site
SYR / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Brain oedema COVID-19 Cerebral mass effect Cerebrovascular accident Computerised tomogram head abnormal Death Endotracheal intubation Fall Influenza like illness Intensive care Mental status changes Neurological examination abnormal SARS-CoV-2 test positive Skull fractured base Subarachnoid haemorrhage Subdural haemorrhage

Symptomtext

Patient presented to ED on 01/10/2022 with AMS, the onset was abrupt. The patient was transferred from small clinic for evaluation and management of a head bleed after a fall, and Covid positive. CT showed occipital fracture, subdural bleed, bilateral subarachnoid frontal bleed. Prior to presentation, history of flu like symptoms for the past week. Patient was admitted to NCCU. On 01/13/2022 patient presented with worsening neurological exam, extensor posturing, not protecting airway, patient was intubated, repeat CT head with worsening edema and evolving left pica stroke with mass effect. Patient code status was changed to DNR. Patient expired on 01/15/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2304969

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
83,0
Geschlecht
F
Eingang
01.06.2022
Impfdatum
30.10.2021
Beginn
22.05.2022
Tage bis Beginn
204,0
Dosis
1
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute myocardial infarction Anticoagulant therapy Asymptomatic COVID-19 Atrioventricular block complete COVID-19 Catheterisation cardiac abnormal Contusion Ejection fraction normal Electrocardiogram ST segment elevation Haematoma Haemoglobin decreased Intensive care Percutaneous coronary intervention SARS-CoV-2 test positive

Symptomtext

Patient presented with severe heart burn symptoms and was found to have inferior ST elevation on the EKG as well as 3AVB in the ER. She was taken emergently to the cath lab by Dr. and had PCI of the RCA on 5/22/2022. Her CHB resolved - there was no recurrence. 2 days later on 5/24/2022 she underwent staged PCI of the ramus branch. Echo showed EF 55-60% with no WMA. The second cardiac cath was complicated by a groin hematoma. Pressor support with Levophed was added and she was kept in the CCU. SQ heparin was held. Her Hgb dropped from ~ 11.4 to 9.5, likely because of continuous IVF being given at 75 mL/hour. See procedure notes for complete details. Her groin was stable with significant bruising, but no firmness or swelling. On day of discharge, she was feeling well with no cardiorespiratory symptoms and was ambulating without difficulty. Vitals were stable and she was maintaining SR / ST; no recurrence of CHB. She was also incidentally found to have COVID - supportive care was recommended. She had no symptoms directly attributable to COVID during her hospitalization. The remainder of her hospital course was unremarkable. """

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
6,0
Labordaten
Positive COVID PCR test 5/22/2022
Aktuelle Erkrankungen
-
Vorgeschichte
Hx TIA (Chronic) 8/3/2012 Type 2 diabetes mellitus with stage 4 chronic kidney disease, without long-term current use of insulin 8/3/2012 HTN (Chronic) 8/3/2012 Gastroesophageal reflux disease with hiatal hernia (Chronic) 8/3/2012 Hyperlipidemia (Chronic) 8/3/2012 Anxiety (Chronic) Unknown Osteoporosis (Chronic) Unknown History of arterial ischemic stroke 10/16/2015 Hx of renal artery stenosis status post renal artery stent (Chronic) 12/29/2015 Atrophy of right kidney (Chronic) 12/29/2015 COPD exacerbation 4/5/2017 Hypomagnesemia 4/5/2017 Chronic diastolic heart failure (Chronic) 4/5/2017 Pneumonia and Anemia 5/31/2018 Acute kidney injury superimposed on chronic kidney disease 5/31/2018 Slow transit constipation 6/9/2018 Microcytic anemia 6/10/2018 Peripheral vascular disease 6/10/2018 Pulmonary nodules 6/10/2018 Vitamin D deficiency 6/10/2018 Primary osteoarthritis of both knees 6/10/2018 Chronic pulmonary aspiration 6/10/2018 Pulmonary hypertension 6/10/2018 Hyperparathyroidism 6/10/2018 Debility 6/19/2018 Simple chronic bronchitis Unknown COPD (chronic obstructive pulmonary disease) with emphysema (Chronic) 7/21/2018 Iron deficiency anemia 7/21/2018 Chronic respiratory failure with hypoxia, on home oxygen therapy (Chronic) 7/21/2018 Coronary artery disease (Chronic) 7/21/2018 Left renal artery stenosis s/p stent 10/22/2019 HTN 10/22/2019 CAD s/p nagetive lexiscan (7/2018) 10/22/2019 GERD 10/22/2019 CKD stage 4 due to type 2 diabetes mellitus (Chronic) 7/14/2020 Coronary artery disease of native artery of native heart with stable angina pectoris 4/1/2021 STEMI involving right coronary artery 5/22/2022 Complete heart block, transient 5/22/2022 COVID-19 virus detected 5/22/2022
Andere Medikamente
EVERY 6 HOURS PRN albuterol sulfate 90 mcg/actuation 2 puffs Inhalation EVERY 6 HOURS PRN alprazolam 0.5 mg Oral DAILY PRN aspirin 81 mg Oral Daily carvedilol 6.25 mg Oral 2 TIMES DAILY WITH MEALS clopidogrel bisulfate 75 mg Oral Daily
Allergien
EVERY 6 HOURS PRN albuterol sulfate 90 mcg/actuation 2 puffs Inhalation EVERY 6 HOURS PRN alprazolam 0.5 mg Oral DAILY PRN aspirin 81 mg Oral Daily carvedilol 6.25 mg Oral 2 TIMES DAILY WITH MEALS clopidogrel bisulfate 75 mg Oral Daily docusate sodium 100 mg Oral DAILY PRN fluticasone propionate 50 mcg/actuation 2 sprays Each Nare Daily fluticasone/vilanterol 200-25 mcg/dose 1 puff Inhalation Daily loratadine 10 mg Oral DAILY PRN losartan potassium 25 mg Oral Daily oxybutynin chloride 10 mg Oral Daily pantoprazole sodium 40 mg Oral DAILY BEFORE BREAKFAST, Take on an empty stomach at least 30 minutes before food. pravastatin sodium 40 mg Oral NIGHTLY roflumilast 500 mcg TAKE 1 TABLET BY MOUTH EVERY DAY tizanidine HCl 4 mg Oral EVERY 12 HOURS PRN torsemide 20 mg Oral Daily, Take an additional 20 mg in PM for weight gain more than 2 pounds tramadol HCl 50 mg 1 tablet Oral DAILY OR AS NEEDED umeclidinium bromide 62.5 mcg/actuation 1 puff Inhalation Daily
Vorherige Impfungen
-

VAERS 2303468

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
90,0
Geschlecht
M
Eingang
31.05.2022
Impfdatum
04.10.2021
Beginn
19.05.2022
Tage bis Beginn
227,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure COVID-19 Dyspnoea Nausea Vomiting

Symptomtext

90 y.o. male with a past medical history of dementia, CKD 3 with anemia, hypertension, hypothyroidism, hyperlipidemia, MVP, prostate cancer, ulcerative colitis, CAD status post stents in 2015, PAD, osteoporosis, abdominal aortic aneurysm who presents nausea and vomiting as well shortness of breath. Patient admitted as observation on 5/19 due to acute respiratory failure with hypoxia due to COVID.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2294779

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
SD
Alter
75,0
Geschlecht
M
Eingang
25.05.2022
Impfdatum
26.02.2021
Beginn
18.09.2021
Tage bis Beginn
204,0
Dosis
2
Route/Site
SYR / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Acute respiratory distress syndrome Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Death Encephalopathy Endotracheal intubation Enterococcal infection Escherichia infection Extubation Pathogen resistance SARS-CoV-2 test positive Subdural haematoma Unresponsive to stimuli Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 02/05/2021 and 02/26/2021. They first tested positive for COVID-19 on 09/18/2021 at an Urgent Care Clinic. They presented to Emergency Department via ambulance on 09/22/2021 with primary complaint of general weakness that had been happening for about the past 6 days. They were admitted to hospital on 09/22/2021. They were found to having multiple complications and co-occurring conditions, including ESBL E. coli and Enterococcus faecalis, a subdural hematoma, severe encephalopathy attributable to COVID-19, acute kidney injury, COVID-19 pneumonia, and Acute Respiratory Distress Syndrome (ARDS) with Acute Hypoxic Respiratory Failure. The individual lapsed into unresponsiveness and was intubated. Given poor prognosis for recovery, the family agreed to comfort care only and the individual was extubated and they died in the hospital on 10/23/2021. A second COVID-19 test on a specimen collected 10/23/2021 was also positive, but was not resulted out until 10/25/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
31,0
Labordaten
Positive COVID-19 tests x2 on 09/18/2021 and 10/23/2021 despite being vaccinated.
Aktuelle Erkrankungen
-
Vorgeschichte
History of acute renal failure prior to the adverse event (on hemodialysis), A-fib, Type II Diabetes, Hyperlipidemia, Hypertension, mild peripheral edema, obstructive sleep apnea
Andere Medikamente
-
Allergien
Penicillin (reaction: rash, bumps on tongue) Levofloxacin (reaction: rash, bumps on tongue)
Vorherige Impfungen
-

VAERS 2290347

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6202

kritisch
Staat
MI
Alter
85,0
Geschlecht
F
Eingang
23.05.2022
Impfdatum
17.03.2021
Beginn
19.05.2022
Tage bis Beginn
428,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Abdominal X-ray Angiogram pulmonary abnormal Anticoagulant therapy COVID-19 Chest pain Computerised tomogram abdomen normal Hypotension Intestinal dilatation Pain Painful respiration Pulmonary embolism Tachycardia White blood cell count increased

Symptomtext

Patient is an 86-year-old female who presents to the emergency department from a local nursing facility for left-sided chest pain. She states she has had it intermittently for a week. Over the last 2 days it has been constant and sharp. Patient does have a history of hypertension and diabetes. Patient states the pain is directly under her left breast, movement, deep breathing, lying still and "just nothing" make the pain worse. Patient has been given Ultram and Norco at the nursing facility without relief. She denies shortness of breath, no nausea vomiting diarrhea or constipation. No recent illness. No fever. Associated Symptoms: chest pain

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
3,0
Labordaten
o ED Clinical Course Patient will have an IV established, she will baseline labs EKG and urinalysis. Patient does have some bowel will add abdominal x-ray. Patient has multiple dilated bowel loops will do CT of the abdomen pelvis. Her white blood cell count is elevated. Her pain is relieved with Toradol. No obstruction on CT, will give reglan Await UA 9:44 PM Case taken over from NP. Patient continues to complain of some left-sided chest pain and her oxygen saturations are in the high 80s. She will have a routine CTA of the chest to rule out underlying pulmonary embolism. She also has some borderline hypotension. 10:33 PM patient remained with some mild tachycardia and oxygen saturations in the high 80s. A CTA of the chest shows bilateral pulmonary embolism. Patient is currently being heparinized and will be admitted for further care and treatment. She has no evidence of heart strain and is a full DNR. The case will be discussed with RPG. 10:36 PM Case discussed with (RPG) who accepted the admission. Patient's outlook is guarded. She was recently diagnosed with COVID which most likely has caused her pulmonary embolism.
Aktuelle Erkrankungen
unknown
Vorgeschichte
HTN, DM
Andere Medikamente
Current Home Medications 1. acetaminophen 500 mg oral tablet : 2 tab(s) orally 4 times a day, As Needed - PRN for Pain 2. amLODIPine 5 mg oral tablet : 1 tab(s) orally once a day 3. betamethasone valerate 0.1% topical ointment : Apply topic
Allergien
NKA
Vorherige Impfungen
-

VAERS 2268951

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
73,0
Geschlecht
F
Eingang
10.05.2022
Impfdatum
21.09.2021
Beginn
09.01.2022
Tage bis Beginn
110,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Chest X-ray abnormal Dyspnoea Fibrin D dimer Lung infiltration Oxygen saturation decreased SARS-CoV-2 test positive Sepsis Serum ferritin increased

Symptomtext

1/9/2022-Preentated via EMS complaint of weakness and SOB, tested positive for Covid 12/29. Po2 of 89 requiring 8L via NRB to maintain sats in low 90's. Ferritin 437 and D-dimer 455. Chest x ray-extensive bilateral interstitial infiltrates. Admit acute hypoxic respiratory failure with sepsis Covid -19 pneumonia. Started IV Decadron, rocephin, doxycycline, Remdesivir and baricitinib. 1/11/2022- O2 12L via NC spo2 96%. Afebrile. 1/12/2022- Down to 10L via NC spo2 94%. 1/15/2022- Improving, afebrile and maintaining o2 sat. 1/19/2022- Spo2 high 90's on 7L o2 via NC. 1/22/2022-Patient oxygen desatting when ambulating. Currently at 4L o2 via NC. 1/23/2022- Afebrile. Spo2 92-97% on 4L o2 via NC. Symptoms improved, discharged home with Hospital at Home service.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
14,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Anemia, hypertension, Lupus, Malignant neoplasm of right breast, Type 2 Dm
Andere Medikamente
-
Allergien
Mirabegron, Nsaids, Viaxin, Oxycodone, Primidone, Tramadol, Tu, Duloxetine, Levofloxacin and Penicllians.
Vorherige Impfungen
-

VAERS 2263557

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
76,0
Geschlecht
F
Eingang
04.05.2022
Impfdatum
04.03.2021
Beginn
01.01.2022
Tage bis Beginn
303,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
COVID-19 Death Dyspnoea Inappropriate schedule of product administration SARS-CoV-2 test positive

Symptomtext

pt presents to the hospital with SOB "for a few weeks"; saw PCP and received steroids and doxycycline; no improvement; to ED; found to be positive for COVID; given O2 supplementation; steroids; DNR; pt in hospital from 1/13/22 - 2/6/22; pt dc'd to home with hospice (name of organization not in medical records) where she passed away

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
22,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
chronic interstitial lung disease, HTN, CAD, OSA, DM, GERD, hypothyroidism
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2263555

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
71,0
Geschlecht
M
Eingang
04.05.2022
Impfdatum
25.03.2021
Beginn
18.01.2022
Tage bis Beginn
299,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

Death COVID-19 as secondary condition

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Atherosclerotic cardiovascular disease OSC: COPD, tnfection with novel coronavirus(COVID-l 9), Renal failure
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2263420

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
74,0
Geschlecht
M
Eingang
04.05.2022
Impfdatum
01.03.2021
Beginn
06.09.2021
Tage bis Beginn
189,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Ankle fracture COVID-19 COVID-19 pneumonia Death Inappropriate schedule of product administration SARS-CoV-2 test positive

Symptomtext

Originally admitted with ankle fx, found to be COVID+ into stay, during routine testing for DC to SNF. Fully vaccinated in June. Dx with COVID pna 9/9. Treated with steroids, zinc, remdesivir, monoclonal antiboides, O2. Oxygen requirements increased, pt was placed on comfort care and expired in hospital 9/15.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
10,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2263410

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
76,0
Geschlecht
M
Eingang
04.05.2022
Impfdatum
06.03.2021
Beginn
09.09.2021
Tage bis Beginn
187,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Bradycardia COVID-19 COVID-19 pneumonia Cardiac arrest Death Dyspnoea Endotracheal intubation Gastrointestinal haemorrhage Hypotension Hypoxia Intensive care Oxygen saturation decreased SARS-CoV-2 test positive

Symptomtext

Presented with SOB x 6 days: + covid PTA 6 days; Admitted to tele with Covid PNA; tx with maxipime, steroids, remdesivir, vanc, Vit D, doxycycline, singulair, zinc, clindamycin; intially LF O2; HF O2; 9/15 increasing O2 needs to HF O2; + GI bleed 9/16; 9/20 tx to PCU due to increasing hypoxia and need for further HF O2 and possible intubation; 9/22 back to tele; 9/23 back to HF O2; 9/24 pt desired DNR order then changed back to full resuscitation status; 9/25 pt on HF o2; desat with repositioning; emergency intubation; after intubation, pt became bradycardic/hypotensive; multiple Cardiac arrests with ultimately asystole and death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
17,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2234205

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
SD
Alter
69,0
Geschlecht
M
Eingang
14.04.2022
Impfdatum
18.03.2021
Beginn
20.08.2021
Tage bis Beginn
155,0
Dosis
1
Route/Site
SYR / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute myocardial infarction Acute respiratory distress syndrome Acute respiratory failure COVID-19 COVID-19 pneumonia Cardiac arrest Death Dyspnoea Inappropriate schedule of product administration Metabolic acidosis Oxygen saturation decreased Respiratory acidosis SARS-CoV-2 test positive Vaccine breakthrough infection Ventricular tachycardia

Symptomtext

This is an instance of breakthrough COVID-19 disease after which death occurred with a possible administration error, in the interval between first and second vaccine dose. The individual was vaccinated with the Pfizer product on 03/01/2021 and 03/18/2021. The individual became symptomatic on 08/20/2021. They tested positive at an urgent care clinic on the same day. They presented to emergency department on 08/27/2021 with primary complaints of shortness of breath and low oxygen (oxygen saturation in the 60's in at-home monitoring). The individual was admitted to hospital the same day. They experienced complications of COVID-19 pneumonia, ventricular tachycardia cardiac arrest, acute myocardial infarction, acute respiratory syndrome, acute hypoxic respiratory failure, and metabolic/respiratory acidosis. They died on 09/06/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
10,0
Labordaten
Positive COVID-19 test on 10/20/2021 despite being vaccinated.
Aktuelle Erkrankungen
-
Vorgeschichte
Type II Diabetes (described as "poorly controlled"), Atherosclerosis Coronary Artery Disease, Stage III Chronic Kidney Disease, History of A-Fib, Wollf-Parkinson-White Syndrome, Hypertension, Hyperlipidemia
Andere Medikamente
-
Allergien
Adhesive Tapes/Silicones, Latex, Emagiflozin: Reactions and severities not listed Exenatide Microspheres: Reaction: GI Intolerance
Vorherige Impfungen
-

VAERS 2231351

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
87,0
Geschlecht
M
Eingang
13.04.2022
Impfdatum
27.02.2021
Beginn
07.04.2022
Tage bis Beginn
404,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Asthenia Blood lactic acid Brain natriuretic peptide increased COVID-19 Cardiac arrest Death Dyspnoea Endotracheal intubation Pulseless electrical activity SARS-CoV-2 test positive Troponin I increased White blood cell count increased

Symptomtext

Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death Received Pfizer Vaccine 2/06/21 and 02/27/21. Presented to ED 04/06/22 via EMS after cardiac arrest 15 min prior. According to the patient's family he has been feeling week for several days, today he seemed more SOB. Upon EMS arrival the patient was in PEA, placed on Lucas device, administered 1 round epinephrine and intubated. ROSC was achieved after total of 5 min. down time estimated by EMS. Intubated and sedated upon arrival to ED. Workup in ED showed AKI, lactic acid 8.3, Trop I HS 90, BNP 618, WBC 19.4 and is Covid-19 positive. Family decided on comfort measure only. Pt expired on 4/7/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
1,0
Labordaten
4/06/22- This sample was analyzed using the Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, aortic and mitral regurgitation, BPH, HLD
Andere Medikamente
albuterol, amlodipine, atorvastatin, cetirizine, clonidine, diclofenac, fluticasone, hydralazine, patiromer, primidone
Allergien
Penicillin V, Lasix
Vorherige Impfungen
-

VAERS 2209180

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
79,0
Geschlecht
M
Eingang
31.03.2022
Impfdatum
14.10.2021
Beginn
01.02.2022
Tage bis Beginn
110,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute myocardial infarction Anticoagulant therapy Bradycardia COVID-19 Catheterisation cardiac abnormal Coronary arterial stent insertion Coronary artery disease Hypotension Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Patient up to date on COVID vaccinations who admitted to hospital with NSTEMI who also tested detected for COVID (mild symptoms of congestion). Provider discharge note below: "80 YO male who was admitted for NSTEMI, he was started on IV heparin. He underwent LHC which showed multivessel disease , multiple overlapping stents, culprit lesion most likely diagonal branch small caliper vessel. He was recommended medical management. Added imdur. His blood pressures have been slightly softer and bradycardic. His lisinopril was changed to 10 mg daily and lopressor to daily rather than BID. Patient had been stable, discussed with cardiology. Will follow up outpatient with cardio and PCP."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
3,0
Labordaten
COVID "detected" PCR on 02/01/2022
Aktuelle Erkrankungen
-
Vorgeschichte
Tinnitus aurium, bilateral Onychomalacia NEOP, BNG, LARGE INTESTINE (211.3) Benign neoplasm of skin HYPERCHOLESTEROLEMIA, PURE (272.0) Hiatal hernia Hypertrophic and atrophic condition of skin LUMBAGO (724.2) CAD (coronary artery disease) Onychomycosis Essential hypertension, benign Right carotid bruit Microalbuminuria Malignant neoplasm of overlapping sites of bladder (HCC) Multiple actinic keratoses Left thyroid nodule Hyperbilirubinemia Esophageal obstruction Anemia Left inguinal hernia History of myocardial infarction Chronic left shoulder pain History of coronary artery bypass graft x 3
Andere Medikamente
Aspirin Tums Zetia Folic Acid Multivitamin Imdur Zestril Lopressor Nitrostat Miralax
Allergien
Statins-hmg-coa Reductase Inhibitors: Myalgia Crestor [Rosuvastatin]: Myalgias
Vorherige Impfungen
-

VAERS 2182603

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
92,0
Geschlecht
F
Eingang
16.03.2022
Impfdatum
15.12.2021
Beginn
03.01.2022
Tage bis Beginn
19,0
Dosis
2
Route/Site
UN / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test

Symptomtext

Patient was vaccinated 2/12/21, 3/5/21 and 12/15/21 with the Pfizer vaccine Patient was diagnosed 1/3/22 with COVID-19 Received Death Abstract stated patient died 1/17/2022 at 05:34 at her living place. No Web report listing a hospitalization was received by the health department No further information is known Please contact the facility for any additional information

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
PCR test for COVID
Aktuelle Erkrankungen
unknown
Vorgeschichte
Hip Fracture Dementia
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2182580

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MT
Alter
78,0
Geschlecht
F
Eingang
16.03.2022
Impfdatum
28.02.2021
Beginn
14.01.2022
Tage bis Beginn
320,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory distress syndrome Asthenia COVID-19 Chills Cough Death Dyspnoea Influenza A virus test Influenza B virus test Pulmonary embolism Pyrexia Rash Respiratory syncytial virus test SARS-CoV-2 test positive

Symptomtext

Case ws vaccinated for Covid in February 2021, then hospitalized for Covid in January 2022. Hospitalized at: Medical Center Admitted to hospital for 36 day stay for treatment of Acute respiratory distress syndrome r/t Covid. Symptoms included Fever, chills, cough, SOB, weakness and rash. She also suffered a pulmonary embolism r/t covid. Discharged home on Hospice. She died 3 days after discharge, but Covid was not listed on her death certificate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
36,0
Labordaten
Ordered Test: FLUABV+SARS-CoV-2+RSV RNA Pnl Resp NAA+p (SARS CoV2-Flu-RSV PCR) Ordered Test Codes: (LN LOINC)/ (L LOCAL) Status: Final Accession Number: Specimen Source: Nasopharynx Specimen Site: Specimen Collection Date/Time: 2022-01-14 10:30:00.0 * Resulted Test: SARS-CoV-2 RNA Resp Ql NAA+probe (SARS CoV-2 PCR (COVID-19)) Coded Result: Positive (LOCAL) Numeric Result: Units: Text Result: Reference Range From: Negative Reference Range To: Performing Facility Details: Date/Time: 2022-01-14 11:21:26.0 Performing Facility: Med Cntr Facility ID: Interpretation: Abnormal Result Method: Status: Final Test Code: (LN LOINC)/(L LOCAL) Result Code: (SCT/Positive (L LOCAL) Result Comments: Positive results are indicative of active infection with SARS-CoV-2. Positive results do not rule out bacterial infection or co-infection with other viruses.
Aktuelle Erkrankungen
CAD, Dyslipidemia, HTN, Former smoker, Macular degeneration (wet), MOrbid obesity, Osteopenia, Type 2 Diabetes, Wegeners granulomatosis
Vorgeschichte
CAD, Dyslipidemia, HTN, Former smoker, Macular degeneration (wet), MOrbid obesity, Osteopenia, Type 2 Diabetes, Wegeners granulomatosis
Andere Medikamente
ASA, Atorvastatin, Cholecalciferol, Losartan, Metformin, Metoprolol Tartrate, Spironolactone
Allergien
Gentamicin, Ibuprofen, Potassium.
Vorherige Impfungen
-

VAERS 2165527

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
76,0
Geschlecht
F
Eingang
08.03.2022
Impfdatum
11.10.2021
Beginn
19.01.2022
Tage bis Beginn
100,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Asymptomatic COVID-19 Cardiac arrest Death Fall Femoral neck fracture Open reduction of fracture SARS-CoV-2 test positive

Symptomtext

According to System report, client admitted to hospital post fall on 1/13/2022. She was diagnosed with a left femoral neck fracture. She was taken to the OR for an ORIF left femoral neck fracture. She tested positive for COVID-19, asymptomatic. On 1/19/2022, she experienced a cardiac arrest and passed away. No other information known.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
-
Labordaten
UNKNOWN
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
UNKNOWN
Andere Medikamente
UNKNOWN
Allergien
UNKNOWN
Vorherige Impfungen
-

VAERS 2165454

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
74,0
Geschlecht
M
Eingang
08.03.2022
Impfdatum
01.03.2021
Beginn
01.09.2021
Tage bis Beginn
184,0
Dosis
2
Route/Site
IM / OT
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Anticoagulant therapy Arrhythmia COVID-19 COVID-19 pneumonia Death Diarrhoea Dyspnoea Hypoxia Poor peripheral circulation Pulmonary haemorrhage SARS-CoV-2 test positive Thromboembolectomy

Symptomtext

Presented with SOB, diarrhea; Covid + in ED; admit with Covid PNA & PE; tx with steroids, maxipime, singulair, vanc, rocephin, remdisivir, actemra, doxycycline, zinc, supplemental O2; He experienced sudden loss of circulation to right leg and embolectomy was done by Dr. (Privacy) Anticoagulation was continued but he experienced pulmonary hemorrhage with further hypoxia and cardiac arrhythmias which were life taking.Discharge Condition:Expired

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
25,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2155094

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
96,0
Geschlecht
F
Eingang
03.03.2022
Impfdatum
02.03.2021
Beginn
28.12.2021
Tage bis Beginn
301,0
Dosis
2
Route/Site
UN / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Activated partial thromboplastin time Acute respiratory failure Alanine aminotransferase normal Angiogram pulmonary abnormal Aortic stenosis Aphasia Aspartate aminotransferase increased Aspiration Blood albumin decreased Blood calcium decreased Blood creatinine normal Blood glucose increased Blood sodium decreased Blood urea increased Bronchial secretion retention Complication associated with device Death Facial wasting

Symptomtext

12/29/21 96 yr/o female with a history of aspiration PNA with sepsis and prolonged hospitalization complicated by COVID pneumonia. The was then discharge dto a subacute rehab but returned to the hospital on 12/26/2021 with concern for infected Gtube as well as being found supine with tube feeds in progress and additional aspiration. She had a CTA of the chest at time of evaluation with lateral lung consolidation in LLL and bilateral lower lung mucous plugging. She had desaturations and acute hypoxic respiratory failure. Initially she was placed on IV antibiotics including vancomycin and zosyn. The Gtube was aspirated by nursing and pus-like material was returned from it. There was noted to be concerns for The Gtube was aspirated by nursing and pus-like material was returned from it. There was noted to be concerns for possible upper GI bleed as well. The pt remained non-verbal and did not have any significant changes/improvements while at the hospital. Family elected to forego further aggressive interventions and decided to focus on comfort as the primary goal. All aggressive interventions, including antibiotics were discontinued. She was transferred to Facility for further symptom management as she was requiring parenteral lorazepam and morphine. The pt is unresponsive at this time but family present at bedside. Spoke with sisters and brother at the bedside and they recounted the previously 2 months of medical issues that have led the pt to where she is currently. They remain focused on comfort as the primary goal and don't have any acute questions at this time. Physical Exam Constitutional: General: She is not in acute distress. Appearance: She is ill-appearing. She is not diaphoretic. Comments: Unresponsive to verbal or tactile stimuli, lying in bed in recovery position; NAD HENT: Head: Comments: Mild temporal wasting present Mouth/Throat: Mouth: Mucous membranes are moist. Pharynx: No oropharyngeal exudate. Comments: No drainage noted Eyes: General: No scleral icterus. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Heart sounds: No murmur heard. No friction rub. No gallop. Pulmonary: Comments: Short, shallow breathing pattern present with rhonchi noted throughout Abdominal: General: There is no distension. Palpations: Abdomen is soft. There is no mass. Tenderness: There is no abdominal tenderness. Comments: Absent bowel sounds Musculoskeletal: General: No swelling or tenderness. Skin: General: Skin is warm and dry. Neurological: Comments: Unresponsive to verbal or tactile stimuli, no myoclonus 1/2/22 Cause of death: aspiration pneumonia SECONDARY DIAGNOSES: 1. COVID 19 2. Aortic stenosis 3. HTN 4. Possible GI bleed HOSPITAL COURSE: The patient was a 96 yr/o-year-old female with a history of aspiration PNA with sepsis and prolonged hospitalization complicated by COVID pneumonia. She was then discharged to subacute rehab but returned to the hospital on 12/26/2021 with concern for infected Gtube as well as being found supine with tube feeds in progress and additional aspiration. She had a CTA of the chest at time of evaluation with lateral lung consolidation in LLL and bilateral lower lung mucous plugging. She had desaturations and acute hypoxic respiratory failure. Initially she was placed on IV antibiotics including vancomycin and zosyn. The Gtube was aspirated by nursing and pus-like material was returned from it. There was noted to be concerns for possible upper GI bleed as well. The pt remained non-verbal and did not have any significant changes/improvements while at the hospital. Family elected to forego further aggressive interventions and decided to focus on comfort as the primary goal. All aggressive interventions, including antibiotics were discontinued. She was transferred the Inpatient Care Center for further symptom management as she was requiring parenteral lorazepam and morphine. At time of admission to the Facility the pt had a PPS of 10% and prognosis judged to be limited to days. Parenteral medications were ordered for comfort including morphine, ativan and haldol. She continued to decline and died 1/2/22 @ 1759

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
2,0
Labordaten
12/28/21 COVID-19 Result Detected Abnormal; Recent Labs Lab 12/23/21 0201 12/26/21 1718 12/27/21 0104 12/27/21 1300 12/28/21 0323 WBC 26.63* 18.19* 20.91* -- 23.18* HGB 10.3* 10.0* 8.4* 7.7* 7.7* HCT 31.1* 32.1* 26.8* 24.0* 23.8* MCV 93.4 96.4 96.1 -- 95.2 Recent Labs Lab 12/23/21 0201 12/26/21 1718 12/27/21 0104 12/28/21 0323 NA 134* 134* 132* 132* CO2 22 27 25 23 BUN 34* 38* 38* 26* CREATININE 0.66 0.80 0.80 0.81 GLUCOSE 218* 160* 177* 100* Recent Labs Lab 12/23/21 0201 12/26/21 1718 12/27/21 0104 12/28/21 0323 CALCIUM 8.7 9.0 8.3* 7.7* No results for input(s): INR, PROTIME, PTT in the last 168 hours. Recent Labs Lab 12/23/21 0201 12/26/21 1718 12/27/21 0104 ALT 24 34 30 AST 20 36* 35* ALBUMIN 2.3* 2.5* 2.3* Recent Labs Lab 12/26/21 2354 COLORU Yellow CLARITYU Clear PH 8.0 LEUKOCYTESUR Negative RBCUA 2 WBCUA 4* CTA chest, 12/26/2021: 1. Bilateral lung consolidation most pronounced in the left lung base with bilateral lower lobe mucous plugging representing pneumonia likely secondary to aspiration, which is favored over COVID-19 pneumonia. Trace left-sided pleural effusion. 2. 7 mm cyst in the pancreas. Yearly follow-up can be obtained as clinically warranted. 3. Findings stercoral colitis. 4. Asymmetric fat stranding in the left lateral abdominal wall at the level gastrostomy tube insertion, which may represent cellulitis in the proper clinical setting. The gastrostomy tube is in proper position and there is no drainable fluid collection. 5. Unchanged T7 compression fracture.
Aktuelle Erkrankungen
-
Vorgeschichte
Aortic stenosis o Benign essential HTN o Bilateral leg edema o Bleeding 12/26/2021 Gtube site o History of rectal fissure o Varicose veins of both lower extremities
Andere Medikamente
acetaminophen (TYLENOL) 650 MG suppository; LORazepam (ATIVAN) 2 MG/ML injection Infuse 1 mL into the vein every 2 (two) hours as needed (anxiety/agitation). morphine 2 MG/ML injection Infuse 1 mL into the vein every 2 (two) hours as n
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2151685

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
68,0
Geschlecht
M
Eingang
02.03.2022
Impfdatum
04.03.2021
Beginn
05.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Amnesia Blood test Cognitive test Dehydration Fall Laboratory test abnormal Lethargy Myocardial infarction Myocarditis Renal failure Sepsis Transient global amnesia

Symptomtext

I got the shot at 5pm on Thursday drove home and the evening I was fine and then I got into an episode. I have no memory from Thursday night, all through Friday, March 5, 2021 and until 01:00 am Saturday. I was in the back of an ambulance and transported to Hospital. My wife tells me that I was awake, I ate meals, I went to the bathroom, but I was very lethargic all day. At two incidents of falling down. Once in late Friday afternoon and EMT were called to helped to get me back up because my wife cannot because I am 300 lbs and 6'4". They gave me a basic mental cognitive test and I answered all the questions, again, this is what my wife tells me. Two and a half hours later, I got up to walk into my family room and I again fell halfway there. EMT and Fire were called again and this time and this time it was decided I should go to the hospital. My first flash of memory is being in back of ambulance on thruway My next memory is in the ER at the hospital and being questioned by a nurse/doctor. From that point on my memory is pretty good and they ran numerous blood tests, I was extremely dehydrated, about 45 -60 minutes later the doctor came back in and told me I was in renal failure, cardiac biomarkers indicated I had a mild heart attack, and I was also septic. The doctor told me if I had not come into the hospital I could have died in 12-18 hours. I did recover within 5 months but I am not sure what I was given during hospitalization. About a month later, my wife was reviewing my blood tests from hospital admission, my wife teaches nursing she said that I had Myocarditis but it did not raise to the clinical level, I am not sure what that means but in other words it was not severe enough to report to CDC. The CDC was aware of a Myocarditis event from the second Pfizer but it was focused on males 18 or younger. Since I was older than that, the hospital didn't connect the two. That's pretty much it and I trust my wife with my life and she said I had the classic symptoms of Myocarditis but at the time it did not raise alert due to my age.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocardial infarction
Hospital-Tage
5,0
Labordaten
First labs March 6, 2021 Saturday morning, March.
Aktuelle Erkrankungen
No
Vorgeschichte
Diagnosed with Multiple systems atrophy MSA No cure
Andere Medikamente
Multivitamin daily; Vitamin C 1000mg daily; Esomeprazole 40mg two times day; Myrbetriq 50mg once daily; Nortriptyline 10mg 4 capsules once a day; Pregabalin 200 mg two times a day; Bupropion 300mg once a day; Spiriva Respimat 2.5mcg; Trazod
Allergien
None
Vorherige Impfungen
-

VAERS 2135022

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MT
Alter
74,0
Geschlecht
F
Eingang
23.02.2022
Impfdatum
07.03.2021
Beginn
02.01.2022
Tage bis Beginn
301,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure Asthenia Atelectasis COVID-19 COVID-19 pneumonia General physical health deterioration Influenza A virus test Influenza B virus test Malaise Nucleic acid test Pickwickian syndrome SARS-CoV-2 test positive Spirometry

Symptomtext

Case completed 2 dose MRNA vaccine in March 2021, and was hospitalized for Covid in January of 2022. * Pneumonia due to COVID-19 virus Presented with COVD symptoms and positive test January 2. Had received Pfizer-BioNtech MRNA vaccine 2/14, 3/7/21. Admitted with COVID19 pneumonia 1/2/21 and treated with Remdesivir, Dexamethasone. Due to deterioration, Tocilizumab given January 4th. Patient improved since. Completed ten days of Dexamethasone on 1/12. Profoundly weak following COVID recovery. Continues to improve, albeit slowly. Acute respiratory failure due to COVID-19 Patient with acute respiratory failure secondary to COVID19 pneumonia, has had high Oxygen requirements and was weaned down to 1-2L of O2. Needs have varied and small increase past few days, suspect from atelectasis and obesity hypoventilation. She is working with incentive spirometer and expect as she become more mobile she will continue to improve.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
33,0
Labordaten
Ordered Test: FLUABV + SARS-CoV-2 Resp NAA+probe Ordered Test Codes: (LN LOINC)/ Status: Final Accession Number: Specimen Source: SOFT TISSUE SAMPLE Specimen Site: ENTIRE NASOPHARYNX Specimen Collection Date/Time: 2022-01-02 18:02:00.0 * Resulted Test: SARS-CoV-2 RNA Resp Ql NAA+probe Coded Result: DETECTED Numeric Result: Units: Text Result: Reference Range From: Not Detected Reference Range To: Performing Facility Details: Date/Time: 2022-01-02 18:49:13.0 Performing Facility: HOSPITAL Facility ID: Interpretation: Very abnormal Result Method: LAB DEVICE: SYSTEM Status: Final Test Code: (LN LOINC)/ Result Code: (SCT/
Aktuelle Erkrankungen
Age-related osteoporosis without current pathological fracture ? Anemia ? Arthritis ? Breast cancer right breast , completed xrt 3/7. lumpectomy 12/7/12. will start tamoxifen in july. ? Cellulitis of face ? Chronic diarrhea ? Depression ? Diabetes mellitus ? Environmental allergies seasonal hay fever ? Genital HSV ? GERD (gastroesophageal reflux disease) ? Hemorrhoids ? Hiatal hernia ? Hyperlipidemia ? Hypertension ? IBS (irritable bowel syndrome) ? Left ventricular diastolic dysfunction, NYHA class ? Obesity ? Osteoarthritis ? RLS (restless legs syndrome)
Vorgeschichte
Age-related osteoporosis without current pathological fracture ? Anemia ? Arthritis ? Breast cancer right breast , completed xrt 3/7. lumpectomy 12/7/12. will start tamoxifen in july. ? Cellulitis of face ? Chronic diarrhea ? Depression ? Diabetes mellitus ? Environmental allergies seasonal hay fever ? Genital HSV ? GERD (gastroesophageal reflux disease) ? Hemorrhoids ? Hiatal hernia ? Hyperlipidemia ? Hypertension ? IBS (irritable bowel syndrome) ? Left ventricular diastolic dysfunction, NYHA class ? Obesity ? Osteoarthritis ? RLS (restless legs syndrome)
Andere Medikamente
atorvaSTATin (LIPITOR) 40 mg tablet Take 1 tablet by mouth nightly. calcium-magnesium-zinc (RA CALCIUM/MAGNESIUM/ZINC) 333-133-5 MG TABS Take 1 tablet by mouth 2 times daily . clopidogrel (PLAVIX) 75 mg tablet Take 1 tablet by mouth
Allergien
Horse-Derived Products ? Morphine And Related ? Salicylates
Vorherige Impfungen
-

VAERS 2134424

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
74,0
Geschlecht
F
Eingang
23.02.2022
Impfdatum
25.03.2021
Beginn
17.02.2022
Tage bis Beginn
329,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute myocardial infarction Bradycardia COVID-19 Cardiac arrest Chest pain Computerised tomogram abnormal Death Dialysis related complication Electrocardiogram abnormal Endotracheal intubation Haemofiltration Illness Life support Perforation Procalcitonin Renal failure SARS-CoV-2 test positive Splenic haematoma

Symptomtext

Pfizer COVID Vaccine: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/4/2021 and 3/25/2021. Presented to ED 2/17/2022 c/o intermittent chest pain x1 week progressing to severe. EKG showed inferior STEMI sent to cathlab unable to pass wire, CP resolved. Elevated white count and procalcitonin, started on iv abx. 2/18/22 Covid+. Later had a cardiac arrest ACLS x/multiple rounds w/ROSC, intubated. Subsequent CT scan showed probable perforation near the GE junction w/hematoma near spleen. Renal failure and was started on CRRT, circuit kept clotting due to her severe illness and COVID, unable to dialyze. Continued to decompensate and then had severe bradycardia tx'd with transcutaneous pacing and eventually the family made her DNR. Expired on 2/19/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
2,0
Labordaten
COVID Positive 2/18/2022 using the Roche LIAT SARS assay platform
Aktuelle Erkrankungen
-
Vorgeschichte
CAD, Diabetes, Hyperlipidemia, Hypertension, Mitral valve disorder, Ischemic cardiomyopathy with EF 40%
Andere Medikamente
Amlodipine, Aspirin, Benazepril, Canagliflozin, Carvedilol, Cholecalciferol, Coenzyme Q10, Ezetimibe, FLuoxetine, Icosapent ethyl, Insulin Aspart, Insulin Degludec, Omeprazole, Pravastatin, Semaglutide, Spironolactone, Valsartan
Allergien
Atorvastatin, Simvastatin
Vorherige Impfungen
-

VAERS 2134418

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
73,0
Geschlecht
M
Eingang
23.02.2022
Impfdatum
04.03.2021
Beginn
11.02.2022
Tage bis Beginn
344,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Blood creatinine increased Blood pH decreased Blood sodium decreased COVID-19 Death Extra dose administered General physical health deterioration Inappropriate schedule of product administration Malaise Metabolic acidosis Oxygen saturation decreased Positive airway pressure therapy Pyrexia SARS-CoV-2 test positive Tachypnoea

Symptomtext

Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 1/15/21, 3/04/21, and 3/25/21. Covid + 1/18/22. Presented to ED 1/27 w/symptoms x9 days related to COVID-19 infection. In ED, vitals showed T 99.4F, BP 104/70 mmHg, satting 99% on RA. Metabolic acidosis (venous pH 7.29), elevated Cr of 1.96, Na 133. Morning of 01/31, acutely desatted to mid 80s and developed mild tachypnea, later fevered to 102.2F placed on CPAP. Continued to deteriorate, transitioned to DNAR. Tx'd with cefepine remdesivir, dexamethasone and vancomycin. Pt expired on 2/11/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
15,0
Labordaten
1/18/22 -This sample was analyzed using the Hologic Panther System platform using PCR or equivalent Nucleic Acid Amplification(NAA)technology.
Aktuelle Erkrankungen
-
Vorgeschichte
ESRD s/p kidney transplant, HFrEF s/p orthotopic heart transplant HTN, HLD, Secondary hyperparathyroidism,, metabolic bone disease, OSA on CPAP, DM, neuropathy
Andere Medikamente
mycophenolate, pravastatin,tacrolimus, tylenol, aspirin, calcium carbonate, carvedilol, vitamin d3, empagliflozin, gabapentin, insulin glargine, insulin lispro, lactobacillus, omega3, omeprazole, patiromer, PEG 3350, prednisone, sodium bica
Allergien
amoxicillin, recephin, sulfasalazine, penicillins, sulfa, aldoseterone antagonists, beta blockers, entresto, tramadol, codeine, niaspan, terazosin
Vorherige Impfungen
-

VAERS 2134413

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
87,0
Geschlecht
M
Eingang
23.02.2022
Impfdatum
04.03.2021
Beginn
07.02.2022
Tage bis Beginn
340,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Acute respiratory failure COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Death Dyspnoea Encephalopathy Fall General physical health deterioration Inappropriate schedule of product administration Lung infiltration Pneumonia aspiration Pulmonary congestion SARS-CoV-2 test positive

Symptomtext

Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 2/03/21, 3/04/21. Covid + 2/03/22. Presented to ED 1/8/22 after fall at home admitted for acute hypoxic resp failure and acute encephalopathy 2/2 Covid PNA, tx'd w/IV Abx and steroids, transferred to rehab facility 1/15/22. At rehab facility had increasing SOB and cough. Readmitted 2/26/22 w/PE and acute renal failure. 1/29/22: CXR showing worsening right sided infiltrates and pulmonary congestion and aspiration PNA. Continued to deteriorate, transitioned to comfort care. Tx'd with cefepine and zosyn during current admission. Expired on 2/07/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
12,0
Labordaten
2/03/22 - This sample was analyzed using the Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
Aktuelle Erkrankungen
COVID19
Vorgeschichte
anemia, BPH, CKD4, Dementia, DM
Andere Medikamente
tylenol, aspirin, calcium carbonate, vitamin b12, dexamethasone, diphenoxalate/atropine, docusate, donepezil, lovenox, escitalopram, fluconazole, glipizde, insulin lispro, mirbegron, nystatin, omeprazole, oxybutynin, pantoprazole, quetiapin
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2129330

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
67,0
Geschlecht
F
Eingang
21.02.2022
Impfdatum
15.03.2021
Beginn
07.02.2022
Tage bis Beginn
329,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Blood glucose increased Blood sodium decreased COVID-19 Cardioversion Chest X-ray abnormal Chills Cough Death Dizziness Dyspnoea Endotracheal intubation Haemoglobin increased Lung opacity Malaise Metabolic acidosis Pyrexia SARS-CoV-2 test positive Supraventricular tachycardia

Symptomtext

Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 02/22/21 and 3/15/21. Covid + 1/23/22. Presented to ED 1/23/22 with SOB, cough, fever, chills, and general malaise/dizziness x 4days. Placed on Airvo then escalated to NIV. Labs significant for glucose 387, Na 128, AGMA, Hgb 16.2. CXR with multifocal opacities. Respiratory status required intubation on 1/25/22. On 2/3 episode of unstable SVT refractory to adenosine, required defibrillation six times. Transitioned to DNR. Treated with remdesivir, solumedrol, and cefepime. Expired 02/07/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
15,0
Labordaten
1/23/22 Covid +: This sample was analyzed using the Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
Aktuelle Erkrankungen
-
Vorgeschichte
renal HTN, immunosuppression, CAD, ESRD s/p renal transplant, DM
Andere Medikamente
tylenol, alendronate, dorzolamide/timolol, glipizide; hydralazine,insulin aspart, insulin degludec, labetalol, methocarbamol, mycophenolate sodium, prednisone, Bactrim, tacrolimus
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2122969

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
LA
Alter
51,0
Geschlecht
F
Eingang
18.02.2022
Impfdatum
18.03.2021
Beginn
01.06.2021
Tage bis Beginn
75,0
Dosis
UNK
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein
Alopecia COVID-19 Cerebrovascular accident Fatigue Feeling abnormal Gait inability Inflammation Laboratory test Myocarditis Neuralgia Plantar fasciitis Quality of life decreased Visual impairment

Symptomtext

I got covid a second time then I started having strokes followed by myocardiatus. I have inflammation throughout my entire body and very exhausted with brain fog.. My quality of life has greatly diminished I also have Plantar fasciitis From the Inflammation. I'm Unable to walk. I have nerve pain throughout my entire body. My hair is falling out. My vision has been affected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
3,0
Labordaten
Many while I was hospitalized
Aktuelle Erkrankungen
Broken T11
Vorgeschichte
Asthma
Andere Medikamente
Depakote Zoloft Aspirin
Allergien
None
Vorherige Impfungen
-

VAERS 2119470

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MT
Alter
63,0
Geschlecht
M
Eingang
17.02.2022
Impfdatum
07.03.2021
Beginn
30.08.2021
Tage bis Beginn
176,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure COVID-19 Cardiac failure congestive Endotracheal intubation Liver function test increased SARS-CoV-2 RNA SARS-CoV-2 test positive

Symptomtext

Case completed 2 dose primary Covid series in March 2021, then was hospitalized for Covid in August of 2021. * Acute hypoxemic respiratory failure due to COVID-19 Assessment & Plan Much improved, extubated 8/31, down to 1L of oxygen at rest, a few liters with exertion. Suspect mostly covid related at this point but acute chf likely contributed. -Day 5 dexamethasone and baricitinib, held remdesivir due to elevated LFTs. Upon discharge, will use dexamethasone alone for an additional 5 days to complete a total 10-day course -Discontinued abx for CAP a few days ago with no firm evidence of bacterial infection -Continue oral diuretics for CHF upon discharge -health department notified of the discharge and he will maintain isolation per their recommendation

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
5,0
Labordaten
Ordered Test: SARS-CoV-2 RNA Resp Ql NAA+probe Status: Final Specimen Source: SOFT TISSUE SAMPLE Specimen Site: BOTH ANTERIOR NARES Specimen Collection Date/Time: 2021-08-30 14:16:00.0 Results:* Resulted Test: SARS-CoV-2 RNA Resp Ql NAA+probe Coded Result: POSITIVE Numeric Result: Units: Text Result: Reference Range From: Negative Reference Range To: Performing Facility Details: Date/Time: 2021-08-30 14:35:18.0 Performing Facility: CLINIC Interpretation: Very abnormal Result Method: LAB DEVICE: ABBOTT ID NOW Status: Final Test Code: Result Code: Result Comments: SARS-CoV-2, NAA (COVID-19)
Aktuelle Erkrankungen
? Anterior chest wall pain ? Chronic constipation ? Chronic diarrhea ? Depression ? Diabetes mellitus ? Hyperlipidemia ? Hypertension ? Osteomyelitis of ankle and foot ? PONV (postoperative nausea and vomiting) ? Sleep apnea
Vorgeschichte
? Anterior chest wall pain ? Chronic constipation ? Chronic diarrhea ? Depression ? Diabetes mellitus ? Hyperlipidemia ? Hypertension ? Osteomyelitis of ankle and foot ? PONV (postoperative nausea and vomiting) ? Sleep apnea
Andere Medikamente
ADDERALL XR 30 MG 24 hr capsule Sig - Route: Take 30 mg by mouth every morning . - Oral Class: Historical Med Earliest Fill Date: 9/24/2019 Apple Cider Vinegar 300 MG TABS Sig - Route: Take 3 tablets by mouth Daily. - Oral Class: Hi
Allergien
No active allergies
Vorherige Impfungen
-

VAERS 2118961

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
80,0
Geschlecht
F
Eingang
17.02.2022
Impfdatum
25.03.2021
Beginn
08.01.2022
Tage bis Beginn
289,0
Dosis
3
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Atrial fibrillation Blood creatinine increased Blood sodium decreased Blood urea increased C-reactive protein increased COVID-19 Chest X-ray abnormal Condition aggravated Cough Death Dyspnoea Full blood count Lung infiltration Metabolic function test Oxygen saturation decreased Positive airway pressure therapy Procalcitonin Renal impairment

Symptomtext

81 year old female s/p renal transplant on immuno-suppressants, atrial fibrillation, hx SSS/PPM. She presented to the ER with complaints of cough and shortness of breath. In the ER she desaturated to 86% and was placed on supplemental oxygen. Her COVID-19 PCR screen came back positive.. CBC and CMP were otherwise unremarkable except for low-sodium 130, creatinine of 1.7, UA abnormal. Chest x-ray shows patchy infiltrates, more on the right. She was started on Decadron, empiric antibiotics and was admitted to hospitalist service. Remdesivir was declined by family due to her renal transplant status. January 13, late afternoon patient desaturated and required BiPAP. She was afib/RVR and metoprolol IV 5 mg was given. Morphine and furosemide were also given. Transfer to Moderate Care was requested. Pulmonology was consulted. january 14, on HF NC 45 L 60%. Added doxycycline 100 mg IV for several days. Changed dexamethasone to IV. Added PRN IV metoprolol for afib/rvr and changed diltiazem to short acting so it may be given via NGT. May need NGT for nutrition and oral meds. WBC 10, BUN/Cr 54/1.2. CRP 10 (rising) and PCT 0.1. January 15, patient is clinically worse now on BiPAP, renal function is worse with rising BUN/Cr despite IVF. January 16, patient was pronounced expired at 06:50 hrs.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
8,0
Labordaten
Positive COVID test: 1/8/22
Aktuelle Erkrankungen
-
Vorgeschichte
7/2013 OA (osteoarthritis) of knee 6/2013 Congestive heart failure, unspecified 2013 Sick sinus syndrome 2-10-12 Wound of left leg 10-21-11 Shingles 4/28/11 Osteoarthritis, shoulder 2006 Glomerulonephritis Date Unknown Anemia Date Unknown Arrhythmia Date Unknown atrial fib Date Unknown Gastrointestinal disorder Date Unknown Heart murmur Date Unknown HTN (hypertension) Date Unknown Hyperlipidemia Date Unknown Hypothyroid Date Unknown Kidney transplanted Date Unknown MRSA (methicillin resistant Staphylococcus aureus) Date Unknown Pacemaker Date Unknown Prophylactic antibiotic Date Unknown Rheumatoid arthritis Date Unknown Sensory disorder Date Unknown Skin disease Date Unknown Skin tear of right forearm without complication Date Unknown Sleep disorder Date Unknown Sleep disorder Date Unknown Steroid long-term use superficial thrombosis
Andere Medikamente
acetaminophen (TYLENOL XR) 650 MG SR tablet apixaban (ELIQUIS) 2.5 MG TABS tablet atorvastatin (LIPITOR) 20 MG tablet calcitRIOL (ROCALTROL) 0.25 MCG capsule calcium-vitamin D (CALTRATE 600 PLUS D) 600-400 MG-UNIT tablet diltiazem coat
Allergien
Cipro [Ciprofloxacin Hydrochloride]Swelling, Unknown Ace InhibitorsCoughing Pain Relief Nausea and Vomiting Sulfa Drugs Nausea
Vorherige Impfungen
-

VAERS 2114186

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
IN
Alter
73,0
Geschlecht
M
Eingang
15.02.2022
Impfdatum
03.03.2021
Beginn
26.01.2022
Tage bis Beginn
329,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Activated partial thromboplastin time shortened Acute myocardial infarction Alanine aminotransferase increased Albumin globulin ratio decreased Ammonia normal Analgesic drug level therapeutic Angiogram pulmonary abnormal Anion gap Arteriosclerosis Arteriosclerosis coronary artery Aspartate aminotransferase increased Asthenia Atelectasis Bacterial test Basophil count decreased Basophil percentage Bilirubin urine Blood albumin normal

Symptomtext

1/26/22 The patient is a pleasant 74 yr/o male presenting to the ED with fall and cough. Patient states that last night he was trying to get out of bed and slid out of bed because he was generally weak and unable to get up. He apparently was lying on the floor for several hours. He did not hit his head and states he did not lose consciousness. He is on Coumadin at this time for history of left lower extremity DVT. He is not complaining of any particular pain on my exam but states that he has been having a cough with dyspnea over the past approximately 1 week. No hemoptysis. He denies having a fever. States he is up-to-date on COVID-19 vaccinations. He has chronic left lower extremity edema from his DVT. Review of Systems Constitutional: Negative for activity change, chills and fever. HENT: Negative for ear pain, congestion, sore throat, neck pain and ear discharge. Eyes: Negative for pain, discharge and redness. Respiratory: Positive for cough. Negative for chest tightness, shortness of breath and wheezing. Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Negative for abdominal distention, abdominal pain, constipation, diarrhea, nausea and vomiting. Genitourinary: Negative for decreased urine volume, difficulty urinating, dysuria, flank pain, hematuria and urgency. Musculoskeletal: Negative for back pain and arthralgias. Skin: Negative for color change and pallor. Neurological: Negative for dizziness, seizures, weakness, numbness and headaches. CBC w/Diff Collection Time: 01/26/22 6:17 PM Result Value Ref Range White Blood Count 3.85 (L) 4.5 - 11.0 10*3/uL Red Blood Count 4.45 (L) 4.5 - 5.9 10*6/uL Hemoglobin 13.0 (L) 13.5 - 17.5 g/dL Hematocrit 38.9 (L) 41.0 - 53.0 % Mean Corpuscular Volume 87.4 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 29.2 26.0 - 34.0 pg Mean Corpuscular HGB Conc 33.4 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 15.1 12.0 - 16.8 % Platelet Count 119 (L) 140 - 440 10*3/uL Mean Platelet Volume 11.1 8.4 - 12.4 fL Diff Type Hospital CBC w/AutoDiff (arb'U) Neutrophils % 70.0 45 - 80 % Lymphocyte % 16.4 15 - 50 % Monocyte % 12.5 0 - 15 % Eosinophil% 0.3 0 - 7 % BASO% 0.5 0 - 2 % Immature Granulocyte% 0.3 0.0 - 1.0 % Nucleated RBC % 0 0 /100(WBC) Neutrophil Abs 2.70 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 0.63 (L) 0.7 - 5.5 10*3/uL Monocyte Absolute 0.48 0.0 - 1.7 10*3/uL EOS-Absolute 0.01 0.0 - 0.8 10*3/uL Basophil Abs 0.02 0.0 - 0.2 10*3/uL Immature Granulocyte Abs 0.01 0.00 - 0.10 10*3/uL Partial Thromboplastin Time Collection Time: 01/26/22 6:17 PM Result Value Ref Range Partial Thromboplastin Time 38.8 (H) 25.1 - 36.5 s Protime-INR Collection Time: 01/26/22 6:17 PM Result Value Ref Range Prothrombin Time 25.2 (H) 10.3 - 13.3 s INR 2.1 INR CMP Collection Time: 01/26/22 6:17 PM Result Value Ref Range Sodium 136 136 - 145 mmol/L Potassium 4.8 3.5 - 5.1 mmol/L Chloride 109 (H) 98 - 107 mmol/L Carbon Dioxide 16 (L) 22 - 29 mmol/L Anion Gap 11 5 - 13 (arb'U) Glucose 158 (H) 74 - 99 mg/dL Blood Urea Nitrogen (BUN) 25 8 - 26 mg/dL Creatinine-Blood 1.35 (H) 0.73 - 1.18 mg/dL BUN/Creatinine Ratio 18.5 RATIO Estimated GFR 52 (L) >60 /1.73 m2 Estimated GFR if race >60 >60 /1.73 m2 Total Protein 7.5 6.2 - 8.0 g/dL Albumin 3.8 3.2 - 4.6 g/dL Globulin 3.7 1.5 - 4.5 g/dL Albumin/Globulin Ratio 1.0 (L) 1.1 - 2.5 RATIO Calcium 10.0 8.4 - 10.2 mg/dL Total Bilirubin 1.8 (H) 0.2 - 1.2 mg/dL AST/SGOT 64 (H) 5 - 34 U/L ALT/SGPT 57 (H) 0 - 55 U/L Alkaline Phosphatase 125 40 - 150 U/L Magnesium Collection Time: 01/26/22 6:17 PM Result Value Ref Range Magnesium 1.8 1.6 - 2.6 mg/dL CK Collection Time: 01/26/22 6:17 PM Result Value Ref Range CK 436 (H) 30 - 200 U/L Troponin Collection Time: 01/26/22 6:17 PM Result Value Ref Range Troponin 0.206 (HH) 0.000 - 0.034 ng/mL Ammonia Collection Time: 01/26/22 6:17 PM Result Value Ref Range Ammonia 45 <72 umol/L Toxicology Screen Collection Time: 01/26/22 6:17 PM Result Value Ref Range Acetaminophen <18.0 <18.0 ug/mL Ethylalcohol <10 <10 mg/dL Salicylate <5.0 2.0 - 20.0 mg/dL Urinalysis Collection Time: 01/26/22 6:26 PM Result Value Ref Range Color-Urine Yellow Clarity-Urine Clear Specific Gravity Urine 1.023 1.005 - 1.030 (arb'U) pH-Urine 5.5 5.0 - 9.0 (pH) Protein-Urine 50 (A) Negative mg/dL Glucose-Urine Negative Negative mg/dL Ketone-Urine Negative Negative mg/dL Bilirubin-Urine Negative Negative mg/dL Occult Blood-Urine 3+ (A) Negative (arb'U) Nitrite-Urine Negative Negative (arb'U) Urobilinogen-Urine Normal Normal (EhrlichU)/dL Leukocyte Esterase-Urine Negative Negative (arb'U) Source-Urine Urine Midstream Reflex Microscopic? Microscopic performed RBC-Urine 143 (H) 0 - 2 (HPF) WBC-Urine 3 0 - 3 (HPF) Squamous Epithelial-Urine 1 0 - 4 (HPF) Bacteria-Urine None Seen None Seen (HPF) Mucus-Urine TRACE (A) None Seen (LPF) Toxicology Screen, urine Collection Time: 01/26/22 6:26 PM Result Value Ref Range Amphetamines-Urine Scrn Negative Negative Barbiturates-Urine Screen Negative Negative Benzodiazepines-Urine Screen Negative Negative Cannabinoids-Urine Screen Negative Negative Cocaine-Urine Screen Negative Negative Opiates-Urine Screen Negative Negative Lactic Acid Collection Time: 01/26/22 7:22 PM Result Value Ref Range Lactic Acid 1.5 0.7 - 2.0 mmol/L XR Chest 1 Vw 1/26/22 IMPRESSION: 1. Hazy increased density in the lungs bilaterally may be mild edema or infiltrate CT Angiogram Chest For PE 1/26/22 IMPRESSION: 1. Limited exam secondary to motion artifact. Heterogeneous enhancement of bilateral pulmonary arteries and veins favored to be related to timing of the contrast bolus and mixing of contrast and motion artifact. No central pulmonary embolus and no convincing peripheral embolus on this limited exam. Correlation with Doppler venous ultrasound and d-dimer levels is recommended. 2. Emphysema. 3. Noncalcified nodule in the left upper lobe measures 3 mm and not seen on the prior exam. Recommend attention on follow-up. 4. Focal atelectasis or infiltrate in the left lung base. 5. Atherosclerotic vascular calcification and coronary artery calcification without aortic dissection. 1/29/22 Discharge: Hospital Course: The patient is a 74 year old male with past medical history of dm, dvt, chronic anticoagulation with coumadin, cirrhosis admitted for viral sepsis, covid 19. Please see h and p for details. The following issues were addressed: 1. Viral sepsis (temp 100.6, heart rate 110), poa - blood cultures no growth to date - afebrile >24 hours 2. Covid 19 infection - vaccinated - cta chest shows no pe - covid pos 1/26/22 - procal neg - continue supportive care - needs repeat imaging as outpatient with pcp to ensure resolution 3. Acute on stage 3 ckd - 2/2 dehydration - creatinine 1.2 on 8/16/21 - creatinine 1.35 on admission - creatinine 1.2 today - needs cmp 1/31/22 with pcp 4. Elevated troponin (peak troponin 0.206) - suspect non mi elevation in setting of covid - ekg shows no acute changes - trend flat 5. Rhabdomyolysis (peak ck 1449) - initial ck 436 - ck downtrending, 651 today - status post iv fluids - needs ck 1/31/22 with pcp 6. Transaminitis 2/2 rhabdomyolysis, covid 19, cirrhosis - alt/ast 41/49 on 6/15/21 - alt/ast 57/64 on admission - alt/ast 44/76 today - needs cmp 1/31/22 with pcp 7. Pancytopenia - wbc/hgb/plt 2.98/11.1/102 on 6/15/21 - wbc/hgb/plt 3.85/13/119 on admission - wbc/hgb/plt 2.35/11.1/97 today - needs cbc 1/31/22 with pcp 8. DM2 - hemoglobin a1c 6.8 - continue metformin, levemir - may need further adjustment of medications as outpatient with pcp 9. Chronic back pain - continue gabapentin 10. Status post fall - ct head shows no acute intracranial abnormality - ct cervical spine shows no fracture - seen by PT 11. Lung nodule - cta chest shows 3 mm left upper lobe nodule - outpatient follow up with pcp 12. DVT - continue chronic anticoagulation with coumadin as outlined below - inr 2.1 on admission - inr 1.6 today - needs inr 1/31/22 with pcp 13. Obesity - bmi 36.07 - dietary and lifestyle modifications 14. Cirrhosis 2/2 nash - on rifaximin, spironolactone at time of admission 2/13/22 Readmission: 74 yr old M with PMH of HTN, T2DM, CKD, NASH cirrhosis, CVA, OSA (wears CPAP), obesity, and chronic back pain who presents for bloody stools. Patient reports that he woke up this morning and had a bowel movement which was dark red blood mixed with his stool. States that he had an additional episode around 8 AM that looks similar. Reports some associated nausea and dry heaves with one episode of clear emesis. Reports resolution of nausea or vomiting and denies abdominal pain. Denies hematemesis, hemoptysis, or melena. Denies NSAIDs use. Denies fevers, chills, chest pain, shortness of breath, cough, sputum production, diarrhea, or urinary complaints. Patient reports being diagnosed with a LLE DVT about 6 months ago and being started on Coumadin. Reports that rash over left shin secondary to DVT and reports improvement in rash after being started on Coumadin. Patient also takes daily aspirin.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
3,0
Labordaten
1/26/22 COVID-19 Result Detected Abnormal 2/14/22 COVID-19 Result Detected Abnormal
Aktuelle Erkrankungen
-
Vorgeschichte
Anemia ohn Iron supplement o Blood transfusion without reported diagnosis o Cervical arthritis injection pain clinic o Cirrhosis o Colon polyp o CPAP (continuous positive airway pressure) dependence o Degenerative disc disease, cervical o Demand ischemia 11/21/2017 In the setting of anemia and GIB o Depression with anxiety o Diabetes 1.5, managed as type 2 o Diabetes mellitus niddm o Gastric bleed 2016 o Generalized osteoarthritis o H/O gastric bypass 1980s o HTN (hypertension) o Hypertension o Insomnia o Kidney stones o NAFLD (nonalcoholic fatty liver disease) o NASH (nonalcoholic steatohepatitis) o Obesity o OSA (obstructive sleep apnea) o Sleep apnea bipap o Spinal stenosis in cervical region o Stroke found on CT old no residual problems o Vascular headache o Vitamin D deficiency
Andere Medikamente
ASPIRIN 81 PO diphenhydrAMINE 25 mg capsule Commonly known as: BENADRYL Ferrous Sulfate 5 MG/20ML Liqd gabapentin 100 MG capsule Commonly known as: NEURONTIN TAKE 2 CAPSULES BY MOUTH 3 TIMES DAILY . insulin detemir 100 UNIT/ML
Allergien
Bumex, Celebrex, Lipitor, Lisinopril, Norvasc, Tricor, Vioxx, Zocor
Vorherige Impfungen
-

VAERS 2113308

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
64,0
Geschlecht
M
Eingang
15.02.2022
Impfdatum
16.11.2021
Beginn
31.01.2022
Tage bis Beginn
76,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Acute kidney injury Acute respiratory failure COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chronic obstructive pulmonary disease Computerised tomogram head abnormal Computerised tomogram thorax abnormal Constipation Dyspnoea Fibrin D dimer increased General physical health deterioration Hypercalcaemia Hypotension Intensive care Ischaemic hepatitis Lactic acidosis Lung adenocarcinoma

Symptomtext

Pt rec'd Pfizer 3/4/21 and 3/25/21 both from facility, then Moderna booster 11/16/21. Pt to ED 1/31/22 c/o SOB. Dx acute hypoxic resp failure. CXR and CT show large mass encroaching on R mainstem bronchus. Admitted to ICU and placed on vent. Pos COVID Pcr in ED. Hypotensive with pressors. After continued deterioration changed to DNR/DNI. Discharge dx: septic shock, acute hypoxic and hypercapnic resp failure, poorly differentiated adenocarcinoma of lungs with distal metastasis, pleural effusion, COPD exacerbation, COVID-19 pneumonia, lactic acidosis, tobacco use disorder, moderate hypercalcemia, D dimer elevated, abnormal head CT (mets), pericardial efusion w/o tamponade, acute renal failure/anuric, metabolic acidosis, respiratory acidosis, constipation, shock liver

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2112832

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
77,0
Geschlecht
F
Eingang
15.02.2022
Impfdatum
25.02.2021
Beginn
01.01.2022
Tage bis Beginn
310,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Event occurred after 2nd vaccine; breakthrough case admission; patient expired

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
1/18/2022 COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2110766

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
90,0
Geschlecht
F
Eingang
14.02.2022
Impfdatum
24.02.2021
Beginn
24.11.2021
Tage bis Beginn
273,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

Death related to COVID-19 as secondary condition

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Parkinson's disease; rheumatic tricuspid insufficiency; atrial fibrillation; DM2; Hx TIA; HTN; HLD
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2110233

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
86,0
Geschlecht
F
Eingang
14.02.2022
Impfdatum
28.02.2021
Beginn
31.08.2021
Tage bis Beginn
184,0
Dosis
2
Route/Site
IM / OT
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure COVID-19 COVID-19 pneumonia Fall SARS-CoV-2 test positive Syncope

Symptomtext

Admit for fall, syncope at home. COVID+ and found to have COVID PNA. Tx w/abx, steroid, remdesivir, baricitinib, O2. Hx COPD, Afib, emphysema. Acute on chronic resp fx. She is now improved and has achieved maximal hospital benefit. She is being discharged to facility to continue recovery

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
18,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2102166

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge #EN6202

kritisch
Staat
MI
Alter
77,0
Geschlecht
F
Eingang
10.02.2022
Impfdatum
06.03.2021
Beginn
19.03.2021
Tage bis Beginn
13,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Arthralgia Back pain Catheter placement Deep vein thrombosis Dyspnoea Emphysema Fatigue Iliac vein occlusion Oxygen therapy Peripheral swelling Pulmonary embolism Pulmonary mass Scan with contrast abnormal Surgery Thrombosis Ultrasound scan abnormal Venous stent insertion

Symptomtext

Shortness breath nodule on lung hospitalized for 4 days hypodox on oxygen sent home with oxygen at home,6 days later blood clots DVT hospitalized again had embolism in lungs,week to see specialized in the health systems , 1. O thx for pulmonisty, then 3 more months have to see vascular dr. Because no information on why my leg was huge for3 months finally ultrasound for blood flow block iliac vein one exploratory catheter to see if unblock then surgery to place venous stents all because I think health system set up terrible to see providers stupid call centers surgery place stents July 26 2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
Lung contrast 3times emergency again in July before surgery think another PE 4 hospital trips it?s now ten months,finally feeling almost back to normal pulmonologist perscripted trelegy in August 2021 immediate improvement still a few issues back ache shoulder ache fatigue not back to my exercise class that I did 3 times a week before vaccine ,blame all this issues on vaccine lung mild emphzma
Aktuelle Erkrankungen
None
Vorgeschichte
Non
Andere Medikamente
2 weeks after 1st shot notice trouble shortness breath got inhaler
Allergien
Napoxin napersin Nasids
Vorherige Impfungen
-

VAERS 2101597

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
50,0
Geschlecht
M
Eingang
10.02.2022
Impfdatum
02.04.2021
Beginn
06.02.2022
Tage bis Beginn
310,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

Death related to COVID-19

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Other significant conditions: ASHD, DM2, HTN, Asthma
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2087748

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
77,0
Geschlecht
M
Eingang
04.02.2022
Impfdatum
17.11.2021
Beginn
13.01.2022
Tage bis Beginn
57,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Abdominal pain Acute respiratory failure COVID-19 Death Hypoxia Renal failure SARS-CoV-2 test positive Septic shock

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/3/2021, 2/24/2021, and 11/17/2021. Patient tested positive at nursing home on 1/13/2022. Presented to ED on 1/20/22 for abdominal pain and hypoxia. Admitted for septic shock, acute respiratory failure, and renal failure. Received oxygen supplementation, dexamethasone, antibiotics, and pressors. On 1/21/2021, patient requested comfort care. Family in agreement. Expired 1/21/2022 at 1255.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
1,0
Labordaten
1/13/2022: COVID positive
Aktuelle Erkrankungen
-
Vorgeschichte
hypertension, dyslipidemia CAD, history of colon cancer, fatty liver disease, mitral regurgitation, gout
Andere Medikamente
allopurinol, aspirin, lipitor, lisinopril, metoprolol, ursodiol, multivitamin
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2082980

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
79,0
Geschlecht
M
Eingang
02.02.2022
Impfdatum
12.03.2021
Beginn
27.01.2022
Tage bis Beginn
321,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure COVID-19 COVID-19 pneumonia Death Dyspnoea Endotracheal intubation Fungaemia Intensive care Respiratory distress SARS-CoV-2 test positive Staphylococcal bacteraemia

Symptomtext

Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/14/21, 3/6/2021, and 9/19/2021. Covid + 1/8/22, Presented to ED 1/13/22 c/o SOB. Placed on HFNC in ED, admitted for acute hypoxemic respiratory failure due to Covid PNA transferred to ICU 1/14/22 due to O2 needs. Intubated 1/15/21. Developed staph epi bacteremia and fungemia during admission. Treated with remdesivir, baricitnib,zosyn, tobramycin, vancomycin, ambisome, micafungin, corticosteroids. Extubated on 1/25/22 leading to respiratory distress but pt declined reintubation. Status changed to DNR on 1/26/22. Expired on 1/27/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
14,0
Labordaten
1/11/21 Covid + Nasopharyngeal from nasopharynx
Aktuelle Erkrankungen
C. diff diarrhea
Vorgeschichte
bliateral lung transplant, afib, DM2, anxiety disorder, HTN
Andere Medikamente
acetominophen, apixaban, ascobic acid,buspirone, calcium citrate/vitamin D3, Vitamin B12, dilitiazem, ferrous sulfate, furosemide, gabapentin, levothyroxine, magnesium oxide, mycophenolate mofetil, pantoprazole, polyethylene glycol, potassi
Allergien
Ciprofloxacin, codeine, levofloxacin, latex, linezolid
Vorherige Impfungen
-

VAERS 2082236

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
66,0
Geschlecht
M
Eingang
02.02.2022
Impfdatum
13.09.2021
Beginn
24.01.2022
Tage bis Beginn
133,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure Atrial fibrillation COVID-19 Death Depressed level of consciousness Dyspnoea Encephalopathy Immunodeficiency Inappropriate schedule of product administration Metabolic disorder Renal failure Respiratory disorder SARS-CoV-2 test positive Sepsis

Symptomtext

Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/27/2021, 3/02/2021 and 9/13/2021. Covid+ 12/27/22 rec'd monoclonal antibody infusion 12/27 w/improvement until 1/1/22. Presented to ED 1/4/22 c/o SOB. Admitted for Afib with RVR, Covid and atypical presentation of sepsis. Treated w/steroids, remidisivir, baricitnib, vancomycin and zosyn. Repiratory status continued to decline to acute hypoxemic respiratory failure complicated by metabolic issues in the setting of immuncomprised state and renal failure. DNR status, obtunded and encephalopathic. Expired 1/24/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
14,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hypothyroidism, HTN, HLD, T2DM with polyneuropathy, CHF class 2 stage C, s/p kidney transplant 3/2019, Afib
Andere Medikamente
apixaban 5mg BID, atorvastatin 10mg 4 times weekly, Vitamin D3 50mcg daily, VitaminB-12 500mcg daily, doxycycline hyclate 100mg BID, famotidine 20mg daily, furosemide 20mg daily prn, glimepiride 2mg daily, insulin aspart 35units injected da
Allergien
NKA
Vorherige Impfungen
-

VAERS 2079407

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
75,0
Geschlecht
M
Eingang
01.02.2022
Impfdatum
17.11.2021
Beginn
23.01.2022
Tage bis Beginn
67,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

Death related to COVID-19 infection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
OSC: COPD; pulmonary fibrosis; DM; CAD; HTN; obesity
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2079100

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
65,0
Geschlecht
M
Eingang
01.02.2022
Impfdatum
06.10.2021
Beginn
30.12.2021
Tage bis Beginn
85,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Aortic valve replacement Blood potassium increased COVID-19 Cardiac arrest Death Dyspnoea SARS-CoV-2 test positive

Symptomtext

Admitted to hospital unit from clinic appt with critical K+, increased SOB, and COVID postiive. He is also s/p TVAR 1 week. Discharged home on 1/12/22, and expired following cardiac arrest.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
13,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2078808

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
56,0
Geschlecht
M
Eingang
01.02.2022
Impfdatum
18.08.2021
Beginn
18.01.2022
Tage bis Beginn
153,0
Dosis
2
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory distress syndrome Acute respiratory failure Agitation Anticoagulant therapy Blood gases COVID-19 COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram thorax abnormal Condition aggravated Culture negative Deep vein thrombosis Endotracheal intubation Hypernatraemia Imaging procedure abnormal Immunosuppression Lung opacity Mechanical ventilation

Symptomtext

Hospitalized 01/15/2022-still currently admitted; COVID-19 positive 01/18/2022; fully vaccinated plus booster COVID 19 infection Acute hypoxemic respiratory failure -Symptom onset 1/2/22 -Vaccination status: vaccinated with pfizer -Currently requiring 4 L O2 (came into ED on room air, began requiring oxygen around midnight) -CXR 1/14 independently reviewed, with bilateral patchy opacities and pulmonary vascular prominence -Repeat CXR ordered 1/15 as patient is now requiring oxygen. Unclear if this is related to fluid bolus or worsening covid 19 pneumonia -Start Decadron 6mg daily x 10 days (start 1/15) -Monitor daily covid immunology labs -VTE prophylaxis with subcutaneous heparin -IS q 1hr while awake, prone positioning prn Acute respiratory failure with hypoxia (HCC) Overview -Admitted on 01/15/2022 with COVID pneumonia, required 4 L nasal cannula -Escalated to 80% high-flow nasal cannula by 1/16 -By 1/17 requiring 95% FiO2 via high-flow nasal cannula, P/F ratio 79 on blood gas, saturations in the low 90s at rest. Nursing concern is desaturations whenever he gets out of bed, often does not hit the call light and pulls off oxygen supply with significant desaturations that take numerous minutes to recover with high-flow and non-rebreather. - Intubated 1/18/22 01/25/2022 notes: Acute respiratory failure with hypoxia (HCC) Assessment & Plan Secondary to COVID pneumonia/ARDS and superimposed bacterial pneumonia. Intubated 1/18. Chest imaging w/ bilateral patchy opacities. - Continue lung protective ventilation, daily SBT/SAT, weaning sedation for vent synchrony, no longer requiring paralysis and proning, VAP ppx. - I/O goal even, lasix had been held per renal for hypernatremia, and will reach back out to nephrology about fluid goals - Completed empiric zosyn x 5 days on 1/21, all cultures negative - Continue therapeutic anticoagulation for multiple RUE thrombi - COVID-specific therapy below Pneumonia due to COVID-19 virus Assessment & Plan Vaccinated, immunosuppressed. Symptom onset: 1/2/22. Test positive: 1/6/22. Admission: 1/15/22. Intubation: 1/18/22. Remdesivir: outside window Steroids: Dexamethasone 6mg daily (1/15-1/17), solumedrol 40mg IV BD (1/17-present), decrease to 30mg IV BID solumedrol 1/26 Plan for 1/27: Will re-culture given persistent fevers this AM Start empiric Vanc/Zosyn; obtain MRSA PCR Continue to wean IV sedation as able; start Seroquel to assist with this. May need precedex. Repeat cultures for fever overnight, procal is elevated,question slightly worse, will restart zosyn and vancomycin with de-escalation based on culture data, if no growth on sputum, will consider bronchoscopy given chronic immunosuppression. Had already completed course of cefazolin for suspected superimposed bacterial pneumonia earlier in course. Continue ventilator support, agitated, using oxycodone and klonapin for sedation weaned off, and will add seroquel for agitation before adding precedex. Steroid wean for COVID-specific therapy, on 30mg solumedrol BID, decreasing every 3d. Lasix for goal negative fluid balance. Tacro per nephrology for renal transplant. Heaprin gtt for RUE DVT. 01/31/2022 notes: Persistently febrile: blood cultures sent again Sputum culture still positive for pseudomonas, continue Zosyn for 7-10 course. Send for CT chest, new right sided pneumothorax, stable on interval chest xray today but with fevers need to exclude a parapneumonic process.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
17,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin (HCC) Hypertension associated with diabetes (HCC) Chronic diastolic congestive heart failure (HCC) Pneumonia due to COVID-19 virus Acute respiratory failure with hypoxia (HCC) Renal transplant recipient, 2020 Acute deep vein thrombosis (DVT) of right upper extremity (HCC) Allergic rhinitis, cause unspecified Mixed hyperlipidemia History of transient ischemic attack (TIA) Neuropathy of left lower extremity Arteriovenous fistula stenosis (HCC) Secondary hyperparathyroidism of renal origin (HCC) Chronic systolic congestive heart failure (HCC)
Andere Medikamente
alendronate (FOSAMAX) 70 MG tablet amLODIPine (NORVASC) 5 MG tablet aspirin 81 MG enteric coated tablet atorvastatin (LIPITOR) 80 MG tablet blood glucose test strips (BAYER CONTOUR NEXT TEST) carvedilol (COREG) 25 MG tablet chlorthalidone (
Allergien
Iodinated contrast media
Vorherige Impfungen
-

VAERS 2078806

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
84,0
Geschlecht
M
Eingang
01.02.2022
Impfdatum
19.11.2021
Beginn
19.01.2022
Tage bis Beginn
61,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Anaemia Angioplasty Anticoagulant therapy Asymptomatic COVID-19 COVID-19 COVID-19 pneumonia Cellulitis Computerised tomogram thorax abnormal Hypoxia Impaired healing Inappropriate schedule of product administration Magnetic resonance imaging Renal impairment SARS-CoV-2 test positive Toe amputation Toxic encephalopathy Vascular operation

Symptomtext

Hospitalized 01/19/2022-still currently admitted; COVID-19 positive 01/19/2022; fully vaccinated plus booster ASSESSMENT / PLAN: COVID Acute hypoxic respiratory failure secondary to above COVID positive 1/19 Asymptomatic; per facility have not noted any symptoms either CT thorax does not show findings of COVID Decadron 6mg daily Remdesivir contraindicated due to renal function Supplemental O2 PRN; currently on 3L, wean as able Admitted with COVID-19 pneumonia and acute hypoxic respiratory failure. On 3 L by nasal cannula. Started on Decadron. Unlikely to benefit from Remdesivir. Wean off O2 as able. CT thorax does not show findings of COVID however the patient is wheezing and hypoxic. He also has right lower extremity cellulitis and nonhealing 2nd toe amputation. Had a recent angioplasty of the right lower extremity with vascular surgery. Will start the patient on vancomycin and Zosyn. Heparin drip in place of Xarelto for now. MRI to rule out osteomyelitis. Vascular surgery consult. Consider podiatry consult pending MRI findings. The patient also has acute encephalopathy likely toxic metabolic in the setting of cellulitis and COVID. Monitor for now. Patient has acute on chronic anemia. 01/23/22 notes: COVID pnuemonia. Acute hypoxic respiratory failure secondary to above -resolved COVID positive 1/19 Asymptomatic; per facility have not noted any symptoms either CT thorax does not show findings of COVID on room air now. Will stop decadron in case that is causing agitation. 01/31/2022 notes: Acute hypoxic respiratory failure resolved COVID-19 pneumonia resolved Currently on room air Disposition: awaiting placement to skilled nursing facility

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
13,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Non-pressure chronic ulcer of other part of right foot with fat layer exposed (HCC) Acute respiratory failure with hypoxia CHF (congestive heart failure) ( Chronic anticoagulation Atrial fibrillation Obesity Tobacco abuse, in remission OSA (obstructive sleep apnea) Hypothyroidism Type 2 diabetes mellitus with diabetic neuropathy, without long-term current use of insulin Chronic diarrhea of unknown origin Peripheral sensory neuropathy Hyperlipidemia Essential hypertension Vasomotor rhinitis Claudication Peripheral vascular disease DOE (dyspnea on exertion) Vitamin B12 deficiency Spinal stenosis of lumbar region without neurogenic claudication Hiatal hernia Osteoarthritis of left knee History of total bilateral knee replacement Unspecified inflammatory spondylopathy, lumbosacral region
Andere Medikamente
apixaban (ELIQUIS) 2.5 MG tablet aspirin 81 MG chewable tablet bisacodyl (DULCOLAX) 10 MG suppository Blood Glucose Monitoring Suppl MISC collagenase ointment cyanocobalamin (B-12) 1000 MCG/ML injection Elastic Bandages & Supports (JOBST RE
Allergien
Atorvastatin Ezetimibe
Vorherige Impfungen
-

VAERS 2071991

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
79,0
Geschlecht
F
Eingang
28.01.2022
Impfdatum
30.03.2021
Beginn
07.12.2021
Tage bis Beginn
252,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute kidney injury Bacteraemia COVID-19 Death Dialysis General physical health deterioration Heart rate decreased Mental status changes Oxygen saturation decreased SARS-CoV-2 test positive

Symptomtext

12/07/2021: admitted from nursing home with low oxygen saturation, altered mental status, positive for COVID x 6 days, health has been declining over the last 5 days. Pt received 2 doses of Pfizer COVID-19 vaccines (on 3/2/21 and 3/30/21) 12/08/2021: treated with vancomycin for bacteremia. Consulted with nephrologist for AKI 12/11/2021: Patient's HR and oxygen levels started dropping 10-15 minutes into dialysis. Not respond to code. Patient was put on comfort care and pronounced deceased at 1206

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2068741

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
84,0
Geschlecht
M
Eingang
27.01.2022
Impfdatum
14.04.2021
Beginn
12.01.2022
Tage bis Beginn
273,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Asthenia COVID-19 Cough Death Dyspnoea Fluid intake reduced General physical health deterioration Hypophagia Inappropriate schedule of product administration Mental status changes SARS-CoV-2 test positive

Symptomtext

Pfizer COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/17/2021 and 4/14/2021. Presented to ED on 1/5/2022 and diagnosed with COVID-19, received monoclonal antibody treatment on 1/10/2022. Returned to ED 1/12/2022 with complaints of worsening shortness of breath, cough, altered mental status and weakness two weeks in duration. Per EMS SpO2 on room air was 78% and improved to the 90s on 2 L NC. Additionally, patient has not been eating or drinking. Continued to decline and expired on 1/17/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
5,0
Labordaten
Positive COVID-19 on 1/5/2022 and 1/12/2022 using the platform using PCR or equivalent testing technology.
Aktuelle Erkrankungen
-
Vorgeschichte
A-fib, Automatic implantable cardioverter-defibrillator in situ, basal cell carcinoma, CAD s/p stent to RCA, CHF, HFrEF, CKD, GERD, C. diff diarrhea, Heart murmur, hyperlipidemia, hypertension, H/O MI, Lumber compression fracture, Osteoarthritis, osteoporosis, Rheumatoid arthritis.
Andere Medikamente
Acetaminophen, Atorvastatin, Benzonatate, Cholecalciferol, Divalproex, folic acid, methotrexate, metoprolol, omeprazole, prednisone, rivaroxaban, sertraline, furosemide.
Allergien
Midodrine, Codeine
Vorherige Impfungen
-

VAERS 2065378

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
75,0
Geschlecht
M
Eingang
26.01.2022
Impfdatum
15.10.2021
Beginn
16.01.2022
Tage bis Beginn
93,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute left ventricular failure Acute myocardial infarction Acute pulmonary oedema Acute respiratory failure Akinesia Anticoagulant therapy Arterial catheterisation Blood culture negative Brain natriuretic peptide increased Bronchoalveolar lavage Bronchoscopy COVID-19 COVID-19 pneumonia Cardiac failure Chest pain Condition aggravated Coronary artery disease Dysphagia

Symptomtext

Hospitalized 01/16/2022-still currently admitted; COVID-19 positive 01/16/2022; fully vaccinated plus booster Admitting Diagnosis: Acute hypoxemic respiratory failure due to COVID-19 Admitted: 1/16/2022 1:35 PM ASSESSMENT / PLAN: Patient is a 75 y.o. male with past medical history of type 2 diabetes, hypertension, hyperlipidemia, chronic obstructive pulmonary disease, PVD status post fem-pop bypass who is admitted to the intensive care unit for further management of acute hypoxic respiratory failure and NSTEMI. New was hypoxic requiring BiPAP with 100% FiO2. His EKG showed ST depressions and elevated troponins he had further chest pain in the ER. Case was discussed with interventional cardiology from ER no recommendation for emergent catheterization recommended heparin and transfer to Hospital. Given patient's tenuous respiratory status and requiring BiPAP recommended intubation prior to transfer patient was intubated. Upon arrival to medical intensive care unit patient was requiring pressors. And had cool lower extremities. We ordered stat echocardiogram and placed arterial line. # Acute hypoxic respiratory failure with bilateral pulmonary infiltrates Pulmonary edema secondary to HF COVID 19 Hx of COPD Possible etiologies include COVID pneumonia, superimposed bacterial pneumonia, pulmonary edema secondary to heart failure. Some of these, most likely is heart failure due to elevated BNP to 19000, reduced ejection fraction noted on echocardiogram. Heart failure likely secondary to ischemic event. Plan: o Empiric coverage with Unasyn o Blood cultures, sputum culture, bronchoscopy with BAL and associated labs, antigens and cultures o Dexamethasone 6 mg for 10 days o Finish course of remdesivir started at outside hospital o Titrate oxygen to maintain saturation greater than 90% o Albuterol PRN 01/20/22 notes: 1. Acute hypoxic respiratory failure - resolved Possible etiologies include COVID pneumonia, superimposed bacterial pneumonia, pulmonary edema secondary to heart failure. Some of these, most likely is heart failure due to elevated BNP to 19000, reduced ejection fraction noted on echocardiogram. Heart failure likely secondary to ischemic event. Patient does have a history of COPD. Patient was successfully extubated to room air on 1/20/22 with no immediate issues. Plan: - COVID 19 - Continue Decadron 6mg qd for 10 d (1/26) - Continue to monitor respiratory status overnight post-extubation - titrate to maintain >90%SpO2 - albuterol PRN - Possible bacterial PNA - unlikely given overall clinical picture showing greater cardiogenic component with little signs of bacterial infection - Cultures NGTD - Unasyn 5 days, last day tomorrow (1/21)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
10,0
Labordaten
Continued notes from ITEM 18 01/26/2022 notes: Acute hypoxic respiratory failure: Likely multifactorial from flash pulmonary edema 2/2 HFrEF 25%, COVID pneumonia, and possible aspiration pneumonia. Patient was treated with 5 days of Unasyn for possible aspiration pneumonia. COVID pneumonia Possible aspiration pneumonia Dysphagia o Intermittent BiPAP as needed for continued dyspnea o Continue Lasix 40 IV TID and spironolactone, he appears to be nearing euvolemia, but will defer management of diuretics to Cardiology o Continue Decadron for 10 days, last day 1/26 o SLP following, continue dysphagia diet Shock, resolved: possibly mixed cardiogenic > septic. Was on pressors in the intensive care unit Acute systolic heart failure: EF of 25% CAD Elevated troponin, type 1 vs type 2: akinesis of mid distal, anterior/anteroseptal/inferior septal, apical, and distal ill inferior segments. Patient status post 48 hours heparin drip. o Cardiology followup planning possible left heart catheterization 1/25 pending their re-evaluation, continuing Lasix 40 mg IV 3 times a day o Cardiology repeating TTE today
Aktuelle Erkrankungen
-
Vorgeschichte
Acute hypoxemic respiratory failure due to COVID-19 Essential hypertension COPD (chronic obstructive pulmonary disease) Anxiety state RLE PAD s/p bypass Insomnia Rosacea Type 2 diabetes mellitus without complication, without long-term current use of insulin Hypokalemia Prostate troubles Pneumonia due to COVID-19 virus AKI (acute kidney injury) NSTEMI (non-ST elevated myocardial infarction) Acute respiratory failure
Andere Medikamente
amLODIPine (NORVASC) 5 MG tablet ascorbic acid (VITAMIN C) 1000 MG tablet aspirin 81 MG tablet citalopram (CELEXA) 40 MG tablet clopidogrel (PLAVIX) 75 MG tablet cyanocobalamin 500 MCG tablet hydroCHLOROthiazide (HYDRODIURIL) 25 MG tablet i
Allergien
Bee Venom Statin (Atorvastatin) Zolpidem
Vorherige Impfungen
-

VAERS 2062908

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MO
Alter
80,0
Geschlecht
M
Eingang
25.01.2022
Impfdatum
19.03.2021
Beginn
26.11.2021
Tage bis Beginn
252,0
Dosis
1
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Bradycardia COVID-19 COVID-19 pneumonia Chest X-ray abnormal Death Dyspnoea Endotracheal intubation General physical health deterioration Hypoxia Intensive care Lung opacity Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

Patient was an 81-year-old gentleman past medical history A. fib on Eliquis, hypertension, prostate cancer diagnosed in 2017 enrolled in clinical trial, admitted to the medical ICU at Hospital for acute hypoxic respiratory failure secondary to Covid pneumonia, transferred from Hedrick Medical Center for acute worsening of his hypoxia. Intubated on 12/2/21. After multiple failed attempts, the patient passed his ZEEP on 12/15 and patient was extubated to NIPPV. s/p Dexamethasone 12/02-12/05, remdesivir 12/02-12/06, baricitinib 12/02-12/09 AND Tocilizumab 12/09 Hospital course complicated by bradycardia and concern for possible AV block vs junctional rhythm. Cardiology felt that the patient did not have a complete heart block. Discussion had with patient on 12/16 with wife at bedside about respiratory status and if need for reintubation occurred what his choice would be. Patient was wearing BiPAP and shaking his head to answer questions. Was following commands appropriately. Patient asked directly if his respiratory status would worsen and he was about to die would he want a tube down his throat again and placed on the ventilator, patient shook his head no multiple times. Wife was present during this encounter and was in agreement to honor patient's wishes. Patient's CODE STATUS is DNR/DNI. since extubation 12/15 patient failed multiple attempts to wean O2 requirement to HFNC and required to be put back on BiPAP due to worsening resp status.s/p lasix with adequate urine output. Chest x-ray noted worsening bilateral opacities consistent with COVID-19 on 12/18. Family discussion 12/19: Goals of care discussion had at bedside with patient's wife, daughter, and daughter (via phone). Discussed worsening respiratory status, increased work of breathing, and patient comfort. Patient expressed his wishes the other day to be DNR/DNI; Family expressed understanding that patient is worsening and they would want to transition to comfort. All family questions were answered. Family was able to gather at bedside on 12/20/2021 and patient was transitioned to comfort care and taken off respiratory support. The patient passed away at 17:45 with family at bedside. Pronounced by MD.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
18,0
Labordaten
COVID+11/26/21
Aktuelle Erkrankungen
-
Vorgeschichte
Patient was an 81-year-old gentleman past medical history A. fib on Eliquis, hypertension, prostate cancer diagnosed in 2017 enrolled in clinical trial at KU
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2060225

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AZ
Alter
69,0
Geschlecht
M
Eingang
24.01.2022
Impfdatum
02.03.2021
Beginn
19.04.2021
Tage bis Beginn
48,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Cerebral thrombosis Cerebrovascular accident Computerised tomogram Implantable cardiac monitor insertion Magnetic resonance imaging Ultrasound scan

Symptomtext

38 days after the vaccine I had a stroke from two blood clots in the brain. EMTs took me to ER then admitted to Hospital. I was there 4 days. I had been under regular preventive care by cardiologists for years and never had any issues

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
4,0
Labordaten
Between 4/19 and 4/23/21 I had CT scan, ultrasounds, MRI repeatedly. All records at hospital or thought Dr After release I had to have a hearth monitor loop implanted for continuing monitoring. So far, nothing of note has been reported to me
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
propranolol, flomax, avodart
Allergien
none
Vorherige Impfungen
yes. see prior VAERS report

VAERS 2059136

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
70,0
Geschlecht
F
Eingang
24.01.2022
Impfdatum
30.11.2021
Beginn
12.01.2022
Tage bis Beginn
43,0
Dosis
1
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Acute respiratory failure COVID-19 COVID-19 pneumonia Cardiomegaly Chest X-ray abnormal Condition aggravated Death General physical health deterioration Hypoxia Lung consolidation Mental status changes Multiple organ dysfunction syndrome Osteomyelitis SARS-CoV-2 test positive Septic shock

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/27/2021, 4/6/2021, and 11/30/2021. Presented to Emergency Department for altered mental status and hypoxia. Per nursing home, patient tested positive for COVID on 1/9/2022. Admitted for COVID-19 pneumonia w/acute hypoxic respiratory failure, osteomyelitis, AKI, and septic shock. Treated with supplemental oxygen, pressors, vitamin C, steroids, antibiotics, and zinc. Continued to decompensate requiring higher doses of oxygen and pressor support with multi-organ failure. Expired on 1/13/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
1,0
Labordaten
1/12/2022: COVID positive; 1/12/2022: Chest x-ray demonstrated enlarged cardiac silhouette and bilateral lung consolidation could reflect CHF or pneumonia
Aktuelle Erkrankungen
-
Vorgeschichte
Osteomyelitis, COPD, cirrhosis, hypertension, diabetes, anxiety, bipolar, CAD, hyperlipidemia, GERD, lymphedema
Andere Medikamente
vitamin C, collagenase, doxycycline, duo-neb, multivitamin, propranolol, zosyn, spironolactone, vitamin A, zinc, furosemide, albuterol, aspirin, cyanocobalamin, dicyclomine, lomotil, ferrous gluconate, gabapenetin, norco, hydroxyzine, lorat
Allergien
Caffeine, codeine, adhesive, feldene, fluoxetine, formaldehde analogs, gold salts, silver, alprazolam
Vorherige Impfungen
-

VAERS 2057771

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
82,0
Geschlecht
M
Eingang
22.01.2022
Impfdatum
19.03.2021
Beginn
14.01.2022
Tage bis Beginn
301,0
Dosis
1
Route/Site
IM / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Acute respiratory failure Asthenia Benign prostatic hyperplasia Blood creatinine increased Brain natriuretic peptide increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chronic kidney disease Condition aggravated Death Diarrhoea Dyspnoea Electrolyte imbalance General physical health deterioration Hyperkalaemia Hypernatraemia

Symptomtext

Patient is DECEASED; hospitalized (1.14.22); COVID-19 positive (1.14.22); fully vaccinated (no booster) Admission Date: 1/14/2022 Preliminary Cause of Death: Acute hypoxemic respiratory failure due to COVID-19 DETAILS OF HOSPITAL STAY: HISTORY OF PRESENT ILLNESS: Patient is a 82 y.o. male who presents today with weakness, SOB and diarrhea. There was initially high concern for COVID and wife was also being tested for COVID. Patient did test positive for COVID in the ER today. Per report his quality of life was poor even prior to contracting COVID. He is unable to provider history due to his clinical state. It sounds as though his symptoms started 10 days ago. He has significant work of breathing and rapid decline. He was started on high flow and NRB in the ER and was unable to bring his oxygen higher than high 80s to low 90s. He was also noted to have hyperkalemia, hypernatremia and acute renal failure with Creatinine of 5 up from baseline near 2. ER provider spoke with family and wife felt that patient would not want resuscitative measure and would want comfort care and wife, children and patient siblings all understood this would be end of life and wished to proceed with comfort care which was started in the ER. Social work was consulted and wanted to have patient seen by hospice. Hospice nurse evaluated patient and discussed case with on-call hospice provider who agreed patient was hospice appropriate. He is being started on versed and fentanyl drip for comfort with plan to wean off high flow. Reviewed comfort care with multiple family members at bedside and verified all were in agreement, they had no questions at this time. They requested that medical history be obtained from chart at this time as patient is comfort care. Per family at bedside he has not really been responding for them but will occasionally move though not really following commands. PRESENTING PROBLEM: Acute respiratory failure with hypoxia Acute hypoxemic respiratory failure due to COVID-19 Acute renal failure superimposed on stage 3b chronic kidney disease, unspecified acute renal failure type Pneumonia due to COVID-19 virus HOSPITAL COURSE: Acute hypoxemic respiratory failure due to COVID-19 Assessment & Plan Patient has had COVID symptoms for 10 days. He is vaccinated with last dose 3/2021 Presented with worsening SOB and hypoxia. COVID positive in the ER, likely multifactorial with COVID, elevated BNP and LLL pneumonia on CXR CXR showing Left lower lobe pneumonia so ? If secondary bacterial source On high flow and NRB in the ER could not get patient above 89% and family did not wish for intubation Family has decided to proceed with comfort care at this time Ativan PRN and morphine drip started in the ER Hospice changing to Fentanyl drip and versed drip with pushes as needed Currently on high flow, wean off to patient and family comfort Social work consulted, family has decided on SH hospice. RN evaluated patient and discussed with hospice provider and patient is now hospice. If oxygen making him more agitated can remove Electrolyte abnormality Assessment & Plan Hypernatremia and hyperkalemia likely associated with acute renal failure Family has decided on comfort care at this time The patient was admitted earlier this evening around 18:00 after presenting to the ER a few hours earlier with weakness, shortness of breath, and diarrhea. He was positive for COVID with symptom onset 10 days prior. He was in respiratory distress in the ER and was placed on high flow and nonrebreather in the ER with persistent hypoxia. He also had multiple lab derangements including hyperkalemia, hypernatremia and acute renal failure. The ER provider discussed the situation with family and they decided on comfort care. Social work was consulted and Hospice became involved. Patient was started on a fentanyl and versed drip for comfort. He was weaned off of high flow oxygen and died shortly after at 20:15. Multiple family members were at the bedside, including his wife. Please see death pronouncement note for exam.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
12/9/21: Primary Care visit - urinary urgency (likely prostate hypertrophy)
Vorgeschichte
Cardiac pacemaker in situ Long term (current) use of anticoagulants Cerebral vascular disease Atrial fibrillation Aortic stenosis, severe DOE (dyspnea on exertion) Abnormal CXR Respiratory crackles Acute renal failure superimposed on chronic kidney disease 3 Hypertension, unspecified type Stenosis of left subclavian artery History of CVA in adulthood Acute hypoxemic respiratory failure due to COVID-19 Left lower lobe pneumonia Electrolyte abnormality
Andere Medikamente
cetirizine (ZYRTEC) 10 MG tablet lisinopril (PRINIVIL,ZESTRIL) 10 MG tablet metoprolol tartrate (LOPRESSOR) 25 MG tablet tamsulosin (FLOMAX) 0.4 MG capsule
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2054004

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
88,0
Geschlecht
F
Eingang
21.01.2022
Impfdatum
27.02.2021
Beginn
15.10.2021
Tage bis Beginn
230,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain lower Blood creatinine increased Blood glucose increased COVID-19 Cardiac failure Cardio-respiratory arrest Chest X-ray abnormal Clostridium test negative Colectomy Computerised tomogram abdomen abnormal Condition aggravated Death Decreased appetite Depressed level of consciousness Diarrhoea Disorientation Dyspnoea Faeces discoloured

Symptomtext

10/15/2021 - arrived in ER with LLQ pain, marked HTN (229/91), hypothermic/afebrile. Vitals WNL. CT reveals mesenteric ischemia - patient taken to OR for right hemicolectomy. Covid positive on 10/1. Received MAB at home and was stable to follow. Covid positive on admission. 10/18 - C/O SOB - xray demonstrates bil pneumonia with rhonchi on exam. Remains afebrile and hypertensive 208/68. Already on Cefepime and Flagyl. Vancomycin added 10/17. Difficulty breathing overnight. NC placed at 3.5L, saturating 92%. WBC 18.4-21.4 10/19 - WBC continues to trend up despite Cefepime, Flagyl, Vancomycin. Vancomycin stopped/started on Linezolid and Azithromycin. Cr 1.2 repeat 1.1. Remdesivir added at 100mg every 24hrs. 10/19 - New onset HF - D-dimer 1336. Breathing improved - 2L at 94-97%. BP- WNL. 10/20 - No complaints. Eating, no SOB- saturating well on 2L, better air movement on exam. Continuing antibiotics, Remdesivir, and diuretics. Adding steroids due to groundglass finding on imaging. 10/23 - Remdesivir and Azithromycin complete. New onset vomiting/diarrhea - C-diff negative. Continuing Cefepime and Flagyl. Cr improving 1.0. HF no change - continuing Lasix. Glucose continuously elevated despite sliding scale. 258-398. Moving from low to medium sliding scale. 10/28 - GI bleed - S/P 3 units blood. Reports no appetite, dark tarry diarrhea since 10/26, free fluid in abdomen seen on CT. WBC 19.1, Hemoglobin 7.4 (down from 10.7). 10/30- Patient no longer alert and oriented. DNR/DNI, comfort care - status changed from full per family. GI bleed suspected. Condition to unstable for endoscopic eval. 10/31 - Made palliative care. 11/4 - Patient expired from cardiopulmonary arrest from complications of mesenteric ischemia.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardio-respiratory arrest
Hospital-Tage
20,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Osteoporosis, hyperlipidemia, acquired hypothyroidism, Type II Diabetes, A-fib, HTN, CKD stage 3, Gout; postmenopausal bleeding, myelodysplastic syndrome, depression
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 1536271

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
76,0
Geschlecht
M
Eingang
21.01.2022
Impfdatum
20.03.2021
Beginn
16.07.2021
Tage bis Beginn
118,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
COVID-19 pneumonia Death COVID-19 Cardioversion Chest X-ray abnormal Cough Dialysis Dyspnoea Endotracheal intubation Intensive care Renal impairment Resuscitation SARS-CoV-2 test positive Ventricular tachycardia

Symptomtext

pt diagnosed positive for COVID on 7/16/21; 7/23/21 pt brought to ED via EMS; c/o increasing SOB, cough; O2 sats 60% on RA; placed on NRB mask (15L); chest xray showed COVID pneumonia; transferred to ICU; required intubation; developed worsening renal function; started dialysis; few hours into dialysis, pt sustained pulseless Ventricular tachycardia requiring CPR, shocking and med; after 20 mins of CPR, pt passed away in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
13,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CAD, HTN, GERD, hyperlipidemia
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1536271

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
76,0
Geschlecht
M
Eingang
21.01.2022
Impfdatum
20.03.2021
Beginn
16.07.2021
Tage bis Beginn
118,0
Dosis
2
Route/Site
IM / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
COVID-19 pneumonia Death COVID-19 Cardioversion Chest X-ray abnormal Cough Dialysis Dyspnoea Endotracheal intubation Intensive care Renal impairment Resuscitation SARS-CoV-2 test positive Ventricular tachycardia

Symptomtext

pt diagnosed positive for COVID on 7/16/21; 7/23/21 pt brought to ED via EMS; c/o increasing SOB, cough; O2 sats 60% on RA; placed on NRB mask (15L); chest xray showed COVID pneumonia; transferred to ICU; required intubation; developed worsening renal function; started dialysis; few hours into dialysis, pt sustained pulseless Ventricular tachycardia requiring CPR, shocking and med; after 20 mins of CPR, pt passed away in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
13,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CAD, HTN, GERD, hyperlipidemia
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2046435

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
77,0
Geschlecht
M
Eingang
19.01.2022
Impfdatum
15.10.2021
Beginn
09.01.2022
Tage bis Beginn
86,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Anticoagulant therapy Asthenia Atrial flutter C-reactive protein increased COVID-19 COVID-19 pneumonia Cardiac failure congestive Chest X-ray abnormal Fibrin D dimer Lung consolidation Lung opacity SARS-CoV-2 test positive

Symptomtext

Hospitalized 01/10/2022-still currently admitted; COVID-19 positive 01/09/2022; fully vaccinated plus booster CHIEF COMPLAINT: COVID Assessment/Plan ASSESSMENT / PLAN: Acute hypoxemic resp failure secondary to COVID-19 pneumonia -positive PCR 1/9/2022 -decadron 6mg qdaily -dvt px: SQ lovenox as below -current o2 req: wean as able Atrial flutter with RVR Reported history of paroxysmal atrial fibrillation, (remote, post-op) -CHADS-vasc score: at least 6 -Echo ordered -rate control: received IV and PO diltiazem at OHS. Start toprol XL, titrate prn -TSH ordered ordered -anticoagulation: high risk of falls, will defer systemic therapeutic anticoagulation after discussion with wife, discussed risks/benefits of oac and stroke risk. Continue lovenox at prophylactic doses Generalized weakness -primary reason for presentation to hospital per wife -monitor oral intake -PT/OT to see 01/13/2022 notes: ASSESSMENT / PLAN: Acute hypoxemic resp failure secondary to COVID-19 pneumonia/ CHF -CXR 1/12: Slightly worsened chest. Follow-up recommended. -positive PCR 1/9/2022 -decadron 1/10-12, Solumedrol 40 mg bid 1/12- -Lovenox 40 mg sq daily -currently HFNC FiO2 95-- >85% -- > 50-- >40 l/min -CRP 72-- >150.9 -D-dimer 440-- > 560 01/19/2022 notes: ASSESSMENT / PLAN: Acute hypoxemic resp failure secondary to COVID-19 pneumonia/ CHF -CXR 1/17: No significant interval change in diffuse bilateral interstitial opacities and patchy left basilar airspace consolidation. -positive PCR 1/9/2022 -decadron 1/10-12, Solumedrol 40 mg bid 1/12- -Lovenox 40 mg sq daily -still on HFNC FiO2 95-- >90%, 55 l/min -CRP 72-- >150.9-- >73.9 -D-dimer 440-- > 560-- >490 -Cefepim/Dox day # 3/5

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
9,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Mixed hyperlipidemia Smoker Major neurocognitive disorder (HCC) Essential hypertension History of small bowel obstruction History of CVA (cerebrovascular accident) History of falling Colon cancer screening declined Skin lesion Weight loss Other urinary incontinence
Andere Medikamente
amLODIPine (NORVASC) 10 MG tablet aspirin 81 MG tablet clopidogrel (PLAVIX) 75 MG tablet simvastatin (ZOCOR) 40 MG tablet
Allergien
Bee Codeine Iodine Penicillins
Vorherige Impfungen
-

VAERS 2043308

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
67,0
Geschlecht
F
Eingang
18.01.2022
Impfdatum
27.03.2021
Beginn
07.12.2021
Tage bis Beginn
255,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 pneumonia Cough Death Dyspnoea General physical health deterioration Myalgia Pyrexia Renal failure Respiratory failure SARS-CoV-2 test positive

Symptomtext

Patient is fully vaccinated. COVID + on 12/3/2021. Hospitalized from 12/7-12/19/2021. Presented with dyspnea. SpO2 88% on RA. She initially presented to an urgent care facility on 12/3, admitting to cough and myalgias for seven days. fever of 100.8 initially on arrival. Patient admitted with respiratory failure due to COVID pneumonia. Multidisciplinary team consulted and placed on remdesivir/decadron and lovenox. Patient continued to deteriorate and went into renal failure. Continued to require high flow oxygen and was decided by family to enter into hospice care. Patient passed away with comfort care.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
13,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2039990

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6202

kritisch
Staat
WI
Alter
67,0
Geschlecht
M
Eingang
17.01.2022
Impfdatum
31.10.2021
Beginn
15.01.2022
Tage bis Beginn
76,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

Death related to COVID 19

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
OSC: Multiple myeloma; CKD Stage 4; acute on chronic systolic CHF
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2039883

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
89,0
Geschlecht
M
Eingang
17.01.2022
Impfdatum
10.03.2021
Beginn
30.12.2021
Tage bis Beginn
295,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute myocardial infarction Asthenia COVID-19 Death Gastrointestinal haemorrhage Inappropriate schedule of product administration Nasal congestion SARS-CoV-2 test positive Troponin increased Urinary tract infection

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/6/2021 and 3/10/2021. Presented to ED 12/29/2021 with complaints of nasal congestion and increasing weakness. Admitted for COVID-19 infection, GI bleed, complicated UTI. Initially no shortness of breath and did not require any oxygen. Subsequently O2 demands increased to high-flow nasal cannula. Treated w/Decadron and remdesivir. STEMI on 01/05/22. Troponins were markedly elevated. Patient is DNR/DNI. Expired 1/10/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
11,0
Labordaten
COVID-19 Positive on 12/29/2021 using the ROCHE LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
Aktuelle Erkrankungen
-
Vorgeschichte
Atrial fibrillation, Basal cell carcinoma, Bladder cancer, CAD, Hyperlipidemia, Hypertension, Chronic kidney, infections, Cataracts, Migraines, H/O MID with 2 stents, Squamous cell carcinoma, vertigo.
Andere Medikamente
B-Complex QD, Ocuvite QD, Digoxin 125 mcg QD, Dimenhydrinate, 50 mg BID, Fish Oil Capsule QD, Flaxseed Oil Capsule QD, Fursosemide 20 mg QD, Restasis Ophthalmic QD, Simvastatin 20 mg QD, topiramate 25 mg BID, Preservision 2 capsules QD, Riv
Allergien
Cephalexin
Vorherige Impfungen
-

VAERS 2034942

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
82,0
Geschlecht
M
Eingang
14.01.2022
Impfdatum
26.02.2021
Beginn
12.01.2022
Tage bis Beginn
320,0
Dosis
UNK
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death

Symptomtext

Death related to COVID 19

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
OSC: CKD Stage 4; DM2; CHF; asthma, PVD, a-fib; HTN; HLD; obesity
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2031971

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
78,0
Geschlecht
M
Eingang
13.01.2022
Impfdatum
31.03.2021
Beginn
17.11.2021
Tage bis Beginn
231,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Cerebrovascular accident Death Endotracheal intubation Fall Hypoxia Intensive care Pneumonia bacterial SARS-CoV-2 test positive

Symptomtext

Patient presented to emergency room on 11/17/2021 after falling. He was hypoxic and was found to be COVID-19 positive. He was intubated and was transferred to intensive care unit. Patient's admission was complicated by bacterial pneumonia and CVA. Patient was discharged to LTAC on 12/9/2021. Patient's condition continued to worsen and was placed on comfort measures on 1/11/22. Patient expired at LTAC on 1/12/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
22,0
Labordaten
COVID-19 test positive on 11/17/2021
Aktuelle Erkrankungen
-
Vorgeschichte
Atrial fibrillation, hypertension
Andere Medikamente
amLODIPine (NORVASC) 10 MG tablet apixaban (ELIQUIS) 5 MG TABS tablet chlorthalidone (HYGROTON) 25 MG tablet Cholecalciferol (VITAMIN D3) 2000 UNIT CAPS Cyanocobalamin (VITAMIN B-12) 1000 MCG tablet Flaxseed, Linseed, (FLAX SEED OIL) 1000 M
Allergien
Butane, Keflex
Vorherige Impfungen
-

VAERS 2031449

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
86,0
Geschlecht
F
Eingang
13.01.2022
Impfdatum
28.09.2021
Beginn
08.01.2022
Tage bis Beginn
102,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Angiogram pulmonary abnormal COVID-19 Chest X-ray abnormal Death Hypoxia Lung consolidation Lung opacity Mental status changes Multiple organ dysfunction syndrome Respiratory failure SARS-CoV-2 test positive Septic shock Urinary tract infection

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/3/2021, 3/3/2021, and 9/28/2021. Bedbound s/p stroke presented to the emergency department for altered mental status and hypoxemia. Amitted for respiratory failure with COVID-19, septic shock, UTI, and altered mental status. Patient received antibiotics, dexamethasone, and remdesivir. Status declined rapidly with multiorgan failure w/increasing O2 demands. Expired 1/9/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
1,0
Labordaten
1/8/2022: COVID positive; 1/8/2022: Chest x-ray revealed left suprahilar and right basilar opacities may reflect pneumonia; 1/8/2022: CTA Chest found no evidence of pulmonary; embolism. Bilateral patchy consolidation within the left greater than right upper lobes and lower lobes.
Aktuelle Erkrankungen
-
Vorgeschichte
Cancer hypertension, bilateral macular degeneration, subdural hematoma, thyroid disease, stroke
Andere Medikamente
amlodipine 5 mg daily, aspirin 81 mg daily, baclofen 5 mg, twice daily, citalopram 20 mg daily, gabapentin 100 mg nightly, levothyroxine 100 mcg daily, liothyronine 5 mcg daily, melatonin 10 mg nightly, toprol XL 25 mg daily, entresto 24-26
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2028341

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
52,0
Geschlecht
F
Eingang
12.01.2022
Impfdatum
06.03.2021
Beginn
06.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Decreased appetite Diarrhoea Headache Nausea Vomiting

Symptomtext

Pt.'s Daughter In-Law states that after receiving the 1st dose of Phizer 03/06/2021, started experiencing symptoms 30min with a slight headache lasting 2hrs. 03/07/2021 started experiencing symptoms vomiting until 10:00pm, loose stool lasting 1hr, 03/08/2021 loss of appetite with nausea. 03/242021 Primary visit routine Physical=Normal with Recommendations for 2nd dose of Phizer (03/27/2021). Pt. D.O.D 04/03/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
HBP
Andere Medikamente
Atorvastatin, Levothriyxm, Motoprolol, Gabapentin, Pantoprazole, Baby Aspirin, Vitamin D
Allergien
N/A
Vorherige Impfungen
-

VAERS 2028070

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
82,0
Geschlecht
M
Eingang
12.01.2022
Impfdatum
25.08.2021
Beginn
23.12.2021
Tage bis Beginn
120,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 Chest X-ray abnormal Death Lung opacity Pneumonia Pulmonary oedema Respiratory disorder

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/7/2021, 2/28/2021, and 8/25/2021. Patient received bamlanivimab/etesevimab on 12/23/2021. Patient received at hospital - as a transfer from outside hospital for continued care of acute hypoxic respiratory failure due to COVID-19. Patient received oxygen supplementation, dexamethasone, and remdesivir. Patient's respiratory status continued to decompensate and patient was transitioned to comfort care. Patient expired on 1/8/2022 at 1520.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
5,0
Labordaten
1/3/2021: Chest x-ray revealed mixed interstitial and alveolar opacities noted throughout both lungs which may be due to edema or multifocal pneumonia
Aktuelle Erkrankungen
-
Vorgeschichte
Non-hodgkin lymphoma, bladder cancer, hypertension, hyperlipidemia
Andere Medikamente
-
Allergien
Amiodarone, gabapentin, pregablin, levofloxacin, penicillin, diphenhydramine, tetanus vaccines and toxoid
Vorherige Impfungen
tetanus vaccine and toxoid causing itching and rash

VAERS 2028013

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
72,0
Geschlecht
M
Eingang
12.01.2022
Impfdatum
02.03.2021
Beginn
28.12.2021
Tage bis Beginn
301,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory distress syndrome COVID-19 Chills Cough Death Dyspnoea Endotracheal intubation Implantable defibrillator insertion Inappropriate schedule of product administration Nausea Oxygen saturation decreased Pain Pyrexia Ventricular tachycardia

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/23/2021 and 3/2/2021. Presented to ED on 12/28/2021 with complaints of worsening shortness of breath for 3 days. Associated symptoms include dry cough, fever, chills, body aches, and nausea. Patient usually on 2-3L of oxygen a home. His oxygen level has dropped to 80s even with increasing oxygen to 4 L. Patient was intubated on 12/30/2021 due to progressive ARDS. Underwent proning, lung protective vent strategy, and remdesivr treatment. On 1/9/2022 patient suffered 5 separate VT episodes for which he underwent automatic defibrillation from ICD. Patient expired on 1/9/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
12,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
GERD, Anemia, Atrial Fibrillation, H/O basal cell carcinoma, Cardiomyopathy, Cellulitis lower extremity, Chest pain, CHF, Colon Polyps, CAD, CVA in 2008, Dementia, Diabetes, Dyslipidemia, Dysphagia, Dysrhymia, Epilepsy, Hearing loss, hiatal hernia, hypertension, Depression, Migraines, Osteoarthritis, peripheral neuropathy, peripheral vascular disease, pneumonia, PONV, Pulmonary embolism, seasonal allergies, obstructive sleep apnea.
Andere Medikamente
Ascorbic Acid 1000 mg QD, Atorvastatin 40 mg QD, Carbamazepine 400 mg BID, Cholecalciferol 5000 units QD, Citalopram 80 mg QD, Diphenhydramine 25 mg PRN, Famotidine 20 mg BID, Ferrous Gluconate QD, Gabapentin 300 mg QAM and Noon 600 mg QHS,
Allergien
Azithromycin, Lisinopril, Nifedipine, Ramipril, Spironolactone, Zolpidem, Morphine, Sumatriptan
Vorherige Impfungen
-

VAERS 1999640

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
IL
Alter
98,0
Geschlecht
F
Eingang
03.01.2022
Impfdatum
08.03.2021
Beginn
06.12.2021
Tage bis Beginn
273,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure Aspiration pleural cavity Atelectasis Blood lactic acid Bradycardia Condition aggravated Cough Full blood count normal Heart rate increased Hypotension COVID-19 COVID-19 pneumonia Cardiac failure congestive Chest X-ray abnormal Computerised tomogram thorax abnormal Lethargy Lung opacity Metabolic function test

Symptomtext

98 year old female presented to ER on 12/6/21 with complaints of worsening cough and lower extremity edema, tested positive for COVID-19 requiring 4 L of nasal cannula, vital signs blood pressure 145/71 heart rate 73 saturating at 94% on 4 L nasal canula. Lactic acid, CMP, CBC unremarkable. BMP 947, troponin negative, CXR- Worsening bibasilar opacification, right greater than left. Worsening bilateral pleural effusions, right greater than left. CT chest- Moderate right pleural effusion. There is a small to moderate left pleural effusion. Subtle patchy ground-glass opacities in the bilateral upper lobes. These findings are nonspecific. Primary differential consideration includes alveolar pulmonary edema or changes from a COVID infection given patient's recent diagnosis patient is admitted for acute respiratory failure with hypoxia likely due to COVID-19 pneumonia and CHF exacerbation, Given Lasix in the emergency. started Decadron, rocephin and azithromycin and Remdesivir. speech therapy evaluated patient. thoracocentesis was performed by IR and removed 1.2 L from Rt pleural space. Patient heart rate was running around 140-160 even with Cardizem and metoprolol order, cardiology is consulted but HR become controlled after thoracocentesis. Patient was doing okay on the morning of 12/9/21 except some cough. But afternoon around 2:00 p.m., rapid response was called because patient was lethargic,vital sign showed bradycardia, hypotension 82/40 along with hypoxia required Non- rebreather mask. chest x-ray- Increased volume left greater than right pleural effusions. Increased opacification diffusely may represent layering effusions with worsening atelectatic change. Superimposed pneumonia not excluded. Patient began more alert and discussed with her about future goal of care and she would like to get comfort care management instead of aggressive IV antibiotics and antiviral medications. Talked to patient's POA and update about patient current condition And they agree with the plan. Patient is discharged with comfort care measure.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
5,0
Labordaten
12/6/21 COVID19: positive 12/7/21 CT chest: Subtle patchy ground-glass opacities in the bilateral upper lobes. These findings are nonspecific. Primary differential consideration includes alveolar pulmonary edema or changes from a COVID infection given patient's recent diagnosis. 12/9/21 chest xray: Increased volume left greater than right pleural effusions. Increased opacification diffusely may represent layering effusions with worsening atelectatic change. Superimposed pneumonia not excluded.
Aktuelle Erkrankungen
-
Vorgeschichte
squamous cell carcinoma of the face, osteoarthritis, hypertension, CHF, history of atrial fibrillation recently discharged early this month admitted for acute on chronic diastolic heart failure and atrial fibrillation with RVR, thyroid disesase,
Andere Medikamente
Alprazolam, diltiazem, furosemide, metoprolol succinate, miralax prn, tylenol prn, aspirin, atorvastatin, levothyroxine, lisinopril, meclizine
Allergien
Latex and antihistamines
Vorherige Impfungen
-

VAERS 1988869

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
59,0
Geschlecht
F
Eingang
29.12.2021
Impfdatum
01.03.2021
Beginn
12.11.2021
Tage bis Beginn
256,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute respiratory failure COVID-19 Death Endotracheal intubation SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/8/2021, and 3/1/2021. PMHx of DMII, HTN, CKD s/p kidney transplant on immunosuppression. Covid+ 11/13/21, hospitalizd x3days. D/c'd home on O2. Readmitted 11/18/21 for worsening symptoms, intubated 11/20. Transferred to Medical Center on 11/24/21 for higher level of care due to acute hypoxemic respiratory failure 2/2 Covid-19. Tx'd steroids, nitric oxide, diuresed, merrem, vancomycin and cresemba. Continued to get worse and expired 12/13/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
31,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Chronic pain, Renal transplant, Diabetes, Hypertension, Peripheral neuropathy
Andere Medikamente
Albuterol MDI Q6H prn, Aspirin 81 mg QD, Benzonatate 100 mgTID prn, Calcium carbonate 2000 mg TID prn, Cellcept 250 mg BID, Dexamethasone 6 mg QD, Doxycycline 100 mgBID, Folic Acid 1 mg QD, Gabapentin 300 mg QD, Furosemide 40 mg QD, Levemir
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1988800

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
79,0
Geschlecht
F
Eingang
29.12.2021
Impfdatum
29.09.2021
Beginn
28.12.2021
Tage bis Beginn
90,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

fully vaccinated covid related death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
DM2, ESRD s/p kidney transplant (2018), HTN
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1982098

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
81,0
Geschlecht
M
Eingang
27.12.2021
Impfdatum
10.12.2021
Beginn
19.12.2021
Tage bis Beginn
9,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Acute myocardial infarction Acute respiratory failure Anticoagulant therapy Atrial fibrillation Blood creatinine increased Blood culture positive Blood gases Blood glucose normal Blood lactic acid normal Blood pH normal Blood urea increased Brain natriuretic peptide increased Bundle branch block right COVID-19 Chronic kidney disease Chronic obstructive pulmonary disease Computerised tomogram head normal

Symptomtext

Hospitalized (12.19.21 - still currently admitted); COVID-19 positive (12.19.21); fully vaccinated PLUS booster CHIEF COMPLAINT Lethargy, fatigue, confusion, fever HISTORY OF PRESENT ILLNESS Pt is a 81 y.o. male with past medical history significant for coronary artery disease, essential hypertension, type 2 diabetes mellitus, chronic obstructive pulmonary disease, prior history of DVT, OSA, persistent atrial fibrillation on Eliquis, CKD 4 who presented to the ED on 12/19 for evaluation of confusion, fever, and shortness of breath which started in the middle of the night on 12/18-12/19. Throughout the day of 12/19 the patient tells me he has not wanted to do anything but sleep, which was concerning to his wife. He was recently admitted 12/15 through 12/18/2021 at a local Hospital for AKI which was thought to be secondary to a combination of over-diuresis and hypotension. Medications were adjusted; he stopped losartan and started torsemide 20mg daily. He reports compliance with this on the one day he has been home for. His main complaints are severe fatigue, fever and dyspnea. He is oriented x 4 at the time of my exam, but does fall asleep frequently. He reports increased thirst and poor intake. Denies diarrhea/nausea/vomiting. Denies chest pain or palpitations. Making urine and denies dysuria. He does tell me he has not been compliant with his CPAP. He expresses frustration that he is here with COVID. Tells me he has done everything right, got his vaccines earlier this year, wears a mask. He is understandably frustrated that he got COVID, as he probably got it in the hospital. COVID 19 infection - Symptom onset 12/19 - Vaccination status: vaccinated with pfizer 1/26/21, 3/8/21, has not been boosted - Currently requiring 1 L O2 - CXR independently reviewed, with stable cardiomegaly and pulmonary vascular congestion - Received decadron in the ED, continue for now - Monitor daily covid immunology labs - VTE prophylaxis with home eliquis - IS q 1hr while awake, prone positioning prn Metabolic encephalopathy, improving Suspect due to combination of fever and hypoxia in the setting of covid 19/volume overload vs. Accumulation of home pain medications in the setting of poor renal function - CT head independently reviewed, negative for acute intracranial process - Blood cultures x 2 obtained - Oriented x 4 on my exam, but quite somnolent - VBG on presentation with pCO2 36, will repeat on a.m. draw - Encourage cpap compliance, patient states he has not been wearing at home - Neuro checks q 4 hours Mild acute hypoxemic respiratory failure, resolved - Patient was in respiratory distress and hypoxic to the 80s when picked up by EMS, requiring 4L NC - He has since been weaned to room air - Unclear cause. COPD vs. covid 19 vs. CHF ? - Only had 350ml out with lasix, but on my exam looks euvolemic, no wheezing on exam... feel it's reasonable to continue decadron for now Chronic systolic CHF EF 44% 6/14/21 - CXR independently reviewed, with stable cardiomegaly, mild-moderate persistent CHF, actually improved from 12/17 - BNP 15147 - S/p 40mg IV lasix in ED with only 350ml UOP - Reports compliance with 20mg PO torsemide at home - Wean oxygen as tolerated - Telemetry, continuous pulse ox - Daily weights, strict I/O, 2g Na/2L fluid restriction Troponin elevation Type 2 MI in setting of demand ischemia - Hstnt 171-- >168 - EKG independently reviewed, with atrial fibrillation, rate 74, stable RBBB, unchanged from 5 days ago - Suspect troponin elevation is related to demand ischemia in setting of volume overload/CHF exacerbation - Denies chest pain - Telemetry AKI on CKD 4 - Patient was hospitalized 12/15-12/18 and nephrology was consulted at that time - Losartan d/c'd on recent admission - Creatinine 3.01, (recent baseline appears to be 2.5) - Nephro - trend BMP - hold home torsemide for now

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
9,0
Labordaten
The patient arrived in the emergency department hemodynamically stable, febrile to 103.1 and hypoxic to 85% on room air. Hypoxia improved with initiation of 2 L nasal cannula. CBC was remarkable for hgb 9.7, plt 111. CMP was remarkable for BUN 83, creatinine 3.01, glucose 153. VBG showed pH 7.45, pCO2 36. NT proBNP elevated to 15,000. Troponin baseline 171, 2 hour troponin 168, delta -3. Blood cultures x2 were obtained. UA with 10 protein, otherwise unremarkable. CT head without contrast was obtained and independently reviewed, negative for acute intracranial process. Chest x-ray was obtained and independently reviewed, with stable/slightly improved mild to moderate findings of congestive heart failure. EKG was obtained and independently reviewed, with atrial fibrillation, stable right bundle branch block, rate 73, no acute changes from prior. In the emergency department, he was given 1 g oral Tylenol, 40 mg IV Lasix and 6 mg IV Decadron. The patient was admitted to the hospitalist service for further workup and management. Progress note from 12.27.21: COVID-19 pneumonia Acute respiratory failure Chronic obstructive pulmonary disease Altered mentation CT head with contrast showing no acute intracranial abnormality Vaccinated COVID positive - placed in severe respiratory isolation Continue dexamethasone 6 mg IV for total of 10 days (12/19-12/29) No remdesivir due to elevated creatinine Continue nebs as needed Continue supportive treatment as needed Chest x-ray on 12/22 showing slightly increased right perihilar infiltrates Lactate within normal limits Procal elevated, started on ceftriaxone on 12/23 x 5d - will stop on 12/28 Blood cultures showing stap epidermis in 1 vial, likely contaminate, will repeat BCX repeated, NGTD x 24 hours Likely respiratory failure multifactorial & related to CHF exacerbation as well Currently on high-flow oxygen at 95%/40, slightly worsened from yesterday Will obtain CXR to eval for possible pleural effusion vs COVID Maintain goal O2 sats greater than 88% PT/OT consulted, appreciate recs AKI on CKD Baseline creatinine prior to admission approximately 2.2 per Nephro Creatinine stable, high Avoid nephrotoxic agents Continue 2 G sodium diet Continue daily BMPs - labs pending still for 12/27 Dose medications at estimated GFR of less than 20 Nephrology consult, appreciate recommendations Continue holding torsemide May consider restarting based on CXR ordered above Congestive heart failure with reduced ejection fraction of 45% CHF exacerbation, BNP 15, 147 Coronary artery disease, history of stenting of LAD in May 2021 Hypertension Atrial fibrillation Normocytic anemia Started on torsemide 20mg (held on 12/25 given worsening kidney function) Admission weight of 89 kg, stable for last 2 days at 84kg Elevated troponin, downtrended - believe 2/2 nonischemic myocardial injury from CHF and CKD Cardiology consulted, appreciate recommendations Continuing Amlodipine and Metoprolol, holding losartan Continuing home Eliquis Continue high potency statin therapy, long-acting nitrate, and clopidogrel H&H stable
Aktuelle Erkrankungen
Admitted to hospital 12.14.21 - 12.18.21: acute kidney injury superimposed on CKD; HOSPITAL COURSE: Pt is a 81 y.o. male with past medical history of coronary artery disease, hypertension, type II DM, CODP, hx of DVT's, OSA, persistent Afib on Xarelto, and gout who presented to the hospital at the direction of his nephrologist due to an AKI on his CKD. His AKI was felt to be due to a combination of over-diuresis and hypotension. He was seen by nephrology in the hospital. His losartan and torsemide were held with improvement in his kidney function tests. He was also seen by palliative care for management of his chronic pain regimen. He was changed to DNR after a goals of care discussion this visit. Patient was noted to be hypoxic and repeat chest x-ray was obtained, which showed worsening pulmonary edema. Torsemide was restarted at 20 mg daily. Patient's renal function was monitored with restarting Torsemide. Creatinine trending down upon discharge. Discharged in stable condition with instructions to follow up with PCP and Nephrology.
Vorgeschichte
ASHD (arteriosclerotic heart disease) Coronary artery disease involving native coronary artery of native heart without angina pectoris Deviated nasal septum OSA (obstructive sleep apnea) Wide-complex tachycardia DVT of lower extremity (deep venous thrombosis) Dyslipidemia Essential hypertension Type 2 diabetes mellitus with stage 4 chronic kidney disease, with long-term current use of insulin Back pain Chronic combined systolic and diastolic congestive heart failure Carotid stenosis COPD (chronic obstructive pulmonary disease) Spinal stenosis of lumbar region with neurogenic claudication Right bundle branch block (RBBB) LBBB (left bundle branch block)-noted during dobutamine stress test-testing was cancelled. NM MPI ordered instead Chronic ITP (idiopathic thrombocytopenia) Persistent atrial fibrillation Heart failure Acute kidney injury superimposed on CKD Ischemic cardiomyopathy Subclinical hyperthyroidism Elevated sedimentation rate Iron deficiency anemia, unspecified Chest pain Gout Cervical myelopathy Dehydration Fall Elevated troponin Nail disorder Vitamin B12 deficiency Hypomagnesemia GERD (gastroesophageal reflux disease) Colon polyp Depression Muscle weakness (generalized) Medication management contract agreement Other constipation Acute kidney injury
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet amLODIPine (NORVASC) 5 MG tablet apixaban (ELIQUIS) 2.5 MG tablet atorvastatin (LIPITOR) 40 MG tablet bisacodyl (DULCOLAX) 10 MG suppository budesonide/formoterol (SYMBICORT) 80-4.5 MCG/ACT inhaler calc
Allergien
LotrisoneRash
Vorherige Impfungen
-

VAERS 1971696

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
90,0
Geschlecht
F
Eingang
22.12.2021
Impfdatum
05.05.2021
Beginn
06.12.2021
Tage bis Beginn
215,0
Dosis
2
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure COVID-19 Pneumonia SARS-CoV-2 test positive

Symptomtext

Pneumonia Acute hypoxic respiratory failure + COVID 19 test

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
8,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1963305

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
83,0
Geschlecht
F
Eingang
20.12.2021
Impfdatum
09.02.2021
Beginn
16.12.2021
Tage bis Beginn
310,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure COVID-19 pneumonia Cough Decreased appetite Dyspnoea Fatigue Fluid intake reduced

Symptomtext

Pt has had 8 days of fatigue, decreased appetite and fluid intake, cough and shortness of breath. Pt was admitted for acute hypoxic respiratory failure secondary to COVID pneumonia.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1962304

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
VA
Alter
77,0
Geschlecht
F
Eingang
19.12.2021
Impfdatum
23.01.2021
Beginn
21.09.2021
Tage bis Beginn
241,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Asthenia Blindness unilateral Cardiac monitoring normal Cerebrovascular accident Chills Fatigue Nausea Resuscitation SARS-CoV-2 test negative Thirst

Symptomtext

After the first dose, my Mother suddenly lost the sight in her right eye. We went to Hospital where they told us she had a stroke in her eye. Then after the second dose on September 22 she had a serious medical emergency where I had to perform CPR to bring her back to life. When she was rushed to the hospital they had no explanation for the incident. She was thoroughly checked and they couldn't explain it. She wore a heart monitor for a month and that was normal. After the booster on 10/21/21, she has had no energy, severe chills and shaking, extreme nausea, and extreme fatigue with no fever.. She has had 3 COVID tests which were negative, and extreme thirst.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
2,0
Labordaten
The two hospitalizations did not have any conclusive reasons for these reactions.
Aktuelle Erkrankungen
-
Vorgeschichte
Blood pressure
Andere Medikamente
Blood pressure medication
Allergien
-
Vorherige Impfungen
-

VAERS 1961959

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
71,0
Geschlecht
F
Eingang
18.12.2021
Impfdatum
18.03.2021
Beginn
12.12.2021
Tage bis Beginn
269,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal rebound tenderness Abdominal tenderness Acute kidney injury Acute left ventricular failure Acute respiratory failure Blood bilirubin increased Blood test COVID-19 COVID-19 pneumonia Cardiac failure congestive Cholelithiasis Chronic left ventricular failure Condition aggravated Drain placement Echocardiogram abnormal Gallbladder enlargement Laboratory test abnormal Liver function test increased

Symptomtext

Hospitalized 12/1/2021-still admitted currently; COVID-19 positive 12/12/2021; fully vaccinated 12/1/2021 admission note: MEDICAL DECISION MAKING: 71-year-old female presents with right upper quadrant tenderness and mild rebound. Afebrile, review of documentation shows that she recently was diagnosed with biliary sludge in her gallbladder. Repeat ultrasound here and blood work is obtained, pain control with morphine is ordered. Her white count returns elevated, her bilirubin, LFTs are bumped, she is covered with ceftriaxone which she has tolerated well in the past and Flagyl. Her ultrasound shows a thickened gallbladder wall concerning for acute cholecystitis, her CBD is 7 mm which is likely normal for her age. I spoke with surgery here who is concerned about the possibility of a retained stone given her elevated bilirubin, he recommends transfer. I spoke with surgery down at another Hospital, they recommend transfer emergency department to emergency department. The patient is accepted by the emergency department physician for transfer there, is stable for transfer. Family is updated on the plan and they verbalized understanding all questions are answered. She does have a mild AKI on labs and fluids are given here. She had a recent negative covid. 12/12/2021 note: Date of Admission: Hospital Day: 12 Chief complaint Acute respiratory failure with hypoxia Assessment and Plan Acute hypoxic respiratory failure multifactorial COVID-19 pneumonia, COVID-19 PCR positive 12/12 Acute on chronic diastolic heart failure Currently requiring 100% non-rebreather, respiratory consult for high-flow nasal cannula Echo showing severe MR with significant pulmonary hypertension Continue dexamethasone 6 mg daily for 10 days Lasix 40 mg IV 2 times a day Strict I&Os, daily weights, 2 g sodium diet Cardiology consult, follow-up recommendations Continuous pulse ox and tele monitoring Trend D-dimer and CRP 12/18/2021 note: CHIEF COMPLAINT Acute respiratory failure with hypoxia Assessment/Plan ASSESSMENT / PLAN Plan: -condition with ongoing trend of improvement; oxygenation improved to the point that she has been weaned to standard nasal cannula -no heart failure complaints at present; appears to be relatively euvolemic Acute hypoxic respiratory failure 2/2 CHF and COVID 19 - weaned to nasal cannula - CHF less likely the primary culprit; hypoxia now likely 2/2 COVID Care Management Note 12/18/2021: SAR recommended Talked with pt and she wants referral to facility Will follow up with facility as they said to check back then. Pts drain still in and IR managing. Pt down to 02 at 4 liters now. Pts covid isolation to end day 10 is 12/22/21. cannot to go this SAR unless out of isolation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
17,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Tobacco abuse COPD (chronic obstructive pulmonary disease) Cholecystitis, acute Acute respiratory failure with hypoxia AS s/p aortic valve replacement Depression Diverticulosis Essential hypertension, benign ASHD (arteriosclerotic heart disease) Chronic kidney disease, stage 3 (moderate) PVD AD s/p b/l iliac stents Sciatica Lumbago Bilateral carotid artery disease Hyperlipidemia, unspecified hyperlipidemia type Stress hyperglycemia Postoperative anemia due to acute blood loss Osteopenia, unspecified location Claudication in peripheral vascular disease Surgical wound breakdown Mitral regurgitation Symptomatic anemia Acute upper GI bleed Ischemic cardiomyopathy Iron deficiency anemia GAVE (gastric antral vascular ectasia) Subclavian artery stenosis, right -80-90% Brachiocephalic artery stenosis, right -60-70% Subclavian artery stenosis, left -50% GI bleed Open wound of right elbow, sequela SIRS (systemic inflammatory response syndrome)
Andere Medikamente
albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler cholecalciferol (VITAMIN D) 25 MCG (1000 UT) tablet diphenhydrAMINE (BENADRYL) 25 MG tablet furosemide (LASIX) 40 MG tablet HYDROcodone-acetaminophen (NOR
Allergien
Penicillins
Vorherige Impfungen
-

VAERS 1958971

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
78,0
Geschlecht
M
Eingang
17.12.2021
Impfdatum
25.02.2021
Beginn
01.12.2021
Tage bis Beginn
279,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Angiogram pulmonary abnormal Asthenia Balance disorder COVID-19 COVID-19 pneumonia Chest discomfort Condition aggravated Cough Decreased appetite Dyspnoea Dyspnoea exertional Dysstasia Fatigue Gait inability Headache Orthostatic hypotension Oxygen saturation decreased

Symptomtext

Hospitalized 12/9/2021-still currently admitted; COVID-19 positive 12/1/2021; fully vaccinated HISTORY OF PRESENT ILLNESS: Patient is a 79 y.o. male with past medical history of parkinsons disease, prostate cancer s/p prostatectomy. Began having symptoms 11/28. Positive home test 11/30. + test at facility 12/1. MAB 12/4. Fever 102 after MAB, none since. Feeling weak and off balance after MAB. Had cough and rhinorrhea, fatigue prior to MAB but no fever. Minimal SOB. SOB now progressively worsening. Dyspnea with exertion worsening. Today unable to ambulate, Feeling very weak. "crumpled to floor" trying to stand. No chest pain, Chest feels heavy. No pleuritic pain. Cough with minimal sputum. No nausea, vomiting, diarrhea, abdominal pain. Denies urinary complaints. Minimal appetite, no loss of smell or taste. Able to stay hydrated. Having mild headaches. Has chronic lightheadedness with parkinsons. Per neuro notes has mild orthostatic hypotension. No other acute symptoms. CHIEF COMPLAINT: Pneumonia due to COVID-19 virus ASSESSMENT / PLAN: COVID Pneumonia Acute hypoxic respiratory failure secondary to above Symptom onset 11/28 COVID +: 11/30 on home test, + at facility 12/1 Received MAB 12/4 CTA thorax: No PE. Moderate to severe covid pneumonitis. Pulse ox at home 80's for a couple days and dipping into 70s since last night Received hydrocortisone 200mg for contrast prep, will hold off on decadron today and start 6mg daily in am Prn antitussives, albuterol MDI PRN tylenol for fever Chief complaint Pneumonia due to COVID-19 virus Assessment and Plan Pneumonia due to COVID virus Acute respiratory failure secondary to COVID - To complete Decadron for 10 days - currently on room air at rest. Bedside nurse to evaluate oxygen requirement with ambulation. - No longer need for severe isolation per infection control Dispo: SAR versus home with home health care based on patient's progress with the PT OT

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
8,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Pneumonia due to COVID-19 virus Acute respiratory failure due to COVID-19 Restless legs Parkinson's disease Prostate cancer Hepatitis Right shoulder pain Osteoarthritis of right shoulder region
Andere Medikamente
Ascorbic Acid (VITAMIN C) 500 MG CAPS carbidopa-levodopa (SINEMET) 25-250 MG per tablet Cholecalciferol (D3 SUPER STRENGTH) 2000 UNITS CAPS Glucosamine Sulfate 500 MG TABS melatonin 10 MG TABS tablet Multiple Vitamin (MULTIVITAMIN ADULT PO)
Allergien
Gadolinium Derivatives Iodinated Contrast Sulfa drugs
Vorherige Impfungen
-

VAERS 1958804

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
59,0
Geschlecht
F
Eingang
17.12.2021
Impfdatum
03.03.2021
Beginn
21.03.2021
Tage bis Beginn
18,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Alanine aminotransferase increased Aspartate aminotransferase increased Blood alkaline phosphatase increased Blood urea increased Death Endotracheal intubation Fibrin D dimer Gamma-glutamyltransferase increased Haematocrit decreased Haemoglobin decreased Haemoptysis Haptoglobin decreased Hypoxia Laboratory test Life support Metastases to bone Metastases to liver Prothrombin time prolonged

Symptomtext

Pt arrived at ER for complaints of massive hemoptysis. She was found to be hypoxic, with subsegmental PE and RLL mass with liver and bone mets. hypoxia, hemoptysis and thrombocytopenia worsened. She was intubated and had a massive hemoptysis event leading to PEA arrest. CPR initiated with ACLS. Remained pulseless and declared deceased.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
1,0
Labordaten
4/11/21- COVID swab negative, BUN 30, ALK PHOS 1,504, ALT 60, AST 132, TROP I 1.540, PT 16.6, FERRITIN 2,820, GGT 187, WBC 17.65, RBC 2.47, HGB 7.5, HCT 22.6, RETIC 2.79, IRF 40.40 , 4/12/21- D-Dimer 95.24, haptoglobin 7,
Aktuelle Erkrankungen
Back pain
Vorgeschichte
-
Andere Medikamente
aspirin daily. Short bout of NSAID, prednisone and gabapentin for back pain
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1955116

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
46,0
Geschlecht
F
Eingang
16.12.2021
Impfdatum
25.02.2021
Beginn
14.12.2021
Tage bis Beginn
292,0
Dosis
UNK
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Patient expired 12/14/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Unknown
Vorgeschichte
hyperlipidemia
Andere Medikamente
Unknown
Allergien
Latex
Vorherige Impfungen
-

VAERS 1947957

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MS
Alter
90,0
Geschlecht
F
Eingang
14.12.2021
Impfdatum
12.03.2021
Beginn
09.12.2021
Tage bis Beginn
272,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Cardiac failure Death

Symptomtext

Patient admitted to Hospital on 12/1/2021 for continued treatment of heart failure. Patient expired on 12/9/2021. Patient was fully vaccinated prior to admission.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1654153

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AZ
Alter
64,0
Geschlecht
F
Eingang
07.12.2021
Impfdatum
09.02.2021
Beginn
29.08.2021
Tage bis Beginn
201,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure Blood lactate dehydrogenase increased C-reactive protein increased COVID-19 COVID-19 pneumonia Endotracheal intubation SARS-CoV-2 test positive White blood cell count increased

Symptomtext

Pt fully vaccinated 2/9/21 and 3/2/21 for COVID, developed severe covid pneumonia requiring intubation and prolonged complicated hospitalization beginning 8/29/21

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2564205

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
57,0
Geschlecht
M
Eingang
04.12.2021
Impfdatum
12.03.2021
Beginn
06.04.2021
Tage bis Beginn
25,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death

Symptomtext

Narrative: 56 y/o pt received first dose of Pfizer COVID-19 vaccine on 3/12. Pt expired 4/6.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2563181

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
86,0
Geschlecht
M
Eingang
04.12.2021
Impfdatum
26.02.2021
Beginn
14.04.2021
Tage bis Beginn
47,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death

Symptomtext

Narrative: 85 y/o pt received first dose of Pfizer COVID-19 vaccine on 2/26. Pt was hospitalized on or prior to 4/7 for unknown causes. Pt had received 2nd COVID-19 vaccine while hospitalized. Pt expired 4/14.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2562019

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
69,0
Geschlecht
M
Eingang
04.12.2021
Impfdatum
05.03.2021
Beginn
06.04.2021
Tage bis Beginn
32,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death Incomplete course of vaccination

Symptomtext

Narrative: 68 year old male, received first dose of COVID-19 vaccine (Pfizer) 3/5/2021. Spouse called facility on 3/25/2021 to cancel second dose appointment scheduled for 3/26/2021. 4/2/2021 wife called to notify facility that patient was on hospice. Patient expired 4/6/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2558354

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
83,0
Geschlecht
M
Eingang
04.12.2021
Impfdatum
25.02.2021
Beginn
08.03.2021
Tage bis Beginn
11,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Asthenia Confusional state Death Disorientation Disturbance in attention Feeling cold Hypotension Intensive care Unresponsive to stimuli

Symptomtext

Narrative: 82 year old male, received his first dose of COVID-19 vaccination (Pfizer) on 2/25/2021. Patient has a PMH of lung cancer, HTN, BPH, OA and dementia. Per wife, patient had been feeling cold and increasingly confused since vaccination. Patient woke up disoriented, unable to focus, weak on 3/8/2021 and was admitted to hospital ICU hypotensive and unresponsive. Patient passed away shortly afterwards.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1924453

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
88,0
Geschlecht
M
Eingang
04.12.2021
Impfdatum
02.03.2021
Beginn
06.04.2021
Tage bis Beginn
35,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death

Symptomtext

Narrative: 86 y/o male who was administered the first dose of COVID-19 (Pfizer) vaccination on 3/2/2021. Patient had been transitioned to a rehab facility and never returned for the second dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2564317

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
67,0
Geschlecht
M
Eingang
03.12.2021
Impfdatum
05.03.2021
Beginn
26.03.2021
Tage bis Beginn
21,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death

Symptomtext

Narrative: 67 y/o male, received first dose of COVID-19 vaccine (Pfizer) on 3/5/2021. Daughter called medical facility 3/22/2021 requesting to speak with PCP to inform that pt was admitted to hospital diagnosed w/ MI and needed to know if pt had DNR. Patient expired 3/26/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1905379

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
89,0
Geschlecht
F
Eingang
29.11.2021
Impfdatum
20.04.2021
Beginn
01.11.2021
Tage bis Beginn
195,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia COVID-19 Cough Death Dyspnoea Respiratory disorder SARS-CoV-2 test positive

Symptomtext

Patient presented to emergency room on 11/2/2021 after testing positive for COVID-19 infection on 11/1/2021. She was experiencing shortness of breath, weakness, and cough. Patient was admitted for further management. Patient's respiratory status continued to decline despite steroids and oxygen supplementation. Patient expired on 11/15/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
13,0
Labordaten
COVID-19 test positive on 11/15/2021.
Aktuelle Erkrankungen
None known
Vorgeschichte
AAA (abdominal aortic aneurysm, ruptured) (HCC) Hypertrophic scar Aortic aneurysm (HCC) Arthritis Atrial fibrillation (HCC) High cholesterol Peripheral vascular disease (HCC) Renal insufficiency Keloid scar of skin Chronic respiratory failure with hypoxia (HCC) Abdominal pain Osteoarthrosis, unspecified whether generalized or localized, unspecified site Essential hypertension Post-menopausal SOB (shortness of breath) on exertion Ruptured thoracic aortic aneurysm (HCC) Nonrheumatic aortic valve insufficiency Non-rheumatic mitral regurgitation Cardiac murmur Palpitations Varicose veins of both lower extremities with pain Unsteady gait Primary osteoarthritis involving multiple joints Chest discomfort Oxygen dependent Vitamin D deficiency Fluid overload Acute respiratory failure with hypoxia (HCC) CHF (congestive heart failure), NYHA class II, acute, systolic (HCC) Hypervolemia, unspecified hypervolemia type Acute on chronic systolic congestive heart failure (HCC)
Andere Medikamente
amLODIPine (NORVASC) 10 MG tablet aspirin (HALFPRIN) 81 MG tablet ergocalciferol D-2 (DRISDOL) 50000 UNIT capsule furosemide (LASIX) 40 MG tablet isosorbide mononitrate (IMDUR) 30 MG SR tablets meclizine (ANTIVERT) 25 MG tablet metoprolol t
Allergien
None known
Vorherige Impfungen
-

VAERS 1899499

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
76,0
Geschlecht
M
Eingang
24.11.2021
Impfdatum
20.03.2021
Beginn
20.11.2021
Tage bis Beginn
245,0
Dosis
1
Route/Site
IM / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Anticoagulant therapy COVID-19 Cardiomyopathy Computerised tomogram thorax abnormal Condition aggravated Death End stage renal disease Hypotension Pleural effusion Pneumonia bacterial SARS-CoV-2 test positive Septic shock Shock

Symptomtext

Patient is now deceased. ED 11.20.21; hospitalized 11.21.21; COVID-19 positive (11.20.21); fully vaccinated Admitted for hypotension, septic shock, COVID-19 (with ESRD, cardiomyopathy, bilateral PE) Admission Date: 11/21/2021 Date of Death: 11/23/21 Time of Death: 12:59 PM Preliminary Cause of Death: Hypotension DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Shock (HCC) [R57.9] Hypotension [I95.9] HOSPITAL COURSE: This is a 77 year old male with a PMH significant for HTN, HLD, ESRD on HD, T2DM with retinopathy & neuropathy, gout, hemochromatosis, hyperparathyroidism, cardiomyopathy, OSA on BiPAP, CAD and obesity who was brought to the emergency department on 11/20 by EMS from his care facility with concerns of hypotension. The patient was noted to be hypotensive on initial evaluation and was given Levophed, also found to be positive for COVID-19 and noted to have CT thorax findings of large right effusion unchanged from prior imaging, increasing moderate left effusion, as well as patchy airspace disease in the right upper lobe and right middle lob suggestive of pneumonia representative of changes secondary to COVID-19 with inflammatory changes and early bacterial pneumonia. There was also question about the possibility of a PE on the CT thorax, however it was deemed unlikely as the patient had been anticoagulated with Warfarin for Atrial Fibrillation with therapeutic INR. The patient was started on broad spectrum antibiotics for bacterial pneumonia and was started on Remdesivir and Decadron for treatment of COVID-19 with admission for further evaluation and management. On the first full day after his ER visit that led to admission, the patient had elected not to pursue treatments any further. Hospice was consulted and patient/patient's family ultimately elected for inpatient hospice. Nephrology had been consulted for assistance with the patient's dialysis, although they ultimately signed off the patient's care due to patient choosing not to pursue further treatment and deciding to pursue inpatient hospice care. During the patient's hospitalization, his ICD was turned off given the patient's decision for hospice care. The patient was kept comfortable with the help of hospice during the remainder of his hospitalization and he expired comfortably on 11/23/21 with his wife and son at bedside. The patient was pronounced expired at 12:59PM on 11/23/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
ED 11.20.21 - CC: low blood pressure -- > hypotension, septic shock, COVID-19
Vorgeschichte
Chronic systolic congestive heart failure Urolithiasis - hx of uric acid stones Pulmonary hypertension Morbid obesity Osteoarthritis Gout Obstructive sleep apnea syndrome CPAP/BiPAP dependent Type 2 diabetes mellitus with diabetic polyneuropathy, with long-term current use of insulin Restless legs syndrome (RLS) Hemochromatosis Depression Permanent atrial fibrillation Cardiomyopathy, ischemic ESRD (end stage renal disease) Dyslipidemia ICD (implantable cardioverter-defibrillator), biventricular, in situ Calcium deficiency disease Secondary hyperparathyroidism Advanced care planning/counseling discussion Renal mass, right Cervical radiculopathy Mixed restrictive and obstructive lung disease Hoarseness of voice Frequent falls Polycystic kidney disease Diabetic retinopathy associated with type 2 diabetes mellitus Anemia in chronic kidney disease Coronary artery disease LAD Cypher stent 2006 Hypertension LBBB Other chronic sinusitis Bilateral pleural effusion OSA treated with BiPAP Idiopathic hypotension Diabetic polyneuropathy Hyperlipidemia Iron deficiency anemia, unspecified Hypotension Cardiomyopathy
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet atorvastatin (LIPITOR) 10 MG tablet B Complex-C-Folic Acid (RENA-VITE) TABS bisacodyl (DULCOLAX) 10 MG suppository citalopram (CELEXA) 20 MG tablet cyanocobalamin (B-12) 1000 MCG/ML injection diclofenac
Allergien
Iron SucroseGI Upset Acetaminophen-codeineDizziness AtenololOther CodeineDizziness
Vorherige Impfungen
-

VAERS 1897883

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
80,0
Geschlecht
F
Eingang
24.11.2021
Impfdatum
17.11.2021
Beginn
23.11.2021
Tage bis Beginn
6,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Angiogram pulmonary abnormal Blood creatinine normal Blood glucose normal C-reactive protein increased COVID-19 Chest X-ray abnormal Culture stool Dyspnoea exertional Fibrin D dimer Full blood count Laboratory test abnormal Lung opacity Metabolic function test SARS-CoV-2 test positive White blood cell count decreased

Symptomtext

Hospitalized 11/23/2021-still admitted currently; COVID-19 positive 11/23/2021; fully vaccinated plus booster CHIEF COMPLAINT: COVID ASSESSMENT / PLAN: Acute Respiratory Failure, secondary to COVID-19 o COVID-19 Infection - confirmed on 11/23/2021. o Vaccine Status: Fully vaccinated (Pfizer). Booster: Yes, dose on 11/17/2021 o Outpatient CXR (11/8/2021) suspicious for CAP - treated with Augmentin and Azithromycin o CTA Thorax (11/23/2021) - bilateral ground glass opacities, negative for PE o Abnormal Labs: ? Glucose - 61 ? Corrected in ER ? Cr - 1.10 ? WBC - 3.94 o Plan for Admission to Blodgett ? Hold Decadron as patient is not requiring O2. Did desaturate with ambulation but otherwise normal. Start if hypoxia occurs. ? Hold ABX, secondary to questionable Cdiff. ? Procalitonin ordered ? Not eligible for Remdesivir ? Trend CBC, CMP, D-Dimer, CRP ? Follow stool cultures ? Acapella, mucinex BID and Albuterol BID ? Encourage prone positioning, tessalon perles PRN, albuterol PRN ? Continuous O2 monitoring - not currently on O2. ? Respiratory Isolation

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Bipolar 2 disorder DM (diabetes mellitus), type 2 with renal complications Chronic kidney disease (CKD), stage III (moderate) HTN (hypertension) Restless leg syndrome IBS (irritable bowel syndrome) Hyperlipidemia PAD (peripheral artery disease) Gastroparesis Coronary artery disease due to lipid rich plaque History of pulmonary embolism Osteoporosis Morbid obesity with BMI of 40.0-44.9, adult S/P total knee arthroplasty Binswanger's encephalopathy Back pain Carotid artery disease Thyroid nodule Colonoscopy refused Urge incontinence of urine Impaired mobility Dyspnea on exertion Chronic diastolic heart failure
Andere Medikamente
amoxicillin-clavulanate (AUGMENTIN) 875-125 MG per tablet Ascorbic Acid (VITAMIN C PO) aspirin 81 MG tablet benzonatate (TESSALON) 200 MG capsule betamethasone dipropionate 0.05 % cream clonazePAM (KLONOPIN) 0.5 MG tablet clotrimazole (LOTR
Allergien
Statins Clonidine Dyazide Norvasc Prilosec
Vorherige Impfungen
-

VAERS 1897280

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
52,0
Geschlecht
M
Eingang
24.11.2021
Impfdatum
05.04.2021
Beginn
05.11.2021
Tage bis Beginn
214,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Cough Death Dyspnoea Endotracheal intubation Intensive care Pyrexia SARS-CoV-2 test positive

Symptomtext

patient presented to emergency department on 11/5/21 with shortness of breath, cough and fever. covid-19 specimen taken and came back positive patient was admitted for further management of covid-19 patient did require treatment for symptoms associated with covid-19 infection. treatment with dexamethasone patient was intubated on 11/9/21 and extubated on 11/13/21 patient's condition worsened requiring transfer to the intensive care unit on 11/7/21 patient expired on 11/13/21

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
8,0
Labordaten
tested at covenant healthcare - covid-19 test positive on 11/5/21
Aktuelle Erkrankungen
none known
Vorgeschichte
Obesity Neuropathy in diabetes LBP (low back pain) HTN (hypertension) Insulin dependent diabetes mellitus Dependent edema Uncontrolled type 2 diabetes mellitus with stage 3 chronic kidney disease, with long-term current use of insulin Hyperlipidemia, unspecified hyperlipidemia type Elevated troponin Lymphadenitis CKD stage 5 due to type 1 diabetes mellitus Class 3 obesity with alveolar hypoventilation and body mass index (BMI) of 40.0 to 44.9 in adult ESR raised Hyperphosphatemia Pre-op evaluation Heart murmur on physical examination Left carotid bruit Acute renal failure (ARF) CHF (congestive heart failure), NYHA class I, unspecified failure chronicity, combined COVID-19 Acute renal failure, unspecified acute renal failure type
Andere Medikamente
bumetanide (BUMEX) 2 MG tablet calcitRIOL (ROCALTROL) 0.5 MCG capsule calcium carbonate (TUMS) 500 MG chew tablet cinacalcet (SENSIPAR) 30 MG tablet heparin 1000 unit/mL injection insulin detemir (LEVEMIR) 100 UNIT/ML VIAL injection i
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 1897236

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
65,0
Geschlecht
M
Eingang
24.11.2021
Impfdatum
18.03.2021
Beginn
20.11.2021
Tage bis Beginn
247,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure Alcohol withdrawal syndrome Balance disorder Bursitis COVID-19 Cognitive disorder Computerised tomogram thorax abnormal Lung opacity Muscular weakness Pleural effusion Polyneuropathy SARS-CoV-2 test positive Spinal stenosis Tremor

Symptomtext

Hospitalized (11.22.21); COVID-19 positive (11.20.21); Fully Vaccinated Diagnosis: COVID-19, Acute respiratory failure with hypoxia Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 11/22/2021 Discharge Date: 11/23/2021 DETAILS OF HOSPITAL STAY PRESENTING PROBLEM: Hypoxic [R09.02] COVID-19 [U07.1] Acute respiratory failure with hypoxia [J96.01] HOSPITAL COURSE: Patient is a 66 y.o. male with a past medical history of liver cirrhosis secondary to alcohol abuse, chronic obstructive pulmonary disease, hypertension and obstructive sleep apnea who with hypoxia, COVID-19 positive. Patient was admitted to the medical service. He was started on dexamethasone and remdesivir. His clinical condition improved overnight. The patient was had no evidence of hypoxia on ambient air. Vital signs were stable. He did receive Ativan for tremors thought to be secondary to alcohol withdrawal. The patient's wife is a nurse. The patient was discharged on 11/23/2021 in stable condition. He was asked to return to the hospital if he had worsening fever chills or evidence of hypoxia.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
11.8.21 - CT thorax with contrast: Small to moderate left pleural effusion, new from previously. Minimal groundglass opacities in the left lung, nearly resolved from previously. No evidence for metastatic disease in the chest. 11.9.21 - outpatient neurology visit (He presents for post-hospital follow-up regarding lower extremities weakness and cognitive concerns. Agree with inpatient team that weakness and imbalance was likely multifactorial and related to polyneuropathy, spinal stenosis, bursitis, and deconditioning.) Alcohol-induced polyneuropathy / alcohol abuse / cirrhosis
Vorgeschichte
Unspecified essential hypertension Former smoker Pulmonary nodules Chronic rhinitis Alcohol abuse Cancer of true vocal cord OSA (obstructive sleep apnea) Prediabetes Neuromuscular weakness Cardiomyopathy
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler Bacillus Coagulans-Inulin (PROBIOTIC FORMULA PO) Calcium Carbonate-Vit D-Min (CALTRATE 600+D PLUS PO) cholecalcifero
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1893708

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
79,0
Geschlecht
F
Eingang
23.11.2021
Impfdatum
04.03.2021
Beginn
21.10.2021
Tage bis Beginn
231,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Pt deceased. Unsure of reason for death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Cardiovascular and Mediastinum Atrial fibrillation with RVR Atrial fibrillation, permanent Exhausted vascular access Respiratory Pneumonia Digestive GERD (gastroesophageal reflux disease) Chronic diarrhea Gastric outlet obstruction GI bleed Endocrine Proteinuria due to type 2 diabetes mellitus Type 2 diabetes mellitus with hemoglobin A1c goal of less than 7.5% Type 2 diabetes mellitus with diabetic neuropathy, with long-term current use of insulin Moderate nonproliferative diabetic retinopathy of both eyes without macular edema associated with type 2 diabetes mellitus Diabetic ketoacidosis without coma associated with type 2 diabetes mellitus Musculoskeletal and Integument DDD (degenerative disc disease), cervical Onychomycosis Genitourinary Acute kidney injury superimposed on CKD CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min Pyelonephritis Other Gout, unspecified Low magnesium levels Monitoring for long-term anticoagulant use Leukocytosis Mixed hyperlipidemia Severe sepsis Chronic anticoagulation Bacteremia due to Klebsiella pneumoniae
Andere Medikamente
allopurinol (ZYLOPRIM) 100 MG tablet apixaban (ELIQUIS) 5 MG tablet atorvastatin (LIPITOR) 40 MG tablet (Expired) Blood Glucose Monitoring Suppl (ACCU-CHEK GUIDE ME) w/Device KIT calcium carbonate (TUMS) 500 MG chewable tablet Continuo
Allergien
MetforminDiarrhea Sulfa AntibioticsDiarrhea Covid-19 Mrna Vaccine (Pfizer) [Covid-19 Mrna Vacc (Moderna)]Swelling Ace Inhibitors Aricept [Donepezil]Diarrhea
Vorherige Impfungen
Swelling after pfizer vaccine

VAERS 1889793

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
73,0
Geschlecht
F
Eingang
22.11.2021
Impfdatum
29.03.2021
Beginn
21.11.2021
Tage bis Beginn
237,0
Dosis
1
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 Dyspnoea

Symptomtext

Acute hypoxemic respiratory failure due to COVID-19; Shortness of breath; History of COPD;

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1882670

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WA
Alter
68,0
Geschlecht
M
Eingang
18.11.2021
Impfdatum
01.03.2021
Beginn
16.11.2021
Tage bis Beginn
260,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient received Pfizer COVID vaccine on 2/8/21 and 3/1/21 out of state. On 11/16/21, patient admitted to our facility for acute respiratory failure with hypoxia due to COVID-19. As of today (11/18/21), patient is still admitted in our med/surg unit.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
2,0
Labordaten
COVID status positive 11/11/21 in outside facility and 11/17/21 in our facility.
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, NIDDM2, history of right pontine CVA 6/2020
Andere Medikamente
allopurinol, amlodipine, baby aspirin, vitamin d3, cq10, metformin, olmesartan
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1877266

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
67,0
Geschlecht
M
Eingang
17.11.2021
Impfdatum
23.09.2021
Beginn
19.10.2021
Tage bis Beginn
26,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Anticoagulant therapy Asthenia COVID-19 Chest X-ray abnormal Chest pain Chest tube insertion Cough Death Diarrhoea Endotracheal intubation Hypotension Hypoxia Intensive care Lung opacity Mechanical ventilation Nausea Pneumonia

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/8/2021, 3/29/2021, and 9/23/2021. Patient tested for COVID at clinic on 10/19/2021 which resulted positive. Presented to ED on 10/20/2021 with complaints of cough, nausea, vomiting, diarrhea and weakness for 10 days. Admitted for acute kidney injury and requiring oxygen supplementation 3-4 L nasal cannula. Received: dexamethasone, full anticoagulation, remdesivir, broad spectrum antibiotics, paralytics, pressors, and nitric oxide. Transferred to ICU for chest pain and hypoxia. Developed pneumothorax, chest tube placed and intubated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
8,0
Labordaten
COVID positive 10/19/2021 and 10/20/2021; CXR: Patchy bibasilar opacities compatible with edema or pneumonia on 10/20/2021.
Aktuelle Erkrankungen
-
Vorgeschichte
Kidney transplant, allergic rhinitis, anemia, Autonomic nervous system disorder, thrombocytopenia, benign prostatic
Andere Medikamente
atorvastatin Take 1 tablet (20 mg total)by mouth daily,
Allergien
Flomax
Vorherige Impfungen
-

VAERS 1876761

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
78,0
Geschlecht
M
Eingang
17.11.2021
Impfdatum
03.03.2021
Beginn
22.05.2021
Tage bis Beginn
80,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Patient deceased. Unsure of cause of death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
Cardiovascular and Mediastinum Chronic atrial fibrillation Essential hypertension Chronic systolic heart failure Coronary artery disease involving native coronary artery of native heart without angina pectoris Respiratory Sleep apnea Digestive Intestinal malabsorption, unspecified GI bleed Radiation proctitis Musculoskeletal and Integument Osteoarthritis of left hip Genitourinary Chronic renal failure, stage 4 (severe) Prostate cancer Other Essential familial hypercholesterolemia History of colon cancer Status post left hip replacement Anemia, iron deficiency Symptomatic anemia Anemia due to chronic blood loss S/P right colectomy
Andere Medikamente
allopurinol (ZYLOPRIM) 100 MG tablet aspirin EC 81 MG EC tablet atorvastatin (LIPITOR) 80 MG tablet benazepril (LOTENSIN) 5 MG tablet Bimatoprost 0.01 % SOLN brinzolamide (AZOPT) 1 % ophthalmic suspension budesonide-formoterol (SYMBIC
Allergien
Nitroglycerin
Vorherige Impfungen
-

VAERS 1873903

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AR
Alter
73,0
Geschlecht
M
Eingang
16.11.2021
Impfdatum
22.02.2021
Beginn
04.10.2021
Tage bis Beginn
224,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute kidney injury Acute respiratory failure Anticoagulant therapy Arthritis Asthenia Atrial fibrillation Blood creatinine normal Blood gases abnormal Blood potassium increased COVID-19 Cardiac ablation Cardiac failure Cardiac failure acute Cardiomyopathy Chronic kidney disease Coagulopathy Computerised tomogram thorax normal Condition aggravated

Symptomtext

ADMITTED ON 10/4/2021: 74 y/o M with PMHx including CKD4, HFrEF / cardiomyopathy (EF 35-40% on last echo), CAD, AFib, pulmonary sarcoidosis, chronic immunosuppression and anticoagulation, etc., presented to the ER complaining of progressive shortness of breath, cough and fevers at home. He had received his Pfizer COVID-19 booster injection on last Tuesday. On the following day, he began to notice shortness of breath and cough. He subsequently developed fevers, generalized weakness with myalgias, etc. He became more short of breath today and presented to the ER for evaluation. Upon arrival, his oxygen saturation was 90% on room air. ABG revealed hypoxemia with PO2 of 53. His SpO2 improved with 2 L supplemental oxygen. Imaging was consistent with viral pneumonia. With concern for COVID-19 and hypoxemia with multiple comorbid conditions, he was admitted to the COVID step-down unit for further workup and management. As mentioned, the patient is fully vaccinated COVID and has received his booster. However, he is immunosuppressed with azathioprine and chronic prednisone. He is followed by Pulmonary DISCHARGED 11/2/2021: Discharge Summary Information Attending Physician, Consulting Physician, Primary Care Physician Discharge Diagnoses: 1. COVID-19 virus infection, Discharge, 10/04/2021 2. Hypoxemia, Discharge, 10/04/2021 acute hypoxic resp failure 3. CKD (chronic kidney disease), stage IV, Discharge, 10/04/2021 4. CAD (coronary artery disease), s/p multiple PCI/stents, Discharge, 10/04/2021 5. Atrial fibrillation, s/p PVI, Discharge, 10/04/2021 6. HFrEF (heart failure with reduced ejection fraction), Discharge, 10/04/2021 acute on chronic 7. Cardiomyopathy, Discharge, 10/04/2021 8. Chronic anticoagulation, Discharge, 10/04/2021 9. Pulmonary sarcoidosis, Discharge, 10/04/2021 10. Immunosuppression, Discharge, 10/04/2021 11. OSA on CPAP, Discharge, 10/04/2021 12. Class 1 obesity with body mass index (BMI) of 31.0 to 31.9 in adult, Discharge, 10/04/2021 13. Arthritis, Discharge, 10/04/2021 Secondary Diagnosis and Comorbidities: Hospital Course SARS-CoV-2, viral pneumonia due to COVID-19. Acute respiratory failure with hypoxemia. - Fully vaccinated and rec?d booster 9/28 - Symptoms began 9/29 - Completed course dexamethasone, 10/14 - Rec?d tocilizumab 10/9 - Completed course remdesivir, 10/9 -CTA chest w/o PE -Back on Imuran for Sarcoid -His oxygenation has ben slow to improve but is now at a manageable level at 6 to 7L -Medical facility states they will take him on current O2 needs AKI on CKD stage IV/Hyperkalemia. - Nephrology consulted, following - SCr in general has been stable - Potassium up slightly again on 10/19 - but improved w/ restarting lasix - Renal diet - Has some volume overload on exam now on po lasix per Nephrology -Creatinine is stable Extensive cardiac history, including CAD s/p multiple PCI/stents, atrial fibrillation s/p PVI, Acute on chronic HFrEF, cardiomyopathy. On chronic anticoagulation. - Appeared volume overloaded w/acute CHF - Now on lasix - Rate controlled; monitoring on telemetry - Initially on therapeutic Lovenox due to DOAC/dexamethasone interaction, now no interaction concerns Pulmonary sarcoidosis on immunosuppression. - Complicates #1 - Azathioprine to be possibly resumed in AM pending labs - Initially held his home prednisone while on dexamethasone - Restarted prednisone as he has completed Decadron - Will eventually need to f/u with his pulmonologist -Resumed imuran, follow LFT in one week Class 1 obesity. OSA on CPAP. - BMI > 31 - Complicates overall care & prognosis - CPAP qHS -he says will bring his home machine when goes HTN. - normotensive - Restarted home losartan and metoprolol Depression. -improved, especially now with some light at the end of the tunnel, moving to rehab

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
29,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1872901

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
71,0
Geschlecht
F
Eingang
16.11.2021
Impfdatum
15.03.2021
Beginn
10.11.2021
Tage bis Beginn
240,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

N/A

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
DMII, hypoglycemia, hyperkalemia, metabolic acidosis, COVID-19
Vorgeschichte
CVA, TIA, CABG, CAD, aortic valve replacement, DMII Insulin dependent, previous hemodialysis d/t chronic kidney injury
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 1641622

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
57,0
Geschlecht
F
Eingang
15.11.2021
Impfdatum
31.03.2021
Beginn
29.06.2021
Tage bis Beginn
90,0
Dosis
1
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Acidosis Acute kidney injury Acute respiratory distress syndrome Acute respiratory failure Bacterial test positive COVID-19 COVID-19 pneumonia Cough Death Bilevel positive airway pressure Blood lactic acid Blood pH decreased Chest X-ray abnormal Convalescent plasma transfusion Culture Culture urine positive Dyspnoea Echocardiogram

Symptomtext

DC: COVID-19 PNEUMONIA____VRE BACTEREMIA____ACUTE RESPIRATORY FAILURE 7/28/2021 S/S SHORTNESS OF BREATH, COUGH, WHEEZING, DIFFICULTY BREATHING. HX OF DIABETES, HYPERTENSION, COPD, CURRENT SMOKER, SUBSTANCE ABUSE, ANXIETY/DEPRESSION, HYPERLIPIDEMIA. PATIENT DECEASED ON 7/26/2021. CRM Non-LTCF. PCR (+) 07/21/2021. S/S: SOA, Cough, Wheezing. PMH: DM, HTN, COPD, current smoker, Substance abuse disorder, Anxiety/depression, HLD. Vaccinated (Pfizer): 03/10/2021, 03/31/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
PMH: DM, HTN, COPD, current smoker, Substance abuse disorder, Anxiety/depression, HLD.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1865583

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
79,0
Geschlecht
F
Eingang
12.11.2021
Impfdatum
23.02.2021
Beginn
19.10.2021
Tage bis Beginn
238,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Patient passed away on 10/19/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1097292

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
78,0
Geschlecht
M
Eingang
12.11.2021
Impfdatum
23.02.2021
Beginn
16.10.2021
Tage bis Beginn
235,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asymptomatic COVID-19 SARS-CoV-2 test Death

Symptomtext

Patient passed away on 10/16/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Zaroxolyn, Lasix, ferrous sulfate, Lexapro, Zyloprim, melatonin, Coreg, Xarelto, Protonix, Aldactone, albuterol, tylenol
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1097292

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
78,0
Geschlecht
M
Eingang
12.11.2021
Impfdatum
23.02.2021
Beginn
16.10.2021
Tage bis Beginn
235,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asymptomatic COVID-19 SARS-CoV-2 test Death

Symptomtext

Patient passed away on 10/16/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Zaroxolyn, Lasix, ferrous sulfate, Lexapro, Zyloprim, melatonin, Coreg, Xarelto, Protonix, Aldactone, albuterol, tylenol
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1857473

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
74,0
Geschlecht
F
Eingang
10.11.2021
Impfdatum
05.03.2021
Beginn
09.11.2021
Tage bis Beginn
249,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Anxiety Death Hypoxia Intensive care Mechanical ventilation Pulse absent Pulseless electrical activity Respiratory failure Resuscitation

Symptomtext

Pt initially admitted to the covid medical floor with respiratory failure. She was on nasal cannula which rapidly progressed to high flow cannula. Pt was struggling with anxiety which did contribute to her increasing oxygen requirements and repetitive hypoxic events. Decision was made to transfer her to the ICU on 11/2/2021 given that she was unable to come off NIV. Once on ventilator, Pt required maximum ventilator settings and eventually even nitric oxide. Despite all interventions, Pt rapidly deteriorated on 11/9/2021. Husband and grandson arrived to bedside. Pt went into PEA, CPR was performed. She was able to regain a pulse for a few minutes then again went pulseless. CPR was performed until husband requested all efforts to be terminated. Pt was pronounced deceased @ 1135 on 11/9/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
14,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1853591

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
65,0
Geschlecht
M
Eingang
09.11.2021
Impfdatum
19.03.2021
Beginn
27.10.2021
Tage bis Beginn
222,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute kidney injury Acute respiratory failure Alanine aminotransferase increased Anticoagulant therapy Aspartate aminotransferase increased Atrial fibrillation C-reactive protein increased COVID-19 COVID-19 pneumonia Cardiac arrest Chest X-ray abnormal Cough Endotracheal intubation Fatigue Fibrin D dimer increased Glomerular filtration rate decreased Hypoxia Intensive care

Symptomtext

Hospitalized 11/1/2021; COVID-19 positive 10/27/2021; fully vaccinated CHIEF COMPLAINT Dyspnea, cough, sent from monoclonal antibody infusion clinic HISTORY OF PRESENT ILLNESS Patient is a 66 y.o. male with past medical history significant for coronary artery disease, history of anterior wall infarct with cardiac arrest in 2016, paroxysmal atrial fibrillation, on Eliquis, obesity, hypertension, who presented to the ER today after being sent from the monoclonal antibody clinic for evaluation. The patient woke up on the morning of 10/23 with a dry cough and funny feeling in his throat, developed high fevers, severe fatigue and worsening cough for over the next couple days. He tested positive for covid 19 PLAN Acute hypoxemic respiratory failure COVID 19 pneumonia - Symptom onset 10/23 - Received pfizer vaccines in March, April - Currently requiring 15 L nonrebreather, transition to high flow - Lungs with diffuse wheezing bilaterally, add albuterol inhaler - CXR independently reviewed, with bibasilar changes of covid 19 pneumonia - Start Decadron 6mg daily x 10 days (start 11/1) - Out of window for remdesivir, also not recommended due to GFR 24 and AKI - IS q 1hr while awake, prone positioning prn - Check d-dimer - Bilateral lower extremity doppler ordered. No missed doses of eliquis other than this morning due to being in the ED. Regardless, has right lower extremity tenderness to palpation and palpable cord, raising concern for DVT 11/3/2021 note: ASSESSMENT / PLAN: Acute hypoxemic respiratory failure Breakthrough COVID 19 pneumonia - CXR: Worsening in the appearance of the chest as discussed. While elements of this may be on the basis of the patient's Covid pneumonia, cannot exclude the possibility of elements of superimposed CHF and pulmonary edema as well. - Symptom onset 10/23, COVID-19 + 10/27, s/p Pfizer vaccines in March, April '21 - Currently on HFNC 100%, 55 l/min, with NRB mask over, Pox 90-94% - on albuterol inhaler - Decadron 6mg daily day # 3/10 days, remdesivir day # 2/5 - IS q 1hr while awake, prone positioning prn - D-dimer 640-- > 640-- >740, on Eliquis - CRP 135-- > 127.6-- > 130.3 - AST 164--. 405 - ALT 101-- > 285 - Doppler US of legs: No deep vein thrombus is seen in the right or left lower extremity - will give Lasix 40 mg IV this am, may need transfer to ICU - discussed with pulmonologist who will see patient today

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
8,0
Labordaten
11/6/2021 note: Acute hypoxemic respiratory failure due to COVID-19 Assessment & Plan Due to COVID-19 pneumonia / ARDS Admitted 11/1 requiring NRB -- > 80% HFNC Progressive hypoxemia CXR with worsening perihilar infiltrates Therapeutically anticoagulated with Eliquis for Afib; 11/1 LE dopplers negative (now on heparin to replace Eliquis) Transfer to ICU on 11/5 pm, saturations persistently low 80's Intubated 11/5 pm Paralytic 11/5 - Prone position 11/6 - 11/8/2021 note: ASSESSMENT / PLAN: Cardiac arrest Assessment & Plan Most likely due to hypoxia as it occurred shortly after being turned to supine position. ROSC after 2 minutes. Unable to assess mental status as he is already proned/paralyzed. Ultimate deficits, if any, unknown at this time Pneumonia due to COVID-19 virus Assessment & Plan Vaccinated - Pfizer 3/19/2021, 2/26/2021 Test positive 10/27/2021 Admitted 11/1 Remdesivir 11/2 - 11/7 (initially held due to AKI) Steroids Dexamethasone 6 mg daily 11/2 - 11/3 Methylprednisolone 40 mg BID 11/3 - 11/4 Methylprednisolone 40 mg Q8H 11/5 - ABX Vancomycin 11/6 - Zosyn 11/6 - Acute hypoxemic respiratory failure due to COVID-19 Assessment & Plan Due to COVID-19. Arrested when supinated yesterday. Oxygen requirements still remain very high in the proned position. I do not think he would tolerate changing position to supine today.
Aktuelle Erkrankungen
-
Vorgeschichte
Asthma Atrial fibrillation CAD (coronary artery disease) Chronic back pain Degenerative disc disease Hemorrhoids High cholesterol HTN (hypertension) Hypertension Mixed hyperlipidemia Myocardial infarct Myocardial infarction anterior wall MI Stented coronary artery stent OM, stent 2nd digonal
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet albuterol (PROVENTIL, VENTOLIN, PROAIR) 108 (90 Base) MCG/ACT inhaler apixaban (ELIQUIS) 5 MG tablet aspirin 81 MG tablet atorvastatin (LIPITOR) 80 MG tablet cholecalciferol (VITAMIN D3) 50 MCG (2000 UT
Allergien
Latex Lactose
Vorherige Impfungen
-

VAERS 1848977

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
CO
Alter
74,0
Geschlecht
M
Eingang
06.11.2021
Impfdatum
07.10.2021
Beginn
09.10.2021
Tage bis Beginn
2,0
Dosis
3
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Acute respiratory failure Atrial fibrillation Laboratory test Pericardial effusion Pneumonia Pneumonia bacterial Sepsis

Symptomtext

Acute respiratory failure with hypoxia POA: Unknown Severe sepsis. POA: Unknown Community acquired bacterial pneumonia.POA: Unknown Pericardial effusion POA: Unknown Atrial fibrillation POA: Unknown Leukocytes is POA: Unknown Elevated LETs POA: Unknown Acute kidney injury POA: Unknown

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
Take to Doctor. NUMEROUS
Aktuelle Erkrankungen
None
Vorgeschichte
Acid reflex Gout COPD COPD
Andere Medikamente
ADVAIR DISKUS VENTOLIN HFA LEVOTHYROXINE BISTOLIC ALLOPURINOL FLUOXETINE COLCRYS SIMVASTATIN OMEPRAZOLE D3
Allergien
None
Vorherige Impfungen
-

VAERS 1836418

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
SC
Alter
77,0
Geschlecht
M
Eingang
02.11.2021
Impfdatum
02.03.2021
Beginn
13.09.2021
Tage bis Beginn
195,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Cardiac assistance device user Catheterisation cardiac abnormal Dyspnoea Echocardiogram abnormal Ejection fraction decreased Electrocardiogram abnormal Heart rate irregular Myocardial infarction

Symptomtext

On 9-17-2021 I experienced difficulty breathing and made an appointment with my primary care physician, Dr. He scheduled me or a pulmonary exam which I took and everything appeared normal. The next day he scheduled me for an EKG and the results of that were abnormal. He referred me to a cardiac specialist, Dr. who ordered an Echocardiogram, the results of which showed an ejection fraction of 15%. He scheduled me two days later for a heart cauterization. The results, as described by Dr. was damage due to a series of small heart attacks, and irregular heart beat. He ordered a heart defibrillator which I am wearing all the time now for the next 3 months.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocardial infarction
Hospital-Tage
1,0
Labordaten
Mentioned above.
Aktuelle Erkrankungen
None
Vorgeschichte
None other than gout
Andere Medikamente
Flonase, Allipurinol, Vitamins C, B-12, D-3, 81mg Aspirin, Centrum Silver, Fish Oil
Allergien
Allergic to Sulfa drugs
Vorherige Impfungen
-

VAERS 1828696

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
91,0
Geschlecht
M
Eingang
29.10.2021
Impfdatum
24.03.2021
Beginn
22.10.2021
Tage bis Beginn
212,0
Dosis
1
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Agitation Asthenia Back pain Brain herniation COVID-19 Chest X-ray normal Computerised tomogram head abnormal Confusional state Death Depressed level of consciousness Dysstasia Epidural haemorrhage Fall Hypoacusis Imaging procedure abnormal Neck pain Productive cough Pupil fixed

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/2/2021 and 3/24/2021. Presented to ED on 10/22/2021 for evaluation of weakness that resulted in falls yesterday and today with associated upper back and neck pain. Pt is unable to give a complete ROS. States that he got COVID from his wife but does not know when his symptoms started, endorses a cough with green sputum for "a long time", weakness, and upper back and neck pain from fall. He states that he is so weak he is unable to stand up. Denies n/v, diarrhea, CP, SOB, ABD pain, ROS otherwise limited. PT extremely HOH. EMS reported O2 sat 90% on RA at home. Patient started on dexamethasone and remdesivir. Further history from patient indicated his prior diagnosis of bacterial of PNA was done over the phone. His imaging findings were consistent with bacterial PNA, he had no WBC and a relatively unimpressive procal, bacterial PNA was unlikely so abx were stopped. The following day patient became agitated and confused. He was alert only to himself but still attempted to converse and answer questions, he had no focal neurological signs. This was thought to be delirium from COVID-19, his UA was negative and his CXR was negative for aspiration and he did not show signs of sepsis. The following morning patient was obtunded and would not respond to sternal rub, he had nonreactive pupils. A stat CT head was ordered which revealed a massive extra-cranial bleed with 5 cm midline shift and subfalcine as well as uncal herniation. The bleed was most likely epidural or subdural in origin. Family elected to make patient comfort care and patient expired on 10/26/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
4,0
Labordaten
Positive COVID-19 on 10/22/2021.
Aktuelle Erkrankungen
-
Vorgeschichte
CAD, GERD, Sleep apnea
Andere Medikamente
Vitamin C 500 mg BID, Aspirin 81 mg QD, Cholecalciferol 2000 units QD, Fexofenadine 60 mg QD, Levothyroxine 100 mcg QD, Meclizine 25 mg TID PRN, Midodrine 5 mg TID, Omeprazole 20 mg QD, Simvastatin 40 mg QD, Tramadol 50 mg Q6H PRN, Zinc 50
Allergien
Codeine (Nausea)
Vorherige Impfungen
-

VAERS 1823600

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
OK
Alter
61,0
Geschlecht
F
Eingang
28.10.2021
Impfdatum
03.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Anxiety Myocardial infarction

Symptomtext

Thought she was having a heart attack; anxiety; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A 61-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6202), intramuscular, administered in left arm on 03Mar2021 at 14:30 (at the age of 61-year-old) as DOSE 1, SINGLE for covid-19 immunisation. The report is related to Study Programme. The patient medical history included stage 4 breast cancer (Diagnosed 15 years ago this August), stage 4 bladder cancer and was taking Chemo (She was off Chemo for a while before having the first dose of the Pfizer COVID Vaccine), rapid heartbeat, a little hair loss (when she was on Chemo), 33 years ago she had compromised immune status (doctors say it was ringworm and hookworm and then saw a dermatologist that said it was autoimmune disease), seasonal allergies (allergies to prescription drugs specifically antibiotics), she had an allergic reaction to Bactrim, anything that had Sulfa drugs in it (they make her itch incredibly bad), She had a little reaction to Penicillin (it makes it difficult to breathe, but she did not have swelling of throat), pain medication, they have not found one her body can tolerate, opioids make her itch (one they put her on, she did not have that bad of a reaction to). The Oxycodone 5mg is the name of the one she can take. She cannot take Hydrocodone. They gave her some strong ones with the first chemo. Brother and died had heart attack. Hers was caused by Stage 4 cancer and PICC line. She confirmed she did not have a heart attack. PICC Line caused damage to heart and when she had stage 4 breast cancer, it causes damage to your heart and that was when she started having trouble with the PICC line in 2020. They had to start her Chemo and she could not take her last 2 treatments. She took 80%. They figured she got enough Chemo. They gave her a child's dose because she weighs so little. She wears an ostomy bag since she does not have a bladder. She had to dehydrate before she went to get the vaccine. She did not get time to heal from major surgery before her doctor made her start with Chemo. They were trying to save her life. She was a Withheld girl and said she would have been ok with it. The patient's concomitant medications included Metoprolol ER Succinate 50 mg capsule. Once daily by mouth since 2020 for high heart rate. Patient did not receive any vaccine Prior within 4 prior vaccinations. Previously she took she took flu shot and did not have any. The patient experienced heart attack on 03Mar2021 at 18:00 and anxiety in Mar2021. She reported that when she had first dose, she thought she was having a heart attack. Even before having vaccine, she had a history of a rapid heartbeat and does take heart medication for that. She asked her brother, who also took his vaccine the next day, if he had any problems and he did not. He told her to take a Benadryl. It was so bad; she felt her heart would come out of her chest and made her go into anxiety. So that was when she took the Benadryl (25 mg), and she did feel better immediately. Within a little bit, it was gone. It lasted just a couple of hours, and then it stopped. It was reported that she saw cardiologist and pulmonary specialist and had to be put on oxygen but this was prior to the vaccine. She also had a PICC line placed prior to the vaccine and that also caused her heart issues. She was so scared of the COVID. Even if she got the vaccine, does not mean she will survive. She needs to cut her ostomy supplies and get in the shower and this was prior to getting the vaccine. She had anxiety when he came home from work, and she wipes everything down. She worried about it and had to let herself calm down instead of having anxiety. She has calmed down a lot. She said her doctor told her she could feel like she may have a little of a cold if she got it. The outcome of heart attack was recovering, and outcome of anxiety was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergic reaction to antibiotics; Autoimmune disorder (has this autoimmune disease that makes these rings on her body); Bladder cancer stage IV (taking Chemo (She was off Chemo for a while before having first dose of the Pfizer COVID Vaccine)); Breast cancer stage IV (Diagnosed 15 years ago this August); Chemotherapy; Drug allergy; Hair loss (when she was on Chemo); Heart attack (Brother and died had heart attack. Hers was caused by Stage 4 cancer and PICC line.); Heart rate high (she had a history of a rapid heartbeat and does take heart medication for that.); Ostomy bag placement; Peripherally inserted central catheterisation; Seasonal allergy; Underweight (They gave her a child's dose because she weighs so little)
Andere Medikamente
METALOC [METOPROLOL SUCCINATE]
Allergien
-
Vorherige Impfungen
-

VAERS 1821708

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
78,0
Geschlecht
F
Eingang
27.10.2021
Impfdatum
18.08.2021
Beginn
18.10.2021
Tage bis Beginn
61,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure C-reactive protein abnormal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Fibrin D dimer increased Lung opacity Malaise SARS-CoV-2 test positive

Symptomtext

Pt received 3 doses of the Pfizer COVID-19 vaccine (initial 2 dose series and immunocompromised 3rd dose. Received on 2/4/2021, 2/24/2021, and 8/18/2021 respectively). Pt still contracted COVID and was ill enough to be hospitalized. Symptom onset of 10/13/2021, tested positive 10/18/2021 and admitted to hospital. **Acute hypoxic respiratory failure secondary to COVID-19 pneumonia: Patient with symptom onset 10/13/2021 with positive Covid test 10/18/2021. Patient is up-to-date on SARS-CoV-2 mRNA vaccine series including recent booster dose, but notably patient is immunosuppressed on chronic immunosuppressive medications. Patient with rapid respiratory decline, initially on room air, progressed rapidly to higher needs. Initial chest x-ray with bilateral opacities, right greater than left with progressive bilateral airspace opacities on repeat chest x-ray 10/20/2021. -Started on dexamethasone 6 mg daily on 10/18/2021, but with progressive respiratory decline, increased to 10 mg twice daily 10/20/2021. Decreased to 6mg twice daily, by mouth, on 10/27. -Remdesivir initiated 10/18, completed 5-day course on 10/22/2021 -Continue baricitinib, started 10/20/2021 with progressive respiratory decline. Plan for 14-day course or until discharge (whichever shorter) -prone positioning as tolerated -Continue supplemental O2. If progressive O2 requirements, would likely need transition to PAP therapy, but not agreeable to intubation if needed for further respiratory decline. -Symptomatic therapies with as needed Tylenol, albuterol -CRP and D-dimer have down trended. No ongoing monitoring needed at this time. -Saline nebulizer treatments, Aerobika, and guaifenesin for mucolytics

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
allergic rhinitis, anxiety, asthma, bronchiectasis, bursitis, cervical ddd, depression, eosinophilia, GERD, HTN, hyperlipidemia, IBS, left carotid bruit, osteoporosis, pulmonary nodules, sciatica, syncope, umbilical hernia
Andere Medikamente
azelastine nasal spray, calcium citrate w/ vitamin D, denosumab, diclofenac, dicyclomine, fluticasone-salmeterol, gabapentin, levoceterizine, losartan, mycophenolate, omalizumab, sertraline, trazodone, vitamin D
Allergien
Melon, Niacin, Cilantro, Fire ants, pineapple, wasp venom, tramadol, papaya derivatives, sulfa antibiotics, amoxicillin-pot clavulanate, fosamax, hydroxyzine, lotensin
Vorherige Impfungen
-

VAERS 1818584

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
65,0
Geschlecht
M
Eingang
26.10.2021
Impfdatum
27.03.2021
Beginn
16.10.2021
Tage bis Beginn
203,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Ageusia Anosmia Asthenia Back pain Bacterial infection Brain natriuretic peptide normal C-reactive protein COVID-19 COVID-19 pneumonia Cardiac failure congestive Cardiac telemetry Chest X-ray abnormal Computerised tomogram thorax abnormal Condition aggravated Decreased appetite Diarrhoea Dyspnoea

Symptomtext

Hospitalized (10.16.21 - current; still admitted); COVID-19 positive (10.16.21); fully vaccinated CHIEF COMPLAINT: Acute respiratory failure due to COVID-19 HISTORY OF PRESENT ILLNESS: Patient is a 65 y.o. male who presents today with increased shortness of breath and fatigue. Patient has history of hypertension, diabetes, obesity, OSA, paroxysmal AFib, and CKD 3. Patient also has chronic respiratory failure in which he requires 2-3 L nasal cannula at baseline. Patient states over the last 5 days he has had decreased urination, appetite, loss of taste and smell, and increasing shortness of breath. Patient does also report 1 day of multiple loose stools approximately 3 days prior to evaluation. Patient also complains of chronic back pain but has had more increase in body aches. Patient does not does not endorse identified fever, chest pain or abdominal pain. Due to increasing shortness of breath and fatigue with continued symptoms patient presented to Emergency Room for further evaluation. In the emergency room, patient was found to have worsening renal function, elevated troponins with decrease on repeat. BNP was normal without leukocytosis. COVID-19 virus was detected upon swab. D-dimer was within normal range however chest x-ray showed concern for focal pneumonia versus large mass. CT thorax was performed without contrast and showed dense infiltrate in right upper lobe with suspected right upper lobe pneumonia. Patient was given IV Rocephin, azithromycin, and Decadron. Patient was also found to be slightly hypoxic on baseline 2-3 L therefore requiring increase of nasal cannula oxygen 4-5 L. admission was accepted to a hospitalist service for care of COVID-19 pneumonia as well as secondary bacterial pneumonia and hypoxia. Acute respiratory failure due to COVID-19 Assessment & Plan Patient had chronic respiratory failure needing 2-3 L supplemental oxygen consistently throughout the day and night. Patient currently requiring 4-5 L while awake and 10 L bleed into BiPAP at night. Acute on chronic respiratory failure secondary to COVID pneumonia. Symptom onset 10/10/2021 with fatigue and weakness. Progressive increased shortness of breath. Due to renal function patient is currently not a candidate for remdesivir if improvement in a.m. will need to reconsider starting. Patient with chest x-ray consistent of right upper lobe pneumonia, elevated procalcitonin and leukocytosis, will treat for secondary bacterial infection as well. Plan: Continuous pulse ox monitoring and supplemental oxygen to maintain saturation greater than 90%. Rocephin and azithromycin day 1 of 5. Daily Dexamethasone 6 mg. Monitor daily complete blood count and BMP with CRP and D-dimer Progress Note 10.26.21: Pneumonia due to COVID-19 virus Assessment & Plan Echo yesterday similar to previous Feeling slightly improved today. Able to be weaned to 6L 02 per nasal cannula. Will trial home CPAP again tonight. GOAL SATS 88-92 Daily Dexamethasone 6 mg, (completed 10/26) Continue home eliquis for anticoagulation Monitor daily CBC, CRP and Ddimer Lasix 40mg IV bid Supportive care Position change from side to side, does not tolerate prone position Monitor on continuous pulse oximetry and cardiac telemetry. Acute respiratory failure due to COVID-19 Assessment & Plan Able to be weaned to 6L 02 per nasal cannula. Continue to monitor on continuous pulse oximetry and tele Wean off oxygen as able.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
11,0
Labordaten
-
Aktuelle Erkrankungen
10.4.21 - office visit - Cardiology - 3 month follow up of CHF. AHA stage C heart failure. The patient reports stable exertional dyspnea. He does have mild lower ext swelling on exam today which he reports is stable. He denies orthopnea or PND. He denies abdominal bloating or fullness. Continue ACE-inh. Not on BB previously due to hypotension
Vorgeschichte
Obesity Hypoventilation Syndrome Chronic respiratory failure with hypoxia Hypercholesterolemia History of colon polyps Hypotension after procedure Recurrent falls Supplemental oxygen dependent Morbid obesity with BMI of 40.0-44.9 Atherosclerosis of native coronary artery of native heart without angina pectoris Benign hypertensive heart disease with heart failure Cardiomegaly Chronic diastolic heart failure Chronic pain CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min Conductive hearing loss Congestive heart failure COPD (chronic obstructive pulmonary disease) Fredrickson type IIa hyperlipoproteinemia Metabolic syndrome X Lumbosacral radiculopathy Neurogenic claudication Polyneuropathy due to type 2 diabetes mellitus Pulmonary hypertension Rubeosis iridis
Andere Medikamente
apixaban (ELIQUIS) 5 MG TABS aspirin 81 MG tablet choline fenofibrate (TRILIPIX) 45 MG delayed release capsule furosemide (LASIX) 40 MG tablet insulin glargine (LANTUS SOLOSTAR) 100 UNIT/ML pen-injector lisinopril-hydrochlorothiazide (PRINZ
Allergien
AtorvastatinMyalgia SimvastatinMyalgia
Vorherige Impfungen
-

VAERS 1818171

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6202

kritisch
Staat
NY
Alter
83,0
Geschlecht
F
Eingang
26.10.2021
Impfdatum
23.02.2021
Beginn
14.03.2021
Tage bis Beginn
19,0
Dosis
2
Route/Site
- / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Adult failure to thrive Agitation Catatonia Cerebrovascular accident Death Deep vein thrombosis Ischaemic stroke

Symptomtext

My mother had a minor stroke the week of March15th she went to the ER on March 16th but since an MRI was not performed they missed the stoke. 10 days later on Friday March 26th she had a larger Ischemic stroke and was hospitalized. She was moved to acute rehab when they found a blood clot in her leg on April 12th. By the end of the month she became non verbal and catatonic so she was moved back to Hospital on May 3rd, 2021. She was so agitated they couldn't even give her a MRI to verify if she indeed she had another stroke. On May 28th she was moved to sub acute rehab and failed to thrive or respond to rehabilitation treatment. She died on June 21, 2021 just 4 months after her second Pfizer shot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
Far too many, please contact hospitals where she was treated. March 16-April 12 April 12-May 3 May 3-May 28 May 28-June 21st
Aktuelle Erkrankungen
Meningioma Brain Tumor (right temporal lobe)
Vorgeschichte
High Blood Pressure (managed with medication), mild hearing loss
Andere Medikamente
Quinapril Baby Asprin
Allergien
none
Vorherige Impfungen
-

VAERS 1815180

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
70,0
Geschlecht
F
Eingang
25.10.2021
Impfdatum
11.10.2021
Beginn
18.10.2021
Tage bis Beginn
7,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Anticoagulant therapy Aspartate aminotransferase increased Asthenia Blood creatinine increased Blood glucose increased C-reactive protein increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chills Depression Diarrhoea Dyspnoea Exposure to SARS-CoV-2 Fall Fibrin D dimer Glomerular filtration rate decreased

Symptomtext

Hospitalized 10/18/2021; COVID-19 positive 10/18/2021; fully vaccinated Chief Complaint: Dyspnea Reason for Admission: Pneumonia due to covid-19 Admission Date: 10/18/2021 Length of Stay: 0 day(s) History of Present Illness: Patient is a 70 y.o. female with a past medical history of Type II diabetes on basal bolus insulin c/b retinopathy, CKD4 s/p renal txp in 2010 at hospital, hypertension, presenting with shortness of breath. Today she states that she has been feeling very weak and and short of breath. Approximately 8-10 days ago ago she noticed she was becoming weak and having vomiting, difficulty keeping food down. She developed chills and shaking, as well. She has received all 3 doses of the pfizer vaccine. Today, she developed shortness of breath and was unable to further care for herself at home and thus she called EMS. No chest pain, mild intermittent diarrhea which she states is infrequent. She does report mild cough with clear mucous. Her son recently had covid and she suspects she may have contracted it from him. She did fall one month ago but is unsure if she hit her head. In the emergency department she was febrile to 39.2, HR 89, BP 145/50, hypoxic and requiring 5L NC. Labs were significant for Cr 1.72, glucose 307, AST 47, hgb 10.4. CXR showed patchy bilateral reticular airspace disease most confluent in the mid left lung zone c/w covid-19. She was given vancomycin and zosyn and subsequently admitted to the internal medicine service for further care. 10/21/2021 note: ASSESSMENT / PLAN: Principal Problem: Pneumonia due to COVID-19 virus 70 yo woman with hx of renal transplant here w/ SOB, dx w/ Covid PNA and acute hypoxic respiratory failure. Sepsis criteria not met. Covid-19 PNA Acute hypoxic respiratory failure Fever last 10/18 PM HA N/V/D Vaccinated x3 (Pfizer) but immune suppressed with renal transplant Sx start 10/8 - 10/21 weakness, vomiting, chills and rigors Covid + 10/18/21 CRP 160 -> 93 D-dimer 3160 -> 2450 Unable to give remdesivir due to renal dysfunction, GFR consistently <30 MAb not given due to O2 use but ID questioned if it could be given under compassionate use protocol; have not heard back as yet? Decadron 6 mg d x10 days; holding daily prednisone 5 while on Decadron Lovenox for DVT ppx Prone as able Goal O2 sat >92% High flow at 100% FiO2 and 60 L/min with 97 - 100% saturations; decreasing support is indicated 10/25/2021 note: ASSESSMENT / PLAN: Principal Problem: Pneumonia due to COVID-19 virus 70 yo woman with hx of renal transplant here w/ SOB, dx w/ Covid PNA and acute hypoxic respiratory failure. Sepsis criteria not met. Orthostatic hypotension, increased creatinine and subdued with dry mm, suspect Lasix effective, in use for edema, currently on hold per Nephrology; strongly agree IVFs, 1 L, given back slowly 10/22/21 but appreciate we want a "dry lung"; she improved with this Depression, acute She declines to discuss what is bothering her or that she is willing to talk with someone about it Covid-19 PNA Acute hypoxic respiratory failure Fever last 10/18 PM HA N/V/D Vaccinated x3 (Pfizer) but immune suppressed with renal transplant Sx start 10/8 - 10/21 weakness, vomiting, chills and rigors Covid + 10/18/21 CRP 160 -> 93 -> 40 D-dimer 3160 -> 2450 -> 1620 Unable to give remdesivir due to renal dysfunction, GFR consistently <30 MAb given despite O2 use under compassionate use protocol, pursued; labor appreciated Decadron 6 mg d x10 days; holding daily prednisone 5 while on Decadron Lovenox for DVT ppx Prone as able Goal O2 sat >92% High flow support decreasing, 50% FiO2 and 40 L/min with 98% saturations; decreasing support is indicated Dispo: 7-10 day stay anticipated but will be based on progress and has potential for prolonged stay. Multiple recent surgeries and now Covid infection with progressive weakness and debility demand rehab.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
7,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Type II or unspecified type diabetes mellitus with ophthalmic Moderate nonproliferative diabetic retinopathy(362.05) Posterior synechiae of iris Cortical senile cataract Myopia CKD (chronic kidney disease) stage 4, GFR 15-29 ml/min Atherosclerosis of renal artery Controlled type 2 diabetes mellitus with complication, with long-term current use of insulin Essential hypertension, malignant GERD (gastroesophageal reflux disease) History of kidney transplant Immunosuppression Renovascular hypertension Type 2 diabetes mellitus with both eyes affected by mild nonproliferative retinopathy without macular edema, with long-term current use of insulin Senile nuclear cataract, bilateral Epiretinal membrane (ERM) of left eye Regular astigmatism of both eyes Chronic pain of right knee Arthralgia of right hand Environmental allergies Peripheral artery disease Arthritis of right knee S/P total knee arthroplasty, right Hyperkalemia Platelets decreased AKI (acute kidney injury) Intractable nausea and vomiting Hypercalcemia
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet ALPRAZolam (XANAX) 0.25 MG tablet aspirin 81 MG enteric coated tablet Bacillus Coagulans-Inulin (PROBIOTIC FORMULA PO) cyclobenzaprine (FLEXERIL) 5 MG tablet diphenhydrAMINE (BENADRYL) 25 MG tablet ferr
Allergien
CT dye Seasonal allergies
Vorherige Impfungen
-

VAERS 1788596

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
SC
Alter
72,0
Geschlecht
M
Eingang
23.10.2021
Impfdatum
26.02.2021
Beginn
12.04.2021
Tage bis Beginn
45,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Atrial fibrillation Balance disorder Balance test Blood test normal Cardiac monitoring abnormal Blood test Cerebrovascular accident Computerised tomogram Condition aggravated Computerised tomogram normal Dysphonia Echocardiogram normal Exercise tolerance decreased Echocardiogram Eye pain Gait disturbance Hypoaesthesia Magnetic resonance imaging head abnormal

Symptomtext

terrible sharp shooting pain occurred frequently in my right sinus above my right eye; right side of my face and head went numb; terrible sharp shooting pain occurred frequently in my right sinus above my right eye; condition worsened, went to (name of hospital) ER; could not walk up the hill to door, placed in a wheel chair; probable TIA or stroke; probable TIA or stroke; slight imbalance & leaning to the right; This is a spontaneous report from a contactable consumer (patient). A 73-year-old male patient (age at vaccination: 72-year-old) received bnt162b2 (BNT162B2, lot EM9810), via an unspecified route of administration in right arm on 26Feb2021 12:30 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included 2 incidents of pulmonary embolism (PE), no known allergies, melanoma, other skin cancers, fatty liver and had familial high cholesterol. Concomitant medications included apixaban (ELIQUIS), eszopiclone (LUNESTA), escitalopram oxalate (LEXAPRO), allopurinol and fish oil taken for an unspecified indication, start and stop date were not reported. The patient previously received bnt162b2 (lot EN6202) via unknown route in the right arm on 05Feb2021 12:30 (age of 72-year-old) for Covid-19 immunisation. On 12Apr2021 19:30, he had slight imbalance and leaning to the right. The patient experienced probable TIA (transient ischaemic attack) or stroke on 13Apr2021. His condition worsened 13Apr2021 19:30 and could not walk up the hill to door and was placed on the wheelchair. On 16Apr2021, the right side of the face and head went numb and felt a terrible sharp shooting pain that occurred frequently on the right sinus above the right eye. The events were serious- hospitalization duration of 2 days, life threatening and disability. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient had 12 weeks physical therapy as treatment. The patient underwent laboratory tests and procedures which included blood test: unknown results on 13Apr2021, blood test: normal on 14Apr2021, computerised tomogram: unknown results on 13Apr2021 , echocardiogram: normal on 14Apr2021, magnetic resonance imaging head abnormal: normal on 14Apr2021, neurological examination: normal on 14Apr2021- neurologist came and performed some bedside tests , physiotherapy: normal on 14Apr2021 physical therapy tests for walking, balance, coordination, Sars-cov-2 test: negative on 13Apr2021, speech rehabilitation: normal on 14Apr2021 speech test , X-ray: unknown results on 13Apr2021. The outcome of events was recovered with sequel. Course of events: On 12Apr2021: slight imbalance & leaning to the right. On 13Apr2021: condition worsened, went to ER, could not walk up the hill to door, placed in a wheel chair, probable TIA or stroke, admitted to hospital, battery of tests initiated to look for TIA or stroke, blood work, COVID test, XRay, CT scan. On 14Apr2021: remained in hospital with more tests performed, Brain MRI, Echo Cardiogram. Neurologist came and performed some bedside tests, more blood work, speech test, physical therapy tests for walking, balance, coordination, etc. all tests were normal and imbalance was gone, discharged at 7:00 PM to go home. On 15Apr2021: imbalance & leaning to the right came back in the evening. On 16Apr2021 thru 18Apr2021: condition worsened to the point where he could not walk unassisted, right side of his face and head went numb, terrible sharp shooting pain occurred frequently in the right sinus above the right eye, only way to relieve pain was to sit reclined with ice pack on the right sinus.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
2,0
Labordaten
Test Date: 20210413; Test Name: Blood work; Result Unstructured Data: Test Result:unknown results; Test Date: 20210414; Test Name: more blood work; Result Unstructured Data: Test Result:Normal; Test Date: 20210413; Test Name: CT Scan; Result Unstructured Data: Test Result:unknown results; Test Date: 20210414; Test Name: Echo Cardiogram; Result Unstructured Data: Test Result:Normal; Test Date: 20210414; Test Name: Brain MRI; Result Unstructured Data: Test Result:Normal; Test Date: 20210414; Test Name: Neurologist came and performed some besides tests; Result Unstructured Data: Test Result:Normal; Comments: Neurologist came and performed some bedside tests; Test Date: 20210414; Test Name: physical therapy tests; Result Unstructured Data: Test Result:Normal; Comments: physical therapy tests for walking, balance, coordination; Test Date: 20210413; Test Name: Nasal swab; Test Result: Negative ; Test Date: 20210414; Test Name: speech test; Result Unstructured Data: Test Result:Normal; Comments: speech test; Test Date: 20210413; Test Name: X-ray; Result Unstructured Data: Test Result:unknown results
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Fatty liver; Melanoma; Pulmonary embolism; Skin cancer
Andere Medikamente
ELIQUIS; LUNESTA; LEXAPRO; ALLOPURINOL; FISH OIL
Allergien
-
Vorherige Impfungen
-

VAERS 1804539

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
93,0
Geschlecht
M
Eingang
21.10.2021
Impfdatum
04.03.2021
Beginn
18.10.2021
Tage bis Beginn
228,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

COVID-19 death of fully immunized individual

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Aflutter with RVR Cardiomyopathy HTN/HLD CKD 3
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1801199

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
79,0
Geschlecht
M
Eingang
20.10.2021
Impfdatum
02.03.2021
Beginn
09.10.2021
Tage bis Beginn
221,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure COVID-19 pneumonia

Symptomtext

Acute hypoxic respiratory failure due to COVID-19 pneumonia

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
12,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1800841

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
75,0
Geschlecht
M
Eingang
20.10.2021
Impfdatum
19.03.2021
Beginn
19.10.2021
Tage bis Beginn
214,0
Dosis
1
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 COVID-19 pneumonia Dyspnoea Hyperkalaemia

Symptomtext

Acute hypoxemic respiratory failure due to COVID-19; shortness of breath; hyperkalemia; pneumonia due to COVID-19 virus

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1798213

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
73,0
Geschlecht
M
Eingang
19.10.2021
Impfdatum
05.03.2021
Beginn
26.07.2021
Tage bis Beginn
143,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Asthenia COVID-19 COVID-19 pneumonia Condition aggravated Death Diarrhoea Endotracheal intubation Hyperhidrosis Nausea Positive airway pressure therapy Pyrexia SARS-CoV-2 test positive Vomiting

Symptomtext

7/26 positive for COVID, placed on Azithromycin and Prednisone; hx of IDDM, chronic lymphocytic leukemia, asthma; presented to ED on 8/4 with weakness, N/V/D, diaphoretic, fever; COVID pneumonia; placed on BIPAP, required reintubation; pt's condition worsened; pt's wishes to not be on life support for long; pt was extubated and passed away in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
32,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1795017

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
83,0
Geschlecht
M
Eingang
18.10.2021
Impfdatum
24.03.2021
Beginn
11.10.2021
Tage bis Beginn
201,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

PATIENT EXPIRED ON 10/11/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
DM HTN
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1788588

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
98,0
Geschlecht
F
Eingang
15.10.2021
Impfdatum
09.04.2021
Beginn
05.10.2021
Tage bis Beginn
179,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Brain natriuretic peptide increased COVID-19 Chest X-ray abnormal Computerised tomogram head normal Death Depressed level of consciousness Hypoxia Lung opacity Procalcitonin SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/12/2021 and 4/09/2021. Patient presented to the emergency department with hypoxia and admitted to hospital. Patient received: dexamethasone, remdesivir, antibiotics, tocilizumab. Patient's respiratory status continued to decline. Patient became obtunded and family elected to initiate comfort care. Patient expired 10/12/2021 at 0340.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
7,0
Labordaten
10/5/2021: COVID positive; 10/5/2021: Chest x-ray: New patchy bilateral airspace opacity, BNP 402, & procalcitonin 0.21; 10/8/2021: Head CT: No acute intracranial abnormality
Aktuelle Erkrankungen
-
Vorgeschichte
Asthma, atrial fibrillation, chronic kidney disease, congestive heart failure, hypertension, osteoarthritis, glaucoma, gout, hyperlipidemia, peripheral artery disease, hypothyroidism, pulmonary hypertension, thalassemia minor, cardiac pacemaker
Andere Medikamente
Acetaminophen 650 mg q6h prn, tylenol #3 1 tablet q6h prn, albuterol inhaler 2 puffs q6h prn, benzonatate 100 mg TID prn, calcium carbonate-vitamin D2 1 tablet BID, zyrtec 10 mg daily prn, biotin 5000 mcg every evening, vitamin D3 1000 unit
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1785229

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
95,0
Geschlecht
M
Eingang
14.10.2021
Impfdatum
26.02.2021
Beginn
02.10.2021
Tage bis Beginn
218,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

Patient received dose one as above. Dose 2 (Pfizer lot#ER2613 given IM in left deltoid on 3/19/21. Patient reported to ED on 10/2/21 and tested positive with PCR for covid. Admitted to hospital. During stay, he was placed on steroids, oxygen and bipap. Patient passed on 10/11/21. Patient was DNR/DNI prior to admission

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1774925

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
83,0
Geschlecht
F
Eingang
09.10.2021
Impfdatum
15.03.2021
Beginn
07.10.2021
Tage bis Beginn
206,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Cardio-respiratory arrest Death Resuscitation

Symptomtext

Patient was admitted and being treated for covid. She was receiving maximal therapy (see my progress note from today), but unfortunately underwent a cardiopulmonary arrest. Patient started to be resuscitated, but discussions with family revealed that she did not want to be put on a machine. She was made a DNR and comfort medications (morphine) were administered given pain of CPR. Patient passed shortly after stopping CPR.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardio-respiratory arrest
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1736870

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NC
Alter
55,0
Geschlecht
F
Eingang
08.10.2021
Impfdatum
20.03.2021
Beginn
25.03.2021
Tage bis Beginn
5,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Adverse reaction Burning sensation Eye swelling Intensive care Laboratory test Dysphagia Investigation Lip swelling Paraesthesia oral Pharyngeal swelling Organ failure Pruritus Septic shock Swelling of eyelid Urticaria Urticarial vasculitis

Symptomtext

I broke out in hives that covered anywhere I had skin/ I had large welts; itching on 100% of my body; My eyelids, lips, and throat swelled; My eyelids, lips, and throat swelled; My eyelids, lips, and throat swelled; My tongue became tingling; difficult to swallow; This is a spontaneous report from a contactable consumer (patient). A 55-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EP7534), via an unspecified route of administration in left arm on 20Mar2021 at 10:00 (at the age of 55-years-old) at dose 2, single for COVID-19 immunization. Medical history was reported as none. She has no COVID prior to vaccination and has no known allergies. Concomitant medication included liraglutide (SAXENDA) and clonidine. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6202), via an unspecified route of administration in right arm on 27Feb2021 at 10:00 (at the age of 55-years-old) at dose 1, single for COVID-19 immunization. There were no other vaccines in four weeks. Facility type was reported as other. She was not tested for COVID post vaccination. On 25Mar2021 at 15:00, the patient broke out in hives that covered anywhere she had skin. She had large welts and itching on 100% of her body. Her eyelids, lips, and throat swelled. Her tongue was tingling, and it was difficult for her to swallow. The events required emergency room/department or urgent care and doctor or other healthcare professional office/clinic visit. She was hospitalized for 6 days from an unspecified date in 2021 to an unspecified date in 2021. The events were also reported as life-threatening illness (immediate risk of death from the event) and caused disability or permanent damage. Therapeutic measures were taken as a result of the events. She was placed on medications and test was done on an unspecified date in 2021 with unknown result. The outcome of the events was not recovered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Septic shock
Hospital-Tage
6,0
Labordaten
Test Date: 2021; Test Name: test; Result Unstructured Data: Test Result:Unknown result
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente
SAXENDA; CLONIDINE
Allergien
-
Vorherige Impfungen
-

VAERS 1768982

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
97,0
Geschlecht
F
Eingang
07.10.2021
Impfdatum
23.03.2021
Beginn
15.09.2021
Tage bis Beginn
176,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Abdominal pain Acute respiratory failure COVID-19 Death Decreased appetite Depressed level of consciousness Diarrhoea Dyspnoea Fatigue Hypoxia Pneumonia SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/5/2021 and 3/23/2021. Presented to ED on 9/18/2021 with reports decreased appetite over the last 3 days, diarrhea and abdominal pain 2 days duration, shortness of breath, and fatigue. She was found to have pneumonia secondary to COVID-19. She was hypoxic and admitted to the hospital. She was started on dexamethasone and determined to not be a candidate for remdesivir. She rapidly decompensated and required high-flow nasal cannula. By September 24th she had become relatively obtunded and stop taking all oral medications. On maximum high-flow she was only maintaining O2 saturations in the 86-89% range. Palliative Care evaluated the patient on that evening and on the morning of the 26th she was transitioned to comfort care. On September 26 at 3:16 a.m. the patient passed away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
8,0
Labordaten
Positive COVID-19 test on 9/18/2021 using the Roche LIAT SARS assay platform using PCR or equivalent technology.
Aktuelle Erkrankungen
-
Vorgeschichte
Hypertension, Left bundle branch block, Hypothyroidism, Dementia, Atrial Fibrillation, Benign neoplasm of kidney, Nodular lymphoma, Angiomyolipoma, Follicular lymphoma, 1st degreee AV block, Bigeminy, SIADH,
Andere Medikamente
Acetaminophen prn, Amlodipine 5 mg QD, Carvedilol 12.5 mg BID, Levothyroxine 37.5 mcg QD, Lisinopril 10 mg QD, Rivastigmine 4.6 mg/24hr Patch QD.
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 1759375

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
51,0
Geschlecht
M
Eingang
04.10.2021
Impfdatum
25.03.2021
Beginn
27.08.2021
Tage bis Beginn
155,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute respiratory failure COVID-19 COVID-19 pneumonia Death Endotracheal intubation Enterococcal infection Fall Hypotension Hypoxia Intensive care Oxygen saturation decreased Pneumonia SARS-CoV-2 test positive Staphylococcal infection Tachycardia

Symptomtext

51 yo male pt s/p Pfizer COVID vaccination: dose 1 on 3/4/21 and dose 2 on 3/25/21. PMH of ALL s/p MUD PBSCT 1/15/20 c/b GVHD of the skin and joints for which he is treated with tacrolimus, prednisone, and ruxolitinib at baseline; tacro and rux held on admission. Presented to the ED 8/26 after an assisted fall at home. Of note, he tested positive for COVID on 8/24 at outside institution. He underwent monoclonal antibody infusion and decompensated shortly afterward. Upon arrival to ED, he was found to be hypoxic requiring HHFNC and was admitted to hospital for further care. Received remdesivir and dexamethasone. Hospital course complicated by acute hypoxic respiratory failure in the setting of COVID PNA with superimposed PsA/MSSA/E. Faecalis PNA. Despite prolonged antibiotic treatment and heated high flow oxygen therapy, pt became increasingly tachycardic and acutely decompensated requiring intubation, 3-pressor support, inhaled veletri, proning, and bicarb infusion. His oxygen saturation continued to drop and he was profoundly hypotensive. After discussion with the patient's wife and children, the decision was made to pursue comfort care. Pressor support was decreased and the patient expired shortly after at 10:30AM on 9/17.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
22,0
Labordaten
Novel Coronavirus PCR- Detected (8/27/2021)
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1759030

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
PA
Alter
74,0
Geschlecht
F
Eingang
04.10.2021
Impfdatum
04.03.2021
Beginn
17.09.2021
Tage bis Beginn
197,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure Adenovirus test Anticoagulant therapy Arteriosclerosis Asthenia Bordetella test negative Bronchiectasis COVID-19 pneumonia Chest X-ray abnormal Chronic obstructive pulmonary disease Computerised tomogram abdomen abnormal Computerised tomogram thorax abnormal Condition aggravated Cough Decreased appetite Diarrhoea Dyspnoea Enterovirus test negative

Symptomtext

ED to Hosp-Admission Discharged 9/19/2021 - 9/23/2021 (4 days) Last attending ? Treatment team Acute respiratory failure with hypoxia Assessment Patient is a 75 y.o. female who presents with with past medical history of COPD, presented with generalized weakness, and shortness of breath x2 days. Plan 1. Acute hypoxic respiratory failure: Presented with generalized weakness, cough and shortness of breath, SPO2 dropped to 77% on room air, likely due to COPD exacerbation, in light of SARS-CoV-2 pneumonia. Supplemental oxygen by nasal cannula, keep SPO2 greater than 90%, start IV dexamethasone, and remdesivir. send and monitor inflammatory markers. 2. COPD with acute exacerbation: Patient use 2 L of oxygen at night, CT chest showed right sided pleural thickening, mild bilateral bronchiectatic changes, with minimal patchy airspace disease. Continue treatment as #1, continue scheduled nebs, resume Breo, 3. SARS-CoV-2 pneumonia: Patient received Pfizer COVID-19 vaccine on 3/21, nasopharyngeal swab positive for SARS-CoV-2, with mild patchy airspace disease. Continue treatment as #1, maintain Covid isolation, 4. Hyponatremia and hypokalemia: Due to decreased p.o. intake, encourage oral hydration, replace potassium 5. Essential hypertension: Resume hydrochlorothiazide 6. GERD: Resume Protonix 7. Generalized anxiety disorder: On sertraline, will continue DVT PPX: low molecular weight heparin Dispo: 3 S., anticipate > 2 midnight inpatient stay DNR (Do Not Resuscitate) CC: Shortness of breath and generalized weakness. HPI Patient is a 75 y.o. female who presents with with past medical history of COPD on 2 L home oxygen at night, presented to the ED with generalized weakness, cough, shortness of breath x3 days. Patient states that her symptoms started last Thursday when she started experiencing body aches, generalized weakness and poor appetite. Since yesterday she has been feeling more out of breath and experienced fever. Patient reports that her cough is dry and about the same. Reports nausea and one episode of diarrhea this morning.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
4,0
Labordaten
09/19/21 2126 Respiratory virus detection panel Collected: 09/19/21 2011 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result Detected Critical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Syncytial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected Procedure Component Value Ref Range Date/Time CT COVID chest without contrast (Abnormal) Resulted: 09/20/21 0038 Order Status: Completed Updated: 09/20/21 0038 Narrative: PROCEDURE INFORMATION: Exam: CT Chest Without Contrast; Diagnostic Exam date and time: 9/19/2021 11:49 PM Age: 75 years old Clinical indication: Covid 19 infection, hypoxia TECHNIQUE: Imaging protocol: Diagnostic computed tomography of the chest without contrast. 3D rendering (Not supervised by radiologist): MIP and/or 3D reconstructed images were created by the technologist. Radiation optimization: All CT scans at this facility use at least one of these dose optimization techniques: automated exposure control; mA and/or kV adjustment per patient size (includes targeted exams where dose is matched to clinical indication); or iterative reconstruction. COMPARISON: CT Chest PE,Abdomen,Pelvis W Contast 3/1/2017 10:32 AM FINDINGS: Lungs: Mild chronic COPD changes are noted. Very minimal patchy airspace disease at left upper lobe. Bilateral mild bronchiectatic changes. Pleural spaces: Right-sided pleural thickening. Heart: Unremarkable. No cardiomegaly. No pericardial effusion. Aorta: Atherosclerotic changes within the aorta. Mild atherosclerotic changes within the aorta. Lymph nodes: Unremarkable. No enlarged lymph nodes. Bones/joints: Degenerative changes within the thoracic spine. Soft tissues: Unremarkable. IMPRESSION: Mild chronic COPD changes are noted. Very minimal patchy airspace disease at left upper lobe. Bilateral mild bronchiectatic changes. THIS DOCUMENT HAS BEEN ELECTRONICALLY SIGNED BY MD X-ray chest 1 view - Portable Resulted: 09/19/21 2151 Order Status: Completed Updated: 09/19/21 2151 Narrative: XR CHEST 1 VW PORT IMPRESSION: Mild interstitial changes. END OF IMPRESSION: INDICATION: WEAKNESS, +COVID Sepsis. TECHNIQUE: Portable AP projection of the chest is acquired. COMPARISON: 3/4/2017 FINDINGS: Heart size appears unremarkable. There is mild bilateral interstitial prominence that represents a change since the prior study. There is no pleural effusion.
Aktuelle Erkrankungen
-
Vorgeschichte
Nervous Sinus pain Neural hearing loss, bilateral Respiratory Chronic obstructive pulmonary disease with acute exacerbation Solitary pulmonary nodule Pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Acute respiratory failure with hypoxia Circulatory Carotid artery disease Hypertension Digestive Incontinence of feces Gastroesophageal reflux disease without esophagitis Musculoskeletal Osteopenia, unspecified location Easy bruisability Endocrine/Metabolic Hyponatremia Hypokalemia Other Generalized anxiety disorder ACP (advance care planning) Screening breast examination Former smoker Predisposition to allergic reaction Hoarseness
Andere Medikamente
acetaminophen (TYLENOL) 500 mg tablet albuterol HFA (PROVENTIL HFA) 90 mcg/actuation inhaler benzocaine-menthoL 15-3.6 mg lozenge benzonatate (TESSALON) 100 mg capsule esomeprazole (NexIUM) 40 mg capsule fluticasone (FLONASE) 50 mcg/ac
Allergien
AzithromycinRash Bupropion HclRash CodeineRash CortisoneRash PrednisoneRash Sulfa (Sulfonamide Antibiotics)Rash
Vorherige Impfungen
-

VAERS 1756641

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
67,0
Geschlecht
F
Eingang
02.10.2021
Impfdatum
03.03.2021
Beginn
23.09.2021
Tage bis Beginn
204,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

PT EXPIRED ON 09/22/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CAD, RHEUMATOID ARTHRITIS
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1753561

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
79,0
Geschlecht
F
Eingang
01.10.2021
Impfdatum
27.03.2021
Beginn
22.09.2021
Tage bis Beginn
179,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure Arteriosclerosis Asthenia Atelectasis COVID-19 Computerised tomogram thorax abnormal Cough Deafness Diarrhoea Diuretic therapy Dyspnoea Fatigue Hypoxia Lung opacity Oxygen saturation abnormal Pleural effusion Productive cough Pyrexia

Symptomtext

Hospitalized (9.22.21); COVID-19 positive (9.21.21); fully vaccinated Discharge Provider: DO Primary Care Provider: PA-C Admission Date: 9/22/2021 Discharge Date: Sep 29, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 79 year old woman who presented for evaluation of fever, productive cough, weakness and shortness of breath. Found to be hypoxic, septic and covid positive. She was started on Remdesivir and Decdaron. O2 was used to maintain adequate saturations. O2 needs increased early in here stay so her admission was a bit prolonged. Gentle diuresis was employed to maintain euvolemia. As the admission progressed, o2 needs leveled out. Currently, she is using 1-2 L and will go home with oxygen as she is eager to go home. I do have concerns about medical non-compliance as many of her listed home medications have not been filled in 10 + months. For her PVD, she is advised to take ASA/Plavix and statin. Her HTN appears to be controlled off home medications Lisinopril, Triamt/HCTZ. Additionally, we resumed Levothyroxine- she had not filled this in 10+ months. I recommend checking outpatient TSH in 4-6 weeks. Two additional days of Decadron will be prescribed to complete 10 days total. Probiotic and fiber for her diarrhea. Close follow up with her pcp is recommended. A follow up cxr is advised per pcp.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
8,0
Labordaten
Narrative: EXAMINATION: Single View Chest EXAM DATE: 9/28/2021 5:31 AM FINDINGS: Lung volumes are diminished since the prior examination. By basilar opacifications continue, and appear increased at the left base, the left hemidiaphragm is more difficult to visualize. Pleural fluid would be difficult to exclude on the left. No visualized pneumothorax. Limited evaluation of heart hilar and mediastinal borders appear stable with atherosclerosis. Limited estimation of heart size. No new tubes or catheters evident. No rib lesions discretely imaged. _________________________ Impression: Increasing opacification at the left base may represent atelectasis from diminished lung volumes or focal airspace disease. Left pleural effusion not excluded. Short-term follow-up recommended
Aktuelle Erkrankungen
9.01.21: ENT appointment - hearing loss 9.15.21 - COVID symptoms started 9.19.21 - called nurse triage line to report symptoms 9.21.21 - at home COVID-19 test positive; increased symptoms fatigue and cough, pulse ox 85-90% at home
Vorgeschichte
Deep vein thrombosis (DVT) DM (diabetes mellitus), type 2, uncontrolled PVD (peripheral vascular disease) Dyslipidemia, goal LDL below 70 Essential hypertension Uterine leiomyoma, unspecified location Adrenal nodule Acquired hypothyroidism History of tobacco abuse History of noncompliance with medical treatment Iron deficiency anemia secondary to inadequate dietary iron intake Anemia History of interstitial lung disease Nonhealing surgical wound, initial encounter Hyperlipemia Hx of BKA, right Dilated cardiomyopathy Interstitial lung disease Platelets decreased Stage 3a chronic kidney disease Sudden right hearing loss Chronic pain of left knee Slow transit constipation COVID-19 Acute respiratory failure with hypoxia
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet aspirin 81 MG EC tablet atorvastatin (LIPITOR) 40 MG tablet clopidogrel (PLAVIX) 75 MG tablet dexamethasone (DECADRON) 6 MG tablet Docusate Sodium (DSS) 100 MG capsule ferrous sulfate 325 (65 Fe) MG tab
Allergien
LatexHives, Itching PenicillinsSwelling TapeItching, Rash
Vorherige Impfungen
-

VAERS 1753470

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
83,0
Geschlecht
F
Eingang
01.10.2021
Impfdatum
05.03.2021
Beginn
25.09.2021
Tage bis Beginn
204,0
Dosis
2
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Aphasia Aspiration Blood pressure increased Breath sounds abnormal COVID-19 Cough Culture Dyspnoea Faecaloma Feeding tube user COVID-19 pneumonia Cerebrovascular accident Cognitive disorder Computerised tomogram abdomen abnormal Condition aggravated Foaming at mouth Heart rate increased Hemiparesis

Symptomtext

Hospitalized (9.19.21 - present); COVID-19 positive (9.25.21); fully vaccinated Elderly woman with recent long admission with progressive mental status decline. No obvious etiology identified despite workup with neurology service. She was discharged on tube feeds through corpak with plans for hospice if not improving. She is actually still improved from her baseline when I saw her last and discharged her. At that time she could not speak, except to say, "hi" and could not follow commands. She can now follow some commands and can say a few words and seems oriented to person and place. I'm not sure there is significant evidence of encephalopathy given her improvement from discharge still. Can treat for possible UTI given concerns from her facility, but will need to further discuss with her husband regarding goals of care. Given her marked limitations and illness,would continue to recommend hospice. In regards to her rigidity, doubt this is related to Parkinsonism. She has severe spinal stenosis which can result in spacticity and alterations in resting tone. On one leg she has fairly normal tone (left) which is almost flaccid, which would be odd and atypical for Parkinson's to affect only 3/4 limbs. We will ask neurology (not neuro psych) about Sinamet trial given she is admitted and they have been consulted overnight, but would defer to their expertise in this matter. I evaluate her ulcer at bedside, doesn't look infected. Does look worse than prior. Unlikely to heal. Monitor cultures. Reviewed her CT images personally with large stool burden. Add bowel regimen. Overall poor prognosis. Resident Hospitalist Significant Event Addendum Date of Service: 9/26/2021 5:27 PM Hover for details Patient did test COVID positive on 09/25/2021. Attempted to call husband to update him however he was unavailable. Patient unable to be transferred to Nursing Home due to new COVID-19 diagnosis, they will not accept her until 10 days after positive diagnosis. Consulted palliative care given most recent discussions about hospice consideration, may need to be considered for hospice in the hospital. Care manager is aware. Patient may qualify for regeneron therapy however in the setting of hospice considerations, but not recommended at this time. Follow-up medicine team will need to follow up conversations with DPOA husband. Will need to follow-up with palliative Care recommendations for further steps, appreciate their input. ASSESSMENT / PLAN: Patient is a 83 y.o. female with a PMH of Afib s/p watchman placement, hyperlipidemia, hypertension, HFrEF (33%), mild mitral regurgitation, prior CVA/TIA who presented to the ED on 09/19/21 for fever and altered mental status. #COVID 19 PNA Pt tested positive for COVID-19 on 09/25/21. Patient was recently visited by husband who was also COVID positive, unclear source of COVID pneumonia for patient. Ongoing discussions with the DPOA, husband , will need to be conducted. Dispo: Patient covid + on 9/25 and needs 10 days of isolation before facility will take her. Plan hospice at discharge with hospice at facility, Corpak will need to be removed. Husband hospitalized at Hospital for Covid infection currently.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
13,0
Labordaten
-
Aktuelle Erkrankungen
9.1.21 - ED COUGH / SOB (per ems, pt from nursing home. nurse reports inc Hr and BP. noticed frothing at mouth needing suctioning and coughing. diminished lower breath sounds. CVA 1 week ago with L sided deficits and nonverbal. r/o aspiration.) and Aspiration
Vorgeschichte
Dyspnea on exertion Decreased diffusion capacity of lung Atrial fibrillation (HCC) HTN (hypertension), benign Posture imbalance Chronic kidney disease, stage 2 (mild) Non-ischemic cardiomyopathy (HCC) Chronic diastolic congestive heart failure (HCC) Hyponatremia At high risk for injury related to fall Cough Mitral valve insufficiency and aortic valve insufficiency Falls frequently Bruit Encephalopathy Mixed hyperlipidemia Major depressive disorder Anxiety TIA (transient ischemic attack) Left-sided weakness Cervical spinal stenosis Presence of Watchman left atrial appendage closure device Decreased level of consciousness Acute cystitis without hematuria Precordial pain AMS (altered mental status) Encephalopathy acute
Andere Medikamente
albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler ascorbic acid (VITAMIN C) 500 MG tablet aspirin 50 MG/ML compounded suspension atorvastatin (LIPITOR) 10 MG tablet buPROPion (WELLBUTRIN XL) 300 MG 24 hr
Allergien
Imdur [Isosorbide]Other Ace InhibitorsCough
Vorherige Impfungen
-

VAERS 1753460

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
72,0
Geschlecht
M
Eingang
01.10.2021
Impfdatum
05.03.2021
Beginn
25.09.2021
Tage bis Beginn
204,0
Dosis
2
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Atrial fibrillation Blood albumin decreased Blood calcium decreased Bradycardia Condition aggravated Cyanosis Diarrhoea Dizziness Dyspnoea COVID-19 COVID-19 pneumonia Cardioactive drug level Chest X-ray abnormal Chronic obstructive pulmonary disease Electrocardiogram abnormal Fatigue Heart rate decreased

Symptomtext

Hospitalized (9.25.21); COVID-19 positive (9.25.21); Fully Vaccinated HISTORY OF PRESENT ILLNESS: Patient is a 72 y.o. male chronic obstructive pulmonary disease on nightly 2 L O2 nasal cannula, OSA on CPAP, chronic diastolic heart failure, permanent atrial fibrillation on Xarelto, history of B-cell lymphoma (2019), orthostatic hypotension, hyperlipidemia, hypothyroidism and depression who presents upper respiratory symptoms for the past 8 days and worsening dyspnea, subsequently found to be COVID-19 positive. He was fully vaccinated with Pfizer in February 2021. Symptoms began 8 days ago with rhinorrhea, body aches, fatigue, few episodes of diarrhea, nausea and 1 episode vomiting. Yesterday, he first noticed increasing shortness of breath and a mildly productive cough. Today, he came to the emergency department when feeling significant dizziness and noticing oxygen was 87% on 2 L nasal cannula. He had a negative rapid COVID test on 9/20 and was seen at urgent care on 09/23 where he was diagnosed with chronic obstructive pulmonary disease exacerbation along with possible cellulitis due to new, bluish discoloration at the distal aspect of his left foot. Discolored area is tender to palpation, but patient is unaware of any trauma to the region and is never had similar symptoms. He was discharged with prednisone and Keflex which is taken for the last 3 days. No fevers, rigors, chest pain, spreading rash, syncope or history of PE. He has been compliant with all his medications including Xarelto during this time. During my exam, patient's heart rate is decreasing to the 30s- 40s briefly before returning to the high 50s. He is asymptomatic during this. On arrival to the emergency department, patient's vital signs were unremarkable with exception of SpO2 93% on 4 L nasal cannula. Heart rate was intermittently dropped to 30s to 40s. Labs remarkable for calcium 7.2 this, albumin 1.8, procalcitonin 0.07, normal WBC digoxin level 1.0. COVID-19 a detected. Chest x-ray shows mild bilateral patchy opacities in a reticular pattern which is mildly increased from prior along with chronic blunting of the left costophrenic angle. Independent review of EKG shows atrial fibrillation with bradycardia and QTC 423 milliseconds. He was given dexamethasone 6 mg. Admitted to hospital medicine for acute hypoxic respiratory failure secondary to COVID-19 pneumonia Acute on chronic hypoxic respiratory failure COVID-19 pneumonia COPD with baseline oxygen at 2L NC nightly, not exacerbated -Fully vaccinated Pfizer 2/2021 -Symptom onset 8 days ago -Positive test 9/25 -Procalcitonin 0.07, no leukocytosis -CXR patchy opacities both lungs, only mildly increased from prior lung findings -Check film array -Monitor off antibiotics -Dexamethasone 6 mg daily -Out of window for remdesivir -Continue spiriva and albuterol prn -Maintain O2 sats 88-92%

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
7,0
Labordaten
-
Aktuelle Erkrankungen
9.23.21 - COPD with acute exacerbation office visit 9.25.21 Shortness of breath - office visit - COVID-19 positive - then send to ED and admitted Hospital: Essential hypertension Permanent atrial fibrillation COPD (chronic obstructive pulmonary disease) OSA (obstructive sleep apnea) Hypothyroidism Diffuse large B-cell lymphoma of lymph nodes of multiple regions CAD in native artery Chronic diastolic (congestive) heart failure Acute hypoxemic respiratory failure due to COVID-19 Pneumonia due to COVID-19 virus
Vorgeschichte
Headache Lyme Disease - 1990s Pleural effusion on left Edema due to hypoalbuminemia Elevated alkaline phosphatase level CHF (congestive heart failure) Bilateral lower extremity edema Incisional hernia, without obstruction or gangrene Squamous cell carcinoma of skin of scalp Dyslipidemia
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet albuterol (PROVENTIL) (2.5 MG/3ML) 0.083% nebulization albuterol (PROVENTIL, VENTOLIN, PROAIR) 108 (90 BASE) MCG/ACT inhaler allopurinol (ZYLOPRIM) 300 MG tablet amitriptyline (ELAVIL) 25 MG tablet asco
Allergien
AspirinAnaphylaxis, Other Budesonide-formoterol FumarateNausea and Vomiting ErythromycinHeadache, Nausea and Vomiting Erythromycin EthylsuccinateNausea Only MacrolidesOther No Known Iodine AllergyOther OmeprazoleOther, Nausea and Vomiting Prilosec [Omeprazole]Nausea Only QuinidineNausea and Vomiting Quinidine GluconateHeadache
Vorherige Impfungen
-

VAERS 1745114

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
92,0
Geschlecht
M
Eingang
29.09.2021
Impfdatum
28.02.2021
Beginn
24.08.2021
Tage bis Beginn
177,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Death SARS-CoV-2 test

Symptomtext

Patient admitted to hospital and tested for COVID 8/24/21. Discharged 8/28/21. Deceased 9/7/21

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
4,0
Labordaten
COVID19 test 8/24/21
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1744174

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
89,0
Geschlecht
F
Eingang
29.09.2021
Impfdatum
06.05.2021
Beginn
31.08.2021
Tage bis Beginn
117,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Cough Dyspnoea Endotracheal intubation Intensive care Oedema peripheral Respiratory arrest SARS-CoV-2 test positive Tracheostomy

Symptomtext

Patient presented to emergency room on 8/30/2021 with shortness of breath, cough, and bilateral lower extremity edema. She was admitted for further management and found to be COVID-19 positive. On 9/1/2021, her condition worsened and she was transferred to ICU and was intubated on 9/4/2021. She was extubated on 9/5/2021 and transferred out of the ICU on 9/6/2021. Patient underwent a pulseless respirator arrest on 9/8/2021 and returned to the ICU. Patient was intubated and underwent tracheostomy. Patient was discharged to LTAC facility on 9/27/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Respiratory arrest
Hospital-Tage
28,0
Labordaten
COVID-19 test positive on 8/30/2021.
Aktuelle Erkrankungen
None known
Vorgeschichte
Gait disturbance Bilateral lower extremity edema DJD (degenerative joint disease) of knee Total hip replacement Generalized OA S/P total hip arthroplasty Atrial fibrillation with controlled ventricular response Status post total replacement of left hip Tinea cruris Essential hypertension Mixed hyperlipidemia S/P AVR (aortic valve replacement) S/P MVR (mitral valve repair) Hx of maze procedure Duodenal ulcer hemorrhage Diastolic congestive heart failure due to valvular disease Retroperitoneal mass Retroperitoneal fibrosis Atrial fibrillation with RVR
Andere Medikamente
acetaminophen (TYLENOL) 325 MG tablet atorvastatin (LIPITOR) 10 MG tablet cephALEXin (KEFLEX) 500 MG capsule diltiazem (DILACOR-XR) 240 MG XR capsule ferrous sulfate (FEOSOL, 65 FE,) 325 (65 FE) MG tablet metoprolol tartrate (LOPRESSOR) 25
Allergien
Xanax (delirium)
Vorherige Impfungen
-

VAERS 1731400

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
74,0
Geschlecht
M
Eingang
24.09.2021
Impfdatum
03.03.2021
Beginn
23.08.2021
Tage bis Beginn
173,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute respiratory failure Asthenia COVID-19 Chills Decreased appetite Diarrhoea Dyspnoea Pyrexia SARS-CoV-2 test positive

Symptomtext

positive for COVID on 8/23; took monoclonal antibodies on 8/25 and dc'd to home; presented to ED 8/27 with SOB, chills, fever, poor appetite, diarrhea x5days, generalized weakness; acute respiratory failure

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1731365

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
65,0
Geschlecht
M
Eingang
24.09.2021
Impfdatum
20.03.2021
Beginn
23.09.2021
Tage bis Beginn
187,0
Dosis
1
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 COVID-19 pneumonia

Symptomtext

Hospitalization - acute hypoxemic respiratory failure due to COVID-19, pnuemonia due to COVID-19 virus

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1731365

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
65,0
Geschlecht
M
Eingang
24.09.2021
Impfdatum
20.03.2021
Beginn
23.09.2021
Tage bis Beginn
187,0
Dosis
2
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 COVID-19 pneumonia

Symptomtext

Hospitalization - acute hypoxemic respiratory failure due to COVID-19, pnuemonia due to COVID-19 virus

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1719035

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
82,0
Geschlecht
F
Eingang
21.09.2021
Impfdatum
23.02.2021
Beginn
14.09.2021
Tage bis Beginn
203,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Patient passed away on 09/14/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Dilaudid, Norco, Mobic, Protonix, Aldactone
Allergien
Penicillins, Percocet, Sulfa drugs, Fosamax, Tolectin, Aspirin, Morphine, Plavix, Tolmetin, Doxycycline
Vorherige Impfungen
-

VAERS 1718871

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
79,0
Geschlecht
F
Eingang
21.09.2021
Impfdatum
25.03.2021
Beginn
11.09.2021
Tage bis Beginn
170,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Akinesia Blood culture negative Blood lactic acid COVID-19 Cardiac failure Chest X-ray abnormal Clostridium test Computerised tomogram head abnormal Condition aggravated Culture urine negative Cytomegalovirus test negative Dehydration Diarrhoea Echocardiogram abnormal Ejection fraction decreased Encephalopathy Febrile neutropenia

Symptomtext

Hospitalized (9.11.21 - present; febrile neutropenia); COVID-19 positive (9.11.21); Fully Vaccinated SUBJECTIVE: This is a 79 y.o. patient with a past medical history significant for cardiomyopathy, hypertension, PVD, CKD, past CVA/SAH, CLL on chemo, recent AKA presenting to the emergency department via EMS from bed for evaluation of fevers, neutropenia, concern for sepsis. Patient found to be COVID positive with questionable lower lobe infiltrate. Given neutropenia, she was started on cefepime and will be admitted for further work-up and monitoring. Upon assessment, patient resting in bed with daughter at bedside. Patient and daughter provided the history. Patient reports she was in last week for left foot/LE amputation related to chronic non-healing wound. She then went to another facility. She denies any sick contacts, states she is fully vaccinated and has been very careful. Denies SOB, no cough. Denies any new rash, pain with urination (though does report frequency). No issues at amputation site. Daughter reports wound on her bottom r/t being in bed and diarrhea - states she has been using skinguard to help. Patient also with recent MI - about 4 weeks ago. Has been taking her meds. Denies any CP, palps, swelling in legs. Labs and plan of care reviewed. All questions answered. DISPO: -continue cefepime, monitor infectious w/u -appreciate ID input -monitor renal fxn, may need to hold entresto/lasix if worsening -please ask to sign blood consent 9/12, declined 9/11 with being tired/overwhelmed ASSESSMENT / PLAN: Febrile Neutropenia -Temp 100.4 in ED, other VSS -lactic 1.6 -- > 0.9 -CXR 9/11 vascular congestion, questionable lower lobe infiltrate on lateral view -COVID positive -recent Cdiff negative on 9/2 -UA small leuks, negative nitrites; UC pending -periph BC x2 pending -Blood cx on 8/27 admit +staph hominis but determined contaminant, was on Zosyn -s/p cefepime 2G in ED, will continue Q12h -will consult ID COVID Infection -Positive PCR on 9/11, likely hospital/facility acquired -CXR 9/11 questionable LL infiltrate -s/p dex 6mg on 9/11 -ID consulted, appreciate input -currently on room air Progress Note from 9.21.21: CHIEF COMPLAINT: Febrile neutropenia COVID-19 ASSESSMENT / PLAN: Acute hypoxic respiratory failure -Multifactorial in setting of HFrEF, recent COVID, pleural effusion, interlobular fluid and b/l patchy airspace disease -sputum culture pending -CXR 9/15 patchy perihilar consolidations pulm edema vs infecction -CXR 9/20 bilateral pneumonia vs pulmonary edema - ECHO 9/16 with EF 56% inferior septal wall is akinetic, right ventricle is mildly dilated and function is mildly decreased -MRSA positive -Pulm now signed off-- rec diuresis, abx, dex -Cardiology now signed off- discontinued Entresto, continue daily IV lasix -ID following -s/p vanco (9 days), and cefepime/ceftazidime (9 days total). Per ID monitor off antibx for now -continue lasix 40mg BID for now -On hi-flow- wean as able. No home O2 at baseline COVID Infection -Positive PCR on 9/11, likely hospital/facility acquired -Asymptomatic until 9/14/21 - now req O2 -CXR 9/11 questionable LL infiltrate -CXR 9/20 pulm edema vs pnumonia -Cont dex 6mg daily x10 days (9/15-9/25) -S/p Regeneron 9/13 per ID -ID does not feel any benefit from remdesivir -Wean off O2 as able Febrile Neutropenia - resolved -Blood cx on 8/27 admit +staph hominis but determined contaminant, was on Zosyn -Most recent fever: 9/15 PM -CXR 9/11 vascular congestion, questionable lower lobe infiltrate on lateral view -COVID positive -MRSA screen positive -C diff negative on 9/2 -UA small leuks, negative nitrites; UrCx neg -CMV blood PCR neg -BCx remain NGTD -CT head 9/13 with pansinusitits - asymptomatic -DC'd cefepime d/t encephalopathy -s/p ceftazidime/vanco-- monitor off per ID

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
11,0
Labordaten
-
Aktuelle Erkrankungen
Discharged from Hospital 8.10.21: s/p NSTEMI, heart failure 8.27.21: Hospital admission - osteomyelitis, dehydration, wound infection, severe sepsis (dc'd 9.3.21) 9.3.21: Admitted to rehabilitation hospital (s/p above knee amputation, unilateral) 9.11.21 - admitted to hospital; COVID-19 positive
Vorgeschichte
Non-Hospital Essential hypertension, benign Leukocytosis Non-healing wound of lower extremity Depression Overactive bladder Cardiomyopathy, unspecified History of intracranial hemorrhage Infection of total knee replacement, initial encounter Painful total knee replacement, left Lumbar stenosis with neurogenic claudication Post-operative complication Ankle arthritis CKD (chronic kidney disease), stage II Multifocal pneumonia Peripheral vascular disease Left foot infection Hyperkalemia Postoperative anemia Soft tissue lesion of knee region Complicated wound infection NSTEMI (non-ST elevated myocardial infarction) Chronic combined systolic and diastolic heart failure Thrombocytopenia Pleural effusion
Andere Medikamente
Outpatient Medications acalabrutinib (CALQUENCE) 100 MG capsule acetaminophen (TYLENOL) 500 MG tablet acetaminophen (TYLENOL) 500 MG tablet acyclovir (ZOVIRAX) 400 MG tablet albuterol HFA (PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 8
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1715718

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
GA
Alter
61,0
Geschlecht
F
Eingang
20.09.2021
Impfdatum
15.03.2021
Beginn
31.07.2021
Tage bis Beginn
138,0
Dosis
1
Route/Site
SYR / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain Chills Cough Death Diarrhoea Dyspnoea Exposure to SARS-CoV-2 Fatigue Headache Myalgia Myocardial infarction Nausea Oropharyngeal pain Pyrexia Rhinorrhoea Vomiting

Symptomtext

The patient reported that she experienced a: Fever, Sore Throat, Headache, Muscle Aches, Chills, Runny nose, Shortness of Breath Abdominal Pains, Cough, Nausea, Vomiting, Diarrhea, and Fatigue. Symptoms started on 7/30. The patient stated that she lives with her husband who tested positive. Reported Chronic Kidney Disease, Hypertension, PROBABLE MYOCARDIAL INFARCTION> DEATH ON 8/28/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Chronic Renal disease Hypertension/High Blood Pressure
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1715136

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
PA
Alter
53,0
Geschlecht
F
Eingang
20.09.2021
Impfdatum
25.02.2021
Beginn
29.06.2021
Tage bis Beginn
124,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Glaucoma

Symptomtext

I have been diagnosed with narrow-angle glaucoma.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Glaucoma
Hospital-Tage
-
Labordaten
Annual eye check-up 6/29/2021. No symptoms.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Allegra (allergy)
Allergien
nonr
Vorherige Impfungen
-

VAERS 1708822

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
74,0
Geschlecht
M
Eingang
17.09.2021
Impfdatum
18.03.2021
Beginn
10.09.2021
Tage bis Beginn
176,0
Dosis
1
Route/Site
IM / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Agitation Asthenia Blood culture negative Blood lactic acid increased COVID-19 Cough Culture urine negative Culture urine positive Death Delirium COVID-19 pneumonia Chest X-ray abnormal Chills Cognitive disorder Condition aggravated Dementia Hypomagnesaemia Hypoxia

Symptomtext

Hospitalization (9.10.21) --- > patient deceased (9.15.21) due to COVID-19 pneumonia; COVID-19 positive 9.10.21; fully vaccinated Date of Death: 9/15/21 Time of Death: 1:29 PM Preliminary Cause of Death: Pneumonia due to COVID-19 virus Discharge Disposition: expired DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pneumonia due to COVID-19 virus COVID-19 HOSPITAL COURSE: 74 yo male presented with the complaint of fever and weakness. He had been admitted on 9/6/21 with fever and weakness and had tested negative for covid. He had a UTI and was discharged home on the 8th. He returned 2 days later and was positive for covid and had hypoxia with CXR findings. He was admitted for the treatment of covid pneumonia dn started on dexamethasone. Over the course of his stay his baseline dementia was worse with note sun downing and associated agitation. He did not like having oxygen on or pulse ox monitoring. Family stayed with him which did not help. They decided to change his goals of care and talked to hospice. He was changed to comfort care and passed away with his family at bedside. (at admission: HISTORY OF PRESENT ILLNESS: Patient is a 74 y.o. male who presents today with fever and weakness . Recently discharged 9/8/2021 with febrile illness meeting sepsis criteria with elevated lactic, wbc, fever . Started with empiric abx With zosyn. Infectious work up neg for covid, film array , cxr, blood and urine cultures neg . Op urine culture growing serratia. He improved clinically and was dc to complete x2 more days cipro. Per wife still having low grade fever on dc . He progressively became more generally weak . continued with higher fever and chills taking tylenol for relief. With fever and weakness brought back in to ed where tested pos for covid 19 . In ed lactic elevated initially then trended down . Per wife he has become more and more wean . Still able to stand and walk to bathroom . Notes increasing urine incontinence now utilizing depends. No co chest pain and really has not been sob significantly . Minimally cough. No dysuria other wise . No diarrhea . No co ha vision changes. Notes progressive decline in cognitive function over last several months. occasionally wit hand tremors . No other sz like movements .)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
6,0
Labordaten
-
Aktuelle Erkrankungen
Hospital admission 9.6.21 - 9.8.21: diagnosis - SIRS; hypomagnesemia; recent UTI (COVID negative during this hospitalization) Worsened and COVID-19 positive 9.10.21
Vorgeschichte
OSA on CPAP Polyneuropathy in diabetes Essential hypertension HLD (hyperlipidemia) Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin Actinic keratosis Medial meniscus, posterior horn derangement, right Mild dementia NSTEMI (non-ST elevated myocardial infarction) Coronary artery disease involving native coronary artery of native heart with other form of angina pectoris Cardiomyopathy, ischemic Shortness of breath Lower abdominal pain Pneumonia due to COVID-19 virus Generalized weakness Metabolic encephalopathy Advanced care planning/counseling discussion Acute respiratory failure with hypoxia
Andere Medikamente
adapalene (DIFFERIN) 0.1 % gel Ascorbic Acid (VITAMIN C PO) aspirin 81 MG chewable tablet atorvastatin (LIPITOR) 80 MG tablet B Complex-C (SUPER B COMPLEX PO) benzonatate (TESSALON) 100 MG capsule Cholecalciferol (VITAMIN D3) 2000 UNITS TAB
Allergien
Ranexa [Ranolazine]
Vorherige Impfungen
-

VAERS 1708239

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
68,0
Geschlecht
M
Eingang
17.09.2021
Impfdatum
25.03.2021
Beginn
15.09.2021
Tage bis Beginn
174,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute kidney injury Acute respiratory failure COVID-19 Culture negative Death Endotracheal intubation Hyperkalaemia Hypophagia Hypotension Intensive care Mechanical ventilation Mental status changes Skin disorder

Symptomtext

Patient was admitted to Hospital for acute hypoxic respiratory failure secondary to COVID-19 infection and acute kidney injury on 09/05/2021. Patient was started on dexamethasone he was also anticoagulated with heparin given AKI. Acute kidney injury suspected to be prerenal secondary to poor oral intake in the setting of COVID-19 infection patient was also taking several medications at home such as Lasix and lisinopril. Patient required of supplemental oxygenation and fell heated high-flow nasal cannula to refractory hypoxemia then required noninvasive positive pressure ventilation. He continued to become more hypoxic and MRT was called 9/7/21 for hypoxia with oxygen saturation in the 70s and change in mental status. Decision was made to intubate the patient. At this time patient was transferred out of the ICU on mechanical ventilation. He continued to have worsening acute kidney injury and hyperkalemia which point nephrology was consulted and decision was made to start CRRT. Concern for superimposed bacterial infection and patient's antibiotics were escalated to cefepime and vancomycin, no growth on cultures. Patient also required norepinephrine intermittently throughout the admission for hypotension. Patient continued to remain hypoxic despite mechanical ventilation requiring paralytics, proning and was also on nitric oxide. Nitric oxide was stopped and protein was also stop later of the admission due to skin breakdown. Fluid removal per CRRT given concerns for volume overload. Family decided to withdraw care transition to comfort measures only. Patient passed shortly after with family at bedside. Time of death 1435 September 15, 2020

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
10,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1700637

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
PA
Alter
87,0
Geschlecht
F
Eingang
15.09.2021
Impfdatum
08.03.2021
Beginn
30.08.2021
Tage bis Beginn
175,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure Adenovirus test Aortic arteriosclerosis Bordetella test negative Bronchiectasis Cough Dyspnoea Enterovirus test negative Fatigue Fibrin D dimer COVID-19 Chest X-ray abnormal Chlamydia test negative Computerised tomogram thorax abnormal Coronavirus test negative Gallbladder disorder Hiatus hernia Human rhinovirus test

Symptomtext

ED to Hosp-Admission Current - 9/6/2021 - present (9 days) Hospital Pneumonia due to COVID-19 virus Assessment/Plan - 88 y.o. female, with past medical history of hypothyroidism, hypertension, rheumatoid arthritis on predisone, DVT, who is admitted on 9/6/2021 with Pneumonia due to COVID-19 virus 1. Acute hypoxic respiratory failure due to COVID-19 pneumonia. Per daughter in law, patient only got her first dose of Covid vaccine. She was told not to get the second dose of vaccine due to the correlation between the vaccine and DVT (in April 2021). Her oxygen saturation was 88% on room air. Patient is put on 4 L nasal cannula oxygen O2 sat 96%. Her D-dimer is elevated 1.54. Elevated 204. proCalcitonin is normal 0.18. CT without contrast shows Multiple foci of ground glass opacification bilaterally. The appearance is consistent with Covid 19. We will admit patient to telemetry. Start remdesivir for 5 days. Patient is on prednisone 15mg at home for RA. We will hold that and give dexamethasone 6mg daily instead for 10 days. Will trend Ferritin, ALT, CRP. No indication for antibiotics. Will put on Heparin subcutaneous for DVT prophylaxis. It is noted that patient has h/o DVT, but not on anticoagulation due to bleeding (GI, ecchymosis etc). PE can not be ruled out. Since the test won't change the management anyway, we will hold CTA chest for now. Patient's daughter in law in agreement with this plan. History of left lower extremity DVT, extensive, provoked due to reduced mobility. Patient is not on anticoagulation due to GI bleeding and ecchymosis. Patient declined GI procedure (EGD/colonoscopy). Patient had IVC filter placement on 3/24/2021. Family is aware that even with IVC filter in, there is still risk for pulmonary embolism/DVT. Acquired hypothyroidism: She is on Synthroid 125 mcg daily (6 times a week from Monday to Saturday). Essential hypertension: continue home Lisinopril HCTZ Rheumatoid arthritis: on steroid as above. Depression: Mood is relatively stable at this time. Continue Effexor 25 mg PO BID. Constipation: Continue MiraLAX and Peri-Colace o DVT Prophylaxis: Heparin sc o Disposition: telemetry o Code Status: DNR (Do Not Resuscitate) Patient has a living will with DNR. Confirmed with daughter in law. o Consult Services: none HPI This is a 88-year-old female with a history of hypertension, rheumatoid arthritis, DVT of the right leg not amenable for anticoagulation due to prior GI bleed who presented to the emergency room with one-week history of increased shortness of breath, cough, fatigue weakness and found to be with a saturation of 89% on room air. Patient presents to the emergency room via EMS that placed patient on 4 L. Patient has only been vaccinated for 1st dose of Covid. Denies any fever chills denies any chest pain. Patient is a poor historian. Her Covid is positive. She has IVC filter. CT chest without contrast shows bilateral Multiple foci of ground glass opacification. Consistent with Covid -19.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
9,0
Labordaten
09/06/21 1732 Respiratory virus detection panel Collected: 09/06/21 1436 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result DetectedCritical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Syncytial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detecte Radiology/Images: I personally reviewed the radiology findings noted. X-ray chest 1 view - Portable Result Date: 9/6/2021 XR CHEST 1 VW PORT IMPRESSION: Multiple foci of hazy airspace opacification with patchy left basilar consolidation. Findings consistent with the history of Covid 19. Large hiatal hernia. END OF IMPRESSION: INDICATION: 88 yo WF with a week h/o SOB, hypoxic. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: X-ray 3/19/2021 FINDINGS: There is hazy opacification and interstitial thickening seen in the right perihilar region. There is hazy opacification in the left perihilar region. Patchy left basilar consolidation. There is a large hiatal hernia. There is no effusion or pneumothorax. The cardiac silhouette is normal size. This calcification of the aorta. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT COVID chest without contrast Result Date: 9/6/2021 CT COVID CHEST WO CONTRAST IMPRESSION: Multiple foci of groundglass opacification bilaterally. The appearance is consistent with Covid 19. Correlate clinically. Large hiatal hernia. Atherosclerotic vascular disease. END OF IMPRESSION: INDICATION: 88-year-old Caucasian female with a history of shortness of breath about a week hypoxic and elevated D-dimer. TECHNIQUE: CT scan of the chest was performed in the axial plane. Sagittal and coronal reconstructions were reviewed. COMPARISON: Chest x-ray same date. CT scan 12/26/2018. FINDINGS: There are small areas of patchy groundglass opacification in the upper lobes superiorly. There are moderate size foci of groundglass opacification in a perihilar distribution bilaterally. There are small foci of groundglass opacification seen in the right middle lobe and lingula inferiorly as well as in the lower lobes bilaterally. In the left lower lobe inferiorly there is mild bronchiectasis with pulmonary fibrotic changes at the present on the prior study. There is no effusion or pneumothorax. This calcified granuloma in the right lower lobe. There is a large hiatal hernia. The heart is normal size. There is moderate calcification of the thoracic aorta. The pulmonary arteries normal caliber. There are calcified nonenlarged mediastinal and right hilar lymph nodes. There is calcification of the upper abdominal aorta. The gallbladder is absent. The adrenal glands are unremarkable. There is a moderate thoracic scoliosis. The thoracic osseous structures are demineralized. There are severe degenerative changes of the thoracic spine. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient.
Aktuelle Erkrankungen
-
Vorgeschichte
Non-Hospital - Sepsis due to pneumonia (HCC), Essential hypertension, Disease of thyroid gland, Incarcerated left inguinal hernia, Diverticulosis of colon, Acquired hypothyroidism, Spondylosis of lumbar region without myelopathy or radiculopathy, Partial small bowel obstruction (HCC) Rheumatoid arthritis (CMS/HCC) Acute DVT (deep venous thrombosis) (CMS/HCC) Leukemoid reaction Acute renal failure (ARF) (CMS/HCC)
Andere Medikamente
gabapentin (NEURONTIN) 100 mg capsule, hydroCHLOROthiazide (HYDRODIURIL) 12.5 mg tablet, levothyroxine 125 mcg oral tablet, lisinopriL (ZESTRIL) 10 mg tablet, lisinopriL-hydroCHLOROthiazide (ZESTORETIC) 20-12.5 mg per tablet, pantoprazole (
Allergien
Etanercept Indigestion / GI upset, Nausea Only, Iodine Itching, Latex Dermatitis, Methotrexate Nausea Only, Indigestion / GI upset
Vorherige Impfungen
-

VAERS 1696910

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
IL
Alter
75,0
Geschlecht
F
Eingang
14.09.2021
Impfdatum
06.03.2021
Beginn
29.07.2021
Tage bis Beginn
145,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Blood glucose normal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Confusional state Death Lethargy Metabolic encephalopathy SARS-CoV-2 test positive Ultrasound scan normal Urinary tract infection

Symptomtext

Came to ER for confusion and possible low blood sugar on 7/29/21. Blood sugar 124 on arrival. Patient was lethargic and tested positive for COVID. Stable vitals temperature 99.7? 0 blood pressure 137/64 below pulse of 93 and 98% on room air. Also found to have acute metabolic encephaloprathy likely secondary to UTI and COVID19. Placed on ceftriaxone for UTI . During her stay she developed acute hypoxic respiratory failure, requiring opti-flow 90% and 60L. Likely from COVID pneumonia. Placed on dexamethasone and remdesivir. Required precedex for BP. Patient went comfort and passed away on 8/25/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
27,0
Labordaten
7/29/21 chest xray: negative 7/30/21 US: Negative for clot 8/6/21 Chest xray: Bilateral patchy pneumonias which seems to have worsened slightly when compared to prior studies
Aktuelle Erkrankungen
-
Vorgeschichte
hypertension, hyperlipidemia, Diabetes mellitus 2 diet controlled, CKD stage 3a
Andere Medikamente
Aspirin, atorvastatin, vitamin B12, Fish Oil, Glucosamine-chondroitin, lisinopril-hydrochlorothiazide, multiple vitamin, ocuvite
Allergien
Penicillins
Vorherige Impfungen
-

VAERS 1696196

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
80,0
Geschlecht
F
Eingang
14.09.2021
Impfdatum
19.02.2021
Beginn
21.02.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Acute respiratory failure Antibody test Blood culture Blood glucose Blood test Brain natriuretic peptide Chest X-ray Culture Dyspnoea Echocardiogram Full blood count Fungal test Metabolic function test Pain in extremity Prothrombin time SARS-CoV-2 test Sputum culture Troponin

Symptomtext

1/29/21 1st dose - sore arm. 2 days after second dose, breathing became more labored, increasing more difficult by the day. Gasping for breath; no relief from emergency inhalers. Taken by ambulance with "acute respiratory failure" to hospital on 3/8/21. Remained there until 3/11/21. Received at-home therapy for 4-6 weeks after hospital discharge.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
3,0
Labordaten
3/8/21 to 3/11/21 troponim, BNP, PT, CBC, blood cultures, gas cultures, COVID testing, sugar, basic metabolic, respiratory cultures, antibody and fungal screening, echocardiogram.
Aktuelle Erkrankungen
COPD, Heart Issues
Vorgeschichte
COPD, Heart issues
Andere Medikamente
Albuterol sulfate, Symbicort, Spiriva, Crestor, Cardizem, NEXT
Allergien
Penicillin, sulfa, MRI dye, tape, Avalox, Cipro, Tramadol
Vorherige Impfungen
-

VAERS 1689574

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
GA
Alter
85,0
Geschlecht
M
Eingang
10.09.2021
Impfdatum
03.03.2021
Beginn
02.08.2021
Tage bis Beginn
152,0
Dosis
UNK
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Death Head injury Syncope

Symptomtext

Patient is fully vaccinated for Covid and later was hospitalized and died. Case son suspects case may have gotten it during a hospital visit July 30th after collapsing and hitting his head. Only close contact was case's son and wife, but he did not want to be contacted by contact tracers, almost through with quarantine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
7,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Cardiovascular disease
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1689360

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MD
Alter
78,0
Geschlecht
M
Eingang
10.09.2021
Impfdatum
03.03.2021
Beginn
23.08.2021
Tage bis Beginn
173,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 Cardiac disorder Cough Death Fatigue SARS-CoV-2 test positive

Symptomtext

Patient tested positive for COVID-19 on 8/23/2021 and was hospitalized. The patient had been having a cough for over a week. He states that he feels tired and fatigue and is worse when he ambulates. The patient was hospitalized for about 8 days until he expired on 9/1/2021 due to cardiac disturbances.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
8,0
Labordaten
COVID-19 Positive (8/23/2021)
Aktuelle Erkrankungen
-
Vorgeschichte
Coronary artery disease, left bundle branch block, congestive heart failure, chronic kidney disease, obstructive sleep apnea, pulmonary fibrosis, cerebrovascular accident, thromboembolism
Andere Medikamente
Aspirin, cholecalciferol, clopidogrel, escitalopram, famotidine, furosemide, gabapentin, Pepto-Bismol, ipratropium-albuterol, isosorbide mononitrate, acidophilus, levothyroxine, magnesium oxide, omega 3, pantoprazole, potassium chloride, p
Allergien
Sulfa antibiotics (rash)
Vorherige Impfungen
-

VAERS 1685126

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
83,0
Geschlecht
M
Eingang
09.09.2021
Impfdatum
05.03.2021
Beginn
02.09.2021
Tage bis Beginn
181,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Nursing notes have been submitted into system, death summary is not available yet.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
10,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1463281

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6202

kritisch
Staat
AZ
Alter
72,0
Geschlecht
F
Eingang
09.09.2021
Impfdatum
04.03.2021
Beginn
18.03.2021
Tage bis Beginn
14,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Blood cholesterol increased Central nervous system lesion Cerebrovascular accident Computerised tomogram Diplopia Dizziness Eye disorder Feeling abnormal Illness Magnetic resonance imaging Vertigo Visual impairment Nausea Vision blurred

Symptomtext

Visual disturbance; Vertigo; The initial case was missing the following minimum criteria: unspecified AE. Upon receipt of follow-up information on 24Aug2021, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable physician and consumer via Pfizer sales representative. A 72-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 intramuscular, administered in Arm Left on 04Mar2021 (Lot Number: En6202) at age of 72-years-old as dose 2, single for COVID-19 immunization. Medical history included Fluid retention, thyroid disorder, Cholestrol, Multiple sclerosis from 01Jan1956 and ongoing, ongoing hypothyroidism Stable, ongoing Hyperlipidemia Stable, ongoing osteopenia Stable. Concomitant medications included ongoing hydrochlorothiazide orally taken for fluid retention; ongoing levothyroxine orally taken for thyroid; ongoing simvastatin orally taken for Cholestrol; ongoing ibandronate sodium orally taken for osteopenia. Prior vaccinations (within 4 weeks) was none. Family medical history relevant to event was none. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 Intramuscular on 10Feb2021 in Left Arm (Batch/Lot number: EL9269) for COVID-19 Immunization. No illness at time of shot. 2nd immunization on 04Mar2021 then had visual disturbance and vertigo on 18Mar2021, no exacerbations 15yrs until 09Apr2021. Seriousness criteria reported as hospitalization for 3 days. Relevant tests included MRI on 09Mar2021 with result abnormal (Pocrl exacerbation). Treatment received included Solumedrol/ Iv. The outcome of the events was not recovered. The patient provided information to the reporting physician regarding the reported adverse event with the use of the product.; Sender's Comments: Based on the available information and a possible contributory role of the suspect product BNT162B2 to the development of events visual impairment and vertigo cannot be totally excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
3,0
Labordaten
Test Date: 20210309; Test Name: MRI; Result Unstructured Data: Test Result: Abnormal; Comments: Pocrl exacerbition
Aktuelle Erkrankungen
Hyperlipidemia (Stable); Hypothyroidism (Stable); Multiple sclerosis; Osteopenia (Stable)
Vorgeschichte
Medical History/Concurrent Conditions: Cholesterol; Fluid retention; Thyroid disorder
Andere Medikamente
HYDROCHLOROTHIAZIDE; LEVOTHYROXINE; SIMVASTATIN; IBANDRONATE SODIUM
Allergien
-
Vorherige Impfungen
-

VAERS 1683451

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
89,0
Geschlecht
M
Eingang
08.09.2021
Impfdatum
17.03.2021
Beginn
08.08.2021
Tage bis Beginn
144,0
Dosis
1
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Abdominal pain lower Asthenia Asymptomatic COVID-19 Atelectasis Atrial fibrillation Bladder catheterisation Candida infection Chest X-ray abnormal Computerised tomogram thorax abnormal Condition aggravated Death Haematuria Hypernatraemia Lung consolidation Lung infiltration Mental status changes Pleural effusion Pneumonia

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/25/2021 and 3/17/2021. Presented to another organizations ED on 8/7/2021 with complaints of hematuria in Foley bag, and pain in lower part of abdomen. Patient was subsequently found to have COVID infection that was asymptomatic (on room air throughout admission) and discharged on 8/12/2021. Patient subsequently presented to ED on 8/26/2021 with generalized weakness and altered mental status. Patient's mentation briefly improved with supplemental oxygen. Chest X-ray Atelectasis/infiltrate especially left mid and lower lung zones, clinical correlation recommended for developing acute pneumonia/pneumonitis. CT Chest shows occlusive and non occlusive PE LUL, small bilat eff, bilat lower lobe consolidation. In ER patient was noted to be in atrial fibrillation with RVR and was initiated on cardizem. Patient was diagnosed with severe sepsis, bilateral pneumonia, and UTI from indwelling foley (Candida albicans), Pulmonary embolism, hypernatremia, as well as continued COVID positive originally diagnosed 8/7/2021 and confirmed with repeat testing on 8/26/2021. Patient was transitioned to inpatient hospice on 8/30/2021, and expired on 9/5/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
7,0
Labordaten
COVID-19 Positive on 8/26/2021 using Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification.
Aktuelle Erkrankungen
Fracture of right shoulder on 7/14/2021
Vorgeschichte
allergic rhinitis, atrial fibrillation, BPH, coronary artery disease, dehydration, GERD, history of pneumoconiosis, IBS, Hyperlipidemia, hypertension, ischemic cardiomyopathy, depression, neuralgia, neuritis, urinary retention, vitamin deficiency.
Andere Medikamente
Ascorbic acid, Aspirin, Azithromycin, Ceftriaxone, Robitussin DM, Duloxetine, finasteride, Norco, Albuterol, Ipratropium, Linaclotide, Meloxicam, Mirtazaepine, pantoprazole, Miralax, Potassium chloride, rosuvastatin, Fluticasone nasal, lis
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1679272

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
IL
Alter
87,0
Geschlecht
F
Eingang
07.09.2021
Impfdatum
08.02.2021
Beginn
18.03.2021
Tage bis Beginn
38,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Angiogram abnormal Atrial fibrillation Atypical pneumonia COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram thorax abnormal Death Hypotension International normalised ratio decreased Liver function test increased Pulmonary congestion

Symptomtext

Patient was transferred to Hospital from different Hospital with acute hypoxic respiratory failure, COVID pneumonia, afib with RVR, and pulmonary vascular congestion. CTA chest was negative for a PE but again demonstrated concern for an atypical pneumonia along with evidence of pulmonary vascular congestion. She was noted to be in afib with RVR and was placed on a cardizem gtt. She received a dose of lovenox as her INR was subtherapeutic at 1.3. Kidney function appeared stable. Received a dose of dexamethasone at the other hospital. BP is on low side while on the cardizem but HR is now in the 80s. She is on 3-4L O2 NC. She was placed on dexamethasone and remdesivir, but remdesivir was stopped due to elevated liver function tests

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
12,0
Labordaten
Chest xray: opacification in left lower lung showing pneumonia
Aktuelle Erkrankungen
None
Vorgeschichte
CLL, chronic atrial fibrillation, chronic systolic CHF EF of 20-25%, stage III A chronic kidney disease, nursing home resident, severe protein calorie malnutrition
Andere Medikamente
Buspirone, calcium carbonate with vitamin D, Tums, docusate, duloxetine, ferrous sulfate, fluticasone, levothyroxine, magnesium oxide, meclizine, metoprolol succinate, omeprazole, potassium chloride, pramipexole, pravastatin, simethicone, t
Allergien
erythromycin, lovastatin, penicillins, prevacid, ropinirole
Vorherige Impfungen
-

VAERS 1658909

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
IL
Alter
88,0
Geschlecht
M
Eingang
31.08.2021
Impfdatum
06.03.2021
Beginn
26.08.2021
Tage bis Beginn
173,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Anticoagulant therapy Asthenia COVID-19 Computerised tomogram thorax abnormal Confusional state Cough Dyspnoea Hypoxia Pulmonary embolism Respiratory failure Respiratory symptom SARS-CoV-2 test positive Wheezing

Symptomtext

Patient started experiencing upper respiratory symptoms (cough, shortness of breath) and weakness on ~ 8/22/21. His son brought him to the ER on 8/26/21 since patient started to wheeze and his symptoms were not improving with OTC medications. He was noted to be confused in the ER as well as hypoxic, and heated high flow oxygen was started due to respiratory failure. Pt was admitted to the hospital and was started on COVID treatment with remdesivir and dexamethasone since he tested positive for COVID in the ER on 8/26. He is also receiving Eliquis 5 mg BID for suspected PE on CT (patient was on Eliquis 2.5 mg BID prior to admission for Afib). Pt is currently on day 5 of hospitalization (on 8/31) and is now on room air with good O2 saturation. Hospital discharge is anticipated to be soon.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CHB/A-fib s/p PPM, BPH
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1629075

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
78,0
Geschlecht
M
Eingang
31.08.2021
Impfdatum
25.02.2021
Beginn
05.08.2021
Tage bis Beginn
161,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal tenderness Agitation Asthenia Blood gases Blood lactic acid normal Acute kidney injury Atelectasis Blood culture negative Blood test abnormal COVID-19 Chest X-ray abnormal Culture urine negative Death Decreased appetite Depressed level of consciousness Haemoglobin decreased Endotracheal intubation Haematemesis

Symptomtext

Patient was sent to the emergency department from his from primary care provider office on 8/10/21 for evaluation of hypotension. He had been complaining of generalized weakness with decreased appetite for 1 week. He also endorsed urinary symptoms, mainly frequency. He was found to have a urinary tract infection and also to incidentally be COVID positive the same day (he was not hypoxic or short of breath). He was started on dexamethasone 6 mg PO daily on 8/13 when he was noted to have oxygen desaturations to the 80s with walking; however, he remained on room air. On 8/17, he had hypotension down to 70s/40s. Ultrasound showed hyperdynamic left ventricle. Of note, WBC increased from 12.3 on to 22.2 with neutrophilic predominance on 8/15. Norepinephrine was started and the patient was transferred to the medical intensive care unit. The patient was experiencing some mild abdominal tenderness of the right lower quadrant. Ordered for CT chest/abdomen/pelvis. In the evening of 8/17, he became agitated, climbing out of bed and pulling off medical equipment. 30 minutes later, he was noted to be increasingly lethargic and unarousable with increasing pressor requirements. ABG obtained at that time 6.94/29/166, lactate >15, Hgb <6. While preparing to intubate, patient lost pulse. ACLS initiated. No sustained ROSC, patient pronounced after 36 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown, if any
Vorgeschichte
Diabetes mellitus, hepatitis C induced-cirrhosis and possible hepatocellular carcinoma, coronary artery disease with stent replacement, hypertension, osteoarthritis
Andere Medikamente
AZOPT 1 % drops 1 drop into both eyes TID COMBIGAN 0.2-0.5 % 1 drop into right eye BID Cholecalciferol, 5,000 units PO daily Ranolazine 1,000 mg tablet ER PO BID amLODIPine 10 mg tablet PO daily. BRINZOLAMIDE-BRIMONIDINE OPHT) 1 drop i
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1629075

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
78,0
Geschlecht
M
Eingang
31.08.2021
Impfdatum
25.02.2021
Beginn
05.08.2021
Tage bis Beginn
161,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal tenderness Agitation Asthenia Blood gases Blood lactic acid normal Acute kidney injury Atelectasis Blood culture negative Blood test abnormal COVID-19 Chest X-ray abnormal Culture urine negative Death Decreased appetite Depressed level of consciousness Haemoglobin decreased Endotracheal intubation Haematemesis

Symptomtext

Patient was sent to the emergency department from his from primary care provider office on 8/10/21 for evaluation of hypotension. He had been complaining of generalized weakness with decreased appetite for 1 week. He also endorsed urinary symptoms, mainly frequency. He was found to have a urinary tract infection and also to incidentally be COVID positive the same day (he was not hypoxic or short of breath). He was started on dexamethasone 6 mg PO daily on 8/13 when he was noted to have oxygen desaturations to the 80s with walking; however, he remained on room air. On 8/17, he had hypotension down to 70s/40s. Ultrasound showed hyperdynamic left ventricle. Of note, WBC increased from 12.3 on to 22.2 with neutrophilic predominance on 8/15. Norepinephrine was started and the patient was transferred to the medical intensive care unit. The patient was experiencing some mild abdominal tenderness of the right lower quadrant. Ordered for CT chest/abdomen/pelvis. In the evening of 8/17, he became agitated, climbing out of bed and pulling off medical equipment. 30 minutes later, he was noted to be increasingly lethargic and unarousable with increasing pressor requirements. ABG obtained at that time 6.94/29/166, lactate >15, Hgb <6. While preparing to intubate, patient lost pulse. ACLS initiated. No sustained ROSC, patient pronounced after 36 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown, if any
Vorgeschichte
Diabetes mellitus, hepatitis C induced-cirrhosis and possible hepatocellular carcinoma, coronary artery disease with stent replacement, hypertension, osteoarthritis
Andere Medikamente
AZOPT 1 % drops 1 drop into both eyes TID COMBIGAN 0.2-0.5 % 1 drop into right eye BID Cholecalciferol, 5,000 units PO daily Ranolazine 1,000 mg tablet ER PO BID amLODIPine 10 mg tablet PO daily. BRINZOLAMIDE-BRIMONIDINE OPHT) 1 drop i
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1656237

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
80,0
Geschlecht
F
Eingang
30.08.2021
Impfdatum
05.03.2021
Beginn
29.08.2021
Tage bis Beginn
177,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Chest pain Death Dyspnoea Nausea Oxygen saturation decreased Respiratory failure SARS-CoV-2 test positive

Symptomtext

Patient is a 81 y.o. female with history of COPD/emphysema on oxygen at home who presents with shortness of breath, chest pain, and nausea. She states her symptoms started this past Thursday. They progressively worsened with time. She normally wears 2 L of oxygen at home at night at baseline. However, her oxygen needs have had to increased since this past Thursday and she was up to 10 L oxygen at home today prior to coming to the emergency department. She came to the emergency department on Saturday 08/21/2021 and was positive for COVID-19. She did not require any more oxygen to be admitted at that time. She did have her COVID-19 vaccine and was fully vaccinated well over a month ago. She denies any other complaints today. Of note, she states only 1 of her lungs is working at 100% as the other 1 is being collapse by an uneven diaphragm. She had a car accident recently and had a ruptured sternum with diaphragmatic rupture. Hospital Course: Patient was treated for COVID-19 protocol. Unfortunately, her respiratory status continued to decompensate. She began telling staff that she was ?done ?and ?ready to go to the lord.? After difficult discussion, patient elected to make herself comfort measures only. Aggressive measures were discontinued and her family was allowed to visit say goodbye. She passed away 08/29/2021 at 1007. May she rest in peace.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1637338

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
76,0
Geschlecht
F
Eingang
26.08.2021
Impfdatum
20.03.2021
Beginn
17.08.2021
Tage bis Beginn
150,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury COVID-19 Carotid artery occlusion Cerebral artery occlusion Cerebral haemorrhage Cerebrovascular accident Chest X-ray normal Computerised tomogram head abnormal Death Diarrhoea Dizziness Dyspnoea Facial paralysis Headache Hypoxia Intensive care Mydriasis Nephropathy

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/27/2021 and 3/20/2021. Presented to ED on 8/17 with complaints of shortness of breath x1 week, diarrhea, light-headedness, headache, and right lower extremity swelling. Patient was placed on supplemental oxygen and admitted. On 8/18 patient exhibited facial droop and left arm/leg weakness. CTA revealed right ICA occlusion and underwent thrombectomy and stenting. ICU, patient had persistent L-sided deficits with concern for devastating neurologic injury. On 08/19, patient was found to have new R pupillary dilation and repeat CTA & CTH revealed re-occlusion of R ICA & R M1 occlusion and petechial hemorrhage. Per Neuro IR, patient not a candidate for repeat MT. Patient was managed with 3% saline and blood pressure control with Cardene gtt with permissive parameters. On 08/21, the patient became hypoxic with increased work of breathing. CXR revealed stable chest and she was placed on HFNC. She was also found to have oliguric AKI in the setting of contrast nephropathy and loss of renal autoregulation in the setting of acute stroke. Nephrology was consulted and discussed with family. Patient's family decided to transition to comfort care measures and withdraw life-sustaining treatment. On 8/22/2021, the patient was pronounced deceased. For COVID, Patient was treated with Remdesivir, Acyclovir, Dexamethasone.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebral haemorrhage
Hospital-Tage
-
Labordaten
COVID-19 positive on 8/17/2021 @ 20:04 analyzed using one or a combination of Real-Time PCR based methods and multiplex reagents including that utilize primer/probe sets specific for the detection of SARS-CoV-2 (COVID-19). The limit of detection of these assays is at least equal to or less than 50 copies/ml.
Aktuelle Erkrankungen
Left Lower extremity DVT 1 month ago, NSTEMI 6/21/2021
Vorgeschichte
Anemia, Multiple myeloma, CHF, Diabetes Type 2, DVT of Leg, Hypertension, Neuropathy, Sleep apnea, Thyroid disorder, Varicose vein of leg, Chronic kidney disease,
Andere Medikamente
Acyclovir 400 mg BID, Apixaban 5 mg BID, Aspirin 81 mg QD, Atrovastatin 40 mg QD, Bortezomib weekly, Cholecalciferol 2000 units QD, Cyanocobalamin 1000 mcg QD, Dexamethasone 20 mg on Fridays and Saturdays after bortezomib, Tylenol PM prn,
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1634215

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
OK
Alter
65,0
Geschlecht
M
Eingang
26.08.2021
Impfdatum
09.02.2021
Beginn
23.07.2021
Tage bis Beginn
164,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Death Myocardial infarction

Symptomtext

Death. Heart attack

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unk
Vorgeschichte
Unk
Andere Medikamente
Unk
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1633991

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
70,0
Geschlecht
F
Eingang
25.08.2021
Impfdatum
04.03.2021
Beginn
14.08.2021
Tage bis Beginn
163,0
Dosis
2
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Cerebrovascular accident Pneumonia

Symptomtext

Patient admitted for CVA/pneumonia

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1632201

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
89,0
Geschlecht
M
Eingang
25.08.2021
Impfdatum
05.03.2021
Beginn
09.08.2021
Tage bis Beginn
157,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Agitation Asthenia COVID-19 Confusional state Cough Death Malaise Pneumonia aspiration Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Patient s/p vaccination in spring 2021. Admitted to the hospital on 8/9/2021 with generalized weakness. Pt reported chronic dry cough, malaise and runny nose; denied chest pain, SOA, V/N/D. No known exposures to COVID. Patient found to be COVID+; started on oxygen, dexamethasone and remdesivir. O2 requirements continued to worsen; imaging showed worsening PNA - concern for secondary aspiration PNA. Started on IV zosyn. After 10 days with worsening confusion, agitation patient family decided to transition to comfort measures. Pt agreed to Hospice on 8/19 and passed on 8/20

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
8/9 COVID 19 detected
Aktuelle Erkrankungen
No acute illness
Vorgeschichte
Hypertension Parkinson's disease Glaucoma Obstructive sleep apnea DM2
Andere Medikamente
Current Outpatient Medications: ? ACCU-CHEK SOFTCLIX LANCETS lancets, , Disp: , Rfl: ? Blood Glucose Calibration (TRUE METRIX LEVEL 1) Low solution, , Disp: , Rfl: ? Blood Glucose Monitoring Suppl (TRUE METRIX AIR GLUCOSE METER) devic
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1627989

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
80,0
Geschlecht
M
Eingang
24.08.2021
Impfdatum
02.03.2021
Beginn
26.07.2021
Tage bis Beginn
146,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 Death Dyspnoea Hypoxia Pyrexia

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA Patient received Pfizer Vaccines on 1/29/2021 and 3/2/2021. Presented to emergency department on 7/20/2021 with c/o fever and dyspnea x24 hours. Patient had a chest xray and positive COVID-19 test at another facility prior to presentation. Patient was hypoxic at 85% and started on Nasal cannula O2. Patient was treated with Remdesivir and dexamethasone. Patient expired on 7/31/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
11,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
COPD, Dementia, hyperthyroidism, BPH, CKD, Basal Cell Carcinoma, Esophageal stricture, REM sleep disorder, squamous cell cancer
Andere Medikamente
Albuterol MDI, Anoro Ellipta 62.5-25 mcg, fludrocortisone 0.1 mg, Olopatadine 0.1%, Donepezil 5 mg, B Complex Vitamin, Cholecalciferol 2000 units, Dutasteride 0.5 mg, Memantine 10 mg, Methimazole 2.5 mg, Miralax 17 grams
Allergien
Bactrim (hives), Tamsulosin (hypotension)
Vorherige Impfungen
-

VAERS 1624538

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
67,0
Geschlecht
M
Eingang
23.08.2021
Impfdatum
22.02.2021
Beginn
12.07.2021
Tage bis Beginn
140,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Cough Death Dyspnoea Endotracheal intubation General physical health deterioration Hypercapnia Hypoxia Pyrexia Renal replacement therapy

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: Patient received Pfizer Vaccines on 1/26/2021 and 2/22/2021. Patient presented to ED on 07/12/2021 with SOB (starting 3 days ago), cough, and fever. Patient received remdesivir x 5 days and was dosed with actemra on 7/20. Patient also completed azithromycin x 5 days and cefepime x 7days. 7/22/21: Patient was intubated on 7/22/21, proned on 7/23/21, started on CRRT on 7/25/21. Pt declined and was found to have worsening hypercapnia and hypoxia despite full support. Patient expired 7/27/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
15,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
left lung transplant, sarcoidosis, COPD, ILD, OSA on CPAP, CHF s/p AICD, HTN, HLD, DM
Andere Medikamente
alendronate 35mg 1 QWeek, Vitamin C 500mg BID, Aspirin 81mg daily, atovaquone 750mg/5ml BID, Azithromycin 250mg 1 tab T,TH, SAT, Bre Ellipta 100-25mcg 1 puff daily, folic acid 1 mg daily, gabapentin 300mg 2 capsules TID, Humalog 1-4 units Q
Allergien
Adhesives
Vorherige Impfungen
-

VAERS 1591931

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
67,0
Geschlecht
M
Eingang
20.08.2021
Impfdatum
26.03.2021
Beginn
26.07.2021
Tage bis Beginn
122,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia COVID-19 Death Dyspnoea General physical health deterioration Pneumonia Renal transplant SARS-CoV-2 antibody test negative SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: Fully Vaccinated Expired Patient received Pfizer Vaccines on 3/5/2021 and 3/26/2021. Patient had a history of ESRD secondary to diabetes and hypertension, renal transplant on 7/13/2021, and was admitted on 7/26/2021 through ED for worsening shortness of breath, weakness and dyspnea. Patient found to be positive for COVID-19 and pneumonia. Patient was treated with remdesivir, dexamethasone, and piperacillin+Tazobactam. Patient continued to decline and expired on 8/11/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
16,0
Labordaten
Positive COVID-19 test 07/27 @ 1827 using PCR Positive COVID-19 test 07/30 @ 1220 using PCR Negative SARS CoV2 Antibodies
Aktuelle Erkrankungen
-
Vorgeschichte
Hyperlipidemia, Hypertension, Anemia in ESRD, Retinal Edema, Chronic venous hypertension w/ ulcer, Mild intermittent asthma, Seasonal allergies, Type 2 diabetes mellitus, End Stage Renal Disease, Chronic Dialysis, OSA on CPAP, Metabolic bone disease, secondary hyperparathyroidism, hyperkalemia, history fo CVA with residual effects, diverticulosis of colon without diverticulitis, Obesity, Coronary artery disease, GERD, History of Junctional dysrhythmia
Andere Medikamente
fluconazole 100 mg QD, furosemide 80 mg QD, gabapentin 100 mg BID, Insulin Lispro sliding scale TID, Mycophenolate 720 mg BID, Oxycodone 5 mg Q4h PRN, Polyethylene glycol 17 grams PRN, Prednisone 5 mg QD, Senna+Docusate PRN, Sulfamethoxazol
Allergien
Chlorhexidine (Dermatitis)
Vorherige Impfungen
-

VAERS 1582941

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
GA
Alter
85,0
Geschlecht
M
Eingang
18.08.2021
Impfdatum
26.02.2021
Beginn
02.03.2021
Tage bis Beginn
4,0
Dosis
2
Route/Site
SYR / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Colon cancer Condition aggravated Death Haemorrhage urinary tract Nephrostomy Prostate cancer Pulmonary oedema Thrombosis

Symptomtext

Four days after the shot, patient started having blood clots in the urine. After a few weeks, was able to get back to normal but seemed to stimulate previously stable cancers into growth. Four days after the 2nd (3/19/21) covid shot blood clots started again.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
7,0
Labordaten
Hospital stays, then nephrostomy, then hospital then death. Water on lungs
Aktuelle Erkrankungen
Stage 4 cancers of prostate and colon
Vorgeschichte
None
Andere Medikamente
Darifenacin, tamsulosin, ciprofloxacin, duloxetine, prednison, abiraterone, mupirocin, psyllium, ammonium lactate, urea topical, acetaminophen, leuprolide, multivitamin
Allergien
Penicillin, some statins
Vorherige Impfungen
-

VAERS 1364309

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
64,0
Geschlecht
M
Eingang
18.08.2021
Impfdatum
28.02.2021
Beginn
15.04.2021
Tage bis Beginn
46,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Anticoagulant therapy Blood pressure increased Chest discomfort Dyspnoea Heart rate increased Palpitations Pulmonary embolism Pulmonary thrombosis

Symptomtext

Shortness of breath, chest tightness, heart palpitations, elevated heart rate and blood pressure, referred to a cardiologist. Was diagnosed with a pulmonary embolism with several blood clots in lungs. Currently on Eliquis 5mg twice a day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None.
Vorgeschichte
None.
Andere Medikamente
Valsartan 320 mg, Triamterene-Hctz 37.5 25mg, Rosuvastatin 10mg, Levocetirizine 5mg 1 tablet per day.
Allergien
None.
Vorherige Impfungen
-

VAERS 1545008

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
71,0
Geschlecht
M
Eingang
11.08.2021
Impfdatum
25.02.2021
Beginn
06.08.2021
Tage bis Beginn
162,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure Atelectasis COVID-19 pneumonia Chest X-ray abnormal Full blood count normal Lung infiltration Lung opacity Metabolic function test normal

Symptomtext

On arrival to the emergency department, patient was hypoxic to 78% on room air. Other vital signs are within normal limits. He required 3 L nasal cannula to maintain O2 sats 93%. CMP and complete blood count were unremarkable. DR frontal and lateral chest x-ray showed faint patchy opacity at the bilateral lung base representing scattered infiltrates versus atelectasis. He was given albuterol and dexamethasone 6 mg. Admitted to hospital medicine for acute hypoxic respiratory failure secondary to COVID-19 pneumonia. "

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
None Known
Vorgeschichte
History of stroke HTN
Andere Medikamente
Norvasc Lipitor Advair Aspirin
Allergien
NKA
Vorherige Impfungen
-

VAERS 1541117

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
83,0
Geschlecht
F
Eingang
10.08.2021
Impfdatum
23.03.2021
Beginn
30.07.2021
Tage bis Beginn
129,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Ageusia COVID-19 Death Delirium Dyspnoea Intensive care Muscular weakness Myalgia Pyrexia SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA Patient received Pfizer Vaccines on 3/5/2021 and 3/23/2021. Presented to urgent care on 7/24 and had a positive COVID test, started on azithromycin and benzonatate. Patient presented to ED on 7/30 with fever, dyspnea, myalgia, loss of taste, muscle weakness. Patient was initially admitted to the medical floor, on 4 L nasal cannula, but quickly escalated to high-flow nasal cannula and was then transferred to the ICU. The patient required high levels of oxygen and also developed delirium, as well as had acute kidney injury. Patient was treated with dexamethasone, terbutaline, remdesivir. In discussion with the patient's primary medical decision makers, including the patient's husband and son, the patient/s status was made a do not attempt resuscitation, but may continue the treatments. The patient was transferred to the medical wards on high levels of oxygen 60 L and 90% FiO2. Unfortunately, the patient continued to decompensate and passed away the evening of 8/3/2021. Additional information for Item 9: Atorvastatin 10 mg QD, Azithromycin 250 mg QD, Benzonatate 100 mg TID prn, Cholecalciferol 1000 units QD, Furosemide 40 mg QD, MagOx QD, Metoprolol 25 mg QD, Mycolog cream BID.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Morbid obesity, Diabetes, Hypertension, Congestive heart failure, Obstructive sleep apnea, Pulmonary Hypertension, fibromyalgia, psoriasis, history of breast cancer.
Andere Medikamente
Acetaminophen PRN, Albuterol 2 puff Q6H Prn, Aspirin 81 mg QD
Allergien
Penicillins (Rash)
Vorherige Impfungen
-

VAERS 1385132

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
77,0
Geschlecht
F
Eingang
10.08.2021
Impfdatum
31.03.2021
Beginn
14.06.2021
Tage bis Beginn
75,0
Dosis
UNK
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory distress syndrome COVID-19 Mechanical ventilation Pneumonia Death SARS-CoV-2 test positive

Symptomtext

Patient was a -year-old Female, fully vaccinated with Pfizer on 03-31-2021. Admitted to hospital as he is tested positive for COVID-19 and passed away on 06-14-2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1512561

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
47,0
Geschlecht
F
Eingang
29.07.2021
Impfdatum
24.02.2021
Beginn
08.05.2021
Tage bis Beginn
73,0
Dosis
1
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 Cardio-respiratory arrest Chest pain Death Intensive care Pericardial drainage Resuscitation SARS-CoV-2 test positive Ventricular tachycardia

Symptomtext

Patient received both doses of the Pfizer vaccine on 2/24/21 and 3/17/21. Patient came to the ER on 5/8/21 with chest pain, where she tested positive for COVID. While patient was receiving a precordial drain she went into V. tach but was successfully resuscitated. She went to ICU but went into cardiopulmonary arrest and died on 5/9/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardio-respiratory arrest
Hospital-Tage
-
Labordaten
Positive COVID test on 5/8/21
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1487285

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
80,0
Geschlecht
F
Eingang
20.07.2021
Impfdatum
23.02.2021
Beginn
12.07.2021
Tage bis Beginn
139,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Patient passed away on 07/12/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Cymbalta, Imdur, Klor-Con, Lasix, Prinivil, Norvasc, magnesium oxide, Flaxseed oil, calcium/vitamin D, cerovite senior tab, plavix, toprol, pepcid, tylenol, aspirin
Allergien
Zocor, Crestor
Vorherige Impfungen
-

VAERS 1466648

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
71,0
Geschlecht
F
Eingang
13.07.2021
Impfdatum
25.02.2021
Beginn
16.03.2021
Tage bis Beginn
19,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute myocardial infarction

Symptomtext

Patient presented to the ED and was subsequently hospitalized for NSTEMI within 6 weeks of receiving COVID vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1466464

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
ME
Alter
76,0
Geschlecht
M
Eingang
13.07.2021
Impfdatum
01.03.2021
Beginn
02.07.2021
Tage bis Beginn
123,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Respiration abnormal

Symptomtext

7/3/2021 7:23:41 AM > phone call from Officer pt deceased. discussed with wife. she heard him make a loud breathing noise at 3am and then could not wake him. had been feeling well with no complaints. planned to run a road race this Sunday. offered support. pls mark chart and then FYI to Dr.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
history of prostate cancer, A fib, renal insufficiency, hypercholesteremia
Andere Medikamente
Eliquis, Prinivil, Allopurinol, prilosec, euflexxa
Allergien
-
Vorherige Impfungen
-

VAERS 1453729

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
71,0
Geschlecht
M
Eingang
07.07.2021
Impfdatum
01.03.2021
Beginn
19.03.2021
Tage bis Beginn
18,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Anaemia Blood potassium Blood pressure decreased Blood pressure measurement Body temperature Cerebrovascular accident Cognitive disorder Confusional state Fall Haemoglobin Haemoglobin abnormal Hypokalaemia Infection Inflammation Investigation Muscle atrophy Neutrophil count Pyrexia

Symptomtext

This is a spontaneous report from a contactable consumer (patient's daughter). This consumer reported similar events for three patients. This is the first of three reports. A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6202), via an unspecified route of administration, administered in left arm on 01Mar2021 (at 71-year-old) as dose 2, single for COVID-19 immunization. Medical history included that he had the cholesterol of a twenty year old, the month prior to getting the second vaccine, he had a yearly work up of his heart and cholesterol and all that, they put a heart monitor on him to be sure everything was fine with that, and he had gotten a clean bill of health. He had never had any sort of medical situation or even surgeries until two years ago (2019), when he had a knee replacement, and he had a history of shingles, he got about fifteen years ago (2006) and they never really went away, so he's had on and off for the past fifteen years. The patient's concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL9267), via an unspecified route of administration, administered in left arm on 10Feb2021 (at 71-year-old) as dose 1, single for COVID-19 immunisation. The patient had two strokes on 19Mar2021 (reported as eighteen days after his second vaccine) and has been in the hospital ever since. He has developed anemia, he had muscle atrophy, and he was experiencing persistent fevers. He said that its like his blood was fighting/contradicting himself and they were pretty sure that it was from the vaccine. He already had 1 blood transfusions and his white blood cells were low and his ANC (absolute neutrophil count) was normal. Caller said nothing medically makes sense. She said it's like the vaccine changed the protein in the blood. The patient has had test after test after test, has had strokes in the medulla cerebellum, his hemoglobin won't stay above seven, he's had multiple blood transfusions, with signs of inflammation and infectious disease, but nothing in his body told them. No scans, blood tests, surgery, biopsies, ultrasound, he's literally had every test. Caller added patient was dying, and they didn't know why. He remained hospital from 23Mar2021 until he went home on 15Apr2021. While in rehab, patient started developing fever of unknown origin, that they can't figure out. On 25Apr2021, the patient went to the emergency room. He was home ten days and was declining that whole time, with fever up and down, lost cognition, really confused, which they thought was a result of stroke, but he was declining rapidly. He had fell a bunch, started losing muscle, muscle started atrophying at that point. When they took him in on the 25Apr2021, it's because his blood pressure dropped, another issue that started all of this, he could not maintain his blood pressure, if he sat up and moved, it would drop. And that day when he tried to stand and it dropped and he slid down. They took him to the emergency room and he had a potassium deficiency and they gave him potassium. He went home that day after the potassium. Then on 27Apr2021, he went back to hospital, into their emergency room, and spent a couple days in the ER, but was admitted into a room once available and stayed until 15May2021, when they transferred him from there. He remained here from 15May2021 to 21May2021. They were wanting to transfer him to another hospital. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
Test Date: 20210425; Test Name: potassium; Result Unstructured Data: Test Result:deficiency; Test Name: blood pressure; Result Unstructured Data: Test Result:dropped; Test Name: body temperature; Result Unstructured Data: Test Result:fever; Comments: fever of unknown origin; Test Name: hemoglobin; Result Unstructured Data: Test Result:won't stay above seven; Test Name: test; Result Unstructured Data: Test Result:unknown results; Comments: had test after test after test; Test Name: ANC; Result Unstructured Data: Test Result:normal; Test Name: white blood cells; Result Unstructured Data: Test Result:low
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Hyperlipidemia (From past 20 years); Knee replacement; Shingles (got 15 years ago on and off for the past fifteen years)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1412823

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AZ
Alter
71,0
Geschlecht
M
Eingang
01.07.2021
Impfdatum
01.03.2021
Beginn
19.03.2021
Tage bis Beginn
18,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Abdomen scan Anaemia Bacterial test Biopsy bone Blood culture Blood test Brain stem stroke Cerebellar stroke Muscle atrophy Cardiac monitoring Cerebrovascular accident Computerised tomogram Culture stool Culture urine Electroencephalogram Fungal test Haemoglobin decreased Lumbar puncture

Symptomtext

Strokes in the medulla and cerebellum; Strokes in the medulla and cerebellum; anemia with high levels of ferritin; anemia with high levels of ferritin; persistent fever; complete muscle atrophy; This is a spontaneous report received from a contactable consumer or other non hcp. A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/lot number: EN6202) via an unspecified route of administration in Arm Left on 01Mar2021 (age at vaccination 71years old) as dose 2, single for covid-19 immunisation. Medical history included herpes zoster from an unknown date and unknown if ongoing other medical history: History of Shingles and medically controlled blood pressure, surgery from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies, biopsy from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies. The patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included amlodipine (AMLODIPINE); losartan potassium (LOSARTIN); hydrochlorothiazide (HYDROCHLOROTHIAZIDE). For all these concomitant products start and stop date and indication were not reported. Since the vaccination, the patient had not been tested positive for COVID-19. The patient received historical vaccine first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EL9267) via an unspecified route of administration in Arm Left on 10Feb2021(age at vaccination 71years old) as single dose for covid-19 immunisation. The patient experienced strokes in the medulla and cerebellum, anemia, anemia with high levels of ferritin, persistent fever, complete muscle atrophy on 19Mar2021.The patient Reported Events as Strokes in the medulla and cerebellum. Hemoglobin struggles to stay above 7. Multiple blood transfusions. He's developed anemia with high levels of ferritin, persistent fever, with no sign of inflammation or infectious disease. He also has complete muscle atrophy. He's had multiple scans, blood tests, surgeries, and biopsies. 3 months, 2 hospitals, and multiple physician and specialist intervention with no determinization of diagnosable cause of symptoms. The patient received any treatment for the adverse events reported as unknown. The patient was hospitalized for strokes in the medulla and cerebellum, anemia with high levels of ferritin, persistent fever for 91 days. The patient underwent lab tests and procedures which included blood test: unknown on unspecified date. He's had multiple scans, blood tests, scan: unknown on unspecified date. The clinical outcome of the event reported as not recovered. Follow up attempt is excepted. Further information is requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
91,0
Labordaten
Test Name: Blood tests; Result Unstructured Data: Test Result:Unknown; Comments: He's had multiple scans, blood tests,; Test Name: multiple scans; Result Unstructured Data: Test Result:Unknown; Comments: He's had multiple scans, blood tests,
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Biopsy (He's had multiple scans, blood tests, surgeries, and biopsies.); Blood pressure inadequately controlled (other_medical_history: History of Shingles and medically controlled blood pressure); Shingles (other_medical_history: History of Shingles and medically controlled blood pressure); Surgery (He's had multiple scans, blood tests, surgeries, and biopsies.)
Andere Medikamente
AMLODIPINE; LOSARTIN; HYDROCHLOROTHIAZIDE
Allergien
-
Vorherige Impfungen
-

VAERS 1412823

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AZ
Alter
71,0
Geschlecht
M
Eingang
01.07.2021
Impfdatum
01.03.2021
Beginn
19.03.2021
Tage bis Beginn
18,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Abdomen scan Anaemia Bacterial test Biopsy bone Blood culture Blood test Brain stem stroke Cerebellar stroke Muscle atrophy Cardiac monitoring Cerebrovascular accident Computerised tomogram Culture stool Culture urine Electroencephalogram Fungal test Haemoglobin decreased Lumbar puncture

Symptomtext

Strokes in the medulla and cerebellum; Strokes in the medulla and cerebellum; anemia with high levels of ferritin; anemia with high levels of ferritin; persistent fever; complete muscle atrophy; This is a spontaneous report received from a contactable consumer or other non hcp. A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/lot number: EN6202) via an unspecified route of administration in Arm Left on 01Mar2021 (age at vaccination 71years old) as dose 2, single for covid-19 immunisation. Medical history included herpes zoster from an unknown date and unknown if ongoing other medical history: History of Shingles and medically controlled blood pressure, surgery from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies, biopsy from an unknown date and unknown if ongoing He's had multiple scans, blood tests, surgeries, and biopsies. The patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included amlodipine (AMLODIPINE); losartan potassium (LOSARTIN); hydrochlorothiazide (HYDROCHLOROTHIAZIDE). For all these concomitant products start and stop date and indication were not reported. Since the vaccination, the patient had not been tested positive for COVID-19. The patient received historical vaccine first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EL9267) via an unspecified route of administration in Arm Left on 10Feb2021(age at vaccination 71years old) as single dose for covid-19 immunisation. The patient experienced strokes in the medulla and cerebellum, anemia, anemia with high levels of ferritin, persistent fever, complete muscle atrophy on 19Mar2021.The patient Reported Events as Strokes in the medulla and cerebellum. Hemoglobin struggles to stay above 7. Multiple blood transfusions. He's developed anemia with high levels of ferritin, persistent fever, with no sign of inflammation or infectious disease. He also has complete muscle atrophy. He's had multiple scans, blood tests, surgeries, and biopsies. 3 months, 2 hospitals, and multiple physician and specialist intervention with no determinization of diagnosable cause of symptoms. The patient received any treatment for the adverse events reported as unknown. The patient was hospitalized for strokes in the medulla and cerebellum, anemia with high levels of ferritin, persistent fever for 91 days. The patient underwent lab tests and procedures which included blood test: unknown on unspecified date. He's had multiple scans, blood tests, scan: unknown on unspecified date. The clinical outcome of the event reported as not recovered. Follow up attempt is excepted. Further information is requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
91,0
Labordaten
Test Name: Blood tests; Result Unstructured Data: Test Result:Unknown; Comments: He's had multiple scans, blood tests,; Test Name: multiple scans; Result Unstructured Data: Test Result:Unknown; Comments: He's had multiple scans, blood tests,
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Biopsy (He's had multiple scans, blood tests, surgeries, and biopsies.); Blood pressure inadequately controlled (other_medical_history: History of Shingles and medically controlled blood pressure); Shingles (other_medical_history: History of Shingles and medically controlled blood pressure); Surgery (He's had multiple scans, blood tests, surgeries, and biopsies.)
Andere Medikamente
AMLODIPINE; LOSARTIN; HYDROCHLOROTHIAZIDE
Allergien
-
Vorherige Impfungen
-

VAERS 1435096

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
OH
Alter
70,0
Geschlecht
F
Eingang
30.06.2021
Impfdatum
30.03.2021
Beginn
11.04.2021
Tage bis Beginn
12,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Blood test Cardiac function test Cerebrovascular accident Computerised tomogram abnormal Hemiplegia Ultrasound scan Walking aid user Wheelchair user

Symptomtext

Diagnosed Stroke resulting in left side paralysis of left arm and left leg. Hospitalized for 28 days Medical Center. Follow on with 6 weeks of in-home therapy and presently out-patient therapy both OT and PT as well as Speech. Using wheelchair and walker.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
28,0
Labordaten
CT Scans, Ultrasounds, Heart tests, Blood Work, during hospital stay
Aktuelle Erkrankungen
None
Vorgeschichte
Asthma
Andere Medikamente
Xopenex (Asthma), Krill Oil (Over Counter)
Allergien
Aspirin, Steroids
Vorherige Impfungen
-

VAERS 1434266

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AK
Alter
45,0
Geschlecht
F
Eingang
29.06.2021
Impfdatum
30.03.2021
Beginn
31.05.2021
Tage bis Beginn
62,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein
Back pain Cardiac arrest Chest pain Implantable defibrillator insertion Intensive care Neck pain Pain in extremity Pulmonary embolism Resuscitation

Symptomtext

5/31/21 had back chest neck arm pain, went to medic, went into cardiac arrest, the did 18 minutes of CPR, got a heart rate, medivac?d me to Anchorage, AK spent 4 days in ICU, was told I had cardiac arrest due to pulmonary embolus,. Got a defibrillator installed in my chest.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
4,0
Labordaten
Too many to list, talk to Dr
Aktuelle Erkrankungen
None
Vorgeschichte
Migraine headaches
Andere Medikamente
Fluoxetine Nortryptoline Atenolol Spironolactone Minocycline Metformin Vita D3
Allergien
None known
Vorherige Impfungen
-

VAERS 1433671

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
89,0
Geschlecht
M
Eingang
29.06.2021
Impfdatum
23.02.2021
Beginn
15.04.2021
Tage bis Beginn
51,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Patient passed away on 04/15/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Type 2 diabetes, CKD (Stage 3),
Andere Medikamente
Norvasc, Ultram, sodium bicarbonate, Cipro, Hyzaar, Glucotrol, Flomax, Bystolic, Multi Vitamin, Lutein, acetaminophen
Allergien
No know allergies
Vorherige Impfungen
-

VAERS 1433542

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
86,0
Geschlecht
M
Eingang
29.06.2021
Impfdatum
23.02.2021
Beginn
05.04.2021
Tage bis Beginn
41,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Patient passed away on 04/05/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Phenergan, Remeron, melatonin, Celexa, Flonase, Buspar, Atrovent, Mycostatin, Tegretol, Multi vitamin, vitamin D3, Demadex, Prilosec, Crestor, Myrbetriq, Klor-Con, Imdur, albuterol, nitroglycerin
Allergien
Ambien, Adhesive tape, Vicodin
Vorherige Impfungen
-

VAERS 1433516

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
84,0
Geschlecht
F
Eingang
29.06.2021
Impfdatum
23.02.2021
Beginn
16.03.2021
Tage bis Beginn
21,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Patient passed away on 03/16/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Pneumonia on 02/11/2021
Vorgeschichte
CHF, PVD
Andere Medikamente
Mucinex, Mirapex, Lasix, Zestril, Vitamin C, Cinnamon Capsule, Shark Cartilage Capsule, cholecalciferol, Biotin, Roxanol, zithromax, Ventolin HFA, Wellbutrin, Toprol XL, desyrel. Advair Diskus, Lipitor, Duo-Neb, Melatonin, Tylenol, Tumeric,
Allergien
Environmental, metolazone
Vorherige Impfungen
-

VAERS 1433491

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
79,0
Geschlecht
M
Eingang
29.06.2021
Impfdatum
23.02.2021
Beginn
12.03.2021
Tage bis Beginn
17,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Patient passed away on 03/12/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Roxanol, atropine sulfate opthalmic solution, lorazepam
Allergien
Dermoplast, Brimonidine
Vorherige Impfungen
-

VAERS 1155897

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
78,0
Geschlecht
F
Eingang
29.06.2021
Impfdatum
23.02.2021
Beginn
08.04.2021
Tage bis Beginn
44,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Unevaluable event

Symptomtext

Patient passed away on 04/08/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Roxanol, Ativan, Miralax, Compazine
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1155897

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
78,0
Geschlecht
F
Eingang
29.06.2021
Impfdatum
23.02.2021
Beginn
08.04.2021
Tage bis Beginn
44,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Unevaluable event

Symptomtext

Patient passed away on 04/08/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Roxanol, Ativan, Miralax, Compazine
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1430661

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NJ
Alter
85,0
Geschlecht
M
Eingang
28.06.2021
Impfdatum
05.02.2021
Beginn
27.02.2021
Tage bis Beginn
22,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Death Fatigue Pyrexia

Symptomtext

Fatigue, chills, fever, exhaustion. The following Sunday, 9 days after his second dose he went to bed and never woke up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
Bilateral Carotid Stenosis, Hypertension, Hypercholesterolemia, Paroxysmal Atrial Fibrillation, Cva due to embolism of cerebellum artery (hcc)
Andere Medikamente
Atorvastatin, Cholecalciferol, Famotidine, Finasteride, Losartan, Metoprolol succinate, Multaq
Allergien
Dabigatran Etexilate Mesylate, Rivaroxaban
Vorherige Impfungen
-

VAERS 1429452

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
-
Geschlecht
M
Eingang
26.06.2021
Impfdatum
01.03.2021
Beginn
01.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Anaemia Blood pressure decreased Blood pressure measurement Cerebrovascular accident Cognitive disorder Confusional state Haemoglobin Haemoglobin increased Hypokalaemia Infection Inflammation Muscle atrophy Pyrexia White blood cell count White blood cell count decreased

Symptomtext

His white blood cells are low; He had 2 strokes; His hemoglobin won't stay within 7; He has developed anemia; He has muscle atrophy; He is experiencing persistent fevers; infectious disease; signs of inflammation; lost cognition, really confused; lost cognition, really confused; blood pressure dropped; potassium deficiency; This is a spontaneous report from a contactable consumer (patients daughter) via medical information team. A 72-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6202) via an unspecified route of administration on 01Mar2021 in the left arm at dose 2 single for COVID-19 Immunization. Medical history included shingles (about fifteen years ago and they never really went away, so he's had on and off for the past fifteen years), knee replacement. Concomitant medications were not reported. Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9267) on 10Feb2021 in left arm for COVID-19 immunization. It was reported that eighteen days after getting the second dose of the vaccine, caller has been in 3 (going on 4) hospitals, he had 2 strokes, his hemoglobin wont stay within 7, he has developed anemia, he has muscle atrophy, and he was experiencing persistent fevers all in Mar2021. He said that its like his blood was fighting/contradicting himself and they are pretty sure that it was from the vaccine. He already had 1 blood transfusions and his white blood cells are low in Mar2021 and his ANC was normal. Caller said nothing medically makes sense. She said its like the vaccine changed the protein in the blood. Patient had been in the hospital for about nine days at this point. States he has had test after test after test, has had strokes in the medulla cerebellum, his hemoglobin wont stay above seven, has had multiple blood transfusions, developed anemia, had persistent fever, with signs of inflammation and infectious disease in Mar2021, but nothing in his body tells them. No scans, blood tests, surgery, biopsies, ultrasound, has literally had every test. Caller states the doctors are saying they have no idea what was happening, but it's something with his blood essentially fighting itself. Caller adds he was dying, and they don't know why. Caller states just a little medical history on patient, he was 72 years old, but had the cholesterol of a twenty-year-old, the month prior to getting the second vaccine, he had a yearly work up of his heart and cholesterol and all that, they put a heart monitor on him to be sure everything was fine with that, and he had gotten a clean bill of health. States he had never had any sort of medical situation or even surgeries until two years ago, when he had a knee replacement. Caller adds the only thing funky with him, is he had a history of shingles, he got about fifteen years ago and they never really went away, so he's had on and off for the past fifteen years, and she was not sure if that's why he reacted the way he did. Caller states he was hospitalized from 19Mar2021 until 23Mar2021, when he was released to rehab. He remained at rehab from 23Mar2021 until he went home on 15Apr2021. while in rehab, patient started developing fever of unknown origin. Caller states on 25Apr2021, her father went to the emergency room. Caller states he was home ten days and was declining that whole time, with fever up and down, lost cognition, really confused in Mar2021, which they thought was a result of stroke, but he was declining rapidly. Caller adds he had fell a bunch, started losing muscle, muscle started atrophying at that point. Caller states when they took him in on the 25Apr2021, its because his blood pressure dropped in Mar2021, another issue that started all of this, he could not maintain his blood pressure, if he sat up and moved, it would drop. And that day when he tried to stand and it dropped and he slid down. They took him to the ER and he had a potassium deficiency in Mar2021 and they gave him potassium. Caller was unsure which ER he went to and he went home that day after the potassium. Caller states then on 27Apr2021, he went back to hospital, into their emergency room, and spent a couple days in the ER, but was admitted into a room once available and stayed until 15May2021. The outcome of events was unknown. Information on the lot/batch was available, Additional information has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021751103 same reporter, drug and event, different patients;US-PFIZER INC-2021751102 same reporter, drug and event, different patients

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
9,0
Labordaten
Test Date: 202103; Test Name: blood pressure; Result Unstructured Data: Test Result:dropped; Test Date: 202103; Test Name: Hemoglobin; Result Unstructured Data: Test Result:7; Comments: Wont stay within 7; Test Date: 202103; Test Name: White blood cell count; Result Unstructured Data: Test Result:Low
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Knee replacement; Shingles (about fifteen years ago)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1394137

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AZ
Alter
57,0
Geschlecht
M
Eingang
12.06.2021
Impfdatum
22.02.2021
Beginn
01.03.2021
Tage bis Beginn
7,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory distress syndrome Adenovirus test Blood calcium Blood chloride Blood creatinine Blood glucose Blood sodium Blood urea COVID-19 Carbon dioxide Chest X-ray Chills Coccidioidomycosis Computed tomographic abscessogram Death Diarrhoea Diffuse alveolar damage Dyspnoea

Symptomtext

Her husband passed away; Sepsis; Shock due to bilateral pulmonary acute disease syndrome; Shock due to bilateral pulmonary acute disease syndrome due to diffuse alveolar damage; misery and feeling horrible; Severe chills; Headache; Shortness of breath; Fever; Fatigue; Diarrhea; Muscle aches; Skin sensitivity and rash; Skin sensitivity and rash; Sore throat; This is a spontaneous report from a contactable consumer. A 57-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm on 22Feb2021 at 10:00 (Lot Number: EN6202) (at the age of 57-year-old) as single dose for COVID-19 immunisation. Medical history included high cholesterol from 2017 to an unknown date, seasonal allergy from an unknown date and unknown if ongoing and arteriosclerosis from 2017 to an unknown date. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 01Feb2021 (Lot Number: EL9264) (at the age of 57-year-old) as single dose for COVID-19 immunisation; the patient previously received ZYRTEC (10mg almost daily) for seasonal allergy, ibuprofen (ADVIL, 200 mg) and TYLENOL both for pain. Caller stated that the patient passed away on 02Mar2021 which was 8 days after the 2nd dose of the Pfizer COVID Vaccine. On 26Feb2021 the patient went to urgent care and then on 01Mar2021 he went to the hospital emergency room (ER). It was reported that an autopsy was performed on 06Mar2021 and the cause of death listed sepsis and complications from sepsis and shock due to bilateral pulmonary acute disease syndrome due to diffuse alveolar damage. The manner of death was natural and the lung presentation is highly suggestive of diffuse alveolar damage due to COVID-19 although the patient had several negative tests for COVID. The patient tested negative for influenza AB, negative for valley fever, negative for Legionnaire's disease and was in the hospital for less than 24 hours. The patient went back to urgent care on 28Feb2021 and was feeling miserable and asking for blood tests and urine tests, stated at that time his platelets were low at 122, glucose was high at 105, sodium was low at 134, calcium was low at 8.3, urine was negative and the patient did not get these labs til Monday when he was on the way to the emergency room and it was all different when he got to the hospital. The test for strep was negative, the oxygen was low at 86 percent when he got to the hospital on Monday and they just had to keep increasing his oxygen, stated a culture, no further details provided about the culture. A CTA done on the chest on Monday which was bad and stated the patient was symptomatic and they did not treat him for COVID but had a clinical suspicion for COVID. Adenovirus was not detected, metapneumonia virus was not detected, respiratory syncytial virus was not detected, parainfluenza was not detected, his platelets kept dropping and he had two tests for valley fever which is Cocci IGG and IGM and those were negative, the sodium level on 02Mar2021 was 126, all of these things were low: chloride 92, CO2 18, calcium 7.8, glucose was high at 222, bun was high at 21, creatinine was high at 1.4, EGFR was low at 52, WBC was high at 18.6, RBC was high at 7.39, HGB was 22.6, HCT was 66.4, RDW was high at 15, RDWFD was 45.5, and platelets were low at 61. The patient came into the emergency room those labs were when he was failing completely and on 01Mar2021 was when he arrived in the ER; at that time his WBC were normal, RBC was high at 6.16, HGB was high at 18.5, HCT was high at 54.9, platelets were low at 73, monocytes absolute were high at 0.96, sodium was low at 129, chloride was low at 95, calcium was low at 8.3, glucose was high at 150 and this was 7 days past the Pfizer COVID Vaccine. The patient was negative for strep pneumonia antigen and negative for Legionnaires Urinary antigen. The chest X-ray was done on 26Feb2021 and the patient was in misery and feeling horrible and they sent him home with albuterol and possible antibiotic to start that Monday and he had severe chills, headache, shortness of breath, fever, fatigue, diarrhea, muscle aches, skin sensitivity and rash, sore throat. Chest X-ray says normal; states the albuterol was PROAIR HFA 90mcg and he tested negative for influenza AB and he never got to the antibiotic because they said to wait til Monday and by that time this was an emergency. The patient outcome of sepsis and shock due to bilateral pulmonary acute disease syndrome due to diffuse alveolar damage was fatal and unknown for the other events. The patient died on 02Mar2021. An autopsy was performed that revealed the cause of death was sepsis and complications from sepsis and shock due to bilateral pulmonary acute disease syndrome due to diffuse alveolar damage.; Reported Cause(s) of Death: Sepsis; Autopsy-determined Cause(s) of Death: Shock due to bilateral pulmonary acute disease syndrome; Diffuse alveolar damage

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Test Name: Adenovirus; Result Unstructured Data: Test Result:Not detected; Comments: Not detected; Test Name: Calcium; Result Unstructured Data: Test Result:8.3; Comments: Calcium was low; Test Date: 20210301; Test Name: Calcium; Result Unstructured Data: Test Result:8.3; Comments: Low; Test Date: 20210302; Test Name: Calcium; Result Unstructured Data: Test Result:7.8; Comments: Low; Test Date: 20210301; Test Name: Chloride; Result Unstructured Data: Test Result:95; Comments: Low; Test Date: 20210302; Test Name: Chloride; Result Unstructured Data: Test Result:92; Comments: Low; Test Date: 20210302; Test Name: Creatinine; Result Unstructured Data: Test Result:1.4; Comments: High; Test Name: Glucose; Result Unstructured Data: Test Result:105; Comments: Glucose was high; Test Date: 20210301; Test Name: Glucose; Result Unstructured Data: Test Result:150; Comments: High; Test Date: 20210302; Test Name: Glucose; Result Unstructured Data: Test Result:222; Comments: High; Test Name: Sodium; Result Unstructured Data: Test Result:134; Comments: Sodium was low; Test Date: 20210301; Test Name: Sodium; Result Unstructured Data: Test Result:129; Comments: Low; Test Date: 20210302; Test Name: Sodium; Result Unstructured Data: Test Result:126; Test Date: 20210302; Test Name: BUN; Result Unstructured Data: Test Result:21; Comments: High; Test Date: 20210302; Test Name: Co2; Result Unstructured Data: Test Result:18; Comments: Low; Test Date: 20210226; Test Name: Chest X-ray; Result Unstructured Data: Test Result:Normal; Test Name: Valley fever; Result Unstructured Data: Test Result:Negative; Comments: Cocci IGG and IGM and those were negative; Test Name: CTA; Result Unstructured Data: Test Result:No results; Test Name: Covid; Result Unstructured Data: Test Result:Negative; Test Date: 20210302; Test Name: EGFR; Result Unstructured Data: Test Result:52; Comments: Low; Test Date: 20210301; Test Name: Hematocrit; Result Unstructured Data: Test Result:54.9; Comments: High; Test Date: 20210302; Test Name: Hematocrit; Result Unstructured Data: Test Result:66.4; Test Date: 20210301; Test Name: HGB; Result Unstructured Data: Test Result:18.5; Comments: High; Test Date: 20210302; Test Name: HGB; Result Unstructured Data: Test Result:22.6; Test Name: Influenza AB; Result Unstructured Data: Test Result:Negative; Test Name: Influenza AB; Result Unstructured Data: Test Result:Negative; Test Name: Metapneumonia; Result Unstructured Data: Test Result:not detected; Test Date: 20210301; Test Name: Monocytes; Result Unstructured Data: Test Result:0.96; Comments: High; Test Name: Oxygen; Result Unstructured Data: Test Result:86; Comments: Oxygen was low; Test Name: parainfluenza; Result Unstructured Data: Test Result:Not detected; Test Name: Platelets; Result Unstructured Data: Test Result:122; Comments: Platelets were low; Test Date: 20210301; Test Name: Platelets; Result Unstructured Data: Test Result:73; Comments: Low; Test Date: 20210302; Test Name: Platelets; Result Unstructured Data: Test Result:61; Comments: Low; Test Name: Legionnaire's disease; Result Unstructured Data: Test Result:Negative; Test Date: 20210301; Test Name: RBC; Result Unstructured Data: Test Result:6.16; Comments: High; Test Date: 20210302; Test Name: RBC; Result Unstructured Data: Test Result:7.39; Comments: High; Test Date: 20210302; Test Name: RDW; Result Unstructured Data: Test Result:15; Comments: RDWFD was 45.5; Test Name: Respiratory syncytial virus; Result Unstructured Data: Test Result:Not detected; Test Name: Strep; Result Unstructured Data: Test Result:Negative; Test Date: 20210301; Test Name: WBC; Result Unstructured Data: Test Result:Normal; Test Date: 20210302; Test Name: WBC; Result Unstructured Data: Test Result:18.6; Comments: High
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Arteriosclerotic cardiovascular disease; High cholesterol; Seasonal allergy
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1365404

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
IL
Alter
59,0
Geschlecht
M
Eingang
01.06.2021
Impfdatum
01.03.2021
Beginn
05.03.2021
Tage bis Beginn
4,0
Dosis
1
Route/Site
SYR / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

My husband past away

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
High blood pressure, gout, sleep apnea
Andere Medikamente
Plavix 75mg, Carvedilol 25mg, Amlodipine 10mg, Losartan 100mg, Lipitor 10mg, Allopurinol 25mg, Aspirin 81mg, Vitamin C, Vitamin D, CoQ10
Allergien
none
Vorherige Impfungen
-

VAERS 1362511

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AZ
Alter
57,0
Geschlecht
M
Eingang
31.05.2021
Impfdatum
22.02.2021
Beginn
22.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / AR
Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Angiogram pulmonary abnormal Back pain Blood calcium decreased Blood chloride decreased Blood glucose increased Blood sodium decreased Brain natriuretic peptide normal Chest X-ray abnormal Chills Condition aggravated Cough Death Diarrhoea Differential white blood cell count abnormal Dyspnoea Eye pain Fatigue Feeling abnormal

Symptomtext

Skin hurting/sensitivity (Day 1 forward), severe chills (day 2 forward), headache (day 1 forward), fatigue (day 1 forward), mild cough on/off, eye pain (? day 4 forward), achey (day 1 forward), chest rash (? day 3 forward), fever (? day 5 forward 101.9 day 5), back pain (? day 5 forward), labored breathing (? day 5 forward), diarrhea (? day 5 forward), sore throat (? day 5 forward) vomit (day 7). Symptoms of chills and miserable feeling increased day 4 on. Tylenol, Albuterol on day 6, Day 8 hospitalized, antibiotics and oxygen, Sepsis and shock, less than one day in hospital - passed on 3/2/21 am.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
2/26/21 UrgentCare: Flu test - neg, Covid-19 test - neg, Chest xray - normal ? 2/28/21 UrgentCare: Urine test - neg, BMP=abnormal: 105H glucose, 134L sodium, 8.3L calcium CBC=ab. CBC=abnormal: 122L platelet count 3/1/2021 HOSPITAL Chest Xray - diffuse patch opacities, moderate central and lower lung predominant opacity which could reflect pneumonia, acute edema might have this appearance however there is no cardiac enlargement or pleural effusion to etiology; CTA chest - Mildly limited at detailed in xray, no pulmonary embolism found, moderate diffuse interlobular septal thickening and patch lung opacity, this could reflect alveolar and interstitial edema or pneumonia, small bilateral pleural effusions, mild mediastinal adenopathy, possible hilar adenopathy, and mild left axillary adenopathy; CBCwDif=abnormal RBC 6.16H, Hemoglobin 18.5H, Hematocrit 54.9H, Platelets 73L, Monocytes Absolute .96, BMP=abnormal Sodium 129L, Choride 95L, Calcium 8.3L, Glucose 150H; UAwMicro=abnormal 100 protein; D-Dimer Quant=abnormal 1.52; Troponin I=normal, B-type natriuretic peptide=normal, POC Covid-19 test=negative, Molecular, ABBOTT ID Now; Procalcitonin ?; Leionella=neg; Pneumococcal antigen=neg; Strep Pneomo antigen urine=neg
Aktuelle Erkrankungen
Possible illness 2 days prior to vaccine - achey from golf/pil. Thought achey from golf and pilates possibly. Stress. High Cholesterol.
Vorgeschichte
High Cholesterol
Andere Medikamente
Zyrtec 10mg, CBD Oil Thoughtcloud Sublingual
Allergien
seasonal and pollens/trees/grasses
Vorherige Impfungen
-

VAERS 1358766

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MD
Alter
27,0
Geschlecht
M
Eingang
28.05.2021
Impfdatum
26.03.2021
Beginn
21.05.2021
Tage bis Beginn
56,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Angiogram retina abnormal Arterial catheterisation abnormal Arterial occlusive disease Cerebral artery thrombosis Cerebrovascular accident Chest X-ray Computerised tomogram Computerised tomogram head Echocardiogram Intensive care Magnetic resonance imaging head abnormal Retinal artery thrombosis Scan with contrast Thrombectomy Ultrasound Doppler Urine analysis

Symptomtext

Stroke - Blood Clot in M2 Brain Artery Friday, May 21, 2021 - Air lifted from Hospital to Hospital Admitted to Neuroradiology Dept and immediate Thrombectomy to remove blood clot behind left eye via angiogram through the groin via catheter. Proceedure was sucessful in removing 100% blocked artery and he was transfered to Resovery, observation and follow-on diagnostic testing in ICU for 4 days. Discharged May 24, 2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
4,0
Labordaten
Measurements, Vital Signs, Hematology, Urinalysis, CT Scan of Head, CT Scan w/ Contrast, Chest Xray, Ultrasound of Heart and legs, MRI of Brain
Aktuelle Erkrankungen
-
Vorgeschichte
Learning Disability
Andere Medikamente
50mg Fluvoxamine Maleate 1X/day, Multi-Vitamin
Allergien
Shellfish
Vorherige Impfungen
-

VAERS 1355301

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
OR
Alter
76,0
Geschlecht
F
Eingang
27.05.2021
Impfdatum
17.04.2021
Beginn
24.04.2021
Tage bis Beginn
7,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Acute myocardial infarction Angiocardiogram Arteriogram coronary abnormal Chest pain Coronary artery disease Echocardiogram Magnetic resonance imaging heart Myocarditis Troponin increased

Symptomtext

Acute Myocarditis

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
7,0
Labordaten
"Patient initially presenting with recurrent atypical chest pain, now third episode in the past week with similar presenting symptoms. Recently hospitalized for suspected non-ST elevation myocardial infarction, with coronary angiogram at that time demonstrating nonobstructive coronary artery disease (4/2021). Readmitted 4/27/2021 with recurrent chest pain and started on antianginal therapy with sublingual nitroglycerin and isosorbide mononitrate which were ineffective, subsequently resulting in current readmission (4/29/2021). Given mild persistent troponin elevation (200s), cardiology consultation was obtained. Repeat TTE (4/30/2021) demonstrating interval improvement in ejection fraction with resolution of previously demonstrated wall motion abnormalities, EF now 65%. Cardiac MRI was obtained which demonstrated abnormal T1 and T2 signal changes in the left ventricle consistent with myocarditis, notably no washing abnormalities were present. Per cardiology, likely resolving viral myocarditis. No further cardiac risk ratification indicated at this time. Cardiology advised symptomatic management of intermittent chest pain with hydrocodone/acetaminophen and avoidance of nonsteroidal medications. Patient was extensively counseled on the etiology of her chest pain, with emphasis on reassuring findings from recent coronary angiogram and cardiac MRI that chest pain DOES NOT appear to be due to acute coronary syndrome/ischemic heart disease. Sublingual nitroglycerin and ISMN were discontinued, and she was restarted on prior dose losartan for GDMT given nonischemic cardiomyopathy." "? CMR 4/30/21: 1. Abnormal T1 and T2 signal changes in the left ventricle with at least one focus of subepicardial enhancement involving the mid inferolateral segment, compatible with myocarditis. There are no wall motion abnormalities on the current exam to suggest stress cardiomyopathy. 2. Normal LV systolic function, ejection fraction 67%. "
Aktuelle Erkrankungen
toe amputation 4/9/2021
Vorgeschichte
Metastatic breast cancer s/p R lumpectomy, chemotherapy, radiation tx SCC of right middle lung NSTEMI 8/2019: ? Requiring admission 8/2019 ? TTE 8/11/19: Normal LV function, EF 65%, elevated left atrial pressure and grade II left ventricular diastolic dysfunction. ? Coronary angiography 8/12/19: mild, calcific disease in proximal LAD, at most 30% in severity, and 40% narrowing of first diagonal. No lesions that would not explain NSTEMI ? *Current admission (4/24/2021) - coronary angiogram without evidence of obstructive CAD* CVA due to transverse sinus thrombosis - Anticoagulated: previously on warfarin -- > now on rivaroxaban Anxiety Depression HLD HTN Hypothyroidism
Andere Medikamente
ALPRAZolam (XANAX) 0.5 mg tablet TAKE 1 TABLET BY MOUTH ONCE TO TWICE DAILY AS NEEDED FOR SEVERE ANXIETY aspirin 325 mg tablet Take 325 mg by mouth Daily. atorvaSTATin (LIPITOR) 20 mg tablet TAKE 1 TABLET BY MOUTH EVERY NIGHT cholecalcifero
Allergien
morphine
Vorherige Impfungen
-

VAERS 1354959

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
GA
Alter
80,0
Geschlecht
M
Eingang
27.05.2021
Impfdatum
04.03.2021
Beginn
05.05.2021
Tage bis Beginn
62,0
Dosis
1
Route/Site
SYR / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Ageusia Anosmia COVID-19 COVID-19 pneumonia Death Decreased appetite Malaise Myalgia Pain Vaccine breakthrough infection

Symptomtext

Muscle ache, loss of smell and taste The PUI started feeling ill on 4/29/21 with minor symptoms. The patient is having body aches and a loss of appetite due to his loss of taste/smell. The patient is currently undergoing chemo therapy and is most likely the reason why he still got sick with COVID-19 even though he is fully vaccinated. Cause of Death: ACUTE HYPOXIC RESPIRATORY FAILURE, COVID 19 PNEUMONIA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Cancer: patient was receiving chemotherapy
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1350572

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MD
Alter
81,0
Geschlecht
M
Eingang
26.05.2021
Impfdatum
01.03.2021
Beginn
30.04.2021
Tage bis Beginn
60,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute myocardial infarction Anticoagulant therapy Coronary arterial stent insertion Dyspepsia Ejection fraction decreased Electrocardiogram abnormal Intensive care

Symptomtext

Patient brought to ED due to what he described as indigestion not improving over time. Diagnosed with ST elevation MI on EKG. 4 stents were placed in the RCA, EF at 50%. Given Brilenta and admitted to ICU. Discharged and placed on atorvastatin and ticagrelor.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1330837

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
37,0
Geschlecht
F
Eingang
19.05.2021
Impfdatum
16.03.2021
Beginn
11.05.2021
Tage bis Beginn
56,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Complication of pregnancy Exposure during pregnancy Foetal death

Symptomtext

Patient had an intrauterine fetal demise at 36 4/7 weeks. Most likely unrelated but want it reported that she had vaccine during pregnancy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Foetal death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Pregnancy
Vorgeschichte
Asthma, Endometriosis
Andere Medikamente
Vitamin B12, Prenatal Vitamins, Sertraline , Albuterol Sulfate
Allergien
Shellfish
Vorherige Impfungen
-

VAERS 1213047

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
PA
Alter
68,0
Geschlecht
F
Eingang
19.05.2021
Impfdatum
02.03.2021
Beginn
14.03.2021
Tage bis Beginn
12,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Abdominal X-ray Acute respiratory failure Alanine aminotransferase increased Aortic arteriosclerosis Aspartate aminotransferase increased Ageusia Anosmia Arthralgia COVID-19 Chills Asthenia Blood alkaline phosphatase increased Blood bilirubin normal Blood calcium normal Blood chloride increased Blood creatinine normal Blood potassium increased Blood sodium increased

Symptomtext

ED to Hosp-Admission Discharged 3/14/2021 - 4/14/2021 (31 days) Hospital Physician Last attending ? Treatment team Severe sepsis (/HCC) Principal problem Discharge Summary MD (Physician) ? ? Internal Medicine HOSPITAL INPATIENT DISCHARGE SUMMARY HOSPITALIST GROUP . Patient: Date: 4/14/2021 Admission Date: 3/14/2021 Length of stay: 31 Days PCP: PA Discharging provider: MD Admission diagnosis: Primary Admission Diagnosis Hospital Problems POA * (Principal) Severe sepsis (/HCC) Yes Shortness of breath Yes Acute respiratory failure with hypoxemia (/HCC) Yes 2019 novel coronavirus?infected pneumonia (NCIP) Yes Elevated liver enzymes Yes Hyponatremia Yes Hypothyroidism Yes Essential hypertension Yes Hyperlipidemia Yes Disposition: Patient Expired on 4/13/2021 at 23:25 _ Hospital Course HPI: patient is a 68 y.o. female presented with covid pneumonia complicated with pneumomediastinum and pneumothorax Severe sepsis POA complicated by acute hypoxic respiratory failure, cytokine release syndrome, Covid pneumonia with superimposed bacterial PNA Complicated by pneumomediastinum, subcutaneous emphysema on 3/29 Right apical pneumothorax Status post ant.chest tube insertion 4/4 and lateral chest tube insertion 4/6, Completed Remdesivir therapy and is on Decadron. Completed 8 days of Cefepime for superimposed bacterial infection. Hyperglycemia without DM2 ICU Acquired Weakness Hypothyroidism HL HTN Patient was placed on comfort measures on 4/13/21. Family was at bedside including husband, son, daughter, and sister. Morphine gtt was infusing up until the patient passed at 2325. The patient appeared to be resting comfortably with no signs of pain or respiratory distress. The patient stopped breathing and this RN was called to the bedside around 1120. She was pronounced at 1125 4/13/21. Family was at bedside. Funeral home was notified and the body was sent to the morgue. _

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
31,0
Labordaten
03/14/21 2148 Respiratory virus detection panel Collected: 03/14/21 2048 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result DetectedCritical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Synctial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected LABORATORY: CBC: Results from last 7 days Lab Units 04/13/21 0536 04/12/21 0509 04/11/21 0552 04/10/21 0421 04/09/21 0512 04/08/21 0510 WBC AUTO K/mcL 10.9 13.4* 13.1* 11.4* 11.0 8.6 HEMOGLOBIN g/dL 15.1 15.3 16.6* 15.8* 14.5 15.1 HEMATOCRIT % 49.5* 51.2* 53.5* 49.7* 44.7 46.1 PLATELETS K/mcL 200 226 203 227 207 174 NEUTROS PCT AUTO % -- -- -- 89 91 94 LYMPHS PCT AUTO % -- -- -- 4 4 4 MONOS PCT AUTO % -- -- -- 5 3 1 EOS PCT AUTO % -- -- -- 0 0 0 CHEMISTRY: Results from last 7 days Lab Units 04/13/21 0536 04/12/21 0509 04/11/21 0552 SODIUM mmol/L 151* 149* 146* POTASSIUM mmol/L 5.2 5.0 5.1 CHLORIDE mmol/L 110* 110* 110* CO2 mmol/L 37* 34* 24 BUN mg/dL 48* 61* 59* CREATININE mg/dL 0.67 0.87 0.79 CALCIUM mg/dL 9.8 9.4 9.6 TOTAL PROTEIN gm/dL 6.1* 5.8* 6.5 BILIRUBIN TOTAL mg/dL 0.6 0.7 0.8 ALK PHOS IU/L 319* 298* 238* ALT IU/L 95* 88* 50 AST IU/L 50* 81* 45* COAGULATION: OTHER TESTS: 0 Lab Value Date/Time TROPONINI <0.03 03/20/2021 1217 TROPONINI <0.03 03/20/2021 0827 TROPONINI <0.03 03/15/2021 0331 TROPONINI <0.03 03/15/2021 0021 TROPONINI <0.03 03/14/2021 2145 TROPONINI <0.03 03/14/2021 1935 IMAGING: X-ray Abdomen 1 View Result Date: 4/9/2021 Single view portable KUB INDICATION: Feeding tube placement, encounter initial Supine portable view of the lower chest and abdomen demonstrates weighted KO feeding tube with tip in the distal stomach. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Ct Chest Without Contrast Result Date: 3/29/2021 CT CHEST WO CONTRAST IMPRESSION: Worsened bilateral groundglass opacification and basilar patchy airspace consolidation. Findings are consistent with the history of Covid 19. Extensive pneumomediastinum and bilateral subcutaneous emphysema in the chest and neck. END OF IMPRESSION: INDICATION: Cough. Shortness of breath. TECHNIQUE: CT scan of the chest was performed in the axial plane. Sagittal and coronal reconstructions were reviewed. Automatic exposure controls were employed. Number of CT scans in the previous 12 months: 1 CONTRAST: No contrast was administered. COMPARISON: CT scan 3/14/2021. Chest x-ray 3/29/2021. FINDINGS: There are large areas of groundglass opacification bilaterally in the upper and lower lobes. There is some patchy consolidation seen in the inferior aspect of both lungs. These findings were present on the prior examination but have mildly increased in severity. There is no effusion or pneumothorax. There is extensive pneumomediastinum. There is a large degree of subcutaneous emphysema and the neck and chest. The heart is normal size. There is no pericardial effusion. The thoracic aorta is normal caliber. There is moderate atherosclerotic calcification. The pulmonary arteries normal caliber. There is no adenopathy. The pancreas is atrophic. There is mild calcification of the upper abdominal aorta. The osseous structures are normally mineralized. There are mild degenerative changes of the thoracic spine. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/13/2021 Single view portable chest INDICATION: Right pneumothorax, pneumonia, encounter initial Frontal portable chest film compared to prior similar study from 4/12/2021. Right thoracostomy tube remains in satisfactory position. Small, less than 5% loculated right lateral pneumothorax. Nasogastric tube is unchanged with tip in the distal stomach. Unchanged bilateral pneumonia, cardiac contours, and osseous structures. IMPRESSION: Less than 5%, loculated right lateral pneumothorax, unchanged from prior. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/12/2021 Chest radiograph HISTORY: Pneumothorax. Covid 19 infection. Comments: Frontal radiograph of the chest was obtained and compared to the prior study dated 4/11/2021. The heart is enlarged. The mediastinum is within normal limits. There is a small right pneumothorax. Right-sided chest tube is seen in place. Interstitial alveolar opacities are noted in the bilateral lungs probably due to pneumonia which were also seen in the prior study. There is a Dobbhoff feeding tube with the distal end in the region of the stomach. The osseous structures are stable. IMPRESSION: 1. Small right pneumothorax with right-sided chest tube. 2. Persistent bilateral interstitial alveolar opacities. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/11/2021 XR CHEST 1 VW PORT IMPRESSION: 1 right-sided chest tube in place. There is a tiny right apical pneumothorax. END OF IMPRESSION: INDICATION: PTX, COVID, chest tube PTX, COVID, chest tube. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: X-ray 4/10/2021. FINDINGS: 1 right-sided chest tube is been removed. One chest tube remains. There is a tiny right apical pneumothorax. There is continued bilateral patchy airspace consolidation. Cardiac silhouette is normal size. This calcification of the aorta. The Dobbhoff tube is unchanged. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/10/2021 XR CHEST 1 VW PORT IMPRESSION: Right pneumothorax is not appreciated. No change in the bilateral airspace consolidation. END OF IMPRESSION: INDICATION: PTX, ARDS. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: X-ray 4/9/2021, 4/8/2021. FINDINGS: There are 2 right-sided chest tubes. No right pneumothorax is appreciated. There is diffuse bilateral patchy airspace consolidation. No significant change. The cardiac silhouette is normal size. This calcification of the aorta. There is a nasogastric tube passing beneath the diaphragm. The tip is not included on the study. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/9/2021 XR CHEST 1 VW INDICATION: PTX, ARDS. Encounter: Subsequent. TECHNIQUE: AP portable semierect projection of the chest is acquired. COMPARISON: Yesterday. FINDINGS: No significant change. Very small persistent right pleural effusion. Stable thoracostomy tubes. Stable extensive pulmonary infiltrates. No change in the heart or mediastinum. IMPRESSIONS: No significant change. END OF IMPRESSION: This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/8/2021 Single view portable chest INDICATION: Right pneumothorax, pneumonia, encounter initial Frontal portable chest film compared to prior similar study from 4/7/2021. Right thoracostomy tubes are stable in position. Recurrent 15% right pneumothorax is noted. No mediastinal shift. Unchanged bilateral pneumonia, cardiac contours, and osseous structures. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/7/2021 Single view portable chest INDICATION: Pneumothorax, ARDS, encounter initial Frontal portable chest film compared to prior similar study from 4/6/2021. Tandem right thoracostomy tubes remain in satisfactory position. No identifiable right pneumothorax. Unchanged bilateral pneumonia, cardiac contours, and osseous structures. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/6/2021 XR CHEST 1 VW PORT INDICATION: chest tube placement. Encounter: Subsequent. TECHNIQUE: AP portable projection of the chest is acquired. COMPARISON: None available. FINDINGS: There is a slight reduction in the still present and still very small right pneumothorax. The prior and a new thoracostomy tube is seen. No change in the extensive pulmonary infiltrates. END OF IMPRESSION: This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/6/2021 XR CHEST 1 VW PORT INDICATION: PTX. Encounter: Subsequent. TECHNIQUE: AP portable erect projection of the chest is acquired. COMPARISON: 6 hours earlier. FINDINGS: No significant change. Stable small right pneumothorax, stable thoracostomy tube. Stable bilateral pulmonary infiltrates. END OF IMPRESSION: This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/6/2021 XR CHEST 1 VW PORT IMPRESSION: Right-sided chest tube in place with small right pneumothorax. This is decreased in size. No significant change in the appearance of the bilateral airspace consolidation. END OF IMPRESSION: INDICATION: PTX, s/p change in sxn and patient reposition. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: X-ray 4/6/2021. FINDINGS: There is a right-sided chest tube in place. There is a small right pneumothorax along the lateral aspect of the right chest and in the right lung apex. There is continued bilateral hazy airspace opacification with patchy consolidation inferiorly. There is no effusion. The cardiac silhouette is top normal size. There is calcification of the aorta. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/6/2021 Single view portable chest INDICATION: Right pneumothorax, encounter initial Frontal portable chest film compared to prior similar study from earlier 4/6/2021. Right thoracostomy tube remains in satisfactory position. Now identified is enlargement of right pneumothorax now approximately 30% magnitude with associated right lung atelectasis. No mediastinal shift. Unchanged bilateral parenchymal infiltrates consistent with pneumonia. No effusion. No left pneumothorax. Unchanged cardiac contours and osseous structures. IMPRESSION: Interval expansion of right pneumothorax, now on the order of 30%. No mediastinal shift. Unchanged bilateral pneumonia. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/6/2021 Single view portable chest INDICATION: Pneumothorax, ARDS, encounter initial Frontal portable chest film compared to prior similar study from 4/5/2021. Right thoracostomy tube has pulled back, however, remains within the chest. 10% right apical pneumothorax is noted. Diffuse bilateral infiltrates, cardiac contours, and the osseous structures are stable. No left pneumothorax. No mediastinal shift. IMPRESSION: 10% right apical pneumothorax with right thoracostomy tube remaining in satisfactory position. Diffuse bilateral pneumonia/ARDS. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/5/2021 XR CHEST 1 VW PORT IMPRESSION: Right chest tube in place with barely discernible right apical pneumothorax decreased in size from prior. Unchanged airspace consolidation. END OF IMPRESSION: INDICATION: Right apical pneumothorax, Covid pneumonia follow-up. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: X-ray 4/4/2021. FINDINGS: There is a right-sided chest tube in place. No change in position. There is a minimal, barely discernible right apical pneumothorax decreased in size from prior study. There is continued patchy consolidation seen in the mid and lower segments of both lungs. There is hazy bilateral interstitial prominence. The cardiac silhouette is top normal size. There is calcification of the aorta. The trachea is midline. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/4/2021 XR CHEST 1 VW PORT IMPRESSION: Bilateral pulmonary airspace disease. Right chest tube placement and diminished but residual right apical pneumothorax. END OF IMPRESSION: INDICATION: rt chest tube placement. TECHNIQUE: Portable AP projection of the chest is acquired. COMPARISON: 4/4/2021 FINDINGS: Bilateral pulmonary infiltrative changes are again demonstrated. Right chest tube has been placed and the pneumothorax is diminished. Aortic atherosclerosis is again noted. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/4/2021 XR CHEST 1 VW PORT IMPRESSION: Enlarging right pneumothorax. END OF IMPRESSION: INDICATION: right apical pneumothorax. TECHNIQUE: Portable AP projection of the chest is acquired. COMPARISON: 4/4/2021 earlier FINDINGS: Right apical pneumothorax is enlarging. Other findings remain stable. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/4/2021 XR CHEST 1 VW PORT IMPRESSION: Bilateral pulmonary consolidation. Mild right apical pneumothorax. END OF IMPRESSION: INDICATION: Right apical pneumothorax, Covid pneumonia follow-up. TECHNIQUE: Portable AP projection of the chest is acquired. COMPARISON: 4/3/2021 FINDINGS: There is apical pneumothorax, clearly defined. Left lung consolidation is unchanged. Right lung consolidation is also stable. Diffuse bilateral pulmonary consolidation is again demonstrated. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/3/2021 XR CHEST 1 VW PORT IMPRESSION: Diffuse bilateral pulmonary alveolar disease. END OF IMPRESSION: INDICATION: Right apical pneumothorax, Covid pneumonia follow-up. TECHNIQUE: Portable AP projection of the chest is acquired. COMPARISON: 4/2/2021 FINDINGS: Heart size appears unremarkable. There is atherosclerosis of the aorta. There is diffuse bilateral mid and lower lung pulmonary opacification. No definite effusion is present at this difficult to exclude. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/2/2021 Chest radiograph HISTORY: Right apical pneumothorax. Comments: Frontal radiograph of the chest was obtained and compared to the prior study dated 4/2/2021. The heart and mediastinum remain stable. Airspace disease is identified in the bilateral mid to lower lungs. There is interstitial thickening identified bilaterally. A small right apical pneumothorax is again noted. This is not significantly changed. The osseous structures are stable. IMPRESSION: 1. Interstitial alveolar opacities in the bilateral lungs consistent with the patient's known pneumonia which is not significantly changed. 2. Unchanged right apical pneumothorax. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/2/2021 Single view portable chest INDICATION: Covid pneumonia, pneumothorax, encounter initial Frontal portable chest film compared to prior similar study from 4/1/2021 as well as CT chest from 3/29/2021. Mild interval expansion small, 20-30% right pneumothorax. Subcutaneous emphysema and pneumomediastinum are improved. No left pneumothorax. No mediastinal shift. Bilateral pneumonia has improved. Unchanged cardiac contours and osseous structures. IMPRESSION: Slight interval expansion of right pneumothorax now on the order of 20-30%. No mediastinal shift. Improved pneumonia. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/1/2021 XR CHEST 1 VW PORT INDICATION: evaluation of subcutaneous emphysema and pneumonia.. Encounter: Subsequent. TECHNIQUE: AP portable erect projection of the chest is acquired. COMPARISON: Yesterday. FINDINGS: The nuchal subcutaneous emphysema as well as pneumomediastinum and pneumopericardium appear relatively stable. The amount of chest wall air appears slightly less. Extensive pulmonary infiltrates are present, waxing and waning, now slightly improved on the left and slightly denser on the right. IMPRESSIONS: No significant change. Waxing and waning infiltrates. END OF IMPRESSION: This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 3/31/2021 Single view portable chest INDICATION: Pneumonia, pneumomediastinum, encounter initial Frontal portable chest film compared to prior similar study from 3/30/2021. Subcutaneous emphysema continues to improve. Pneumomediastinum is no longer evident. No pneumothorax. Bilateral pneumonia, cardiac contours, and the osseous structures are stable. IMPRESSION: Continued improvement of subcutaneous emphysema and pneumomediastinum. Unchanged bilateral diffuse pneumonia. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 3/30/2021 Single view portable chest INDICATION: Pneumonia, pneumomediastinum, encounter initial Frontal portable chest compared to prior similar study from 3/29/2021. Improved bilateral subcutaneous emphysema and pneumomediastinum. Lungs again demonstrate diffuse bilateral infiltrates without effusion. No pneumothorax. Unchanged cardiac contours and osseous structures. IMPRESSION: Improved subcutaneous emphysema and pneumomediastinum. Unchanged pneumonia. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 3/29/2021 Single view portable chest INDICATION: Covid pneumonia, encounter initial Frontal portable chest film compared to prior similar study from 3/26/2021. Now identified is evidence of subcutaneous emphysema at the right lateral greater than left lateral chest. In addition, small bilateral, less than 10% pneumothoraces are suspected. Bilateral pneumonia is unchanged. No effusion, pneumothorax, or congestive failure. Normal size heart. No acute interval osseous finding. Above critical findings personally communicated to the referring pulmonologist at the close of this dictation. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 3/26/2021 XR CHEST 1 VW PORT IMPRESSION: No significant change in the bilateral airspace consolidation. END OF IMPRESSION: INDICATION: worsening hypoxemia, covid. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: X-ray 3/20/2021. FINDINGS: There is patchy consolidation and glass opacification seen in the mid and lower portions of both lungs. The findings are not significantly changed from prior. There is no effusion or pneumothorax. The cardiac silhouette is normal size. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 3/20/2021 XR CHEST 1 VW PORT INDICATION: f/u worsened hypoxia. Encounter: Initial. TECHNIQUE: AP portable erect projection of the chest is acquired. COMPARISON: 3/14/2021. FINDINGS: No significant change. Fairly extensive bilateral lower lobe infiltrates. No change in the heart, mediastinum, or bony thorax. IMPRESSIONS: No significant change. END OF IMPRESSION: This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Transthoracic Echo (tte) Complete Result Date: 4/7/2021 Patient Name: patient Gender: Female Age: 68 Procedure Date: 4/7/2021 01:16 PM Location: Hospital Room Study Quality: Fair Ht / Wt / BSA: 62.00 in / 193.00 lb / 1.88 m2 Heart Rate: 105 bpm BP: 124 / 58 mmHg Sonographer: Referring MD: Indications: Pulmonary Hypertension Transthoracic 2D, Color Flow, and Doppler Echocardiogram Conclusions: The visually estimated ejection fraction is 55-60% (normal range 50-70%). There is moderate tricuspid valve regurgitation by color flow and doppler analysis. The pulmonary artery systolic pressure is 46.00 mmHg. No prior study for comparison. Presentation and History: Indication: The patient presents for evaluation of pulmonary hypertension. The patient has a history of hypertension, dyslipidemia, obesity, and previous tobacco use. Findings: Procedure Information: Contrast agent, definity, is being given per protocol without apparent complications. Due to technical limitations in the assessment of the left ventricle, imaging was performed after the administration of intravenous Definity echocontrast, as per protocol. Left Ventricle: Normal left ventricular size and systolic function. The visually estimated ejection fraction is 55-60% (normal range 50-70%). Doppler findings are consistent with grade I diastolic function. Impaired relaxation with normal filling pressures. Wall Motion: All wall segments showed normal motion. Right Ventricle: Normal right ventricular cavity size and systolic function. Atria: Both atria are normal in size. Aortic Valve: There is mild thickening of the aortic valve. There is trace (trivial) aortic valve regurgitation by color flow and doppler analysis. Mitral Valve: There is mild thickening in both mitral valve leaflets. There is trace mitral valve regurgitation by color flow and doppler analysis. Pulmonic Valve: Normal pulmonic valve structure and function. There is no evidence of pulmonic valve stenosis or insufficiency by color flow and doppler analysis. Tricuspid Valve: Normal tricuspid valve structure. There is moderate tricuspid valve regurgitation by color flow and doppler analysis. The pulmonary artery systolic pressure is 46.00 mmHg. Great Vessels: All visible segments of the aorta are normal in size. Venous: The inferior vena cava is normal in size. Pericardium/Pleural: There is no evidence of pericardial effusion. Prior Study Comparison: No prior study for comparison. Measurements: Left Ventricle: Ao Root: 3.00 cm (2.1-3.5) LA Diam: 3.30 cm (2.7-3.8/3.0-4.0) LAIDs Index: 1.76 cm/m2 (1.5-2.3) LVOT Diam: 1.90 cm (3.0+(-)1.3) LVOT Pk Vel: 1.05 LVOT Mn Vel: 0.62 LVOT VTI: 0.19 LVOT Pk Grad: 4.00 LVOT Mn Grad: 2.00 LVOT Diam: 1.90 LVOT Area: 2.84 MV Pk E: 0.48 MV Pk A: 0.81 E/A: 0.60 E'Medial: 3.70 E/E' Med: 13.00 E' Laterial: 4.68 E/E' Lat: 10.30 Mitral Valve: MV Pk E: 0.48 MV PK A: 0.81 MV Decel Time: 158.00 E/A: 0.60 E'Lateral: 4.68 E'Medial: 3.70 E/E' Med: 13.00 E/E' Lat: 10.30 Aortic Valve: AoV Pk Vel: 1.21 AoV Pk Grad: 6.00 Tricuspid Valve: TR Pk Vel: 2.99 TR Pk Grad: 36.00 RA Press: 10.00 RVSP: 46.00 Pulmonary Artery Systolic Pressure: 46.00 Great Vessels: Ao Root-2D: 3.00 cm (2.0-3.7) Updated by on 4/7/2021 2:14:15 PM with Status of Final electronically signed on 4/7/2021 2:14:15 PM with status of Final Ultrasound Lower Extremity Venous Bilateral Result Date: 3/31/2021 US LOWER EXTREMITY VENOUS BILATERAL IMPRESSION: No evidence of DVT. END OF IMPRESSION: INDICATION: r/o dvt. Encounter: Initial. TECHNIQUE: Multiple longitudinal and transverse 2D real-time ultrasound images were performed from groin to knee, and at the calf and ankle. Color and grayscale and duplex Doppler imaging was also performed. Permanently recorded images were obtained and stored. COMPARISON: None available. FINDINGS: No evidence of deep venous thrombosis. On each side, there is normal flow, compressibility and augmentation in the common femoral, greater saphenous, superficial and deep femoral veins and popliteal veins. There is also normal flow, compressibility and augmentation in the posterior tibial veins, peroneal veins and small saphenous veins in the calves. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient.
Aktuelle Erkrankungen
-
Vorgeschichte
Respiratory Shortness of breath Acute respiratory failure with hypoxemia (/HCC) 2019 novel coronavirus?infected pneumonia (NCIP) Circulatory Essential hypertension Endocrine/Metabolic Hyponatremia Hypothyroidism Hyperlipidemia Immune Severe sepsis (/HCC) Other Elevated liver enzymes
Andere Medikamente
calcium carbonate (CALCIUM 500) 500 mg calcium (1,250 mg) chewable tablet levothyroxine (SYNTHROID, LEVOTHROID) 150 mcg tablet meclizine (ANTIVERT) 12.5 mg tablet metoprolol tartrate (LOPRESSOR) 25 mg tablet mometasone (NASONEX) 50 mcg/actu
Allergien
CiprofloxacinDiarrhea Sulfa (Sulfonamide Antibiotics)Rash
Vorherige Impfungen
-

VAERS 1213047

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
PA
Alter
68,0
Geschlecht
F
Eingang
19.05.2021
Impfdatum
02.03.2021
Beginn
14.03.2021
Tage bis Beginn
12,0
Dosis
1
Route/Site
SYR / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Abdominal X-ray Acute respiratory failure Alanine aminotransferase increased Aortic arteriosclerosis Aspartate aminotransferase increased Ageusia Anosmia Arthralgia COVID-19 Chills Asthenia Blood alkaline phosphatase increased Blood bilirubin normal Blood calcium normal Blood chloride increased Blood creatinine normal Blood potassium increased Blood sodium increased

Symptomtext

ED to Hosp-Admission Discharged 3/14/2021 - 4/14/2021 (31 days) Hospital Physician Last attending ? Treatment team Severe sepsis (/HCC) Principal problem Discharge Summary MD (Physician) ? ? Internal Medicine HOSPITAL INPATIENT DISCHARGE SUMMARY HOSPITALIST GROUP . Patient: Date: 4/14/2021 Admission Date: 3/14/2021 Length of stay: 31 Days PCP: PA Discharging provider: MD Admission diagnosis: Primary Admission Diagnosis Hospital Problems POA * (Principal) Severe sepsis (/HCC) Yes Shortness of breath Yes Acute respiratory failure with hypoxemia (/HCC) Yes 2019 novel coronavirus?infected pneumonia (NCIP) Yes Elevated liver enzymes Yes Hyponatremia Yes Hypothyroidism Yes Essential hypertension Yes Hyperlipidemia Yes Disposition: Patient Expired on 4/13/2021 at 23:25 _ Hospital Course HPI: patient is a 68 y.o. female presented with covid pneumonia complicated with pneumomediastinum and pneumothorax Severe sepsis POA complicated by acute hypoxic respiratory failure, cytokine release syndrome, Covid pneumonia with superimposed bacterial PNA Complicated by pneumomediastinum, subcutaneous emphysema on 3/29 Right apical pneumothorax Status post ant.chest tube insertion 4/4 and lateral chest tube insertion 4/6, Completed Remdesivir therapy and is on Decadron. Completed 8 days of Cefepime for superimposed bacterial infection. Hyperglycemia without DM2 ICU Acquired Weakness Hypothyroidism HL HTN Patient was placed on comfort measures on 4/13/21. Family was at bedside including husband, son, daughter, and sister. Morphine gtt was infusing up until the patient passed at 2325. The patient appeared to be resting comfortably with no signs of pain or respiratory distress. The patient stopped breathing and this RN was called to the bedside around 1120. She was pronounced at 1125 4/13/21. Family was at bedside. Funeral home was notified and the body was sent to the morgue. _

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
31,0
Labordaten
03/14/21 2148 Respiratory virus detection panel Collected: 03/14/21 2048 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result DetectedCritical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Synctial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected LABORATORY: CBC: Results from last 7 days Lab Units 04/13/21 0536 04/12/21 0509 04/11/21 0552 04/10/21 0421 04/09/21 0512 04/08/21 0510 WBC AUTO K/mcL 10.9 13.4* 13.1* 11.4* 11.0 8.6 HEMOGLOBIN g/dL 15.1 15.3 16.6* 15.8* 14.5 15.1 HEMATOCRIT % 49.5* 51.2* 53.5* 49.7* 44.7 46.1 PLATELETS K/mcL 200 226 203 227 207 174 NEUTROS PCT AUTO % -- -- -- 89 91 94 LYMPHS PCT AUTO % -- -- -- 4 4 4 MONOS PCT AUTO % -- -- -- 5 3 1 EOS PCT AUTO % -- -- -- 0 0 0 CHEMISTRY: Results from last 7 days Lab Units 04/13/21 0536 04/12/21 0509 04/11/21 0552 SODIUM mmol/L 151* 149* 146* POTASSIUM mmol/L 5.2 5.0 5.1 CHLORIDE mmol/L 110* 110* 110* CO2 mmol/L 37* 34* 24 BUN mg/dL 48* 61* 59* CREATININE mg/dL 0.67 0.87 0.79 CALCIUM mg/dL 9.8 9.4 9.6 TOTAL PROTEIN gm/dL 6.1* 5.8* 6.5 BILIRUBIN TOTAL mg/dL 0.6 0.7 0.8 ALK PHOS IU/L 319* 298* 238* ALT IU/L 95* 88* 50 AST IU/L 50* 81* 45* COAGULATION: OTHER TESTS: 0 Lab Value Date/Time TROPONINI <0.03 03/20/2021 1217 TROPONINI <0.03 03/20/2021 0827 TROPONINI <0.03 03/15/2021 0331 TROPONINI <0.03 03/15/2021 0021 TROPONINI <0.03 03/14/2021 2145 TROPONINI <0.03 03/14/2021 1935 IMAGING: X-ray Abdomen 1 View Result Date: 4/9/2021 Single view portable KUB INDICATION: Feeding tube placement, encounter initial Supine portable view of the lower chest and abdomen demonstrates weighted KO feeding tube with tip in the distal stomach. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Ct Chest Without Contrast Result Date: 3/29/2021 CT CHEST WO CONTRAST IMPRESSION: Worsened bilateral groundglass opacification and basilar patchy airspace consolidation. Findings are consistent with the history of Covid 19. Extensive pneumomediastinum and bilateral subcutaneous emphysema in the chest and neck. END OF IMPRESSION: INDICATION: Cough. Shortness of breath. TECHNIQUE: CT scan of the chest was performed in the axial plane. Sagittal and coronal reconstructions were reviewed. Automatic exposure controls were employed. Number of CT scans in the previous 12 months: 1 CONTRAST: No contrast was administered. COMPARISON: CT scan 3/14/2021. Chest x-ray 3/29/2021. FINDINGS: There are large areas of groundglass opacification bilaterally in the upper and lower lobes. There is some patchy consolidation seen in the inferior aspect of both lungs. These findings were present on the prior examination but have mildly increased in severity. There is no effusion or pneumothorax. There is extensive pneumomediastinum. There is a large degree of subcutaneous emphysema and the neck and chest. The heart is normal size. There is no pericardial effusion. The thoracic aorta is normal caliber. There is moderate atherosclerotic calcification. The pulmonary arteries normal caliber. There is no adenopathy. The pancreas is atrophic. There is mild calcification of the upper abdominal aorta. The osseous structures are normally mineralized. There are mild degenerative changes of the thoracic spine. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/13/2021 Single view portable chest INDICATION: Right pneumothorax, pneumonia, encounter initial Frontal portable chest film compared to prior similar study from 4/12/2021. Right thoracostomy tube remains in satisfactory position. Small, less than 5% loculated right lateral pneumothorax. Nasogastric tube is unchanged with tip in the distal stomach. Unchanged bilateral pneumonia, cardiac contours, and osseous structures. IMPRESSION: Less than 5%, loculated right lateral pneumothorax, unchanged from prior. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/12/2021 Chest radiograph HISTORY: Pneumothorax. Covid 19 infection. Comments: Frontal radiograph of the chest was obtained and compared to the prior study dated 4/11/2021. The heart is enlarged. The mediastinum is within normal limits. There is a small right pneumothorax. Right-sided chest tube is seen in place. Interstitial alveolar opacities are noted in the bilateral lungs probably due to pneumonia which were also seen in the prior study. There is a Dobbhoff feeding tube with the distal end in the region of the stomach. The osseous structures are stable. IMPRESSION: 1. Small right pneumothorax with right-sided chest tube. 2. Persistent bilateral interstitial alveolar opacities. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/11/2021 XR CHEST 1 VW PORT IMPRESSION: 1 right-sided chest tube in place. There is a tiny right apical pneumothorax. END OF IMPRESSION: INDICATION: PTX, COVID, chest tube PTX, COVID, chest tube. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: X-ray 4/10/2021. FINDINGS: 1 right-sided chest tube is been removed. One chest tube remains. There is a tiny right apical pneumothorax. There is continued bilateral patchy airspace consolidation. Cardiac silhouette is normal size. This calcification of the aorta. The Dobbhoff tube is unchanged. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/10/2021 XR CHEST 1 VW PORT IMPRESSION: Right pneumothorax is not appreciated. No change in the bilateral airspace consolidation. END OF IMPRESSION: INDICATION: PTX, ARDS. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: X-ray 4/9/2021, 4/8/2021. FINDINGS: There are 2 right-sided chest tubes. No right pneumothorax is appreciated. There is diffuse bilateral patchy airspace consolidation. No significant change. The cardiac silhouette is normal size. This calcification of the aorta. There is a nasogastric tube passing beneath the diaphragm. The tip is not included on the study. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/9/2021 XR CHEST 1 VW INDICATION: PTX, ARDS. Encounter: Subsequent. TECHNIQUE: AP portable semierect projection of the chest is acquired. COMPARISON: Yesterday. FINDINGS: No significant change. Very small persistent right pleural effusion. Stable thoracostomy tubes. Stable extensive pulmonary infiltrates. No change in the heart or mediastinum. IMPRESSIONS: No significant change. END OF IMPRESSION: This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/8/2021 Single view portable chest INDICATION: Right pneumothorax, pneumonia, encounter initial Frontal portable chest film compared to prior similar study from 4/7/2021. Right thoracostomy tubes are stable in position. Recurrent 15% right pneumothorax is noted. No mediastinal shift. Unchanged bilateral pneumonia, cardiac contours, and osseous structures. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/7/2021 Single view portable chest INDICATION: Pneumothorax, ARDS, encounter initial Frontal portable chest film compared to prior similar study from 4/6/2021. Tandem right thoracostomy tubes remain in satisfactory position. No identifiable right pneumothorax. Unchanged bilateral pneumonia, cardiac contours, and osseous structures. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/6/2021 XR CHEST 1 VW PORT INDICATION: chest tube placement. Encounter: Subsequent. TECHNIQUE: AP portable projection of the chest is acquired. COMPARISON: None available. FINDINGS: There is a slight reduction in the still present and still very small right pneumothorax. The prior and a new thoracostomy tube is seen. No change in the extensive pulmonary infiltrates. END OF IMPRESSION: This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/6/2021 XR CHEST 1 VW PORT INDICATION: PTX. Encounter: Subsequent. TECHNIQUE: AP portable erect projection of the chest is acquired. COMPARISON: 6 hours earlier. FINDINGS: No significant change. Stable small right pneumothorax, stable thoracostomy tube. Stable bilateral pulmonary infiltrates. END OF IMPRESSION: This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/6/2021 XR CHEST 1 VW PORT IMPRESSION: Right-sided chest tube in place with small right pneumothorax. This is decreased in size. No significant change in the appearance of the bilateral airspace consolidation. END OF IMPRESSION: INDICATION: PTX, s/p change in sxn and patient reposition. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: X-ray 4/6/2021. FINDINGS: There is a right-sided chest tube in place. There is a small right pneumothorax along the lateral aspect of the right chest and in the right lung apex. There is continued bilateral hazy airspace opacification with patchy consolidation inferiorly. There is no effusion. The cardiac silhouette is top normal size. There is calcification of the aorta. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/6/2021 Single view portable chest INDICATION: Right pneumothorax, encounter initial Frontal portable chest film compared to prior similar study from earlier 4/6/2021. Right thoracostomy tube remains in satisfactory position. Now identified is enlargement of right pneumothorax now approximately 30% magnitude with associated right lung atelectasis. No mediastinal shift. Unchanged bilateral parenchymal infiltrates consistent with pneumonia. No effusion. No left pneumothorax. Unchanged cardiac contours and osseous structures. IMPRESSION: Interval expansion of right pneumothorax, now on the order of 30%. No mediastinal shift. Unchanged bilateral pneumonia. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/6/2021 Single view portable chest INDICATION: Pneumothorax, ARDS, encounter initial Frontal portable chest film compared to prior similar study from 4/5/2021. Right thoracostomy tube has pulled back, however, remains within the chest. 10% right apical pneumothorax is noted. Diffuse bilateral infiltrates, cardiac contours, and the osseous structures are stable. No left pneumothorax. No mediastinal shift. IMPRESSION: 10% right apical pneumothorax with right thoracostomy tube remaining in satisfactory position. Diffuse bilateral pneumonia/ARDS. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/5/2021 XR CHEST 1 VW PORT IMPRESSION: Right chest tube in place with barely discernible right apical pneumothorax decreased in size from prior. Unchanged airspace consolidation. END OF IMPRESSION: INDICATION: Right apical pneumothorax, Covid pneumonia follow-up. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: X-ray 4/4/2021. FINDINGS: There is a right-sided chest tube in place. No change in position. There is a minimal, barely discernible right apical pneumothorax decreased in size from prior study. There is continued patchy consolidation seen in the mid and lower segments of both lungs. There is hazy bilateral interstitial prominence. The cardiac silhouette is top normal size. There is calcification of the aorta. The trachea is midline. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/4/2021 XR CHEST 1 VW PORT IMPRESSION: Bilateral pulmonary airspace disease. Right chest tube placement and diminished but residual right apical pneumothorax. END OF IMPRESSION: INDICATION: rt chest tube placement. TECHNIQUE: Portable AP projection of the chest is acquired. COMPARISON: 4/4/2021 FINDINGS: Bilateral pulmonary infiltrative changes are again demonstrated. Right chest tube has been placed and the pneumothorax is diminished. Aortic atherosclerosis is again noted. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/4/2021 XR CHEST 1 VW PORT IMPRESSION: Enlarging right pneumothorax. END OF IMPRESSION: INDICATION: right apical pneumothorax. TECHNIQUE: Portable AP projection of the chest is acquired. COMPARISON: 4/4/2021 earlier FINDINGS: Right apical pneumothorax is enlarging. Other findings remain stable. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/4/2021 XR CHEST 1 VW PORT IMPRESSION: Bilateral pulmonary consolidation. Mild right apical pneumothorax. END OF IMPRESSION: INDICATION: Right apical pneumothorax, Covid pneumonia follow-up. TECHNIQUE: Portable AP projection of the chest is acquired. COMPARISON: 4/3/2021 FINDINGS: There is apical pneumothorax, clearly defined. Left lung consolidation is unchanged. Right lung consolidation is also stable. Diffuse bilateral pulmonary consolidation is again demonstrated. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/3/2021 XR CHEST 1 VW PORT IMPRESSION: Diffuse bilateral pulmonary alveolar disease. END OF IMPRESSION: INDICATION: Right apical pneumothorax, Covid pneumonia follow-up. TECHNIQUE: Portable AP projection of the chest is acquired. COMPARISON: 4/2/2021 FINDINGS: Heart size appears unremarkable. There is atherosclerosis of the aorta. There is diffuse bilateral mid and lower lung pulmonary opacification. No definite effusion is present at this difficult to exclude. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/2/2021 Chest radiograph HISTORY: Right apical pneumothorax. Comments: Frontal radiograph of the chest was obtained and compared to the prior study dated 4/2/2021. The heart and mediastinum remain stable. Airspace disease is identified in the bilateral mid to lower lungs. There is interstitial thickening identified bilaterally. A small right apical pneumothorax is again noted. This is not significantly changed. The osseous structures are stable. IMPRESSION: 1. Interstitial alveolar opacities in the bilateral lungs consistent with the patient's known pneumonia which is not significantly changed. 2. Unchanged right apical pneumothorax. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 4/2/2021 Single view portable chest INDICATION: Covid pneumonia, pneumothorax, encounter initial Frontal portable chest film compared to prior similar study from 4/1/2021 as well as CT chest from 3/29/2021. Mild interval expansion small, 20-30% right pneumothorax. Subcutaneous emphysema and pneumomediastinum are improved. No left pneumothorax. No mediastinal shift. Bilateral pneumonia has improved. Unchanged cardiac contours and osseous structures. IMPRESSION: Slight interval expansion of right pneumothorax now on the order of 20-30%. No mediastinal shift. Improved pneumonia. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 4/1/2021 XR CHEST 1 VW PORT INDICATION: evaluation of subcutaneous emphysema and pneumonia.. Encounter: Subsequent. TECHNIQUE: AP portable erect projection of the chest is acquired. COMPARISON: Yesterday. FINDINGS: The nuchal subcutaneous emphysema as well as pneumomediastinum and pneumopericardium appear relatively stable. The amount of chest wall air appears slightly less. Extensive pulmonary infiltrates are present, waxing and waning, now slightly improved on the left and slightly denser on the right. IMPRESSIONS: No significant change. Waxing and waning infiltrates. END OF IMPRESSION: This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 3/31/2021 Single view portable chest INDICATION: Pneumonia, pneumomediastinum, encounter initial Frontal portable chest film compared to prior similar study from 3/30/2021. Subcutaneous emphysema continues to improve. Pneumomediastinum is no longer evident. No pneumothorax. Bilateral pneumonia, cardiac contours, and the osseous structures are stable. IMPRESSION: Continued improvement of subcutaneous emphysema and pneumomediastinum. Unchanged bilateral diffuse pneumonia. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 3/30/2021 Single view portable chest INDICATION: Pneumonia, pneumomediastinum, encounter initial Frontal portable chest compared to prior similar study from 3/29/2021. Improved bilateral subcutaneous emphysema and pneumomediastinum. Lungs again demonstrate diffuse bilateral infiltrates without effusion. No pneumothorax. Unchanged cardiac contours and osseous structures. IMPRESSION: Improved subcutaneous emphysema and pneumomediastinum. Unchanged pneumonia. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 3/29/2021 Single view portable chest INDICATION: Covid pneumonia, encounter initial Frontal portable chest film compared to prior similar study from 3/26/2021. Now identified is evidence of subcutaneous emphysema at the right lateral greater than left lateral chest. In addition, small bilateral, less than 10% pneumothoraces are suspected. Bilateral pneumonia is unchanged. No effusion, pneumothorax, or congestive failure. Normal size heart. No acute interval osseous finding. Above critical findings personally communicated to the referring pulmonologist at the close of this dictation. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View Result Date: 3/26/2021 XR CHEST 1 VW PORT IMPRESSION: No significant change in the bilateral airspace consolidation. END OF IMPRESSION: INDICATION: worsening hypoxemia, covid. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: X-ray 3/20/2021. FINDINGS: There is patchy consolidation and glass opacification seen in the mid and lower portions of both lungs. The findings are not significantly changed from prior. There is no effusion or pneumothorax. The cardiac silhouette is normal size. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray Chest 1 View, Portable Result Date: 3/20/2021 XR CHEST 1 VW PORT INDICATION: f/u worsened hypoxia. Encounter: Initial. TECHNIQUE: AP portable erect projection of the chest is acquired. COMPARISON: 3/14/2021. FINDINGS: No significant change. Fairly extensive bilateral lower lobe infiltrates. No change in the heart, mediastinum, or bony thorax. IMPRESSIONS: No significant change. END OF IMPRESSION: This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Transthoracic Echo (tte) Complete Result Date: 4/7/2021 Patient Name: patient Gender: Female Age: 68 Procedure Date: 4/7/2021 01:16 PM Location: Hospital Room Study Quality: Fair Ht / Wt / BSA: 62.00 in / 193.00 lb / 1.88 m2 Heart Rate: 105 bpm BP: 124 / 58 mmHg Sonographer: Referring MD: Indications: Pulmonary Hypertension Transthoracic 2D, Color Flow, and Doppler Echocardiogram Conclusions: The visually estimated ejection fraction is 55-60% (normal range 50-70%). There is moderate tricuspid valve regurgitation by color flow and doppler analysis. The pulmonary artery systolic pressure is 46.00 mmHg. No prior study for comparison. Presentation and History: Indication: The patient presents for evaluation of pulmonary hypertension. The patient has a history of hypertension, dyslipidemia, obesity, and previous tobacco use. Findings: Procedure Information: Contrast agent, definity, is being given per protocol without apparent complications. Due to technical limitations in the assessment of the left ventricle, imaging was performed after the administration of intravenous Definity echocontrast, as per protocol. Left Ventricle: Normal left ventricular size and systolic function. The visually estimated ejection fraction is 55-60% (normal range 50-70%). Doppler findings are consistent with grade I diastolic function. Impaired relaxation with normal filling pressures. Wall Motion: All wall segments showed normal motion. Right Ventricle: Normal right ventricular cavity size and systolic function. Atria: Both atria are normal in size. Aortic Valve: There is mild thickening of the aortic valve. There is trace (trivial) aortic valve regurgitation by color flow and doppler analysis. Mitral Valve: There is mild thickening in both mitral valve leaflets. There is trace mitral valve regurgitation by color flow and doppler analysis. Pulmonic Valve: Normal pulmonic valve structure and function. There is no evidence of pulmonic valve stenosis or insufficiency by color flow and doppler analysis. Tricuspid Valve: Normal tricuspid valve structure. There is moderate tricuspid valve regurgitation by color flow and doppler analysis. The pulmonary artery systolic pressure is 46.00 mmHg. Great Vessels: All visible segments of the aorta are normal in size. Venous: The inferior vena cava is normal in size. Pericardium/Pleural: There is no evidence of pericardial effusion. Prior Study Comparison: No prior study for comparison. Measurements: Left Ventricle: Ao Root: 3.00 cm (2.1-3.5) LA Diam: 3.30 cm (2.7-3.8/3.0-4.0) LAIDs Index: 1.76 cm/m2 (1.5-2.3) LVOT Diam: 1.90 cm (3.0+(-)1.3) LVOT Pk Vel: 1.05 LVOT Mn Vel: 0.62 LVOT VTI: 0.19 LVOT Pk Grad: 4.00 LVOT Mn Grad: 2.00 LVOT Diam: 1.90 LVOT Area: 2.84 MV Pk E: 0.48 MV Pk A: 0.81 E/A: 0.60 E'Medial: 3.70 E/E' Med: 13.00 E' Laterial: 4.68 E/E' Lat: 10.30 Mitral Valve: MV Pk E: 0.48 MV PK A: 0.81 MV Decel Time: 158.00 E/A: 0.60 E'Lateral: 4.68 E'Medial: 3.70 E/E' Med: 13.00 E/E' Lat: 10.30 Aortic Valve: AoV Pk Vel: 1.21 AoV Pk Grad: 6.00 Tricuspid Valve: TR Pk Vel: 2.99 TR Pk Grad: 36.00 RA Press: 10.00 RVSP: 46.00 Pulmonary Artery Systolic Pressure: 46.00 Great Vessels: Ao Root-2D: 3.00 cm (2.0-3.7) Updated by on 4/7/2021 2:14:15 PM with Status of Final electronically signed on 4/7/2021 2:14:15 PM with status of Final Ultrasound Lower Extremity Venous Bilateral Result Date: 3/31/2021 US LOWER EXTREMITY VENOUS BILATERAL IMPRESSION: No evidence of DVT. END OF IMPRESSION: INDICATION: r/o dvt. Encounter: Initial. TECHNIQUE: Multiple longitudinal and transverse 2D real-time ultrasound images were performed from groin to knee, and at the calf and ankle. Color and grayscale and duplex Doppler imaging was also performed. Permanently recorded images were obtained and stored. COMPARISON: None available. FINDINGS: No evidence of deep venous thrombosis. On each side, there is normal flow, compressibility and augmentation in the common femoral, greater saphenous, superficial and deep femoral veins and popliteal veins. There is also normal flow, compressibility and augmentation in the posterior tibial veins, peroneal veins and small saphenous veins in the calves. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient.
Aktuelle Erkrankungen
-
Vorgeschichte
Respiratory Shortness of breath Acute respiratory failure with hypoxemia (/HCC) 2019 novel coronavirus?infected pneumonia (NCIP) Circulatory Essential hypertension Endocrine/Metabolic Hyponatremia Hypothyroidism Hyperlipidemia Immune Severe sepsis (/HCC) Other Elevated liver enzymes
Andere Medikamente
calcium carbonate (CALCIUM 500) 500 mg calcium (1,250 mg) chewable tablet levothyroxine (SYNTHROID, LEVOTHROID) 150 mcg tablet meclizine (ANTIVERT) 12.5 mg tablet metoprolol tartrate (LOPRESSOR) 25 mg tablet mometasone (NASONEX) 50 mcg/actu
Allergien
CiprofloxacinDiarrhea Sulfa (Sulfonamide Antibiotics)Rash
Vorherige Impfungen
-

VAERS 1313057

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6202

kritisch
Staat
TX
Alter
63,0
Geschlecht
F
Eingang
13.05.2021
Impfdatum
28.02.2021
Beginn
11.03.2021
Tage bis Beginn
11,0
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein
Pulmonary embolism

Symptomtext

a blot clot discovered in lung within 2 weeks of first shot.; This is a spontaneous report from a contactable consumer (patient). A 63-year-old patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number En6202, on 28Feb2021 10:45 at single dose in right arm for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient had no known allergies. The patient had no covid prior vaccination. The patient had not tested covid post vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient had a blot clot discovered in lung within 2 weeks of first shot on 11Mar2021. The event resulted in Physician Office Visit. Treatment included blood thinner for blood clot. The outcome of the event was unknown. The event is serious with hospitalization and disability. Follow-up attempts are needed. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1310171

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6202

kritisch
Staat
DE
Alter
76,0
Geschlecht
F
Eingang
12.05.2021
Impfdatum
11.03.2021
Beginn
19.03.2021
Tage bis Beginn
8,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Deep vein thrombosis Pulmonary embolism

Symptomtext

Unprovoked Dvt/pe

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Osteoporosis
Andere Medikamente
Calcium-vit d
Allergien
Nkda
Vorherige Impfungen
-

VAERS 1309531

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
39,0
Geschlecht
F
Eingang
12.05.2021
Impfdatum
04.02.2021
Beginn
21.04.2021
Tage bis Beginn
76,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Blindness Blood pressure decreased Chest pain Investigation Pain in jaw Presyncope Pulmonary embolism

Symptomtext

blood pressure drop; nearly fainted; chest pain; jaw pain; loss of vision; Multiple bilateral pulmonary embolisms in my lungs; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (at 39 years of age), via an unspecified route of administration, administered in arm left on 04Feb2021 (Batch/Lot Number: EN6202) as 2nd dose, single for COVID-19 immunisation. Medical history included MTHFR blood clotting gene mutation. Concomitant medications included citalopram, metoprolol, omeprazole and minastein fe24, all taken for an unspecified indication, start and stop date were not reported. Historical vaccine included BNT162B2 (lot number: EN9581) dose 1 on an unknown date (also reported as 04Feb2021) 01:00 PM in left arm for COVID-19 immunisation. The patient was not pregnant. The patient did not have any other vaccine within 4 weeks prior to the COVID vaccine. She was not diagnosed with COVID-19 prior to vaccination. She had not been tested for COVID-19 prior since vaccination. It was reported that 6 weeks after the second dose on 21Apr2021 12:00, the patient had a blood pressure drop, nearly fainted, chest pain, jaw pain, loss of vision. She went to emergency room (ER), they did tests and found multiple bilateral pulmonary embolisms in her lungs. The adverse events resulted in Emergency room/department or urgent care. Therapeutic measures were taken as a result of the events, Eliquis (reported as 'Eloquis') blood thinners given. The patient was hospitalized for the events for one day. The outcome of the events was not recovered. Information on the batch lot/batch number has been obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
1,0
Labordaten
Test Name: tests; Result Unstructured Data: Test Result: Multiple bilateral pulmonary embolisms in my lungs
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: MTHFR gene mutation
Andere Medikamente
CITALOPRAM; METOPROLOL; OMEPRAZOLE
Allergien
-
Vorherige Impfungen
-

VAERS 1302513

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AZ
Alter
87,0
Geschlecht
M
Eingang
10.05.2021
Impfdatum
01.03.2021
Beginn
02.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death Myocardial infarction

Symptomtext

Death listed as a heart attack. No symptoms, but took an abnormally long nap just prior to the attack.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Emergency room attempt to necessitate. Medical examiner determined cause of death.
Aktuelle Erkrankungen
None
Vorgeschichte
Diabetes, neuropathy.
Andere Medikamente
Losartan, Metformin, Nexium, Levothyroxine, Simvastan, Calcium 500+D, Vitamin B complex plus B12.
Allergien
None
Vorherige Impfungen
-

VAERS 1302451

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
PA
Alter
56,0
Geschlecht
M
Eingang
10.05.2021
Impfdatum
25.03.2021
Beginn
08.04.2021
Tage bis Beginn
14,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Cerebrovascular accident

Symptomtext

SUFFERED STROKE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
30,0
Labordaten
-
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 1296154

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MN
Alter
70,0
Geschlecht
M
Eingang
07.05.2021
Impfdatum
24.02.2021
Beginn
05.04.2021
Tage bis Beginn
40,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Cerebrovascular accident

Symptomtext

Patient presented to the ED and was subsequently hospitalized for CVA within 6 weeks of receiving COVID vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1295768

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
CO
Alter
71,0
Geschlecht
F
Eingang
07.05.2021
Impfdatum
26.02.2021
Beginn
12.04.2021
Tage bis Beginn
45,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Chest X-ray Fibrin D dimer increased Pulmonary embolism

Symptomtext

Saddle PE resulting in hospitalization - now on anticoagulation treatment

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
2,0
Labordaten
D-dimer >10,000 (4/12/21), XR Chest
Aktuelle Erkrankungen
None
Vorgeschichte
Hyperlipidemia, history of DVT (after hormone replacement therapy), Stage I breast cancer, age related osteoporosis, heterozygous Factor V Leiden
Andere Medikamente
Acetaminophen, cetirizine, Coenzyme Q-10, hydroxyzine, simvastatin 20 mg
Allergien
Aspirin, sulfa antibiotics
Vorherige Impfungen
-

VAERS 1294226

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
55,0
Geschlecht
M
Eingang
06.05.2021
Impfdatum
10.03.2021
Beginn
19.03.2021
Tage bis Beginn
9,0
Dosis
UNK
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Acute myocardial infarction Coronary artery disease Coronary artery occlusion Percutaneous coronary intervention

Symptomtext

NSTEMI, treated with PCI, DES evidence of multivessel coronary artery disease PCX 100% occluded submitting out of abundance of caution in case vaccine poses risk of clots in coronary artery disease patients

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
mild asthma mildly elevated blood pressure, typically under 130/90 , no bp meds
Vorgeschichte
-
Andere Medikamente
none albuterol prescription, not used past 6 months
Allergien
none
Vorherige Impfungen
-

VAERS 1291292

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
72,0
Geschlecht
M
Eingang
05.05.2021
Impfdatum
26.02.2021
Beginn
07.03.2021
Tage bis Beginn
9,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Balance disorder Cerebrovascular accident Computerised tomogram abnormal Fall Magnetic resonance imaging abnormal Visual impairment X-ray abnormal

Symptomtext

On March 7 at 23:30 (11:30) I awakened to go to urinate and everything seemed darker. Went back to bed not realizing I was possibly having a stroke. I had a Diabetic Dr Appointmnet at 0800 on the 8th so In went to the appointment and informed Dr that I was partially blind in my right eye. She immediately had me hospitalized and the diagnosis of a stroke was confirmed by CAT Scan and x-ray and I think a MRI. I was discharged and returned 9 days later with worsening vision and balance. I had a severe fall on discharge and hit head kept me in a extra day and actually broke a rod on a low back fusion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
3,0
Labordaten
3-8-2021 Xray CT Scan MRI? (I think) all in hospital
Aktuelle Erkrankungen
Diabetes (1995) Treatment Lantus 35 - Humalog 20-25-28 Ozempic 0.50
Vorgeschichte
Diabetes Bi-Gemini Tri-Gemini since 2000 after MI CABG in 2013
Andere Medikamente
Ozempic 0.5 - Percocet 5 PRN 10-325 - Desipramine 10mg - Simvastatin 40mg - Gabapentin 900mg x 3 - Metropolol 25mg - Lantus 35 - Humalog 20-25-28 Slifing Scale - Multi Vit - Vitamin C 1000 - Fish Oil - Fibercon - Vit D3 - Zinc 50mg x 3 -
Allergien
Shellfish - Azithromax (Hallucinations) - Prednisone (Hallucination) - Duloxetine (Hallucination) - Metformin (Diarrhea) - Wellbutrin (Hallucination)
Vorherige Impfungen
-

VAERS 1289416

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NH
Alter
50,0
Geschlecht
F
Eingang
05.05.2021
Impfdatum
30.03.2021
Beginn
04.04.2021
Tage bis Beginn
5,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Activated partial thromboplastin time shortened Angiogram pulmonary abnormal Chest X-ray Dyspnoea Dyspnoea exertional Haematocrit normal Haemoglobin normal International normalised ratio normal Prothrombin time shortened Pulmonary embolism Pulmonary hypertension Ultrasound scan normal White blood cell count increased

Symptomtext

Shortness of breath, DOE, worsening daily from time of shot to now. PCP on 4/13, CXRAY 4/16, Pulmonology 4/26/21, ER 5/3/21 and admitted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
3,0
Labordaten
CT Angio, Positive for bilateral segmental and subsegmental pulmonary emboli noted in lungs and bilateral upper lobes, right middle lobe and also bilateral lower lobes. Reflux of contrast noted in hepatic veins, early pulmonary hypertension, no septal bowing or cardiomegaly. US BLE is clear. WBC 11.16 H+H 14.7/44.4. PT 9.5, INR 1.0 PTT 19.6
Aktuelle Erkrankungen
-
Vorgeschichte
Hasimoto's hypothyroidism, perimenopause, anxiety, osteoarthritis.
Andere Medikamente
estradiol, imipramine, levothyroxine, medroxyprogesterone, naproxen, sumatriptan succinate, albuterol Sulfate
Allergien
None known.
Vorherige Impfungen
-

VAERS 1285279

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
57,0
Geschlecht
M
Eingang
04.05.2021
Impfdatum
24.04.2021
Beginn
25.04.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Blood glucose decreased Brain injury Brain stem syndrome Cardio-respiratory arrest Endotracheal intubation Hypoglycaemia Posture abnormal Resuscitation Seizure Septic shock

Symptomtext

Pfizer COVID-19 Vaccine EUA Patient received dose #1 of Pfizer COVID-19 vaccine on 3/6/2021 and Dose #2 on 4/24/2021. Patient was found down on 4/25/2021 for an unknown amount of time and EMS was called. Patient noted to be seizing on EMS arrival. Blood glucose was noted to be 32 and an amp of D50 was administered. Patient arrested, received CPR (approximately 1 round) and was intubated in the field. His second glucose reading was undetectable and he received a second amp of D50. Patient also received sodium bicarb, calcium, and epinephrine and transported to ED. Patient subsequently transferred to Medical Center. He was treated for septic shock. His mentation remained very poor after pressors weaned off and sedation stopped. He likely had severe brain injury from hypoglycemia and anoxia - poor brainstem reflexed but did have spontaneous breathing - very poor prognosis - patient was extubated for comfort measures and all interventions stopped after family discussion and per their plan.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardio-respiratory arrest
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CHF, ESRD, Hematoma, Hyperlipidemia, Hypertension, Insomnia, Anxiety, Depression, Restless Legsm Seasonal Allergies
Andere Medikamente
Amlodipine 10 mg BID, Calcitriol 0.5 mcg QD, (continued)arvedilol 12.5 mg BID, Ferrous sulfate 325 mg QD, Gabapentin 100 mg QD, Lisinopril 40 mg QD, Nicotine 7 mg Patch QD, Vitamin D2 50,000 units Weekly, Citalopram 20 mg QD, Flonase 2 spra
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1278759

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
FL
Alter
-
Geschlecht
F
Eingang
01.05.2021
Impfdatum
23.02.2021
Beginn
24.02.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Burning sensation Chills Diarrhoea Headache Malaise Near death experience Retching

Symptomtext

"I was going to pass out, thought I was going to die"; dry heaves; burning sensation inside my body; Severe Diarrhea; I had chills; headache; Feeling sick; This is a spontaneous report from a contactable consumer. A 70-year-old elderly female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Right Arm on 23Feb2021 (Batch/Lot Number: EN6202) as SINGLE DOSE for covid-19 immunisation. Dose 1 of BNT162B2 for COVID-19 immunisation was given on 29Jan2021 lot number unknown in right arm. Medical history included macular degeneration from an unknown date, glaucoma from an unknown date, hypertension from an unknown date (controlled), and herpes zoster from 2017 to an unknown date. The patient is not pregnant. The patient did not have Covid-19 prior vaccination. The patient had no known allergies. Concomitant medications included losartan (LOSARTAN) taken for an unspecified indication, start and stop date were not reported; amlodipine besilate (AMLODIPINE BESILATE) taken for an unspecified indication, start and stop date were not reported; and carvedilol (CARVEDILOL) taken for an unspecified indication, start and stop date were not reported. Other medications in two weeks also included unspecified eye drops for glaucoma. No other vaccine was given in last four weeks. The patient experienced "I was going to pass out, thought I was going to die" on 24Feb2021, dry heaves on 24Feb2021 with outcome of recovered, burning sensation inside my body on 24Feb2021 with outcome of recovered, severe diarrhea on 24Feb2021 with outcome of recovered, chills on 24Feb2021 with outcome of recovered, headache on 24Feb2021 with outcome of recovered and feeling sick on 24Feb2021 with outcome of recovered. All events recovered on an unspecified date in 2021. The patient was not Covid tested post vaccination. No follow-up attempts are possible; No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Near death experience
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Blood pressure high (controlled); Glaucoma; Macular degeneration; Shingles
Andere Medikamente
LOSARTAN; AMLODIPINE BESILATE; CARVEDILOL
Allergien
-
Vorherige Impfungen
-

VAERS 1274254

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
57,0
Geschlecht
M
Eingang
30.04.2021
Impfdatum
13.03.2021
Beginn
07.04.2021
Tage bis Beginn
25,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Angiogram Pulmonary embolism

Symptomtext

Pulmonary Embolism. Survived.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
4,0
Labordaten
CT angiogram
Aktuelle Erkrankungen
Asthma
Vorgeschichte
Asthma
Andere Medikamente
ProAir
Allergien
None
Vorherige Impfungen
-

VAERS 1273835

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
PA
Alter
27,0
Geschlecht
F
Eingang
30.04.2021
Impfdatum
23.03.2021
Beginn
06.04.2021
Tage bis Beginn
14,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abortion spontaneous Exposure during pregnancy Foetal death Ultrasound abdomen Ultrasound foetal abnormal

Symptomtext

Missed Miscarriage discovered at routine pregnancy ultrasound on 4/6/2021 (12 weeks 5 days pregnant) Deceased fetus measured at 9 weeks 5 days D&C performed as a result on 4/7/2021 Estimated due date was 10/14/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Foetal death
Hospital-Tage
-
Labordaten
Abdominal ultrasound
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Prenatal vitamins and 81mg aspirin daily
Allergien
Peanuts, tree nuts, shellfish
Vorherige Impfungen
-

VAERS 1272625

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
93,0
Geschlecht
M
Eingang
30.04.2021
Impfdatum
03.03.2021
Beginn
11.03.2021
Tage bis Beginn
8,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Brain injury Cerebral haemorrhage Computerised tomogram Confusional state

Symptomtext

Brain Bleed Brain Damage Severe Confusion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebral haemorrhage
Hospital-Tage
3,0
Labordaten
CT scan 03/11/2021
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1269643

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
65,0
Geschlecht
F
Eingang
29.04.2021
Impfdatum
16.03.2021
Beginn
21.03.2021
Tage bis Beginn
5,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Cerebrovascular accident

Symptomtext

stroke; face sunk in and changed/Bells Palsy; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a 65-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EN6202), via an unspecified route of administration, administered in the left arm on 16Mar2021 at 14:00 as a single dose for COVID-19 immunization. Medical history included a mild case of COVID-19, last year, on an unspecified date in 2020. There were no concomitant medications. The patient had no prior vaccinations within 4 weeks of the COVID vaccine. On 21Mar2021, the patient's face sunk in and changed. The patient's symptoms were not improving. Her eye and right side of her face are affected. She cannot close her right eye. She worked on it and is now able to close right eye not like the left eye closes, but it doesn't blink as the left eye does. She has been using eye drops for this. She said it was Bells Palsy. The patient added that it is hard to look in the mirror. She will not get the second dose. She was not interested in taking the vaccine now. She wanted to wait and see. It being so new and see. Her sister took it and encouraged her, and said it is necessary because they like to travel. She got Prednisone when she was at the hospital, they gave her 60mg Prednisone. Her physician didn't want to keep her on it too long and said it may cause other complications. Her physician cut her off, she weaned her down 50mg, 40mg, 30mg, 20mg, then 10mg. When the patient noticed her face start to turn, she went to the ER. She thought she was having a stroke. The patient was not admitted to the hospital. The outcome of the event face sunk in and changed/bells palsy was not recovered while the outcome of the event stroke was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19 (mild case)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1095184

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
67,0
Geschlecht
F
Eingang
28.04.2021
Impfdatum
11.03.2021
Beginn
12.03.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Unknown, tested positive for COVID-19 on 10/26/2020 and died at home on 3/12/2021 per death certificate. Vaccinated with 1st does of Pfizer vaccine on 3/11/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Tested for COVID-19 on 10/26/2020 by rapid antigen
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 1095184

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
KY
Alter
67,0
Geschlecht
F
Eingang
28.04.2021
Impfdatum
11.03.2021
Beginn
12.03.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Unknown, tested positive for COVID-19 on 10/26/2020 and died at home on 3/12/2021 per death certificate. Vaccinated with 1st does of Pfizer vaccine on 3/11/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Tested for COVID-19 on 10/26/2020 by rapid antigen
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 1263539

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AZ
Alter
72,0
Geschlecht
F
Eingang
27.04.2021
Impfdatum
28.02.2021
Beginn
28.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Blood pressure decreased Cardiac arrest Death Diarrhoea Dysstasia Fall Intensive care Myocardial infarction Stent placement Vomiting

Symptomtext

With in one hour patient experienced severe Vomiting and Diarrhea. She had called her Doctors office. She saw a PA which told her to drink more water. She experienced Uncontrollable Diarrhea For 18 days. She was sent to Hospital by ambulance on Monday March 15, 2021. She was was treated with an IV and sent home discharged with Weakness. She continued to have Uncontrollable Diarrhea to were she was wearing Diapers. She fell from Weakness on March 16, 2021 to the point where she laid on the floor for an hour and half before she could drag herself up. She went to Hospital on March 18, 2021. Her blood pressure dropped and was admitted to ICU on the March 18th. She started suffering from a Heart attack and was taken back to have a stent put in her wrist to help with possible heart blockage. She went into cardiac arrest and passed away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
Dialysis patient 3 times a week
Vorgeschichte
Stage 4 Kidney failure Harden of the arteries
Andere Medikamente
no list at this time
Allergien
-
Vorherige Impfungen
-

VAERS 1254833

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
48,0
Geschlecht
F
Eingang
25.04.2021
Impfdatum
28.02.2021
Beginn
28.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Anaphylactic shock Balance disorder Blood cholesterol Blood cholesterol abnormal Flushing Heart rate Heart rate increased Oropharyngeal discomfort Pain Throat tightness Thyroid function test Thyroid function test abnormal

Symptomtext

Pt. Complaint of throat tightness after receiving vaccine. Benadryl administered and symptoms relieved after 35 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic shock
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
1. Benign cardiac murmur (R01.0) 2. Benign colon polyp (211.3) (K63.5) 3. Graves disease (242.00) (E05.00) 4. History of cardiac murmur (V12.59) (Z86.79) 5. History of positive purified protein derivative test (V15.89) (Z92.89) 6. Hypothyroidism, postradioiodine therapy (244.1) (E89.0)
Vorgeschichte
-
Andere Medikamente
None
Allergien
Iodine Some foods, but unknown
Vorherige Impfungen
-

VAERS 1246357

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NJ
Alter
68,0
Geschlecht
F
Eingang
23.04.2021
Impfdatum
17.03.2021
Beginn
19.04.2021
Tage bis Beginn
33,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Angiogram abnormal Anticoagulant therapy Blood glucose increased Blood urea increased Brain natriuretic peptide normal Chest X-ray normal Coagulation test Computerised tomogram thorax abnormal Dyspnoea Echocardiogram normal Electrocardiogram normal Fibrin D dimer Flatulence Full blood count normal Hepatic mass International normalised ratio normal Intracardiac mass Lipoma

Symptomtext

presented to clinic with complaints of R calf cramping for 15 days which had become acutely worse over the last week, especially bad when patient was walking. She has never experienced pain like this before. The R leg is also swollen from the calf down. She reports that sometimes the leg looks purple-ish and she endorses some tingling in the foot. Over the past couple weeks, she has also noted new dyspnea when walking. She denies fevers, chills, chest pain, palpitations, or cough. Of note, the patient had COVID-19 in November and since then has had some upper back pain which she currently has but it feels the same as usually does for her

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
2,0
Labordaten
In the emergency department, the patient had a cxr which was normal. US of right lower extremity was negative for DVT. CTA was done which showed bilateral lower segmental and subsegmental PEs. EKG showed normal sinus rhythm with no signs of right heart strain. CBC was grossly normal, D dimer was 3.08. INR normal. Troponin normal. BNP normal. BMP showed glucose of 134 and slightly elevated BUN of 22. Covid testing was negative. Started on heparin drip in the Ed then switched to lovenox. Hematology was consulted and ordered coagulation studies, pending results. Echo showed preserved cardiac dimensions with normal biventricular function. Estimated LVEF is 60%. No significant regurgitant valvular abnormality. There is no clear evidence of right-sided strain. IVC is not dilated. Extracardiac mass identified, likely hepatic with dimensions of approximately 3.9 x 4.3 cm. Ultrasound abdomen was performed and found Perihepatic lipoma is not visualized on this study, likely related to interposed bowel gas. Probable 6 mm left lower pole calculus. The perihepatic lipoma seen on yesterday's chest CT lies between the left hepatic lobe and right atrium and measures 6.6 x 4.5 cm, previously 5.6 x 4.0 cm in 2016. Patient to be discharged on eliquis, with follow up with hematology and family medicine in the next few days. Patient was stable for discharge home.
Aktuelle Erkrankungen
Bilateral pulmonary embolism Mixed hyperlipidemia Chronic upper back pain History of 2019 novel coronavirus disease (COVID-19)
Vorgeschichte
Pulmonary embolism, bilateral (HCC) ? Mixed hyperlipidemia ? Chronic upper back pain ? History of 2019 novel coronavirus disease (COVID-19)
Andere Medikamente
ASA 81 mg. Atorvastatin 40 mg Losartan 50 mg.
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1232805

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
81,0
Geschlecht
F
Eingang
20.04.2021
Impfdatum
24.02.2021
Beginn
05.03.2021
Tage bis Beginn
9,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Death

Symptomtext

Patient had several ED visits and was admitted to the hospital, all within 6 weeks of receiving COVID vaccination. ED visits 3/5/21, 3/18/21, and admissions on 3/22/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
9,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1225688

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
34,0
Geschlecht
F
Eingang
18.04.2021
Impfdatum
07.03.2021
Beginn
15.03.2021
Tage bis Beginn
8,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Cerebrovascular accident Computerised tomogram Dizziness Magnetic resonance imaging Nausea Neck pain Paraesthesia Vertebral artery dissection

Symptomtext

Verterbal artery dissection that caused a stroke Very sharp neck pain, tingling on left side, dizziness, nausea (this went on for about 20 minutes prior to getting to the hospital)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
3,0
Labordaten
MRI, CT scan- 3/15/21
Aktuelle Erkrankungen
No illnesses-- I had a c-section 2/17/2021
Vorgeschichte
none
Andere Medikamente
Prenatal vitamins (I was four weeks post partum/c-section), levothyroxine, Vitamin D supplements
Allergien
ceclor, sulpha drugs
Vorherige Impfungen
-

VAERS 1211441

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NC
Alter
55,0
Geschlecht
M
Eingang
15.04.2021
Impfdatum
03.03.2021
Beginn
05.03.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Anticoagulant therapy Chills Dyspnoea Fatigue Headache Pulmonary embolism Pyrexia

Symptomtext

fatigue mild headache shortness of breath chills low grade fever diagnosed with ACUTE PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONATE had two hospital doctors two hematologist two pa-c specialist all suspect pfizer shot . taking eloquis for 90 days

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
3,0
Labordaten
hospital performed all the test cant leave much info because of site time out this is third try
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
escitalopram 10 milligram once daily
Allergien
none
Vorherige Impfungen
-

VAERS 1211001

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6202

kritisch
Staat
AZ
Alter
66,0
Geschlecht
F
Eingang
15.04.2021
Impfdatum
22.03.2021
Beginn
28.03.2021
Tage bis Beginn
6,0
Dosis
1
Route/Site
SYR / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Brain injury Cerebral thrombosis Cerebrovascular accident Death Endotracheal intubation

Symptomtext

Patient is deceased. Had a blood clot travel to her brain and causes an un recoverable stroke

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
8,0
Labordaten
03/28. Flown to another state after suffering a massive stroke due to a blood clot in the brain 03/29. Put into surgery to try to relieve pressure on her brain due to the blood clot. 04/2. Removed breathing tube due to 80% brain loss. 04/05. Mom died. My kids found her while she was having the stroke and called 911 on 03/28.
Aktuelle Erkrankungen
-
Vorgeschichte
High blood pressure; diabetes
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1211131

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6202

kritisch
Staat
AZ
Alter
68,0
Geschlecht
M
Eingang
14.04.2021
Impfdatum
02.03.2021
Beginn
04.03.2021
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
SYR / LA
Tod: ja Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Abdominal pain upper Anal incontinence Arthralgia Cardiac arrest Cardioversion Death Diarrhoea Endotracheal intubation Nausea Neck pain Vomiting

Symptomtext

The patient had stomach pains nausea thowing up diarehha 33 hours after came in waves and neck pain and pain in top of shoulder blade.. we dind't realize it because it was on the right side......... not the left looking back IT WEAKENED HIS HEART and kille dhim he went to be March 21, 2021 just fine....... woke up at 2:30 lost control of bowels dind't know what was wrong i called 911 his heart rate was 40's and his BP 79/51 took him to facility in ambulance he was dead by 5:17 am ................ this covid killed him....... they tried to shock his heart and in tubed but coudn't save him

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
-
Labordaten
they dindt' do an AUTOPSY AND I DONT' HAVE THE MONEY TO DO IT they said it was a cariac arrest in minutes an dheart disease for years they rushed this shot out to fast and now I have no hubby living we were together 50 years
Aktuelle Erkrankungen
none patient was a pic of helth
Vorgeschichte
Heart disease and type 2 diabetes
Andere Medikamente
one tumeric pill 750 mg Plavix metformin chol lowering drugs and b/p and type 2 diabetes and heart disease and open heart in 1995 by pases PATIENT WAS FINE BEFORE THE vacinne
Allergien
No
Vorherige Impfungen
-

VAERS 1205241

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NC
Alter
65,0
Geschlecht
M
Eingang
13.04.2021
Impfdatum
11.03.2021
Beginn
12.03.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Cerebrovascular accident Disease recurrence

Symptomtext

stroke; stroke; This is a spontaneous report from a contactable nurse (reporting for her husband). A 65-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6202), dose 1 via an unspecified route of administration, administered in Arm Left on 11Mar2021 (at the age of 65years) as single dose for Covid-19 immunization. Medical history included diabetes from an unknown date and unknown if ongoing, stroke from 03Dec2018 to an unknown date, and cancer from an unknown date and unknown if ongoing. Concomitant medication included unspecified medication (He is taking medication for his diabetes, his stroke the 2nd stoke that he had in last 2 weeks he is taking medication). It was reported that the patient had a Covid vaccine this month on 11Mar2021. That was the 1st vaccine the patient had. Next day on the 12Mar2021, the patient stated having some unbalanced in walking and in his train of thinking. The reporter (nurse) ended up on 15Mar2021 taking the patient to Emergency room, and he had a stroke. The reporter stated, "Now, he had a stroke 2 year before. I called to let you know I talked to the neurologist he has sent him to his family doctor for checkup and his family doctor wanted me to let you know that this happen. Does not know if there is any relation or not but just to let you all know and this coming Thursday, he is supposed to get his 2nd vaccine. I am, just calling to let you know". The patient was taking medication for his 1st stroke and now he is taking medication for his 2nd stroke (treatment). He is taking physical therapy and occupational therapy and for his cancer, he is taking medication for that. The patient was hospitalized for stroke from 15Mar2021 to 17Mar2021, then he was discharged. The outcome of event was not recovered. Follow-up needed; further information has been requested.; Sender's Comments: Event stroke represents an intercurrent medical condition and unrelated to BNT162B2 . The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Cancer; Diabetes; Stroke
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1190415

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AZ
Alter
67,0
Geschlecht
M
Eingang
10.04.2021
Impfdatum
02.03.2021
Beginn
12.03.2021
Tage bis Beginn
10,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Cerebrovascular accident Computerised tomogram head abnormal Echocardiogram abnormal Magnetic resonance imaging head abnormal Muscular weakness Thrombosis

Symptomtext

Blood clot in brain causing a small stroke affecting right arm, wrist and hand

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
3,0
Labordaten
MRI, CT SCAN, ECHOCARDIOGRAM Results: Blood Clot in the brain
Aktuelle Erkrankungen
Diabetes, Heart Disease, Nueropathy
Vorgeschichte
See item 11
Andere Medikamente
Metformin 500mg, Aspirin 81mg, Ezetimibe10mg, Ramipril 2.5 mg, Rosuvstatin 20mg, Duloxetine 60mg, Trulicity 1.5mg
Allergien
None
Vorherige Impfungen
-

VAERS 1176064

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
82,0
Geschlecht
M
Eingang
07.04.2021
Impfdatum
26.02.2021
Beginn
30.03.2021
Tage bis Beginn
32,0
Dosis
1
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Death

Symptomtext

Patient death within 60 days of receiving a COVID vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
14,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1173972

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
OH
Alter
70,0
Geschlecht
F
Eingang
07.04.2021
Impfdatum
27.02.2021
Beginn
27.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Asthenia Blood pressure fluctuation Blood pressure measurement Blood test Chest discomfort Chills Dehydration Dizziness Dyspnoea Fatigue Headache Heart rate Heart rate increased Magnetic resonance imaging head Malaise Myocardial infarction Nausea Pyrexia

Symptomtext

Tiredness; Headaches; Chills; Fever; Nauseated; Dizziness; Weakness; felt sick; can't see as good, her eyes are weak; Difficulty breathing; thought she was having a heart attack; dehydrated; fast heart beat that felt like her chest was full; fast heart beat that felt like her chest was full; Injection Site Pain; blood pressure fluctuated; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 27Feb2021 12:00 (lot number: EN6202; expiration date: 30Jun2021) as single dose for COVID-19 immunisation. Medical history included ongoing high blood pressure and stroke from 2012 to an unknown date. Concomitant medications included aspirin [acetylsalicylic acid] (ASPIRIN) taken for stroke from 2012 and ongoing; clopidogrel bisulfate (CLOPIDA) and simvastatin both taken for high blood pressure from 2012 and ongoing; ongoing amlodipine, lisinopril, and metoprolol all taken for high blood pressure. On 27Feb2021, she took the first vaccine. From that day, for 2 days, she had injection site pain. On 07Mar2021, she started having tiredness, headaches, chills, fever, felt nauseated, had a fast heart beat that felt like her chest was full and thought she was having a heart attack, dizziness, weakness, felt sick, and difficulty breathing. The patient added that she can't see as good, her eyes are weak. She was going to make an appointment to get her eyes checked. For dizziness event, she has to sit on the side of her bed for 10 minutes and she was still dizzy. She has to hold on to something because she feels like she is going to fall. She was given meclizine three times a day for this event. For tiredness event, she stated that it fluctuates during day. After she takes a paracetamol (EXTRA STRENGTH TYLENOL) and lays down for a while, she feels ok and then she feels tired again. For fast heart beat that felt like her chest was full and thought she was having a heart attack event, it comes and goes, she had it yesterday (21Mar2021) but hasn't had it today (22Mar2021) but she doesn't know if it is gone. Her symptoms were usually in the morning when she first gets up. She has been to the emergency room (ER) on 07Mar2021 and on 13Mar2021 and they say that nothing is wrong. On 07Mar2021, they gave her an IV because they thought she was dehydrated. On 13Mar2021, she went back to another hospital ER. She felt worse and her son came and got her and took her to the ER. They did a whole workup MRI of her head, x rays, blood work and everything. They didn't know what was causing it because it had it been over a week since her vaccine and they sent her home. She has been laying down and staying hydrated. She couldn't hardly get up and they asked her what has she done different and the only thing different was the vaccine. Everything listed on the risk factors [side effects] is how she is feeling. She was not hospitalized, they gave her medicine and told her to stay hydrated and sent her home and was told to follow up with her physician. She finally got an appointment for tomorrow (23Mar2021) with her physician. She can't drive because of the dizziness. All of her tests came back normal. They said her blood pressure fluctuated on 2021 but that is normal. Outcome of the injection site pain was recovered on 01Mar2021, of the difficulty breathing was recovering, of the headache, chills, fever, dizziness, weakness, and felt sick was not recovered, while of the remaining events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocardial infarction
Hospital-Tage
-
Labordaten
Test Date: 2021; Test Name: blood pressure; Result Unstructured Data: Test Result:fluctuated but is normal; Test Date: 20210313; Test Name: Bloodwork; Result Unstructured Data: Test Result:Normal; Test Date: 20210307; Test Name: Heartbeat; Result Unstructured Data: Test Result:fast; Test Date: 20210313; Test Name: Head MRI; Result Unstructured Data: Test Result:Normal; Test Date: 20210313; Test Name: X-ray; Result Unstructured Data: Test Result:Normal
Aktuelle Erkrankungen
Blood pressure high
Vorgeschichte
Medical History/Concurrent Conditions: Stroke
Andere Medikamente
ASPIRIN [ACETYLSALICYLIC ACID]; AMLODIPINE; CLOPIDA; LISINOPRIL; METOPROLOL; SIMVASTATIN
Allergien
-
Vorherige Impfungen
-

VAERS 1077148

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
64,0
Geschlecht
M
Eingang
06.04.2021
Impfdatum
05.03.2021
Beginn
05.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Feeling abnormal Seizure like phenomena Resuscitation Seizure

Symptomtext

decedent claimed after 2 hours he felt like someone gave him Valium, seizure like symptoms

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
high cholesterol, smoker (1 pack per day)
Andere Medikamente
medication for high cholesterol
Allergien
-
Vorherige Impfungen
-

VAERS 1166778

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
PA
Alter
85,0
Geschlecht
M
Eingang
04.04.2021
Impfdatum
01.04.2021
Beginn
01.04.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Anxiety Blood creatinine increased Cardiac failure congestive Chills Death Decreased appetite Dyspnoea Haemoptysis Myocardial infarction Myocardial necrosis marker increased Oxygen saturation decreased Poor quality sleep Pulmonary oedema Resuscitation Unresponsive to stimuli

Symptomtext

Patient had chills the night after the vaccine and throughout the night pulse ox dropped to 88, given 3L O2. Pt had little sleep and the next day had no appetite pulse ox between 88-90. After dinner had severe chills, no fever ,extreme SOB , pulse ox down to 79, coughing up blood tinged sputum, fluid in lungs, anxious. EMT called sent to hospital confirmed to have had an MI and new onset CHF, enzymes elevated, creat 1.8. Transferred to hospital and was stable. The next day still SOB, enzymes lessening, trying to wean from O2. The nurse attempted to get the pt to the bathroom he became extremely SOB and became unresponsive. They attempted CPR and the pt expired shortly thereafter due to another MI.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
1,0
Labordaten
cardiac enzymes positive, creatinine 1.8
Aktuelle Erkrankungen
none
Vorgeschichte
COPD, quadruple bypass, MI post Covid, COVID, prostate Cancer, basal cell skin cancer,HBP, High cholesterol,
Andere Medikamente
Eloquis, Plavix, Atorvastatin, Tylenol ,Dutasteride, Famotidine, Isosorbide, Metropolol, Amlodopine, Lisinopril, Vit D, Vit C, Vit B Complex, Cq10, Calcum chloride
Allergien
Rocephin
Vorherige Impfungen
Covid 19 Pfizer first shot chill and flu like symptoms for 2-3 days

VAERS 1164796

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
LA
Alter
59,0
Geschlecht
F
Eingang
03.04.2021
Impfdatum
05.03.2021
Beginn
06.03.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Cardiac arrest Cardio-respiratory arrest Chest pain Ventricular tachycardia

Symptomtext

brought in by EMS due to code. Started as CP and proceeded to cardiac arrest. Went into Vtach twice in the field. No cardiac issues other than HTN & afib. Per ED note, received COVID vaccine yesterday

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
HTN, Afib
Vorgeschichte
HTN, Afib
Andere Medikamente
-
Allergien
ADHESIVE TAPE-SILICONES; ASPIRIN; IBUPROFEN; NAPROXEN SODIUM; NSAIDS
Vorherige Impfungen
-

VAERS 1162057

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
PA
Alter
55,0
Geschlecht
F
Eingang
02.04.2021
Impfdatum
03.03.2021
Beginn
04.03.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal discomfort Blood pressure increased Cerebrovascular accident Facial paralysis Fatigue Fibromyalgia Head discomfort Headache Hypersensitivity Hypoaesthesia Mastocytosis Neurological examination Pain Paraesthesia Rheumatoid arthritis Swollen tongue

Symptomtext

her stomach was bothering her; her daughter told her the right side of her tongue looked swollen; allergic reaction to the COVID-19 Vaccine; heaviness with her headache; stroke; Facial droop; Numbness / left half of her face was numb /numbness in her left hand/numbness and tingling all over her body; Tingling; Tiredness; Pain; Headache; This is a spontaneous report received from a contactable consumer, the patient. A 55-year-old adult female received the first dose of BNT162b2 (solution for injection; Lot EN6202 and expiry information not provided) via unspecified route in the left arm on 03Mar2021 between 17:10 and 17:30 (at 55-years-old) for COVID-19 immunisation. Relevant medical history included Frozen shoulder (2020-2020), and severe migraines (especially in the past ten years). The patient further stated that she has always had migraines. She said sometimes when her migraines escalate, her blood pressure goes up, and her left side tingles. She said several times in the past, she thought her migraine symptoms may have been a stroke. She said she her doctor is checking her for any kind of things like rheumatoid arthritis, mast cells, constant (chronic) fatigue, and fibromyalgia. She said right before the COVID-19 Virus pandemic she had passed out unexpectedly. She said she doesn't know what caused her to pass out. She said she needs another neurological test done. She said she had a neurological test that maybe showed that veins were dying in her brain, but she wasn't sure. She said her doctor had been doing heart tests too, but because of the pandemic, it was taking longer to have the tests done. The patient also mentioned that her last blood work was probably in/around Nov2020. There were no concomitant medications or past drug history reported. The patient denied receiving any other vaccination within the four weeks prior to the vaccination. The patient also denied receiving any other vaccination on the same date as the vaccination. The patient reported that on 04Mar2021, approximately seventeen hours after she received the COVID-19 vaccine, she had what she thought was a kind of severe reaction. She said she had an inside numbness and tingling all over her body. She said the left side of her body, especially, had a very strong numbness and tingling, like a stroke. She said the numbness was in her left hand, and outside left shoulder. She said the left half of her face was numb. She said at the time she felt weird. She said she was speaking to her friend on a video call and did not want her friend to think she was a cry baby. She said then her friend told her there was something happening with her face. She said the right side of her face had dropped. She said her right eye and the right side of her mouth were drooping. She said she told her friend she thought she had an allergic reaction to the COVID-19 Vaccine. She said it took about three hours for her symptoms to pass. She said afterward she was so tired, had pain, and a headache. She said it was strange for her to have a headache because she was used to migraines. She said she still had a headache today (08Mar2021). She said she had a heaviness with her headache. She said if she had a migraine, she would not be able to do anything, but with the headache she had, she was able to go about her everyday things. She said her stomach was bothering her too, but she was not worried about how her stomach felt. The events did not require any visits to a physician's office nor the emergency room. Treatment for the events included drinking a lot of water and moving around. The outcome of the events, inside numbness and tingling all over her body, very strong numbness and tingling, like a stroke? numbness was in her left hand, and outside left shoulder, half of her face was numb, right side of her face had dropped, and tongue looked swollen, and allergic reaction to the COVID-19 Vaccine was recovered on 04Mar2021 after about three hours duration. The outcome of the events so tired, and pain was recovered on an unspecified date in Mar2021. The outcome of the events, headache, and heaviness with her headache was not recovered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
Test Name: Blood pressure; Result Unstructured Data: Test Result:increased; Test Name: Fatigue; Result Unstructured Data: Test Result:Constant(Chronic); Test Name: fibromyalgia; Result Unstructured Data: Test Result:Unknown Results; Test Name: mast cells; Result Unstructured Data: Test Result:Unknown Results; Test Name: neurological test; Result Unstructured Data: Test Result:Unknown Results; Test Name: rheumatoid arthritis; Result Unstructured Data: Test Result:Unknown Results
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Blood pressure increased; Frozen shoulder; Migraine; Passed out
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1156669

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
79,0
Geschlecht
F
Eingang
01.04.2021
Impfdatum
26.02.2021
Beginn
16.03.2021
Tage bis Beginn
18,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Pulmonary embolism

Symptomtext

bilateral pulmonary embolism

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1068850

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
70,0
Geschlecht
M
Eingang
01.04.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Death Fatigue Seizure

Symptomtext

Per the decedent's wife- the decedent reported feeling a little weak and tired after receiving the second shot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
kidney transplant 2012, HTN, 2nd Covid vaccination 2/26/2021, kidney failure
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1153498

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
SC
Alter
78,0
Geschlecht
F
Eingang
31.03.2021
Impfdatum
25.02.2021
Beginn
01.03.2021
Tage bis Beginn
4,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Blood pressure increased Blood pressure measurement Cerebrovascular accident Condition aggravated Dizziness Gait disturbance

Symptomtext

blood pressure sky high; blood pressure sky high; couldn't walk; almost having a stroke; little dizzy; This is a spontaneous report from a contactable consumer. A 78-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 25Feb2021 (Batch/Lot Number: EN6202) as SINGLE DOSE for covid-19 immunisation. Medical history included atrial fibrillation, blood pressure high, asthma. There were no concomitant medications. No other products. They have not had any other recent vaccinations or started any new medications. Caller said she had her first dose of the Pfizer COVID-19 vaccine shot 25Feb2021, then two weeks later her blood pressure was sky high and she couldn't walk and she went to the emergency room and they said that she was almost having a stroke. She said she was admitted 11Mar2021 and stayed until this past Sunday which was 14Mar2021. She hadn't seen her primary care provider (PCP) yet she only saw the doctor at the hospital. She was supposed to go back on 18Mar to get her second shot, so she wanted to know if it was gonna be safe. Caller said that she has recovered, and when she came home, she was a little dizzy, but they gave her a medication for vertigo and right now she was ok. Outcome of the events was recovered in Mar2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
Test Date: 202103; Test Name: blood pressure; Result Unstructured Data: Test Result:sky high
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Asthma; Atrial fibrillation; Blood pressure high
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1151921

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
PA
Alter
79,0
Geschlecht
M
Eingang
31.03.2021
Impfdatum
06.03.2021
Beginn
06.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Activated partial thromboplastin time prolonged Alanine aminotransferase normal Anion gap decreased Antiphospholipid antibodies negative Aspartate aminotransferase normal Atelectasis Basophil count decreased Basophil percentage Beta-2 glycoprotein antibody Blood albumin decreased Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium normal Blood chloride normal Blood creatinine increased Blood glucose normal Blood lactic acid decreased Blood magnesium increased

Symptomtext

Male patient who to the hospital on 3/15/2021 due to 10 days of shortness of breath on exertion and right-sided chest pain. He went to his PCP for follow-up and had a CT PE study today which was positive for right upper lobe and right lower lobe pulmonary embolism. He notes that he received a 2nd 5 0 COVID-19 vaccination on March 6th and since then has not felt well, feeling short of breath and generally fatigued. He notes that he has not been very active since receiving the vaccine. CT PE study showed an increased RV to LV ratio 1.2. He had no elevation in his troponin or BNP. His echocardiogram showed an EF of 60% and there were no wall motion abnormalities and grade 1 diastolic dysfunction. Patient would prefer Eliquis at this time. He will need a 6 month course of Eliquis. Given the setting of recent COVID vaccination and recent decreased mobility as possible provoking factors, this will be treated as a provoked pulmonary embolus. Per hospital COVID vaccine protocol, patient presentation will be reported to pharmacy for FDA reporting.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Gynaecomastia
Hospital-Tage
-
Labordaten
CTA - CHEST WITH IV CONTRAST - PULMONARY ANGIOGRAM INDICATION: R06.02: Shortness of breath. COMPARISON: None. TECHNIQUE: CTA examination of the chest was performed using angiographic technique according to a protocol specifically tailored to evaluate for pulmonary embolism. Axial, sagittal, and coronal 2D reformatted images were created from the source data and submitted for interpretation. In addition, coronal 3D MIP postprocessing was performed on the acquisition scanner. Radiation dose length product (DLP) for this visit: 396 mGy-cm . This examination, like all CT scans performed in the Hospital Network, was performed utilizing techniques to minimize radiation dose exposure, including the use of iterative reconstruction and automated exposure control. IV Contrast: 85 mL of iohexol (OMNIPAQUE) FINDINGS: PULMONARY ARTERIAL TREE: Right upper and lower lobe pulmonary emboli involving lobar and segmental branches. LUNGS: Patchy subpleural opacities in the right upper lobe. While this may represent fibrosis or pneumonia, appearance consistent with pulmonary infarct. Subsegmental atelectasis in the bases of the right middle and lower lobes and lingula. Lungs otherwise clear. PLEURA: Unremarkable. HEART/GREAT VESSELS: Unremarkable for patient's age. MEDIASTINUM AND HILA: No lymphadenopathy or mass. Esophagus unremarkable. Trachea and main stem bronchi normal. CHEST WALL AND LOWER NECK: Unilateral right-sided gynecomastia. No lymphadenopathy or mass. VISUALIZED STRUCTURES IN THE UPPER ABDOMEN: 1 cm low-attenuation mass in the right lobe, nonspecific, but most likely cyst. Left renal cyst. Otherwise unremarkable. OSSEOUS STRUCTURES: No acute fracture or destructive osseous lesion. Impression: 1. Right upper lobe and right lower lobe pulmonary emboli. 2. Patchy opacities in the right upper lobe, most likely pulmonary infarcts. Differential diagnosis includes pneumonia. The calculated ratio of right ventricular to left ventricular diameter (RV/LV ratio) is 1.2. This is greater than 0.9, which is abnormal and indicates right heart strain. An abnormal RV/LV ratio has been shown to be associated with an increased risk of 30 day mortality in the setting of acute pulmonary embolism. Urgent consultation with the medical critical care team is recommended. CHEM PROFILE Sodium 139 138 Sodium Potassium 4.2 3.6 Potassium Chloride 104 106 Chloride CO2 24 22 CO2 Anion Gap 11 10 Anion Gap BUN 16 16 12 BUN Creatinine 1.22 1.20 0.97 Creatinine Glucose, Random 106 103 Glucose, Random Calcium 9.3 9.1 Calcium CORRECTED CALCIUM 9.9 CORRECTED CALCIUM AST 17 AST ALT 17 ALT Alkaline Phosphatase 106 Alkaline Phosphatase Total Protein 7.8 Total Protein Albumin 3.2 Albumin TOTAL BILIRUBIN 0.77 TOTAL BILIRUBIN eGFR 56 57 74 eGFR Magnesium 2.2 Magnesium CARDIAC PROFILE Troponin I <0.02 Troponin I NT-proBNP 163 NT-proBNP OTHER CHEM LACTIC ACID 1.4 LACTIC ACID CBC WBC 10.09 9.09 WBC Red Blood Cell Count 5.28 4.45 Red Blood Cell Count Hemoglobin 15.4 13.0 Hemoglobin HCT 48.1 40.1 HCT MCV 91 90 MCV MCH 29.2 29.2 MCH MCHC 32.0 32.4 MCHC RDW 12.5 12.4 RDW Platelet Count 261 253 Platelet Count MPV 9.6 9.4 MPV nRBC 0 nRBC DIFFERENTIAL Neutrophils % 76 Neutrophils % Immat GRANS % 1 Immat GRANS % Lymphocytes Relative 10 Lymphocytes Relative Monocytes Relative 11 Monocytes Relative Eosinophils 1 Eosinophils Basophils Relative 1 Basophils Relative Immature Grans Absolute 0.08 Immature Grans Absolute Absolute Neutrophils 6.99 Absolute Neutrophils Lymphocytes Absolute 0.86 Lymphocytes Absolute Absolute Monocytes 1.04 Absolute Monocytes Absolute Eosinophils 0.06 Absolute Eosinophils Basophils Absolute 0.06 Basophils Absolute BETA2 GLYCOPROTEIN 1 AB BETA-2 GLYCOPROTEIN 1 IGG ANTIBODY 0.9 BETA-2 GLYCOPROTEIN 1 IGG ANTIBODY BETA-2 GLYCOPROTEIN 1 IGM ANTIBODY <2.9 BETA-2 GLYCOPROTEIN 1 IGM ANTIBODY BETA-2 GLYCOPROTEIN 1 IGA ANTIBODY 1.0 BETA-2 GLYCOPROTEIN 1 IGA ANTIBODY COAG FACTOR ACTIVITY ANTITHROMBIN III ACTIVITY 116 ANTITHROMBIN III ACTIVITY HYPERCOAGULATION PROTHROMBIN G20210A MUTATION Comment PROTHROMBIN G20210A MUTATION FACTOR V LEIDEN Comment FACTOR V LEIDEN LUPUS ANTICOAG SCREEN PTT LUPUS ANTICOAGULANT 31.9 PTT LUPUS ANTICOAGULANT DILUTE RUSSELL VIPER VENOM TIME 41.3 DILUTE RUSSELL VIPER VENOM TIME DPT CONFIRM RATIO 1.07 DPT CONFIRM RATIO LUPUS REFLEX INTERPRETATION Comme... LUPUS REFLEX INTERPRETATION PROTEIN C ACTIVITY Protein C Activity 88.0 Protein C Activity PROTEIN S ACTIVITY PROTEIN S ACTIVITY 96 PROTEIN S ACTIVITY PROTEIN S ANTIGEN FREE 125 PROTEIN S ANTIGEN FREE PROTEIN S ANTIGEN TOTAL 88 PROTEIN S ANTIGEN TOTAL PROTIME W/ INR Protime 14.9 15.6 Protime INR 1.16 1.23 INR DILUTE PROTHROMBIN TIME(DPT) 39.4 DILUTE PROTHROMBIN TIME(DPT) PTT PTT 30 199 100 75 PTT THROMBIN TIME THROMBIN TIME (DRVW) 13.6 THROMBIN TIME (DRVW) VIRAL TESTS INFLU A PCR Negat... INFLU A PCR INFLU B PCR Negat... INFLU B PCR RSV PCR Negat... RSV PCR SARS-COV-2 Negat... SARS-COV-2 T& B LYMPHOCYTES nRBC 0 nRBC ANTICARDIOLIPIN IGA ANTIBODY 1.4 ANTICARDIOLIPIN IGA ANTIBODY ANTICARDIOLIPIN IGG ANTIBODY 0.5 ANTICARDIOLIPIN IGG ANTIBODY ANTICARDIOLIPIN IGM ANTIBODY <0.8 ANTICARDIOLIPIN
Aktuelle Erkrankungen
Cardiovascular and Mediastinum Pulmonary embolism (HCC) Essential hypertension DVT (deep venous thrombosis) (HCC) Genitourinary BPH (benign prostatic hyperplasia) Elevated prostate specific antigen (PSA) Male erectile dysfunction Hyperlipidemia Glaucoma
Vorgeschichte
Cardiovascular and Mediastinum Pulmonary embolism (HCC) Essential hypertension DVT (deep venous thrombosis) (HCC) Genitourinary BPH (benign prostatic hyperplasia) Elevated prostate specific antigen (PSA) Male erectile dysfunction Hyperlipidemia Glaucoma
Andere Medikamente
apixaban (ELIQUIS) 5 mg atorvastatin (LIPITOR) 10 mg tablet finasteride (PROSCAR) 5 mg tablet latanoprost (XALATAN) 0.005 % ophthalmic solution olmesartan (BENICAR) 40 mg tablet sildenafil (VIAGRA) 100 mg tablet timolol (TIMOPTIC) 0.
Allergien
None known
Vorherige Impfungen
-

VAERS 1095221

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MD
Alter
66,0
Geschlecht
M
Eingang
31.03.2021
Impfdatum
09.03.2021
Beginn
17.03.2021
Tage bis Beginn
8,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute myocardial infarction Chest pain Stent placement Angina unstable Condition aggravated Dyspnoea Hypertensive urgency Pain in jaw

Symptomtext

3/17/21: patient presented and was admitted through ED for chest pain. Patient had recent event of NSTEMI and stent was placed last Friday. Per the EUA, hospitalizations are to be reported irrespective of attribution to vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hypertension and Thromboembolism.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1148826

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
IL
Alter
95,0
Geschlecht
M
Eingang
30.03.2021
Impfdatum
26.02.2021
Beginn
22.03.2021
Tage bis Beginn
24,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Condition aggravated Death General physical health deterioration Respiratory tract congestion

Symptomtext

Overall Decline w/congestion and ABT tx, Hospice Care, Crisis Care, Expired

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
Congestion, Pneumonia
Vorgeschichte
Cardiac arrhythmia, Dementia, Aphasia, Dysphagia, HTN
Andere Medikamente
ProHeal, calmoseptine, acetaminophen, Naproxen, Clopidogrel, Metoprolol tartrate, Lidocaine, Vit D3
Allergien
PCN
Vorherige Impfungen
-

VAERS 1147541

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6202

kritisch
Staat
OK
Alter
51,0
Geschlecht
M
Eingang
30.03.2021
Impfdatum
27.02.2021
Beginn
27.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Dyspnoea Injection site pain Peripheral embolism Pulmonary embolism Tension

Symptomtext

Pain in left arm . Tension in arms and shoulders. Shortness of breath. On 3/19/2021 I was diagnosed with pulmonary embolisms in both lungs and right leg

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
2,0
Labordaten
Hospitalized on 3/19/2021
Aktuelle Erkrankungen
None
Vorgeschichte
High blood pressure
Andere Medikamente
Diltiazem, losarten
Allergien
None
Vorherige Impfungen
-

VAERS 1144235

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
71,0
Geschlecht
F
Eingang
29.03.2021
Impfdatum
23.03.2021
Beginn
23.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Death

Symptomtext

Patient deceased on 3/23/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Cerebrovascular Accident, Acute Respiratory Failure, Type 1 Di
Vorgeschichte
Cerebrovascular Accident, Acute Respiratory Failure, Type 1 Diabetes Mellitus, Urinary Retention, Pancreatic Disease,
Andere Medikamente
APAP 325MG, Aspirin 81MG, Atorvastatin 40MG, Cefepime 1 GM,
Allergien
No Known Drug Allergies
Vorherige Impfungen
-

VAERS 1140394

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AZ
Alter
69,0
Geschlecht
F
Eingang
27.03.2021
Impfdatum
25.02.2021
Beginn
24.03.2021
Tage bis Beginn
27,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure Anion gap normal Arthralgia Basophil count decreased Basophil percentage decreased Blood calcium normal Blood chloride decreased Blood creatinine normal Blood glucose normal Blood lactic acid normal Blood magnesium increased Blood potassium normal Blood sodium decreased Blood urea decreased Breath sounds abnormal Cough Dyspnoea Dyspnoea exertional

Symptomtext

This is a 70 year old female with paroxysmal atrial fibrillation (anticoagualted on Eliquis), obstructive sleep apnea (uses CPAP), mitral valve regurgitation, remote tobacco use, hypertension and dyslipidemia who presents to the ED for worsening dyspnea, cough, subjective fever, chills and body aches that have been ongoing for the past several days. The patient indicates that her dyspnea is exacerbated with exertion but she denies chest pain, pleuritic chest pain, leg swelling or calf pain. She mentions that she has received both of her COVID-19 vaccines (Pfizer); the first immunization was on 02/25 followed by her second immunization which took place eight days ago on 03/18. She is not confident that she has had any contact with a known sick or definitive COVID-positive individual recently. Of note, the last documented incidence of testing for COVID-19 was performed on 10/31/2020 after the patient was seen at a Clinic after a exposure for a COVID-positive individual. Testing at that time had resulted negative. To her knowledge, she states that she had, in fact, tested positive for COVID-19 in late fall of 2020, but she was not hospitalized. Yesterday (3/26/2021), she was evaluated at a Pharmacy where she was testing for COVID-19 which has since resulted positive. The patient denies any other acute symptoms of illness. In the ED, the patient was found to have acute respiratory failure with hypoxemia and pneumonia due to SARS-CoV-2 infection. Review of Systems Constitutional: Positive for chills, fatigue and fever. Negative for activity change. Respiratory: Positive for cough and shortness of breath. Cardiovascular: Negative for chest pain and leg swelling. Gastrointestinal: Negative for abdominal pain, diarrhea, nausea and vomiting. Genitourinary: Negative for dysuria. Musculoskeletal: Positive for arthralgias and myalgias. Negative for gait problem. Neurological: Negative for syncope. All other systems reviewed and are negative. Vitals Blood pressure 159/79, pulse 65, temperature 36.4 ?C (97.5 ?F), temperature source Oral, resp. rate 18, height 1.6 m (5' 3"), weight 107 kg, SpO2 98 %. Physical Exam Vitals reviewed. Constitutional: General: She is awake. She is not in acute distress. Appearance: Normal appearance. She is well-developed. She is morbidly obese. She is ill-appearing. She is not toxic-appearing. Interventions: Nasal cannula in place. HENT: Head: Normocephalic and atraumatic. Nose: Congestion present. Mouth/Throat: Mouth: Mucous membranes are dry. Pharynx: Oropharynx is clear. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Pulses: Normal pulses. Heart sounds: Normal heart sounds. Pulmonary: Effort: Pulmonary effort is normal. Breath sounds: Decreased breath sounds present. Comments: Diminished breath sounds in all lung fields. Occasional cough. Abdominal: General: Bowel sounds are normal. There is no distension. Palpations: Abdomen is soft. Tenderness: There is no abdominal tenderness. Musculoskeletal: General: Normal range of motion. Cervical back: Normal range of motion and neck supple. Skin: General: Skin is warm and dry. Neurological: General: No focal deficit present. Mental Status: She is alert and oriented to person, place, and time. Psychiatric: Behavior: Behavior is cooperative.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
2,0
Labordaten
Diagnostic Results LABS Recent Results (from the past 24 hour(s)) Basic Metabolic Panel Collection Time: 03/26/21 7:52 PM Result Value Ref Range Glucose 163 (H) 70 - 99 mg/dL Urea Nitrogen (BUN) 9 8 - 23 mg/dL Creatinine 0.8 0.5 - 0.9 mg/dL Calcium (Ca) 9.3 8.8 - 10.2 mg/dL Sodium (Na) 131 (L) 136 - 145 mmol/L Potassium (K) 4.0 3.4 - 5.1 mmol/L Chloride (Cl) 92 (L) 98 - 107 mmol/L Carbon Dioxide (CO2) 25 22 - 29 mmol/L Anion Gap 14 (H) 3 - 11 mEq/L CBC with Auto Differential Collection Time: 03/26/21 7:52 PM Result Value Ref Range WBC 5.7 4.0 - 11.0 X1000/UL RBC 4.83 4.20 - 5.40 M/UL HGB 15.1 12.0 - 16.0 g/dL HCT 43.4 35.0 - 50.0 % MCV 89.8 80.0 - 100.0 FL MCH 31.2 (H) 27.0 - 31.0 PG MCHC 34.7 32.0 - 36.0 G/DL RDW 13.1 11.5 - 14.5 % Platelet Count 121 (L) 130 - 450 K/UL MPV 7.9 7.4 - 10.4 FL Neutrophils, auto 87.0 (H) 54 - 62 % Lymphocytes, auto 9.1 (L) 25 - 35 % Monocytes, auto 3.6 (L) 5.5 - 11.7 % Eosinophils, auto 0.0 0 - 5 % Basophils, auto 0.3 0 - 2.9 % Absolute Lymphocytes 0.5 (L) 1.0 - 3.2 K/uL Absolute Monocytes 0.2 (L) 0.3 - 1.1 K/uL Absolute Neutrophils 5.0 1.7 - 7.6 K/uL Absolute Eosinophils 0.0 0.0 - 0.5 K/uL Absolute Basophils 0.0 0.0 - 0.1 K/uL Troponin T Collection Time: 03/26/21 7:52 PM Result Value Ref Range TROPONIN T <0.01 0.00 - 0.01 ng/mL Troponin Note See Comment Lactic Acid Collection Time: 03/26/21 7:52 PM Result Value Ref Range LACTIC ACID 1.9 0.5 - 2.2 mmol/L Magnesium Collection Time: 03/26/21 7:52 PM Result Value Ref Range Magnesium 2.4 1.6 - 2.4 mg/dL PT/INR Collection Time: 03/26/21 7:52 PM Result Value Ref Range PT 20.3 (H) 9.4 - 12.6 SEC INR 1.74 (H) 0.90 - 1.20 Procalcitonin Collection Time: 03/26/21 7:52 PM Result Value Ref Range Procalcitonin 0.09 0.00 - 0.50 ng/mL Procalcitonin Note See Comment Note TMC Lab COVID-19 (In-house) Collection Time: 03/26/21 7:55 PM Specimen: Nasopharyngeal ; SWAB Result Value Ref Range COVID Source Nasopharyngeal swab SARS-CoV-2 (COVID-19) Positive (A) NEG Previously tested for COVID-19 Y Employed in healthcare Unknown COVID-19 Symptomatic as defined by CDC Y Date of Symptom Onset 20,210,326 Hospitalized for COVID-19 N Admitted to ICU for COVID-19 N Resident in a congregate care setting Unknown Is Patient Pregnant? Not Pregnant Respiratory Panel By PCR Collection Time: 03/26/21 8:46 PM Result Value Ref Range Resp Spec Source Nasopharyngeal swab Resp Panel Results No Organisms Detected Resp Panel Comment See Comment IMAGING ? Chest 1 view Portable, 3/26/2021 Poor inspiratory effort. Bilateral multifocal infiltrate. CARDIAC ? EKG 12 Lead, 3/26/2021 @ 16:01 Sinus rhythm at a rate of 76 bpm. Baseline wander in lead(s) II, III, aVF.
Aktuelle Erkrankungen
No other acute illnesses known at the time of vaccinations.
Vorgeschichte
OSA on CPAP Class 3 severe obesity in adult (HCC) Atrial fibrillation (HCC) Essential hypertension Dyslipidemia
Andere Medikamente
Albuterol Sulfate (ALBUTEROL, USE PROVENTIL HFA,) 90 MCG/ACT Inhale 1-2 puffs into the lungs every four hours as needed amiodarone (PACERONE) 200 MG tablet Take 200 mg by mouth daily. apixaban (ELIQUIS) 5 MG tablet Take 5 mg by mouth tw
Allergien
Morphine (nausea/vomiting)
Vorherige Impfungen
-

VAERS 1138370

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AZ
Alter
50,0
Geschlecht
M
Eingang
26.03.2021
Impfdatum
04.03.2021
Beginn
05.03.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death Influenza like illness Malaise

Symptomtext

he started feeling sick day after vaccine with flu like symptoms, seen in ED 5 days after vaccination, diagnosed with COVID19, About 1 week after that, he was found dead at home on his couch.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Not sure if autopsy was done
Aktuelle Erkrankungen
None
Vorgeschichte
diabetes, hypertension
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1129801

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
84,0
Geschlecht
M
Eingang
24.03.2021
Impfdatum
24.02.2021
Beginn
09.03.2021
Tage bis Beginn
13,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Myocardial infarction

Symptomtext

RECEIVED REPORT THAT TWO WEEKS AFTER HIS SECOND DOSE, HE DIED OF A MYOCARDIAL INFARCTION.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
UNKNOWN
Aktuelle Erkrankungen
NONE
Vorgeschichte
HEART DISEASE
Andere Medikamente
UNKNOWN
Allergien
UNKNOWN
Vorherige Impfungen
-

VAERS 1125283

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
IL
Alter
89,0
Geschlecht
F
Eingang
23.03.2021
Impfdatum
22.02.2021
Beginn
09.03.2021
Tage bis Beginn
15,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Systemic: Patient passed away-Severe, Additional Details: Patient passed away on 3/9/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1311817

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
56,0
Geschlecht
M
Eingang
22.03.2021
Impfdatum
27.02.2021
Beginn
02.03.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Angiogram pulmonary abnormal Pulmonary embolism

Symptomtext

Acute unprovoked pulmanary embolism 3 days after 2nd dose

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
3,0
Labordaten
ER 3-2-21 Ct Angio + PE
Aktuelle Erkrankungen
Diabetes, Asthma, Psoriasis
Vorgeschichte
Psoriatic arthrites, hyparlipidema
Andere Medikamente
sulfasalazine, empagliflozin , fluticasone/salmeterol,semaglutid losartan,metformin,montelukast, pantoprazole stela a
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1123622

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NC
Alter
80,0
Geschlecht
F
Eingang
22.03.2021
Impfdatum
23.02.2021
Beginn
23.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Angiogram pulmonary abnormal Dyspnoea exertional Productive cough Pulmonary embolism Respiratory viral panel

Symptomtext

- day after vaccine developed cough productive of white mucus, dyspnea on exertion. Finally sought care 3/17 due to progression of symptoms and was found to have bilateral pulmonary emboli. No DVTs. No risk factors for PE. No prolonged immobilization, travel, surgeries, obesity, active cancer. - COVID negative rapid and PCR test on admission. No known prior COVID infection.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
7,0
Labordaten
Extended viral respiratory panel negative CTA chest Findings: Moderate amount of acute pulmonary emboli in the right middle lobe, right lower lobe, and left upper lobe. Areas of peripheral vessels are not well visualized. Mild groundglass opacity and consolidation in a predominantly peripheral distribution relatively sparing the bases. Areas of septal thickening worse in the upper lungs. No mediastinal adenopathy. No pleural effusion. IMPRESSION: Moderate amount of acute pulmonary emboli in the right middle lobe, right lower lobe, and left upper lobe. Areas of peripheral vessels are not well visualized. Mild groundglass opacity and consolidation in a predominantly peripheral distribution relatively sparing the bases. Areas of septal thickening worse in the upper lungs. This distribution can be seen with atypical viral pneumonia.
Aktuelle Erkrankungen
- foot arthritis with flare of pain requiring steroid shot
Vorgeschichte
- hypertension - diabetes - recurrent UTIs - GERD
Andere Medikamente
- got steroid injection of foot 2/19/21 Home meds - aspirin 81mg daily - wellbutrin 150mg once daily - vitamin d2 5000 units once daily - tricor 145mg once daily - flaxseed oil 1000mg once daily - vit C 500mg once daily - gabapentin 200mg
Allergien
- augmentin - ciprofloxacin - clindamycin - sulfa - vancomycin
Vorherige Impfungen
-

VAERS 1116913

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
76,0
Geschlecht
M
Eingang
19.03.2021
Impfdatum
25.02.2021
Beginn
27.02.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood cholesterol Blood glucose abnormal Blood glucose increased Blood test Cerebrovascular accident Computerised tomogram Echocardiogram Hypertension Magnetic resonance imaging

Symptomtext

Minor Stroke affecting the right side (hand and leg). Went to emergency room Monday and Tuesday (3/1/21)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
Blood work, CT Scan, MRI and echo cardiogram. High glucose, moderately high blood pressure. Normal cholesterol. Released from hospital on 3/2/21.
Aktuelle Erkrankungen
-
Vorgeschichte
Pre-diabetic
Andere Medikamente
Metformin, nexuim, Centrum multi-vitamin, B-12
Allergien
none
Vorherige Impfungen
-

VAERS 1116808

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
-
Alter
39,0
Geschlecht
F
Eingang
19.03.2021
Impfdatum
13.03.2021
Beginn
13.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Autopsy Death Obesity cardiomyopathy

Symptomtext

No symptoms reported. Found dead seated on couch the day after vaccination (3/14/2021). Autopsy performed on 3/15/2021 showed no evidence of anaphylaxis. Cause of death = Cardiomyopathy of Obesity.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1115731

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
AZ
Alter
86,0
Geschlecht
M
Eingang
19.03.2021
Impfdatum
24.02.2021
Beginn
09.03.2021
Tage bis Beginn
13,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Computerised tomogram thorax abnormal Pulmonary embolism

Symptomtext

Large bilateral pulmonary embolus

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
5,0
Labordaten
CT chest 3-11-21
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, chronic low back pain, Gerd
Andere Medikamente
atorvastatin, oxycodone, omeprazole losartan
Allergien
nkda
Vorherige Impfungen
-

VAERS 1108531

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MS
Alter
65,0
Geschlecht
F
Eingang
17.03.2021
Impfdatum
04.03.2021
Beginn
06.03.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Bilevel positive airway pressure Cardiac failure congestive Catheterisation cardiac Condition aggravated Echocardiogram Echocardiogram abnormal Ejection fraction decreased Hypoxia

Symptomtext

Patient was noted to have abrupt respiratory failure 2 days after taking the 1st dose. The patient was admitted to the hospital for acute respiratory failure with hypoxemia secondary to acute CHF exacerbation. The patient had a transthoracic echocardiogram performed 2 weeks prior to hospitalization that was noted to show a left ventricular ejection fraction of 60-65%. At the hospitalization, her left ventricular ejection fraction was noted to decrease to 25-30%. Left heart catheterization was performed and showed no signs of ischemic heart disease (coronary artery disease). Patient was started on Entresto 24/26mg PO BID and Toprol XL 50mg PO daily and was diuresed with Bumex 1mg IV daily and was noted to have improvement in respiratory symptoms for which she was weaned off of BiPAP 15/5 with FiO2 of 50% down to room air. Patient had repeat transthoracic echocardiogram ordered prior to discharge and was noted to have an improvement in left ventricular ejection fraction to 48% prior to discharge. The only change was that the patient had the COVID-19 vaccination. Patient does not have any history of coronary artery disease or heart failure. Patient was worked up extensively for other etiologies of heart failure and none were found.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
COPD HTN HLD
Vorgeschichte
-
Andere Medikamente
Trelegy ellipta 1 inhalation daily Albuterol HFA 1 inhalation PRN
Allergien
Buspar Simvastatin Codeine Amoxicillin
Vorherige Impfungen
-

VAERS 1104693

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
PA
Alter
69,0
Geschlecht
M
Eingang
16.03.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Dizziness Myocardial infarction

Symptomtext

Light-headedness for several hours following vaccine, followed by massive heart attack.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocardial infarction
Hospital-Tage
5,0
Labordaten
Numerous. Transported by ambulance to Hospital.
Aktuelle Erkrankungen
none
Vorgeschichte
HIV
Andere Medikamente
Triumeq, calcium, vitamin D3
Allergien
none
Vorherige Impfungen
-

VAERS 1098756

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
LA
Alter
65,0
Geschlecht
M
Eingang
14.03.2021
Impfdatum
03.03.2021
Beginn
13.03.2021
Tage bis Beginn
10,0
Dosis
UNK
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Angiogram pulmonary Deep vein thrombosis Pulmonary embolism Ultrasound Doppler

Symptomtext

Patient has rt lower lobe Pulmonary emboli and rt popliteal dvt

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
2,0
Labordaten
CTA Lung and venous doppler
Aktuelle Erkrankungen
-
Vorgeschichte
Hypertension
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1095175

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MD
Alter
84,0
Geschlecht
M
Eingang
12.03.2021
Impfdatum
26.02.2021
Beginn
11.03.2021
Tage bis Beginn
13,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Abdominal pain Blood sodium decreased Cerebrovascular accident Fatigue Hyponatraemia Magnetic resonance imaging head abnormal

Symptomtext

The patient presented to the ED on 3/11/2021 with fatigue for a few weeks, and recent abdomen pain. The patient was found to be hyponatremic and there was also evidence of a CVA on MRI findings.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
CLL on ibrutinib
Vorgeschichte
CLL, CAD, hypertension, type 2 DM, stage 2 CKD, renal artery stenosis, COPD, anxiety
Andere Medikamente
aspirin, vitamin D3, fish oil-omega-3, glimepiride, Imbruvica, lisinopril, lorazepam, nifedipine, Miralax, risperidone, Anoro Ellipta, PreserVision
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 1094490

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
OK
Alter
66,0
Geschlecht
F
Eingang
12.03.2021
Impfdatum
24.02.2021
Beginn
10.03.2021
Tage bis Beginn
14,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cardiac arrest Death Loss of consciousness

Symptomtext

Patient was vaccinated with her second dose on Wednesday, February 24th. A family member contacted us to let us know she was sitting in a casino exactly one week later and passed out, going into cardiac arrest. The patient did pass away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Heart disease, high blood pressure
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 1092517

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
WI
Alter
69,0
Geschlecht
M
Eingang
11.03.2021
Impfdatum
02.03.2021
Beginn
06.03.2021
Tage bis Beginn
4,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood pressure normal Blood test normal Cerebrovascular accident Computerised tomogram head Electrocardiogram Hypoaesthesia Magnetic resonance imaging Ultrasound scan

Symptomtext

On March 6, I had a mild stroke. Left arm, leg, and foot went numb for 15 minutes. Hospital performed diagnostic tests. Stayed overnight for observation and tests. Symptoms went away. I had an EKG, CT scan of brain, ultrasound of neck veins, brain MRI, and echo cardiogram.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
Blood pressure normal, blood work normal, arteries normal, MRI showed stroke on 3-7 -2021. Cardiologist appointment on 3-9-2021 showed no reason for stroke. Blood tests ordered - results still pending from Clinic. Physician appointment 3-11-2021 no apparent reason for stroke.
Aktuelle Erkrankungen
None
Vorgeschichte
Supraventricular Tachycardia
Andere Medikamente
Low Dose Aspirin, Atorvastatin, Metoprolol,
Allergien
Erythromycin
Vorherige Impfungen
-

VAERS 1088741

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
85,0
Geschlecht
F
Eingang
10.03.2021
Impfdatum
26.02.2021
Beginn
27.02.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cardiac arrest Death Stenosis Unresponsive to stimuli

Symptomtext

Patient found unresponsive approx 16 hours after vaccination. Death listed as Cardiac arrest secondary to stenosis. Patient had inoperable cardiac issues and was reportedly in a terminal state.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
multiple cardiac issues, arterial/aortic stenosis
Vorgeschichte
aortic stenosis
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 1087885

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
68,0
Geschlecht
M
Eingang
10.03.2021
Impfdatum
08.03.2021
Beginn
09.03.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Patient was found deceased in garage one day post vaccination

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
2/25: Saw provider for Adrenal Nodule
Vorgeschichte
Obesity, Hypothyroidism, Pre-diabetes, hypertension, and aortic aneurysm 4.5cm
Andere Medikamente
Asprin 325mg daily, Viagra 50mg- 1 daily as needed, Levothyroxine 225mcg daily, Metformin 500 mg daily, Lisinopril 40mg daily, Metoprolol 50mg extended release daily, Simvastatin 20mg daily
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1082985

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
86,0
Geschlecht
M
Eingang
08.03.2021
Impfdatum
25.02.2021
Beginn
28.02.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cardiac arrest Death Dyspnoea Eye movement disorder Foaming at mouth Grunting Resuscitation

Symptomtext

Patient had been feeling dyspneic for 1.5 weeks to 1 month prior to his death on 2/28/21. He received vaccine on 2/25/21. On his family found him leaning on the couch with eyes rolled back and foaming at the mouth. He was making noises (like grunting sounds?). EMS was called. He had cardiac arrest while in ambulance enroute to EMS. Resuscitation efforts continued in ED. Family was informed about his status and resuscitation efforts were stopped.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
Worsened dyspnea x 1.5 to 2 weeks prior.
Vorgeschichte
Polymyalgia rheumatica, on prednisone; diagnosed 9/2020.
Andere Medikamente
LISINOPRIL 5MG TAB TAKE ONE TABLET BY MOUTH ONCE DAILY PREDNISONE 5MG TAB TAKE THREE TABLETS BY MOUTH EVERY MORNING TERAZOSIN HCL 10MG CAP TAKE ONE CAPSULE BY MOUTH AT BEDTIME FOR PROSTATE
Allergien
Levothyroxine (lower extremity edema)
Vorherige Impfungen
-

VAERS 1080716

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
MI
Alter
67,0
Geschlecht
F
Eingang
08.03.2021
Impfdatum
27.02.2021
Beginn
01.03.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

On day three after vaccine administration patient expired. quite an active man, no signs led up to his death until maybe a half hour prior to the event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
Arthritis Hyperlipidemia Hypertension
Andere Medikamente
amLODIPine (NORVASC) 5 mg tablet meloxicam (MOBIC) 15 mg tablet metoprolol succinate (TOPROL XL) 100 mg 24 hr tablet valsartan-hydrochlorothiazide (DIOVAN-HCT) 320-25 mg per tablet
Allergien
none
Vorherige Impfungen
-

VAERS 1068700

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
PA
Alter
77,0
Geschlecht
M
Eingang
03.03.2021
Impfdatum
25.02.2021
Beginn
26.02.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Patient passed away 24 hours after receipt of 1st Dose Pfizer vaccine. Provider does not feel death was due to vaccination. but underlying conditions. No immediate side effects noted from vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Known pneumothorax w/ chest tube placement after percutaneous lung biopsy;
Vorgeschichte
current smoker; severe emphysema ; enlarging lung nodules w/ avidity; IA Lung CA with right lower lobectomy;
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1053847

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
29,0
Geschlecht
M
Eingang
02.03.2021
Impfdatum
25.02.2021
Beginn
25.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Anaphylactic shock Asthenia Feeling jittery Injection site reaction Loss of consciousness Dizziness Syncope Pain in extremity Sensory disturbance

Symptomtext

Five minutes after injection, a sensation spread from the injection site, through my body, until I fell unconscious. After I was awakened by staff soon after, I nearly lost consciousness again. I was administered an epi pen. After several minutes, I was given a 2nd epi pen (first in right arm, 2nd in right thigh). At this time, it was believed to be anaphylactic shock. I was then rushed to Hospital, where my vitals were monitored for about 2 hours. I was released around 730 am, and told that it was likely a vasovagal syncope. After that, I was jittery and weak for the rest of the day, and had a bit of a sore arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic shock
Hospital-Tage
1,0
Labordaten
See above.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1053847

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NY
Alter
29,0
Geschlecht
M
Eingang
02.03.2021
Impfdatum
25.02.2021
Beginn
25.02.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Anaphylactic shock Asthenia Feeling jittery Injection site reaction Loss of consciousness Dizziness Syncope Pain in extremity Sensory disturbance

Symptomtext

Five minutes after injection, a sensation spread from the injection site, through my body, until I fell unconscious. After I was awakened by staff soon after, I nearly lost consciousness again. I was administered an epi pen. After several minutes, I was given a 2nd epi pen (first in right arm, 2nd in right thigh). At this time, it was believed to be anaphylactic shock. I was then rushed to Hospital, where my vitals were monitored for about 2 hours. I was released around 730 am, and told that it was likely a vasovagal syncope. After that, I was jittery and weak for the rest of the day, and had a bit of a sore arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic shock
Hospital-Tage
1,0
Labordaten
See above.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1061064

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
SD
Alter
85,0
Geschlecht
F
Eingang
28.02.2021
Impfdatum
26.02.2021
Beginn
27.02.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
SYR / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Respiratory arrest

Symptomtext

Unable to breathe and died. Doctors unable to save her upon arrival

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Bacterial infection
Vorgeschichte
Depression, anxiety, and pain in joints from arthritis
Andere Medikamente
Sulfamethoxazole and Trimethoprim Tablets Oxy Antidepressants Anxiety meds Bladder control
Allergien
-
Vorherige Impfungen
-

VAERS 1060833

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
NC
Alter
74,0
Geschlecht
F
Eingang
28.02.2021
Impfdatum
24.02.2021
Beginn
25.02.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Headache Nausea Vomiting

Symptomtext

Severe headache, nausea and vomiting

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1059471

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
TX
Alter
62,0
Geschlecht
M
Eingang
27.02.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Cardiac arrest Cardioversion Immediate post-injection reaction Loss of consciousness Resuscitation

Symptomtext

Patient experience sudden cardiac arrest approximately 2 minutes after vaccine was administered. Paramedics on scene provided CPR and defibrillation and pulse was restored. Patient was regained consciousness prior to transport to the hospital.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1058793

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

kritisch
Staat
OK
Alter
66,0
Geschlecht
M
Eingang
26.02.2021
Impfdatum
24.02.2021
Beginn
25.02.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Pain in extremity

Symptomtext

Pt had only complained of a sore arm after receiving the vaccine- pt died on 2/25/21 from what they feel was a massive heart attack- unsure if related to vaccine at all

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
diabetes- type 2 High bp
Vorgeschichte
diabetes- type 2 High bp
Andere Medikamente
unsure
Allergien
unsure
Vorherige Impfungen
-

VAERS 2719936

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
84,0
Geschlecht
F
Eingang
01.12.2023
Impfdatum
01.03.2021
Beginn
13.01.2022
Tage bis Beginn
318,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Angiogram pulmonary abnormal COVID-19 Fibrin D dimer increased Hypotension Pulmonary oedema SARS-CoV-2 test positive Unresponsive to stimuli

Symptomtext

Pt found unresponsive at home, hypotensive: + covid in ED; No shortness of breath and saturating well on 2 L by nasal cannula Tx: vitamin-C zinc and Lovenox; Elevated D-dimers, CTA of the chest is negative for PE but showed mild pulmonary edema.Discontinue IV fluid, give Lasix.iv.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary oedema
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1143324

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
85,0
Geschlecht
F
Eingang
08.11.2023
Impfdatum
25.02.2021
Beginn
10.07.2023
Tage bis Beginn
865,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Atrial fibrillation Cardioversion Dry skin Dyspnoea Erythema Blood sodium decreased COVID-19 Chest X-ray abnormal Computerised tomogram thorax normal Cough Diarrhoea Hypophagia Hypoxia Influenza like illness Feeling cold Heart rate increased Heart rate irregular Malaise

Symptomtext

BRIEF OVERVIEW: Admission Date: 7/10/2023 Discharge Date: 7/15/2023 Discharge Disposition: home health care svc DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] COVID-19 [U07.1] HOSPITAL COURSE: Patient is 87-year-old female PMH significant for CKD stage 4, chronic diastolic HF, paroxysmal AFib, hypertension--presents to the hospital 7/10 with complaints of dyspnea. Patient had flu-like symptoms, nausea, vomiting, diarrhea and cough about 11 days prior to admit and tested positive for COVID-19. She tried to nurse herself at home but did not notice any improvement over several days. She continued to have progressive dyspnea, especially about 5 days prior to presentation, ongoing poor oral intake. Patient was noted to be hypoxic in ER and was placed on supplemental oxygen, along with sodium of 125. Chest x-ray showed right lung pneumonia in left lung streaky opacity. Film array confirmed positive COVID-19. Patient was placed on supplemental oxygen given hypoxia and admitted to the hospital for further management of COVID infection. Patient does not qualify for remdesivir due to duration of her illness, was started on dexamethasone at 6 mg daily along with encouragement for pulmonary toilet, deep breathing/coughing, increased out of bed mobility and maintaining adequate nutrition. She was maintained on her home dose apixaban for DVT prophylaxis. Patient's hypoxia worsened to need Ventimask, CT thorax was obtained which was negative for any lobar consolidations and hence was not started any antibiotics. Her procalcitonin was negative as well. Since no clinical improvement was noted, pulmonary consultation was requested, recommended to continue with present management, possibly consideration for high-flow nasal cannula if FiO2 need> 50%/or oxygen pendant if FiO2 requirement < 40%, instead of Ventimask. Will need outpatient repeat CT for follow-up in 2-3 months. Commented on other available therapies including remdesivir (if patient gets worse), baricitinib, antibiotics, diuretics etc.. Oxygen needs however started to improve by 7/14, pulmonary rehab consulted and recommended d/c home with 3L at rest and 6L with activity. Portable O2 tank dropped off too room and pt discharged home in stable condition on 7/15. HHC was arranged for her ongoing home therapy. Her presenting symptoms of nausea, vomiting and diarrhea mostly resolved. Renal function consistent with her stage IV CKD, remained stable. Atrial fibrillation also states stable, maintained on anticoagulation

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Chronic renal disease, stage IV Paroxysmal atrial fibrillation Chronic diastolic heart failure Family history of ovarian cancer Tubular adenoma Coronary artery disease involving native coronary artery without angina pectoris, unspecified whether native or transplanted heart Bladder cancer Chronic pruritus Dyslipidemia Hypertension, benign Postmenopausal osteoporosis Long term current use of antiarrhythmic drug Acute respiratory failure with hypoxia Pneumonia due to COVID-19 virus
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet amiodarone (PACERONE) 200 MG tablet apixaban (ELIQUIS) 2.5 MG tablet Cannabidiol Oil Carboxymethylcellulose Sodium (ARTIFICIAL TEARS OPTH) cholecalciferol (VITAMIN D3) 50 MCG (2000 UT) tablet ferrous su
Allergien
AmpicillinNausea Only Ciprofloxacin Fosamax Lyrica Prednisolone Pregabalin Simvastatin Xanax [Alprazolam] Zetia [Ezetimibe]Myalgia
Vorherige Impfungen
-

VAERS 2679473

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
81,0
Geschlecht
M
Eingang
06.09.2023
Impfdatum
26.02.2021
Beginn
14.02.2022
Tage bis Beginn
353,0
Dosis
2
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory distress syndrome Anticoagulant therapy Bradycardia C-reactive protein increased COVID-19 COVID-19 pneumonia Cardiac pacemaker insertion Computerised tomogram thorax abnormal Cough Dyspnoea Fibrin D dimer Hypoxia Intensive care Lung opacity Positive airway pressure therapy SARS-CoV-2 test positive Serum ferritin increased

Symptomtext

Presented to ED with SOB, hypoxia, cough x 5 days; + covid 4 days PTA; dx Covid PNA/ARDS; Labs: D-dimer 1.55; CRP 486: Ferritin: 1841; Chest CT: Covid 19 PNA groundglass opacities; TX: Rocephin, Decadron, Lovenox, 2/15 Tocilizumab x1 dose; HFO2 2/17 To ICU; dopamine, veletri neb added; 2/18 Bipap 2/19 bradycardia due to Covid; PPM inserted; 2/21 back to HFNC for O2; at 7LPM HFNC at discharge

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory distress syndrome
Hospital-Tage
11,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2659294

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
78,0
Geschlecht
F
Eingang
21.07.2023
Impfdatum
23.02.2021
Beginn
16.07.2023
Tage bis Beginn
873,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Syncope

Symptomtext

syncope

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2433451

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
70,0
Geschlecht
M
Eingang
08.09.2022
Impfdatum
02.03.2021
Beginn
18.08.2022
Tage bis Beginn
534,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Anaemia Blood creatinine increased COVID-19 Chest X-ray normal Computerised tomogram abdomen normal Computerised tomogram head normal Computerised tomogram spine Cough Haemoglobin decreased Laboratory test abnormal Loss of consciousness Road traffic accident SARS-CoV-2 test positive Troponin normal Urine analysis normal

Symptomtext

72y.o. male with hx of prostate CA, DM-II, HTN, CAD (mild), PAD, recurrent syncope, current smoker presented to the ED after a MVC. Patient was driving at around 45 mph when he hit a fire hydrant and his car flipped over in the city. Pt states he lost consciousness prior to the crash. On arrival in ED BP 181/78, O2 100% on RA. Labs revealed Cr 1.49, mild anemia hgb 11.9, trop negative x1. UA negative. COVID-19 PCR positive in ED. CT hea/C-spine negative for acute process. CT C/A/P negative for acute process. CXR negative for acute process or infiltrates. He was cleared by trauma sx team for DC. However, he was admitted for further work up for recurrent syncopal episodes and cardiology is consulted.Patient states he had a similar episodes few months ago but he was not driving at, did not seek medical attention at that time. Patient denies any recent changes to his meds. Pt states he is vaccinated against COVID 19 x2 and boosted x2. He reports mild dry cough, but no shortness of breath, chest pain, or GI symptoms. Patient was not aware that he had COVID-19 infection a prior to the admission. States his mild dry cough started about couple days ago but he thought was related to allergies. All imaging studies including CT head/C-spine, CT C/A/P, CXR, pelvic XR all negative for acute process or fracture. Okay to discharge and schedule loop monitor implant outpatient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
10,0
Labordaten
8/18 SARS-CoV-2 (COVID-19) by Nucleic Acid Amplification, POC --detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2408639

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NM
Alter
62,0
Geschlecht
M
Eingang
11.08.2022
Impfdatum
29.04.2022
Beginn
20.06.2022
Tage bis Beginn
52,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Eyelid ptosis Facial paralysis Visual impairment

Symptomtext

Right Hand eye lid began drooping on 20Jun2022 adversely affecting my eyesight. Consulted my primary doctor at earliest opportunity on 24Jun2022. My primary Doctor referred me to an ophthalmologist which I visited on 12Jul2022. I am now awaiting my appointment to the eyelid surgical ophthalmologist which the earliest I could get was 29Sep2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
-
Labordaten
Initial results indicated Ptosis of the right eyelid.
Aktuelle Erkrankungen
None
Vorgeschichte
High Blood Pressure
Andere Medikamente
Valsartan 320mg, Atorvastatin 40mg, Amlodipine Besylate 5mg, Multi Vitamin , Allegra
Allergien
Cats
Vorherige Impfungen
-

VAERS 2402979

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
85,0
Geschlecht
F
Eingang
05.08.2022
Impfdatum
26.02.2021
Beginn
20.07.2022
Tage bis Beginn
509,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Atrial fibrillation COVID-19 Dizziness Dyspnoea exertional Echocardiogram Head injury Injury Loss of consciousness SARS-CoV-2 test positive Syncope

Symptomtext

7/20--7/20 87y.o. female with a PMH of persistent Afib (on eliquis), CAD s/p stents, HFpEF (EF 45%), DM type 2, HLD, and ischemic cardiomyopathy s/p ICD who presents s/p syncopal episode this morning. LOC lasted "a few seconds" per her daughter. + head trauma on eliquis. Patient was at a HCF for TEE. Prior to the TEE, she got up to the bathroom and synopsized. She has been experiencing lightheadedness upon standing and with ambulation since Sunday. Also admits to SOB on exertion which has been ongoing since May. Denies current lightheadedness, palpitations, chest pain, dyspnea, orthopnea, weight gain, or diaphoresis. Pt had COVID in May 2022. Subsequently, she was diagnosed with persistent Afib. Had a negative COVID test at an urgent care on Monday. Incidentally found to be COVID positive while in the ED. Vaccinated with Pfizer x2. Denies fevers, chills, headache, cough, abdominal pain, nausea, vomiting, diarrhea, hematuria, dysuria, or hematochezia. Received message that pt wants to leave AMA because she refuses to be admitted to COVID floor. Spoke again with pt and her daughter at bedside regarding possible consequences of leaving AMA. Pt verbalized her understanding. Pt cleared by cardiology for discharge. Pt to decrease lasix to the following dose: Lasix 40mg q AM and 20mg qhs. D/c hydralazine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
7/20 -- SARS-CoV-2 by NAA, detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2398157

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
GA
Alter
55,0
Geschlecht
F
Eingang
01.08.2022
Impfdatum
10.02.2021
Beginn
10.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Arthralgia Bell's palsy Blood test Chest discomfort Computerised tomogram Dry mouth Dyspnoea Electromyogram normal Epistaxis Erythema Gingival erythema Headache Hypoaesthesia Hypoaesthesia oral Impaired work ability Lethargy Lip swelling Magnetic resonance imaging head

Symptomtext

After the first shot at 2 30pm on February 10th 2021, Wednesday my left arm hurt all night. the nurse said not to take any Tylenol after the shot so I didn't. My left knee and other joints also hurt, I was unable to sleep. Left arm was very sore all the next day on Thursday 2/11/2021. Chest tightness as well, but that was over by Friday. On Friday, I took Tylenol that night and didn't feel as sore but I had a mild headache. That Saturday I woke up with a headache, I took some Advil to help with the body ache as well. Did not sleep very well that night. Woke up at 4 am unable to breathe, I think I was extremely congested. Went to bed with slight nausea feeling. Took Advil again on Sunday 2/14. Headache finally went away and overall body soreness went away, but I had another bloody nose. I don't remember what day the first bloody nose happened. Monday February 15th, I had two bloody noses and felt nauseous before and after I ate. I didn't write it in my notes, but I remember that I also had a fever at this time. After the 2nd dose of Pfizer, two weeks later, It was not as bad. I had more arm soreness, lethargy for a few days. No fever or previous symptoms. Joints really hurt again. I got a COVID-19 test, negative. I noticed some numbness and tingly in my left foot and left hand. I had previously had a cortisone shot for my knee and after the 2nd dose Vaccine it negated the effectiveness of it. On May 26th 2021 I had an annual visit with my doctor and briefly discussed everything but didn't raise any alarms. A few weeks after that, on June 7th, I was instructed to go to ER my left face, from my mouth and ear it was numb and tingling. I had woken up and my upper left lip was slightly swollen and burning. The left part of my throat was numb. I also had left arm numbness starting from upper arm all the way down to hands. The ER ruled out a stroke, did not know what caused the numbness. While at the ER I also started to feel it in my right arm and foot. When I left ER I still had the numbness. Possible migraine explanation, but no definite answer from ER Doctor. Saw dentist on June 8th, he did not see any type of nerve damage, some slight gum redness. No medications prescribed. On June 9th I saw my doctor again for the numbness in my face, and she wasn't sure what it was. Possibly signs of shingles or bells palsy but no other rashes or drooping. Prescribed a virus medication for Bells Palsy and Shingles to help with numbness and an ointment for dryness and redness around corner of mouth. Follow up tele-health visit and wanted a cervical MRI. Vision became more blurry. Numbness in the right arm after taking antiviral on June 10th. By Thursday June 17th the right forearm and left forearm were matched in numbness. July 19th, had another MRI. Didn't really find anything significant that would explain the numbness. July 26th 2021- still having numbness continual in hands and feet and face, affecting my work and sleep. Doctor ordered EMG, everything was fine, no nerves were blocked. In March of 2022 I was still speaking with Neurologists, and she still was at a loss.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
COVID-19 test, CT Scan (07/07/21), Blood work (07/07/21), Cervical Spine MRI with and without Contrast( July 19th) , Brain MRI (July 19th), EMG
Aktuelle Erkrankungen
-
Vorgeschichte
Pain issues with left knee (previous surgery); Arthritis in right foot
Andere Medikamente
Probiotic; Alive 50+ Multivitamin; Cranberry tablets; Fish Oil; Magnesium
Allergien
Seasonal
Vorherige Impfungen
-

VAERS 2396140

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
AZ
Alter
-
Geschlecht
M
Eingang
29.07.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Drug ineffective Guillain-Barre syndrome Paralysis Pneumonia SARS-CoV-2 test

Symptomtext

He was paralyzed, He was put into hospital he came into another hospital, He spend two months in a hospital; her husband got GBS; Pneumonia; Her husband got the Pfizer (COVID-19) Vaccine, was tested positive for COVID now.; Her husband got the Pfizer (COVID-19) Vaccine, was tested positive for COVID now.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group, Program ID. A 77-year-old male patient received BNT162b2 (BNT162B2), as dose number unknow, single (Lot number: EN6202) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PARALYSIS (hospitalization, medically significant), outcome "unknown", described as "He was paralyzed, He was put into hospital he came into another hospital, He spend two months in a hospital"; GUILLAIN-BARRE SYNDROME (hospitalization, medically significant), outcome "unknown", described as "her husband got GBS"; PNEUMONIA (medically significant), outcome "unknown"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Her husband got the Pfizer (COVID-19) Vaccine, was tested positive for COVID now.". The patient was hospitalized for paralysis, guillain-barre syndrome (hospitalization duration: 60 day(s)). The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of paralysis, guillain-barre syndrome. Clinical course: The reporter mentioned that her husband got the Pfizer vaccine and her husband was tested positive for COVID now, she added as well that her husband got pneumonia as well her husband got GBS and she mention that she feels GBS was the symptom of Pfizer vaccine." The reporter mentioned that her husband got pneumonia as well GBS and she wants to clarify if GBS was the symptom of Pfizer Vaccine?". Regarding Lot no, Consumer stated, "Which one do you want? For COVID Pfizer EN6202 (Clarified and captured in tab) and second one it says COVID Pfizer it looks like EDAEP I can't read the second letter and then its 69SS." Expiration date: Reporter stated, "No, there was no expiration date on there." Treatment for the side effect: Reporter stated, "Yes, he was paralyzed from, he ended up with GBS. He was put into hospital he came into another hospital. He spend two months in a hospital in and out and he was in rehab he was, at the towards the end of rehab at that time in his right leg he has 8 muscles out of 10 that are not working so he looked like he was paralyzed from the neck down."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
60,0
Labordaten
Test Name: Covid 19 test; Test Result: Positive
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2374787

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
33,0
Geschlecht
F
Eingang
20.07.2022
Impfdatum
27.02.2021
Beginn
27.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Abdominal pain Blood test Chills Computerised tomogram abnormal Condition aggravated Decreased appetite Dysstasia Ear infection Ear pain Fall Fibromyalgia Inflammation Laboratory test abnormal Loss of consciousness Magnetic resonance imaging abnormal Mobility decreased Muscle tightness Pain

Symptomtext

On the same day of vaccination of Dose 2, I started having muscle tightness with difficulty moving, lockjaw, fever up to 101.0, chills and body aches. Three days after vaccination, I actually started feeling a little better but the 4th day, all symptoms came back with intensity. After 3 or 4 weeks, I was still experiencing muscle tightness but started pushing myself to move more which caused me to "convulse and fall". I passed out and my husband said it looked like a seizure. The same seizure activity happened again a week after the 1st one. On 4-21-2021 I could not move at all. I had abd pain and loss of appetite. I put my feet on the floor and could not feel the floor due to my feet tingling. I tried to stand up and fell down. My husband took me to the doctor that day and I was sent to the Emergency Room They did a CT scan (unsure if spine or of specific area). The ER told me that my arthritis in my lower back was inflamed. They gave me medication for inflammation in the ER but I do not recall the name of the medicine. In May, 2021 I went to the Internal Medicine and he told me it was an arthritis flare and fibromyalgia and he started me on Gabapentin, baclofen and Buspirone. I felt like I was having behavioral and mental differences with the Buspirone so I stopped taking it. In May 2021, I started hurting all over and both ears were hurting so I went to the ER and they done a head CT which showed double ear infections. In the last week of May 2021, the orthopedic doctor started me on aquatic therapy and sent me to a pain management clinic. In June, 2021, I started going to the pain management and they upped the Gabapentin to a stronger dose and increased frequency. They started me on Cymbalta and injected a steroid into my spine. The spinal injections gave me approx 60% of my mobility back but they are wearing off now and I am having trouble sitting.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
April 21, 2021 Hospital ER (CT scan of back and bloodwork) May 5, 2021 Hospital ER - bloodwork and head CT scan (May 5th, 2021) June or July 2021- bloodwork - "showed some type of infection but unsure what kind", also vit B, Vit K, Vit D insufficiencies. Also performed labwork Oct 2021, Jan 2022, MRI imaging of Hip/brain, lumbar and neck. MRI neck/lumbar 12/2021 MRI head 01/2022
Aktuelle Erkrankungen
None
Vorgeschichte
Migraines, rheumatoid arthritis, hx TBI, Irritable Bowel Syndrome, GERD, gastritis, possible Multiple Sclerosis, Chronic Bronchitis
Andere Medikamente
None
Allergien
Gluten, tomatoes, dairy, pollen, dust, pine sol, guava, flexaril, prednisone, aspirin, no ibuprofen, adhesives, pet dander/fur, some trees
Vorherige Impfungen
-

VAERS 2314236

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OK
Alter
52,0
Geschlecht
M
Eingang
09.06.2022
Impfdatum
02.03.2021
Beginn
01.04.2021
Tage bis Beginn
30,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Atrial fibrillation Blood thyroid stimulating hormone decreased Cardiac failure congestive Cardiac function test abnormal Heart rate irregular Hyperthyroidism Insomnia Laboratory test Left atrial enlargement Loss of consciousness Peripheral swelling Weight decreased

Symptomtext

After 2nd Pfizer vaccine on 3-2-21, patient noticed insomnia and weight loss. Then after booster received on 12-17-21 noted swelling in legs and erratic heart rate. Arranged to get lab tests at hospital and passed out while at hospital. Patient did get lab tests done and was told by Dr. that it was the lowest TSH result that he had ever seen. Reports that heart tests were done, and left atrium was enlarged, there was atrial fibrillation and signs of Congestive Heart Failure. Was diagnosed with hyperthyroidism. Reports 50-pound weight loss from approx. 275 to 225.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
9,0
Labordaten
Unknown of all tests completed but TSH level and some cardiac testing completed.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
heartburn medications
Allergien
None
Vorherige Impfungen
-

VAERS 2076003

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
87,0
Geschlecht
F
Eingang
11.05.2022
Impfdatum
03.02.2021
Beginn
14.02.2022
Tage bis Beginn
376,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Decreased appetite Peripheral swelling SARS-CoV-2 test positive Urinary retention Fall Syncope

Symptomtext

02/14/22 presents to ED for "urinary retention, BLE swelling and decreased appetite". PMHx of "anemia, A fib, CKD, CHF"

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
02/14/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2256865

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
PA
Alter
68,0
Geschlecht
F
Eingang
28.04.2022
Impfdatum
31.03.2021
Beginn
18.05.2021
Tage bis Beginn
48,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Anaemia Anticoagulant therapy Blood test Dyspnoea Laboratory test normal Pulmonary function test normal Pulmonary thrombosis Thrombosis

Symptomtext

After 2nd shot on 3/31/2021, near the end of April I began having shortness of breath. I got a new inhaler 5/18/21, but was more easily winded than usual even with the inhaler. Was prescribed a daily inhaler in June with no improvement. Went to the emergency room 6/30/2021, because I could not breathe. Admitted to Hospital 7/1/2021 with bilateral blood clots in the lungs and a blood clot in my L leg. Clots were said to be so large that Drs. could not use clot buster drugs. I also had anemia. I was hospitalized for a week. Subsequent tests did not turn up a cause. I have had extensive bood tests during and after my hospitalization. I have had cancer screenings with no problems. I am seeing a Hemotologist, a Pulmonary doctor and my GP. My lung function is good. I am on xarelto since my hospitalization. I read a pdf of VAERS reporting that showed dpeople with problems up to 120 days later, so I am reporting my experience.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary thrombosis
Hospital-Tage
7,0
Labordaten
see above
Aktuelle Erkrankungen
none
Vorgeschichte
asthma
Andere Medikamente
Zyrtec,Pepcid AC
Allergien
dander, hay fever
Vorherige Impfungen
-

VAERS 2228415

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
74,0
Geschlecht
M
Eingang
12.04.2022
Impfdatum
07.10.2021
Beginn
20.02.2022
Tage bis Beginn
136,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Anticoagulant therapy Asthenia Atelectasis Body temperature increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Dyspnoea Hypoxia Lung infiltration Productive cough Respiratory distress SARS-CoV-2 test positive

Symptomtext

2/20/21-Arrived at ER, with complaints of SOB, weakness and productive cough. Hx of COPD, baseline o2 Sat 92-94% on 2L o2 via NC, o2 sat today at home 88-90%. Positive home COVID test x 2. 86% o2 sat placed on 4LNC, RR-17, HR 90, 100.04 oral temp. Covid+ test on admission. Admit with Acute Hypoxic distress secondary to Covid Pneumonia CXR showed bi basilar atelectasis or infiltrates. IV Azithromycin, IV Decadron, IV Remdesivir, DuoNeb, baricitinib , Elliquis and acetaminophen started. 2/21/21- Patient continues on 4LNC o2 sat 92%, states SOB and coughing improving. Afebrile. Supplemental 02 continued will try to to taper off to his home o2 level (2.5L), Continue on IV remdesivir, dexamethasone 2/21/21- dexamethasone and baricitinib. Will continue home inhalers ordered, Dulera instead of Symbicort, Albuterol as needed, Spiriva instead of Ellipta and Combivent instead of DuoNeb. 2/22/21-Patient currently requiring his baseline oxygen, 2.5L sat 92%. Stop remdesivir and discharged to home, resume home medications.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Respiratory distress
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Aortic aortic aneurysm, Aortic valve stenosis, CAD, COPD, Thoracic aortic aneurysm w/o rupture , compression fracture of thoracic vertebra, Panacinar emphysema, paroxysmal atrial fibrillation and hyperlipidemia.
Andere Medikamente
-
Allergien
Atorvastatin, Sulfa
Vorherige Impfungen
-

VAERS 2216379

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
IL
Alter
67,0
Geschlecht
F
Eingang
05.04.2022
Impfdatum
04.03.2021
Beginn
27.08.2021
Tage bis Beginn
176,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Computerised tomogram thorax abnormal Dyspnoea Laboratory test Pulmonary thrombosis Scan with contrast abnormal

Symptomtext

I had the 2 vacines and than by late summer have shortnes of breath

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary thrombosis
Hospital-Tage
2,0
Labordaten
Not sure of all the test that were done but on September 29 had a ct scan with contrast and sent directly to hospital with blood clots in both lungs
Aktuelle Erkrankungen
None
Vorgeschichte
Thyroid issue
Andere Medikamente
Multiply Vitamin , Vitamin D and Levothroxine
Allergien
None
Vorherige Impfungen
-

VAERS 2211005

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MO
Alter
69,0
Geschlecht
F
Eingang
31.03.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Bone disorder Fatigue Gait disturbance Headache Heart rate irregular Herpes zoster Hypersomnia Hypophagia Influenza like illness Muscle spasms Myalgia Nervous system disorder Pain Paralysis Sciatica

Symptomtext

#1=week long severe headache, shingles, extreme pain in muscles, cramping feet, bones weakened, no energy #2=1st day paralyzed-could not move for about a half hour-ate through bones & extreme symptoms same as #1 (took months of rehab to eliminate pain) #3(booster) = extreme flu-like symptoms slept & did not eat for 21/2 days - still have unnamed sharp pains in muscles-cramping, etc. #1st shot - week long severe headaches (which I never get) - broke out in shingles for a month - extreme pain in muscles (sharp) & still throbbing - bones felt brittle, hard to walk - feet & hands other muscles sometimes cramped up - no energy #2 nd shot - Same as above, except I did not break out in shingles again, though nerves kept flaring of as if I had it - Extreme problems with the shot causing sciattica, which I never have had before, took months of physical Therapy to straighten leg & muscles to keep from cramping & being in extreme pain - The morning after The shot, I was temporarily paralyzed - my heart beat has changed somewhat - I overall feel weaker Than before. Booster - Extreme flu-like symptoms & slept 21/2 days before I could wake up. After effects- still very tired, feet & hands still cramp up all the time, still get pains in my muscles & my nerves still fire off like I have shingles Note - There is a genetic defect in our family (SMDC?) That I am a carrier. None of my family seemed to have any side effects, but I am also The least affected by this gene defect and am the only one with (A-) blood-type.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paralysis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a - ostopenia
Andere Medikamente
calcium, full-dose aspirin, glucosamine
Allergien
chloroquine, sulpha drugs
Vorherige Impfungen
-

VAERS 2200738

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
20,0
Geschlecht
F
Eingang
27.03.2022
Impfdatum
01.03.2021
Beginn
01.04.2021
Tage bis Beginn
31,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Myocarditis Troponin increased

Symptomtext

Hospitalized for myocarditis and high troponin. Potential worsening of chronic dysautonomia

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
3,0
Labordaten
430 troponin 1/15/22
Aktuelle Erkrankungen
Dysautonomia Ehlers Danlos
Vorgeschichte
Dysautonomia
Andere Medikamente
Adderall 15 mg Benadryl 50 mg
Allergien
None
Vorherige Impfungen
-

VAERS 2195834

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NM
Alter
58,0
Geschlecht
F
Eingang
24.03.2022
Impfdatum
20.02.2021
Beginn
20.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood cholesterol Dizziness Electric shock sensation Expired product administered Feeling abnormal Headache Investigation Tinnitus Vertigo

Symptomtext

Expiration: Consumer stated, "It was 02Feb2021."; brain zaps; brain fog; there was a doctor that gave me some medication for vertigo which seems like it made it worse; I have ringing in my ears now; brain dash / headache; light headedness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 59 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 20Feb2021 (Lot number: EN6202, Expiration Date: 02Feb2021) at the age of 58 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: EXPIRED PRODUCT ADMINISTERED (non-serious) with onset 20Feb2021, outcome "unknown", described as "Expiration: Consumer stated, "It was 02Feb2021.""; ELECTRIC SHOCK SENSATION (non-serious) with onset 2021, outcome "unknown", described as "brain zaps"; FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "brain fog"; VERTIGO (non-serious) with onset 2021, outcome "not recovered", described as "there was a doctor that gave me some medication for vertigo which seems like it made it worse"; TINNITUS (non-serious) with onset 2021, outcome "unknown", described as "I have ringing in my ears now"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "brain dash / headache"; DIZZINESS (non-serious) with onset 2021, outcome "unknown", described as "light headedness". The patient underwent the following laboratory tests and procedures: blood cholesterol: unknown results; investigation: unknown results. Therapeutic measures were taken as a result of vertigo. Additional Information: On the first shot, she had side effects for a long period of time which have gotten better but afraid to take a full dose of the vaccine as a booster. She experienced "brain zaps" and on some days "brain fog" exactly two weeks after the first dose. She has heard that vaccines given in a vein could be why so many people are having side effects. She "small person who hasn't done well on medications in the past." "I know of other people in the same situation that I had. Why can't we choose a lower dose" "If its the same, made up with the same chemicals, I would have some type of protection. Updated Information: RMH added, Lab data added, New event added. Dates for develop side effects; Brain zap; brain fog on some days and it continued to occur; brain fog: (From: Unspecified To: Unspecified) Reporter seriousness for develop side effects; Brain zap; brain fog on some days and it continued to occur; brain fog: Unspecified. Dates for Vertigo; seems like it made it worse; stopped: (From: Unspecified To: Unspecified) Reporter seriousness for Vertigo; seems like it made it worse; stopped: Unspecified Dates for they actually accidently give a vein when they are vaccinating you that can cause side effects: (From: Unspecified To: Unspecified) Reporter seriousness for they actually accidently give a vein when they are vaccinating you that cause side effects: Unspecified. Dates for Dizziness: (From: Unspecified To: Unspecified) Reporter seriousness for Dizziness: Unspecified. Dates for have ringing in my ears: (From: Unspecified To: Unspecified) Reporter seriousness for have ringing in my ears: Unspecified. Dates for getting brain dash; not going away; bad at night: (From: Unspecified To: Unspecified) Reporter seriousness for getting brain dash; not going away; bad at night: Unspecified. Dates for brain dash which not going away; which really bad at night: (From: Unspecified To: Unspecified). Reporter seriousness for brain dash which not going away; which really bad at night: Unspecified. Dates for Headache: (From: Unspecified To: Unspecified) Reporter seriousness for Headache: Unspecified. Dates for lot of pain on my second vaccine like throughout my leg that was like a shooting pain: (From: Unspecified To: Unspecified). Reporter seriousness for lot of pain on my second vaccine like throughout my leg that was like a shooting pain: Unspecified. Dates for brain and light headedness has not gone away: (From: Unspecified To: Unspecified). Reporter seriousness for brain and light headedness has not gone away: Unspecified Transferring agent stated, "She received both doses of Pfizer BioNtech Covid19 Vaccine (Suspect captured) the first primary series. The first dose was given on the 20Feb2021. The LOT number was EN6202. Dose 2 was given on 18Mar2021, lot number was EN6207. She said that after exactly 2 weeks after she got the first dose she develop side effects like she called them Brain zap and having brain fog on somedays and it continues to occur. So the reason for her call to ask his if she could get a half of her dose or a dose of a Pediatric vaccine as a booster to lessen the chance or her having additional side effects. So she said she is rather a small person that does not do well on medication historically (Further clarification unknown hence suspect not made) . She said she heard that doses being administered into a vein could be so many people are having side effects (Further clarification unknown hence split case was not made) and that's the main complaint that she has so she thought, she need to get over to Report her side effects from her first and second doses. Did you need some other information from me. Consumer was informed about the role of Pfizer drug safety. Date of Birth: Consumer stated, "Yeah, my first one was which is when she had her side effects exactly two weeks after the vaccine (Not clarified)." Age: Consumer stated, "You want to know my age now or when started 59 (Further clarification unknown hence not captured)." Height and Weight: Consumer stated, "it's like 5.2 she was not sure she was about 108 pounds, she thought." Expiration: Consumer stated, "It was 02Feb2021." Lab test: Consumer stated, "Actually, Yes she did have some lab test done recently. she know, just all kind of basics lab tests you know Cholesterol (Further not clarified) yeah, she don't have it all. she was not sure (Further not clarified)." Treatment: Consumer stated, "Yeah, there was a doctor that gave me some medication for vertigo which seems like it made it worse (Hence, PC filed). So, she stopped that." Name of Medication: Meclizine." Expiration date: Consumer stated, "Yeah, there is an expiration she think, 30Nov2022. I don't think that's the Expiration where that be it its 30Nov. Yeah, 30Nov2022(Further clarification unknown hence not captured)."Date of 1st and 2nd Vaccination: Consumer stated, "The second vaccination was on 18Mar2021 (Not clarified)." Date of 1st vaccination: Consumer stated, "24Feb2021. the first one was on Feb2021 that would be 24Feb2021, 24Feb2021 (Not clarified)."Anatomical Site: Consumer stated, "It was on the Left arm, both times." Consumer stated, "Actually after the 1st vaccine, no she 'had been those she was confuse if it was first or second' but she have experienced Dizziness, Brain fog, 'Kenites' she have ringing in my ears now. She was getting brain dash which was, just are not going away which is really bad at night. She have also have headache but the headache also the due to you know everything. But did get like a lot of pain on my second vaccine like throughout my leg that was like a shooting pain that was probably just couple of night, couple of days that not went away but the brain and light headedness has not gone away."Reassurance: Consumer stated, "No she think that will do, she probably just should, ya should take half of because she don't like not being protected. Because now I don't feel as healthy as she used to because of this side effects unfortunately. It's good that they know the side effects."Description of Product Complaint: Transferring agent stated, "She received both doses of Pfizer BioNtech Covid19 Vaccine (Suspect captured) the first primary series. The first dose was given on the 20Feb2021. The LOT number was EN6202. Dose 2 was given on 18Mar2021, lot number was EN6207. She said that after exactly 2 weeks after she got the first dose she develop side effects like she called them Brain zap and having brain fog on some days and it continues to occur. So the reason for her call to ask his if she could get a half of her dose or a dose of a Paediatric vaccine as a booster to lessen the chance or her having additional side effects. So she said she is rather a small person that does not do well on medication historically (Further clarification unknown hence suspect not made) . She said she heard that doses being administered into a vein could be so many people are having side effects (Further clarification unknown hence split case was not made) and that's the main complaint that she has so I thought, she need to get over to Report her side effects from her first and second doses. Did you need some other information from me." Treatment: Consumer stated, "Yeah, there was a doctor that gave me some medication for vertigo which seems like it made it worse (Hence, PC filed). So, she stopped that." Name of Medication: Meclizine Expiration date: Consumer stated, "Yeah, there is an expiration I think, 30Nov2022. I don't think that's the Expiration where that be it its Nov30.Yeah, 30Nov2022(Further clarification unknown hence not captured)." No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
Test Name: Cholesterol; Result Unstructured Data: Test Result:Unknown results; Test Name: all kind of basics lab tests; Result Unstructured Data: Test Result:Unknown results
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Patient History: No.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2180123

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
73,0
Geschlecht
F
Eingang
15.03.2022
Impfdatum
27.02.2021
Beginn
21.09.2021
Tage bis Beginn
206,0
Dosis
2
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 pneumonia Cough Dyspnoea Endotracheal intubation Intensive care Mechanical ventilation Positive airway pressure therapy Wean from ventilator

Symptomtext

Presented with 2 weeks SOB & cough; Admitted to medical with Covid PNA; tx with Velletri, steroids, Aviptadil, zinc, Actemra, Maxipime, flagyl; initially on HFO2, TX to ICU 9/25; intubated on 10/2/21; currently remains intubated with FiO2 75% and SpO2 holding >93%; no pressors; Renal function holding but precarious. She is on minimal amounts of Precedex and is planning for transfer to long-term acute care for vent weaning. She is doing some weaning on CPAP currently. Disposition: She will be discharged today to long term acute care.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
33,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2177259

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
47,0
Geschlecht
F
Eingang
13.03.2022
Impfdatum
27.01.2022
Beginn
24.02.2022
Tage bis Beginn
28,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Angiogram cerebral abnormal Cerebral infarction Computerised tomogram head normal Endotracheal intubation Headache Intensive care Lumbar puncture normal Magnetic resonance imaging head abnormal Mental status changes Nausea Pneumonia viral Vomiting

Symptomtext

Starting on 2/24 patient had altered mental status, headache and BP was in 200s. Patient went to hospital and was treated for viral pneumonia and discharged 3/1. On 3/5 patient began having severe headache, nausea, vomiting and altered mental status. She was then transferred to Neuro department. 2/25: LP (negative). 3/5: Head CT (negative) 3/11: MRI: Restricted diffusion in bilateral frontal, parietal, occipital and temporal lobes as well as Right Cerebellum. 3/12: CTA head: Moderate to large infarction in bilateral cerebral hemispheres with diminished venous flow. Patient was intubated upon admission to neuro critical care for protection of airway.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
14,0
Labordaten
See above.
Aktuelle Erkrankungen
GERD, HTN, Anxiety, Diabetes Type 2
Vorgeschichte
same as above
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2157688

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
74,0
Geschlecht
M
Eingang
04.03.2022
Impfdatum
01.03.2021
Beginn
14.02.2022
Tage bis Beginn
350,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Chest X-ray Computerised tomogram Confusional state Dialysis Full blood count Intensive care Laboratory test Mechanical ventilation Metabolic function test SARS-CoV-2 test positive

Symptomtext

Participant was put in hospital after testing positive for Covid. He is still on ventilator and oxygen. Participant is confused and is on dialysis. He is in ICU but will be moved to a long care treatment facility today 03/4/2022. Had lots of chest xrays, Ct scans. Labs were done.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
42,0
Labordaten
CBC, CMP, BMP
Aktuelle Erkrankungen
No
Vorgeschichte
Blood Pressure Problem
Andere Medikamente
Blood Pressure Medication
Allergien
Codeine
Vorherige Impfungen
-

VAERS 2155703

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
58,0
Geschlecht
F
Eingang
03.03.2022
Impfdatum
03.03.2021
Beginn
05.03.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Bell's palsy Blood test Computerised tomogram head normal Dyskinesia Eyelid function disorder Facial paralysis Magnetic resonance imaging

Symptomtext

Two days after my first dose (03/05/2021), I was taking a nap on the sofa, and when I got up my husband said he thought I had a stroke because the left side of my face was drooping, my left eye would not close, I could not manipulate my mouth. We immediately went to a local Hospital. In the ER they immediately called a stroke because of how I looked. One of the Physician Assistants said that it looked like herpes. They proceeded with the stroke call as that was most the severe outcome. A CT scan showed no stroke damage, so Bells palsy was the next logical thought.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
2,0
Labordaten
CT scan 03-05-2021 MRI 03-11-2021 or 03-12-2021 The usual bloodwork done for stroke victims
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Venlafaxine 150mg/day Lamotrigine 100mg/twice/day Lithium 600mg/twice/day Aspirin 325mg/day Simvastatin 20mg/day
Allergien
None
Vorherige Impfungen
-

VAERS 2155703

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
58,0
Geschlecht
F
Eingang
03.03.2022
Impfdatum
03.03.2021
Beginn
05.03.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Bell's palsy Blood test Computerised tomogram head normal Dyskinesia Eyelid function disorder Facial paralysis Magnetic resonance imaging

Symptomtext

Two days after my first dose (03/05/2021), I was taking a nap on the sofa, and when I got up my husband said he thought I had a stroke because the left side of my face was drooping, my left eye would not close, I could not manipulate my mouth. We immediately went to a local Hospital. In the ER they immediately called a stroke because of how I looked. One of the Physician Assistants said that it looked like herpes. They proceeded with the stroke call as that was most the severe outcome. A CT scan showed no stroke damage, so Bells palsy was the next logical thought.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
2,0
Labordaten
CT scan 03-05-2021 MRI 03-11-2021 or 03-12-2021 The usual bloodwork done for stroke victims
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Venlafaxine 150mg/day Lamotrigine 100mg/twice/day Lithium 600mg/twice/day Aspirin 325mg/day Simvastatin 20mg/day
Allergien
None
Vorherige Impfungen
-

VAERS 2151917

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
ID
Alter
69,0
Geschlecht
M
Eingang
02.03.2022
Impfdatum
05.03.2021
Beginn
05.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Bone contusion Chest injury Contusion Discomfort Fall Head injury Joint injury Loss of consciousness Musculoskeletal chest pain X-ray

Symptomtext

I awoke from regular night sleep 11 hours after receiving vaccine for typical bathroom/water break. While standing in kitchen drinking water, I passed out and fell backwards to the floor. My wife helped me get to my feet and back to bed. The back of my head, right hip and lower, right ribs were bruised and sore. Two days later, at the site of the injured ribs I felt extreme pain and could not find a comfortable position. I contacted local Sports Medicine and was seen by onsite Doctor. An X-ray and exam suggested possible rib fracture but no injury beyond that. With pain medication and rest, I recovered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
03/09/2021 Examination and X-Ray. Indeterminate result with no clear sign of broken rib or other injury.
Aktuelle Erkrankungen
none
Vorgeschichte
Benign Prostate Hyperplasia, High Cholesterol, Hearing loss
Andere Medikamente
traZODone 100 MG tablet 1 TABLET BY MOUTH AT NIGHT, propranolol 10 MG tablet 1TABLET BY MOUTH TWICE DAILY, pravastatin 20 MG tablet 1 TABLET BY MOUTH DAILY, sildenafil 20 mg tablet 5 tablets about 2 x per week, ascorbic acid (vitamin C) 50
Allergien
none
Vorherige Impfungen
-

VAERS 2116007

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
WI
Alter
74,0
Geschlecht
M
Eingang
16.02.2022
Impfdatum
09.11.2021
Beginn
05.02.2022
Tage bis Beginn
88,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Device kink Dialysis Endotracheal intubation Intensive care Resuscitation SARS-CoV-2 test positive Tachycardia Unresponsive to stimuli

Symptomtext

Pt presents to Facility on 02/05/2022 via Ambulance from dialysis after becoming unresponsive. He is intubated upon arrival. Art line was kinked during dialysis. Became tachycardic. Transported by Ambulance to ER ER - CPR for two minutes -Incidentlly found to be COVID positive on admission to ICU

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2115844

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
-
Geschlecht
M
Eingang
16.02.2022
Impfdatum
12.02.2021
Beginn
21.02.2021
Tage bis Beginn
9,0
Dosis
2
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Brain natriuretic peptide normal COVID-19 Cardiac imaging procedure abnormal Chest pain Echocardiogram normal Ejection fraction decreased Electrocardiogram normal Interleukin level increased Myocarditis Pericardial effusion Pleural effusion Troponin normal Vaccination failure Vaccine breakthrough infection

Symptomtext

Per patient report he developed chest pain and effort intolerance and underwent ED evaluation at Hospital and understood he had vaccine induced myocarditis. He reported multiple cardiac imaging studies demonstrating reduced LVEF. He was treated with Entresto and had recovery of LV function. When he was seen by Dr in Jan 2022 he had normal ECG, echocardiography LVEF but an elevated ST2 level. Troponin and BNP were normal. He had no clinical signs of heart failure at that time but did have mild pleural pericardial symptoms were treated with prednisone and colchicine. On January 18, 2022 he had mild COVID-19 breakthrough infection with failure of vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
-
Labordaten
Per patient report multiple cardiac imaging tests in 2021 demonstrating reduced LVEF. January 2022, ST2 elevated.
Aktuelle Erkrankungen
Migraine headaches
Vorgeschichte
Migraine headaches
Andere Medikamente
Emgality Pen 120 mg/mL subcutaneous pen injector Inject 1 mL every month by sub-q route for 28 days.
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1381126

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
AZ
Alter
53,0
Geschlecht
F
Eingang
06.02.2022
Impfdatum
01.03.2021
Beginn
14.03.2021
Tage bis Beginn
13,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Asthenia Blood pressure fluctuation Blood test abnormal Cardiac imaging procedure abnormal Chest pain Blood pressure increased Blood pressure measurement Chest discomfort Dyspnoea Fatigue Dehydration Dysstasia Ejection fraction decreased Fibrin D dimer increased Gait inability Haematemesis Haemorrhage Heart rate

Symptomtext

Chest pain, nausea, pounding heart beats, extreme fluctuating heart rate and blood pressure. Extreme fatigue; barely able to stand. Vomited dark red blood on 3/14/21. Still has not fully recovered ability/energy since the vaccines last March.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
1,0
Labordaten
Nov 2020 cardiac u/s prior to vaccines normal; EF 58%. April 2021 cardiac MRI showed non ischemic myocarditis EF 33/37% Treated with ivabradine and recheck u/s after a month EF had returned to normal around 58% Hospitalized in March; blood work showed elevated d-dimer, dehydration, low ferritin.
Aktuelle Erkrankungen
-
Vorgeschichte
Acquired brain injury from neurotoxin exposure in 2014 affecting neurological and physiological body systems. Autonomic disorder, chronic inflammatory syndrome, tachycardia
Andere Medikamente
Tramadol, cyclobenzaprine
Allergien
none
Vorherige Impfungen
-

VAERS 1381126

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
AZ
Alter
53,0
Geschlecht
F
Eingang
06.02.2022
Impfdatum
01.03.2021
Beginn
14.03.2021
Tage bis Beginn
13,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Asthenia Blood pressure fluctuation Blood test abnormal Cardiac imaging procedure abnormal Chest pain Blood pressure increased Blood pressure measurement Chest discomfort Dyspnoea Fatigue Dehydration Dysstasia Ejection fraction decreased Fibrin D dimer increased Gait inability Haematemesis Haemorrhage Heart rate

Symptomtext

Chest pain, nausea, pounding heart beats, extreme fluctuating heart rate and blood pressure. Extreme fatigue; barely able to stand. Vomited dark red blood on 3/14/21. Still has not fully recovered ability/energy since the vaccines last March.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
1,0
Labordaten
Nov 2020 cardiac u/s prior to vaccines normal; EF 58%. April 2021 cardiac MRI showed non ischemic myocarditis EF 33/37% Treated with ivabradine and recheck u/s after a month EF had returned to normal around 58% Hospitalized in March; blood work showed elevated d-dimer, dehydration, low ferritin.
Aktuelle Erkrankungen
-
Vorgeschichte
Acquired brain injury from neurotoxin exposure in 2014 affecting neurological and physiological body systems. Autonomic disorder, chronic inflammatory syndrome, tachycardia
Andere Medikamente
Tramadol, cyclobenzaprine
Allergien
none
Vorherige Impfungen
-

VAERS 2082708

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
WI
Alter
60,0
Geschlecht
F
Eingang
02.02.2022
Impfdatum
03.03.2021
Beginn
01.07.2021
Tage bis Beginn
120,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein
Arrhythmia Cardiac failure Cardiomegaly Chest X-ray abnormal Dyspnoea Echocardiogram abnormal Ejection fraction decreased Ejection fraction normal Haemangioma Hepatic cyst Hiatus hernia Impaired work ability Left atrial enlargement Left ventricular end-diastolic pressure increased Left ventricular enlargement Mitral valve incompetence Myocarditis Nasal congestion

Symptomtext

PATIENT RECEIVED DOSE 1. ON 3/3/2021 IN THE LEFT UPPER ARM, PFIZER, LOT NUMBER EN 6202. DOSE 2 GIVEN 3/24/2021, LEFT UPPER ARM, PFIZER, LOT NUMBER ER 8733 DOSE 3. 12/14/2021 LEFT DELTOID, PFIZER, LOT NUMBER FJ 1620 HAD ONSET OF UPPER RESPIRATORY SYMPTOMS IN JULY 2021 WITH STUFFY NOSE, HEAD CONGESTION, WHEEZING AND SHORTNESS OF BREATH. PROGRESSIVE SYMPTOMS, SEEN IN URGENT CARE OCTOBER 2021. AT THAT TIME, CHEST X-RAY SHOWED CARDIOMEGALY AND PULMONARY EDEMA CONSISTENT WITH HEART FAILURE. STARTED ON MEDICAL THERAPY. DUE TO PROGRESSIVE, SEVERE SYMPTOMS, HAD TO QUIT HER JOB.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
-
Labordaten
Echocardiogram: 11/29/2021 1. Moderately enlarged left ventricular chamber size with moderately reduced systolic function; EF 40%. 2. Moderately elevated left ventricular filling pressure. 3. Moderate generalized left ventricular hypokinesis. 4. Normal right ventricular chamber size and function. 5. Unable to detect peak tricuspid regurgitation velocity for pulmonary artery systolic pressure calculation. 6. Mildly enlarged left atrial size. 7. Mild mitral valve regurgitation. 8. Normal inferior vena cava size with normal inspiratory collapse (>50%). 9. No pericardial effusion. LEFT VENTRICLE: Normal left ventricular chamber size is index. Normal wall thickness. Global hypokinesis with some beat to beat variability due to arrythmia. Reduced systolic function. Left ventricular ejection fraction = 42%. Postcontrast images show no first-pass myocardial perfusion abnormalities. Delayed postcontrast images demonstrate subendocardial and mid myocardial enhancement in the basal inferolateral wall extending into basal anterolateral wall (series 19 image 6, series 20 image 5). No corresponding myocardial edema or wall motion abnormality. RIGHT VENTRICLE: Normal right ventricular chamber size. Normal systolic function. Right ventricular ejection fraction = 55%. ATRIA: Normal-sized left atrium. Normal-sized right atrium. PERICARDIUM: Normal pericardial thickness. No pericardial effusion. No abnormal pericardial enhancement. ADDITIONAL FINDINGS: Hepatic cysts vs hemangiomas. Small esophageal hiatal hernia. MEASUREMENTS: Patient weight: 66 kg Patient height: 160.5 cm BSA: 1.7 m2 Series 9: LEFT VENTRICLE: LV End Diastolic Volume = 143mL; Index = 83mL/m2 (normal = 50-98) LV End Systolic Volume = 84mL; Index = 49mL/m2 (normal = 17-41) LV Stroke Volume = 59mL; Index = 35mL/m2 (normal = 29-61) LV Ejection Fraction = 42% (normal = 51-71) LV End Diastolic Mass = 126g; Index = 73g/m2 (normal = 28-56) Series 9: RIGHT VENTRICLE: RV End Diastolic Volume = 106mL; Index = 62mL/m2 (normal = 51-103) RV End Systolic Volume = 47mL; Index = 28mL/m2 (normal = 15-51) RV Stroke Volume = 59mL; Index = 34mL/m2 (normal = 29-61) RV Ejection Fraction = 55% (normal = 46-70) IMPRESSION: 1. Normal left ventricular chamber size and wall thickness. Focal subendocardial and mid myocardial delayed enhancement in the basal inferolateral wall without corresponding wall motion abnormality, myocardial edema or perfusion defect. The findings favor non-ischemic etiology such as MYOCARDITIS or sarcoidosis. Mildly decreased systolic function. LVEF= 42%. 2. Normal right ventricular size and systolic function. RVEF= 55%. Specimen Collected: 02/02/22 09:00 Last Resulted: 02/02/22 14:09
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, Hyperlipidemia
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2036789

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
DC
Alter
45,0
Geschlecht
F
Eingang
14.01.2022
Impfdatum
24.03.2021
Beginn
12.04.2021
Tage bis Beginn
19,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Anal incontinence Dysstasia Electric shock sensation Electroencephalogram Fatigue Lymphadenopathy Muscular weakness Tinnitus Ultrasound Doppler Urinary incontinence Vertigo Vibratory sense increased

Symptomtext

vibration, buzzing, electrical surge sensation in brain with odd loud low pitch sound vibrating through brain (15 minutes) vibration, buzzing, electrical surge in brain without noise (ongoing) vertigo (ongoing) weak muscles in legs, like a baby deer trying to stand (waxes and wanes, ongoing) weak muscles all over, including those that control pee and poop - muscles let go at times causing accidents swollen lymph nodes in armpit of arm receiving shot (10 days each shot) extreme fatigue (24 hours)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
TCD In office EEG
Aktuelle Erkrankungen
none
Vorgeschichte
chronic migraines, dysautonomia, MCI, chronic fatigue syndrome/me, fibromyalgia, allergies, asthma
Andere Medikamente
Tirosint (thyroid) and Benadryl
Allergien
sulfa medications, morphine sulfate, silicon dioxide, silica, sodium lauryl sulfate, povidones, crospovidones, wheat, yeast, potato
Vorherige Impfungen
measles from live measles vaccines (as a child, as reported by mother) very ill from flu vaccine the 1 time I got it (around age

VAERS 2035685

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
41,0
Geschlecht
M
Eingang
14.01.2022
Impfdatum
27.03.2021
Beginn
02.01.2022
Tage bis Beginn
281,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Chest pain Dizziness SARS-CoV-2 test positive Syncope Vaccine breakthrough infection

Symptomtext

Covid Breathrough. First vaccine 03/06/21. On 1/5/22 Patient presents to ED c/o dizziness, syncope, and CP. Patient tested positive for Covid 8 days prior to admission at outside facility.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
Patient tested positive for Covid at outside facility 8 days prior to ED admission. Patient not tested at WP.
Aktuelle Erkrankungen
-
Vorgeschichte
GERD, anxiety
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 2020690

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
61,0
Geschlecht
M
Eingang
10.01.2022
Impfdatum
05.04.2021
Beginn
03.01.2022
Tage bis Beginn
273,0
Dosis
2
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Asthenia COVID-19 Cough Dyspnoea Exposure to SARS-CoV-2 Gait inability Intensive care Malaise Positive airway pressure therapy Respiratory rate decreased SARS-CoV-2 test positive

Symptomtext

01/03/2022: Event occurred after 2nd vaccine. presents to the emergency department via EMS from home for weakness and shortness of breath. Patient had Covid positive today as an outpatient. He has been symptomatic for 3 days since 1/1/2022. Patient states his son with whom he lives is also Covid positive. He denies any fevers at home, he is not on home oxygen. He has minimal cough but his most prominent symptom is generalized weakness. States he has been unable to walk for the last 3 days. aced on high flow nasal cannula and respirations increased to greater than 40 times per minute. He is placed on BiPAP with increased patient comfort and improved oxygenation with decreased respiratory rate. Due to continuous BiPAP, he will be placed in the ICU for further management. 01/03/2022: remains in ICU.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
7,0
Labordaten
01/03/2022: tested externally for COVID. Not tested at Ascension.
Aktuelle Erkrankungen
unknown
Vorgeschichte
history of CVA left-sided deficits, anxiety depression
Andere Medikamente
unknown
Allergien
Apresoline, Ativan, Hydralazine, lisinopril
Vorherige Impfungen
-

VAERS 2005825

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
80,0
Geschlecht
M
Eingang
05.01.2022
Impfdatum
04.03.2021
Beginn
19.12.2021
Tage bis Beginn
290,0
Dosis
2
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
COVID-19 Dyspnoea Hypoxia Intensive care Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

12/19/2021: Patient seen and examined for shortness of breath. On arrival to the ED. Patient was hypoxic, with increased work of breathing, AOx4. On nasal cannula liters per minute. Saturations 85%. Patient was immediately placed on BiPAP which improved his work of breathing and his oxygen saturations. Concern for worsening COVID-19 Admitted to critical care. Remains in ICU currently., on Jan 5 2022- Hospital day 16

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
16,0
Labordaten
External COVID positive test as per patient report. Not tested at hospital
Aktuelle Erkrankungen
unknown
Vorgeschichte
CAD, a fib, hypertension
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2002948

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
IN
Alter
84,0
Geschlecht
M
Eingang
04.01.2022
Impfdatum
29.12.2021
Beginn
03.01.2022
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Asymptomatic COVID-19 Computerised tomogram head abnormal Dizziness Echocardiogram Ejection fraction normal Myocardial ischaemia Orthostatic hypotension SARS-CoV-2 test positive Subdural haematoma Syncope Troponin increased

Symptomtext

Syncopal episode at home, occurred after standing up quickly, no loss of consciousness, no head trauma, no chest pain, no shortness of breath. CT head shows chronic subdural hematoma. Reported dizziness, likely orthostatic hypotension Patient incidentally noted to be COVID positive, asymptomatic received vaccine and booster.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
2,0
Labordaten
1/3/22 Troponin level 63 1/3/22 Transthroacic echocardiogram - Ejection fraction 55-60%, mitral valve, aortic valve and tricuspid valve: no significant regurgitation. 1/3/2022 Atrial-sensed ventricular spaced rhythm Cardiac consult: elev troponin, very mildly elevated likely demand ischemia without issues. 1/3/2022 COVID19 rapid test is positive
Aktuelle Erkrankungen
-
Vorgeschichte
Pulmonary embolism diabetes dementia AV block s/p pacemaker
Andere Medikamente
Xarelto
Allergien
Beta Blockers
Vorherige Impfungen
-

VAERS 1995330

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
WI
Alter
-
Geschlecht
F
Eingang
31.12.2021
Impfdatum
01.02.2021
Beginn
01.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Fatigue Inappropriate schedule of product administration Lymphadenopathy Malaise Myocarditis Night sweats Pyrexia Weight decreased

Symptomtext

myocarditis; tiredness for 2 months; fever; night sweats; feeling unwell; swollen lymph glands; lost 15 pounds; dose 1 on 26Feb2021, dose 2 in Feb2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. An 81 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date Feb2021 (Batch/Lot number: EN6202) as dose 2, single for covid-19 immunisation in Clinic. The patient was not pregnant when administration. Known allergies: dairy & preservatives. Other medical history: some digestive. The patient took some vitamins & Blood pressure, & coloresterol pre in 2 weeks. The patient didn't receive other vaccines in 4 weeks. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3242, Location of injection: Arm Left), administration date: 26Feb2021 01:30 PM, when the patient was 81 years old, for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 post vaccination. The following information was reported: MYOCARDITIS (medically significant) with onset 01Mar2021 14:00, outcome "recovered", described as "myocarditis"; FATIGUE (non-serious) with onset 01Mar2021 14:00, outcome "recovered", described as "tiredness for 2 months"; PYREXIA (non-serious) with onset 01Mar2021 14:00, outcome "recovered", described as "fever"; NIGHT SWEATS (non-serious) with onset 01Mar2021 14:00, outcome "recovered", described as "night sweats"; MALAISE (non-serious) with onset 01Mar2021 14:00, outcome "recovered", described as "feeling unwell"; LYMPHADENOPATHY (non-serious) with onset 01Mar2021 14:00, outcome "recovered", described as "swollen lymph glands"; WEIGHT DECREASED (non-serious) with onset 01Mar2021 14:00, outcome "recovered", described as "lost 15 pounds". The events "myocarditis", "fever", "night sweats", "feeling unwell", "swollen lymph glands" and "lost 15 pounds" were evaluated at the emergency room visit. It was unknown if therapeutic measures were taken as a result of myocarditis, fatigue, pyrexia, night sweats, malaise, lymphadenopathy, weight decreased. The lot number for bnt162b2 was not provided and will be requested during follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Milk allergy; Reaction to food additive
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1972046

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
52,0
Geschlecht
M
Eingang
22.12.2021
Impfdatum
24.02.2021
Beginn
13.10.2021
Tage bis Beginn
231,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Computerised tomogram thorax abnormal Dyspnoea exertional Echocardiogram Pulmonary artery occlusion Pulmonary artery thrombosis Ultrasound Doppler

Symptomtext

At a routine office visit on Sept 30 the patient complained of some shortness of breath on exertion. He states he first started noticing it about May 2021. During the work-up a CT of chest was done and the following was found: There is a nearly occlusive thrombus of the distal right main pulmonary artery extending into right lower lobar, segmental and subsegmental pulmonary arteries. Occlusive thrombus in the right upper segmental and subsegmental pulmonary arteries. Nearly occlusive embolus in the left lower lobar, segmental and subsegmental pulmonary arteries.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary artery thrombosis
Hospital-Tage
1,0
Labordaten
CT chest - 10/13/2021, Lower extremity doppler -10/13/2021, Echocardiogram - 10/13/2021
Aktuelle Erkrankungen
Had surgery - Right tympanomastoidectomy for cholesteatoma in Jan 2021
Vorgeschichte
Hypothyroid
Andere Medikamente
Levothyroxine
Allergien
None
Vorherige Impfungen
-

VAERS 1970792

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
AZ
Alter
80,0
Geschlecht
F
Eingang
22.12.2021
Impfdatum
22.02.2021
Beginn
01.02.2021
Tage bis Beginn
-
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Antibody test Chills Dizziness Headache Hyperhidrosis Loss of consciousness Somnolence Tremor

Symptomtext

pass out; was drenched in sweat; she slept throughout the day and the next day she was okay.; chills; shaking; Headache; dizzy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 80 year-old female patient received bnt162b2 (COVID-19 MANUFACTURER UNKNOWN), administered in arm left, administration date 22Feb2021 (Lot number: EN6202) at the age of 80 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: LEVOXYL taken for hypothyroidism (ongoing). No additional vaccines administered on same date of the Pfizer suspect. Vaccination history included: Bnt162b2 (First Dose , Date: 01Feb2021 , Lot- EL1283, Administered in left arm , AE(s) following prior vaccinations: None), administration date: 01Feb2021, when the patient was 80 years old, for COVID-19 immunisation, reaction(s): "None". The night she got the vaccine (22Feb2021), she had chills and shakes for over an hour that she could not stop. In the morning she got up, went to the bathroom and passed out. Her husband came in there and she was sweating, drenched in sweat. Her husband was finally able to get her up out the bathroom and put her to bed and she slept. The sweats went away by mid afternoon. However, she slept all day. By the next day she was okay. She commented she is in excellent health. Everything is perfect. She recently went to the doctor to have an annual physical. Her doctor gave her a little test first, this was in Dec2021. The blood test was to test to see how much antibodies she had in her system and she had antibodies. The following information was reported: LOSS OF CONSCIOUSNESS (medically significant) with onset 23Feb2021, outcome "recovered" (24Feb2021), described as "pass out"; CHILLS (non-serious) with onset 22Feb2021, outcome "recovered" (23Feb2021), described as "chills"; TREMOR (non-serious) with onset 22Feb2021, outcome "recovered" (23Feb2021), described as "shaking"; HYPERHIDROSIS (non-serious) with onset 23Feb2021, outcome "recovering", described as "was drenched in sweat"; HEADACHE (non-serious) with onset Feb2021, outcome "recovering", described as "Headache"; DIZZINESS (non-serious) with onset Feb2021, outcome "recovering", described as "dizzy"; SOMNOLENCE (non-serious) with onset 23Feb2021, outcome "recovered" (24Feb2021), described as "she slept throughout the day and the next day she was okay.". No Emergency Room. No Physician Office; Only went to doctor due to annual physical. The patient underwent the following laboratory tests and procedures: antibody test: (Dec2021) had antibodies.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
Test Date: 202112; Test Name: antibody testing; Result Unstructured Data: Test Result:had antibodies
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Patient History: No
Andere Medikamente
LEVOXYL
Allergien
-
Vorherige Impfungen
-

VAERS 1967027

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
85,0
Geschlecht
M
Eingang
21.12.2021
Impfdatum
22.02.2021
Beginn
04.04.2021
Tage bis Beginn
41,0
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abnormal behaviour Asthenia Bradykinesia Diarrhoea Guillain-Barre syndrome Lethargy Magnetic resonance imaging Malaise Neurological symptom Personality change Slow speech

Symptomtext

Guillain Barr Syndrome; neurological effects; Diarrhea; His demeanor, personality, his entire self went from light to dark over night; His demeanor, personality, his entire self went from light to dark over night; Feeling of weakness and unwell; Feeling of weakness and unwell; He speaks, walks, and reacts very slow; He speaks, walks, and reacts very slow; He speaks, walks, and reacts very slow; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). A 85 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 22Feb2021 10:00 (Lot number: EN6202) at the age of 85 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "known_allergies:Penicillin" (unspecified if ongoing), notes: known_allergies:Penicillin. There were no concomitant medications. Vaccination history included: Bnt162b2 (Covid vaccine details:, Product=COVID 19, Brand= Pfizer, Lot number= EN5318, Lot unknown=False, Administration date=23Jan2021, Administration time=10:15 AM, Vaccine location=Right arm, Dose number=1), administration date: 23Jan2021, when the patient was 85 years old, for COVID-19 immunisation. The following information was reported: GUILLAIN-BARRE SYNDROME (medically significant), outcome "unknown", described as "Guillain Barr Syndrome"; NEUROLOGICAL SYMPTOM (non-serious), outcome "unknown", described as "neurological effects"; DIARRHOEA (non-serious) with onset 04Apr2021 10:00, outcome "not recovered", described as "Diarrhea"; ABNORMAL BEHAVIOUR (non-serious), PERSONALITY CHANGE (non-serious) all with onset 04Apr2021 10:00, outcome "not recovered" and all described as "His demeanor, personality, his entire self went from light to dark over night"; ASTHENIA (non-serious), MALAISE (non-serious) all with onset 04Apr2021 10:00, outcome "not recovered" and all described as "Feeling of weakness and unwell"; LETHARGY (non-serious), SLOW SPEECH (non-serious), BRADYKINESIA (non-serious) all with onset 04Apr2021 10:00, outcome "not recovered" and all described as "He speaks, walks, and reacts very slow". The events "diarrhea", "his demeanor, personality, his entire self went from light to dark over night", "his demeanor, personality, his entire self went from light to dark over night", "feeling of weakness and unwell", "feeling of weakness and unwell", "he speaks, walks, and reacts very slow", "he speaks, walks, and reacts very slow" and "he speaks, walks, and reacts very slow" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: magnetic resonance imaging: (2021) nothing significant came back as wrong, notes: He labs and even an MRI nothing significant came back as wrong. Therapeutic measures were not taken as a result of diarrhoea, abnormal behaviour, personality change, asthenia, malaise, lethargy, slow speech, bradykinesia. Additional information: Patient had a bad experience with diarrhea. After that he completely changed. AE resulted in Doctor or other healthcare professional office/clinic. The patient did not received other vaccine in four week and Other medications in two weeks. Prior to vaccination, the patient was not diagnosed with COVID. Post vaccination, the patient has not been tested for COVID-19. Other medical history was none. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
-
Labordaten
Test Date: 2021; Test Name: MRI; Result Unstructured Data: Test Result:nothing significant came back as wrong; Comments: He labs and even an MRI nothing significant came back as wrong
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Penicillin allergy (known_allergies:Penicillin)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1869718

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
78,0
Geschlecht
M
Eingang
15.11.2021
Impfdatum
24.02.2021
Beginn
06.11.2021
Tage bis Beginn
255,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dyspnoea Productive cough Respiratory distress

Symptomtext

Pt complained of shortness of breath with productive cough. Pt admitted for respiratory distress.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Respiratory distress
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1861368

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
PA
Alter
83,0
Geschlecht
M
Eingang
11.11.2021
Impfdatum
05.03.2021
Beginn
01.05.2021
Tage bis Beginn
57,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Activated partial thromboplastin time Aggression Ammonia Angiotensin converting enzyme Anti-NMDA antibody Antibody test Blood bicarbonate Blood cortisol Blood creatine phosphokinase Blood culture Blood ethanol Blood gases Blood glucose Blood grouping Blood lactic acid Blood magnesium Blood osmolarity Blood pH

Symptomtext

Herpes encephalitis (Primary Dx); Details of the Hospital Course: Patient is a 83 y.o. male with history significant for polymyalgia rheumatica on chronic steroids 1 mg prednisone daily (dx 3 yrs ago), history of PE/DVT for which he is prescribed outpatient Eliquis (2020), benign essential tremor, hypertension prescribed outpatient valsartan, recent admission for intractable headaches. Patient lives in the independent living was brought to the hospital by EMS for reported confusion and combativeness. Patient upon arrival is unresponsive and already intubated upon my examination however per records of EMS he had a last known well time on the evening of 4/30 at about 8:00 p.m.. He reportedly is AAO x3 at baseline and completes all of his ADLs independently. When found by EMS he was having reportedly incomprehensible speech and was found lying with the head near his radiator and noted to have a right frontal hematoma. Patient was admitted to the ICU secondary to acute encephalopathy and intubated for protection of airways. Patient was placed on empiric antibiotics for encephalitis, patient was evaluated by neurology and ID. He had an LP x2. Meningitis encephalitis workup was negative. He was continued on acyclovir for total of 14 days for viral encephalitis. His mental status slowly improved. He was noted to have her incidental renal cell mass which will need outpatient follow-up with urology. Will need close follow-up with neurology as outpatient. He had pending paraneoplastic antibody testing which was sent out to the clinic and pending on discharge. He unfortunately had a fall with head laceration requiring sutures by general surgery. He was seen by Physical therapy and will need a skilled nursing facility. He was amenable to this. Uncontrolled hypertension blood pressure was improved and he was started back on verapamil and valsartan History of PE/DVT he was diagnosed with a PE in November 2020 and had previous DVT. He is asked to follow-up with hematology to discuss further anticoagulation needs. He can resume if safely under the supervision of skilled nursing facility. He reports alcohol use which is 1 glass of wine and scotch daily. He was monitored for DTs which he did not have and low suspicion for Wernicke's encephalopathy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
11,0
Labordaten
CARDIAC ULTRASOUND COMPLETE (2D/COLOR/DOPPLER) (05/10/2021 9:52 AM) XR Chest PA Or Ap Portable (05/08/2021 8:25 AM) FL Lumbar Puncture Diagnostic W Imaging Guide (05/06/2021 11:39 AM) XR Chest PA Or Ap Portable (05/06/2021 10:30 AM) XR Chest PA Or Ap Portable (05/06/2021 6:55 AM) CT Cervical Spine Wo Contrast (05/06/2021 4:48 AM) CT Brain Or Head Wo Contrast (05/06/2021 4:48 AM) CT Chest / Abd / Pelvis Wo Contrast (05/05/2021 2:46 PM) CT Cervical Spine Wo Contrast (05/05/2021 2:46 PM) CT Brain Or Head Wo Contrast (05/05/2021 2:46 PM) US Upper Extremity Vein Bil Complete (05/05/2021 2:01 PM) XR Chest PA Or Ap Portable (05/05/2021 5:33 AM) EEG awake or drowsy routine (05/04/2021 12:32 PM) XR Chest PA Or Ap Portable (05/04/2021 5:40 AM) MRI Brain Wo W Contrast (05/03/2021 3:59 PM) FL Lumbar Puncture Diagnostic W Imaging Guide (05/03/2021 12:08 PM) CARDIAC ULTRASOUND COMPLETE (2D/COLOR/DOPPLER) (05/03/2021 11:26 AM) XR Chest PA Or Ap Portable (05/03/2021 6:18 AM) CT Brain Or Head W Contrast (05/02/2021 2:50 AM) CT Cervical Spine Wo Contrast (05/01/2021 10:35 PM) CT Brain Or Head Wo Contrast (05/01/2021 10:35 PM) XR Chest PA Or Ap Portable (05/01/2021 9:51 PM) CBC with Auto Diff (05/11/2021 6:54 AM) Comprehensive Metabolic Panel (05/11/2021 6:54 AM) CBC and Differential (05/11/2021 6:54 AM) Magnesium (05/11/2021 6:54 AM) INFLUENZA A & B, RSV AND COVID 19, NAAT (05/10/2021 1:42 PM) CBC with Auto Diff (05/10/2021 7:12 AM) Comprehensive Metabolic Panel (05/10/2021 7:12 AM) CBC and Differential (05/10/2021 7:12 AM) Magnesium (05/10/2021 7:12 AM) Magnesium (05/09/2021 4:26 PM) CBC with Auto Diff (05/09/2021 4:26 PM) CBC and Differential (05/09/2021 4:26 PM) Glucose P.O.C.T. Group (05/09/2021 7:46 AM) DRUGS OF ABUSE SCREEN, URINE (05/07/2021 10:24 AM) CBC with Auto Diff (05/07/2021 4:40 AM) Magnesium (05/07/2021 4:40 AM) Comprehensive metabolic panel (05/07/2021 4:40 AM) CBC and differential (05/07/2021 4:40 AM) Retype (05/07/2021 4:40 AM) LYME DISEASE PCR (BORRELIA SPPP) (05/06/2021 12:04 PM) Oligoclonal Banding (05/06/2021 11:51 AM) FLOW CYTOMETRY (LEUKEMIA/LYMPHOMA EVALUATION) (05/06/2021 11:51 AM) Flow Cytometry (BM or BF) (05/06/2021 11:51 AM) West Nile Virus, CSF (05/06/2021 11:51 AM) Fungus Culture (Molds and Yeast) (05/06/2021 11:51 AM) Angiotensin converting enzyme, CSF (05/06/2021 11:51 AM) India Ink Prep (CSF) (05/06/2021 11:51 AM) CSF Collection Oligoclonal Bands (05/06/2021 11:51 AM) Oligoclonal Banding (05/06/2021 11:51 AM) CSF Collection IgG SYN Rate (05/06/2021 11:51 AM) NMDAR antibody -Misc Lab Test (05/06/2021 11:51 AM) Myelin basic protein, CSF (05/06/2021 11:51 AM) Epstein-Barr Virus DNA Quantitative (05/06/2021 11:51 AM) JC VIRUS PCR (05/06/2021 11:51 AM) Cytology Non-Gyn (05/06/2021 11:33 AM) CSF Cell Count (05/06/2021 11:33 AM) CSF Cell Count (05/06/2021 11:33 AM) HSV PCR (05/06/2021 11:33 AM) Glucose, CSF (05/06/2021 11:33 AM) AFB CULTURE (INCLUDES AFB SMEAR) (05/06/2021 11:33 AM) Protein, CSF (05/06/2021 11:33 AM) Cytology Spinal Fluid (CSF) (05/06/2021 11:33 AM) CSF CULTURE (W GRAM STAIN) (05/06/2021 11:33 AM) CSF cell count with differential (05/06/2021 11:33 AM) CSF cell count with differential (05/06/2021 11:33 AM) Paraneoplastic Antibody Evaluation CSF (05/06/2021 11:33 AM) Arterial Blood Gas (05/06/2021 5:16 AM) CBC with Auto Diff (05/06/2021 5:14 AM) Magnesium (05/06/2021 5:14 AM) Comprehensive metabolic panel (05/06/2021 5:14 AM) CBC and differential (05/06/2021 5:14 AM) CSF IgG Index (05/06/2021 5:14 AM) CSF IgG index (05/06/2021 5:14 AM) Phosphorus (05/06/2021 5:14 AM) Type and screen (05/06/2021 4:15 AM) Arterial Blood Gas (05/05/2021 3:48 PM) CBC with Auto Diff (05/05/2021 4:52 AM) Magnesium (05/05/2021 4:52 AM) Comprehensive metabolic panel (05/05/2021 4:52 AM) CBC and differential (05/05/2021 4:52 AM) Phosphorus (05/05/2021 4:52 AM) Arterial Blood Gas (05/05/2021 4:25 AM) HIV 1,2 AG/AB Screen w/Reflex Confirmation (05/04/2021 10:01 AM) HSV 1 IgG & HSV 2 IgG Antibodies (05/04/2021 6:19 AM) CBC with Auto Diff (05/04/2021 5:07 AM) Magnesium (05/04/2021 5:07 AM) Comprehensive metabolic panel (05/04/2021 5:07 AM) CBC and differential (05/04/2021 5:07 AM) Triglycerides (05/04/2021 5:07 AM) Phosphorus (05/04/2021 5:07 AM) Vancomycin, random (05/04/2021 5:07 AM) Arterial Blood Gas (05/04/2021 4:09 AM) HSV PCR (05/03/2021 6:43 PM) MENINGITIS/ENCEPHALITIS (ME) PANEL PCR (05/03/2021 12:10 PM) West Nile Virus Ab, CSF (05/03/2021 12:10 PM) BODY FLUID PATHOLOGIST REVIEW (05/03/2021 12:10 PM) Cytology Non-Gyn (05/03/2021 12:10 PM) CSF Differential (05/03/2021 12:10 PM) CSF CULTURE (W GRAM STAIN) (05/03/2021 12:10 PM) CSF Cell Count (05/03/2021 12:10 PM) CULTURE (AEROBIC) AND SENSITIVITIES (05/03/2021 12:10 PM) Cytology Spinal Fluid (CSF) (05/03/2021 12:10 PM) VARICELLA ZOSTER PCR (05/03/2021 12:10 PM) ENTEROVIRUS BY PCR, CSF (05/03/2021 12:10 PM) Protein, CSF (05/03/2021 12:10 PM) Glucose, CSF (05/03/2021 12:10 PM) CSF cell count with differential (05/03/2021 12:10 PM) VDRL, CSF (05/03/2021 12:09 PM) Carboxyhemoglobin (05/03/2021 9:26 AM) West Nile Antibodies, IgG and IgM, Serum (05/03/2021 9:26 AM) Strep Pneumoniae Urinary Antigen (05/03/2021 9:03 AM) CBC with Auto Diff (05/03/2021 4:40 AM) Comprehensive metabolic panel (05/03/2021 4:40 AM) CBC and differential (05/03/2021 4:40 AM) Protime-INR (05/03/2021 4:40 AM) Arterial Blood Gas (05/03/2021 4:34 AM) Potassium Urine, random (05/02/2021 3:33 PM) Chloride, Urine, Random (05/02/2021 3:33 PM) Sodium Urine, random (05/02/2021 3:33 PM) MRSA SCREEN CULTURE (05/02/2021 3:33 PM) SYPHILIS SCREENING REFLEX TO CONFIRMATION (05/02/2021 3:32 PM) Troponin I (05/02/2021 12:31 PM) ESR (05/02/2021 12:31 PM) CK (05/02/2021 8:27 AM) Troponin I (05/02/2021 8:27 AM) Basic metabolic panel (05/02/2021 8:27 AM) Phosphorus (05/02/2021 6:36 AM) Magnesium (05/02/2021 6:36 AM) Troponin I (05/02/2021 6:36 AM) Comprehensive metabolic panel (05/02/2021 6:36 AM) Arterial Blood Gas (05/02/2021 6:26 AM) CBC with Auto Diff (05/02/2021 6:18 AM) CBC and differential (05/02/2021 6:18 AM) Cortisol AM (05/02/2021 6:18 AM) APTT (05/02/2021 6:18 AM) Protime-INR (05/02/2021 6:18 AM) C-reactive protein (CRP) (05/02/2021 1:12 AM) Troponin I (05/02/2021 1:12 AM) Ammonia (05/02/2021 1:12 AM) Prolactin (05/02/2021 1:12 AM) TSH (05/02/2021 12:22 AM) Osmolality (05/02/2021 12:22 AM) SYPHILIS SCREENING REFLEX TO CONFIRMATION (05/02/2021 12:22 AM) Blood Culture (05/01/2021 10:47 PM) DRUGS OF ABUSE SCREEN, URINE (05/01/2021 10:47 PM) INFLUENZA A & B, RSV AND COVID 19, NAAT (05/01/2021 10:44 PM) Venous pH and HCO3 (05/01/2021 10:37 PM) Lactic Acid (05/01/2021 10:37 PM) Blood Culture (05/01/2021 10:37 PM) Ethanol (05/01/2021 10:37 PM) CK (05/01/2021 10:35 PM) Phosphorus (05/01/2021 10:35 PM) Magnesium (05/01/2021 10:35 PM) Troponin (05/01/2021 10:35 PM) Comprehensive metabolic panel (05/01/2021 10:35 PM) Microscopic-Urinalysis (05/01/2021 9:14 PM) Urinalysis (05/01/2021 9:14 PM) Urinalysis w/Micro & Reflex to Culture **Not to be used for Pediatric patient** (05/01/2021 9:14 PM) CBC with Auto Diff (05/01/2021 9:13 PM) CBC with differential (05/01/2021 9:13 PM) Glucose P.O.C.T. Group (05/01/2021 9:06 PM)
Aktuelle Erkrankungen
-
Vorgeschichte
Problem List 28 items Varicose veins of both lower extremities Altered mental status Aphasia Bite wound of finger CAD (coronary artery disease) Cataract, right Chronic deep vein thrombosis (DVT) of distal vein of lower extremity Corn Degenerative joint disease of right knee Diarrhea Encephalopathy acute Hemorrhoid Herpes encephalitis History of pulmonary embolus (PE) Hypertension Migraine aura, persistent Lesion of lung Lung nodule Medication management Nephrolithiasis Phlebitis PMR (polymyalgia rheumatica) Preop examination Pulmonary embolism Scalp laceration Sinus bradycardia Tick bite of right lower leg Vitamin D deficiency
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1845793

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
64,0
Geschlecht
M
Eingang
05.11.2021
Impfdatum
26.02.2021
Beginn
27.02.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Arthralgia Asthenia Computerised tomogram abnormal Fatigue Inflammation Influenza like illness Laboratory test Painful respiration Pericardial excision Pericarditis Pneumonia

Symptomtext

Initial flu like symptoms, continuing fatigue, pain in joints. Two months later, pleurisy symptoms, treated for pneumonia. In June, ER visit, pain on inspiration the same. In July, ER visit, same. Cat scan revealed pericarditis. Pericardial window performed. Post hospital discontinued Mesalamine which was also contributing to systemic inflammation. As of today, joint pain and extreme fatigue and weakness continue. GI Doctor calls this a "confounding event" as both the vaccine and Mesalamine could have worked together, but the cascade of effects started with the second vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pericarditis
Hospital-Tage
7,0
Labordaten
Every test imaginable was performed in the hospital visit.
Aktuelle Erkrankungen
Ulcerative Colitis, Arthritis
Vorgeschichte
-
Andere Medikamente
-
Allergien
Prednisone, NSAIDS
Vorherige Impfungen
-

VAERS 1835646

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NC
Alter
57,0
Geschlecht
F
Eingang
02.11.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Electric shock sensation Muscle spasms Muscle twitching Pain in extremity Sensory disturbance Vaccination site pain Vaccination site swelling

Symptomtext

"muscle spasms or twitching" on her middle finger of her left hand also "going to the center of her forearm."; "muscle spasms or twitching" on her middle finger of her left hand also "going to the center of her forearm."; sation on her right elbow of "a strand of hair touching her arm" without anything actually being there and describes it as an "electric feeling."; right elbow feels like a piece of hair is touching her skin, like an electric shock; site soreness and swelling at the injection site; site soreness and swelling at the injection site; Her arm is sore when she raises it above her head; This is a spontaneous report from a contactable consumer. This 57-Year-old female consumer reported for herself that: A 57-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EN6202), via an unspecified route of administration, administered in left arm on 26Feb2021 at 13:30 (at the age of 57-year-old) as DOSE 1, SINGLE for covid-19 immunization. Medical history included ongoing hypertension (has had for over a decade). The patient's concomitant medications were not reported. No history of all previous immunization with the Pfizer vaccine considered as suspect and no additional vaccines administered on same date of the Pfizer suspect. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Both of her parents were fine after getting the vaccine. The patient experienced site soreness and swelling at the injection site on 26Feb2021, muscle spasms or twitching on her middle finger of her left hand also going to the center of her forearm, on 27Feb2021, "a sensation on her right elbow of" a strand of hair touching her arm" without anything actually being there and describes it as an electric feeling on 26Feb2021, right elbow feels like a piece of hair was touching her skin, like an electric shock on 26Feb2021, arm sore when she raises it above her head on an unspecified date in 2021. Patient who received the Pfizer BioNTech COVID-19 vaccine this past Friday (on 26Feb2021) and afterwards she experienced site soreness and a small area of swelling at the injection site. Patient also reported muscle spasms or twitching on her middle finger of her left hand also going to the center of her forearm on 27Feb2021. She noticed it on 27Feb2021. It could have been there on 26Feb2021. Patient also reported a sensation on her right elbow of a strand of hair touching her arm without anything actually being there and describes it as an electric feeling on 27Feb2021. Patient's arm was sore when she raises it above her head on unspecified date in 2021. Patient reported that these symptoms are persistent every day and now it was still going on. Patient would like to know if tingling and muscle spasms were a side effect of the vaccine. Patient did not have a primary care provider. Adverse events did require a visit to emergency Room or physician office. Patient would like to know if she would recommend getting her second dose in the right arm this time. At the time of this report, the outcome of event vaccination site pain was recovering, the outcome of events vaccination site swelling and sensation on her right elbow of a strand of hair touching her arm without anything actually being there and describes it as an electric feeling was recovered on 01Mar2021; the outcome of event muscle spasms or twitching on her middle finger of her left hand also going to the center of her forearm was not recovered and arm sore when she raises it above her head was unknown. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Hypertension (has had for over a decade)
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1833641

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
61,0
Geschlecht
M
Eingang
01.11.2021
Impfdatum
06.03.2021
Beginn
26.10.2021
Tage bis Beginn
234,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Syncope

Symptomtext

10/26/21 presents to EC ED after syncope; PMHx most significant for HTN, hypothyroidism, had a recent mild COVID-19 infection on 10/7/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
10/26/21 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1833310

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
60,0
Geschlecht
F
Eingang
01.11.2021
Impfdatum
30.08.2021
Beginn
30.08.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Abdominal hernia Abdominal wall mass Angioedema Computerised tomogram abdomen abnormal Endotracheal intubation Intensive care Lip swelling Mechanical ventilation No reaction on previous exposure to drug Swollen tongue

Symptomtext

POSSIBLE ALLERGIC REACTION (Received second pfizer vaccine yesterday and developed angioedema with tongue involvement - hospitalized. Admission Date: 8/31/2021 Discharge Date: 09/04/2021 Presented to ED - transferred and admitted to hospital. 60-year-old woman significant past medical history of tonsillar squamous cell carcinoma with resection on immunotherapy as well as oropharyngeal dysphasia presents emergency department today with increasing swelling of her lips and tongue symptoms 1st started 12 hours after receiving Pfizer vaccination as a booster no problems with the other vaccinations. This morning despite taking Benadryl last night noticed increasing swelling although very gradually worsening swelling in this prompted presentation is not on any ACE-inhibitor medications or arbs has never had a reaction like this before I do favor angioedema as a cause for her symptoms here today although allergic reaction is very possible in will treat with Benadryl, Pepcid, Solu-Medrol patient is also febrile emergency department but denies any clear source on history with recent COVID-19 vaccination I feel is most likely related to this. PRESENTING PROBLEM: Angioedema of lips, sequela Angioedema, initial encounter HOSPITAL COURSE: 60 year old female with history of tonsillar squamous cell carcinoma status post surgical resection, currently on treatment with immunotherapy (nivolumab), HTN, and oropharyngeal dysphagia who is admitted to the ICU for management of angioedema requiring intubation and mechanical ventilation following COVID vaccination administration. She presented initially to the ED with increasing swelling of her tongue and lips which first started about 12 hours after receiving her 3rd Pfizer booster vaccination on 8/30/2021. Pt reportedly had no problems or adverse effects with her first two vaccinations. The morning after the 3rd vaccination, she noted increasing swelling despite having taken Benadryl the night before. She noted to the ED provider that she had never had a reaction to this before, and that she does not take chronic ACE inhibitor or ARB medication. There were concerns for airway protection, and the decision was made to intubate the pt. Intubation was performed in the ED with the assistance of Anesthesia. Intubation was initially attempted with the fiberoptic bronchoscope, but was unsuccessful. Anesthesia was eventually able to intubate the pt orotracheally with the Glidescope. The view was not easy to obtain due to secretions and edema, but a 7.0 ETT was finally passed successfully. Pt was otherwise treated with Benadryl, Pepcid, and IV solumedrol. CT showed large ventral abdominal wall hernia with new large thick walled cystic mass measuring 19cm - General surgery and Interventional radiology consulted plan to work up as outpatient. Extubated 9/2. Transferred to the floor to the IM service. There continued to improve and was weaned off of oxygen. Continued prednisone taper per ICU recs. Will send on zyrtec as well. SLP evaluated- patient was able to transition to moist ground and thin liquids diet. Providing BMX at d/c. HH SLP to follow at home as well. At this time she is stable, improved, and ready for d/c home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
NA
Vorgeschichte
Oropharyngeal dysphagia Lymphedema of face Essential hypertension Fibromyalgia Gout involving toe of right foot H/O gastric bypass Hearing loss History of CHF (congestive heart failure) Hypothyroid Chronic pain Squamous cell carcinoma of tonsil (HCC) Dehydration Hip pain Hyponatremia Encounter for antineoplastic immunotherapy Mucosal irritation of oral cavity Liver lesion Abnormal cortisol level
Andere Medikamente
allopurinol (ZYLOPRIM) 300 MG tablet Cetirizine HCl (ZYRTEC ALLERGY PO) cholecalciferol (VITAMIN D3) 25 MCG (1000 UT) capsule compounded medication (MAGIC MOUTHWASH) suspension cyclobenzaprine (FLEXERIL) 10 MG tablet DULoxetine (CYMBALTA) 6
Allergien
Covid-19 (Mrna) VaccineAngioedema Covid-19 (Mrna) Vaccine (Pfizer)Angioedema MorphineShortness of Breath SulfamethoxazoleHives Sulfamethoxazole W-trimethoprimHives TrimethoprimHives Bactrim [Sulfa Drugs]Confusion PenicillinsUnknown TemazepamOther ZolpidemOther
Vorherige Impfungen
-

VAERS 1827595

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
PA
Alter
36,0
Geschlecht
F
Eingang
29.10.2021
Impfdatum
24.02.2021
Beginn
25.02.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Electric shock sensation Photopsia

Symptomtext

she notices mild symptoms of withdrawal described as electrical impulses in finger tips and visual flashes (mild strobe like effect).; visual flashes (mild strobe like effect); This is a spontaneous report from a contactable consumer (patient) and physician. A 36-year-old non pregnant female patient received BNT162B2 (BNT162B2, solution for injection, Lot Number: EN6202), via an unspecified route of administration, administered in the left arm on 24Feb2021 (at the age of 36 years old) as DOSE 2, SINGLE for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine administered was hospital. Medical history included Crohn's (has had ileostomy), allergies to medications, food, or other products: sulfa, feraheme & gadolinium contrast, PCOS (polycystic ovarian syndrome), depression, anxiety. Concomitant medication(s) included Humira, Methotrexate, Folic acid, Pepcid, Lo lo estrin, Depakote, Trazadone, venlafaxine & medical marijuana (cannabis). Patient previously received BNT162B2 (BNT162B2, solution for injection, Lot Number: EL8982), via an unspecified route of administration, administered in the left arm on 01Feb2021 as DOSE 1, SINGLE for COVID-19 immunization. No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 25Feb2021 08:00 the patient experienced she notices mild symptoms of withdrawal described as electrical impulses in fingertips and visual flashes (mild strobe like effect), visual flashes (mild strobe like effect). No treatment was received for events. Reporter stated that events was similar to what she's experienced when she's been a couple of hours late with a dose. The clinical outcome of the events was reported as recovering. No Follow-up attempts are needed. No further information expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergy to chemicals NOS; Anxiety; Depression; Ileostomy; Polycystic ovarian syndrome
Andere Medikamente
HUMIRA; METHOTREXATE SODIUM; FOLIC ACID; PEPCID AC; LO LOESTRIN FE; DEPAKOTE; TRAZODONE; VENLAFAXINE HYDROCHLORIDE; CANNABIS
Allergien
-
Vorherige Impfungen
-

VAERS 1818375

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
64,0
Geschlecht
F
Eingang
26.10.2021
Impfdatum
10.04.2021
Beginn
15.10.2021
Tage bis Beginn
188,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Anticoagulant therapy Bile duct stone Blood creatinine increased Blood folate normal Blood glucose decreased Blood smear test abnormal COVID-19 Chest X-ray normal Cholecystectomy Cholecystitis Computerised tomogram abnormal Condition aggravated Debridement Deep vein thrombosis Dyspnoea exertional Hypoglycaemia Loss of consciousness Necrotising fasciitis

Symptomtext

Hospitalized 10.15.21 - 10.22.21; COVID-19 positive (10.15.21); fully vaccinated Admission Date: 10/15/2021 Discharge Date: 10/22/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoglycemia [E16.2] Type 2 diabetes mellitus with hypoglycemia without coma, without long-term current use of insulin (HCC) [E11.649] COVID-19 virus infection [U07.1] HOSPITAL COURSE: Patient is a 64 y.o. female who presents to hospital with low blood sugar. Patient developed necrotizing fasciitis in July of this year requiring extensive surgery. She then developed a DVT, cholecystitis and choledocholithiasis requiring cholecystectomy in August. Since then she reports episodes of recurrent hypoglycemia. She is a poor historian but states that she passed out last night and was brought in by EMS after her sugar was found to be 34. Last took her diabetes meds on 10/13. She received multiple boluses of dextrose and a dextrose infusion but continued to have hypoglycemia. Workup also showed her to be COVID positive. A chest xray did not reveal any infiltrates and she was at her baseline oxygen. Because of her chronic oxygen therapy she is not a candidate for monoclonal antibody therapy. Due to her persistent hypoglycemia she was referred to the hospital for further evaluation and care. 10/22 and Hospital Course: Patient was treated with dexamethasone. She slowly improved with pulmonary toilet, pronation as able, incentive spirometry. For the last day of her hospitalization she was weaned down to 3-4 L per nasal cannula. She was ambulating with assistance and was really hoping to go home, stating she has her daughter and family members to help her. Patient did receive a dose of IV Lasix and has a net -8.2 L fluid balance. She was tolerating a good diet, her vital signs have been stable. Renal function has remained stable as well, creatinine 1.12 on day of discharge. Patient completed 5 days of remdesivir. She was felt to not need further Decadron on day of discharge. It is felt that the risk of ongoing she will continue Decadron to complete 10 days, she still has episodes of desaturation with ambulation.. She will continue on home oxygen. She will follow up closely with her primary care provider. Patient was also no to have anemia, normocytic. Peripheral smear did show some rouleaux present. Ferritin, B12, folate and reticulocyte count normal. She showed no evidence of bleeding. She will need this followed up as an outpatient. Possibly Hematology referral as well as Gastroenterology evaluation. Patient is stable for discharge. Patient will continue Eliquis for her history of DVT. Addendum: We did get patient up in she desatted on 3 L, we will hold on discharge until she is assessed by respiratory therapy, oxygen is titrated appropriately and she does not have any further such desaturations.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
8,0
Labordaten
-
Aktuelle Erkrankungen
9.16.21 Office Visit - Necrotizing fasciitis of pelvic region and thigh (HCC) 9.20.21 - ED - fever, fatigue, recent necrotizing fasciitis and surgical debridement; CT returns showing choledocholithiasis 9.21.21 - 9.25.21 - patient admitted from ED: started on IV antibiotics / mgmt choledocholithiasis 10.12.21: ED leg pain; r/o DVT
Vorgeschichte
Anemia Acute on chronic respiratory failure with hypoxia (HCC) History of CVA (cerebrovascular accident) Diabetes mellitus, type II (HCC) Dyslipidemia CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min (HCC) Tobacco use RBBB Necrotizing fasciitis (HCC) Necrotizing soft tissue infection DVT, lower extremity, recurrent, unspecified laterality (HCC) Type 2 diabetes mellitus with hypoglycemia without coma (HCC) COPD (chronic obstructive pulmonary disease) (HCC) Hypothyroid Essential hypertension
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler apixaban (ELIQUIS) 5 MG tablet benzonatate (TESSALON) 100 MG capsule dexamethasone (DECADRON) 6 MG tablet ferrous su
Allergien
Cardizem - hives
Vorherige Impfungen
-

VAERS 1818034

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
DE
Alter
75,0
Geschlecht
F
Eingang
26.10.2021
Impfdatum
10.02.2021
Beginn
19.05.2021
Tage bis Beginn
98,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Blood test Computerised tomogram Thrombosis Ultrasound Doppler

Symptomtext

Blood formed-unknown date, had a stroke May 2019. TPA was given. Tests were ran.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
3,0
Labordaten
Blood work Cat scan Ultrasound on leg
Aktuelle Erkrankungen
N/A
Vorgeschichte
Arthritis High blood pressure Hashimotos
Andere Medikamente
Simvastatin- 20 mg 1 x a day Hydralazine 25mg 2x a day Hydrochlorothiazide/irbesartan-300mg-12.5mg 1 x a day Lezothyroxine sodium -88mg Metotrolol tartrate-25 mg 1x a day Aspirin-1x a day Probiotics
Allergien
Amlodiphine Augmentine Azithromycin
Vorherige Impfungen
-

VAERS 1768377

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
84,0
Geschlecht
M
Eingang
07.10.2021
Impfdatum
19.03.2021
Beginn
02.10.2021
Tage bis Beginn
197,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Blood culture negative COVID-19 Chest X-ray abnormal Chest pain Diabetic diet Diarrhoea Dyspnoea Hypoxia Lung disorder Nausea Oedema peripheral Oxygen saturation decreased Pyrexia Respiratory distress SARS-CoV-2 test positive Staphylococcus test positive

Symptomtext

Hospitalized (9.29.21); COVID-19 positive (10.2.21); fully vaccinated Discharge Provider: DO Primary Care Provider: MD Admission Date: 9/29/2021 Discharge Date: Oct 3, 2021 HOSPITAL COURSE 84-year-old gentleman presented with one week of weakness, nausea, feeling like he could not breathe. Fever over 100?. Some chest pain that would come and go. See H&P for full details. EMS was called and he was found to be hypoxic on room air in the low 80s and in respiratory distress (is supposed to be on 2 L oxygen at home.) Chest x-ray showed bilateral airspace disease. COVID testing positive. Admitted for treatment. Received five days Remdesivir in five days Decadron. Symptoms markedly improved. One day before discharge she had increased lower extremity edema and received one dose Lasix 40 mg IV. By the day of discharge he felt well enough to return home. Lower extremity edema significantly improved. He will complete another five days of Decadron (which will be 10 days total.) He is on his home oxygen at discharge. The patient had some hyperglycemia due to steroids which was treated appropriately with insulin. The rest of the patient's chronic medical issues were stable while here. PROCEDURES 9/29 BC x1: Staph epi 9/29 BC x1: Negative 9/29 CXR: Bilateral airspace disease Exam at discharge 36.3, 60, 20, 156/73, 93% 3 L Heart regular rate and rhythm Lungs clear to auscultation Abdomen nondistended nontender Extremities trace edema DISCHARGE RECOMMENDATIONS 1. Follow up with PCP in one week 2. Complete five additional days Decadron 3. Diabetic diet 4. Activity as tolerated Patient discharged home in improved and stable condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Respiratory distress
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
9.26.21: ED - diarrhea
Vorgeschichte
Coronary artery disease Hypertension CHF (congestive heart failure) (HCC) Dyslipidemia Moderate COPD (chronic obstructive pulmonary disease) (HCC) Stroke (HCC) PVD (peripheral vascular disease) (HCC) OSA (obstructive sleep apnea) Avulsion fracture of femoral condyle, left, closed, with routine healing, subsequent encounter Cognitive impairment Bladder mass Diastolic dysfunction Hypotension Acute cholecystitis Acute respiratory failure with hypoxia (HCC)
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler amLODIPine (NORVASC) 10 MG tablet apixaban (ELIQUIS) 5 MG tablet atorvastatin (LIPITOR) 80 MG tablet B Complex Vitam
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1758823

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
84,0
Geschlecht
M
Eingang
04.10.2021
Impfdatum
29.01.2021
Beginn
26.09.2021
Tage bis Beginn
240,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 SARS-CoV-2 test positive Syncope

Symptomtext

Admitted for syncope

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
4,0
Labordaten
positive for covid on admission 9.26.21
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1719813

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
39,0
Geschlecht
F
Eingang
21.09.2021
Impfdatum
01.02.2021
Beginn
01.04.2021
Tage bis Beginn
59,0
Dosis
2
Route/Site
SYR / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Heavy menstrual bleeding Thrombosis

Symptomtext

Blood clots at time of periods that have been abnormally large. Much heavier bleeding than last 20 years.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1719781

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
IL
Alter
42,0
Geschlecht
M
Eingang
21.09.2021
Impfdatum
04.02.2021
Beginn
13.09.2021
Tage bis Beginn
221,0
Dosis
2
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Full blood count Hypoaesthesia Magnetic resonance imaging Metabolic function test

Symptomtext

Bells palsy, left arm and left leg numbness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
MRI, CBC, BMP
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1693113

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6202

schwer
Staat
AZ
Alter
65,0
Geschlecht
F
Eingang
11.09.2021
Impfdatum
28.02.2021
Beginn
31.05.2021
Tage bis Beginn
92,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Atrial fibrillation Bell's palsy Cardiac monitoring Computerised tomogram Echocardiogram Electrocardiogram Magnetic resonance imaging

Symptomtext

On May 31, 2021, I went into A-Fib and was hospitalized for four days. I did go back into sinus rhythm with medication. On July 5, I thought I having either a stroke or TIA. It turned out to be Bell's Palsy. Prescribed prednisolone, then prednisone. The palsy is almost all gone.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
4,0
Labordaten
EKG (May 31, - June 3) , CT scan (May 31), Heart Monitor (May 31 - June 3) EKG (July 5) CT Scan (July 5), MRI (July 6), Echogram (July 6) Hospitalized 3 days
Aktuelle Erkrankungen
None
Vorgeschichte
High Blood Pressure
Andere Medikamente
? Aspirin (81mg/1) - Heart ? Biotin (5000mcg/1) - Hair & Nails ? Amlodipine/Valsartan (10/320 mg) - Blood Pressure ? Omeprazole (40mg/MWF) - Acid Reflux ? Rosuvastatin (Crestor) 10mg/1x ? Vitamin C 2000mg ? Vitamin D3 4000iu
Allergien
Biaxin
Vorherige Impfungen
-

VAERS 1678953

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OK
Alter
65,0
Geschlecht
F
Eingang
07.09.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Chills Dizziness Dysstasia Fatigue Feeling abnormal Headache Loss of consciousness Migraine Nausea Pyrexia Vomiting

Symptomtext

Exactly 12 hours after administration I experienced these symptoms: Exploding headache, nausea, vomiting, chills, fever, dizziness, unable to stand up I had a partial loss of consciousness with the exploding headache. This lasted for 6 1/2 hours. Then the headache diminished to that of a severe migraine and I regained full consciousness. Over the course of another 12 hours I gradually improved so that 24 hours after onset of severe reaction I could stand up, move around, and eat a little. Some symptoms such as extreme fatigue and brain fog lasted for another week. I have never had a headache like that and I hope I would never experience anything like that again.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
I was unable to rouse myself enough to ask my husband to call 9-1-1 and as he had only mild symptoms in response to vaccine, he thought of 9-1-1 but kept expecting that I would show improvement as time went on (which turned out to be true).
Aktuelle Erkrankungen
NONE
Vorgeschichte
Restless legs syndrome
Andere Medikamente
Combipatch estrogine/progesterine changed 2ce weekly; Amitriptyline 5 mg/daily, Famotidine dose? daily; Clonazepam .5mg prn for restless legs Benadryl 50mg at night; 1000 IU Calcium daily; vitamin B12 daily; Allegra a.m. daily
Allergien
Allergic to Sulfa drugs, Cipro class of antibiotics, Cyproheptadine, and Sinemet Sensitive to Codeine, Lortab Mild allergic response to cows milk, beef and other mammal meats, paprika and honey
Vorherige Impfungen
-

VAERS 1674509

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OK
Alter
38,0
Geschlecht
F
Eingang
04.09.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Anaphylactic reaction Head discomfort Migraine

Symptomtext

A couple of minutes after the vaccine I started to have a little migraine. I felt pressure in my head. Then 30 min later I started to have an anaphylactic reaction. I stayed for 2 hrs in a half until I was able to drive. When I left I got to my friends house and I started having another reaction there but I took lots of Benadryl and that helped me.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Obese
Andere Medikamente
-
Allergien
color greens; latex; cantaloupe; pineapple
Vorherige Impfungen
-

VAERS 1666266

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
WI
Alter
83,0
Geschlecht
F
Eingang
02.09.2021
Impfdatum
26.02.2021
Beginn
29.08.2021
Tage bis Beginn
184,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Cough Decreased appetite Gait disturbance Hypotension Respiratory tract congestion SARS-CoV-2 test positive Seizure

Symptomtext

Patient admitted as inpatient on 8/29 due to COVID-19. Patient was tested for COVID-19 and was positive on 8/29. Since Friday (8/27)patient states she has been having low blood pressures while at home. With this she has been having a cough seizing feeling congested having a decreased appetite. She states that she has been stumbling a little bit as well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Acetaminophen, allopurinol, amoxicillion, atorvastatin, cholecalciferol, famotidine, fluticasone propionate, flucosam sul Na/chondr, losartan, meclizine, metoprolol sussinate, prednisone, rivaroxaban, senna-docusate, tamoxifen, torsemide
Allergien
Steri-strip [Adhesive Tape], Diflucan [Fluconazole], Flagyl [Metronidazole], Hydrochlorothiazide, Citalopram, Doxycycline, Nitrofurantoin
Vorherige Impfungen
-

VAERS 1096319

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
59,0
Geschlecht
F
Eingang
28.08.2021
Impfdatum
10.03.2021
Beginn
10.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Facial paralysis Tongue paralysis Hypoaesthesia Hypoaesthesia oral Paraesthesia oral SARS-CoV-2 test

Symptomtext

both sides of her face, lip and tongue went numb; both sides of her face, lip and tongue went numb; About an hour later her tongue tingled for a while; This is a spontaneous report from a contactable consumer (patient). A 59-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in Arm Left on 10Mar2021 11:52 (at the age of 59-years-old) (Lot Number: EN6202; Expiration Date: Jun2021) as single dose for COVID-19 immunization. Medical history included blood pressure, allergies, Heartburn. Concomitant medication(s) included hydrochlorothiazide taken for blood pressure from 03Mar2021 and ongoing; atenolol (TENORMIN) taken for blood pressure from 03Mar2021 and ongoing; loratadine (CLARITIN) taken for allergies from an unspecified start date 10 years ago and ongoing; pantoprazole sodium sesquihydrate (PROTONIX) taken for heartburn from 03Mar2021 and ongoing. The patient did not receive any prior vaccinations (within 4 weeks). The patient received the first dose of the Pfizer COVID on 10Mar2021. On 10Mar2021 12:22, about an half hour after receiving the vaccine, both sides of her face, lip and tongue went numb. She stated the numbness in her face came back after 5 minutes, numbness in her lips came back after 10 minutes and the numbness in her tongue came back after about an hour. She never had any swelling, trouble swallowing or breathing. Caller states everything just went numb after the injection and she has had no problems since. Caller says that she was trying to get information on whether she should get the second dose of the Pfizer COVID vaccine because she had an adverse event with the first dose of the COVID vaccine. She was wondering what the guidance is that Pfizer is providing. She received her COVID vaccine on 10Mar2021 and 30 minutes after the COVID vaccine her face, on both sides, went numb, then her lips went numb and then her tongue went numb. She had no droop, her face just froze. About 5 minutes later her face came back, 5 minutes after that her lips came back, and then her tongue slowly came back over the next hour and it slowly got better and better. It was like she had gotten 2 shots of Novocain in both sides of her face. She was trying to decide if she should get the next dose of the COVID vaccine. Caller said that she will email her provider about this but she wanted to see if the medical information department has any general guidance on this to provide to her provider. She says that she went to the VAERS site and had what she experienced sent on that site so that what she experienced would be recorded. She has had nothing new that has occurred since then. 30 minutes after 1st dose face, lips and tongue went numb about 10-15 minutes later the feeling in her face came back. Another 10 minutes her lips she could feel. About an hour later her tongue tingled for a while and then went back to normal. She consulted her primary care doctors who made an appointment with an allergist to confirm if she should get the 2nd dose. The doctor said to get it and received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in left upper arm on 31Mar2021 11:58 (Lot Number: ER8732; Expiration Date: Jul2021) for COVID-19 immunization. The patient did not receive any treatment for the events. AE required visit to: Physician dept. virtual. The patient underwent lab tests which included Covid test rapid on 25Mar2021 to travel out of state which was negative; Covid test PCR on 12Apr2021 in order to get endoscopy for heart burn which was negative. Outcome of the events was recovered on 10Mar2021. Follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
-
Labordaten
Test Date: 20210412; Test Name: Covid test PCR; Test Result: Negative ; Comments: needed to get in order to get endoscopy for heart burn; Test Date: 20210325; Test Name: Covid test rapid; Test Result: Negative ; Comments: needed to get had traveled out of state.
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergy; Blood pressure abnormal; Heartburn
Andere Medikamente
HYDROCHLOROTHIAZIDE; TENORMIN; CLARITIN [LORATADINE]; PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]
Allergien
-
Vorherige Impfungen
-

VAERS 1096319

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6202

schwer
Staat
NY
Alter
59,0
Geschlecht
F
Eingang
28.08.2021
Impfdatum
10.03.2021
Beginn
10.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Facial paralysis Tongue paralysis Hypoaesthesia Hypoaesthesia oral Paraesthesia oral SARS-CoV-2 test

Symptomtext

both sides of her face, lip and tongue went numb; both sides of her face, lip and tongue went numb; About an hour later her tongue tingled for a while; This is a spontaneous report from a contactable consumer (patient). A 59-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in Arm Left on 10Mar2021 11:52 (at the age of 59-years-old) (Lot Number: EN6202; Expiration Date: Jun2021) as single dose for COVID-19 immunization. Medical history included blood pressure, allergies, Heartburn. Concomitant medication(s) included hydrochlorothiazide taken for blood pressure from 03Mar2021 and ongoing; atenolol (TENORMIN) taken for blood pressure from 03Mar2021 and ongoing; loratadine (CLARITIN) taken for allergies from an unspecified start date 10 years ago and ongoing; pantoprazole sodium sesquihydrate (PROTONIX) taken for heartburn from 03Mar2021 and ongoing. The patient did not receive any prior vaccinations (within 4 weeks). The patient received the first dose of the Pfizer COVID on 10Mar2021. On 10Mar2021 12:22, about an half hour after receiving the vaccine, both sides of her face, lip and tongue went numb. She stated the numbness in her face came back after 5 minutes, numbness in her lips came back after 10 minutes and the numbness in her tongue came back after about an hour. She never had any swelling, trouble swallowing or breathing. Caller states everything just went numb after the injection and she has had no problems since. Caller says that she was trying to get information on whether she should get the second dose of the Pfizer COVID vaccine because she had an adverse event with the first dose of the COVID vaccine. She was wondering what the guidance is that Pfizer is providing. She received her COVID vaccine on 10Mar2021 and 30 minutes after the COVID vaccine her face, on both sides, went numb, then her lips went numb and then her tongue went numb. She had no droop, her face just froze. About 5 minutes later her face came back, 5 minutes after that her lips came back, and then her tongue slowly came back over the next hour and it slowly got better and better. It was like she had gotten 2 shots of Novocain in both sides of her face. She was trying to decide if she should get the next dose of the COVID vaccine. Caller said that she will email her provider about this but she wanted to see if the medical information department has any general guidance on this to provide to her provider. She says that she went to the VAERS site and had what she experienced sent on that site so that what she experienced would be recorded. She has had nothing new that has occurred since then. 30 minutes after 1st dose face, lips and tongue went numb about 10-15 minutes later the feeling in her face came back. Another 10 minutes her lips she could feel. About an hour later her tongue tingled for a while and then went back to normal. She consulted her primary care doctors who made an appointment with an allergist to confirm if she should get the 2nd dose. The doctor said to get it and received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in left upper arm on 31Mar2021 11:58 (Lot Number: ER8732; Expiration Date: Jul2021) for COVID-19 immunization. The patient did not receive any treatment for the events. AE required visit to: Physician dept. virtual. The patient underwent lab tests which included Covid test rapid on 25Mar2021 to travel out of state which was negative; Covid test PCR on 12Apr2021 in order to get endoscopy for heart burn which was negative. Outcome of the events was recovered on 10Mar2021. Follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
-
Labordaten
Test Date: 20210412; Test Name: Covid test PCR; Test Result: Negative ; Comments: needed to get in order to get endoscopy for heart burn; Test Date: 20210325; Test Name: Covid test rapid; Test Result: Negative ; Comments: needed to get had traveled out of state.
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergy; Blood pressure abnormal; Heartburn
Andere Medikamente
HYDROCHLOROTHIAZIDE; TENORMIN; CLARITIN [LORATADINE]; PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]
Allergien
-
Vorherige Impfungen
-

VAERS 1637297

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6202

schwer
Staat
WI
Alter
66,0
Geschlecht
F
Eingang
26.08.2021
Impfdatum
25.02.2021
Beginn
20.03.2021
Tage bis Beginn
23,0
Dosis
UNK
Route/Site
SC / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein
Aldolase Asthenia Blood heavy metal test Blood immunoglobulin A Blood thyroid stimulating hormone Borrelia test Computerised tomogram head Guillain-Barre syndrome HIV test Hepatitis viral test Lumbar puncture abnormal Magnetic resonance imaging abnormal Myoglobin blood SARS-CoV-2 test Treponema test Viral titre Vitamin B12

Symptomtext

pfizer #1 on 2/25/2021 weakness 3/20/2021 subsequently determined by neurologist after MRI and lumbar puncture and serologies June 2021 to be Guillaine Barre

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
7,0
Labordaten
brain CT and MRI lumbar puncture TSH, myoglobin, aldolase, Vit B12, heavy metals, HIV, Hepatitis panel, LYme titer, RPR, VDRL, Immunoglob IgA, Covid
Aktuelle Erkrankungen
resolved diverticulitis (one month before)
Vorgeschichte
sleep apnea, obesity, diabetes, hyperlipidemia, GERD, depression
Andere Medikamente
atorvastatin, glimiperide, albuterol,
Allergien
NSAIDs, savella, gabapentin, lyrica, diazepam, pantoprazole, prednisone, metformin
Vorherige Impfungen
-

VAERS 1623991

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
AZ
Alter
82,0
Geschlecht
F
Eingang
23.08.2021
Impfdatum
24.02.2021
Beginn
23.03.2021
Tage bis Beginn
27,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Asthenia Lethargy Pulmonary thrombosis

Symptomtext

Blood Clot on left Lung, Very weak and lethargic,

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary thrombosis
Hospital-Tage
4,0
Labordaten
Hospital visit for four days, April 5th thru April 9th
Aktuelle Erkrankungen
None
Vorgeschichte
COPD
Andere Medikamente
Trilogy,
Allergien
None
Vorherige Impfungen
-

VAERS 1617730

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
69,0
Geschlecht
M
Eingang
22.08.2021
Impfdatum
08.03.2021
Beginn
11.03.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Asthenia Asthma Back pain Blood test Cardiac stress test Computerised tomogram Condition aggravated Dyspnoea Echocardiogram Electrocardiogram Loss of personal independence in daily activities Magnetic resonance imaging Pericarditis Peripheral swelling

Symptomtext

1) Massive asthma attack. Felt close to dying. Breathing is still not controlled. 2) Excruciating lower left back pain. Could not be alleviated with hydrocodone or even morphine. Lasted 4 months. Tolerable now after 6 months. 3) Pericarditis 4) Extreme weakness. Could barely do daily routine chores. 5) Both legs and feet swollen tremendously.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pericarditis
Hospital-Tage
3,0
Labordaten
I was admitted at first at an Urgent Care facility as there were no beds anywhere in town. Regular nor ER. After trying for 2 days, I was examined at a Hospital's ER. A day later, was admitted to hospital. Have been treated (until now) by numerous specialists- cardiologist, pulmonologist, allergy/immunology expert, pain/spine specialist Numerous blood tests were conducted on multiple occasions. covering the entire routine and non-routine spectrum. CT Scans MRI Echocardiograms Stress Test with EKG. All results are available from hospital as well as another Hospital where I was seen as well.
Aktuelle Erkrankungen
-
Vorgeschichte
Stent in one artery. High Blood Pressure, BPH, Asthma
Andere Medikamente
Metformin, Ramipril, Amlodipine, Rosuvastatin, Clopidogrel, Travatan eye drops, Vitamin D, Vitamin B complex, Zinc, Glucosamine
Allergien
Aspirin, Sea food (only with shell)
Vorherige Impfungen
-

VAERS 1546328

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NJ
Alter
57,0
Geschlecht
M
Eingang
11.08.2021
Impfdatum
20.03.2021
Beginn
03.04.2021
Tage bis Beginn
14,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Anticoagulant therapy Blood test Dyspnoea Intensive care Pulmonary thrombosis Sleep disorder Thrombosis

Symptomtext

evening of 3 Apr 21 woke up from sleep with sense that I could not breath; something wrong. i drove to local ER where I was admitted to ICU fo2 days, with numerous blood clots in both lungs and one on my right upper leg. I was not in any vehicle accident nor suffered any fall or injury prior to this diagnosis. I was in complete shock. No family history of blood clots.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
2,0
Labordaten
4 Apr 21, blood work and put on blood thinner (I cannot recall names and amount)
Aktuelle Erkrankungen
none
Vorgeschichte
pTSD and lower back herniated disk
Andere Medikamente
indomathacin as needed
Allergien
none
Vorherige Impfungen
-

VAERS 1534366

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
GA
Alter
63,0
Geschlecht
M
Eingang
07.08.2021
Impfdatum
10.03.2021
Beginn
17.03.2021
Tage bis Beginn
7,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Burning sensation Deep vein thrombosis Pain in extremity Peripheral swelling

Symptomtext

2 "DVTs" in left leg; 7 days later left leg and arm swelled up; inside left thigh very sore burns when I walk since the 17th of march; inside left thigh very sore; This is a spontaneous report received from a contactable consumer (patient). This 63-year-old male patient received dose 2 of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EN6202) via an unspecified route of administration on 10Mar2021 (at the age of 63-years-old) as a single dose for COVID-19 immunization. Medical history was none. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications included atorvastatin, metoprolol, and losartan from unknown dates for unknown indications. The patient previously received warfarin (COUMADIN) from an unknown date and experienced allergy. The patient received dose 1 of bnt162b2 (lot number El9267) on 20Feb2021 at 11:00 as a single dose in the left arm for COVID-19 immunization and experienced joint pain severe 14 days, tired 14 days, headache 14 days, and couldn't lift his arm for 3 days. With dose 2 the patient had no pain, tiredness, or headache. Seven days later (on 17Mar2021) the patient experienced left leg and arm swelled up, had 2 "DVTS" in left leg. The swelling was down but inside left thigh was very sore and burned when he walked since 17Mar2021. The events were reported as non-serious. The patient was not hospitalized for the events. The patient visited a doctor or other healthcare professional office/clinic and emergency room./department or urgent care as a result of the events. The patient received treatment with rivaroxaban for clots. The outcomes of had 2 "DVTs," inside left thigh was very sore and burned when he walked were not recovered. The outcome of left leg and arm swelled up was recovering. It was also reported that since the vaccination the patient had not been tested for COVID-19. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021400070 Same patient and drug, different dose/events

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
ATORVASTATIN; METOPROLOL; LOSARTAN
Allergien
-
Vorherige Impfungen
-

VAERS 1526033

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
PA
Alter
49,0
Geschlecht
M
Eingang
04.08.2021
Impfdatum
19.03.2021
Beginn
07.04.2021
Tage bis Beginn
19,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Blood pressure increased Bronchitis chronic C-reactive protein increased Cardiac imaging procedure abnormal Cardiomyopathy Chest pain Computerised tomogram thorax Echocardiogram Ejection fraction decreased Influenza virus test negative Left ventricular hypertrophy Myocarditis Pleuritic pain Red blood cell sedimentation rate increased Respiratory syncytial virus test negative Right ventricular hypertrophy SARS-CoV-2 test negative Troponin T increased

Symptomtext

Myocarditis: The patient presented to the emergency department with pleuritic, positional, non-radiating, non-exertional, chest pain and an elevated blood pressure reading at home. Labs were notable for elevated ESR, CRP, as well as elevated troponins which increased and then trended back down (0.076 -- > 0.109 -- > 0.105 -- > 0.088). EKG was negative for acute ischemic changes. The patient was admitted to the hospital. TTE was notable for LVEF 61% with normal RV function without significant valvular disease and no pericardial effusion. Cardiac MRI was notable for myocardial edema and inflammation with findings overall consistent with acute myocarditis without pericarditis. Patient was initially treated with prednisone 40 mg daily. Cardiology was consulted who recommended stopping the increased prednisone. Etiology of myocarditis remained unclear; given onset after second Pfizer mRNA vaccine, it was considered whether it might be a reaction to the vaccine. The patient was recommended to avoid NSAIDS, extensive exercise, and alcohol, follow-up with outpatient Cardiology. The patient has now been seen in follow up - his chest pain has resolved, blood pressure normalized, and repeat cardiac MRI shows stable to improved myocarditis (6/3/21 cardiac MRI read: "1. Overall, compared to prior CMR from 4/12/21, the findings are similar. The pattern and extent of LGE is unchanged. 2. Normal left ventricular size and function. Moderate concentric hypertrophy, with the thickest segment measuring 18mm at the mid inferoseptum. Diffuse midmyocardial LGE with mildly elevated myocardial T2 suggestive of mild inflammation. The differential for these findings include 1) resolving myocarditis in the setting of a preexisting nonischemic cardiomyopathy, most likely underlying hypertrophic cardiomyopathy, 2) amyloidosis given the diffuse pattern of delayed enhancement and moderate hypertrophy (although the pattern of LGE and lack of atrial enlargement is unusual), and 3) resolving myocarditis in the context of underlying hypertensive cardiomyopathy. 3. Normal right ventricular size and function.")

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
5,0
Labordaten
4/8/21 Troponin T 0.098 -> 0.076 -> 0.109 -> 0.105 -> 0.088 4/8/2021 SARS CoV2 PCR (NP swab) negative 4/8/2021 Flu, RSV PCR (NP swab) negative 4/8/21 CT chest: 1. No pulmonary embolism. 2. Bronchial wall thickening, suggesting chronic bronchitis 4/12/21 Cardiac MRI: 1. Overall findings are consistent with acute myocarditis, though the extent of delayed enhancement and LV hypertrophy suggest pre-existing non-ischemic cardiomyopathy, which could be related to hypertensive cardiomyopathy compounded by PCKD. Hypertrophic cardiomyopathy is also on the differential, though the pattern of LVH is atypical and mitral abnormalities are absent. Findings are also not typical of cardiac amyloid, in the absence of atrial enlargement or valvular thickening. Clinical correlation recommended. 2. Normal left ventricular size and systolic function with no regional wall motion abnormalities. Moderate concentric LV hypertrophy most pronounced in the mid inferoseptum which measures 18 mm. Moderately increased myocardial mass (LV mass index 105 g/m2). There is diffuse mid-myocardial delayed enhancement throughout the myocardium (involving estimated 49% of the LV). There is moderate elevation in native T1 and ECV, which appears more pronounced in the mid segment. T2 is also diffusely elevated, suggesting myocardial edema/inflammation. 3. Normal right ventricular size with mild RVH and normal systolic function. 4. No obvious pericardial delayed enhancement. No evidence of constrictive physiology.
Aktuelle Erkrankungen
No active illnesses at the time of vaccination/up to one month prior.
Vorgeschichte
The patient has a history of end-stage renal disease due to polycystic kidney disease. He had a deceased donor kidney transplant in 1/2014. He also has a history of hypertension, asthma, hyperparathyroidism, and urinary tract infections.
Andere Medikamente
albuterol, eplerenone, latanoprost eye drops, levocetirizine, mycophenolate mofetil, pravastatin, predniSONE, propranolol, tacrolimus
Allergien
No allergies to medications/foods. Allergic to dust, seasonal allergies.
Vorherige Impfungen
-

VAERS 1505905

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
67,0
Geschlecht
M
Eingang
27.07.2021
Impfdatum
24.02.2021
Beginn
02.04.2021
Tage bis Beginn
37,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Loss of consciousness Road traffic accident Upper limb fracture

Symptomtext

Transient loss of consciousness while driving motor vehicle resulting in contact with another vehicle and injuries from airbag, specificly a broken arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1370587

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
74,0
Geschlecht
F
Eingang
26.07.2021
Impfdatum
27.02.2021
Beginn
10.03.2021
Tage bis Beginn
11,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Atrial fibrillation Chest X-ray Chest pain Computerised tomogram Echocardiogram Electrocardiogram abnormal Endoscopy Laboratory test Pericarditis Inflammatory marker test Investigation Pneumonitis Red blood cell sedimentation rate Red blood cell sedimentation rate increased

Symptomtext

Diagnosis Pericarditis . Went to ER with stabbing chest pains, then was admitted to hospital; also had AFib. Had EKG, CT scan, chest Xray, Echocardiogram; blood work. As of today's date, 7/26/2021, I still have it; now diagnosed as recurrent pericarditis. I have taken Colchicine, Predisone, Indomethacin, Xarelto, Advil, Lasix, Potassium, Amiodarone, Metroprolol, Losartan over the last4 to 5 months.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pericarditis
Hospital-Tage
-
Labordaten
March 10, 11, 12, 2021 in ER and hospital: lab work, CT Scan, EKG, Echo cardiagram, chest Xray. Doctor listened and heard pericardial rub. Since then, have had additional chest Xrays, EKGs, Echo cardiagrams, lab work, Endoscopy.
Aktuelle Erkrankungen
On Jan. 14, 2021, had aortic valve replacement via Mini Thoracotomy. I had Aortic Regurgitation for 7 or 8 years; it was mild during most of that time, but in the year to year and a half prior to the surgery, it went to moderate to severe. So, I was on the drugs listed above following the surgery.
Vorgeschichte
I had Aortic Regurgitation for 7 or 8 years; it was mild during most of that time, but in the year to year and a half prior to the surgery in Jan. 2021, it went to moderate to severe. I have a Pacemaker for sinus bradycardia; it was put in in 2016.
Andere Medikamente
Xarelto 20mg per day; Losartan 25mg twice per day; Metoprolol Tartrate 25mg per day; Torsemide 10mg per day; Potassium chloride 20meq per day; baby aspirin 81mg 1 per day; Tylenol 500 mg as needed. (I took pain medicine in the hospital for
Allergien
Sulfa Drugs, Penicillin, Z-pac
Vorherige Impfungen
-

VAERS 1370587

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
74,0
Geschlecht
F
Eingang
26.07.2021
Impfdatum
27.02.2021
Beginn
10.03.2021
Tage bis Beginn
11,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Atrial fibrillation Chest X-ray Chest pain Computerised tomogram Echocardiogram Electrocardiogram abnormal Endoscopy Laboratory test Pericarditis Inflammatory marker test Investigation Pneumonitis Red blood cell sedimentation rate Red blood cell sedimentation rate increased

Symptomtext

Diagnosis Pericarditis . Went to ER with stabbing chest pains, then was admitted to hospital; also had AFib. Had EKG, CT scan, chest Xray, Echocardiogram; blood work. As of today's date, 7/26/2021, I still have it; now diagnosed as recurrent pericarditis. I have taken Colchicine, Predisone, Indomethacin, Xarelto, Advil, Lasix, Potassium, Amiodarone, Metroprolol, Losartan over the last4 to 5 months.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pericarditis
Hospital-Tage
-
Labordaten
March 10, 11, 12, 2021 in ER and hospital: lab work, CT Scan, EKG, Echo cardiagram, chest Xray. Doctor listened and heard pericardial rub. Since then, have had additional chest Xrays, EKGs, Echo cardiagrams, lab work, Endoscopy.
Aktuelle Erkrankungen
On Jan. 14, 2021, had aortic valve replacement via Mini Thoracotomy. I had Aortic Regurgitation for 7 or 8 years; it was mild during most of that time, but in the year to year and a half prior to the surgery, it went to moderate to severe. So, I was on the drugs listed above following the surgery.
Vorgeschichte
I had Aortic Regurgitation for 7 or 8 years; it was mild during most of that time, but in the year to year and a half prior to the surgery in Jan. 2021, it went to moderate to severe. I have a Pacemaker for sinus bradycardia; it was put in in 2016.
Andere Medikamente
Xarelto 20mg per day; Losartan 25mg twice per day; Metoprolol Tartrate 25mg per day; Torsemide 10mg per day; Potassium chloride 20meq per day; baby aspirin 81mg 1 per day; Tylenol 500 mg as needed. (I took pain medicine in the hospital for
Allergien
Sulfa Drugs, Penicillin, Z-pac
Vorherige Impfungen
-

VAERS 1426850

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OK
Alter
58,0
Geschlecht
F
Eingang
13.07.2021
Impfdatum
25.02.2021
Beginn
05.03.2021
Tage bis Beginn
8,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Acoustic neuroma Arteriovenous malformation Asthenia Electric shock sensation Electrocardiogram Feeling cold Hypoaesthesia Magnetic resonance imaging Magnetic resonance imaging neck Magnetic resonance imaging spinal Ultrasound Doppler

Symptomtext

The left side of my body starting at the bottom of my foot went totally numb and weak. It progressed right up and across my waist - left side only and up to my chest and then arm. The feeling came back within 15 minutes but has come and gone with less frequency since then. A feeling of coldness accompanies the numbness or just a small shock feeling sometimes. Mainly my upper thigh, calf and arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
MRI 3-10-21 Ultrasound of my carotid arteries - 3-10-21 EKG and other heart tests 3-10-21 MRI of neck and upper spine 6-23-21 An acoustic neuroma was found and an AVM in the brain. The neurologist doesn't think either of these things are causing numbness.
Aktuelle Erkrankungen
NONE I WAS AWARE OF
Vorgeschichte
SLIGHTLY HIGH CHOLESTEROL WITHOUT MEDICATION
Andere Medikamente
PRAVASTATIN
Allergien
LIPITOR
Vorherige Impfungen
-

VAERS 1426850

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OK
Alter
58,0
Geschlecht
F
Eingang
13.07.2021
Impfdatum
25.02.2021
Beginn
05.03.2021
Tage bis Beginn
8,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Acoustic neuroma Arteriovenous malformation Asthenia Electric shock sensation Electrocardiogram Feeling cold Hypoaesthesia Magnetic resonance imaging Magnetic resonance imaging neck Magnetic resonance imaging spinal Ultrasound Doppler

Symptomtext

The left side of my body starting at the bottom of my foot went totally numb and weak. It progressed right up and across my waist - left side only and up to my chest and then arm. The feeling came back within 15 minutes but has come and gone with less frequency since then. A feeling of coldness accompanies the numbness or just a small shock feeling sometimes. Mainly my upper thigh, calf and arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
MRI 3-10-21 Ultrasound of my carotid arteries - 3-10-21 EKG and other heart tests 3-10-21 MRI of neck and upper spine 6-23-21 An acoustic neuroma was found and an AVM in the brain. The neurologist doesn't think either of these things are causing numbness.
Aktuelle Erkrankungen
NONE I WAS AWARE OF
Vorgeschichte
SLIGHTLY HIGH CHOLESTEROL WITHOUT MEDICATION
Andere Medikamente
PRAVASTATIN
Allergien
LIPITOR
Vorherige Impfungen
-

VAERS 1454210

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
40,0
Geschlecht
F
Eingang
07.07.2021
Impfdatum
27.04.2021
Beginn
28.04.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Behaviour disorder Bell's palsy Corneal reflex decreased Ear pain Eating disorder Eye disorder Eye pain Facial nerve disorder

Symptomtext

Dose #1: Just a sore arm Dose #2: Within 24 hours my left ear hurt like I was getting an ear infection. I just assumed it was allergies. Within 48 hours my left eye began stinging and hurting, as well as continuation of a left earache. Within 72 hours I noticed that me left eye blinking was delayed and not symmetrical with that of my right. On May 1st I went to the ER and was diagnosed with Bell's Palsy. I had total loss of muscle/nerve control to the left side of my face. It affected my speech, ability to eat, and ability to drink. I was scared that I was having a stroke and went to the ER.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
N/A No diagnostic tests performed. My ER doctor diagnosed me with Bell's Palsy.
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
Women's Multi Vitamin Vitamin C Allegra (Allergy Pill)
Allergien
N/A Unknown
Vorherige Impfungen
-

VAERS 1453785

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
46,0
Geschlecht
U
Eingang
07.07.2021
Impfdatum
27.02.2021
Beginn
04.03.2021
Tage bis Beginn
5,0
Dosis
2
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Blood test Chest X-ray Condition aggravated Nephropathy Presyncope Sarcoidosis Uveitis

Symptomtext

Vaso vagal; Uveitis aggravated; Condition aggravated; Renal disease aggravated; Renal disease aggravated; sarcoidosis aggravated; sarcoidosis aggravated; This is a spontaneous report from a contactable consumer. This consumer reported in response to consumer letter sent via follow-up letter. A 46-year-old (non-pregnant) female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6202, Expiration date: unknown), via intramuscular route of administration, administered in right arm on 27Feb2021 at 04:00 pm (at the age of 46-year-old) as dose 2, single for COVID-19 immunization. Patient historical vaccine included 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EM9809) via intramuscular route of administration administered in right arm as dose 1, single on 06Feb2021 1:00 pm for COVID-19 immunisation and patient experienced Extreme Fatigue, sarcoidosis, Uveitis, Renal disease aggravations. The patient medical history includes Covid -19 from 09July2020 till 26Jul2020 with no hospitalization and breast cancer from 12Oct2006 to 15Mar2007 (Stage 2. Treated with Lumpectomy, chemo, radiation). concomitant medications included escitalopram oxalate (LEXAPRO), orally at 30 mg for Anxiety, buspirone hydrochloride (BUSPAR) orally at 5 mg (twice a day) orally for Anxiety, prednilison and cyclopentolate Hcl ophthalmic for uveitis, levocetirizine dihydrochloride (XYZAL), oral 5mg for allergy, Potassium chloride 20 meq (twice a day) orally for kidney potassium, iron- orally 30 mg for anaemia all from an unspecified date and ongoing. The patient did not take any prior vaccinations within 4 weeks. On 04Mar2021, 4 days after the vaccination, the patient experienced Vaso vagal which resulted in hospitalisation, also patient experienced worsening of uveitis, sarcoidosis and renal disease after second dose of vaccine. Patient had sarcoidosis caused by Covid-19 (Jul2020) and then worsened/ flared by vaccine. Patient has uveitis, fatigue and renal disease. Under care of GP, Nephrologist, retina specialist and rheumatologist. Treatment was given to the patient with prednisone 60 mg. Patient lab data includes blood test with unknown result in Mar2021 and chest X-ray with normal findings in Mar2021. The outcome of the event vasovagal (presyncope) was recovered on 07Mar2021, and the outcome of uveitis and renal disease aggravated was not recovered and the outcome of sarcoidosis aggravated was unknown. No follow-up attempts possible. No further information expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
4,0
Labordaten
Test Date: 202103; Test Name: Blood work; Result Unstructured Data: Test Result:Unknown; Test Date: 202103; Test Name: Chest X-ray; Result Unstructured Data: Test Result:Normal; Comments: Normal
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Breast cancer (Stage 2. Treated with Lumpectomy, chemo, radiation); COVID-19 (No hospitalization).
Andere Medikamente
LEXAPRO; BUSPAR; XYZAL; CYCLOPENTOLATE HCL; POTASSIUM CHLORIDE; IRON.
Allergien
-
Vorherige Impfungen
-

VAERS 1443198

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
54,0
Geschlecht
F
Eingang
02.07.2021
Impfdatum
24.02.2021
Beginn
17.03.2021
Tage bis Beginn
21,0
Dosis
2
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Computerised tomogram normal Echocardiogram Facial paralysis Magnetic resonance imaging head normal Neurological symptom

Symptomtext

Bell's Palsy symptom, face drooped on left side, diagnosed at ER on 3/18/2021 after several tests run to rule out a stroke. Was given anti viral meds and steroids for 7-10 days. Physical therapy for face. Treatment for 2 mos. Ongoing at home treatment on face and speech therapy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
3,0
Labordaten
Cat Scan and MRI showed negative for brain bleed / stroke. Ultrasound on heart showed normal results. 3/18/2021.
Aktuelle Erkrankungen
none
Vorgeschichte
type 2 diabetic
Andere Medikamente
Tylenol, motrin, lisinopril 10 mg,
Allergien
Erythromycin and vicodin
Vorherige Impfungen
-

VAERS 1438243

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
PA
Alter
79,0
Geschlecht
F
Eingang
30.06.2021
Impfdatum
-
Beginn
05.05.2021
Tage bis Beginn
-
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Loss of consciousness Syncope Urinary tract infection Urine analysis

Symptomtext

Dizziness/ syncopal event with loss of consciousness and urinary tract infection on 5/5/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
ED visit with urine analysis on 5/5 positive for bacteria.
Aktuelle Erkrankungen
Osteoporosis Prediabetes Hyperlipidemia Developed dizziness and Urinary tract infection in 5/5/2021
Vorgeschichte
Osteoporosis Prediabetes Hyperlipidemia
Andere Medikamente
Atorvastatin 40 mg at bedtime. Meloxicam 7.5 mg daily Nutrafol vitamins Woman?s Balance 4 tablets by mouth daily Glucosamine chondroitin 1,100 mg daily Probiotic Formula once daily Calcium carbonate 1000 mg daily Vitamin D 3 1,000 IU dail
Allergien
None
Vorherige Impfungen
-

VAERS 1437639

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MN
Alter
66,0
Geschlecht
M
Eingang
30.06.2021
Impfdatum
02.03.2021
Beginn
03.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
C-reactive protein increased Cardiac imaging procedure abnormal Cardiac tamponade Chest pain Dyspnoea Laboratory test normal Myocarditis Painful respiration Pericardial drainage Pericardial fibrosis Pericarditis Pyrexia Scan normal Vaccination complication

Symptomtext

Starting the next morning, patient started noticing slight chest pain with deep breaths. Pain grew significantly over the next three days and mild fever began. Went to the ER and was sent home after doctor ruled out heart attack. Returned to ER the next day with significant increase in pain when breathing, especially when lying down. Fever increased significantly to 102.5. He was then admitted with a diagnosis of pericarditis and discharged two days later. He returned to the ER the day after discharge with increasing pain, ever, and breathing difficulty. CR-P was nearly 200. Diagnosed then with Cardiac Tamponade. About 500 ml of fluid was drained in an emergency procedure. He was admitted again. Over the course of the month of March, he was in the ER five times and admitted four times. He continues to suffer with thickened pericardium and is still being treated with anti-inflammatories, including ibuprofen, colchicine, and Prednisone as of June 30, 2021. Doctors are trying to taper the steroids but have had to increase the dose several times during this process as some symptoms return on tapering. CR-P has finally started to go down and is currently at 3.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
18,0
Labordaten
During hospital stays medical teams from infectious disease, cardiology, internal medicine, oncology and others ran various tests and scans to determine any underlying cause of the pericarditis (which was later called myopericarditis). No other cause was found, so the teams concluded it was due to the 2nd Pfizer vaccine. When he returned, he went to the ER due to returning symptoms during the tapering process. In follow-ups with Dr. at the clinic, he received a cardiac MRI that revealed the pericardium is still significantly thickened (12 mm)
Aktuelle Erkrankungen
None
Vorgeschichte
Heart disease
Andere Medikamente
Synthroid, Plavix, Cholesterol meds
Allergien
-
Vorherige Impfungen
-

VAERS 1437503

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
44,0
Geschlecht
M
Eingang
30.06.2021
Impfdatum
19.04.2021
Beginn
23.05.2021
Tage bis Beginn
34,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Ageusia Bell's palsy Blood glucose Blood test Chest X-ray Computerised tomogram Computerised tomogram head Coronavirus test negative Dyskinesia Dyspnoea Electrocardiogram Eyelid function disorder Facial paralysis Fear Magnetic resonance imaging head Magnetic resonance imaging neck Urine analysis

Symptomtext

Approximately one month after my second shot, beginning around 5/20, I began to lose the sense of taste on the right side of my tongue. I thought it would go away but by 5/23 I had partial paralysis on the right side of my face. Fearing a stroke I went to the ER and after a full battery of tests I was diagnosed with Bell's Palsy. The symptoms worsened for a few days and I was unable to close my right eye, had difficulty breathing out of my right nostril and both eating and drinking were difficult because my lips would not close fully. The symptoms stabilized and then finally began to improve after steroid and antiviral treatment for a week, then on to regular aspirin.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
1,0
Labordaten
5/23/21 tests included full blood work up, CT scan of head and shoulders, MRI of head and neck, EKG, bedside glucose, urinalysis, two chest xrays and a coronavirus test (which was negative).
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
aspirin, loratadine
Allergien
none
Vorherige Impfungen
-

VAERS 1066830

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
31,0
Geschlecht
F
Eingang
16.06.2021
Impfdatum
25.02.2021
Beginn
25.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Abdominal pain Anaphylactic reaction Chest pain Chills Headache Arthralgia Diarrhoea Dizziness Hypertension Flushing Heart rate increased Nausea Pharyngeal swelling Laboratory test normal Neck pain Tinnitus Palpitations Vomiting

Symptomtext

Swollen throat; increased heart rate; nausea; flushing; This is a spontaneous report from a contactable consumer (patient, reported for herself). A 31-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, in arm left on 25Feb2021 at 14:15 (at the age of 31-years-old) as 1st dose, single dose for Covid-19 immunisation. The patient medical history included osteoma from an unknown date and unknown if ongoing, anxiety from an unknown date and unknown if ongoing, allergy to animal from an unknown date and unknown if ongoing and seasonal allergy from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient previously took penicillin nos (PENICILLIN) and experienced allergy and she was allergic to animal (cat, pollen). The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, it was unknown if patient diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines on the same day of vaccine vaccination. On 25Feb2021 at 14:15, the patient had experienced swollen throat, increased heart rate, nausea and flushing. The patient was treated with Benadryl and Deltasone. The reporter stated the events result in emergency room/department or urgent care. The outcome of the events was resolving. No follow-up attempts are possible; information about lot/batch number cannot been obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergy to animal; Anxiety; Osteoma; Pollen allergy
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1399502

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
IL
Alter
31,0
Geschlecht
F
Eingang
15.06.2021
Impfdatum
27.02.2021
Beginn
22.04.2021
Tage bis Beginn
54,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Blood albumin decreased Blood thyroid stimulating hormone C-reactive protein increased Eye disorder Facial paralysis Full blood count Hypoaesthesia Metabolic function test Migraine Vitamin B12 Vitamin D

Symptomtext

Numbness started after the second covid vaccine numbness throughout her body started in late April and early May, felt like facial droop and squeezing her left eye then saw neurologist. Has been treated with topirimate and mostly improved but still with facial numbness. Also reports new dx atypical Migraines reports they started prior to getting vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
-
Labordaten
, went to urgent care 4/30 - CBC, CMP, VIt D, B12, Tsh all nl other than low albumin and high CRP,
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Lexapro
Allergien
none
Vorherige Impfungen
-

VAERS 1387740

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
WA
Alter
50,0
Geschlecht
F
Eingang
10.06.2021
Impfdatum
23.02.2021
Beginn
15.03.2021
Tage bis Beginn
20,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dyspnoea Fatigue Myocarditis Peripheral swelling SARS-CoV-2 test

Symptomtext

potential myocarditis; severe fatigue; SOB; swelling of legs; This is a spontaneous report received from a contactable healthcare professional (patient) via COVAES. A non-pregnant 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 23Feb2021 (at the age of 50 years old; Lot Number: EN6202, unknown expiration) as 1st dose, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications included paracetamol (TYLENOL); bupropion hydrochloride (WELLBUTRIN); esomeprazole sodium (NEXIUM); ascorbic acid, chromium, copper, folic acid, inositol, magnesium, manganese, nicotinamide, pantothenic acid, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, vitamin b1 nos, vitamin b12 nos, vitamin e nos, zinc (MULTI VIT); and curcuma longa rhizome, piper nigrum fruit (TURMERIC +). The patient experienced potential myocarditis on 15Mar2021. The patient cannot get into cardiology to confirm severe fatigue, SOB, and swelling of legs, which all started on 15Mar2021. The patient underwent lab tests and procedures which included PCR (nasal swab): Negative on 17Mar2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The events resulted in emergency room/department or urgent care and doctor or other healthcare professional office/clinic visit. The patient had not yet recovered from the events. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Current information is limited and does not allow a full medical assessment. Myocarditis was not a confirmed diagnosis, but rather a provisional diagnosis based on reported symptoms. Case will be reassessed once receiving additional information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
-
Labordaten
Test Date: 20210317; Test Name: PCR (nasal swab); Test Result: Negative
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
TYLENOL; WELLBUTRIN; NEXIUM [ESOMEPRAZOLE SODIUM]; MULTI VIT; TURMERIC +
Allergien
-
Vorherige Impfungen
-

VAERS 1378382

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
AZ
Alter
23,0
Geschlecht
F
Eingang
07.06.2021
Impfdatum
23.02.2021
Beginn
23.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Autoscopy Colitis Crohn's disease Dyspnoea Electrocardiogram Headache Heart rate increased Metabolic function test Platelet count increased Pyrexia Thrombosis Tremor

Symptomtext

2/23 vaccination Within 12 hours, I started shaking, spiked fever, HR increase, SOB, out of body experience, scary experience. Called 911 transported to ER. Monitored cardiac unit for 24 hours, HA. Two months of HAs. I went home and I don't recall exact how everything transpired. I do remember they wanted follow up with PCP. I developed blood clots in R arm, platelets were high since getting vaccinated. *originally diagnosed with colitis but now diagnosed with Chrohns disease. 1/16 I did have a personal injury in a parking lot that exacerbated the issues, I was vaccinated after. *In transition with new doctors now and have not really discussed the potential of this being caused by vaccine, focused more on pain management. **before this vaccine, I was relatively healthy before, no issues.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
Blood panel EKG CMP
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
Clindamycin, Penicillin, Erythromycin, Tramadol, Hydrocodone, Benadryl
Vorherige Impfungen
-

VAERS 1376363

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6202

schwer
Staat
AK
Alter
14,0
Geschlecht
F
Eingang
06.06.2021
Impfdatum
05.06.2021
Beginn
05.06.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Mydriasis Pallor Syncope Unresponsive to stimuli

Symptomtext

Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: patient received vaccine. directly after administration patients pupils were dilated, she was pale, and was not answering questions. Patient was placed on floor with legs elevated, we called 911. after a couple minutes patient said she felt fine, so we sat her up in chair and gave her glass of water, which she drank. Patient again reported feeling light headed and her pupils were dilated. medics took her the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1365414

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
CO
Alter
70,0
Geschlecht
F
Eingang
01.06.2021
Impfdatum
02.03.2021
Beginn
23.04.2021
Tage bis Beginn
52,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Anticoagulant therapy Arrhythmia Arteriosclerosis Atrial enlargement Cerebral infarction Echocardiogram normal Embolism Implantable cardiac monitor insertion Magnetic resonance imaging head abnormal Neurological examination abnormal Ultrasound Doppler abnormal

Symptomtext

- Brain MRI on 4/23 with multiple small infarcts in both cerebral hemispheres concerning for embolic source - Carotid dopplers without significant atherosclerosis - No evidence of atrial or ventricular thrombus on TEE - Neurology evaluated, still not certain that patient's neurologic symptoms were from CVAs as these are relatively small and that they might be medication related on admission - Continue ASA and atorvastatin - Started Eliquis 5 mg BID on 4/25 for concern of embolic disease with possible occult afib given severe left atrial enlargement and MRI findings - Loop recorder placed 4/27 per Cardiology for long term monitoring for occult arrhythmias - PT/OT/SLP recommending facility based rehab

Weitere VAERSDATA-Felder
Praegender Schweregrund
Embolism
Hospital-Tage
7,0
Labordaten
- Brain MRI on 4/23 with multiple small infarcts in both cerebral hemispheres concerning for embolic source - Carotid dopplers without significant atherosclerosis - No evidence of atrial or ventricular thrombus on TEE - Neurology evaluated, still not certain that patient's neurologic symptoms were from CVAs as these are relatively small and that they might be medication related on admission - Continue ASA and atorvastatin - Started Eliquis 5 mg BID on 4/25 for concern of embolic disease with possible occult afib given severe left atrial enlargement and MRI findings - Loop recorder placed 4/27 per Cardiology for long term monitoring for occult arrhythmias - PT/OT/SLP recommending facility based rehab
Aktuelle Erkrankungen
# Moderate to severe mitral regurgitation # CVA # Chest pain, non cardiac # Non-MI troponin elevation # MS # Hematuria # Possible UTI, not poa, not catheter associated # H/o nephrolithiasis # Hypothyroidism # Essential hypertension # RLS # Depression # OSA # Obesity
Vorgeschichte
Vitamin D deficiency 5/8/2015 64y Stable angina (HC code) 10/28/2014 63y Sleep apnea just got cpap Rosacea RLS (restless legs syndrome) Pseudobulbar affect Osteoporosis 2018 67 - 68y Neuromuscular disorder (HC code) MS (multiple sclerosis) (HC code) 04/2011 60y Morbid obesity (HC code) Treated previously with Roux-en-Y Gastric Bypass Mixed stress and urge urinary incontinence Mitral regurgitation 04/2021 70y Mild intermittent asthma Migraine with aura Migraine variant Menopausal disorder Major depression in partial remission (HC code) Lump or mass in breast left Kidney stone IFG (impaired fasting glucose) Hypothyroidism Hypercholesteremia HTN (hypertension) Hearing loss Environmental allergies Encounter for pre-bariatric surgery counseling and education 07/16/2012 61y Deviated nasal septum Depression CVA (cerebral vascular accident) (HC code) 04/2021 70y Coronary artery disease 11/11/2014 63y Cath 11/2014: nonobstructive lesions (20%) in LAD and diagonal Cat allergies Benign essential hypertension 2000 49 - 50y Asthma 2010 59 - 60y Arthritis 2018 67 - 68y Aortic atherosclerosis (HC code) 10/2/2018 67y Seen on CXR 2014 Anxiety 1990 39 - 40y Alopecia Acquired hypothyroidism
Andere Medikamente
acetaminophen (TYLENOL) 500 mg tablet Sig: Take 1,000 mg by mouth every 8 hours as needed for Pain. Route: Oral PRN Reason(s): Pain Class: Historical Med albuterol HFA 90 mcg/actuation inhaler 4/30/2021 Sig: Inhale
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 1365300

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
57,0
Geschlecht
F
Eingang
01.06.2021
Impfdatum
03.03.2021
Beginn
15.03.2021
Tage bis Beginn
12,0
Dosis
1
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Alcohol use Angiogram pulmonary normal Cardiac stress test abnormal Chest discomfort Condition aggravated Echocardiogram normal Electrocardiogram normal Laboratory test normal Pericardial effusion Pericarditis Supraventricular tachycardia Tachycardia Troponin increased

Symptomtext

Pt is a 57 y.o. female with hx episodic svt, on no meds, presented after 4 hrs of tachycardia and chest discomfort, given 6mg then 12 mg adenosine by EMTs which worked in the field. Arrived here, trop is 0.21, CTA chest neg for PE, labs otherwise ok, DR consulted with another Dr, thought it was ok to go home on low dose metop, but patient has continued chest discomfort and was afraid to go home, was decided to admit for serial trop. Dr will see in am. No cardiac risk factors; nonsmoker, brother has svt and had successful ablation, no fam hx CAD. Drinks up to 3 glasses wine per night. Office worker. EKG now nsr without ischemic changes. Hospital Course by Problem: #Paroxsymal SVT: No recurrence of sxs following adenosine administered by EMTs. Associated mild troponin elevation as below to 0.41 likely due to persistent tachycardia. EKG NSR w/o ischemic changes. Admitted and started on metop 25 mg XL nightly without recurrence. Cardiology consulted. Echo showed no WMAs or valvular issues, with preserved LVEF (although E/A flow reversal suggestive of possible diastolic dysfunction). Pt stable to discharge 3/16 with outpatient cardiology follow-up. - discharge on metop XL 25 mg nightly - referred to follow up w/ Dr (info added to AVS) w/ TOC cardiology. Since she is a patient, she may elect to seek a referral through her PCP. #Elevated troponin: Trop peak 0.4. No ischemic changes on EKG. Suspect due to prolonged tachycardia. Also possible mild pericarditis as below. No WMAs seen on echo. Outpatient stress test recommended by cardiology. - outpatient follow up with Dr for stress test #Small pericardial effusion, ?mild pericarditis: Small effusion seen on echo. Given associated mild chest discomfort, query possible pericarditis. Unclear if this triggered SVT or vice versa. Hemodynamically stable w/ no evidence of tamponade physiology on echo and only mild symptoms. - given small size and mild sxs, no anti-inflammatories rx'd - pt given return precautions and advised of signs/symptoms that should prompt her to reach out to PCP or cardiologist

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pericarditis
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
inflammatory polyarthritis GERD
Andere Medikamente
-
Allergien
Tdap
Vorherige Impfungen
Tdap, 6/6/2017, abnormal arm pain and swelling

VAERS 1350545

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
81,0
Geschlecht
F
Eingang
26.05.2021
Impfdatum
30.03.2021
Beginn
30.04.2021
Tage bis Beginn
31,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Anticoagulant therapy Asthenia Brain compression Cardiac stress test abnormal Fall General physical health deterioration Head injury Hyponatraemia Loss of consciousness Myocardial ischaemia Percutaneous coronary intervention Skin laceration Stent placement Troponin Vomiting

Symptomtext

Patient brought to the ED with generalized weakness worsening over prior 2-3 days, states she started experiencing after receiving 2nd dose of Covid vaccine. Found to have a positive troponin, hyponatremia. Stress test revealed reversible myocardial ischemia of the inferior and lateral walls of left ventricle with a large defect size but mild defect severity. Patient underwent PCI with DES placement and was placed on triple therapy with aspirin, clopidogrel and eliquis. Patient presented to ED again on 5/23/21 outcome: patient is brought to ED after a fall and loss of unconsciousness, hit her head with large laceration at back of head, 2 episodes of vomiting, leading to terminal events: brainstem compression and rapid deterioration and CS of 2T preclude meaningful survival

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
6,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1350400

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
68,0
Geschlecht
M
Eingang
26.05.2021
Impfdatum
19.03.2021
Beginn
30.04.2021
Tage bis Beginn
42,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Anticoagulant therapy Atrioventricular block second degree Bradycardia Cardiac pacemaker replacement Dyspnoea Pulmonary thrombosis

Symptomtext

Patient presented to the ED for bradycardia and dyspnea present for one week prior to admission, he was found to have a second degree AV block. He underwent a procedure to correct atrial lead dislodging/placement of pacemaker. Patient was also started on anticoagulation therapy for a clot in lung. Discharged after 5 days inpatient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary thrombosis
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1346465

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
WI
Alter
86,0
Geschlecht
M
Eingang
25.05.2021
Impfdatum
24.02.2021
Beginn
20.03.2021
Tage bis Beginn
24,0
Dosis
2
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein
Cerebral infarction Dysphagia Facial paralysis Hemiplegia Magnetic resonance imaging abnormal

Symptomtext

On 3/20 this patient started exhibiting right sided facial droop and paralysis of right arm and leg, dysphagia. On 3/25 he was discharged from the hospital on hospice.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
5,0
Labordaten
MRI during hospitalization revealed acute infarct in the superior right parietal centrum semi ovale.
Aktuelle Erkrankungen
None
Vorgeschichte
CKD Heart failure HTN BPH Cardiac arrhythmia GERD Hyperlipidemia Dementia
Andere Medikamente
Sertraline Senna Omega 3 Mirtazapine Metoprolol Furosemide Famotidine Donepezil Calcium Atorvastatin ASA APAP
Allergien
No known allergies.
Vorherige Impfungen
-

VAERS 1343556

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6202

schwer
Staat
PA
Alter
48,0
Geschlecht
F
Eingang
24.05.2021
Impfdatum
27.02.2021
Beginn
20.03.2021
Tage bis Beginn
21,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Computerised tomogram head Magnetic resonance imaging Magnetic resonance imaging head

Symptomtext

bells palsy

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
june, 2, 2021 mri, ct scan may 10th, 2021 blood work may 10th,2021
Aktuelle Erkrankungen
anemia
Vorgeschichte
none
Andere Medikamente
budesonide
Allergien
corn, metal
Vorherige Impfungen
-

VAERS 1342225

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
WI
Alter
41,0
Geschlecht
F
Eingang
23.05.2021
Impfdatum
24.02.2021
Beginn
07.03.2021
Tage bis Beginn
11,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Feeling hot Joint swelling Thrombosis

Symptomtext

Developed a blood clot. Symptoms presented by 03/05/21 (palpable bump behind left knee). By 03./07/21, the area was red and hot to touch with a palpable cord extending in both directions from the original bump. Blood clot diagnosed on 03/09/21. Xarelto prescribed on 04/23/21 (10 mg once daily). Symptoms persist as of today (05/23/21).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
03/09/21: The left common femoral, femoral, popliteal, proximal medial saphenous, and deep femoral veins are patent and free of thrombus. The veins are normally compressible and have normal phasic flow and augmentation response. There is an acute thrombus at the left saphenous vein inferiorly between the mid thigh and proximal calf. 03/12/21: The left common femoral, femoral, popliteal, proximal medial saphenous, and deep femoral veins are patent and free of thrombus. The veins are normally compressible and have normal phasic flow and augmentation response. Incidental bifid left femoral vein. Redemonstrated thrombus at the left saphenous vein at the level of the mid thigh, unchanged. The paired peroneal and posterior tibial calf veins are patent. The contralateral (right) common femoral vein is patent and free of thrombus. 03/18/21: The left common femoral, femoral, popliteal, proximal medial saphenous, and deep femoral veins are patent and free of thrombus. The veins are normally compressible and have normal phasic flow and augmentation response. The paired peroneal and posterior tibial calf veins are patent. Note is again made of thrombus in the left saphenous vein at the mid thigh extending inferiorly. The contralateral (right) common femoral vein is patent and free of thrombus. 04/23/21: The left common femoral, femoral, popliteal, proximal medial saphenous, and deep femoral veins are patent and free of thrombus. The veins are normally compressible and have normal phasic flow and augmentation response. Duplication of the left femoral vein. The paired peroneal and posterior tibial calf veins are patent. There is persistent thrombus and impaired compressibility within the left saphenous vein in the mid thigh and knee level. The contralateral (right) common femoral vein is patent and free of thrombus. Upcoming US on 05/27/21; follow up office visit on 06/04/21.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Loestrin FE taken one week prior to first COVID vaccination, off for 6 weeks at time of second vaccination
Allergien
Cefdinir?
Vorherige Impfungen
-

VAERS 1341652

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
74,0
Geschlecht
F
Eingang
23.05.2021
Impfdatum
03.03.2021
Beginn
03.03.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Arthralgia Pruritus Syncope

Symptomtext

Itching, more joint pain, lasted days, needed prednisone. Next dose was the same (3/30), also with syncope 2 days later. Resolved over a few weeks.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1341539

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
WI
Alter
67,0
Geschlecht
M
Eingang
23.05.2021
Impfdatum
27.02.2021
Beginn
01.04.2021
Tage bis Beginn
33,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: ja ER: ja Erholt: nein
Arthralgia Bradycardia Bundle branch block right Chest X-ray normal Cough Coxsackie virus test Electrocardiogram QRS complex prolonged Electrocardiogram abnormal Laboratory test normal Pain Painful respiration Pericarditis Troponin normal

Symptomtext

4/1/2021 odd tickling cough, brief. Biked anyway, 60 min hard ride. But just in case started 81mg ASA qd. 4/2 odd tickling cough brief. Biked anyway, 60 min, good hard ride. not feeling ill, no fever, cough did not continue, not productive, no URI symptoms. Cough was different. 4/3 woke with pain upon taking a deep breath HR in high 40's (normal 60 +-) Like the pain of breathing after aspirating a lot of pool water. This pain was only on deep breathing; a second 'radiating?' pain was more of a constant ache in region of R scapula or supra scapular region, no tenderness to palpation. Had GB out Feb 2020.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pericarditis
Hospital-Tage
-
Labordaten
EKG Bradycardia, wide QRS, RBBB was not initially seen, neg for tropinins, normal chem, normal CXR, no pleural or pericardial effusions; 4/23/2021 high Coxsackie B3 & B4 titers 1:160 each. Symptoms this episode were quite different than the Devil's Grip symptoms in 2000. Question: chronic viral infection for 20 years that the vaccination activated v. chronic inflammation & EKG changes
Aktuelle Erkrankungen
BPH, joint pains from prior injury
Vorgeschichte
Hx of Several viral pneumonitides: persistent 'walking pneumonia' in 1964, missed 3 weeks of school; Hosp'd with flu in 1969; Coxsackie B3 pleurodynia in Nov 2000, was air med-evac'd to ICU, discharged after 2 weeks no dx; viral test came back positive 1 month after discharge; 2012, again med evac'd to Medical center for 6 month productive cough & ?cardiomyopathy v. low grade respiratory infection with low PO2. Now have new RBBB. 3wks after acuter pericarditis ER visit 4/4/2021, I had a high Coxsackie B3 & B4 titer. Wonder if vaccination triggered heart inflammation.
Andere Medikamente
Tamsulosin for BPH, Naproxin on days I bike, about 1/2 the days
Allergien
none
Vorherige Impfungen
-

VAERS 1337751

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
19,0
Geschlecht
F
Eingang
21.05.2021
Impfdatum
01.03.2021
Beginn
29.04.2021
Tage bis Beginn
59,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Neurological examination Seizure

Symptomtext

Patient had a Seizure 6- or 7-weeks post 2nd dose. Patient has never had a seizure before. My wife and I are just curious if it could be possible that she could have a seizure due to the shot. We are all vaccinated and have been very safe through this pandemic. Patient also has Turners Syndrome, a genetic disorder.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
Patient did a full cardiac and Neurological work up after her seizure. Nothing thankfully was found.
Aktuelle Erkrankungen
None
Vorgeschichte
Heart repairs ( co arch repair , stint )
Andere Medikamente
progesterone, montelukast,, ferrous sulfate, Losartin, Estradiol
Allergien
None
Vorherige Impfungen
-

VAERS 1331049

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
VA
Alter
79,0
Geschlecht
M
Eingang
19.05.2021
Impfdatum
06.03.2021
Beginn
29.03.2021
Tage bis Beginn
23,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Ear pain Facial paralysis Injury corneal Magnetic resonance imaging head abnormal Peripheral nerve palsy

Symptomtext

Diagnnosis: Bell's Palsy, right ear ache, right peripheral facial palsy, and corneal injury. March 29 to April first. Treatment by Opthomologist: eye drops every hour and eye lubricant before bed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
2,0
Labordaten
MRI with abnormal finding of brain.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Omeprazole 20mg Tamsulosin 0.4mg
Allergien
None
Vorherige Impfungen
-

VAERS 1330243

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6202

schwer
Staat
PA
Alter
52,0
Geschlecht
F
Eingang
19.05.2021
Impfdatum
09.03.2021
Beginn
12.03.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fall Fatigue Feeling abnormal Feeling drunk Headache Heavy menstrual bleeding Laboratory test Menopause Oligomenorrhoea Pain in extremity Peripheral swelling Thrombosis Tongue coated Tongue discomfort Tongue erythema Vertigo

Symptomtext

frontal headache for 3 days, left arm pain for 3 days and swelling, general fatigue for 1 week, redness on the tongue, middle anterior part as if it were burned, and the middle distal part a whitish plaque for two days as if I had oral candidosis, Then it started at 300 am I felt something so intense that I woke up, as if the brain were tipping me inside my head and vertigo began, everything turned me when I opened my eyes, as if I had drunk a lot of alcohol and everything gave around me when I opened my eyes, it was lake so strong that I felt that I was falling from my bed,I had to go to my primary doctor because when I changed the position of my head and lowered it, the severe vertigo began and I had to hold on to avoid falling.Then I decided to get the second dose to complete my vaccination despite these adverse effects, the doctor indicated drugs for vertigo and examined me, and now 2 weeks ago that after having a year without menstruation, I was already in menopause, I I have profuse bleeding with clots and I have been bleeding for 15 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
The doctor told me the laboratory to see if there was anemia, but I have not yet had the appointment to see the results.
Aktuelle Erkrankungen
none.
Vorgeschichte
Angina pectoris, vasovagal syncope, osteoporosis, stomach ulcer, gastritis. sinusitis
Andere Medikamente
vitamin c,
Allergien
pollen, mites in the dust
Vorherige Impfungen
-

VAERS 1329495

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OK
Alter
78,0
Geschlecht
F
Eingang
19.05.2021
Impfdatum
24.02.2021
Beginn
28.02.2021
Tage bis Beginn
4,0
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test Pain Peripheral swelling Thrombosis Ultrasound joint Vital signs measurement

Symptomtext

numerous blood clots below the knee; left leg swelling/ It got so swollen/left foot swelling; pain with walking left leg; This is a spontaneous report from a contactable nurse reporting for herself. A 78-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Right Arm on 24Feb2021 (Batch/Lot Number: EN6202) as single dose for covid-19 immunisation (Age at vaccination 78 years). The patient medical history was not reported. On 04Feb2021 the patient received the first dose of BNT162B2 and experienced sore arm. The patient's concomitant medications were not reported. The patient experienced pain with walking left leg on 28Feb2021 with outcome of recovering , left leg swelling/ it got so swollen/left foot swelling on 03Mar2021 with outcome of not recovered , numerous blood clots below the knee on 04Apr2021 with outcome of not recovered. The patient underwent lab tests and procedures which included blood test: unknown results, ultrasound joint: numerous blood clots below the knee on 04Apr2021 , vital signs measurement: unknown results. Course of the event: The patient waited for the timeframe after the second dose and had no problems. 4 days after, she experienced pain with walking in her left leg. She took Aleve for a few days. It got so swollen, she should have gone then to her Primary Medical Doctor, but she did not go until 25Mar2021. She was sent to Hospital for an Ultrasound of her leg on 04Apr2021. After the Ultrasound, she was taken to the Emergency Department at the hospital. The doctor told her she had numerous blood clots below the knee. Was prescribed Eliquis 5mg. She was instructed to take 2 tablets or 10mg twice a day, 8hrs apart for 1 week and then 1 tablet twice a day for the remainder of the 74 tablets. She completed that. She was out of them and got a refill of Eliquis 5mg on 26Apr2021. She received 60 tablets and can refill for 5 times. She is really concerned. The swelling is still so bad and so that could that mean blood clots are still in there. The ER doctor told her that the medication is dangerous. It thins the blood and can cause bleeding and the blood clot can go to her heart. Follow up information has been requested.; Sender's Comments: The causality has been assessed as related to bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Right Arm on 24Feb2021 (Batch/Lot Number: EN6202) as single dose for covid-19 immunization, based on temporal association and profile of the product.,Linked Report(s) : 2021499984 same patient/drug, diff dose/event

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
Test Name: blood drawn; Result Unstructured Data: Test Result:unknown results; Test Date: 20210404; Test Name: Left leg Ultrasound; Result Unstructured Data: Test Result:numerous blood clots below the knee; Test Name: vital signs taken; Result Unstructured Data: Test Result:unknown results
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1322368

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
IL
Alter
36,0
Geschlecht
F
Eingang
16.05.2021
Impfdatum
17.03.2021
Beginn
16.05.2021
Tage bis Beginn
60,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Blood thyroid stimulating hormone Dizziness Dyspnoea Echocardiogram Electrocardiogram abnormal Full blood count Metabolic function test Presyncope Pruritus Tachycardia Urticaria

Symptomtext

Tachycardia with symptoms of lightheadedness, shortness of breath, presyncope. Started 11 days after second dose of vaccine. Tachycardia is occurring daily now and appears to be associated with standing/walking and better/normal when sitting/laying. Also new itching/hives on face, neck, and chest that began 4/1/2021. Lasts 1-2 days and happens once a week or so.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
EKG sinus tachycardia ECHO and tilt table test pending CBC, BMP, TSH WNL
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1267931

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
66,0
Geschlecht
F
Eingang
14.05.2021
Impfdatum
02.03.2021
Beginn
24.04.2021
Tage bis Beginn
53,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Blood test normal Computerised tomogram normal Electrocardiogram normal Laboratory test abnormal Body height Ear pain Oral herpes Stress Weight

Symptomtext

fever blisters; ear ache; stress; 2nd dose of the Pfizer Covid vaccine on 02Mar2021 and on 24Apr2021 she went to the emergency room with Bell's Palsy; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A currently 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the left arm on 02Mar2021 16:00 (also reported as 16:30) (Batch/Lot Number: Unknown) as 2nd dose, single dose (at the age of 66-years-old) for COVID-19 immunisation. Medical history included bell's palsy from 07Jan2015; and an unspecified risk factor. The patient had no concomitant medications. The patient did not have any prior vaccinations within 4 weeks. The patient did not have family medical history that was relevant to adverse events and no relevant tests were done. The patient previously took shingles vaccine (Merck) that started with the letter 'Z' and had Bell's Palsy in Jan2015 which was exactly 6 weeks after she got a shingles vaccine; tetanus vaccines 10 years ago as a booster and experienced severe swelling on her arm, swelling in her body; Quadravalent flu vaccine and never had a reaction to the flu vaccines; and the first dose of BNT162B2 (reported as 'Pfizer COVID') for COVID-19 immunisation on 02Feb2021 in the left arm. On 24Apr2021, the patient experienced bell's palsy. On unspecified dates, the patient experienced fever blisters, ear ache and stress. The events were reported as follows: Her HCP should have the information on the shingles vaccine she got in 2015. When she had bell's palsy the 1st time in 2015, she had to go to the hospital for a day and a half to rule out everything and the best they found was that she had herpes simplex based on the blood work done at that time and it was what her HCP believed it was at that because it showed she had some kind of virus but neither time she had bell's palsy did she have seizure or other symptoms other than the ear ache she had this time. The patient got the second dose of the vaccine on 02Mar2021 and on 24Apr2021 she went to the emergency room with Bell's palsy. She can talk better when she holds her mouth. She was out of town when she noticed the symptoms of bell's palsy the night before on 24Apr2021 and when she got home she then went to the emergency room on 25Apr2021; she could tell something was happening again and it was noticeable and she had an ear ache the day before and her face was drooping. The HCPs swear there was no correlation between the vaccine and bell's palsy but she found this very coincidental. The patient stated that she would rather get bell's palsy again than get covid. For treatment, the only thing she has done was to call the HCP to schedule the follow-up visit as directed by the emergency room (ER) HCP; she went to the ER to rule out stroke and they did rule out stroke; states the only other thing she can think of is that she had quite a bit of stress because they put down her dog on Sunday and other than that she had an ear ache at her granddaughter's track meet on the day before on 24Apr2021 and the emergency room visit was on 25Apr2021. She has had recurrent fever blisters and her HCP has given her a prescription for Valcyclovir and she takes that at the onset of fever blisters and where she gets the fever blisters is constantly on the previous side where she had bell's palsy and was in the same spot on her left side of her lip. States the Valcyclovir she has was one gram tablets and she takes one when she has a fever blister and one 12 hours later; states she has two prescriptions for the Valcyclovir and they are in orange pharmacy bottles with no lot numbers, expiry dates and NDC numbers and the other prescription for Valcyclovir is also 1 gram and she takes it three times per day now after this outbreak. The patient required a visit to the ER or medical doctor office. The outcome of the events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
Test Name: HEIGHT; Result Unstructured Data: Test Result:157; Test Name: WEIGHT; Result Unstructured Data: Test Result:113.4
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Bell's palsy
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1314360

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
IL
Alter
78,0
Geschlecht
F
Eingang
13.05.2021
Impfdatum
28.02.2021
Beginn
26.04.2021
Tage bis Beginn
57,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Anticoagulant therapy Blood test Chest X-ray Chest pain Computerised tomogram Echocardiogram Pulmonary thrombosis Thrombosis

Symptomtext

Patient stated she developed clots during hospital admission with the complaint of chest pain. Patient stated at hospital admission, they discovered blood clot in her right leg and right lung. Patient was treated with oxygen and medication. Patient was inpatient for two nights and sent home lovenox injections for one week and continuing with Eliquis. Patient is currently on Eliquis for unknown duration. Patient will see cardiologist in three weeks and reevaluate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary thrombosis
Hospital-Tage
2,0
Labordaten
Patient got CT, ECHO cardiogram, blood work, Chest X-ray, and CAT scan on on 4/26/2021 and 4/27/2021.
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension Anemia
Andere Medikamente
Lisinopril 10mg, hydrochlorothiazide 25mg, Restasis for eye, Vitamin B12 2000mcg, Iron 29mg
Allergien
No known drug allergies
Vorherige Impfungen
-

VAERS 1311960

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
PA
Alter
76,0
Geschlecht
M
Eingang
12.05.2021
Impfdatum
11.02.2021
Beginn
12.03.2021
Tage bis Beginn
29,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory distress syndrome Cough Exposure to SARS-CoV-2 Pneumonia SARS-CoV-2 test positive

Symptomtext

Acute respiratory disease Exposure to SARS-associated coronavirus COUGH UNRESOOLVED PNEUMONIA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory distress syndrome
Hospital-Tage
-
Labordaten
03/12/21 1836 COVID-19 (SARS CoV-2,RNA Molecular Amplification) Collected: 03/12/21 1256 | Final result | Specimen: Swab from Nasopharynx COVID-19 SARS-CoV-2 Overall Result DetectedCritical 03/12/2021 XR CHEST 2 VW IMPRESSION: No lung consolidation. END OF IMPRESSION: INDICATION: Pneumonia, unspecified organism. Cough. TECHNIQUE: Frontal and lateral radiographs of the chest were performed. Comparison is made to the prior study dated 12/4/2015. FINDINGS: The heart and mediastinum are within normal limits. There are no lung consolidations, congestive heart failure, pleural effusions or pneumothoraces. Acetabular granulomas are noted in the left upper chest. The osseous structures are stable.
Aktuelle Erkrankungen
-
Vorgeschichte
Nervous Cervical radiculitis Cataract of both eyes Chronic pain of left knee Respiratory Pulmonary edema Sleep apnea Circulatory Essential hypertension Digestive Polyp of colon, unspecified part of colon, unspecified type Acute pancreatitis Benign neoplasm of colon Cholelithiasis Gastroesophageal reflux disease Genitourinary Benign prostatic hyperplasia with lower urinary tract symptoms, symptom details unspecified Retention of urine Disorder of urinary tract Musculoskeletal Primary osteoarthritis of left hip Endocrine/Metabolic Hypercholesterolemia
Andere Medikamente
alfuzosin (UroxatraL) 10 mg 24 hr tablet amLODIPine (NORVASC) 5 mg tablet ciprofloxacin (CIPRO) 500 mg tablet colesevelam (WELCHOL) 625 mg tablet colesevelam (WELCHOL) 625 mg tablet finasteride (PROSCAR) 5 mg tablet omeprazole (PriLOSEC) 40
Allergien
NKA
Vorherige Impfungen
-

VAERS 1307066

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
29,0
Geschlecht
M
Eingang
11.05.2021
Impfdatum
27.02.2021
Beginn
29.04.2021
Tage bis Beginn
61,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Deep vein thrombosis Thrombosis

Symptomtext

Blood clot in right calf and part of the thigh

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Finasteride
Allergien
-
Vorherige Impfungen
-

VAERS 1303441

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
46,0
Geschlecht
F
Eingang
10.05.2021
Impfdatum
02.03.2021
Beginn
22.05.2021
Tage bis Beginn
81,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Full blood count Heavy menstrual bleeding Metabolic function test Thrombosis Ultrasound prostate

Symptomtext

Prolonged heavy menstrual cycle with excessive blood clot starting on 3/22/21 till present 5/10/21. Despite intervention by ob/gyn such as performing pelvis ultrasound and performing a uterine biopsy with negative result for cancer as well as treating me with medroxyprogesterone for a course of 15 days that I completed as prescribed . After the medroxyprogesterone, I have to be placed 3 days ago on birth control pill, the menstrual bleeding continues . It?s been almost for 50 days. Need help!

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
Transvahinsl ultrasound Uterine biopsy CBC blood count level, basic metabolic panel, anemia Panel
Aktuelle Erkrankungen
None
Vorgeschichte
HTN Pinched cervical nerve c5-c6 Tenditintis to left shoulder/ Bursitis to left Shoulder Chronic Migraine
Andere Medikamente
Bystolic 10 mg one tablet daily Chlorthalidone 25 mg one tablet daily Vitamin C 1000 mg one tablet daily Zinc sulfate 50 mg one tab daily Probiotic one tab daily Vitamin D3 1000mg one tab daily Folic acid 1 mg one tab daily
Allergien
None
Vorherige Impfungen
-

VAERS 1298034

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
ID
Alter
66,0
Geschlecht
M
Eingang
08.05.2021
Impfdatum
10.03.2021
Beginn
18.03.2021
Tage bis Beginn
8,0
Dosis
1
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Brain natriuretic peptide Deep vein thrombosis Echocardiogram Full blood count Metabolic function test Ultrasound Doppler abnormal

Symptomtext

Pt developed a very large DVT in his left lower extremity. The symptoms started approximately 10 days after receiving his first Covid vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
-
Labordaten
Doppler US of LLE - 4/30/2021 Echo - 4/12/21 CBC, CMP, BNP
Aktuelle Erkrankungen
none
Vorgeschichte
Psoriatic arthritis - well controlled with Humira - has been on Humira for 6 years COPD HTN, well controlled
Andere Medikamente
Breo inhaler, Humira injections weekly 40 mg, Metoprolol ER 25 mg qday; omeprazole 40 mg qd, tamsulosin 0.4 mg qd; valsartan160mg/HCTZ 12.5 mg a day
Allergien
aspirin - nausea
Vorherige Impfungen
-

VAERS 1291858

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
PA
Alter
56,0
Geschlecht
M
Eingang
06.05.2021
Impfdatum
26.02.2021
Beginn
23.03.2021
Tage bis Beginn
25,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Balance disorder Bell's palsy Cognitive disorder Facial paralysis Motor dysfunction

Symptomtext

woke up on 3/23 with left facial paralysis; confirmed no balance, cognitive or motor function loss Met with Dr on 3/24. Confirmed Bells Palsy. Started on Valtrax (7 days) and Prednisone (10 days) Now 6 weeks post-event; have some movement on left side of face; estimate 40% recovery so far No plans for additional medication No plans for 2nd dose due to uncertainty on how it will impact current condition

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
Lyme disease - negative
Aktuelle Erkrankungen
None
Vorgeschichte
High blood pressure, pre-diabetes, high cholesterol
Andere Medikamente
Atorvastatin, Metformin, Lisonopril, Jardiance, Aspirin
Allergien
None
Vorherige Impfungen
-

VAERS 1288330

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
DE
Alter
65,0
Geschlecht
F
Eingang
05.05.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bell's palsy Burning sensation Dry eye Ear pain Facial discomfort Lymphadenopathy Magnetic resonance imaging Pain in jaw Paraesthesia Paranasal sinus discomfort Pruritus Salivary hypersecretion

Symptomtext

it sounded like a form of Bell's Palsy; left cheek tingle; my left forehead, cheek, side of lip and chin felt like I had razor burn.; My head itched; left eye felt dry; salivate more than usual from the left side of my mouth; left side of my face began to feel heavy, sometimes also my sinuses, but more often my lower jaw; left side of my face began to feel heavy, sometimes also my sinuses, but more often my lower jaw; left side of my face began to feel heavy, sometimes also my sinuses, but more often my lower jaw; feel pain in my left ear; My lymph nodes on the left side of my face became swollen; This is a spontaneous report from a contactable consumer. A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 26Feb2021 12:45 (Batch/Lot Number: EN6202), at the age of 65-years-old, as single dose for COVID-19 immunization. Medical history included allergy to Sulfa. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included calcium; magnesium; colecalciferol, menadione (VITAMIN K+D); glutathione; all taken for an unspecified indication, start and stop date were not reported. Within 45 mins (also reported as 20-25 minutes) of receiving the shot, she began to feel her left cheek tingle. In the intervening days, her left forehead, cheek, side of lip and chin felt like she had razor burn. Her head itched. Her left eye felt dry, but that went away. She began to salivate more than usual from the left side of her mouth. The left side of her face began to feel heavy, sometimes also my sinuses, but more often my lower jaw. Sometimes, she would feel pain in her left ear. Her lymph nodes on the left side of my face became swollen. Her doctor on Zoom said it sounded like a form of Bell's Palsy (medically significant), though she does not have the drooping eye or mouth. She had an MRI of her left lymph node that did not reveal any issues. Her symptoms, while they have abated, are still present five weeks after the shot. The events started on 26Feb2021 13:30. No treatment was received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. The outcome of the event left eye felt dry was recovered while other events was not recovered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
Test Name: MRI; Result Unstructured Data: Test Result:did not reveal any issues
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Drug allergy (Known allergy:sulfa)
Andere Medikamente
CALCIUM; MAGNESIUM; VITAMIN K+D; GLUTATHIONE
Allergien
-
Vorherige Impfungen
-

VAERS 1282059

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
83,0
Geschlecht
M
Eingang
03.05.2021
Impfdatum
02.03.2021
Beginn
02.05.2021
Tage bis Beginn
61,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
COVID-19 Dyspnoea Hypoglycaemia Hypoxia Lethargy SARS-CoV-2 test positive Syncope

Symptomtext

Positive COVID + 5/2/2021 Admitted with extreme lethargy and syncopal episode, hypoglycemia, increased dyspnea with hypoxemia

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1272277

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
VA
Alter
45,0
Geschlecht
F
Eingang
29.04.2021
Impfdatum
05.02.2021
Beginn
29.04.2021
Tage bis Beginn
83,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Arnold-Chiari malformation Blood test Borrelia test Burning sensation Fatigue Feeling abnormal Feeling hot Full blood count Gait inability Impaired work ability Intervertebral disc protrusion Magnetic resonance imaging Metabolic function test Muscular weakness Myelitis transverse Paraesthesia Red blood cell sedimentation rate Seizure

Symptomtext

Approximately 5-6 days after my second Pfizer vaccine dose, I began having paresthesias in patchy areas on the outside of my right ankle. Over the next 3-4 weeks, the paresthesias (burning, tingling, temperature sensation) progressed to the other leg and then ascended up the legs bilaterally to the upper thigh area. I consulted my neurologist and he ordered a MRI of the cervical and thoracic spine. The day after the MRI (4/15/21), I had two seizures in the morning after being seizure free for a year. I had significant fatigue and felt very poorly. A few hours later, I had a sudden onset of severe bilateral leg weakness. Because I could not walk, EMS was called. I went to Hospital where I was admitted for leg weakness. Additional imaging was performed. I was able to walk a few steps after receiving a dose of 1g solumedrol via IV that night. My symptoms improved over the next few days with IV steroid treatment. I was discharged on 4/19/21 and was advised to follow up with outpatient neurology. My neurologist initially diagnosed acute transverse myelitis and ordered physical therapy. I continued a steroid taper for 6 days after hospital discharge. Today (4/29/21), my symptoms have improved but continue to have adverse effects. I am able to walk but tire quickly and am very fatigued. I have been unable to work since hospital discharge.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
5,0
Labordaten
MRI - brain, cervical, thoracic and lumbar spine - degenerative disc changes and herniations in cervical and lumbar spine, brain - chiari malformation 1, thoracic - syrinx at T6-7. I consulted a neurosurgeon about the chiari malformation and syrinx and he advised that they were misdiagnosed. He identified the vaccine as the cause of the symptoms. Lyme, B12, Vit D, Sed Rate, CMP,CBC normal in hospital. Slight elevation in CRP EEG done in hospital - normal No lumbar puncture done
Aktuelle Erkrankungen
None
Vorgeschichte
Partial seizure disorder - well controlled on lamotrigine hypothyroidism mild exercise induced asthma
Andere Medikamente
Lamotrigine, levothyroxine, sertraline, vitamin D, multivitamin
Allergien
Seasonal allergies - pollens cats
Vorherige Impfungen
-

VAERS 1271348

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
FL
Alter
43,0
Geschlecht
F
Eingang
29.04.2021
Impfdatum
15.04.2021
Beginn
16.04.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dysmenorrhoea Fatigue Feeling abnormal Pain in extremity Thrombosis

Symptomtext

The day after the vaccine I experienced brain fog, fatigue, and sore arm. I also got my period. I have a history of painful periods but after an endometrial ablation over 10 years ago I have had normal pain. The period after the vaccine was incredibly painful and the consistency of the discharge was completely different. Pale pink clots that almost looked like uterine lining instead of clots I'm used to seeing. I want to report this because I've talked to other women who've had something similar but I didn't see anything about it on the CDC website.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Migraines
Vorgeschichte
hypothyroidism, PTSD, Bipolar Disorder, migraines
Andere Medikamente
Seroquel, Zyrtec, Synthroid, Naltrexone, Wellbutrin, biotin, omeprazole, rizatriptan, multivitamin
Allergien
Lactose intolerant, seasonal allergies, morphine
Vorherige Impfungen
-

VAERS 1269746

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
AZ
Alter
46,0
Geschlecht
M
Eingang
29.04.2021
Impfdatum
12.03.2021
Beginn
12.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Headache Muscle tightness Musculoskeletal stiffness Myalgia Pain Pain in extremity Thrombosis

Symptomtext

Regular pain feeling; Headache; Muscle pain; Calf feels tight, stiff, it feels like dead weight; Calf feels tight, stiff, it feels like dead weight; Pain running up the right arm up to the shoulder/Calf pain; He asked if someone can tell him if it is a blood clot in the back of his calf; This is a spontaneous report from a contactable consumer (patient). A 46-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in left arm (shoulder) on 12Mar2021 10:07 (Lot Number: EN6202) as single dose for covid-19 immunization. There were no medical history and concomitant medications. The patient has no prior vaccinations within 4 weeks. The patient was not sick at time of vaccination. The patient reported that on 12Mar2021, he has been feeling the regular pain feeling, a headache, muscle pain before, it comes and goes. However, he said that the last few days (2021), there had been, by his calf muscle in the back there, they've been tightening, like stiffening up on him when he's sleeping. His calf feels tight, stiff, it feels like dead weight. It wakes him up at times. He also reported pain running up the right arm up to the shoulder on unknown date in 2021. He was just curious in terms of what that might be. He asked if someone can tell him if it is a blood clot in the back of his calf. The headache went away after 2-3 days. He also reported that his eyes also hurt a little bit and was the same time frame as the headache (onset date reported as 12Apr2021: after the second dose, pending clarification). He stated that those things were just mild, nothing major. He did not take anything for these. He confirmed he no longer had muscle pain. He just has pain behind the calf and right arm up to his shoulder. His calf pain, started to feel tight, started within the last 2- 3 weeks (2021). The arm pain in right arm up to shoulder started maybe within 2 days. The patient received the second dose on 02Apr2021. Outcome of the events muscle pain and headache was recovered in Mar2021, events pain running up the right arm up to the shoulder/Calf pain was not recovered, and outcome of other events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1269617

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
AZ
Alter
81,0
Geschlecht
M
Eingang
29.04.2021
Impfdatum
23.02.2021
Beginn
01.03.2021
Tage bis Beginn
6,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Arthralgia Blood test Pain in extremity Peripheral swelling Thrombosis Ultrasound scan

Symptomtext

Got worse and the leg swelled and was also having foot swelling because blood flow wasn't there; sore arm; blood clot; pain behind left knee; This is a spontaneous report from a contactable consumer (patient's wife). An 81-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in right shoulder on 23Feb2021 (Batch/Lot Number: EN6202) (at the age of 81-years-old) as single dose for covid-19 immunisation. Medical history included diabetes mellitus, stage 3 renal failure (was not bad, was in stage 5 couple of years ago, was a month or so away from full failure, was in the hospital and had dialysis, was able to get reversed with medication and diet), high blood pressure, and blood cholesterol increased/high cholesterol. The reporter stated that with regards to patient's height, he shrunk a little. Patient had no prior vaccinations within 4 weeks, didn't get flu shots. Concomitant medications include about 12 other unspecified drugs, takes statins, has high blood pressure and high cholesterol. Patient started experiencing pain behind his left knee about 6 or 7 days later in Mar2021 (also reported as 04 or 05Apr2021, pending clarification). By that Sunday, it had gotten worse. The leg swelled and was also having foot swelling because blood flow wasn't there. There was no TIA's no stroke, no heart racing, no sweating, was all pain. Got leg up and kept elevated until they could get to the doctor and get imaging. Patient went Monday 08Mar2021 to see the doctor. Patient was brought to the doctor and was then sent to the imaging place. Radiology read the imaging around 5:15pm on the Monday, 08Mar2021. The radiologist said there was 2.5" blood clot behind the left knee. He had never had a blood clot before. Patient was then sent to the Emergency Room at (Name) Hospital, in (Name) where they live. Was kept there several hours. Did a lot more blood tests. He was immediately put on 10mg ELIQUIS 10mg, once in the morning, and once at night. He is now taking 5mg Eliquis in the morning, and 5mg at night. He has not had any of these problems before the Pfizer shot. The reporter knew that not a lot had been reported. It seemed it should be safe. The correlation and timing having the shot on 23Feb2021 and all of a sudden a week and a half later this happened. It was 10 days later. There was nothing they can do about it. Just continuing with the ELIQUIS, trying to dissolve the blood clot, will be staying on it for 4 to 6 months. It was a pretty big blood clot and were worried about it breaking up and traveling. The patient had no other symptoms, had a sore arm, that was it. Patient going back to (Name) 01Jun2021 and he will have another CT scan or ultra sound when they get back. The reporter did not want to need to get the leg amputated. Patient was only in the ER, was not admitted to the hospital. Patient was concerned because of his age. If it doesn't dissolve, they know there will be a lot more trouble. The event of pain left knee, blood clot and sore arm required a visit to the emergency room and physician's office. The patient received the second dose of BNT162B2 on 01Apr2021 (lot number: ER8730) in the right arm. The outcome of events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
Test Name: blood tests; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210308; Test Name: ultrasound; Result Unstructured Data: Test Result:2.5" blood clot
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Blood pressure high; Diabetes; High cholesterol; Renal failure
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1268176

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OK
Alter
74,0
Geschlecht
M
Eingang
28.04.2021
Impfdatum
09.04.2021
Beginn
27.04.2021
Tage bis Beginn
18,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Dyspnoea Intensive care SARS-CoV-2 test positive

Symptomtext

Patient presented to ED with progressive and worsening SOB 4/27. Tested positive for COVID-19. Requiring 60 l/min high flow O2 in ICU at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
2,0
Labordaten
COVID-19 positive - 4/27
Aktuelle Erkrankungen
Malignant melanoma
Vorgeschichte
BPH CKD CLL GERD SCC hyperlipidemia HTN NHL SCC of scalp
Andere Medikamente
diphenhydramine hydrocodone-apap levothyroxine metronidazole omeprazole ondansetron prednisone promethazine tamsulosin abraxane belimumab
Allergien
Iodinated contrast Iodine
Vorherige Impfungen
-

VAERS 1205576

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
49,0
Geschlecht
F
Eingang
27.04.2021
Impfdatum
03.03.2021
Beginn
04.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Thrombosis

Symptomtext

I was diagnosed with a blood clot in my right leg; This is a spontaneous report from a contactable consumer (patient). A 49-year-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in right arm on 03Mar2021 15:45 (Lot Number: EN6202), at the age of 49-years at vaccination, as SINGLE DOSE for covid-19 immunisation. Medical history included none. The patient is not pregnant at the time of vaccination. The patient received dose 1 of the vaccine on 10Feb2021, lot number: EM9810, on 10Feb2021 03:45 PM at right arm. The patient did not have COVID-19 prior vaccination. The patient's concomitant medications were not reported. On 04Mar2021 12:00 AM, patient was diagnosed with a blood clot in her right leg. The event required emergency room visit. The patient was put on Xarelto, a blood thinner for clots. The patient has not been tested for COVID-19 post vaccination. The outcome of the event was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1205576

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
49,0
Geschlecht
F
Eingang
27.04.2021
Impfdatum
03.03.2021
Beginn
04.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Thrombosis

Symptomtext

I was diagnosed with a blood clot in my right leg; This is a spontaneous report from a contactable consumer (patient). A 49-year-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in right arm on 03Mar2021 15:45 (Lot Number: EN6202), at the age of 49-years at vaccination, as SINGLE DOSE for covid-19 immunisation. Medical history included none. The patient is not pregnant at the time of vaccination. The patient received dose 1 of the vaccine on 10Feb2021, lot number: EM9810, on 10Feb2021 03:45 PM at right arm. The patient did not have COVID-19 prior vaccination. The patient's concomitant medications were not reported. On 04Mar2021 12:00 AM, patient was diagnosed with a blood clot in her right leg. The event required emergency room visit. The patient was put on Xarelto, a blood thinner for clots. The patient has not been tested for COVID-19 post vaccination. The outcome of the event was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1242481

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
59,0
Geschlecht
M
Eingang
22.04.2021
Impfdatum
27.02.2021
Beginn
22.03.2021
Tage bis Beginn
23,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Deep vein thrombosis Pain in extremity Peripheral swelling

Symptomtext

pt had right leg swelling and pain starting on 03-22-21 and presented for medical care on 03-29-21 was found to have elevated d-Dimers and Doppler RLE showed occlusive clot in right peroneal vein and non-occlusive clot in right popliteal vein

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
-
Labordaten
03-29-21: d-dimers = 3.65 mg/L FEU, 03-30-21: Doppler RLE positive for DVT as above
Aktuelle Erkrankungen
seasonal allergies
Vorgeschichte
peri-rectal herpes simplex on chronic suppressive acyclovir since 2010
Andere Medikamente
fexofenadine, flonase, acyclovir
Allergien
penicillin
Vorherige Impfungen
-

VAERS 1238941

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
68,0
Geschlecht
M
Eingang
21.04.2021
Impfdatum
17.03.2021
Beginn
17.04.2021
Tage bis Beginn
31,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Cough Dyspnoea Febrile convulsion Hypoxia Pain Pyrexia SARS-CoV-2 test positive Tachycardia

Symptomtext

Patient was fully vaccinated (dose 1: 2/24, dose 2: 3/17). Patient developed body aches, fever, cough and SOB on 4/17 and presented to healthcare facility where he tested positive for SARS-CoV-2 on 4/21. In ED patient was febrile (38.8), hypoxic satting 90% on RA requiring NC, tachycardic (HR 114 bpm) and in AKI (sCr 1.2 mg/dL). Medications initiated for COVID-19 included enoxaparin and remdesivir. Patient is admitted, today is day 1 of hospitalization (4/21).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Febrile convulsion
Hospital-Tage
1,0
Labordaten
SARS-CoV-2 PCR - positive (4/21) COVID-19 Rapid Ab - negative (4/21)
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, HLD, prostate cancer, NASH cirrhosis/HCC (treated with SBRT in 2019) s/p OLT 9/23/2020
Andere Medikamente
Amlodipine, mycophenolate mofetil, pantoprazole, predniSONE , tacrolimus
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1237422

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
34,0
Geschlecht
M
Eingang
21.04.2021
Impfdatum
19.03.2021
Beginn
21.03.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Clonic convulsion Condition aggravated Electroencephalogram Epilepsy Laboratory test Magnetic resonance imaging Seizure

Symptomtext

After receiving dose one of covid 19 vaccine on 3/19/21, patient experienced a tonic clonic seizure on 3/21/21 at 2pm. After receiving dose two of covid 19 vaccine on 4/8/21, patient experience a different kind of seizure on 4/10/21 at 11pm. Patient has history of epilepsy but is controlled and has not experienced a seizure in many years. the adverse even occured approx 2 days after each dose. Follow-up with Neurologist has determined that most likely the immune response to the vaccines triggered the seizures. Patient had EEG and has appointments for more testing including MRI.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Clonic convulsion
Hospital-Tage
-
Labordaten
EEG, labwork and MRI, etc
Aktuelle Erkrankungen
-
Vorgeschichte
epilepsy
Andere Medikamente
Lamictal and Aptium
Allergien
Cephalosporins
Vorherige Impfungen
-

VAERS 1235759

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
IL
Alter
-
Geschlecht
F
Eingang
21.04.2021
Impfdatum
06.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abnormal sensation in eye Bell's palsy Facial paresis Headache Hypoaesthesia Muscle tightness Paraesthesia Pyrexia Tremor

Symptomtext

Numbness to left side of face; Low grade tremor in left jaw; pins and needles up left jaw and cheek; weakness across left cheek; Feels like whole muscle jaw is under tension; potential for Bell's Palsy; weird sensation left flickering in left eye immediately; Fever; Headache; This is a spontaneous report received from a contactable other health-care professional. A 64-year-old-female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: ER8730), via an unspecified route of administration at the right arm on 27Mar2021 13:00 at single dose for COVID-19 immunization. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EN6202), via an unspecified route of administration at the left arm on 06Mar2021 at single dose for COVID-19 immunization. The patients medical history included Sjogren syndrome (states is an autoimmune disease that she was diagnosed with a really long time ago; maybe around 2005 and ongoing) and on unspecified date either on 2018 or 2019 patient had administered with Whooping Cough Vaccine for which she experienced Sore Spot on Arm. Concomitant medications were not reported. It was reported that after first dose states of the vaccine patient had immediate numbness to the left side of her face that went away after a while. The patient had a low grade tremor in her left jaw and a twitching, flickering in her eye. Patients jaw feels dull like the whole muscle is under tension. It was reported that she didn't have much of a reaction after her second vaccine besides a fever and a headache and stated that they started about 5 hours after the vaccine and were gone the next day. The patient had a fever and headache after the first vaccine also; they started about the same, 5 hours or so after the vaccine but they lasted for about 5 days. On 06Mar2021 13:00 patient got immediately dull, pins and needles up left jaw and cheek. went away and has left tremor in lower jaw and now flickering twitch in left eye. weakness across left cheek continues. Outcome was reported as unknown for potential for Bell's Palsy and Feels like whole muscle jaw is under tension, not recovered for weird sensation left flickering in left eye immediately, pins and needles up left jaw and cheek and weakness across left cheek, recovered from pyrexia and headache, recovering from Numbness facial and low grade tremor in left jaw. No follow up attempts are needed. No further information is expected.; Sender's Comments: Based on the information provided and plausible temporal association, the causality between the suspect drug and the event potential for Bell's Palsy cannot be excluded. This impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Sjogren's syndrome (States is an autoimmune disease that she was diagnosed with a really long time ago; maybe around 2005. (Ongoing))
Vorgeschichte
Medical History/Concurrent Conditions: Bell's palsy (Patient's her mother had Bell's Palsy at one point.)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1235718

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
51,0
Geschlecht
F
Eingang
21.04.2021
Impfdatum
10.03.2021
Beginn
19.03.2021
Tage bis Beginn
9,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein
Ageusia Bell's palsy Chills Dizziness Headache Nausea Neck pain Pain in extremity Swollen tongue

Symptomtext

Bell Palsy; pain in arm; pain in neck; headache worsen from center of head to neck; dizzy; nausea; chills; tongue swollen; no taste; This is a spontaneous report from a contactable consumer (patient). A 51-year-old (also reported as 52-year-old) female patient received bnt162b2 (BNT162B2), via an unspecified route of administration at the age of 51-years-old, administered in Arm Left on 10Mar2021 10:45 (Lot Number: EN6202) as single dose for COVID-19 immunization. Medical history included asthma and high blood pressure. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient experienced "Bell palsy", pain in arm, pain in neck, headache worsen from center of head to neck, dizzy, nausea, chills, tongue swollen, no taste; all on 19Mar2021 22:30. Description was as follows: "pain in arm, neck, headache, dizzy, nausea, chills and then days later other symptoms, headache worsen from center of head to neck, neck hurting, tongue swollen, no taste, and then woke up with Bell Palsy and was taken to the emergency room". Therapeutic measures were taken as a result of Bell palsy. The outcome of the events was recovering. The events were considered as serious (Disability or permanent damage/ Disabling/Incapacitating). The adverse events resulted in any Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. More information has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Asthma; Hypertension
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1233627

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
57,0
Geschlecht
F
Eingang
20.04.2021
Impfdatum
02.04.2021
Beginn
04.04.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Computerised tomogram Deep vein thrombosis Magnetic resonance imaging Pain in extremity Peripheral swelling

Symptomtext

Deep vein thrombosis was the diagnostic from the after effects of the second vaccination. Blood cot caused leg swelling and pain They did a cat scan & MRI Treatment was being given Eliquis (4 pills a day for 7 days) (2 pills after) It is a blood thinner and must follow up with my doctor.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
-
Labordaten
They did a cat scan & MRI Treatment was being given Eliquis (4 pills a day for 7 days) (2 pills after) It is a blood thinner and must follow up with my doctor.
Aktuelle Erkrankungen
Myelodysplastic syndrome (MDS)
Vorgeschichte
Pre-Diabetes
Andere Medikamente
Depakote, Metformin HCI, Omeprazole DR, Metroprolol Succinate, Lisinopril, Hydrochlorothiazide
Allergien
Allergy to Singular
Vorherige Impfungen
-

VAERS 1225470

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NH
Alter
19,0
Geschlecht
F
Eingang
18.04.2021
Impfdatum
13.04.2021
Beginn
16.04.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Computerised tomogram head Culture urine Differential white blood cell count Disorientation Dysarthria Electrocardiogram Full blood count Human chorionic gonadotropin Loss of consciousness Metabolic function test Nausea Speech disorder Syncope Urine analysis

Symptomtext

While talking to my parents I started to say things completely opposite of the conversation we were having. My speech began to slur and then I passed out/fainted and was unconscious for approx 1 minute. Once I came to I was disoriented and nauseated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
All done on 4/16/2021- Labs: CBC with automated diff, HCG QL Serum, Metobolic Panel, comprehensive UA with reflex micro and culture. Imaging: CT head, and spine verb without contrast EKG, 12 lead, initial
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Famotidine 20mg twice a day , drospirene-ethinyl estradioL 3mg at morning, Melatonin 12 mg at night
Allergien
Peanuts and treenuts
Vorherige Impfungen
-

VAERS 1224441

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
PA
Alter
43,0
Geschlecht
M
Eingang
18.04.2021
Impfdatum
09.03.2021
Beginn
27.03.2021
Tage bis Beginn
18,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Chest pain Myocarditis SARS-CoV-2 test negative Troponin Troponin increased

Symptomtext

Chest Pain as a Result of Elevated Troponin Levels Caused by Myocarditis; Chest Pain as a Result of Elevated Troponin Levels Caused by Myocarditis; Chest Pain as a Result of Elevated Troponin Levels Caused by Myocarditis; This is a spontaneous report from Pfizer Sponsored Patient Support Program. A contactable consumer (patient) reported for himself that a 43-year-old male patient received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6202), via an unspecified route of administration at the age of 43-year-old at arm left on 09Mar2021 14:00 at single dose for covid-19 immunisation. Medical history included high blood pressure. The patient wasn't allergies to medications, food, or other products. Concomitant medications included metoprolol tartrate and vitamin D NOS. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6202) at left arm on 15Feb2021 6:00 PM for COVID-19 immunisation. The patient experienced chest pain as a result of elevated troponin levels caused by myocarditis on 27Mar2021 14:00. The events were serious for being hospitalized (duration 3 days). The adverse events result in Emergency room/department or urgent care. Facility where the most recent COVID-19 vaccine was administered in hospital. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab tests included nasal swab: negative on 29Mar2021. The patient was received treatment (Heparin, Nitroglycerin and Cardiac Catheterization) for events. The outcome of events was recovering.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
3,0
Labordaten
Test Date: 20210329; Test Name: Nasal Swab; Test Result: Negative ; Test Date: 20210327; Test Name: troponin levels; Result Unstructured Data: Test Result:elevated
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: High Blood Pressure
Andere Medikamente
METOPROLOL TARTRATE; VITAMIN D NOS
Allergien
-
Vorherige Impfungen
-

VAERS 1224026

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
-
Geschlecht
U
Eingang
17.04.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Presyncope Syncope

Symptomtext

Since Jan 2020 I have been experiencing positional/vasovagal fainting spells once every 4-6 weeks. They tapered off and were manageable. Since 3/6/2021, I have had 7 episodes, 5 of those since 4/2/2021, two weeks after my second vaccine. My family suggested I look thru my journal to see what could have triggered this explosion in events. My physician contact was thru messaging. I don?t go out much and had only two social interactions during that time period. I had my second Pfizer vaccine at same location on 3/18/2021 at 4 pm; lot number EP7534

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2625392

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
61,0
Geschlecht
M
Eingang
16.04.2021
Impfdatum
03.03.2021
Beginn
03.03.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy

Symptomtext

Bell's Palsy Narrative:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1215952

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
LA
Alter
72,0
Geschlecht
F
Eingang
15.04.2021
Impfdatum
24.02.2021
Beginn
26.02.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test Computerised tomogram Cough Influenza virus test negative SARS-CoV-2 test positive Thrombosis

Symptomtext

Began with a severe cough 02/27/21 lasting for days....possibly causing blood clots in the lungs.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
Tested for Covid as well as several local Flu's 03/04/21; All tested Negative. Dr. had me do a complete Blood test, followed by a blood test for Kidney function, followed by a C.T. Scan of the lungs that showed six BLOOD CLOTS in my lungs. So I went on Xarelto and am still on it for the next three months.
Aktuelle Erkrankungen
N/A
Vorgeschichte
Had Uterine Cancer in 2019
Andere Medikamente
Caltrate, Vit. E, Omeprazole
Allergien
none
Vorherige Impfungen
-

VAERS 1178648

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NC
Alter
40,0
Geschlecht
M
Eingang
13.04.2021
Impfdatum
18.03.2021
Beginn
20.03.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Chills Computerised tomogram neck Computerised tomogram thorax Dyspnoea Fatigue Lymphadenopathy Odynophagia Intensive care Pain Pyrexia SARS-CoV-2 test Swelling face Vomiting SARS-CoV-2 test negative

Symptomtext

shortness of breath; 2 days post vaccine small hard lump under chin developed.; 4 days post vaccine lump / lymph nodes severely enlarged the size of a racquet ball and area around chin and neck severely swollen; chills; fever; fatigue; body aches; vomiting; painful to swallow; This is a spontaneous report from a contactable Other-HCP (patient). A 40-year-old male patient received second dose of BNT162B2 (BNT162B2, Solution for injection, Lot number: EN6206, Expiration date was not provided) via unspecified route of administration at left arm on 18Mar2021 09:30 at single dose for COVID-19 immunisation. The patient medical history included type 1 diabetes and Sulfa drugs. Concomitant medications included insulin human (HUMULIN R), insulin human injection, isophane (HUMULIN N) and sildenafil. Historical vaccine included first dose of BNT162B2 (lot number: EN6202) via unspecified route of administration on right arm on 25Feb2021 12:30 PM for COVID-19 immunisation. If other vaccine in four weeks and Covid prior vaccination reported as no. Patient tested Covid post vaccination. On 20Mar2021 09:00, 2 days post vaccine small hard lump under chin developed. 4 days post vaccine lump/lymph nodes severely enlarged the size of a racquet ball and area around chin and neck severely swollen. The subject developed chills, fever, fatigue, body aches, shortness of breath, vomiting, painful to swallow. Due to pain from swelling Percocet , Fentanyl, Ketorolac, and Morphine were administered. It is also reported that the subject received antibiotics for the adverse events. 2 COVID test were negative. Due to difficulty breathing issues the subject was admitted through ER to hospital critical care unit for 9 days post vaccine. The subject was still in hospital 11 days post vaccine. The patient underwent lab test procedure included Nasal Swab (SARS-CoV-2 test): Negative on 26Mar2021 and Negative on 27Mar2021. The outcome of the events was not recovered.; Sender's Comments: Assuming a plausible drug-events temporal association, the company cannot completely exclude a causal association between the reported, serious dyspnea and BNT162B2 administration. The impacts of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
-
Labordaten
Test Date: 20210326; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative; Comments: covid test name post vaccination=Covid-19-PCR Test; Test Date: 20210327; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative; Comments: covid test name post vaccination=SARS-CoV2 RNA
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Sulfonamide allergy; Type 1 diabetes mellitus
Andere Medikamente
HUMULIN R; HUMULIN N; SILDENAFIL
Allergien
-
Vorherige Impfungen
-

VAERS 1191609

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
42,0
Geschlecht
M
Eingang
10.04.2021
Impfdatum
06.02.2021
Beginn
07.03.2021
Tage bis Beginn
29,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Blood test normal Peripheral swelling Thrombosis

Symptomtext

Approximately one week after my second dose my right leg began swelling. For three weeks after the swelling began it would get better than get worse. On Tuesday, March 30, 2021 my entire leg swelled to twice its normal size at which time I went to the emergency room and a blood clot was diagnosed in my right leg. I completed a multitude of tests and bloodwork with a hematologist and there are no factors or reasons they can identify as to why I developed a blood clot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1184823

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
25,0
Geschlecht
F
Eingang
09.04.2021
Impfdatum
07.04.2021
Beginn
07.04.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Blood glucose Blood magnesium Chest X-ray Dizziness Electrocardiogram Feeling hot Full blood count Hyperhidrosis Metabolic function test Muscle spasms N-terminal prohormone brain natriuretic peptide Nausea Paraesthesia Pregnancy test urine Seizure Troponin T Visual impairment

Symptomtext

- got my phizer vaccine in my left arm - walks to 10-15 min waiting room - sits down and is looking at my phone for 3-5 mins - slight nausea hits and I start feeling dizzy - my eyes start going black snd I feel really hot - I tell the lady watching everyone that I don't feel good. A nurse and another woman come and put me in a wheelchair so I don't fall out of a chair if I faint - my eyes are going more black and I'm profusely sweating all over my body - I faint and convulse for 5 seconds - I wake up from passing out and my hands and feet are extremely tingly and feel like they have a million pins in them - my hands started cramping really bad and I can almost not open them for 5 minutes - over the next 15 mins the tingleynes and hand cramps completely fade away and I feel normal

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
- POC GLucose - Magnesium level - CBC with auto differential - NT-PRO- B-Type Maturiertic - Troponin T-HS - Comprehensive Metabolic Panel - Complete Blood Count W/ DIFF - EKG - XR CHest 1 view - POC Urine Pregnancy Screen Everything came back completley normal
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
Zinc, Allegra, lysine
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 1059487

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
31,0
Geschlecht
F
Eingang
09.04.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Aura Blood cadmium Blood magnesium Bronchospasm Chest X-ray Dizziness Dyspnoea Loose body in joint Liver function test Metabolic function test Muscular weakness Syncope Tonic convulsion Retching SARS-CoV-2 test Seizure Throat tightness Tremor

Symptomtext

convulsions; bronchospasms; throat closure; difficulty breathing; Felt an "aura"; joints loosening; dizziness; This is a spontaneous report from a contactable nurse (patient). A 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 31-year-old, via an unspecified route of administration, administered in left deltoid on 26Feb2021 15:15 (Lot Number: EN6202) as single dose for COVID-19 immunisation. Medical history included known allergies to opioids, Toradol, Valium, and a lot of foods; mast cell activation disorder, eosinophilic oesophagitis (EoE), asthma, celiac disease, Hashimoto, and hypothyroidism. The patient was not pregnant at the time of vaccination. Concomitant medications included montelukast sodium (SINGULAIR), levocetirizine dihydrochloride (XYZAL), meloxicam (MOBIC), paracetamol (TYLENOL), and levothyroxine sodium (SYNTHROID); all taken for an unspecified indication, start and stop date were not reported. It was reported that one min later after the vaccination (26Feb2021 15:16), the patient felt an "aura" (joints loosening, dizziness), gave herself two puffs of albuterol and pulled out her epi pen and called for help. Two mins later (26Feb2021 15:17), the patient experienced convulsions, bronchospasms, throat closure, dizziness, difficulty breathing. Two rounds of epi, non-rebreather O2, rescue efforts. The patient was then transferred to emergency department (ED) to continue rescue efforts. The patient was treated with O2, Ativan, Steroids, Epinephrine, and Benadryl. The patient underwent lab tests and procedures which included Covid nasal swab PCR test: negative on 26Feb2021 (post vaccination). The patient was recovering from the events.; Sender's Comments: Considering temporal relationship, a possible contribution role of vaccination with the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) to the onset of the reported events, cannot be completely excluded. The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
Test Date: 20210226; Test Name: Covid nasal swab PCR test; Test Result: Negative ; Comments: post vaccination
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Asthma; Celiac disease; Eosinophilic esophagitis; Food allergy (known allergies: A Lot of foods); Hashimoto's disease; Hypothyroidism; Mast cell activation syndrome
Andere Medikamente
SINGULAIR; XYZAL; MOBIC; TYLENOL; SYNTHROID
Allergien
-
Vorherige Impfungen
-

VAERS 1059487

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
31,0
Geschlecht
F
Eingang
09.04.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Aura Blood cadmium Blood magnesium Bronchospasm Chest X-ray Dizziness Dyspnoea Loose body in joint Liver function test Metabolic function test Muscular weakness Syncope Tonic convulsion Retching SARS-CoV-2 test Seizure Throat tightness Tremor

Symptomtext

convulsions; bronchospasms; throat closure; difficulty breathing; Felt an "aura"; joints loosening; dizziness; This is a spontaneous report from a contactable nurse (patient). A 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 31-year-old, via an unspecified route of administration, administered in left deltoid on 26Feb2021 15:15 (Lot Number: EN6202) as single dose for COVID-19 immunisation. Medical history included known allergies to opioids, Toradol, Valium, and a lot of foods; mast cell activation disorder, eosinophilic oesophagitis (EoE), asthma, celiac disease, Hashimoto, and hypothyroidism. The patient was not pregnant at the time of vaccination. Concomitant medications included montelukast sodium (SINGULAIR), levocetirizine dihydrochloride (XYZAL), meloxicam (MOBIC), paracetamol (TYLENOL), and levothyroxine sodium (SYNTHROID); all taken for an unspecified indication, start and stop date were not reported. It was reported that one min later after the vaccination (26Feb2021 15:16), the patient felt an "aura" (joints loosening, dizziness), gave herself two puffs of albuterol and pulled out her epi pen and called for help. Two mins later (26Feb2021 15:17), the patient experienced convulsions, bronchospasms, throat closure, dizziness, difficulty breathing. Two rounds of epi, non-rebreather O2, rescue efforts. The patient was then transferred to emergency department (ED) to continue rescue efforts. The patient was treated with O2, Ativan, Steroids, Epinephrine, and Benadryl. The patient underwent lab tests and procedures which included Covid nasal swab PCR test: negative on 26Feb2021 (post vaccination). The patient was recovering from the events.; Sender's Comments: Considering temporal relationship, a possible contribution role of vaccination with the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) to the onset of the reported events, cannot be completely excluded. The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
Test Date: 20210226; Test Name: Covid nasal swab PCR test; Test Result: Negative ; Comments: post vaccination
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Asthma; Celiac disease; Eosinophilic esophagitis; Food allergy (known allergies: A Lot of foods); Hashimoto's disease; Hypothyroidism; Mast cell activation syndrome
Andere Medikamente
SINGULAIR; XYZAL; MOBIC; TYLENOL; SYNTHROID
Allergien
-
Vorherige Impfungen
-

VAERS 1178038

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
43,0
Geschlecht
F
Eingang
07.04.2021
Impfdatum
05.03.2021
Beginn
06.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Eye disorder Ophthalmological examination abnormal Paraesthesia

Symptomtext

Left eye began feeling odd the next morning, face pins and needles, eye feeling weird

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
Emergency ophamogy visit, where he noted swelling and slight left eye droop, a few days later it was worse, walk in emergent clinic, diagnosed Bell?s palsy, referral to neurology that confirmed. Otherwise healthy.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Daily vitamin
Allergien
Penicillin, wasp venom, pollen
Vorherige Impfungen
-

VAERS 1169165

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
WI
Alter
89,0
Geschlecht
M
Eingang
05.04.2021
Impfdatum
01.03.2021
Beginn
02.04.2021
Tage bis Beginn
32,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 SARS-CoV-2 test positive Syncope

Symptomtext

Pt originally tested positive for COVID -19 10/19/2020. PT received both doses of the pfizer COVID-19 vaccine on 2/8 and 3/1. Pt was hospitalized on 3/31 for syncope with pacemaker implantation. Appeared to be asymptomatic for COVID-19, but had a positive SARS-CoV-2 PCR test on 4/1.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
SARS-CoV-2 PCR - Positive 4/1
Aktuelle Erkrankungen
-
Vorgeschichte
Vitamin D deficiency, sleep apnea, renal insufficiency, polyneuropathy, osteoarthrosis, orthostatic hypotension, obesity, insomnia, hyperlipidemia, hypertension, gout, GERD, diastolic dysfunction, diabetes, COPD, CKD, chronic venous insufficiency, chronic pain disorder, afib, CHF, CAD, BPH, anemia,
Andere Medikamente
allopurinol, apixaban, carvedilol, dicloxacillin, finasteride, fluticasone, insulin degludec, isosorbide mononitrate, liraglutide, lisinopril, omega-3 fatty acid, oxybutynin, pantoprazole, prenatal plus, probiotic products, rosuvastatin, to
Allergien
Bee Venom, codeine, fentanyl, polymyxin B sulfate, pentoxifylline
Vorherige Impfungen
-

VAERS 1167750

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
37,0
Geschlecht
F
Eingang
05.04.2021
Impfdatum
09.03.2021
Beginn
19.03.2021
Tage bis Beginn
10,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Bell's palsy Computerised tomogram head normal Facial asymmetry Facial nerve disorder Facial pain Facial paralysis Hypoaesthesia Magnetic resonance imaging head abnormal Taste disorder

Symptomtext

On 3/19/21, presented to ED with new right facial droop and numbness. CT head negative, neurology consult and thought to be Bell's Palsy. Discharged home on Solumedrol 5 day pack. Patient noted asymmetry in her taste sensation and then started to have R sided facial pain, followed by R sided facial droop. On 3/23/21, brain MRI showed no acute infarction, intracranial hemorrhage or mass lesion, very minimal asymmetric enhancement of the labyrinthine segment of the right facial nerve as compared to the left side.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
7,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1165245

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
UT
Alter
34,0
Geschlecht
F
Eingang
04.04.2021
Impfdatum
02.03.2021
Beginn
02.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Back pain Blood glucose normal Chills Dizziness Fatigue Feeling abnormal Headache Heart rate decreased Heart rate increased Hot flush Malaise Nausea Neck pain Pain Pruritus Rash Syncope

Symptomtext

Within five minutes I experienced a hot wave, rapid heart rate, syncope, dizzy, light headed, dip in pulse, headache, nauseous, chills, shaking, body ache especially back, fatigue, out of it/dreamlike, worse standing/sitting up. Was kept for monitoring at facility for three hours then sent home. Next day I had my opposite arm from the shot and neck itching, rash on chest. Felt ill for many days afterwards.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
Blood glucose level was checked and was normal. Heart rate and blood pressure monitored.
Aktuelle Erkrankungen
-
Vorgeschichte
Stroke, fibromyalgia, endometriosis, adenomyosis, orthostatic hypotension, inappropriate sinus tachycardia, migraine with aura, osteoarthritis, ibs.
Andere Medikamente
Duloxetine 20mg, Sprintec, Loratadine, multivitamin, omega 3, vitamin b12, vitamin d, vitamin c
Allergien
N/a
Vorherige Impfungen
-

VAERS 1164400

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
DE
Alter
65,0
Geschlecht
F
Eingang
03.04.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bell's palsy Burning sensation Computerised tomogram Discomfort Dry eye Ear pain Lymphadenopathy Pain in jaw Paraesthesia Pruritus Salivary hypersecretion Swelling face

Symptomtext

About 20-25 minutes after receiving the shot, my left cheek began to tingle. In the days that followed, the left side of my face, especially my cheek felt like I had razor burn. My left eye became dry, but that went away, as did scalp itching. I began to produce more saliva on the left side of mouth. My face felt heavy, my upper jaw at times aching, but mostly my lower jaw. The inside of my left ear hurt occasionally along with upper jaw pain. My left lymph node became swollen, as did the left side of my face. My doctor on Zoom said these were symptoms of Bell's Palsy, though I did not have the characteristic drooping eye or mouth of Bell's Palsy. My symptoms have abated, but persist five weeks after administration of the shot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
CAT-SCAN of lymph nodes
Aktuelle Erkrankungen
N/A
Vorgeschichte
Periodic migraines
Andere Medikamente
Liquid Cal/Mg, L-Glutathione, Vitamin D plus K
Allergien
Sulfa
Vorherige Impfungen
-

VAERS 1163021

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
64,0
Geschlecht
F
Eingang
03.04.2021
Impfdatum
27.02.2021
Beginn
27.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Syncope

Symptomtext

syncopal episode 15 minutes after vaccination, no fall

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
primary malignant neoplasm of peritoneum
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1162082

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
KY
Alter
71,0
Geschlecht
M
Eingang
02.04.2021
Impfdatum
02.03.2021
Beginn
12.03.2021
Tage bis Beginn
10,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Computerised tomogram Pain in extremity Peripheral swelling Thrombosis Ultrasound scan

Symptomtext

developed blood clots in my left leg that began swelling some on 12Mar2021 and by Monday 15Mar2021 it was huge and 16Mar2021 big and hurting; developed blood clots in my left leg that began swelling some on 12Mar2021 and by Monday 15Mar2021 it was huge and 16Mar2021 big and hurting; developed blood clots in my left leg that began swelling some on 12Mar2021 and by Monday 15Mar2021 it was huge and 16Mar2021 big and hurting; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: EN6202), via an unspecified route of administration, administered in Arm Left on 02Mar2021 16:00 (at 71-year-old) as single dose for COVID-19 immunization. Medical history included Arthritis in knee. High blood pressure. Patient had no covid prior vaccination and no covid tested post vaccination. Patient has no known allergies. Concomitant medication included hydrochlorothiazide. The patient previously took first dose of BNT162B2 for COVID-19 immunization. The patient developed blood clots in my left leg that began swelling some on 12Mar2021 17:00 and by Monday 15Mar2021 it was huge and 16Mar2021 big and hurting. So he went to urgent care and they sent him to hospital ER. The patient was hospitalized for 3 days. Events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization. Events treatment included Ultra sound, CT scan, heparin blood thinner. The outcome of the events was not recovered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
3,0
Labordaten
Test Name: CT scan; Result Unstructured Data: Test Result:Unknown; Test Name: Ultrasound; Result Unstructured Data: Test Result:Unknown
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Blood pressure high; Knee arthritis
Andere Medikamente
HYDROCHLOROTHIAZIDE
Allergien
-
Vorherige Impfungen
-

VAERS 1159283

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
69,0
Geschlecht
M
Eingang
02.04.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Loss of consciousness

Symptomtext

when patient got home after receiving 2nd dose he passed out

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1106664

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
53,0
Geschlecht
F
Eingang
02.04.2021
Impfdatum
04.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthma Chills Dehydration Dysphagia Dyspnoea Balance disorder Dysarthria Eating disorder Electric shock sensation Fatigue Gait disturbance Headache Immobile Increased upper airway secretion Lethargy Mastication disorder Musculoskeletal stiffness Myalgia

Symptomtext

difficulty swallowing,chewing and speaking; difficulty swallowing,chewing and speaking; difficulty swallowing,chewing and speaking; had a lot of mucus in my throat; difficulty breathing; asthma acting up; lethargic; dehydrated; headaches; immobility; fever; chills; muscle aches; stiffness; electrical shocks up and down my body; fatigue; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 04Mar2021 14:00 (Batch/Lot Number: EN6202), at the age of 53-years at vaccination, as SINGLE DOSE for covid-19 immunisation. Medical history included asthma, multiple sclerosis, seasonal allergies, dust, animals. The patient did not have COVID prior vaccination. The patient is not pregnant at the time of vaccination. Concomitant medication included glatiramer acetate (COPAXONE); lamotrigine (LAMICTAL); risperidone (RISPERDAL); alprazolam (XANAX); salbutamol (ALBUTEROL HFA), all taken for an unspecified indication, start and stop date were not reported. The patient previously took dilaudid and experienced allergies. On 04Mar2021 17:00, the patient got fever, chills, headaches, muscle aches and stiffness. The patient treated the symptoms with ibuprofen and ice packs. The next day, on 05Mar2021, the patient had difficulty swallowing, chewing and speaking. The patient had a lot of mucus in my throat and difficulty breathing from asthma acting up. The patient was very lethargic and dehydrated. The patient had to use inhalers, benedryl and musinex to treat symptoms. The patient had the chills, headaches, fever and aches through Tuesday, 09Mar2021. The patient touched base with her general practitioner's and neurologists' offices on March 5 & 6 and left messages. They suggested she go to the ER. (She didn't go out of fear of getting COVID), she was too fatigued and weak to walk. No balance. She had electrical shocks up and down her body. The patient was still experiencing immobility and fatigue. The outcome of the events chills, headaches, fever and aches was recovered on 09Mar2021; the other events were not recovered. The patient was not tested for COVID post vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergy to animals; Asthma; Dust allergy; Multiple sclerosis; Seasonal allergy
Andere Medikamente
COPAXONE; LAMICTAL; RISPERDAL; XANAX; ALBUTEROL HFA
Allergien
-
Vorherige Impfungen
-

VAERS 1106664

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
53,0
Geschlecht
F
Eingang
02.04.2021
Impfdatum
04.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthma Chills Dehydration Dysphagia Dyspnoea Balance disorder Dysarthria Eating disorder Electric shock sensation Fatigue Gait disturbance Headache Immobile Increased upper airway secretion Lethargy Mastication disorder Musculoskeletal stiffness Myalgia

Symptomtext

difficulty swallowing,chewing and speaking; difficulty swallowing,chewing and speaking; difficulty swallowing,chewing and speaking; had a lot of mucus in my throat; difficulty breathing; asthma acting up; lethargic; dehydrated; headaches; immobility; fever; chills; muscle aches; stiffness; electrical shocks up and down my body; fatigue; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 04Mar2021 14:00 (Batch/Lot Number: EN6202), at the age of 53-years at vaccination, as SINGLE DOSE for covid-19 immunisation. Medical history included asthma, multiple sclerosis, seasonal allergies, dust, animals. The patient did not have COVID prior vaccination. The patient is not pregnant at the time of vaccination. Concomitant medication included glatiramer acetate (COPAXONE); lamotrigine (LAMICTAL); risperidone (RISPERDAL); alprazolam (XANAX); salbutamol (ALBUTEROL HFA), all taken for an unspecified indication, start and stop date were not reported. The patient previously took dilaudid and experienced allergies. On 04Mar2021 17:00, the patient got fever, chills, headaches, muscle aches and stiffness. The patient treated the symptoms with ibuprofen and ice packs. The next day, on 05Mar2021, the patient had difficulty swallowing, chewing and speaking. The patient had a lot of mucus in my throat and difficulty breathing from asthma acting up. The patient was very lethargic and dehydrated. The patient had to use inhalers, benedryl and musinex to treat symptoms. The patient had the chills, headaches, fever and aches through Tuesday, 09Mar2021. The patient touched base with her general practitioner's and neurologists' offices on March 5 & 6 and left messages. They suggested she go to the ER. (She didn't go out of fear of getting COVID), she was too fatigued and weak to walk. No balance. She had electrical shocks up and down her body. The patient was still experiencing immobility and fatigue. The outcome of the events chills, headaches, fever and aches was recovered on 09Mar2021; the other events were not recovered. The patient was not tested for COVID post vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergy to animals; Asthma; Dust allergy; Multiple sclerosis; Seasonal allergy
Andere Medikamente
COPAXONE; LAMICTAL; RISPERDAL; XANAX; ALBUTEROL HFA
Allergien
-
Vorherige Impfungen
-

VAERS 1097192

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6202

schwer
Staat
AZ
Alter
66,0
Geschlecht
F
Eingang
02.04.2021
Impfdatum
12.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Blood pressure measurement Blood test Computerised tomogram Disease recurrence Feeling hot Generalised tonic-clonic seizure Glossodynia Herpes zoster Hypersensitivity Peripheral swelling Seizure

Symptomtext

Had 2 seizures; Had 2 seizures; Tongue hurts; it was an allergic reaction; Patient reported that next the day her arm was so hot that she could have roasted a weenie over her arm and it was very swollen; Patient reported that next the day her arm was so hot; got shingles again after receiving the vaccination; got shingles again after receiving the vaccination; This is a spontaneous report from a contactable consumer (patient's husband). A 66-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot: EN6202), via an unspecified route of administration, administered in left arm on 12Mar2021 10:30 (at the age of 66-years-old) as single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The vaccination facility type was a health clinic. The vaccine was not administered at a facility. The patient had no additional administered vaccines. No prior vaccinations (within 4 weeks). Medical history included ongoing seizures from 1982 (began shortly after she had the surgery for her brain aneurysm (in 1982 to 1982). The patient had not had any seizure activity for 20 years before the seizures that occurred on 13Mar2021. Sometimes electrical activity in the brain hits the metal clamp used to treat the brain aneurysm and that triggers the seizures); migraines (suffered from migraines when she was younger but hasn't had one in umpteen years. The patient gets tension headaches like most people but not very often); shingles (patient had shingles three times. Patient's first case of shingles was in the early 1990's and that patient had recurrences in the mid 1990's and the early 2000's. The first incidence was the worst and that the second and third occurrences weren't nearly as bad as the first); blood pressure high; ongoing cholesterol; ongoing headache (tension headaches) and was adopted. Family history included migraines with grandkids, a couple of them had migraines and had MRI's she'd had a sister that was 6 years older than her that had died of a brain aneurysm. Concomitant medications included levetiracetam (KEPPRA) for seizures from an unspecified date (in the late 90's) to an unspecified date then from Mar2021 and ongoing; nadolol for headache from 2001 and ongoing; lovastatin for cholesterol from an unspecified date (been on it for a long time) and ongoing and on a low dose of medication for high blood. The patient had the Pfizer vaccine first shot on Friday (12Mar2021). The husband stated his wife (patient) had a possible side effect to the vaccine shot and was concerned with getting the second dose of Pfizer's COVID vaccine. She had 2 seizures the next morning after the shot (on 13Mar2021) which she hasn't had in 20 years. The patient experienced her first seizure about 11:00 on 13Mar2021. It took the patient about 45 minutes to come out of the first one completely, until she was conscious again. The second seizure occurred about 13:00 on 13Mar2021, about an hour and a half after the patient recovered from the first seizure. fter the second seizure, the fire department was called and she was transported to the Emergency Room. The doctor told the husband that it was up to them if they wanted to receive the second dose. The husband stated, "I know there is something out there that I heard about where you can disqualify yourself from getting the vaccine for medical reasons." Also on 13Mar2021, the patient's tongue hurts in the Emergency Room, no one was willing to give her a new tongue after she bit it. The patient's tongue was what hurt's the most, but that it was slowly healing. The patient seemed to be fine since Saturday. he patient's father was really persistent about them getting the Covid-19 vaccinations. A CT scan and blood work were performed while she was in the Emergency Room on 13Mar2021 and reported that everything was fine. The patient went to the emergency room on 13Mar2021 and physician office on 17Mar2021 as a result of the seizure activity on 13Mar2021. On 17Mar2021, the patient's blood pressure was 130/82 with blood work with result of everything was fine. The patient went to her physician on 17Mar2021 due to concern about getting the second dose of the Covid-19 vaccine. When asked about prior vaccinations within 4 weeks of the Covid-19 vaccine, the patient stated that she didn't want to get the first dose of the Covid-19 vaccine because she's never even had the flu shot. The patient stated that back in 1977 when they first came out with the flu shot, she was unable to receive the vaccine as she was pregnant and she has never gotten the flu. The patient reported that she was unable to get MRIs due to the metal clamp in her. Patient reported that the clamp in her head was metal, not surgical metal, and that she has to be very careful because getting an MRI could kill her. The patient reported that next the day (in Mar2021) her arm was so hot that she could have roasted a weenie over her arm and it was very swollen. The patient reported that she went to urgent care and was told that it was an allergic reaction. The patient also reported that she got shingles again after receiving the vaccination. The husband considered the case as non-serious. The patient recovered from seizure with associated disease recurrence on 13Mar2021; for tongue pain was recovering while for the remaining events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Generalised tonic-clonic seizure
Hospital-Tage
-
Labordaten
Test Date: 20210317; Test Name: Blood pressure; Result Unstructured Data: Test Result:130/82; Test Date: 20210313; Test Name: Blood work; Result Unstructured Data: Test Result:Everything was fine; Test Date: 20210317; Test Name: Blood work; Result Unstructured Data: Test Result:Everything was fine; Test Date: 20210313; Test Name: CT scan; Result Unstructured Data: Test Result:Everything was fine
Aktuelle Erkrankungen
Cholesterol; Headache (tension headaches); Seizures (seizures began shortly after she had the surgery for her brain aneurysm)
Vorgeschichte
Medical History/Concurrent Conditions: Adopted person; Aneurysm cerebral (had a sister that was 6 years older than her that had died of a brain aneurysm); Aneurysm cerebral (had a brain aneurysm in 1982 that was treated with a metal clamp); Blood pressure high; Intra-cerebral aneurysm operation; Migraine (suffered from migraines when she was younger but hasn't had one in umpteen years.); Migraine (grandkids, a couple of them had migraines and had MRI's); Shingles (first case of shingles was in early 1990's and had recurrences in mid 1990's and early 2000's)
Andere Medikamente
KEPPRA; NADOLOL; LOVASTATIN
Allergien
-
Vorherige Impfungen
-

VAERS 1097192

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
AZ
Alter
66,0
Geschlecht
F
Eingang
02.04.2021
Impfdatum
12.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Blood pressure measurement Blood test Computerised tomogram Disease recurrence Feeling hot Generalised tonic-clonic seizure Glossodynia Herpes zoster Hypersensitivity Peripheral swelling Seizure

Symptomtext

Had 2 seizures; Had 2 seizures; Tongue hurts; it was an allergic reaction; Patient reported that next the day her arm was so hot that she could have roasted a weenie over her arm and it was very swollen; Patient reported that next the day her arm was so hot; got shingles again after receiving the vaccination; got shingles again after receiving the vaccination; This is a spontaneous report from a contactable consumer (patient's husband). A 66-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot: EN6202), via an unspecified route of administration, administered in left arm on 12Mar2021 10:30 (at the age of 66-years-old) as single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The vaccination facility type was a health clinic. The vaccine was not administered at a facility. The patient had no additional administered vaccines. No prior vaccinations (within 4 weeks). Medical history included ongoing seizures from 1982 (began shortly after she had the surgery for her brain aneurysm (in 1982 to 1982). The patient had not had any seizure activity for 20 years before the seizures that occurred on 13Mar2021. Sometimes electrical activity in the brain hits the metal clamp used to treat the brain aneurysm and that triggers the seizures); migraines (suffered from migraines when she was younger but hasn't had one in umpteen years. The patient gets tension headaches like most people but not very often); shingles (patient had shingles three times. Patient's first case of shingles was in the early 1990's and that patient had recurrences in the mid 1990's and the early 2000's. The first incidence was the worst and that the second and third occurrences weren't nearly as bad as the first); blood pressure high; ongoing cholesterol; ongoing headache (tension headaches) and was adopted. Family history included migraines with grandkids, a couple of them had migraines and had MRI's she'd had a sister that was 6 years older than her that had died of a brain aneurysm. Concomitant medications included levetiracetam (KEPPRA) for seizures from an unspecified date (in the late 90's) to an unspecified date then from Mar2021 and ongoing; nadolol for headache from 2001 and ongoing; lovastatin for cholesterol from an unspecified date (been on it for a long time) and ongoing and on a low dose of medication for high blood. The patient had the Pfizer vaccine first shot on Friday (12Mar2021). The husband stated his wife (patient) had a possible side effect to the vaccine shot and was concerned with getting the second dose of Pfizer's COVID vaccine. She had 2 seizures the next morning after the shot (on 13Mar2021) which she hasn't had in 20 years. The patient experienced her first seizure about 11:00 on 13Mar2021. It took the patient about 45 minutes to come out of the first one completely, until she was conscious again. The second seizure occurred about 13:00 on 13Mar2021, about an hour and a half after the patient recovered from the first seizure. fter the second seizure, the fire department was called and she was transported to the Emergency Room. The doctor told the husband that it was up to them if they wanted to receive the second dose. The husband stated, "I know there is something out there that I heard about where you can disqualify yourself from getting the vaccine for medical reasons." Also on 13Mar2021, the patient's tongue hurts in the Emergency Room, no one was willing to give her a new tongue after she bit it. The patient's tongue was what hurt's the most, but that it was slowly healing. The patient seemed to be fine since Saturday. he patient's father was really persistent about them getting the Covid-19 vaccinations. A CT scan and blood work were performed while she was in the Emergency Room on 13Mar2021 and reported that everything was fine. The patient went to the emergency room on 13Mar2021 and physician office on 17Mar2021 as a result of the seizure activity on 13Mar2021. On 17Mar2021, the patient's blood pressure was 130/82 with blood work with result of everything was fine. The patient went to her physician on 17Mar2021 due to concern about getting the second dose of the Covid-19 vaccine. When asked about prior vaccinations within 4 weeks of the Covid-19 vaccine, the patient stated that she didn't want to get the first dose of the Covid-19 vaccine because she's never even had the flu shot. The patient stated that back in 1977 when they first came out with the flu shot, she was unable to receive the vaccine as she was pregnant and she has never gotten the flu. The patient reported that she was unable to get MRIs due to the metal clamp in her. Patient reported that the clamp in her head was metal, not surgical metal, and that she has to be very careful because getting an MRI could kill her. The patient reported that next the day (in Mar2021) her arm was so hot that she could have roasted a weenie over her arm and it was very swollen. The patient reported that she went to urgent care and was told that it was an allergic reaction. The patient also reported that she got shingles again after receiving the vaccination. The husband considered the case as non-serious. The patient recovered from seizure with associated disease recurrence on 13Mar2021; for tongue pain was recovering while for the remaining events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Generalised tonic-clonic seizure
Hospital-Tage
-
Labordaten
Test Date: 20210317; Test Name: Blood pressure; Result Unstructured Data: Test Result:130/82; Test Date: 20210313; Test Name: Blood work; Result Unstructured Data: Test Result:Everything was fine; Test Date: 20210317; Test Name: Blood work; Result Unstructured Data: Test Result:Everything was fine; Test Date: 20210313; Test Name: CT scan; Result Unstructured Data: Test Result:Everything was fine
Aktuelle Erkrankungen
Cholesterol; Headache (tension headaches); Seizures (seizures began shortly after she had the surgery for her brain aneurysm)
Vorgeschichte
Medical History/Concurrent Conditions: Adopted person; Aneurysm cerebral (had a sister that was 6 years older than her that had died of a brain aneurysm); Aneurysm cerebral (had a brain aneurysm in 1982 that was treated with a metal clamp); Blood pressure high; Intra-cerebral aneurysm operation; Migraine (suffered from migraines when she was younger but hasn't had one in umpteen years.); Migraine (grandkids, a couple of them had migraines and had MRI's); Shingles (first case of shingles was in early 1990's and had recurrences in mid 1990's and early 2000's)
Andere Medikamente
KEPPRA; NADOLOL; LOVASTATIN
Allergien
-
Vorherige Impfungen
-

VAERS 1154074

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
57,0
Geschlecht
M
Eingang
01.04.2021
Impfdatum
25.02.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Arthralgia Chills Gait inability Pain in extremity Thrombosis

Symptomtext

Blood clot/very large blood clot from his thigh to his calf; Joint pain; chills; he can't even walk now; leg pain; This is a spontaneous report received from a contactable consumer (patient's wife). A 57-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EN6202), via an unspecified route of administration, on 25Feb2021 (at the age of 57-years-old), at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The consumer stated she's asking on behalf of her husband. He received his first dose of Pfizer-BioNTech COVID-19 Vaccine on 25Feb2021 and had Joint pain and chills after that (on unspecified date in 2021) he was diagnosed with Blood clot (unspecified date in 2021); she stated he had no history of similar health issues and wanted to know if it could be directly linked to this vaccine. The wife further reported that it's dramatically changing his life, he can't even walk now. He had the Covid vaccine on 25Feb2021 and he has no history of blood clots. He developed a leg pain (on unspecified date in 2021) which was odd and they thought that maybe it was some arthritis or something like that. They went to the orthopedist and he was being treated for what the orthopedist thought was a bakers cyst. But then they discovered it was a very large blood clot from his thigh to his calf. They would like to know about this. They have been looking into what he had experienced, and it seems very unusual. It just seems too coincidental that this happened after the Covid vaccine. The emergency room doctor of course shut them down immediately and said that the Covid vaccine never would have done this. But the patient's doctor yesterday said that there are too many unknowns to say for sure that the Covid vaccine didn't cause this. She is not saying that they are against the Covid vaccine, but they are concerned. The patient is on blood thinners now and they just need to know if there is a possible correlation. She had heard on the world news that there is a connection after receiving the (company name) Covid vaccine and now they are shutting this vaccine down in (region name). She saw on the news last night they were asking if there is a correlation with the Pfizer and (company name) Covid vaccines and this. It is very concerning. They have been trying to do research and there is nothing that you can find. The only thing that they did see online was about the doctor that died of a blood disorder in (state name), he had thrombocytopenia. The patient is going to be sent to see a vein doctor. She stated that he has a lot of things ahead of him and he is too young to be dealing with all of this. They are going to be following up with the vein doctor and she would like to have this information when the vein doctor calls later today. The reported adverse events resulted to an emergency room and physician office visit (went to the orthopedist). The patient received corrective treatment as response to the reported events. Outcome of the events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1151616

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
KY
Alter
32,0
Geschlecht
F
Eingang
31.03.2021
Impfdatum
12.03.2021
Beginn
15.03.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Balance disorder Chest discomfort Facial pain Fatigue Gait disturbance Headache Insomnia Joint swelling Lymphadenopathy Muscle swelling Pain Pain in extremity Periorbital pain Pyrexia Skin discolouration Syncope Tinnitus Vertigo

Symptomtext

I didn?t have many side effects in my arm right after the shot other than it being really sore for about 20 min after leaving while I was on the way home. Other than that, it just felt like I had a bruise at the injection sight. I ran a slight fever of 99.4 on and off for the first few days but felt okay. No longer have a fever (but hard to tell because I?m taking Tylenol around the clock) but symptoms have progressed since the first few days and not getting better. Now for the bad... I?ve experienced tightness in the middle of my chest randomly, extreme fatigue, feet turning more blue/purple than the usual, sleeplessness, and headaches that are in the middle front part of my head (don?t experience these types of headaches. Usually I get more of a pressure headache to the left side of my head). I?m having random shooting pain under my eyes where the eye socket/cheekbones are (not usually correlating with my headaches). Started with the left side and now both get random shooting pains. I?ve never felt the pain under my eyes before until I got the vaccine. Random falling/rising stars (usually falling stars indicates a migraine) just happening more often than normal. My lymph nodes in my neck where my throat is, have been swollen on both sides worse on my left side (similar to how they react with strep). My joints and muscles have been worse than ever and swollen all over. Already had issues with my knees but now can hardly walk up and down stairs. I?ve also had ringing in my ears that can sometimes be intense. Vertigo and randomly feel like falling over. Collapsed on stairs a week after vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Common cold
Vorgeschichte
Autoimmune, endometriosis, diverticulosis
Andere Medikamente
Adderall
Allergien
Ciprofloxacin, ceclor, iodine, shellfish, eggs, ibuprofen, latex
Vorherige Impfungen
-

VAERS 1148771

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
PA
Alter
-
Geschlecht
M
Eingang
31.03.2021
Impfdatum
25.02.2021
Beginn
01.03.2021
Tage bis Beginn
4,0
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Blood creatinine Blood glucose Full blood count Guillain-Barre syndrome Haemoglobin Metabolic function test Paraesthesia

Symptomtext

ascending bilateral symmetrical paresthesias in the legs to upper thighs and fingers of both hands; slight weakness; Guillain-Barre Syndrome; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6202, expiration date: unknown), via an unspecified route of administration in right arm on 25Feb2021 at 15:30 as single dose for COVID-19 immunization. The patient's medical history included hypertension, type 2 diabetes, and cardiac issues. Concomitant medication included dulaglutide (TRULICITY); metoprolol fumarate; alopurinol; atorvastatin calcium (LIPITOR ORIFARM); acetylsalicylic acid, ascorbic acid (ASPIRIN [ACETYLSALICYLIC ACID;ASCORBIC ACID]); vitamin d3; bifidobacterium lactis (PROBIOTIC [BIFIDOBACTERIUM LACTIS]), all ongoing for unspecified indication. The patient previously took Flu vaccine on an unspecified date for immunization. In Mar2021 (reported as after several days), the patient developed ascending bilateral symmetrical paresthesias in the legs to upper thighs and fingers of both hands peaking at 7-8 days and now slightly improving but persistent and associated with slight weakness suggesting Guillain-Barre Syndrome. The patient underwent lab tests and procedures which included blood creatinine: 1.19 (slightly elevated), blood sugar 140-160, complete blood count (CBC): good, haemoglobin: 7.6 (out of range), metabolic function test: all good on 13Mar2021. The patient did not received treatment for the events. The outcome of the events was recovering.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of event Guillain-Barre syndrome cannot be excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
-
Labordaten
Test Date: 20210313; Test Name: creatinine; Result Unstructured Data: Test Result:1.19; Comments: slightly elevated; Test Date: 20210313; Test Name: Blood Sugar; Result Unstructured Data: Test Result:140-160; Test Date: 20210313; Test Name: CBC; Result Unstructured Data: Test Result:good; Test Date: 20210313; Test Name: hemoglobin; Result Unstructured Data: Test Result:7.6; Comments: 7.6 out of range; Test Date: 20210313; Test Name: CMP; Result Unstructured Data: Test Result:all good
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Cardiac disorder; Gastrointestinal disorder; Hypertension; Type 2 diabetes mellitus
Andere Medikamente
TRULICITY; METOPROLOL [METOPROLOL FUMARATE]; ALOPURINOL; LIPITOR ORIFARM; ASPIRIN [ACETYLSALICYLIC ACID;ASCORBIC ACID]; VITAMIN D3; PROBIOTIC [BIFIDOBACTERIUM LACTIS]
Allergien
-
Vorherige Impfungen
-

VAERS 1091885

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6202

schwer
Staat
OH
Alter
69,0
Geschlecht
M
Eingang
31.03.2021
Impfdatum
26.02.2021
Beginn
27.02.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bell's palsy Facial paresis

Symptomtext

Facial Muscle Weakness; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN 6202) via an unspecified route of administration administered in left arm on 26Feb2021 17:45 as single dose for COVID-19 immunisation. The patient had known allergies to NSAIDS. There was no other medical history. The patient's concomitant medications were not reported. It reported that there were other medications in two weeks. No COVID prior vaccination. No COVID tested post vaccination. The patient did not other vaccine in four weeks. The patient experienced facial muscle weakness on 27Feb2021 18:00. The patient did not receive treatment for event. The outcome of event was not recovered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1091885

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
69,0
Geschlecht
M
Eingang
31.03.2021
Impfdatum
26.02.2021
Beginn
27.02.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bell's palsy Facial paresis

Symptomtext

Facial Muscle Weakness; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN 6202) via an unspecified route of administration administered in left arm on 26Feb2021 17:45 as single dose for COVID-19 immunisation. The patient had known allergies to NSAIDS. There was no other medical history. The patient's concomitant medications were not reported. It reported that there were other medications in two weeks. No COVID prior vaccination. No COVID tested post vaccination. The patient did not other vaccine in four weeks. The patient experienced facial muscle weakness on 27Feb2021 18:00. The patient did not receive treatment for event. The outcome of event was not recovered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1148462

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MD
Alter
36,0
Geschlecht
M
Eingang
30.03.2021
Impfdatum
17.03.2021
Beginn
18.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein
Agitation Blood culture negative Computerised tomogram head normal Condition aggravated Confusional state Epilepsy Impaired self-care Loss of personal independence in daily activities Pyrexia Seizure

Symptomtext

The day after the 2nd dose of COVID19 vaccination series this person had a seizure while at work. EMS was called and he had another seizure for them before they could transport him to the hospital. He also had a fever38.6. The individual was admitted and overnight became increasingly agitated and confused. Family reports that that after discharge from the hospital he has not returned to his normal functioning. Prior to this episode he was living alone and working. Now he cannot be left alone as his neurological status has quite deteriorated . He has had a ?substantial disruption of the ability to conduct normal life functions? Family have had to take time off of work and make arrangements to care for him.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
4,0
Labordaten
CT head on admission was negative for any acute intracranial process. Normal routine lab work on admission to hospital. Blood culture were negative.
Aktuelle Erkrankungen
-
Vorgeschichte
Past medical history of epilepsy and mental disability
Andere Medikamente
Depakote, Keppra
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1135566

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OK
Alter
54,0
Geschlecht
F
Eingang
25.03.2021
Impfdatum
05.03.2021
Beginn
06.03.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Asthenia Chest pain Chills Cough Delirium Fatigue Feeding disorder Feeling abnormal Hangover Headache Hypersomnia Impaired driving ability Lethargy Malaise Nausea Presyncope Vaccination site pain

Symptomtext

delirous as if I was hungover; delirous as if I was hungover; felt on the brink of fainting; chills; joint pain; pain at the injection site; lethargic; dry cough; severely nauseous; could not eat; serious fogginess; General malaise; fatigued; a debilitating headache; did not feel comfortable driving; weak; hurt in my chest; slept the whole day; This is a spontaneous report from a contactable consumer. A 54-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, administered in the left arm on 05Mar2021 at 13:30 (Batch/Lot Number: EN6202) at 54-years-old as a single dose for COVID-19 immunization; administered in a hospital. The patient did not receive any other vaccine within four weeks of the suspect vaccine. Medical history included hypertension, and acne from an unknown date and unknown if ongoing. The patient did not have COVID prior to the vaccination. Concomitant medications included hydrochlorothiazide, olmesartan medoxomil (MANUFACTURER UNKNOWN) taken for an unspecified indication, start and stop date were not reported; isotretinoin (MANUFACTURER UNKNOWN) taken for an unspecified indication, start and stop date were not reported. The patient previously took (ceftriaxone sodium) ANCEF, start and stop date were not reported, and experienced drug allergy. On 06Mar2021 at 04:00 (as reported), the patient experienced: delirious as if i was hungover (medically significant), felt on the brink of fainting (non-serious), chills (non-serious), joint pain (non-serious), pain at the injection site (non-serious), lethargic (non-serious), dry cough (non-serious), severely nauseous (non-serious), could not eat (non-serious), serious fogginess (non-serious), general malaise (non-serious), fatigued (non-serious), a debilitating headache (non-serious), did not feel comfortable driving (non-serious), weak (non-serious), hurt in my chest (non-serious), slept the whole day (non-serious); with no treatment received. The clinical course was reported as follows: The patient reported that on the first night (as reported) she had chills, joint pain and pain at the injection site. The next day (as reported) she was lethargic and was severely nauseous to the extent she could not eat. The patient also experienced serious fogginess, felt delirious as if she was hungover. The patient felt general malaise and a debilitating headache all day. The patient was fatigued to the extent she did not feel comfortable driving. The patient was so weak, that she felt on the brink of fainting. That evening, the patient slept the whole night through, except when she would awake with a dry cough that hurt in her chest. This cough was not as persistent and intense but was lasting even now. The patient slept the whole day and was just now beginning to feel as if she had recuperated from the vaccine four days later. The clinical outcome of the events was recovered with sequelae on an unspecified date (also reported as "recovered with lasting effects"). The patient was not tested for COVID post vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Acne; Hypertension
Andere Medikamente
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE; ISOTRETINOIN
Allergien
-
Vorherige Impfungen
-

VAERS 1133027

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
60,0
Geschlecht
M
Eingang
25.03.2021
Impfdatum
03.03.2021
Beginn
04.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Asthenia Bell's palsy Discomfort Feeling abnormal Foreign body sensation in eyes Lacrimation increased

Symptomtext

ER Doctor said I have Bell's Palsy. Left side facial paralysis.; I started feeling funny; I started feeling funny and weak; Eye is watering, feels like there is grit in there; Eye is watering, feels like there is grit; Uncomfortable.; This is a spontaneous report from a contactable consumer, the patient. A 60-years-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Batch/Lot Number: EN6202), via an unspecified route of administration, administered in Arm Left on 03Mar2021 at 12:15 (at the age of 60 years old) as SINGLE DOSE for covid-19 immunisation. Historical Vaccine includes BNT162b2 Dose 1, 10Feb2021 at 14:00 , Lot number=EL9263 in Left arm Medical history included diabetes mellitus. There were no concomitant medications. The patient has no known allergies. No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19 Facility where the most recent COVID-19 vaccine was administered was a Hospital. On 04Mar2021 at 13:15, The patient experienced Bell's palsy. left side facial paralysis (medically significant), started feeling funny and weak, eye is watering, feels like there is grit and uncomfortable. The adverse events resulted in an Emergency Room Visit. Treatment was given for the events. The clinical course is as follows the day after I went to the (Withheld). Patient started feeling funny and weak. Since he was close to a local Hospital Emergency room. ER Doctor said 'I have Bell's Palsy. Left side facial paralysis'. He prescribed prednisone. Have to wear eye patch on left eye. Eye wont close. Can't eat or drink on left side. I was told by my primary care doctor that this could last up to 6 months. And that 85 percent of cases clear up. Eye is watering, feels like there is grit in there. Uncomfortable. Treatment (Prednisone therapy) was given for the events. The clinical outcome of the events Bell's palsy. left side facial paralysis, started feeling funny and weak, eye is watering, feels like there is grit and uncomfortable was not recovered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Diabetes
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1133022

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
28,0
Geschlecht
F
Eingang
25.03.2021
Impfdatum
05.03.2021
Beginn
08.03.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Gait disturbance Generalised tonic-clonic seizure Malaise Nausea Slow speech

Symptomtext

Generalized Tonic-Clonic Seizure; feeling unwell; slightly nauseous; still a little slow in speech and gait; still a little slow in speech and gait; This is a spontaneous report from a contactable consumer (patient). A 28-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6202), via an unspecified route of administration, administered in arm right on 05Mar2021 08:00 as a single dose (at the age of 28-years-old) for Covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included epilepsy, hypopituitarism, central diabetes insipidus, neoplasm of brain, irregular menses, short-term memory loss, elevated LDL, and myopia w/ astigmatism. The patient had known allergies to surgical tape and contrast dyes. Concomitant medications included desmopressin acetate (DDAVP), lamotrigine (LAMICTAL), levetiracetam, and zonisamide; all were taken for an unspecified indication, start and stop date were not reported. The patient previously took amoxicillin and experienced drug allergy. On 08Mar2021 at 06:15 PM, the patient experienced generalized tonic-clonic seizure, feeling unwell, slightly nauseous, still a little slow in speech and gait. Therapeutic measures were taken as a result of generalized tonic-clonic seizure, feeling unwell, slightly nauseous, still a little slow in speech and gait as Nayzilam 5 mg two doses was administered. Clinical course details as reported: the patient finished dinner and evening medications before 6 pm and started feeling unwell and slightly nauseous soon after. Laid on sofa, started to sit up at 6:20 pm, and went into a Generalized Tonic-Clonic Seizure. The patient's father administered Nayzilam 5 mg (2 doses); seizure ended and the patient went into a deep sleep until 8:00 pm. The patient was largely recovered, but still a little slow in speech and gait. The outcome of the events was recovering as reported. Information on the lot/batch number has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Generalised tonic-clonic seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Adhesive tape allergy (Known allergies: Surgical tape); Astigmatism (Myopia w/Astigmatism); Central diabetes insipidus; Contrast media allergy (Known allergies: Contrast Dye); Epilepsy; Hypopituitarism; Irregular menstruation (Irregular Menses); LDL raised (Elevated LDL); Myopia (Myopia w/Astigmatism); Neoplasm (Neoplasm of brain); Short-term memory loss
Andere Medikamente
DDAVP; LAMICTAL; LEVETIRACETAM; ZONISAMIDE
Allergien
-
Vorherige Impfungen
-

VAERS 1132488

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
KY
Alter
37,0
Geschlecht
M
Eingang
25.03.2021
Impfdatum
12.03.2021
Beginn
12.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Dyspnoea Feeling abnormal Heart rate Heart rate irregular Loss of consciousness Palpitations Vertigo

Symptomtext

struggling to catch my breath; swinging from 120+ BPM to 50 BPM in an instant; pass out; racing heart; big rush of the room spinning; I could feel the medicine in my body, almost to my toes; This is a spontaneous report from a contactable consumer. A 37-year-old male patient received the first dose of BNT162B2 (Pfizer-BIONTECH COVID-19 Vaccine; lot number: EL9267) on 26Feb2021 and the second dose of BNT162B2 (Pfizer-BIONTECH COVID-19 Vaccine; lot number: EN6202) on 12Mar2021, via an unspecified route of administration on Left Arm at single dose for COVID-19 immunisation. The administration of first dose of BNT162B2 resulted in Palpitations, dizziness, hyperhidrosis and Syncope the same day of administration. Relevant medical history included allergy to penicillin. Relevant concomitant medications included testosterone cipionate (TESTOSTERONE CYPIONATE). During second dose of vaccine the patient stated that he feels the medicine in his body, almost to his toes. The patient was fine for a minute or two but then he reported a big rush of the room spinning, struggling to catch my breath, racing heart. EMS personnel was called over and they monitored my heart rate. It was swinging from 120+ BPM to 50 BPM in an instant and during the low BPM was when he passed out. The patient was treated with Epinephrine due a potential reaction and transported to hospital. The reported events were feeling abnormal, vertigo, dyspnoea, palpitations, heart rate irregular and loss of consciousness. All events were serious as hospitalization and Life-threatening illness (immediate risk of death from the event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
1,0
Labordaten
Test Date: 20210312; Test Name: BPM; Result Unstructured Data: Test Result:120+ BPM to 50 BPM; Comments: It was swinging from 120+ BPM to 50 BPM
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Penicillin allergy
Andere Medikamente
TESTOSTERONE CYPIONATE
Allergien
-
Vorherige Impfungen
-

VAERS 1088869

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
43,0
Geschlecht
M
Eingang
25.03.2021
Impfdatum
02.03.2021
Beginn
05.03.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Blood test normal Computerised tomogram head Facial paralysis Full blood count normal Blood test Computerised tomogram Headache Metabolic function test

Symptomtext

experiencing facial paralysis in lips which progressed to the rest of right side of face; Bell's Palsy; Headache in right back portion of head; This is a spontaneous report from a contactable consumer (the patient). A 43-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot #: EN6202) via an unspecified route of administration, in the right arm on 02Mar2021 at 14:30 PM (at the age of 43 years). Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included hydrochlorothiazid. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took ibuprofen and experienced hypersensitivity. It was reported that the patient experienced headache in right back portion of head which started in PM on 05Mar2021. On 07Mar2021 the patient began experiencing facial paralysis in lips which progressed to the rest of right side of face. The patient went to the hospital emergency department. Bloodwork was normal. Computerized tomogram (CT) scan was noted as "unremarkable". He was diagnosed with Bell's Palsy and prescribed Valtrex and Prednisone. On 10Mar2021 he was still experiencing facial paralysis and headache. The clinical outcome of the events was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
Test Date: 20210307; Test Name: Bloodwork; Result Unstructured Data: Test Result:normal; Test Date: 20210307; Test Name: CT Scan; Result Unstructured Data: Test Result:unremarkable. Was diagnosed with Bell's Palsy
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Blood pressure increased
Andere Medikamente
HYDROCHLOROTHIAZID
Allergien
-
Vorherige Impfungen
-

VAERS 1088869

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6202

schwer
Staat
NY
Alter
43,0
Geschlecht
M
Eingang
25.03.2021
Impfdatum
02.03.2021
Beginn
05.03.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Blood test normal Computerised tomogram head Facial paralysis Full blood count normal Blood test Computerised tomogram Headache Metabolic function test

Symptomtext

experiencing facial paralysis in lips which progressed to the rest of right side of face; Bell's Palsy; Headache in right back portion of head; This is a spontaneous report from a contactable consumer (the patient). A 43-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot #: EN6202) via an unspecified route of administration, in the right arm on 02Mar2021 at 14:30 PM (at the age of 43 years). Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included hydrochlorothiazid. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took ibuprofen and experienced hypersensitivity. It was reported that the patient experienced headache in right back portion of head which started in PM on 05Mar2021. On 07Mar2021 the patient began experiencing facial paralysis in lips which progressed to the rest of right side of face. The patient went to the hospital emergency department. Bloodwork was normal. Computerized tomogram (CT) scan was noted as "unremarkable". He was diagnosed with Bell's Palsy and prescribed Valtrex and Prednisone. On 10Mar2021 he was still experiencing facial paralysis and headache. The clinical outcome of the events was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
Test Date: 20210307; Test Name: Bloodwork; Result Unstructured Data: Test Result:normal; Test Date: 20210307; Test Name: CT Scan; Result Unstructured Data: Test Result:unremarkable. Was diagnosed with Bell's Palsy
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Blood pressure increased
Andere Medikamente
HYDROCHLOROTHIAZID
Allergien
-
Vorherige Impfungen
-

VAERS 1125591

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
46,0
Geschlecht
M
Eingang
23.03.2021
Impfdatum
05.03.2021
Beginn
06.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Fall Loss of consciousness Pain in extremity

Symptomtext

Lost consciousness; fell face first onto floor; Arm pain; Chills shivering; This is a spontaneous report from a contactable other health professional (patient). A 46-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EN6202), via an unspecified route of administration, administered in right arm on 05Mar2021 08:45 as single dose for COVID-19 immunization at a hospital. The patient has no medical history. Concomitant medications were not reported. Patient has no known allergies. The patient previously received the first dose of bnt162b2 (lot number: EL9264) on 12Feb2021 14:30 (2:30 pm) for COVID-19 immunization. The patient did not received other vaccines in four weeks. No COVID-19 test post vaccination was done. On 06Mar2021 at 13:45 (1:45 pm), the patient lost consciousness and fell face first onto floor. The patient also experienced arm pain and chills shivering. No treatment was received. The event required doctor's office visit. The outcome of the events was recovering.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1294885

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
-
Alter
70,0
Geschlecht
M
Eingang
22.03.2021
Impfdatum
09.03.2021
Beginn
19.03.2021
Tage bis Beginn
10,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 Hypoxia Intensive care Pneumonia Pulmonary imaging procedure abnormal SARS-CoV-2 test positive

Symptomtext

hospital admission for COVID-19 Narrative: Patient received first Pfizer COVID-19 vaccine on 3/9/21, admitted to Medical Center on 3/19/21 with severe COVID-19, diagnosed by positive PCR assay (COVID-19 Fluvid, cycle threshold 19.2), and clinical syndrome with hypoxia, multifocal pneumonia. Patient required HFNC and was admitted to MICU for additional care, currently remains in MICU and receiving dexamethasone, remdesivir, and one dose of tociluzimab.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
-
Labordaten
Positive SARS CoV-2 PCR assay (Fluvid), cycle threshold 19.2 Multifocal pneumonia on cross-sectional imaging
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1124472

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
48,0
Geschlecht
F
Eingang
22.03.2021
Impfdatum
22.03.2021
Beginn
22.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Loss of consciousness

Symptomtext

After the patient received the Pfizer vaccine, she began to complain being dizzy. We gave her water, but afterwards, she began to lose conscious. We gave her 1 epinephrine (0.3 mg) dose, injected into her thigh. Thirty minutes later, the patient regained consciousness and was able to stand up and walk.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
-
Allergien
None
Vorherige Impfungen
-

VAERS 1122198

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
AZ
Alter
77,0
Geschlecht
F
Eingang
22.03.2021
Impfdatum
11.03.2021
Beginn
11.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Condition aggravated Confusional state Dementia Disorientation Dysarthria Headache NIH stroke scale Vision blurred

Symptomtext

Slurred speech, extreme confusion and disorientation, headache, blurred vision. Symptoms of mild Demetia increased to meditate to severe dementia in a matter of hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
NIH stroke scale
Hospital-Tage
-
Labordaten
Stroke assessment. Preliminary tests performed by nurse were negative for stroke
Aktuelle Erkrankungen
Type 2 Diabetes Mild Dementia Stroke- Dec 2019 Depression
Vorgeschichte
Type 2 Diabetes Mild Demetia Stroke: Dec 2019
Andere Medikamente
Clopidegrel Atorvastatin Prorenal Plus Kidney Vitamins Eacitalapram Glipizide Badaglar Ceylon Cinnamon Tablets Vitamin D tablets
Allergien
N/A
Vorherige Impfungen
-

VAERS 1122004

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
76,0
Geschlecht
F
Eingang
22.03.2021
Impfdatum
25.02.2021
Beginn
09.03.2021
Tage bis Beginn
12,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain Decreased appetite Diarrhoea Dyspnoea Fatigue Intensive care Nasal congestion Nausea Pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Visited PCP on 3/8/21 with reports of nausea, fatigue, and anorexia following COVID-19 vaccine. Reports body aches, nausea without vomiting, abdominal pain, diarrhea, runny/stuffy nose. Presented to ED on 3/9/21 and reported shortness of breath started 2/28/21. Had COVID positive contact on 2/24. Required supplemental oxygen on presentation. Admitted to ICU on 3/14/21 until present.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
13,0
Labordaten
COVID-19 test positive on 3/9/21
Aktuelle Erkrankungen
None known
Vorgeschichte
Type 2 diabetes, hypertension, hyperlipidemia, osteoarthritis
Andere Medikamente
Tylenol, aspirin, atorvastatin, clopidogrel, empagliflozin, exenatide ER, ezetimibe, furosemide, glipizide CR, hydrochlorothiazide, losartan, metformin, certavite, potassium chloride.
Allergien
Metoprolol (nausea), metformin (diarrhea)
Vorherige Impfungen
-

VAERS 2191681

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
-
Geschlecht
F
Eingang
21.03.2021
Impfdatum
05.03.2021
Beginn
13.03.2021
Tage bis Beginn
8,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein
Bell's palsy Computerised tomogram Electrocardiogram Facial paresis Full blood count

Symptomtext

Lt side facial weakness (Bell's Palsy) -

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
CT CBC EKG all done on ER Visit ? 3/13/21
Aktuelle Erkrankungen
HTN
Vorgeschichte
HTN
Andere Medikamente
Norvasc HTCR Zoloft Synthroid
Allergien
Augmentin Bactrim
Vorherige Impfungen
-

VAERS 1120935

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
51,0
Geschlecht
M
Eingang
21.03.2021
Impfdatum
01.03.2021
Beginn
01.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cold sweat Dizziness Fall Feeling hot Headache Hyperhidrosis Loss of consciousness Skin laceration

Symptomtext

About 10 minutes after the shot I started feeling hot, started sweating, clammy hands, dizzy and then I passed out walking to get help. I hit my head on a chair when I was falling and cut my head. I stayed laying down because I was still dizzy and hot. They called the squad and did vitals and I was fine. I sat there for about another half an hour and I went home. I have felt fine ever since. Only thing that hurt was my head from the fall.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
Squad check for my vitals everything came back fine.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1116877

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
WY
Alter
65,0
Geschlecht
F
Eingang
19.03.2021
Impfdatum
01.03.2021
Beginn
02.03.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Bell's palsy

Symptomtext

The patient called the pharmacy reporting that she developed Bells Palsy shortly after receiving her first COVID-19 Pfizer BioNTech vaccine. She did report that she had some dental procedure within the same time frame and was not sure if the vaccine or her dental work that caused her symptoms. She did tell me that her symptoms were on the same side as her dental work and that her symptoms resolved within 2 days, but her physician did tell her it was Bells Palsy. She called our pharmacy as she is supposed to receive her second COVID vaccine tomorrow and was not sure if she should still get it still with this reaction. I informed her that the vaccine was unlikely to be the cause of her Bells Palsy symptoms and that she is still indicated as an individual who should receive the second vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1116853

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
61,0
Geschlecht
F
Eingang
19.03.2021
Impfdatum
26.02.2021
Beginn
10.03.2021
Tage bis Beginn
12,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Aptyalism Bell's palsy Eyelid function disorder Facial paralysis Mastication disorder Reduced facial expression

Symptomtext

Bell's Palsy, right side. Onset 3/10/21. Facial palsy impairing eating/drinking/speaking/blinking/eye closure unable/facial expression droop/unilateral lack of facial movement or facial expression. Reduced salivation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
R/0 other weakness/cognitive impairments. 3/10/21 and 3/11/21
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Multivitamin-mineral supplement
Allergien
Bee venom
Vorherige Impfungen
-

VAERS 1116724

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OR
Alter
25,0
Geschlecht
F
Eingang
19.03.2021
Impfdatum
14.03.2021
Beginn
14.03.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Presyncope Vomiting

Symptomtext

Pt experienced a vasovagal episode and emesis x1 post-vaccination at 11:30 AM. BP manually measured at 128/78, pulse ~100, O2 sat 100%. Pt instructed to recline to the supine position and episode self resolved without further sequelae.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
Not reported
Aktuelle Erkrankungen
Not reported
Vorgeschichte
Chronic back pain, Bipolar 2 disorder, ADD, Asthma, Iron deficiency, OCD, PTSD
Andere Medikamente
Not reported
Allergien
Imitrex, Latex, Methadone, Sumatriptan
Vorherige Impfungen
-

VAERS 1115730

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
IL
Alter
79,0
Geschlecht
M
Eingang
19.03.2021
Impfdatum
03.03.2021
Beginn
12.03.2021
Tage bis Beginn
9,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Computerised tomogram head Generalised tonic-clonic seizure Postictal state Urine analysis X-ray

Symptomtext

Patient experienced a witnessed tonic clonic seizure on 3/12 /21 at 5:30am. Seizure lasted for 3 minutes. He was post-ictal for approximately 15-20 minutes afterwards. No prior history of seizure. He was taken for further evaluation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Generalised tonic-clonic seizure
Hospital-Tage
-
Labordaten
He had a negative CT brain, chest x ray, and urine studies done on 3/12/21
Aktuelle Erkrankungen
none
Vorgeschichte
Hyperlipidemia, thoracic aortic aneurysm, aortic valve replacement
Andere Medikamente
Simvastatin 40mg qd, Toprol XL 50mg qd, Aspirin 81mg qd
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1114946

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
38,0
Geschlecht
F
Eingang
19.03.2021
Impfdatum
26.02.2021
Beginn
27.02.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Blood test Chills Computerised tomogram Electrocardiogram Fall Headache Pain Pyrexia Syncope Urine analysis

Symptomtext

Episode of Syncope which caused a fall; Episode of Syncope which caused a fall; Headache; Chills; Fever; Body Aches; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6202), via an unspecified route of administration, administered in the left arm on 26Feb2021 at a single dose (at the age of 38-years-old) for Covid-19 immunisation in a workplace clinic. Medical history included allergies, migraines, low vitamin D and penicillin. Concomitant medication included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported. The patient previously took Bactrum and doxycycline and experienced allergies. The patient was not pregnant at time of vaccination. The patient took the first dose of BNT162B2 on 05Feb2021 10:30 in the left arm at the age of 38-years-old for Covid-19 immunisation. No other vaccine was received in four weeks. The patient did not have COVID prior to vaccination. On 27Feb2021 at 02:30 AM, the patient experienced headache, chills, fever, body aches and an episode of syncope which caused a fall. The events resulted in emergency room/department or urgent care. The patient had a CatScan, EKG, IV medications, blood and urine test. The patient was not tested for COVID post vaccination. The patient recovered from the events on an unspecified date.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
Test Name: Blood and urine test; Result Unstructured Data: Test Result:Unknown results; Test Name: CatScan; Result Unstructured Data: Test Result:Unknown results; Test Name: EKG; Result Unstructured Data: Test Result:Unknown results; Test Name: Blood and urine test; Result Unstructured Data: Test Result:Unknown results
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergy; Migraine; Penicillin allergy; Vitamin D low
Andere Medikamente
ZYRTEC [CETIRIZINE HYDROCHLORIDE]
Allergien
-
Vorherige Impfungen
-

VAERS 1113924

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
AZ
Alter
71,0
Geschlecht
F
Eingang
19.03.2021
Impfdatum
28.02.2021
Beginn
01.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bell's palsy

Symptomtext

Bell's palsy left side of face; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6202) at the age of 71-years-old, intramuscular on left arm on 28Feb2021 at 13:30 at single dose for COVID-19 immunization. Medical history included asthma, allergies, blood cholesterol abnormal (reported as cholesterol), and allergies to penicillin which were all ongoing. The patient was not pregnant. She has no COVID prior to vaccination and has no prior vaccination and other vaccines in four weeks. Ongoing concomitant medications included zileuton (ZYFLO CR) and budesonide, formoterol fumarate (SYMBICORT) for asthma; levocetirizine and azelastine hydrochloride, fluticasone propionate (DYMISTA) for allergies; immunoglobulin human normal (HIZENTRA); and atorvastatin (LIPITOR) for cholesterol. The patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9264) at the age of 71-years-old, intramuscular on left arm on 02Feb2021 at 14:30 at single dose for COVID-19 immunization. The patient previously took aspirin and experienced allergy. The allergy was reported to be ongoing. The facility type where the vaccine was administered as reported to be other and mega-site. The patient experienced Bell's palsy left side of face on 01Mar2021 which required physician office visit. The patient was not tested for COVID post vaccination. Therapeutic measures were taken as a result of the event and included treatment with valacyclovir 1g, 3x/day. The outcome of the event was not recovered. The event was assessed as non-serious by the reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Allergy; Asthma; Blood cholesterol abnormal; Penicillin allergy
Vorgeschichte
-
Andere Medikamente
ZYFLO CR; SYMBICORT; LEVOCETIRIZINE; DYMISTA; HIZENTRA; LIPITOR [ATORVASTATIN]
Allergien
-
Vorherige Impfungen
-

VAERS 1112573

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MN
Alter
75,0
Geschlecht
F
Eingang
18.03.2021
Impfdatum
12.03.2021
Beginn
16.03.2021
Tage bis Beginn
4,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Facial pain Facial paralysis Oral pain Sinus pain

Symptomtext

Pain on left side of face, nasal cavities, mouth. Dull headache, fatigue The following morning when I woke up the left side of my face was drooping especially in cheek and mouth areas

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
On March 18, I called my doctor as we were vacationing. His nurse took information from me and told me to go to urgent care. I went there and was diagnosed with Bells Palsy and given prescriptions for valacyclovir and methylprednisolone.
Aktuelle Erkrankungen
Bladder infection two weeks prior
Vorgeschichte
Colon cancer 2017, chemotherapy and colon resection Now clear History of herpes simplex 1
Andere Medikamente
Atorvastatin, hydrochlorothyazide, vitamin c, calcium, multivitamin, zinc,
Allergien
No
Vorherige Impfungen
-

VAERS 1109460

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6202

schwer
Staat
NH
Alter
37,0
Geschlecht
M
Eingang
17.03.2021
Impfdatum
12.03.2021
Beginn
15.03.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Headache Laboratory test Myocarditis Troponin increased

Symptomtext

Headache Five days Elevated Troponin Myocarditis

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
-
Labordaten
Cardiac labs
Aktuelle Erkrankungen
none
Vorgeschichte
Myocarditis x 2 Ptsd TBI Hypo gonadism
Andere Medikamente
depo Testosterone straterra biagra
Allergien
none
Vorherige Impfungen
-

VAERS 1108638

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
22,0
Geschlecht
F
Eingang
17.03.2021
Impfdatum
17.03.2021
Beginn
17.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Presyncope Vomiting

Symptomtext

Patient received COVID-19 vaccination. Patient reported to RN that she may have vagal response. Mother was prepared with juice. Patient received injection and then slumped back in chair and RN assisted her to the floor. A cold compress was placed on her head, patient was conscious the entire time. Mother gave her juice and patient did throw that up. Sat with patient for about 10 minutes. NP did respond to assess the patient. Patient then reported she was feeling better. We then got patient put back in chair and after about another five minutes she was placed in a wheelchair and taken to an empty room with her mother. Patient left with mother in the wheelchair and was escorted out to the car. Patient had no complaints at discharge.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Unknown
Allergien
-
Vorherige Impfungen
-

VAERS 1108439

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
AZ
Alter
69,0
Geschlecht
M
Eingang
17.03.2021
Impfdatum
19.02.2021
Beginn
08.03.2021
Tage bis Beginn
17,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Embolic stroke

Symptomtext

Acute Embolic Stroke (Diagnostic Code I63.9)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Embolic stroke
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
High Blood Pressure
Andere Medikamente
Metoprolol Succinate 50mg, Irbesartan 300mg, Amlodipine Besylate 5mg
Allergien
None
Vorherige Impfungen
-

VAERS 1085873

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
ID
Alter
75,0
Geschlecht
F
Eingang
17.03.2021
Impfdatum
27.02.2021
Beginn
01.02.2021
Tage bis Beginn
-
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Asthenia Chest discomfort Chills Dizziness Dyspnoea Feeling abnormal Feeling drunk Heart rate Heart rate increased Fear of disease Hypoaesthesia Investigation Lymphadenopathy Malaise Nasopharyngitis Nausea Ocular hyperaemia

Symptomtext

I had shock from taking the vaccine twice; fuzzy brain; Feeling drunk; she couldn't see well; Cold; I'm sleeping 12-15 hours a day. I'm very sick right now; tingling in the top of her mouth; difficulty breathing; heart palpitations; heavy chest; red eyes; half of her face was numb; Runny nose; phlegm in the back of her throat; throat swelling; facial swelling; dizziness; weakness; fast heart beat; Injection site swelling; Injection site pain; Chills; Nausea; Joint pain; Feeling unwell; swollen lymph nodes under her left arm (clarified as left armpit) the first night after she got the COVID-19 Vaccine. She said 2 days later her right underarm lymph nodes were swollen and sore.; hurt so bad; This is a spontaneous report from a contactable consumer or other non hcp. A 75-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 27Feb2021 (Batch/Lot Number: EN6202) as single dose for Covid-19 immunisation . Medical history included autoimmune disorder from 1996 , arthropathy , covid-19 from Mar2020 , severe acute respiratory syndrome from 2005, severe acute respiratory syndrome from 2008 , avian influenza osteoporosis, osteoarthritis (diagnosed with osteoarthritis while she was out of the country, between 2006-2008) , allergy to bee sting and anaphylactic reaction. There were no concomitant medications. The patient received the first dose BNT162b2 vaccine on 06Feb2021 The patient experienced i had shock from taking the vaccine twice on Feb2021 with outcome of unknown , fuzzy brain on Feb2021 with outcome of unknown , feeling drunk on Feb2021 with outcome of unknown , she couldn't see well on Feb2021 with outcome of unknown , cold on Feb2021 with outcome of unknown , i'm sleeping 12-15 hours a day. i'm very sick right now on Feb2021 with outcome of unknown , tingling in the top of her mouth on Feb2021 with outcome of unknown , difficulty breathing on Feb2021 with outcome of unknown , heart palpitations on Feb2021 with outcome of unknown , heavy chest on Feb2021 with outcome of unknown , red eyes on Feb2021 with outcome of unknown , half of her face was numb on Feb2021 with outcome of unknown , runny nose on Feb2021 with outcome of unknown , phlegm in the back of her throat on Feb2021 with outcome of unknown , throat swelling on Feb2021 with outcome of unknown , facial swelling on Feb2021 with outcome of unknown , dizziness on Feb2021 with outcome of unknown , weakness on Feb2021 with outcome of unknown , fast heart beat on Feb2021 with outcome of unknown , injection site swelling on Feb2021 with outcome of unknown. Shock was considered an Important Medical Event. The remaining events were non serious. The patient underwent lab tests and procedures which included , heart rate: fast on Feb2021, sars-cov-2 test: negative on 2020. Follow up information has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Shock
Hospital-Tage
-
Labordaten
Test Date: 202102; Test Name: heart beat; Result Unstructured Data: Test Result:fast; Test Date: 2020; Test Name: blood work; Result Unstructured Data: Test Result:Unknown Results; Test Date: 2020; Test Name: COVID-19 Virus test; Test Result: Negative
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergic reaction to bee sting; Anaphylactic reaction; Autoimmune disorder; Bird flu; COVID-19; Joint disorder; Osteoarthritis (diagnosed with osteoarthritis, between 2006-2008); Osteoporosis; SARS
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1085873

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6202

schwer
Staat
ID
Alter
75,0
Geschlecht
F
Eingang
17.03.2021
Impfdatum
27.02.2021
Beginn
01.02.2021
Tage bis Beginn
-
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Asthenia Chest discomfort Chills Dizziness Dyspnoea Feeling abnormal Feeling drunk Heart rate Heart rate increased Fear of disease Hypoaesthesia Investigation Lymphadenopathy Malaise Nasopharyngitis Nausea Ocular hyperaemia

Symptomtext

I had shock from taking the vaccine twice; fuzzy brain; Feeling drunk; she couldn't see well; Cold; I'm sleeping 12-15 hours a day. I'm very sick right now; tingling in the top of her mouth; difficulty breathing; heart palpitations; heavy chest; red eyes; half of her face was numb; Runny nose; phlegm in the back of her throat; throat swelling; facial swelling; dizziness; weakness; fast heart beat; Injection site swelling; Injection site pain; Chills; Nausea; Joint pain; Feeling unwell; swollen lymph nodes under her left arm (clarified as left armpit) the first night after she got the COVID-19 Vaccine. She said 2 days later her right underarm lymph nodes were swollen and sore.; hurt so bad; This is a spontaneous report from a contactable consumer or other non hcp. A 75-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 27Feb2021 (Batch/Lot Number: EN6202) as single dose for Covid-19 immunisation . Medical history included autoimmune disorder from 1996 , arthropathy , covid-19 from Mar2020 , severe acute respiratory syndrome from 2005, severe acute respiratory syndrome from 2008 , avian influenza osteoporosis, osteoarthritis (diagnosed with osteoarthritis while she was out of the country, between 2006-2008) , allergy to bee sting and anaphylactic reaction. There were no concomitant medications. The patient received the first dose BNT162b2 vaccine on 06Feb2021 The patient experienced i had shock from taking the vaccine twice on Feb2021 with outcome of unknown , fuzzy brain on Feb2021 with outcome of unknown , feeling drunk on Feb2021 with outcome of unknown , she couldn't see well on Feb2021 with outcome of unknown , cold on Feb2021 with outcome of unknown , i'm sleeping 12-15 hours a day. i'm very sick right now on Feb2021 with outcome of unknown , tingling in the top of her mouth on Feb2021 with outcome of unknown , difficulty breathing on Feb2021 with outcome of unknown , heart palpitations on Feb2021 with outcome of unknown , heavy chest on Feb2021 with outcome of unknown , red eyes on Feb2021 with outcome of unknown , half of her face was numb on Feb2021 with outcome of unknown , runny nose on Feb2021 with outcome of unknown , phlegm in the back of her throat on Feb2021 with outcome of unknown , throat swelling on Feb2021 with outcome of unknown , facial swelling on Feb2021 with outcome of unknown , dizziness on Feb2021 with outcome of unknown , weakness on Feb2021 with outcome of unknown , fast heart beat on Feb2021 with outcome of unknown , injection site swelling on Feb2021 with outcome of unknown. Shock was considered an Important Medical Event. The remaining events were non serious. The patient underwent lab tests and procedures which included , heart rate: fast on Feb2021, sars-cov-2 test: negative on 2020. Follow up information has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Shock
Hospital-Tage
-
Labordaten
Test Date: 202102; Test Name: heart beat; Result Unstructured Data: Test Result:fast; Test Date: 2020; Test Name: blood work; Result Unstructured Data: Test Result:Unknown Results; Test Date: 2020; Test Name: COVID-19 Virus test; Test Result: Negative
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergic reaction to bee sting; Anaphylactic reaction; Autoimmune disorder; Bird flu; COVID-19; Joint disorder; Osteoarthritis (diagnosed with osteoarthritis, between 2006-2008); Osteoporosis; SARS
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1063688

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MO
Alter
44,0
Geschlecht
F
Eingang
17.03.2021
Impfdatum
27.02.2021
Beginn
27.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Anaphylactic reaction Blood pressure measurement Dysphagia Dyspnoea Heart rate Heart rate decreased Hypotension SARS-CoV-2 test negative Pharyngeal swelling

Symptomtext

anaphylaxis; Blood pressure dropped to 60/40, pulse 22; Blood pressure dropped to 60/40, pulse 22; Doctor could not hear breathing; I couldn't swallow during anaphylaxis.; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female patient received the 1st dose of bnt162b2 (BNT162B2) at single dose at right arm on 27Feb2021 08:30 for COVID-19 immunisation. Medical history included oesophageal achalasia, lupus-like syndrome, (SLE) asthma, post-traumatic stress disorder (PTSD), gastroparesis, chronic serotonin syndrome, high blood pressure, anxiety, known allergies (unspecified). Patient was not pregnant. The patient had not experienced Covid-19 prior vaccination. Concomitant medication included insulin human (AFREZZA), alprazolam (XANAX), clonidine (CLONIDINE), lisinopril (LISINOPRIL), torsemide (TORSEMIDE). No other vaccine in four weeks. On 27Feb2021 08:30 the patient experienced anaphylaxis, blood pressure dropped to 60/40, pulse 22, doctor could not hear breathing, she could not swallow during anaphylaxis. Anaphylaxis was considered medically significant as resulted in Emergency room/department or urgent care. Course of events as follows: About 5 minutes after shot she got lightened, tingling all over, and anaphylaxis set in. Blood pressure dropped to 60/40, pulse 22. Doctor could not hear breathing was turning purple. Two Epi-pens administered which opened her air ways, than 2 Benadryl were given to me. They tried liquid Benadryl but she could not swallow during anaphylaxis. The patient underwent lab tests and procedures which included blood pressure measurement: 60/40 on 27Feb2021, pulse rate: 22 on 27Feb2021. COVID was tested post vaccination with nasal swab resulted negative on 07Feb2021 (as reported). Treatment received: 2 Epi-pens, 2 Benadryl, Prednisone and Prilosec. The outcome of events was not recovered. Information about lot/batch number has been requested

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
Test Date: 20210227; Test Name: Blood pressure; Result Unstructured Data: Test Result:60/40; Test Date: 20210227; Test Name: pulse; Result Unstructured Data: Test Result:22; Test Date: 20210207; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Achalasia; Allergy (known allergies (unspecified)); Anxiety; Asthma; Blood pressure high; Gastroparesis; Lupus-like syndrome; Post-traumatic stress disorder; Serotonin syndrome
Andere Medikamente
AFREZZA; XANAX; CLONIDINE; LISINOPRIL; TORSEMIDE
Allergien
-
Vorherige Impfungen
-

VAERS 1105641

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
36,0
Geschlecht
M
Eingang
16.03.2021
Impfdatum
13.03.2021
Beginn
13.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Fall Head injury Hyperhidrosis Paraesthesia Syncope

Symptomtext

Patient fainted and ended up falling and hitting her head on the floor. Once she came to, she felt "tingling" and ended up breaking into a sweat.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
Unknown, but patient was taken to hospital to be checked out.
Aktuelle Erkrankungen
None reported
Vorgeschichte
None reported
Andere Medikamente
None reported by patient
Allergien
None reported
Vorherige Impfungen
-

VAERS 1105488

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
56,0
Geschlecht
M
Eingang
16.03.2021
Impfdatum
02.03.2021
Beginn
07.03.2021
Tage bis Beginn
5,0
Dosis
2
Route/Site
SYR / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bell's palsy Eyelid disorder Facial paralysis

Symptomtext

Developed new onset unilateral facial drooping, difficulty with eyelid closure, loss of nasolabial fold, and loss of forehead furrow on 3/7/2021 diagnosed as Bell's palsy

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
None
Vorgeschichte
BPH HTN GERD OA of left hip
Andere Medikamente
Avodart 0.5 mg daily Multivitamin Omeprazole 40 mg daily
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1105044

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
CA
Alter
39,0
Geschlecht
M
Eingang
16.03.2021
Impfdatum
16.03.2021
Beginn
16.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Drooling Fall Head injury Headache Hyperhidrosis Loss of consciousness Skin abrasion Syncope Tremor

Symptomtext

39y/o male presents with syncope, head injury and body shaking within 5min of receiving Pfizer vaccine in left arm on 3/16/21. Patient lost consciousness, fell from a seated position and hit the left side of scalp on the floor. Patient then experienced uncontrolled body shaking for <5sec. He had drool from his mouth during episode. Patient regained consciousness after cessation of shaking. He reports associated sweating and head pain. He denies throat enclosing, difficulty speaking, lip/tongue swelling or itching, injection site pain or itching, blurring of vision, light headedness, chest pain, palpitations, or shortness of breath. He reports history of syncope when getting his blood drawn and at site of blood. He denies allergies to medication or vaccinations. He denies any current medical conditions or h/o seizures. On physical exam: Vitals: Heart rate 88, blood pressure 150/100 Skin: his skin is diaphoretic and ~4x2cm skin abrasion to his left scalp is noted. Cardiovascular: Radial Pulse 2+ . Heart regular rate and rhythm. Lungs: clear to auscultation bilaterally Patient was examined by EMS and informed that he could be transported to hospital via ambulance for immediate consultation with provider or can decline services and seek care at a later time. Patient opted to drive on his own to seek care at a later time. He was advised to contact his primary care provider regarding his adverse reaction, seizure and head injury. Note: MA called for PA on site when patient fell and hit head. PA told site manager to call 911 while attending to patient. When PA arrived to patient's side, he had regained consciousness and PA proceeded to provide care and investigate incident.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 1104348

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
24,0
Geschlecht
M
Eingang
16.03.2021
Impfdatum
06.03.2021
Beginn
06.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Malaise Nausea Syncope

Symptomtext

6:25 pm report: pt rec'd vaccine immediately c/o of not feeling well and had syncopal episode was given smelling salts then brought to recovery vaccinator and Dr accompanied. Pt laid on cot supine, feet elevated. Assess: AAO, + nausea - dizzy, no complaints of pain of any kind. VS 146/94, heart rate 74 regular, resps 16 reg non labored, SPO2 97% RA Mnitor 30 min. provided reassurance. Pt stated he felt better sat him at edge of cot 6:50 pm VS 152/92, heart rate 71 reg. resp 16 reg non labored, SpO2 98%. Encouraged fluids ok to exit. Encouraged him to follow up with primary MD. V-safe. 3/7/21 Followed up with phone call - pt stated he felt much better today.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
VS monitored, Monitored 30 min
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 1104194

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
79,0
Geschlecht
F
Eingang
16.03.2021
Impfdatum
01.03.2021
Beginn
02.03.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Ear pain Headache Mononucleosis heterophile test negative Nausea Oropharyngeal pain Otitis media Pyrexia SARS-CoV-2 test negative

Symptomtext

sore throat, followed by headache and right ear pain. Nausea and fever of 101.0 on March 8th, in addition to previous symptoms. In the emergency department on March 11th with complete right facial droop consistent with Bell's palsy; this has persisted as of today, also with evidence of right serous otitis media

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
negative COVID-19 test on March 9th. negative Monospot test on March 11.
Aktuelle Erkrankungen
-
Vorgeschichte
hypertension, rheumatoid arthritis, osteoporosis
Andere Medikamente
Sulfasalazine, lisinopril -hydrochlorothiazide
Allergien
influenza immunization, Prevnar 13
Vorherige Impfungen
influenza immunization November 2015, causing rash. Pneumococcal conjugate immunization November 2018 causing rash

VAERS 1102134

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
PA
Alter
23,0
Geschlecht
F
Eingang
15.03.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Disease recurrence Presyncope

Symptomtext

vasovagal reaction (i.e., dizziness, ringing in ears, feeling faint); vasovagal reaction (i.e., dizziness, ringing in ears, feeling faint)/prior instances of vasovagal reaction to getting a shot; This is a spontaneous report from a contactable consumer. A 23-year-old female patient (reporter's daughter) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EN6202), via an unspecified route of administration on 26Feb2021 15:30 (at 23-years-old) at single dose (Left arm) for COVID-19 immunization. Facility type vaccine: Public Health Clinic facility. Medical history included asthma and prior instances of vasovagal reaction to getting a shot. Known allergies included sulfa drugs, penicillin, and amoxicillin. Patient had no COVID prior vaccination. Patient is not pregnant. Concomitant medication included ethinylestradiol, norgestimate (SPRINTEC), clindamycin (manufacturer unknown), triamcinolone acetonide (manufacturer unknown), tretinoin (RETIN-A), and multivitamin. Within 5 minutes on 26Feb2021 (also reported to be 03:30 PM) of receiving the vaccination, she experienced a vasovagal reaction (i.e., dizziness, ringing in ears, feeling faint). She immediately laid on the floor and the symptoms resolved within 15 minutes. No treatment was given. Patient was not COVID tested post vaccination. The outcome of the events was recovered on 26Feb2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Asthma; Penicillin allergy; Sulfonamide allergy; Vasovagal reaction
Andere Medikamente
SPRINTEC; CLINDAMYCIN; TRIAMCINOLONE ACETONIDE; RETIN-A
Allergien
-
Vorherige Impfungen
-

VAERS 1058868

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6202

schwer
Staat
WI
Alter
27,0
Geschlecht
F
Eingang
15.03.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Anaphylactic reaction Blood test Electrocardiogram Intensive care Mobility decreased Anaphylactoid reaction Erythema Flushing Irregular breathing Nausea Pruritus

Symptomtext

anaphylactic reaction, then pharmacist gave epi and called 911, taken to the hospital and admitted for 4 days. Sent home, after my steroids ran out after 5 days, the reaction came back. Ambulance called and taken to the hospital and put in the ICU. discharged home, then again after the steroids ran out 5 days later all symptoms came back again. Went to the ER then discharged home with steroids and seeing allergist thursday . In between hospital stays i was unable to get out of bed. I did go to two separate hospitals. The first one was farther from home due to getting the vaccine farther from home

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
7,0
Labordaten
blood, ekg, er visits, hospital stays, medications.
Aktuelle Erkrankungen
none
Vorgeschichte
POTS EDS MCAS
Andere Medikamente
none
Allergien
NSaids Doxycycline Sulfa Drugs Amoxicillin
Vorherige Impfungen
-

VAERS 1096876

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MO
Alter
66,0
Geschlecht
F
Eingang
13.03.2021
Impfdatum
03.03.2021
Beginn
10.03.2021
Tage bis Beginn
7,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bell's palsy Facial paralysis

Symptomtext

Developed Bells Palsy, distorted face, droopy mouth and eyelid, not able to fully close left eye and mouth not functioning correctly. Given Prednisone and ointment and lubricant for eye Afraid to get second shot! Need recommendation!

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
Went to be checked out at doctor?s office
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Took levothyroxine the day before the vaccine. Didn?t take that morning.
Allergien
None known
Vorherige Impfungen
-

VAERS 1094193

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
AZ
Alter
71,0
Geschlecht
M
Eingang
12.03.2021
Impfdatum
25.02.2021
Beginn
26.02.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bell's palsy Facial paresis

Symptomtext

Bells Palsy ...moderate symptoms next morning. Left facial. As of March 12 it is still somewhat noticeable. No treatment. I had Bells Palsy in fall of 1999.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Finasteride
Allergien
None
Vorherige Impfungen
-

VAERS 1093985

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
KY
Alter
68,0
Geschlecht
F
Eingang
12.03.2021
Impfdatum
02.03.2021
Beginn
02.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Blood lactic acid C-reactive protein increased COVID-19 Chills Computerised tomogram thorax abnormal Dyspnoea Endotracheal intubation Fibrin D dimer increased Intensive care Lymphadenopathy mediastinal Pneumonia Procalcitonin normal Pyrexia Respiratory distress SARS-CoV-2 test positive Serum ferritin increased

Symptomtext

Patient hospitalized on 3/9/21 with one week history of fever, chills, and shortness of breath. Tested positive for COVID-19. Respiratory status worsened on 3/11 requiring transfer to ICU and intubation. Currently intubated in ICU.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
-
Labordaten
3/9: CT angiogram: bilateral PNA and prominent mediastinal lymph nodes 3/9 lactate 2.4 3/9 procalcitonin 0.15 3/11 ferritin: 929 3/11 CRP: 10.21 3/11 D-dimer 1.17
Aktuelle Erkrankungen
-
Vorgeschichte
hypertension, diabetes type II, sleep apnea, restless leg syndrome, hyperlipidemia, chronic venous insufficiency
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1093782

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MD
Alter
75,0
Geschlecht
F
Eingang
12.03.2021
Impfdatum
04.03.2021
Beginn
07.03.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Presyncope Staring

Symptomtext

On 3/7 the patient presented to the ED after having 3 episodes of presyncopal staring events in the past week, and reports having them over the past year and a half. Reason for admission: syncope and collapse. Per, EUA all hospitalizations must be report after recently receiving a vaccine. This patient has had a history of syncope and this hospitalization does not seem to be related to the vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Coronary artery disease, anxiety/depression, asthma, hypertension, hyperlipidemia, GERD, osteoarthritis,
Andere Medikamente
albuterol HFA, alendronate, alprazolam, aspirin, buspirone, vitamin D2, fexofenadine, Flonase, hydrochlorothiazide, levetiracetam, metoprolol tartrate, omeprazole, potassium chloride, sertraline, simvastatin, tizanidine, zolpidem.
Allergien
Morphine
Vorherige Impfungen
-

VAERS 1092578

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
WI
Alter
78,0
Geschlecht
F
Eingang
11.03.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Blood creatinine normal Blood potassium decreased Blood urea normal Dehydration Face injury Fall Hypophagia Nausea Syncope Vomiting

Symptomtext

LTC Pharmacy was notified of a potential vaccine related hospital admission on 3/8/2021. The following information was gathered from discussion with RPH at Hospital. The patient received second dose of Pfizer COVID vaccine on 2/26/2021. The patient then had nausea, vomiting, and poor oral intake. On 2/27/2021, the patient went to the bathroom and while on the toilet, had a vasovagal event which led to her hitting the side of the face while falling. Patient was then taken to the hospital for evaluation. The patient does have a pacemaker but the cause of the event was determined to likely be due to dehydration. Lab work was performed and pertinent lab values include: potassium of 3.1, SCr of 0.8, and BUN of 13. The patient received potassium supplementation and IV hydration in the hospital. Patient was discharged on 2/28/2021. Of note, the patient does have a pacemaker and a follow-up appointment with cardiology to evaluate the pacemaker was scheduled upon discharge.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Implanted Pacemaker
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1091394

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6202

schwer
Staat
NY
Alter
53,0
Geschlecht
F
Eingang
11.03.2021
Impfdatum
28.02.2021
Beginn
03.03.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Drooling Facial paralysis Mastication disorder

Symptomtext

Patient reports that about 3-4 days after receiving the first dose, she started experiencing difficulty in chewing and drooling out of the left side of her face. She then noticed a mild facial droop. On March 7th, 2021 she was evaluated in the Emergency room and diagnosed with Bells' Palsy. Shewas discharged home the same day and was prescribed Valtrex and Prednisone. On March 9th, 2021 she consulted with a neurologist. She came in for consultation with us (infectious disease) on March 10th, 2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
unknown
Aktuelle Erkrankungen
-
Vorgeschichte
high blood pressure and history of hysterectomy
Andere Medikamente
Losartan-HCTz, Klor Con, Zyrtec, Youth collagen w/ botin
Allergien
shellfish, pollen, some beauty product preservatives
Vorherige Impfungen
-

VAERS 1090514

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
SC
Alter
68,0
Geschlecht
M
Eingang
11.03.2021
Impfdatum
24.02.2021
Beginn
10.03.2021
Tage bis Beginn
14,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bell's palsy

Symptomtext

Bell's Palsy diagnosed March 10, 2010

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
Doctor visit
Aktuelle Erkrankungen
No
Vorgeschichte
DISH, various skin cancers
Andere Medikamente
Losartin, Simvastatin, multi-vitamin
Allergien
Mobec
Vorherige Impfungen
-

VAERS 1090329

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
38,0
Geschlecht
M
Eingang
11.03.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Bell's palsy Hypoaesthesia

Symptomtext

Felt mild numbness on left side of face the same night as I received the vaccine. It got worse the next day. I contacted a doctor via telemedicine and she did an evaluation. She said it was a mild Bell?s Palsy but likely not serious because she couldn?t observe it when asking me to raise my eyebrows or smile ? it was just something I could feel. It went away on its own within another day or so.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Alpha 1 Antitrypsin deficiency
Andere Medikamente
Finasteride, multivitamin, vitamin D, calcium, vitamin B, magnesium, vitamin E
Allergien
None
Vorherige Impfungen
-

VAERS 1084371

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OK
Alter
70,0
Geschlecht
F
Eingang
11.03.2021
Impfdatum
24.02.2021
Beginn
24.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Blood test Dysphagia Dyspnoea Headache Muscle tightness Chest discomfort Chills Myalgia Seizure Urine analysis Pyrexia Throat tightness Tremor

Symptomtext

Muscle pain; Headache; Having issues breathing; could not swallow; Muscle tightness in right jaw, mouth, neck, shoulder; Muscle type convulsions in neck, shoulder, arms and upper chest; This is a spontaneous report from a contactable consumer reported for self. This 70-year-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown) via intramuscular on 24Feb2021 at 10:00 AM at single dose in left arm in a pharmacy or drug store for COVID-19 immunization. The patient's medical history included high blood pressure. The patient had known allergies: anabolic steroids, many antibiotics. The patient did not have COVID prior vaccination. The patient's concomitant medications included hydrochlorothiazide, triamterene (MAXZIDE) and vitamins. At 24Feb2021 at 10:00 PM, the patient experienced muscles in neck, jaws and throat started clinching up and she could not swallow. The patient began having issues breathing. The patient was advised to go to emergency room (ER). At ER, patient started with muscle type convulsions in neck, shoulder, arms and upper chest. The patient had several episodes. Doctor administered diphenhydramine hydrochloride (BENADRYL) intravenously, did blood and urine workup. After 4 hours the shaking stopped, and the muscle contractions lessened. The patient was sent home. Next day 25Feb2021, she still had some residual muscle tightness in right jaw, mouth, neck, shoulder. On third day 26Feb2021, she had light shaking of hands and arms. The patient was still taking 25 mg diphenhydramine hydrochloride every 8 hours. She added ibuprofen (ADVIL) because she also had muscle pain and headache. The patient was recovering from the events. The patient did not test COVID post vaccination. Information on lot/batch number has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
Test Name: Blood workup; Result Unstructured Data: Test Result:unknown results; Test Name: Urine workup; Result Unstructured Data: Test Result:unknown results
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergy to antibiotic; Blood pressure high; Drug allergy
Andere Medikamente
MAXZIDE
Allergien
-
Vorherige Impfungen
-

VAERS 1089015

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
53,0
Geschlecht
M
Eingang
10.03.2021
Impfdatum
04.03.2021
Beginn
04.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Facial paralysis Lacrimation increased Reduced facial expression

Symptomtext

About 7pm the same day I got my vaccine. My right eye started watering profusely. I didn't think much of it. at 10:30 I went outside to whistle for a dog and I could not whistle. The next morning I found that the right side of my face was completely drooped and I have no expression control.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
I went to the ER and they gave me medications (prednisone 20mg 3 tablets daily. Valacyclovir HCL 1gram tablets, 1 every 8 hours. Laprolube for the eye and eye is taped shut.) for Bells Palsy and I was referred to a specialist. An eye doctor says its most likely due to the vaccine.
Aktuelle Erkrankungen
Severe Case of Bronchitis Staff infection
Vorgeschichte
No
Andere Medikamente
No
Allergien
Bactrim-SEVERE
Vorherige Impfungen
-

VAERS 1088508

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
67,0
Geschlecht
M
Eingang
10.03.2021
Impfdatum
23.02.2021
Beginn
24.02.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Body temperature Chills Diarrhoea Dizziness Headache Syncope

Symptomtext

diarrhea; 12 hours after injection - fainted in bathroom/fainted 2nd time; woozieness when trying to walk/just felt woozy; headache; chills; This is a spontaneous report from contactable consumers (patient and wife). This 67-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6202) in right arm on 23Feb2021 05:00pm at single dose for COVID-19 immunisation. Medical history included high cholesterol, acid reflux (esophageal). The patient had no known allergies. Concomitant medications in two weeks included atorvastatin for high cholesterol, ongoing omeprazole for acid reflux (esophageal), and ongoing multivitamins (1 tablet a day for men over 50 by mouth as supplementation therapy). The patient did not receive other vaccine in four weeks. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EM9810) at the age of 67-year on 02Feb2021 at 05:00PM in left arm at single dose for COVID-19 immunisation, had no reaction with the first dose, had no issues in the waiting period or while shopping afterwards; received influenza vaccine (FLU) and pneumonia shot for immunization on an unknown date a couple of months ago. The patient did not have COVID prior vaccination, COVID was not tested post vaccination. The patient received second dose of the Covid-19 Vaccine, then on 24Feb2021, fainted twice 12 hours after receiving the second dose, fainted in the morning of 24Feb2021 around 05:20, he got up because he had diarrhea and that was when he first fainted in the bathroom. He also had chills and a headache in the morning of 24Feb2021 at 05:15, but she reported that he did not have a fever. Temperature was normal on 24Feb2021. The patient reported that he just felt woozy, wooziness when trying to walk/just felt woozy in the morning of 24Feb2021 at 05:15. She said that he fainted for a second time just minutes after he fainted the first time when the reporter was helping the patient get back from the bathroom to the bedroom, the patient collapsed on the floor and reporter got him up. He developed the diarrhea around 05:30 in the morning of 24Feb2021. He took some ibuprofen to treat the headache. It was unknown if the treatment received for the other events. He has been resting since he had the diarrhea. Outcome of the events faint and diarrhea was unknown, wooziness when trying to walk/just felt woozy was recovering, while other events was recovered on 24Feb2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
Test Date: 20210224; Test Name: Body temperature; Result Unstructured Data: Test Result:normal
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Acid reflux (esophageal); High cholesterol
Andere Medikamente
ATORVASTATIN; OMEPRAZOLE
Allergien
-
Vorherige Impfungen
-

VAERS 1087612

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
PA
Alter
72,0
Geschlecht
F
Eingang
10.03.2021
Impfdatum
08.03.2021
Beginn
08.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Blood sodium decreased Chills Dizziness Headache Hypertension Laboratory test normal Night sweats Pyrexia Syncope

Symptomtext

in less than a minute I had a vasvagal syncope response and my blood pressure got so high that the machine couldn't take it--in the 200's/100 something. I was taken to the ER and monitored for a few hours and labs. BP came down slowly, but not perfect. I was released around 7pm. Event happened at 3:46pm. The next day I had chills first, then I had a slight fever, a terrible headache in the back of my head, dizziness and night sweats. By the 2nd day after I am feeling better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
sodium-132 (but on a pill that lowers my sodium-Chlorthalidone) all other labs normal
Aktuelle Erkrankungen
none
Vorgeschichte
hypertension asthma
Andere Medikamente
Carvidelol 12.5 2x day Candesartan 32 mg 1xday Clorthalidone 6.25 Famotidine 20mg 2x day Levothyroxine .88 restatis 2x day
Allergien
scallops and maybe anchovies adhesive tape advair amlodipine asthmanex atorvastatin bacrim diovan HCTZ lipitor lisinopril nexium pantroprazole pravastatin simvistatin doxycycline
Vorherige Impfungen
-

VAERS 1086201

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6202

schwer
Staat
GA
Alter
23,0
Geschlecht
F
Eingang
09.03.2021
Impfdatum
09.03.2021
Beginn
09.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Heart rate increased Hyperhidrosis Lethargy Loss of consciousness Muscle rigidity

Symptomtext

patient became lethargic and briefly passed out 1 minute after receiving vaccine. Patient did not have swelling or breathing problems so an epinephrine pen was not needed. Patient became sweaty and had muscle rigidity of her hands and arms. Patient had rapid heart rate and extreme exhaustion. Ambulance was called and patient care was passed off to the EMTs and the hospital.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
unknown
Aktuelle Erkrankungen
panic attacks
Vorgeschichte
unknown
Andere Medikamente
citalopram
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 1084413

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
67,0
Geschlecht
M
Eingang
09.03.2021
Impfdatum
01.03.2021
Beginn
02.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Blood test Computerised tomogram Dizziness Dysarthria Echocardiogram Electroencephalogram Eye irritation Facial paralysis Feeling abnormal Magnetic resonance imaging

Symptomtext

PI Patient is a 67 year old male who presents with dizziness and left facial droop. The patient reports that he woke up this morning and felt very unsteady on his feet and dizzy. That has since subsided. However, he noted some slurred speech and left facial droop. He woke up at 7:30 AM. He went to bed last night at 11 PM. Last known well is 11 PM, as he woke up with his symptoms. He reports some weakness of the left upper extremity and left lower extremity. Acute left arm, leg, face weakness, slurred speech and buring eyes. Symptoms came and went over 42 hour period.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
-
Labordaten
MRI, CT Scan, Echo, EEG and various blood tests. The Continuation page is not working, so I can not cut/paste the test reults.
Aktuelle Erkrankungen
root canal week before (2-24-21)
Vorgeschichte
asthma, early COPD
Andere Medikamente
Cozaar, dilitiaZEM, Flomax, Simvastatin, 81mg Aspirin,Anoro El
Allergien
latex
Vorherige Impfungen
-

VAERS 1082674

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MI
Alter
72,0
Geschlecht
M
Eingang
08.03.2021
Impfdatum
26.02.2021
Beginn
27.02.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Deep vein thrombosis Peripheral swelling Pulmonary thrombosis Surgery

Symptomtext

Patient received Covid19(Pfizer) vaccine on 02/26/2021 at 3.55pm and on 02/27/2021 in the morning he had swelling in his left leg ( patient had knee replacement in same leg 9 months ago). He waited 2 days and still no improvement. He went to Beaumont urgent care on 03/03/2021 and he was referred to emergency room at hospital. He was admitted due to blood clot in left leg and lungs, where he had leg surgery. He was prescribed Eliquis 5 mg twice a day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
4,0
Labordaten
unknown
Aktuelle Erkrankungen
Unknown
Vorgeschichte
High Blood Pressure
Andere Medikamente
Thiamin , folic Acid, Docusate Sodium, Mylanta Suspension, Multivitamin
Allergien
No Known Allergy
Vorherige Impfungen
-

VAERS 1081014

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
WI
Alter
40,0
Geschlecht
F
Eingang
08.03.2021
Impfdatum
05.03.2021
Beginn
05.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Chills Differential white blood cell count Fibrin D dimer Full blood count Headache Metabolic function test Presyncope Troponin I Vomiting

Symptomtext

Near syncope (multiple events); vomiting (multiple events); chills; headache Onset approx. 12 hours following vaccine. Rapid onset with little to no warning, lasting approx. 2-3 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
CBC and Differential Comprehensive Metabolic Panel D-Dimer Quantitative Troponin I (05 March 2021)
Aktuelle Erkrankungen
None
Vorgeschichte
Migraine, Hayfever
Andere Medikamente
LoLoestrin FE Aimovig
Allergien
Latex; Neosporine; Mold/Hayfever
Vorherige Impfungen
-

VAERS 1078992

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6202

schwer
Staat
WI
Alter
24,0
Geschlecht
M
Eingang
07.03.2021
Impfdatum
07.03.2021
Beginn
07.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

VAR form was reviewed with patient prior to vaccinating. It was noted that he has a history of syncopal episodes with vaccines. Patient was advised to sit for 15 minutes after receiving the vaccine so we could observe him. After receiving the vaccine, patient was escorted to observation chair. Immunizer advised registration technician that patient had a history of fainting, so to keep a watchful eye on him. Patient said I need to get some ice and stood up before we were able to advise him to sit and we would assist him. Upon standing, patient had syncopal episode. Patient did not has loss of consciousness an denied any injury from the fall. Patient was assisted back to the observation chair and monitored for the next 15 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
previous syncopal episodes with several vaccines

VAERS 1078624

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
AZ
Alter
30,0
Geschlecht
M
Eingang
06.03.2021
Impfdatum
06.03.2021
Beginn
06.03.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Fall Myoclonus Syncope Vomiting

Symptomtext

Patient received his 1 dose of Pfizer vaccine and was waiting in our lobby for the recommended 15 minutes. He fainted after about 10 minutes. He fell from the bench to the floor where he landed on his stomach. When I ran over to him, his eyes were open but his body was limp. I tapped his back and asked if he was ok, and he was startled as if I woke him up from sleep. He was alert and was able to speak, he asked for water and I gave it to him. I asked of he wanted me to call emergency services but he declined. He then vomited in the waiting room trash can. His sister was with him and began to rub his back and fan him. I asked again if he needed to go to the hospital and again her declined. I told them to please wait in the lobby at least another 15 minutes before leaving and he did. I called to patient around 8pm to check on him and he said he was fine and had no more symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE REPORTED
Vorgeschichte
NONE REPORTED
Andere Medikamente
NONE REPORTED
Allergien
NONE REPORTED
Vorherige Impfungen
-

VAERS 1077671

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
60,0
Geschlecht
M
Eingang
06.03.2021
Impfdatum
26.02.2021
Beginn
27.02.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Computerised tomogram Eyelid ptosis Facial paralysis Physical examination

Symptomtext

I got my second Pfizer COVID vaccine on Friday February 26. On Saturday February 27 I started getting a droopy lip and a droopy eye lid on the ight side of my face. I went to my doctor on Monday March 1 and after and examination and a CT scan (to eliminate other things), I was diagnosed with Bell?s Palsy. I am now on steroids and antiviral medication. I still have Bell's Palsy at this time,

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
I had a physical examination at the doctor's office and a CT scan at the emergency room. I was diagnosed with Bell's Palsy shortly after my second Pfizer COVID vaccine.
Aktuelle Erkrankungen
none
Vorgeschichte
diabetes
Andere Medikamente
Toujou insulin, Pravastatin, Synjardy
Allergien
none
Vorherige Impfungen
-

VAERS 2194106

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
OH
Alter
33,0
Geschlecht
M
Eingang
05.03.2021
Impfdatum
05.03.2021
Beginn
05.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood glucose normal Blood pressure increased Heart rate increased Oxygen saturation Syncope

Symptomtext

Patient had syncope in observation area post vaccination. He developed increased heart rate and blood pressure which resolved in 20 minutes. His vitals were monitored by EMTs at the site, blood sugar and pulse ox were normal. Patient was monitored after episode and released without administering any medications.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
Blood glucose-WNL Pulse Ox-WNL
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1076787

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
NY
Alter
46,0
Geschlecht
M
Eingang
05.03.2021
Impfdatum
05.03.2021
Beginn
05.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Bradycardia Dizziness Feeling abnormal Nausea Presyncope

Symptomtext

Patient received his Pfizer vaccine at 08:10 and at 08:25 he started feeling light headed and nauseated and had a vagal response. Episode lasted about 40 seconds but he did not become cyanotic or stop breathing. Pt denies any chest pain but was diaphoretic after episode. Called EMS for transport to CPH. Pt had syncopal episode with persistent Bradycardia. Current VS are P=40 R=22 BP 101/63 Pt A&O x4 with no focal neural deficits. Pulse ox is 100% on RA and pt states still feels a little "foggy". No rash or evidence of an allergic reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
Telemetry - Sinus Brady
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1075736

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
TX
Alter
68,0
Geschlecht
F
Eingang
05.03.2021
Impfdatum
01.03.2021
Beginn
01.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Anaphylactic reaction Dyspnoea Electrocardiogram Pharyngeal swelling Wheezing

Symptomtext

Clinic course: 13:50 patient given covid vaccine #2-Pfizer. 14:10 patient c/o sob and throat closing. 02 sat 94%. Epipen 0.15 mg given IM to lt thigh. 02 at 4l/nc started. 14;15 EMS called to transport patient to UTMB ER. Bp-150/88, p-75. O2 sAT 98% ON O2@4L/NC. Patient Has audible wheezing and unable to talk above slight whisper. 14:20 Patient feeling a little better. Talking in a louder whisper now. Denies sob. States throat still feels like throat is opening a little. 02Sat 98% on 02 at 4l/nc. Patient was evaluated by NP- Employee Health. 14: 25- patient feeling better. I asked her if she has ever had a reaction needing epi pen before and she stated yes. For allergy shot. I asked her if she told MA when asked and she stated no as I didn't think I would be able to get covid vaccine if I said anything about it. She states no reaction to 1st covid vaccine. ED Course: is a 68 year old female with CAD s/p PCI, HLD, OSA, seizures, HTN, asthma who presents after anaphylaxis following 2nd dose of COVID-19 vaccine. Chest tightness and original EKG concerning for STEMI, but on review EKG was artifact and did not evolve. Normal sinus the following day with resolution of symptoms. Epipen also improved symptoms which would be inconsistent with ischemia. Patient respiratory status improved on prednisone and breathing treatments. Patient is now stable for discharge.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
EKG
Aktuelle Erkrankungen
None
Vorgeschichte
HTN Allergic rhinitis Epilepsy with seizures OSA CAD Chondromalacia of patella, knee pain joint pain, back and hip OA hyperglycemia Metabolic syndrome PTCA Dermatochalsis of eys DM Hx anaphylaxis
Andere Medikamente
lamotrigine advair diskus albuterol cetirizine diclofenac hctz levalbuterol inh pravastatin prednisone amlodipine olopatadine neomycin-polymyxin-dexamethasone albuterol azelastine epi fluticasone zafirlukast trazadone asa methylcellulose o
Allergien
losartan anaphylaxis
Vorherige Impfungen
-

VAERS 1075613

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MT
Alter
30,0
Geschlecht
F
Eingang
05.03.2021
Impfdatum
02.03.2021
Beginn
02.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Hyperhidrosis Loss of consciousness Nausea Pallor Syncope Urticaria

Symptomtext

Patient was given vaccine and then sent to observation area for 15 minute observation. Patient appeared pale and diaphoretic when she got to the observation area and then suffered a syncopal episode. She was unconscious for several seconds. She did not hit her head or have any trauma. Patient complained of nausea, and dizziness when she regained consciousness. Patient appeared pale and diaphoretic. Patient then developed hives over her abdomen, upper torso, and upper arms. Patient never complained of difficulty breathing but was constantly pulling at the neck of her sweater. Pt was a Type I diabetic and had a BG reading of 262. She was given 0.3 mL of epinephrine with an immediate positive response. Transported to local hospital emergency room.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
DM1
Vorgeschichte
DM1
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1075286

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6202

schwer
Staat
MD
Alter
87,0
Geschlecht
F
Eingang
05.03.2021
Impfdatum
03.03.2021
Beginn
04.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Chest X-ray abnormal Confusional state Dyspnoea Lung infiltration Pulmonary oedema Troponin increased

Symptomtext

Patient presents to ER from EMS for SOB and confusion. Of note, patient's husband passed this morning. Troponins elevated. Chest xray shows edema and likely left lower infiltrate. Patient admitted and started on IV antibiotics, Lasix, aspirin, nitroglycerin, and albuterol nebulizers. Patient is currently still admitted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary oedema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
stage III chronic renal insufficiency, non-O2 dependent COPD, hypertension, CAD, hyponatremia, and chronically elevated troponin
Andere Medikamente
-
Allergien
nkda
Vorherige Impfungen
-

VAERS 1073821

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
GA
Alter
36,0
Geschlecht
M
Eingang
04.03.2021
Impfdatum
04.03.2021
Beginn
04.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dizziness Seizure Unresponsive to stimuli

Symptomtext

Was administered the Pfizer COVID-19 vaccine in our drive-thru clinic on 3/4/21 at approximately 2:15pm. Was in the driver's seat of his SUV with his father in the passenger seat. Nothing in the PQCF gave us any reason to be concerned over this particular administration. After administration, was asked to pull forward and park in a spot on the right in order to sit for his required 15 minutes post-administration. became unresponsive as he was attempting to park and continue to turn the wheel causing him to drive in a U shape into a rock covered median. The SUV was able to clear the median and the car stopped at the APEX. When I saw the car heading towards the median, I started to head toward the site safely. I approached the car slowly asking him to stop. When I did not receive a response, I knew something was wrong. Once I felt the car was safe to approach, I ran to assist the patient. The patient was barely able to communicate but did say he was dizzy. 15 seconds later he was unable to communicate, I called a second pharmacist to run over with an epi pen just in case (this was NOT administered). I immediately called 911 at 2:21 pm. reached into the vehicle and got the vehicle into park, while I assessed his airway, breathing, and pulse from a seated position. The patient began to seize. I continued to hold the patient from outside of the vehicle to maintain the patient's airway and keep him from hurting himself on the steering wheel. The patient regained consciousness approximately 3 minutes later with no memory of what happened. EMS arrived on scene about 2 minutes after he regained the ability to communicate. While EMS assessed the patient, and I reached out to and division one store management per SOP. EMS determined that the patient had a seizure and was able to go home if they wanted. The father moved into the driver seat. We monitored the patient for 30 minutes and allowed them to leave. We followed up with the patient via phone 2 hours later with no concerns noted. No property damage or bodily harm occurred during this incident. If we are given approval to vaccinate this patient with a second dose, we will arrange for this patient to be taken care of in the pharmacy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
No
Allergien
Ibuprofen
Vorherige Impfungen
-

VAERS 1073391

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
WI
Alter
50,0
Geschlecht
F
Eingang
04.03.2021
Impfdatum
04.03.2021
Beginn
04.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dizziness Pruritus Rash Syncope

Symptomtext

Scratchy, dizzy, rash, faint

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Just had spine surgery and vertigo
Andere Medikamente
-
Allergien
Fruits, Veggies, Ibuprofen
Vorherige Impfungen
-

VAERS 1073100

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
ID
Alter
38,0
Geschlecht
F
Eingang
04.03.2021
Impfdatum
03.03.2021
Beginn
03.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cold sweat Dizziness Syncope

Symptomtext

PATIENT STATED SHE FELT LIKE SHE WAS GOING TO PASSOUT, DIZZY. PT. STATED HISTORY OF FAINTING/SYCOPY. MEDICAL HISTORY INCLUDES ASTHMA, REACTIONS TO VACCINATIONS, AND VOMITS AFTER FLU SHOT. PT. BP 120/70 HR 79 O2SAT 97 CLAMMY SKIN, BREATH SOUNDS CLEAR BILATERALLYVAT 1555. OBSERVED TREATMENT: BP 130/76 HR 67 02SAT 95 AT 1613 ELEVATED TO SITTING POSITION AT 1616 WITH NO NEGATIVE EFFECTS.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
YES
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
VOMITS AFTER FLU SHOT

VAERS 1061199

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MO
Alter
34,0
Geschlecht
F
Eingang
04.03.2021
Impfdatum
23.02.2021
Beginn
26.02.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Computerised tomogram normal Eyelid function disorder Facial paresis Headache Hypoaesthesia

Symptomtext

On 2/4 patient recieved 1st dose of COVID vaccination and experienced headache and arm pain. On 2/23 patient received 2nd dose of COVID vaccination at 12:47 p.m. Noticed headache at base of head and took Ibuprofen for relief. On 2/26 at 1:30 pm patient noticed that her right eye was not closing well. Had to force eye closed. On 2/27 early in the morning patient's eyebrows were not moving and it was still hard to close right eye. Stated that the right side of her face was 'not working'. Presented Emergency Department around 8:30 a.m. with complaints of facial numbness. Full workup led to diagnosis of Bell's Palsy. Initiated Acyclovir and Prednisone and discharged to home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
CT scan - negative for stroke (2/27)
Aktuelle Erkrankungen
-
Vorgeschichte
Allergic Rhinitis, Obesity
Andere Medikamente
Meclizine, Hyoscamine, Loestrin 24 FE, Fluticasone, Claritin
Allergien
NKA
Vorherige Impfungen
-

VAERS 1061199

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202

schwer
Staat
MO
Alter
34,0
Geschlecht
F
Eingang
04.03.2021
Impfdatum
23.02.2021
Beginn
26.02.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Bell's palsy Computerised tomogram normal Eyelid function disorder Facial paresis Headache Hypoaesthesia

Symptomtext

On 2/4 patient recieved 1st dose of COVID vaccination and experienced headache and arm pain. On 2/23 patient received 2nd dose of COVID vaccination at 12:47 p.m. Noticed headache at base of head and took Ibuprofen for relief. On 2/26 at 1:30 pm patient noticed that her right eye was not closing well. Had to force eye closed. On 2/27 early in the morning patient's eyebrows were not moving and it was still hard to close right eye. Stated that the right side of her face was 'not working'. Presented Emergency Department around 8:30 a.m. with complaints of facial numbness. Full workup led to diagnosis of Bell's Palsy. Initiated Acyclovir and Prednisone and discharged to home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
CT scan - negative for stroke (2/27)
Aktuelle Erkrankungen
-
Vorgeschichte
Allergic Rhinitis, Obesity
Andere Medikamente
Meclizine, Hyoscamine, Loestrin 24 FE, Fluticasone, Claritin
Allergien
NKA
Vorherige Impfungen
-